Clustering O 0 5.2885309287376e-07
of O 0 6.032230999153398e-07
missense O 0 2.4885102902771905e-06
mutations O 0 3.480403520939035e-08
in O 0 9.777350484796443e-09
the O 0 2.351342573092552e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 2.191922703786986e-06
in O 0 1.8705331683577242e-07
a O 0 9.823132529618306e-08
sporadic B-Disease 0 0.0009163390495814383
T I-Disease 1 0.9999608993530273
- I-Disease 0 0.28246742486953735
cell I-Disease 0 0.09843574464321136
leukaemia I-Disease 1 0.9996514320373535
. O 0 5.801471161248628e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999921321868896
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.159610238005598e-09
is O 0 1.8257734213378285e-10
a O 0 7.664613388413954e-10
recessive B-Disease 0 1.893015223686234e-06
multi I-Disease 1 0.9970377683639526
- I-Disease 1 0.9994753003120422
system I-Disease 1 0.9998623132705688
disorder I-Disease 1 0.9979198575019836
caused O 0 1.916770298038273e-09
by O 0 8.522041579361872e-12
mutations O 0 1.3248815933231128e-10
in O 0 1.3278592114751575e-10
the O 0 5.756351506569501e-10
ATM O 0 8.689047348298118e-08
gene O 0 3.599679665455824e-09
at O 0 1.5627207972102042e-07
11q22 O 0 1.346363518450744e-07
- O 0 1.3806986665088061e-08
q23 O 0 3.149762761722741e-08
( O 0 9.69576419151963e-10
ref O 0 1.610601962909186e-08
. O 0 2.4529792086447344e-10
3 O 0 3.424987937705737e-08
) O 0 5.773441724699069e-09
. O 0 7.789435585436877e-08

The O 0 2.2600258375859994e-07
risk O 0 6.773349809918727e-07
of O 0 6.276225121837342e-07
cancer B-Disease 0 1.7073591152438894e-05
, O 0 3.5005274234833905e-09
especially O 0 1.050223819021312e-08
lymphoid B-Disease 0 3.918160018656636e-06
neoplasias I-Disease 0 3.858261334244162e-05
, O 0 5.829773885857037e-10
is O 0 3.025651257315687e-11
substantially O 0 1.2758023526515672e-09
elevated O 0 2.868795263566426e-07
in O 0 3.588220209849169e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.972065527108498e-06
and O 0 5.42145395243665e-09
has O 0 2.3927762549114107e-10
long O 0 2.3494236070509267e-11
been O 0 4.243071172194135e-12
associated O 0 2.356030093242367e-10
with O 0 1.2186428532956484e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 0.00031145973480306566

By O 0 5.041672856975765e-09
analysing O 0 7.536672228525276e-07
tumour B-Disease 1 0.9997773766517639
DNA O 0 4.901709615978689e-08
from O 0 1.7362613569105179e-09
patients O 0 1.3241968632726753e-10
with O 0 9.126095018574532e-11
sporadic B-Disease 0 1.8498516283216304e-06
T I-Disease 0 0.0004526840057224035
- I-Disease 0 9.168412361759692e-06
cell I-Disease 0 7.766848284518346e-06
prolymphocytic I-Disease 0 0.0003357429523020983
leukaemia I-Disease 1 0.9986745119094849
( O 0 1.6237628130966186e-07
T B-Disease 0 8.595912731834687e-06
- I-Disease 0 3.9638970861233247e-07
PLL I-Disease 0 6.581468028343807e-07
) O 0 1.4373692514002556e-10
, O 0 2.449620888078652e-11
a O 0 1.0059136856810369e-10
rare O 0 5.044488715633122e-10
clonal B-Disease 0 1.4046313445703618e-08
malignancy I-Disease 0 9.34450454792568e-08
with O 0 1.7786284944865116e-10
similarities O 0 2.85056978022169e-09
to O 0 1.0194248778461201e-09
a O 0 1.3018298439249065e-08
mature B-Disease 0 5.701373595456971e-08
T I-Disease 0 2.00957219931297e-05
- I-Disease 0 3.8354755815817043e-07
cell I-Disease 0 1.9891622571321932e-07
leukaemia I-Disease 0 1.974850874830736e-06
seen O 0 1.0241866910121189e-08
in O 0 1.0767832847591308e-08
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9997175335884094
T I-Disease 1 0.9999998807907104
, O 0 1.9724955002686784e-09
we O 0 1.202429406044203e-10
demonstrate O 0 2.427417988837277e-10
a O 0 3.925833269580181e-11
high O 0 1.9742373014164372e-10
frequency O 0 9.79046510529713e-10
of O 0 1.8110892785472288e-09
ATM O 0 1.7771982641079376e-07
mutations O 0 1.4377738111193139e-08
in O 0 3.682024285467378e-08
T B-Disease 0 0.0001550960587337613
- I-Disease 0 1.8656315660336986e-05
PLL I-Disease 0 0.00019233823695685714
. O 0 1.49409527239186e-06

In O 0 5.43410791919996e-08
marked O 0 1.7474784286264367e-08
contrast O 0 3.6100344935618978e-09
to O 0 1.6375058253803587e-10
the O 0 4.02779726238478e-10
ATM O 0 9.880029239184296e-08
mutation O 0 4.156564814561392e-10
pattern O 0 2.2544885069919474e-08
in O 0 6.116540163247919e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999959468841553
T I-Disease 1 1.0
, O 0 1.094488721875564e-09
the O 0 9.293071867588765e-11
most O 0 1.1006108351085953e-11
frequent O 0 6.378162754894223e-12
nucleotide O 0 3.7690333493101136e-11
changes O 0 4.466866113106427e-11
in O 0 7.380492744735179e-11
this O 0 2.051785824574992e-10
leukaemia B-Disease 0 1.920473550853785e-05
were O 0 2.4009160881632852e-08
missense O 0 1.9125479866488604e-06
mutations O 0 2.4860523240022303e-07
. O 0 6.328575636871392e-07

These O 0 6.696543319861803e-09
clustered O 0 4.6123421526544917e-08
in O 0 9.196273187406234e-10
the O 0 4.2404862954370515e-10
region O 0 8.946256513375772e-10
corresponding O 0 1.4310646001547411e-09
to O 0 4.448723889272088e-10
the O 0 2.082726879848451e-09
kinase O 0 7.2147998686489245e-09
domain O 0 2.5063243924705603e-08
, O 0 8.242573845684831e-10
which O 0 7.549538078022167e-11
is O 0 3.907836207406312e-11
highly O 0 5.50052836612025e-10
conserved O 0 2.3589497022413752e-09
in O 0 6.54770571095753e-10
ATM O 0 1.313936337510313e-07
- O 0 1.0666159511174556e-08
related O 0 1.063864440986606e-09
proteins O 0 1.0382288778698623e-10
in O 0 4.757169658198279e-10
mouse O 0 2.7678883629533857e-09
, O 0 4.3562420337650565e-10
yeast O 0 1.7447208122689517e-08
and O 0 6.560672893840547e-09
Drosophila O 0 3.411037141631823e-07
. O 0 1.4536962567035516e-07

The O 0 9.693128077969959e-08
resulting O 0 8.567104714529705e-08
amino O 0 1.962243487696469e-07
- O 0 7.143353286664933e-08
acid O 0 8.826885000701168e-09
substitutions O 0 9.03775987382005e-09
are O 0 1.2449220820887064e-10
predicted O 0 1.1236010344362057e-08
to O 0 9.20090503786497e-10
interfere O 0 8.518190242057244e-08
with O 0 2.1401846961310866e-09
ATP O 0 1.1679901490424527e-06
binding O 0 4.523045049609209e-08
or O 0 6.494277116075864e-09
substrate O 0 8.898292236381167e-08
recognition O 0 2.389691644566483e-07
. O 0 9.651026857682155e-07

Two O 0 5.084000065380678e-08
of O 0 1.789926074025061e-07
seventeen O 0 9.415514057309338e-08
mutated O 0 1.2447428865414167e-08
T B-Disease 0 5.447390094559523e-07
- I-Disease 0 3.811562265809698e-08
PLL I-Disease 0 1.28807783994489e-07
samples O 0 1.2525610548763666e-09
had O 0 7.080487307575822e-10
a O 0 1.434876661932094e-10
previously O 0 1.9601267275959344e-09
reported O 0 1.6157898130586545e-08
A B-Disease 1 0.9999938011169434
- I-Disease 1 0.9811334013938904
T I-Disease 1 0.9999992847442627
allele O 0 1.3549475852414616e-06
. O 0 5.853255515830824e-07

In O 0 5.398580071869219e-08
contrast O 0 1.3064912707250187e-08
, O 0 3.736895237693716e-10
no O 0 1.808130450919876e-10
mutations O 0 4.1303405140524774e-11
were O 0 4.0087190511517434e-11
detected O 0 3.219328970072155e-10
in O 0 3.423741498642663e-11
the O 0 2.097036017056908e-10
p53 O 0 3.898837086513396e-10
gene O 0 6.4029648250141236e-09
, O 0 1.452334030815905e-09
suggesting O 0 3.1436151459729444e-09
that O 0 3.6899983069105247e-11
this O 0 3.229266853921331e-10
tumour B-Disease 1 0.9999995231628418
suppressor O 0 4.025216185254976e-06
is O 0 2.7723370266130587e-09
not O 0 1.3774775764474612e-10
frequently O 0 6.44771458446769e-11
altered O 0 3.476054444284671e-10
in O 0 1.5141679576835543e-10
this O 0 3.083575061957333e-10
leukaemia B-Disease 0 1.152722143160645e-05
. O 0 2.386576056778722e-07

Occasional O 0 8.840771101858991e-07
missense O 0 6.869458957226016e-07
mutations O 0 5.238401712404084e-09
in O 0 2.6148421206073635e-09
ATM O 0 4.0581033999842475e-07
were O 0 2.94185320548479e-09
also O 0 7.797837375811412e-11
found O 0 8.137641949179653e-11
in O 0 1.6129460267411133e-10
tumour B-Disease 1 0.9999444484710693
DNA O 0 1.541144456496113e-08
from O 0 1.2382681546796448e-09
patients O 0 6.212212688705421e-11
with O 0 3.200848613937879e-11
B B-Disease 0 2.190833583881613e-05
- I-Disease 0 6.6427105593902525e-06
cell I-Disease 0 0.0001337815629085526
non I-Disease 1 0.9987567663192749
- I-Disease 1 0.999717652797699
Hodgkins I-Disease 1 0.9999997615814209
lymphomas I-Disease 0 7.297316915355623e-05
( O 0 5.96462390589636e-09
B B-Disease 0 2.054431860187833e-07
- I-Disease 0 1.8964709802560265e-09
NHL I-Disease 0 1.7312357769583286e-08
) O 0 7.704785420781235e-11
and O 0 8.288746772278088e-11
a O 0 5.930972379886157e-10
B B-Disease 0 7.041866183499224e-07
- I-Disease 0 6.751076142563761e-08
NHL I-Disease 0 1.341169877377979e-06
cell O 0 7.794830708007794e-06
line O 0 1.0528190159675432e-06
. O 0 8.884589419722033e-08

The O 0 2.0252862498182367e-08
evidence O 0 2.2032718760556236e-08
of O 0 2.7401638735824463e-09
a O 0 4.1573952613838117e-11
significant O 0 1.4473660117642062e-11
proportion O 0 2.3274537852557842e-10
of O 0 1.555740247738413e-08
loss O 0 3.455677699548687e-08
- O 0 2.153251266179268e-08
of O 0 1.0868405553310367e-07
- O 0 1.1454692305790104e-08
function O 0 7.308803784411566e-09
mutations O 0 3.22817078624027e-10
and O 0 2.3235505186569583e-10
a O 0 2.63356031426909e-10
complete O 0 2.5941271353246975e-09
absence O 0 1.05318093801543e-07
of O 0 2.0071965423085203e-08
the O 0 7.75485786697061e-10
normal O 0 5.972455863201276e-09
copy O 0 7.1844796778464115e-09
of O 0 3.0355791214020655e-09
ATM O 0 2.6185968948766458e-08
in O 0 2.5649257717752505e-10
the O 0 2.1571708308520954e-10
majority O 0 1.5617859783212396e-10
of O 0 9.797417988011148e-09
mutated O 0 1.6045208894865937e-07
tumours B-Disease 1 0.9999971389770508
establishes O 0 3.636380370153347e-07
somatic O 0 7.882908192868854e-08
inactivation O 0 2.7662386514748505e-07
of O 0 1.192622711698732e-08
this O 0 3.487235847310366e-11
gene O 0 2.66396377179845e-10
in O 0 1.9805811157791453e-10
the O 0 2.329382242649558e-09
pathogenesis O 0 7.449552413163474e-06
of O 0 7.142494382605946e-07
sporadic B-Disease 0 0.0005823543760925531
T I-Disease 0 0.2979212999343872
- I-Disease 0 8.400891601922922e-06
PLL I-Disease 0 6.352475793391932e-06
and O 0 1.2242178382138036e-09
suggests O 0 1.1335798966172206e-09
that O 0 2.3297488938034405e-11
ATM O 0 3.240295853856878e-08
acts O 0 4.189375069074686e-09
as O 0 2.3273662996814437e-09
a O 0 2.718934410950169e-08
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.00026659603463485837
. O 0 7.484693924197927e-06

As O 0 4.9083332953614445e-08
constitutional O 0 7.22871448033402e-07
DNA O 0 4.5497380085635086e-08
was O 0 1.4206492870982856e-08
not O 0 1.2120490375244763e-11
available O 0 7.949331470857857e-11
, O 0 4.378255744064141e-11
a O 0 9.421181612623286e-10
putative O 0 9.64920729984442e-08
hereditary O 1 0.9937426447868347
predisposition O 0 0.0009267008863389492
to O 0 1.3110067811794579e-05
T B-Disease 1 0.9999963045120239
- I-Disease 0 0.1846245974302292
PLL I-Disease 0 0.00017852644668892026
will O 0 4.1948280404824345e-09
require O 0 1.1025828028365936e-09
further O 0 3.1522237597947367e-10
investigation O 0 3.46858564093111e-09
. O 0 3.9538952667506067e-10
. O 0 7.75807240671611e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 5.314653753885068e-05
kinase O 0 1.0881448133659433e-06
is O 0 7.568602411467396e-10
involved O 0 5.896210186762119e-10
in O 0 3.639719081682813e-11
the O 0 1.898430718183519e-11
modulation O 0 1.8749592989308894e-09
of O 0 1.280556327643012e-09
the O 0 2.505083918080686e-10
Ca2 O 0 8.354163583135232e-09
+ O 0 2.811843273775594e-07
homeostasis O 0 6.279217632254586e-05
in O 0 1.2158154731878312e-06
skeletal O 1 0.9998021721839905
muscle O 0 0.0030291005969047546
cells O 0 2.958854793178034e-06
. O 0 9.500259920969256e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999308705329895
DM B-Disease 1 1.0
) O 0 1.8655853750715323e-08
, O 0 9.537923228997158e-11
the O 0 3.2837246810579757e-11
most O 0 1.6389618828771546e-10
prevalent O 0 5.524273365153931e-05
muscular B-Disease 1 0.9999606609344482
disorder I-Disease 1 0.9998996257781982
in O 0 7.475968288872537e-08
adults O 0 8.691992903209211e-09
, O 0 6.827858417546295e-11
is O 0 2.647318128601306e-11
caused O 0 2.0060463012949725e-10
by O 0 1.5961716670620518e-10
( O 0 6.666947549582858e-10
CTG O 0 1.6127791013786918e-07
) O 0 3.4463468190359947e-10
n O 0 9.395310307525051e-09
- O 0 7.729222817332015e-10
repeat O 0 2.59712584771421e-10
expansion O 0 4.5890660715919296e-10
in O 0 1.2234352420037453e-10
a O 0 4.53001455791302e-11
gene O 0 2.6016463289257885e-11
encoding O 0 1.4423958694109729e-09
a O 0 1.6092201349238167e-08
protein O 0 1.2834500751068845e-07
kinase O 0 3.549147322701174e-07
( O 0 2.310871138888615e-07
DM B-Disease 1 0.999998927116394
protein O 0 8.084131877694745e-06
kinase O 0 3.7272965869306063e-07
; O 0 5.15003195644681e-09
DMPK O 0 2.715884647841449e-06
) O 0 8.453973632249756e-10
and O 0 1.3214039584763526e-10
involves O 0 4.908122797075976e-10
changes O 0 4.55040172209209e-10
in O 0 1.9578436649680953e-09
cytoarchitecture O 0 1.3036880091021885e-06
and O 0 2.0115502152862064e-08
ion O 0 0.061970055103302
homeostasis O 1 0.7993456125259399
. O 0 1.1738465218513738e-05

To O 0 3.318618269076978e-08
obtain O 0 1.0812496498147084e-07
clues O 0 8.602735590557131e-08
to O 0 6.626897919304042e-10
the O 0 1.3576727520003828e-09
normal O 0 6.308269462351745e-08
biological O 0 2.12814086353319e-08
role O 0 6.9616166165076265e-09
of O 0 2.929156117659204e-08
DMPK O 0 3.4935303574457066e-06
in O 0 1.2361685897133157e-08
cellular O 0 5.931566420258605e-07
ion O 0 2.0841838704654947e-05
homeostasis O 0 3.385773379704915e-05
, O 0 5.398999469719001e-09
we O 0 5.486717746805425e-10
have O 0 1.2810925063833078e-11
compared O 0 5.34789296180449e-11
the O 0 1.2650382130718896e-10
resting O 0 7.516642419602704e-09
[ O 0 4.37814895448696e-10
Ca2 O 0 9.14517961358996e-10
+ O 0 1.2366686341636068e-08
] O 0 3.1555835278140876e-08
i O 0 6.906031302378324e-09
, O 0 9.094208719417907e-11
the O 0 3.9722385103413416e-11
amplitude O 0 4.2437875436007744e-10
and O 0 4.389484956068834e-11
shape O 0 1.9752175450804543e-09
of O 0 4.832529043596878e-09
depolarization O 0 9.53860723740263e-09
- O 0 2.9387477340492296e-08
induced O 0 1.576073671571976e-08
Ca2 O 0 3.883713350916196e-09
+ O 0 8.131835471658633e-08
transients O 0 4.1382213566976134e-07
, O 0 1.6562552718202284e-10
and O 0 1.6706365457697103e-11
the O 0 3.4338917126452984e-11
content O 0 2.6075494541366595e-10
of O 0 1.2802582327609002e-09
ATP O 0 1.7501376703421556e-07
- O 0 1.9739493595238855e-08
driven O 0 5.5744844296157225e-09
ion O 0 3.1911039855003764e-07
pumps O 0 5.368801225813513e-08
in O 0 3.743224841201709e-09
cultured O 0 3.2869257893253234e-07
skeletal O 0 0.00011511852062540129
muscle O 0 2.0024916125294112e-07
cells O 0 5.205553321729894e-09
of O 0 8.99559466915889e-08
wild O 0 3.696770112249226e-10
- O 0 1.429206197833821e-10
type O 0 6.727790546889878e-10
and O 0 1.631610263563843e-10
DMPK O 0 3.461080950728501e-07
[ O 0 1.0595434751792254e-08
- O 0 4.375415230128965e-08
/ O 0 1.2455224407403875e-07
- O 0 5.525560098362803e-08
] O 0 2.643704277716097e-08
knockout O 0 5.9604019043035805e-05
mice O 0 7.040308673822437e-07
. O 0 6.280907882683096e-08

In O 0 2.175982132257559e-07
vitro O 0 9.593857157597085e-07
- O 0 1.484294500642136e-07
differentiated O 0 4.567135647448595e-08
DMPK O 0 1.3240918633528054e-05
[ O 0 1.9412274809837982e-07
- O 0 2.1100500191550964e-07
/ O 0 2.3907765012154414e-07
- O 0 1.852829889514851e-08
] O 0 2.066117055221639e-09
myotubes O 0 1.2047584263541466e-08
exhibit O 0 5.200350705614198e-10
a O 0 1.1940508304331132e-10
higher O 0 3.7914590911292123e-10
resting O 0 5.7511964079992595e-09
[ O 0 4.044625745436292e-10
Ca2 O 0 7.765958986993837e-10
+ O 0 6.691410536774356e-09
] O 0 2.5011619442238953e-08
i O 0 1.037141306170497e-08
than O 0 2.0656390486983867e-10
do O 0 6.703514132677668e-11
wild O 0 9.3870439199506e-11
- O 0 1.3066295267982753e-10
type O 0 4.638106565479916e-10
myotubes O 0 1.2462299636695207e-08
because O 0 1.2102062407759462e-10
of O 0 6.044041378494569e-10
an O 0 9.871345928169628e-12
altered O 0 1.2506054525296406e-10
open O 0 1.2607367372297063e-09
probability O 0 7.846808758316115e-10
of O 0 2.5738806641584233e-09
voltage O 0 5.7388394480994975e-08
- O 0 1.9327619504849736e-09
dependent O 0 9.172274051394425e-10
l O 0 2.8431199616818503e-09
- O 0 2.9437827175904374e-10
type O 0 2.577691671223903e-10
Ca2 O 0 5.507351796829596e-10
+ O 0 5.130726954405418e-09
and O 0 1.621562328857351e-09
Na O 0 7.064116971378098e-07
+ O 0 9.576747572737077e-08
channels O 0 5.141555448062718e-07
. O 0 2.1619391077365435e-07

The O 0 1.2490552592225868e-07
mutant O 0 7.504125676405238e-08
myotubes O 0 4.607906305409415e-07
exhibit O 0 3.734830666957123e-09
smaller O 0 5.910239520012794e-10
and O 0 1.1770240337938276e-10
slower O 0 1.3945186116970376e-09
Ca2 O 0 2.8318397626847513e-10
+ O 0 6.151892328887243e-10
responses O 0 4.1961843721960435e-11
upon O 0 3.4444280760936863e-10
triggering O 0 1.1807955724307817e-09
by O 0 1.102661625201895e-11
acetylcholine O 0 8.250977678869731e-09
or O 0 1.3459078296307325e-09
high O 0 1.2377045166545031e-08
external O 0 1.8708615812101925e-07
K O 0 1.5171405038927332e-06
+ O 0 5.665075946126308e-07
. O 0 1.1468950589232918e-07

In O 0 4.369319128727511e-08
addition O 0 4.0277452484360765e-09
, O 0 2.6968263733273545e-10
we O 0 4.782751278353814e-11
observed O 0 1.7217822653736725e-11
that O 0 3.6496424372228775e-13
these O 0 6.312056996873872e-13
Ca2 O 0 1.5280766929581802e-10
+ O 0 5.084540344313382e-09
transients O 0 6.586290623999957e-08
partially O 0 5.245821110833049e-09
result O 0 7.08194614063018e-10
from O 0 3.6622673643682546e-11
an O 0 2.48227978970339e-12
influx O 0 4.8710115801986476e-11
of O 0 3.871743758931956e-10
extracellular O 0 3.1256728316719773e-09
Ca2 O 0 2.637794649373859e-09
+ O 0 2.9257540834493057e-09
through O 0 2.564568279961321e-10
the O 0 4.675348441729454e-10
l O 0 2.9103759402460128e-09
- O 0 2.495227080512308e-10
type O 0 1.6886610165744997e-10
Ca2 O 0 2.497880791096918e-09
+ O 0 6.405410601928452e-08
channel O 0 6.656463824583625e-07
. O 0 1.1178896386354609e-07

Neither O 0 5.063233174951165e-07
the O 0 6.029893029335653e-09
content O 0 1.2302546759102029e-09
nor O 0 3.7099576188914796e-10
the O 0 7.756876738151952e-12
activity O 0 5.2631843328043715e-11
of O 0 3.8136527269472253e-10
Na O 0 2.2710615610321838e-08
+ O 0 6.904648408578851e-09
/ O 0 2.91528330365054e-08
K O 0 2.4762366379604828e-08
+ O 0 1.7661021090020768e-08
ATPase O 0 9.28419083834342e-08
and O 0 6.161712473584657e-09
sarcoplasmic O 0 5.397708946475177e-07
reticulum O 0 1.3396930853559752e-07
Ca2 O 0 1.2680790462127334e-07
+ O 0 6.531396934406075e-07
- O 0 1.831992051393172e-07
ATPase O 0 8.746246038526806e-08
are O 0 8.21377132975698e-11
affected O 0 8.894579517360057e-11
by O 0 1.6239415367991228e-10
DMPK O 0 2.1818324967171066e-05
absence O 0 3.5989994557894534e-06
. O 0 4.343941952811292e-07

In O 0 1.0078931467205621e-07
conclusion O 0 6.333103641509297e-08
, O 0 1.444824371255038e-09
our O 0 4.559402300152726e-10
data O 0 9.819265400778932e-10
suggest O 0 6.743580138746097e-10
that O 0 3.347698507294439e-11
DMPK O 0 2.0384985077726014e-07
is O 0 1.7624121606552023e-10
involved O 0 6.204164404444157e-10
in O 0 1.0917215742534125e-10
modulating O 0 1.1580348235895599e-08
the O 0 6.195224333538363e-10
initial O 0 1.9844682841441141e-10
events O 0 5.161237409678776e-11
of O 0 6.752229331219439e-10
excitation O 0 4.0983297822094755e-07
- O 0 4.26372650963458e-07
contraction O 0 7.072018348708298e-08
coupling O 0 1.051172091592889e-07
in O 0 2.2211622763279593e-08
skeletal O 0 0.000538723252248019
muscle O 0 3.0549103939847555e-06
. O 0 4.31928022237571e-08
. O 0 1.9239655557612423e-07

Constitutional O 0 0.00012468571367207915
RB1 O 0 0.00038586565642617643
- O 0 1.2862687981396448e-06
gene O 0 1.4463692465938038e-08
mutations O 0 8.122252204145752e-09
in O 0 1.6693640914056118e-09
patients O 0 1.998874399333772e-09
with O 0 5.663692848045798e-10
isolated O 0 7.980971531651448e-06
unilateral B-Disease 0 3.6678833566838875e-05
retinoblastoma I-Disease 1 0.9984948635101318
. O 0 2.0094956198590808e-05

In O 0 9.252600108311526e-08
most O 0 2.990564018645614e-09
patients O 0 6.555703757626929e-10
with O 0 2.184989689180128e-10
isolated O 0 2.440866353481397e-07
unilateral B-Disease 0 8.978698815553798e-07
retinoblastoma I-Disease 1 0.9309343099594116
, O 0 4.475270376502749e-09
tumor B-Disease 0 1.1885804340749928e-08
development O 0 2.2284514233916752e-09
is O 0 6.047647105322795e-11
initiated O 0 5.615460318963983e-10
by O 0 2.0621620730465473e-11
somatic O 0 1.9593864308831144e-09
inactivation O 0 3.93747008331502e-08
of O 0 3.6551530691042444e-09
both O 0 3.3215086236992875e-10
alleles O 0 7.67743035812174e-10
of O 0 9.313825266588083e-09
the O 0 2.3900145862398858e-08
RB1 O 0 9.711069651530124e-06
gene O 0 3.7050898527013487e-07
. O 0 5.934576847721473e-07

However O 0 2.9070319484958418e-08
, O 0 4.817710119731089e-10
some O 0 1.342931928854929e-11
of O 0 2.5501498135405143e-10
these O 0 2.649035504842523e-11
patients O 0 1.8203351326295802e-10
can O 0 1.6497823940309075e-10
transmit O 0 9.824574931371899e-08
retinoblastoma B-Disease 0 0.00013245485024526715
predisposition O 0 1.0985372682625894e-06
to O 0 4.514114415599124e-09
their O 0 6.253495499208839e-09
offspring O 0 4.190543734239327e-08
. O 0 1.2481919497986382e-07

To O 0 3.691036809527759e-09
determine O 0 2.8225768389233963e-09
the O 0 1.0955805707091315e-10
frequency O 0 2.5568087647087623e-09
and O 0 1.4582170540511363e-11
nature O 0 1.1271974326154677e-10
of O 0 6.000381302939672e-10
constitutional O 0 1.9698278208579723e-07
RB1 O 0 1.6232438611041289e-06
- O 0 1.4375407531019846e-08
gene O 0 9.748241103224586e-10
mutations O 0 5.207487774328001e-10
in O 0 3.1931671196083755e-10
patients O 0 3.2689970175248106e-10
with O 0 1.1240072067542073e-10
isolated O 0 5.605674857633858e-08
unilateral B-Disease 0 9.830629466023311e-08
retinoblastoma I-Disease 0 2.3057862563291565e-05
, O 0 5.54014945031156e-10
we O 0 6.53876675027476e-11
analyzed O 0 4.5123557668169667e-10
DNA O 0 4.2097184071998583e-10
from O 0 1.3226469919302986e-10
peripheral O 0 7.839007309939916e-08
blood O 0 2.3740627241863876e-08
and O 0 3.123890701672849e-09
from O 0 6.993680301548011e-08
tumor B-Disease 0 1.0471401765244082e-05
tissue O 0 3.560208642738871e-05
. O 0 6.901925644342555e-06

The O 0 1.6738603392241203e-08
analysis O 0 2.1646496151106476e-08
of O 0 5.073276909683955e-08
tumors B-Disease 1 0.9999985694885254
from O 0 2.8224814485611205e-08
54 O 0 8.51713508609464e-08
( O 0 4.990265978221942e-10
71 O 0 1.7138688690465642e-08
% O 0 6.120409179466435e-10
) O 0 1.0593464994101964e-10
of O 0 1.6372418087939877e-08
76 O 0 1.1226647984585725e-06
informative O 0 7.42479571158583e-08
patients O 0 9.718875482178646e-09
showed O 0 7.911283184114382e-09
loss O 0 9.502723941068325e-09
of O 0 1.1377788666777633e-07
constitutional O 0 2.020306419581175e-05
heterozygosity O 0 0.0031932475976645947
( O 0 5.977792056910403e-07
LOH O 0 0.11948996782302856
) O 0 4.545892995366785e-09
at O 0 5.126924520482135e-07
intragenic O 0 2.9195682600402506e-06
loci O 0 8.495311476508505e-07
. O 0 6.892952910675376e-07

Three O 0 2.1458713916899796e-08
of O 0 4.811598586229593e-08
13 O 0 2.643500636168028e-07
uninformative O 0 7.411834667436779e-05
patients O 0 1.7582462419341027e-07
had O 0 3.4132749959780995e-08
constitutional O 0 3.3769970286812168e-06
deletions O 0 1.775740770426637e-06
. O 0 2.6267812813784985e-07

For O 0 3.020673489118053e-08
39 O 0 5.4329056808910536e-08
randomly O 0 2.583392610944202e-09
selected O 0 5.004406844477671e-08
tumors B-Disease 1 1.0
, O 0 2.3620350120268085e-08
SSCP O 0 4.984265615348704e-05
, O 0 4.864120839442876e-08
hetero O 0 6.269635832722997e-06
- O 0 2.225046280557308e-08
duplex O 0 3.8951102965256723e-07
analysis O 0 1.2995218234834738e-09
, O 0 1.2278154187805868e-11
sequencing O 0 5.092426133557204e-11
, O 0 1.8780641972138135e-11
and O 0 2.359887806002714e-11
Southern O 0 1.402954419305047e-09
blot O 0 9.955236635050824e-09
analysis O 0 6.272581898336682e-10
were O 0 1.9187371136375475e-10
used O 0 1.878211891570558e-10
to O 0 6.419173526062139e-11
identify O 0 1.8785934585707764e-08
mutations O 0 5.12348378833849e-07
. O 0 1.287952841266815e-06

Mutations O 0 1.025835132395514e-07
were O 0 4.414526522111828e-09
detected O 0 3.1038756009849067e-09
in O 0 1.2130187132530779e-10
21 O 0 2.8504500981796355e-09
( O 0 9.124215272215963e-11
91 O 0 4.2357517493485375e-09
% O 0 4.3762957147031045e-10
) O 0 3.873701359680126e-10
of O 0 2.1111148384989065e-07
23 O 1 0.9663040041923523
tumors B-Disease 1 1.0
with O 1 0.702532172203064
LOH O 1 1.0
. O 0 0.00017452087195124477

In O 0 6.797980489636757e-08
6 O 0 1.869666448328644e-07
( O 0 8.386280003769286e-10
38 O 0 5.881005460395272e-09
% O 0 1.0971740876941638e-10
) O 0 7.236844457025882e-11
of O 0 2.1712242670446358e-08
16 O 0 0.0003599584160838276
tumors B-Disease 1 1.0
without O 0 0.17074257135391235
LOH O 1 0.9999929666519165
, O 0 4.826063104701461e-09
one O 0 1.1525556203872966e-10
mutation O 0 2.9966591708063817e-11
was O 0 8.346593971531036e-10
detected O 0 1.2566794271862136e-09
, O 0 1.1844213977652007e-11
and O 0 8.275694365900144e-12
in O 0 9.478277190888562e-11
9 O 0 1.1230183005750405e-08
( O 0 1.3575245094710198e-10
56 O 0 2.449235481094547e-09
% O 0 1.71712921659406e-10
) O 0 1.3393054720811648e-10
of O 0 2.7509738487196955e-08
the O 0 1.7687250419839984e-06
tumors B-Disease 1 1.0
without O 0 0.24726295471191406
LOH O 1 0.9999995231628418
, O 0 1.0198902167246615e-08
both O 0 4.78155159910898e-09
mutations O 0 1.340364796931226e-08
were O 0 2.0190995542179735e-08
found O 0 2.1977777819870425e-08
. O 0 6.345122471884679e-08

Thus O 0 8.805768914044165e-08
, O 0 5.789273505030224e-10
a O 0 6.767672533491975e-11
total O 0 2.5508199719137536e-11
of O 0 9.343338325251693e-10
45 O 0 4.2972694846987736e-10
mutations O 0 5.5007980809262946e-11
were O 0 7.025624526590946e-11
identified O 0 5.171724715147263e-10
in O 0 6.758236192894174e-09
tumors B-Disease 1 1.0
of O 0 0.0027704054955393076
36 O 0 0.0030155787244439125
patients O 0 4.2767529521370307e-05
. O 0 6.203996690601343e-06

Thirty O 0 3.6748162983712973e-06
- O 0 3.916609969678575e-08
nine O 0 1.7523806850050505e-09
of O 0 3.354923283627187e-10
the O 0 1.0778918035914131e-10
mutations O 0 3.4330076975619406e-11
- O 0 1.901076657206957e-10
including O 0 1.0790519866521464e-10
34 O 0 1.241664993045788e-08
small O 0 1.9189871913738443e-09
mutations O 0 4.3036694208353765e-09
, O 0 4.633943895271386e-09
2 O 0 6.085116410758928e-07
large O 0 1.1335501426401606e-08
structural O 0 0.00011225924390600994
alterations O 0 2.7593732738750987e-05
, O 0 9.084561547467729e-09
and O 0 6.915152894748644e-09
hypermethylation O 0 0.12569458782672882
in O 0 1.0802579708979465e-05
3 O 1 0.9978439807891846
tumors O 1 1.0
- O 0 2.342244670217042e-06
were O 0 4.518110774398565e-09
not O 0 1.353771868911613e-11
detected O 0 1.3792653130728638e-10
in O 0 7.161142338840687e-12
the O 0 2.5737110359580484e-11
corresponding O 0 2.9077402707855526e-09
peripheral O 0 1.9953897663071984e-06
blood O 0 7.58407168177655e-08
DNA O 0 1.1593611759508349e-07
. O 0 9.261339783961375e-08

In O 0 9.60389243687132e-08
6 O 0 4.686924910402013e-07
( O 0 1.2277792116321962e-09
17 O 0 8.497416104091826e-09
% O 0 1.450268377611863e-10
) O 0 2.932226336738175e-11
of O 0 4.838116018923699e-10
the O 0 2.24558660555374e-09
36 O 0 8.404527562788644e-08
patients O 0 1.0098936131797132e-09
, O 0 5.093504437669871e-11
a O 0 9.944143425366647e-11
mutation O 0 1.5212827525479256e-11
was O 0 1.6409490433133556e-09
detected O 0 1.8068834206630413e-09
in O 0 1.7400961227487244e-10
constitutional O 0 1.2116001535389387e-08
DNA O 0 1.599061438817273e-09
, O 0 4.0890079516797684e-11
and O 0 1.765853435697906e-11
1 O 0 2.6438289335573018e-09
of O 0 6.512221317755973e-10
these O 0 1.3640279877824568e-11
mutations O 0 1.1751981332519534e-10
is O 0 6.157688248187299e-11
known O 0 2.2726191761801573e-10
to O 0 1.00446997941539e-10
be O 0 7.766610687909292e-10
associated O 0 2.725663783564869e-08
with O 0 2.60703370003057e-09
reduced O 0 1.1713633512044908e-06
expressivity O 0 0.00016341499576810747
. O 0 2.393236400166643e-06

The O 0 2.145715960466532e-08
presence O 0 5.2388617888254885e-09
of O 0 8.488020064589819e-09
a O 0 7.568891069453798e-10
constitutional O 0 1.529098803132456e-08
mutation O 0 1.4066298126280685e-10
was O 0 1.4016197091848426e-09
not O 0 1.0127782293367638e-11
associated O 0 5.914476547408398e-11
with O 0 2.1626890816389688e-12
an O 0 5.296140696137153e-12
early O 0 4.238992268312813e-09
age O 0 6.380182071552554e-08
at O 0 6.508421961370914e-07
treatment O 0 5.94362154515693e-06
. O 0 3.7689747500735393e-07

In O 0 5.517987347047892e-07
1 O 0 5.819652869831771e-06
patient O 0 3.013521165939892e-07
, O 0 4.014385268646947e-09
somatic O 0 2.0649152077112376e-07
mosaicism O 0 1.4157326404529158e-05
was O 0 3.1863926608366455e-08
demonstrated O 0 6.543236508171901e-10
by O 0 3.0320561599656015e-12
molecular O 0 2.80876794045426e-10
analysis O 0 6.593646462160763e-11
of O 0 1.9028470465976e-10
DNA O 0 4.661955821383401e-10
and O 0 1.6287714232898765e-10
RNA O 0 1.710694341738872e-08
from O 0 1.0579966236434757e-08
peripheral O 0 4.914647797704674e-05
blood O 0 8.798800990916789e-06
. O 0 1.024120138026774e-06

In O 0 3.064499765059736e-07
2 O 0 3.2451378046971513e-06
patients O 0 5.383092194222172e-09
without O 0 1.7822323616911717e-09
a O 0 4.0995212780003953e-10
detectable O 0 8.412160923398915e-08
mutation O 0 1.4710128670714084e-09
in O 0 1.103778068944905e-09
peripheral O 0 2.381424792474718e-06
blood O 0 4.08794278428104e-07
, O 0 1.4635803680107529e-08
mosaicism O 0 3.3362572139594704e-05
was O 0 1.3844477564362023e-07
suggested O 0 1.1084580364695285e-08
because O 0 1.567629498433476e-10
1 O 0 7.080869224296293e-09
of O 0 9.174950799106796e-10
the O 0 9.146975954443803e-10
patients O 0 5.755764931336671e-08
showed O 0 3.995888164354255e-06
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 1.87939875218035e-07
the O 0 2.965832912593669e-08
other O 0 7.812043234523003e-10
later O 0 1.8870940365900424e-08
developed O 0 8.31775608389762e-08
bilateral B-Disease 0 0.11698650568723679
retinoblastoma I-Disease 0 0.06786323338747025
. O 0 1.0192279660259373e-06

In O 0 1.6668552405008086e-07
conclusion O 0 2.4589266445218527e-07
, O 0 2.8589388634259194e-09
our O 0 5.297379201962826e-10
results O 0 5.076939979531403e-10
emphasize O 0 6.028578747319102e-10
that O 0 7.361326825883197e-12
the O 0 5.238207090307867e-11
manifestation O 0 5.687468274118146e-09
and O 0 2.61984323124409e-10
transmissibility O 0 4.888675562142453e-07
of O 0 3.409794047115611e-08
retinoblastoma B-Disease 0 2.986558627071645e-07
depend O 0 1.8099358678469457e-09
on O 0 7.813522273636408e-09
the O 0 3.2012531514524767e-10
nature O 0 1.3032054324568776e-09
of O 0 7.408746949266742e-10
the O 0 7.579910310528959e-11
first O 0 9.423603564151506e-11
mutation O 0 8.410331459041132e-12
, O 0 1.0912004806684639e-11
its O 0 1.843970072121226e-12
time O 0 7.558326881040855e-11
in O 0 4.196680850054868e-11
development O 0 2.451033542794079e-10
, O 0 5.735197733391928e-11
and O 0 1.0874958919493416e-11
the O 0 3.8374376593042214e-11
number O 0 2.5193330061012986e-11
and O 0 1.874689119218953e-11
types O 0 3.369347023607361e-09
of O 0 3.854476915421401e-08
cells O 0 4.178838663992934e-10
that O 0 1.5943999592815672e-11
are O 0 3.268076998255709e-12
affected O 0 2.4118361821590106e-11
. O 0 1.8081063035690903e-10
. O 0 1.3347623450954416e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9944421648979187
the I-Disease 0 1.055183747666888e-05
fifth I-Disease 0 1.4240723658076604e-06
component I-Disease 0 3.2074302680484834e-07
of I-Disease 0 6.140432873280588e-08
complement I-Disease 0 3.378261226316681e-08
in O 0 1.1984460002167907e-07
man O 0 1.2400138075463474e-05
. O 0 4.5139918825043424e-07

I O 0 0.0011236740974709392
. O 0 9.150121513812337e-06

Clinical O 0 7.794928023940884e-06
, O 0 1.7866884860495702e-08
immunochemical O 0 4.513377461989876e-06
, O 0 3.594534003781291e-09
and O 0 1.4868433151349336e-09
family O 0 4.669807207591248e-09
studies O 0 2.039108437656978e-08
. O 0 3.112170432473249e-08

The O 0 1.4376614565492218e-08
first O 0 1.0737064570776056e-09
recognized O 0 1.7129005991378676e-09
human O 0 1.3320410552353223e-08
kindred O 0 3.1001966362964595e-06
with O 0 4.417308474558013e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999717473983765
the I-Disease 0 0.00016681668057572097
fifth I-Disease 0 3.727310968315578e-06
component I-Disease 0 8.126065722535714e-07
of I-Disease 0 1.5172591929513146e-06
complement I-Disease 0 1.2952732504345477e-06
( O 0 4.6419521027019073e-07
C5 O 0 4.183714554528706e-05
) O 0 9.976145243228984e-09
is O 0 3.326328545938395e-09
described O 0 5.2582553422553246e-08
. O 0 7.551191316679251e-08

The O 0 2.1481528733602318e-07
proband O 0 3.934012966055889e-06
, O 0 5.884439158165833e-09
a O 0 3.746452925668109e-09
20 O 0 1.3784092978141871e-08
- O 0 2.339775262427679e-09
year O 0 8.876755441811213e-10
- O 0 3.3783191355496456e-08
old O 0 7.97885775227769e-08
black O 0 3.492644617963947e-09
female O 0 3.943533499750629e-09
with O 0 4.893648224424396e-07
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.993599534034729
age O 1 0.8445588946342468
11 O 0 1.2003026768070413e-06
, O 0 3.060350639572107e-09
lacked O 0 3.7875099678785773e-07
serum O 0 9.551864366130758e-08
hemolytic O 0 1.1159345376654528e-06
complement O 0 4.202590275781404e-08
activity O 0 1.4268412940054986e-07
, O 0 8.107668425516579e-10
even O 0 4.846317236406605e-10
during O 0 3.295274098036316e-08
remission O 0 1.9861484190641931e-07
. O 0 4.856852697798786e-08

C5 O 0 0.001597886672243476
was O 0 6.290766123129288e-06
undetectable O 0 1.0675403245841153e-05
in O 0 5.992172535940199e-09
her O 0 7.301819149319044e-10
serum O 0 8.074396151691587e-10
by O 0 2.181399158529551e-11
both O 0 7.151335634780764e-10
immunodiffusion O 0 4.506146638050268e-07
and O 0 2.5121201119304715e-08
hemolytic O 0 0.001144808134995401
assays O 0 4.075819106219569e-06
. O 0 2.1027110506111057e-06

Other O 0 7.392348955193029e-09
complement O 0 6.708419597600823e-09
components O 0 1.3953352606677072e-07
were O 0 9.304675918642147e-10
normal O 0 5.246421519444766e-09
during O 0 1.916017344782972e-09
remission O 0 2.0236104347759465e-08
of O 0 1.1216653383883113e-08
lupus O 0 1.1764152674231809e-07
, O 0 3.6484941734471477e-09
but O 0 4.365659833638347e-09
C1 O 0 2.065684566332493e-05
, O 0 2.6834829469635224e-08
C4 O 0 0.0020506149157881737
, O 0 9.420720203934252e-09
C2 O 0 7.844673746149056e-07
, O 0 3.3401628130036443e-09
and O 0 4.015013210789675e-09
C3 O 0 0.00020975744700990617
levels O 0 5.254428288026247e-06
fell O 0 0.004599025472998619
during O 0 1.4019193486092263e-06
exacerbations O 0 0.00015077070565894246
. O 0 4.146517369463254e-07

A O 0 3.3410455216653645e-05
younger O 0 2.8226536414877046e-06
half O 0 3.831447088487039e-07
- O 0 1.2465478960166365e-07
sister O 0 1.1891910389749683e-07
, O 0 3.5666836151193593e-09
who O 0 2.88785950708359e-09
had O 0 1.0168716535474687e-08
no O 0 1.94415790133462e-08
underlying O 1 0.986748456954956
disease O 0 0.004726854618638754
, O 0 1.7285481379580858e-10
was O 0 9.03293528864424e-09
also O 0 6.820205511459676e-11
found O 0 1.7099324733926835e-10
to O 0 1.0026113966832284e-10
lack O 0 2.906692202486738e-07
immunochemically O 0 0.000168620579643175
detectable O 0 0.018800925463438034
C5 O 0 0.018815604969859123
. O 0 1.948899353010347e-06

By O 0 1.364906268008781e-07
hemolytic O 0 0.00015951978275552392
assay O 0 1.1224035461054882e-06
, O 0 3.4627436917844534e-08
she O 0 3.7142007247581432e-09
exhibited O 0 2.1941966465988116e-08
1 O 0 1.6531519975160336e-07
- O 0 5.764649646522457e-09
2 O 0 1.663986104460946e-08
% O 0 1.1422936208038692e-10
of O 0 1.2208507538247204e-09
the O 0 1.0082999990501662e-09
normal O 0 1.72146854993116e-07
serum O 0 2.3314370878324553e-08
C5 O 0 2.2407280653169437e-07
level O 0 1.563850204888695e-08
and O 0 7.780425609338337e-11
normal O 0 1.5442863654513417e-09
concentrations O 0 1.3319616520846012e-09
of O 0 4.45478653965381e-10
other O 0 8.89941592641108e-11
complement O 0 2.993703063225439e-09
components O 0 8.286322668027424e-07
. O 0 2.051446017503622e-07

C5 O 0 0.00014132224896457046
levels O 0 1.6835691951655463e-07
of O 0 1.7262896889747026e-08
other O 0 2.4944751819688804e-10
family O 0 9.774058645772854e-11
members O 0 1.1451485593116928e-11
were O 0 9.284407964660346e-11
either O 0 1.403853006065603e-10
normal O 0 1.1350083539696243e-08
or O 0 3.697729067386746e-10
approximately O 0 1.6943715874795373e-10
half O 0 1.2434704377284334e-09
- O 0 4.890647331556863e-10
normal O 0 2.0414383516964563e-09
, O 0 2.5051639582218677e-11
consistent O 0 3.4846045493530653e-10
with O 0 6.180822520462925e-11
autosomal O 0 8.16417653481949e-08
codominant O 0 2.525861120261652e-08
inheritance O 0 8.272613705173626e-09
of O 0 3.1079394613442446e-09
the O 0 2.5683390969533093e-09
gene O 0 2.2217474793251313e-07
determining O 0 0.001460348954424262
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.814746691612527e-05

Normal O 0 7.273868686752394e-05
hemolytic O 0 0.0002667353837750852
titers O 0 1.9817143765976653e-05
were O 0 3.82979514768067e-08
restored O 0 7.696556991731995e-08
to O 0 5.818831527726331e-10
both O 0 5.006179915056919e-09
homozygous O 0 1.0049069715023506e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.7102827769122086e-05
C5D B-Disease 1 1.0
) O 0 2.826498812780187e-09
sera O 0 1.6809375225079748e-08
by O 0 6.6652876794248694e-12
addition O 0 1.395129706205367e-10
of O 0 4.643419426741957e-09
highly O 0 2.907587486333796e-07
purified O 0 2.384828690082941e-07
human O 0 7.080020623106975e-07
C5 O 0 0.0005407570861279964
. O 0 7.686169283260824e-07

In O 0 4.679296594645166e-08
specific O 0 1.0826302343502903e-07
C5 O 0 3.6132041714154184e-05
titrations O 0 2.8500494408945087e-06
, O 0 2.820015332360981e-09
however O 0 8.477920032667896e-10
, O 0 9.833747705023654e-11
it O 0 5.064246331315525e-12
was O 0 5.477704401180006e-10
noted O 0 1.1575389952112047e-10
that O 0 2.6711096442338933e-12
when O 0 4.700863830142676e-12
limited O 0 1.6871148575403616e-11
amounts O 0 2.1082209589184941e-10
of O 0 5.78569991915856e-09
C5 O 0 1.898379764497804e-07
were O 0 7.540820745610688e-10
assayed O 0 5.583380424667439e-09
in O 0 6.547553471625278e-11
the O 0 2.2512967184917798e-11
presence O 0 4.93070480278579e-11
of O 0 1.3247332120158717e-09
low O 0 5.594096208483279e-08
dilutions O 0 5.73979662021884e-07
of O 0 6.525121420963842e-08
either O 0 2.8027994858348393e-07
C5D B-Disease 1 1.0
serum O 0 3.357865523412329e-07
, O 0 1.0417959828146195e-09
curving O 0 2.2609219385572032e-08
rather O 0 1.4635183065436763e-09
than O 0 7.429885873211362e-11
linear O 0 4.996345115415579e-09
dose O 0 3.862498232365397e-08
- O 0 3.243217083781502e-10
response O 0 5.0710536464437794e-11
plots O 0 2.1169366259954359e-10
were O 0 2.6225865229489997e-11
consistently O 0 1.2821386313754957e-11
obtained O 0 7.305939880852819e-11
, O 0 1.517023312525012e-11
suggesting O 0 1.1077065653619655e-10
some O 0 1.4409810150661784e-11
inhibitory O 0 2.6268256902994835e-08
effect O 0 8.893066194559651e-08
. O 0 1.1790029930125456e-07

Further O 0 3.5098153716717206e-08
studies O 0 5.895786081566712e-09
suggested O 0 2.130275955636307e-09
that O 0 1.7165258797691152e-11
low O 0 9.526806898918494e-09
dilutions O 0 5.082065968053939e-07
of O 0 1.1745498795789899e-07
C5D B-Disease 1 0.9999991655349731
serum O 0 1.2890851053271035e-08
contain O 0 1.5157600175008668e-10
a O 0 7.770089432979077e-11
factor O 0 4.366005473821488e-11
( O 0 1.3889161522284699e-11
or O 0 1.9858227909286263e-11
factors O 0 3.493481892657968e-10
) O 0 1.1274511879655336e-10
interfering O 0 1.7437759680660747e-08
at O 0 3.2530959259702286e-08
some O 0 4.521736110540964e-11
step O 0 2.4282711397205503e-09
in O 0 7.153490577671562e-10
the O 0 2.3714501473648397e-09
hemolytic O 0 4.553281542030163e-06
assay O 0 9.801279929888551e-07
of O 0 0.00026495583006180823
C5 O 0 0.022754093632102013
, O 0 6.9121988133247214e-09
rather O 0 1.2564925766511692e-09
than O 0 1.0985728299273134e-10
a O 0 6.978669864210474e-10
true O 0 7.757525288809575e-09
C5 O 0 5.308821073413128e-06
inhibitor O 0 2.249079784633068e-07
or O 0 1.75272916180802e-08
inactivator O 0 1.5236042827382335e-06
. O 0 1.4645095802734431e-07

Of O 0 7.568362434540177e-07
clinical O 0 1.7279390931435046e-06
interest O 0 5.31590700347806e-08
are O 0 1.5646303697103292e-10
( O 0 7.822283099034877e-11
a O 0 6.689579445939842e-11
) O 0 1.764893027729475e-12
the O 0 1.1466850906305392e-11
documentation O 0 8.470909307334296e-09
of O 0 3.077597341416549e-07
membranous O 1 0.9999978542327881
glomerulonephritis B-Disease 1 1.0
, O 0 0.023250525817275047
vasculitis B-Disease 1 1.0
, O 0 1.4800075405219104e-06
and O 0 1.3690596460946836e-05
arthritis B-Disease 1 1.0
in O 0 2.9865980195609154e-06
an O 0 6.211105407771811e-09
individual O 0 2.0443346571141774e-08
lacking O 1 0.9997345805168152
C5 O 1 0.8399552702903748
( O 0 3.6462521890712196e-10
and O 0 8.596534074867268e-12
its O 0 8.08610123304021e-12
biologic O 0 5.33259925106222e-09
functions O 0 4.3732750754088556e-10
) O 0 2.2664193438659552e-11
, O 0 2.103336081693552e-11
and O 0 2.559221411180257e-11
( O 0 4.495584460251223e-11
b O 0 3.375103752034647e-09
) O 0 3.2841378921899533e-11
a O 0 2.028206769200125e-10
remarkable O 0 1.4007351945011237e-09
propensity O 0 3.6064989217265975e-08
to O 0 5.003383041213283e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.829268114761362e-08
the O 0 4.2855665682850486e-09
proband O 0 1.5170147094067943e-07
, O 0 7.33492572235761e-11
even O 0 1.1369740218758473e-11
during O 0 1.9066544176826739e-10
periods O 0 2.2507924413162073e-09
of O 0 8.55517545694795e-10
low O 0 2.3359415735058064e-08
- O 0 2.128943465962152e-09
dose O 0 4.216454296823713e-09
or O 0 1.0285707702228919e-10
alternate O 0 1.0996593635681506e-09
- O 0 6.90808654724151e-09
day O 0 8.065041967597608e-09
corticosteroid O 0 5.622240678349044e-06
therapy O 0 1.827954110922292e-05
. O 0 1.8619688546550606e-07

Other O 0 2.157847944772584e-08
observations O 0 1.7808705621291665e-08
indicate O 0 1.2236318625014064e-09
that O 0 4.730890679205402e-11
the O 0 1.0183016652121069e-09
C5D B-Disease 1 0.9999951124191284
state O 0 1.637181723523895e-09
is O 0 1.7945547825526376e-11
compatible O 0 1.0105141168281762e-09
with O 0 3.361416353597768e-11
normal O 0 2.020540357250411e-08
coagulation O 0 9.982103144068333e-09
function O 0 4.846171908212682e-09
and O 0 4.0388367650301404e-10
the O 0 4.2844119918505896e-10
capacity O 0 1.424498741187108e-09
to O 0 2.867795723116018e-10
mount O 0 2.472386313456809e-07
a O 0 5.813257430986596e-08
neutrophilic O 0 0.007797302678227425
leukocytosis O 0 0.005825316999107599
during O 0 3.065635246457532e-05
pyogenic B-Disease 0 0.0005212528049014509
infection I-Disease 0 1.394187620462617e-06
. O 0 3.6222909116645496e-09
. O 0 5.015654025442018e-08

Susceptibility O 0 0.0002619402075652033
to O 0 1.1953954526688904e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.09247376024723053
twins O 0 2.114934659402934e-06
: O 0 3.227419720364111e-10
the O 0 1.641264346652349e-10
role O 0 2.948425725790571e-09
of O 0 1.7979630229092436e-08
genes O 0 9.280238799647123e-09
, O 0 4.392672003916687e-09
HLA O 0 2.1335468147754e-07
, O 0 4.911805628893262e-09
and O 0 1.2972929397392363e-09
the O 0 5.923254331463568e-09
environment O 0 3.2506325169379124e-06
. O 0 6.671634196209197e-07

OBJECTIVE O 0 1.3097996088617947e-05
To O 0 4.586627078140282e-09
determine O 0 6.123938689484021e-09
the O 0 4.316936530468496e-10
relative O 0 1.163472251874964e-08
effects O 0 1.2653428882458684e-07
of O 0 7.386401268405507e-09
genetic O 0 2.2640365138215657e-09
and O 0 2.963521442134187e-11
environmental O 0 4.943410680802174e-10
factors O 0 3.377587931563397e-10
in O 0 2.6609472958405433e-10
susceptibility O 0 1.1007153943864978e-06
to O 0 2.766341367532732e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9992252588272095
AS B-Disease 1 1.0
) O 0 7.272110735812021e-08
. O 0 6.10800654499144e-08

METHODS O 0 2.8558599296957254e-05
Twins O 0 3.611451973029034e-07
with O 0 7.505693289111548e-10
AS B-Disease 1 0.9997215867042542
were O 0 5.965599125801191e-10
identified O 0 1.3451013913812204e-10
from O 0 1.7257603332487825e-11
the O 0 1.0234664678254735e-11
Royal O 0 7.519857803117702e-08
National O 0 2.583477787254651e-08
Hospital O 0 3.4056207368848845e-05
for O 0 5.5972343204757635e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999979734420776
database O 0 2.282263949382468e-06
. O 0 5.01749991599354e-06

Clinical O 0 5.04185709360172e-06
and O 0 2.810051746848785e-08
radiographic O 0 1.5379415572169819e-06
examinations O 0 5.152963353793893e-07
were O 0 1.6506205291477727e-09
performed O 0 1.4834892203552386e-09
to O 0 5.469485628295523e-11
establish O 0 4.501157224723329e-09
diagnoses O 0 1.2158393758454622e-07
, O 0 6.115624673341813e-10
and O 0 2.6120905438631326e-09
disease O 0 1.0606013347569387e-05
severity O 0 3.564533926692093e-06
was O 0 3.8561459803077014e-08
assessed O 0 3.1811080436483508e-09
using O 0 7.098075599509812e-11
a O 0 7.915863103891141e-11
combination O 0 2.48901899091436e-10
of O 0 1.8328852879889723e-09
validated O 0 1.2117319592164222e-08
scoring O 0 1.6366206168072495e-08
systems O 0 1.676604142630822e-06
. O 0 3.995435804426961e-07

HLA O 0 8.161378900695127e-06
typing O 0 1.1102141570518143e-06
for O 0 1.8763804732202516e-08
HLA O 0 9.283089639211539e-07
- O 0 1.963052085329764e-07
B27 O 0 1.4366614209393447e-07
, O 0 1.2840611907094512e-09
HLA O 0 3.0718027232978784e-08
- O 0 8.778146209920124e-09
B60 O 0 2.729019143998812e-08
, O 0 1.6871576358212792e-10
and O 0 2.4244103946635676e-10
HLA O 0 1.3893321693103644e-07
- O 0 5.497092843143037e-07
DR1 O 0 0.003132448298856616
was O 0 1.3247540842087346e-08
performed O 0 1.6379939626887108e-09
by O 0 2.939360213560782e-11
polymerase O 0 2.0127936650737865e-08
chain O 0 8.898385916999985e-10
reaction O 0 4.5076740951000005e-11
with O 0 2.248816063921133e-11
sequence O 0 6.448382383617002e-10
- O 0 1.8864948492236522e-10
specific O 0 4.6640167422618006e-11
primers O 0 2.8219631076353835e-09
, O 0 7.817525099484968e-11
and O 0 1.015626333034092e-10
zygosity O 0 5.2225125557470164e-08
was O 0 1.3737846416006505e-08
assessed O 0 1.6967213412044657e-08
using O 0 1.4383910063031635e-08
microsatellite O 0 6.893090471749019e-07
markers O 0 9.167662256004405e-07
. O 0 6.328153290269256e-07

Genetic O 0 2.9247914312691137e-07
and O 0 1.3561275435947096e-09
environmental O 0 1.2883862865464835e-09
variance O 0 4.0845590798532783e-10
components O 0 1.7565009002851184e-08
were O 0 2.825430167607834e-10
assessed O 0 1.1648573217115654e-09
with O 0 1.0799903506220065e-11
the O 0 1.6122353452274751e-10
program O 0 2.2695523238525084e-10
Mx O 0 3.785376900822257e-09
, O 0 7.63992428348681e-12
using O 0 7.076416275869635e-12
data O 0 5.4462292314871874e-11
from O 0 2.0060527891607727e-11
this O 0 3.483497995268592e-12
and O 0 3.968472685883517e-12
previous O 0 1.1571018448952586e-10
studies O 0 6.310393318997853e-10
of O 0 6.6473457849269835e-09
twins O 0 1.3215640137786977e-08
with O 0 3.5227711858709654e-09
AS B-Disease 1 0.9999996423721313
. O 0 2.280275566590717e-06

RESULTS O 0 1.6034516647778219e-07
Six O 0 6.17112405620901e-08
of O 0 4.0397107881062766e-08
8 O 0 4.772342663272866e-07
monozygotic O 0 1.011416998153436e-06
( O 0 1.0588061982730324e-08
MZ O 0 2.3826648885005852e-06
) O 0 3.9809573415539035e-09
twin O 0 9.134240031016816e-08
pairs O 0 9.916727883307885e-09
were O 0 7.2454970911906e-09
disease O 0 1.686563955161091e-08
concordant O 0 1.387970272048733e-08
, O 0 3.813636212379734e-11
compared O 0 2.2433080393291505e-10
with O 0 4.783408044661819e-11
4 O 0 1.2712702890382843e-08
of O 0 1.2476307986730717e-08
15 O 0 9.939090439559095e-09
B27 O 0 1.803699056779351e-08
- O 0 1.8612910102078217e-09
positive O 0 1.2041781460858658e-10
dizygotic O 0 2.563793444210205e-08
( O 0 4.6273704312760344e-10
DZ O 0 1.0317572929352536e-07
) O 0 7.387412348514033e-10
twin O 0 1.0918600246156984e-08
pairs O 0 1.5571940403802387e-09
( O 0 2.0591406357794995e-10
27 O 0 5.871366948184686e-09
% O 0 1.1026621282717031e-10
) O 0 5.125469840217001e-11
and O 0 8.570753134984344e-11
4 O 0 1.6010305969871297e-08
of O 0 9.313881577099892e-08
32 O 0 2.2470503608928993e-06
DZ O 0 6.704338738927618e-05
twin O 0 1.0100887948283344e-06
pairs O 0 2.286281919339217e-08
overall O 0 1.5401072417375872e-08
( O 0 4.47167580741592e-10
12 O 0 2.689805045363869e-09
. O 0 5.546818213075788e-11
5 O 0 2.5596536001870618e-09
% O 0 5.640686806529516e-10
) O 0 1.2128897886043433e-09
. O 0 4.564697420050834e-08

Nonsignificant O 0 3.1020715596241644e-06
increases O 0 9.384779176002667e-09
in O 0 2.735994764080374e-10
similarity O 0 4.835919997780991e-10
with O 0 2.2316648529141503e-11
regard O 0 1.1783185538405405e-09
to O 0 5.581192452641659e-11
age O 0 2.4897197192785825e-08
at O 0 4.247942513302405e-07
disease O 0 1.0394097671451163e-06
onset O 0 8.519360505943041e-08
and O 0 1.4776682655259776e-10
all O 0 9.899671360447115e-11
of O 0 4.478053927670089e-09
the O 0 3.2450999665201152e-09
disease O 0 4.487692706334201e-08
severity O 0 1.0988379983700725e-08
scores O 0 2.0456976390637038e-10
assessed O 0 5.889028154015818e-10
were O 0 4.544856851973478e-11
noted O 0 2.6768703920154735e-10
in O 0 2.627278949951517e-10
disease O 0 6.978502824495081e-07
- O 0 1.4123972391644202e-07
concordant O 0 1.845172164394171e-06
MZ O 0 9.318145748693496e-05
twins O 0 4.76759367984414e-07
compared O 0 6.820123843453985e-08
with O 0 1.7051888789865188e-08
concordant O 0 0.00011719504982465878
DZ O 0 0.0047791763208806515
twins O 0 1.714262180030346e-05
. O 0 6.731402777404583e-07

HLA O 0 7.457534957211465e-05
- O 0 1.0705475688155275e-06
B27 O 0 1.584976416779682e-07
and O 0 3.452360342048877e-10
B60 O 0 2.2040786973320792e-08
were O 0 1.383401726506861e-10
associated O 0 3.506994694646437e-10
with O 0 1.2419236646021847e-11
the O 0 8.845859045258919e-10
disease O 0 7.882096753064616e-08
in O 0 1.1059738680430087e-09
probands O 0 3.375621133727691e-07
, O 0 1.3506544493946393e-10
and O 0 1.2983264637000946e-11
the O 0 1.5316893586803104e-10
rate O 0 9.38696320673671e-09
of O 0 4.544124632133162e-09
disease O 0 4.246868812174398e-08
concordance O 0 1.2122952641746565e-09
was O 0 4.993512825457458e-10
significantly O 0 1.7356843740046202e-10
increased O 0 3.897275835385017e-10
among O 0 1.7278889430372146e-10
DZ O 0 5.293496201375092e-07
twin O 0 4.4828247780515085e-08
pairs O 0 4.407375797654822e-09
in O 0 8.957918851137947e-10
which O 0 1.4153872518463118e-10
the O 0 2.6838502531489894e-09
co O 0 1.0047721588080094e-07
- O 0 2.4678250554188708e-08
twin O 0 1.8845797811195553e-08
was O 0 7.353325504055874e-09
positive O 0 5.4398447552062024e-11
for O 0 6.540563229906482e-11
both O 0 1.9968853237628537e-09
B27 O 0 2.7992064133286476e-07
and O 0 3.299922113342291e-08
DR1 O 0 0.07849439978599548
. O 0 5.832704346175888e-07

Additive O 0 1.9602217093961372e-07
genetic O 0 7.768306886646315e-08
effects O 0 2.719542067097791e-07
were O 0 1.2997103393530551e-09
estimated O 0 7.410735913815358e-11
to O 0 1.1275366924856645e-11
contribute O 0 4.9852313249720837e-11
97 O 0 4.801346875638046e-09
% O 0 3.7644157235838804e-10
of O 0 1.0261023142277281e-09
the O 0 3.152247629589766e-10
population O 0 6.108297895268677e-12
variance O 0 3.2562230689592297e-09
. O 0 2.2735536120421784e-08

CONCLUSION O 0 1.2700023717115982e-06
Susceptibility O 0 6.599456128242309e-07
to O 0 1.1880546324505303e-08
AS B-Disease 1 0.9998853206634521
is O 0 9.172833603798836e-10
largely O 0 2.221559380899407e-09
genetically O 0 1.7455611955874417e-10
determined O 0 1.3628851380786955e-09
, O 0 2.6259350596746778e-11
and O 0 1.7863722653888026e-11
the O 0 1.9455953514935231e-10
environmental O 0 1.5507039208273454e-08
trigger O 0 1.3315577529482425e-09
for O 0 2.0084810203879755e-10
the O 0 1.9743408685712893e-08
disease O 0 3.202835432603024e-05
is O 0 2.344662686226684e-09
probably O 0 4.597244540605061e-08
ubiquitous O 0 3.5884085036741453e-07
. O 0 8.383425154079305e-08

HLA O 0 6.40093203401193e-05
- O 0 1.2141655361119774e-06
B27 O 0 1.1986973902367026e-07
accounts O 0 2.1921194026663926e-10
for O 0 4.0221062591605516e-11
a O 0 1.5063875147269812e-10
minority O 0 4.551544904862759e-11
of O 0 7.073212016095454e-10
the O 0 3.9874220592039933e-10
overall O 0 8.587780264690537e-09
genetic O 0 1.0684485296508228e-08
susceptibility O 0 3.8735795016009433e-08
to O 0 3.853621866056756e-09
AS B-Disease 1 0.9999996423721313
. O 0 3.907349764631363e-06

Cell O 0 4.052888471051119e-06
cycle O 0 1.1554241297062617e-07
- O 0 7.246478528344369e-09
dependent O 0 2.3543558214100813e-09
colocalization O 0 6.037605970732329e-08
of O 0 3.3994169257312024e-08
BARD1 O 0 1.3104993740853388e-05
and O 0 1.0368109926162106e-08
BRCA1 O 0 4.26802859720965e-09
proteins O 0 5.550631065887046e-10
in O 0 9.095775799217165e-10
discrete O 0 1.4379828883193113e-07
nuclear O 0 1.6251041188297677e-06
domains O 0 2.8055379175384587e-07
. O 0 8.906714299428131e-08

Germ O 0 0.028103556483983994
- O 0 1.5697995650043595e-06
line O 0 3.7193206736674256e-08
mutations O 0 3.8756894915614737e-10
of O 0 2.6987623247265446e-09
the O 0 2.9811444424154843e-09
BRCA1 O 0 8.808083151734536e-09
gene O 0 1.3340852866861042e-08
predispose O 0 1.0881723255806719e-07
women O 0 5.156732818534238e-10
to O 0 1.0881271578222496e-10
early O 0 4.3545037442527246e-06
- O 0 0.03531453385949135
onset O 1 0.9999996423721313
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.0805564443217008e-06
compromising O 0 0.0002040836407104507
the O 0 5.001610858812455e-08
genes O 0 7.386908418283156e-09
presumptive O 0 4.979641516911215e-07
function O 0 3.1632609420739755e-08
as O 0 4.31150759538923e-09
a O 0 8.631066528153042e-09
tumor B-Disease 0 5.548439503400004e-07
suppressor O 0 1.2480098121159244e-05
. O 0 1.9454491848591715e-06

Although O 0 1.5290229526954136e-08
the O 0 3.7887430970329206e-09
biochemical O 0 8.826115305282656e-08
properties O 0 3.250398208365368e-07
of O 0 9.376764182889019e-07
BRCA1 O 0 7.963319603732089e-08
polypeptides O 0 2.1427917218375114e-08
are O 0 4.7110447487508367e-11
not O 0 1.3639993648451032e-11
understood O 0 2.881728466963551e-10
, O 0 3.280523856036277e-12
their O 0 6.163557077915049e-13
expression O 0 3.014792235300767e-11
pattern O 0 1.9294799091795767e-09
and O 0 1.1250001624718564e-10
subcellular O 0 1.1762784168922735e-07
localization O 0 5.746023816755041e-07
suggest O 0 1.096480128914834e-09
a O 0 2.778105523404406e-10
role O 0 1.530326421139705e-09
in O 0 3.0390143734848607e-09
cell O 0 2.3543941551906755e-06
- O 0 4.311148131819209e-07
cycle O 0 5.3054737492175263e-08
regulation O 0 8.156291073646571e-07
. O 0 1.245633995949902e-07

When O 0 5.552351467486005e-07
resting O 0 2.0873108951491304e-05
cells O 0 7.228050158403221e-09
are O 0 1.6956615278562737e-10
induced O 0 4.468131642454409e-09
to O 0 9.236964665371161e-11
proliferate O 0 2.5498836375703604e-09
, O 0 1.3864343006986246e-10
the O 0 3.7920955264780787e-10
steady O 0 7.509678212613835e-09
- O 0 2.714382330015752e-10
state O 0 3.227011713402561e-11
levels O 0 5.234024880174104e-10
of O 0 4.59800281182865e-10
BRCA1 O 0 1.1003826322353305e-10
increase O 0 4.715126206145115e-11
in O 0 1.4495547817627852e-10
late O 0 2.4110763163776028e-08
G1 O 0 3.706290740979057e-08
and O 0 4.154678268086798e-10
reach O 0 1.1128721277842146e-09
a O 0 5.187828500119451e-10
maximum O 0 7.867703821773375e-09
during O 0 1.553196327108708e-08
S O 0 5.262339755063294e-07
phase O 0 9.581915492162807e-07
. O 0 3.005350208695745e-07

Moreover O 0 3.1322667837230256e-07
, O 0 2.378752972376219e-09
in O 0 1.5578121015380475e-09
S O 0 4.665358588340496e-08
phase O 0 1.6141839864758367e-07
cells O 0 1.268135929599623e-09
, O 0 8.713568200313659e-10
BRCA1 O 0 1.2557929141010504e-09
polypeptides O 0 1.175960995247749e-09
are O 0 2.5537115824758594e-11
hyperphosphorylated O 0 1.0838239639099356e-08
and O 0 5.6129094427870285e-11
accumulate O 0 1.8300129467352377e-10
into O 0 6.357639414922289e-11
discrete O 0 1.9692787844860504e-08
subnuclear O 0 2.333751325522826e-07
foci O 0 1.2361755352685577e-06
termed O 0 1.2254045600457175e-07
" O 0 5.6621217936481116e-08
BRCA1 O 0 2.4378746843467525e-07
nuclear O 0 2.735513135121437e-06
dots O 0 1.0213638006462133e-06
. O 0 2.3600181009442167e-07

" O 0 2.46842387241486e-06
BRCA1 O 0 7.276563565028482e-07
associates O 0 8.677881169205648e-07
in O 0 4.724024726954212e-09
vivo O 0 8.119916827808993e-08
with O 0 1.1435803415338341e-09
a O 0 4.451359458812476e-08
structurally O 0 7.777634164085612e-05
related O 0 1.6308147678500973e-05
protein O 0 6.923886394361034e-05
termed O 0 3.530026151565835e-05
BARD1 O 0 0.0037808711640536785
. O 0 2.5055892365344334e-06

Here O 0 6.967250669731584e-07
we O 0 6.886275105699724e-09
show O 0 9.726307537150092e-10
that O 0 1.2168949875546176e-11
the O 0 1.0178991677323168e-10
steady O 0 3.288503913623231e-09
- O 0 8.30896046410956e-11
state O 0 8.073833268618102e-12
levels O 0 2.7058016938141805e-10
of O 0 5.313387507754896e-10
BARD1 O 0 5.942324676766475e-08
, O 0 3.0740368583970223e-11
unlike O 0 3.326953296189927e-11
those O 0 1.7765762819199615e-11
of O 0 1.8936299195360107e-09
BRCA1 O 0 2.2594379700535683e-09
, O 0 1.0709120396024119e-10
remain O 0 1.3800607323588565e-09
relatively O 0 7.977008498194493e-10
constant O 0 2.098469620293031e-09
during O 0 4.2132386468551886e-09
cell O 0 7.374846688890102e-08
cycle O 0 2.2298554114286162e-08
progression O 0 1.4579057960872888e-07
. O 0 1.3724246628044057e-07

However O 0 1.8315203931251745e-07
, O 0 8.386844108088098e-09
immunostaining O 0 6.081026526771893e-07
revealed O 0 4.3557477624744934e-08
that O 0 2.33528890669632e-10
BARD1 O 0 9.044641728905845e-07
resides O 0 1.0231190117337974e-07
within O 0 3.077285626318371e-08
BRCA1 O 0 3.107953006065145e-08
nuclear O 0 4.336669121585146e-07
dots O 0 1.0477348766357863e-08
during O 0 5.5138085208739085e-09
S O 0 9.30494614692634e-09
phase O 0 8.804320827948686e-09
of O 0 1.590519826955017e-09
the O 0 4.586231117098549e-10
cell O 0 5.966899419007632e-09
cycle O 0 2.0642762499356593e-10
, O 0 5.744938812862754e-12
but O 0 2.8390297925062757e-12
not O 0 3.540555652478683e-12
during O 0 3.590544250808847e-10
the O 0 5.890544718667456e-10
G1 O 0 1.10476051418118e-07
phase O 0 7.238427315314766e-07
. O 0 2.3760748035783763e-07

Nevertheless O 0 3.6676458421425195e-06
, O 0 5.021358617796068e-08
BARD1 O 0 3.2523194022360258e-06
polypeptides O 0 2.2938559496310518e-08
are O 0 1.5356639571084685e-11
found O 0 8.688366866238528e-12
exclusively O 0 2.2587291412246024e-11
in O 0 2.0123912952696443e-11
the O 0 1.3034533175027008e-10
nuclear O 0 5.009054504512278e-09
fractions O 0 2.706214419223585e-10
of O 0 2.860852110764256e-10
both O 0 1.582795977617124e-10
G1 O 0 9.687357582777167e-09
- O 0 5.157798188548668e-09
and O 0 1.0035798858609724e-09
S O 0 6.534593239848618e-07
- O 0 3.532940340278401e-08
phase O 0 3.528718366396788e-07
cells O 0 2.481839622703319e-08
. O 0 6.572010136096651e-08

Therefore O 0 3.497403326946369e-07
, O 0 8.610709478773515e-09
progression O 0 2.6009359999079606e-08
to O 0 2.672270404957544e-09
S O 0 9.952183432915263e-08
phase O 0 6.80267575603466e-08
is O 0 5.123680646423878e-11
accompanied O 0 5.589832416386109e-11
by O 0 2.4327920320615926e-12
the O 0 3.201270151742541e-11
aggregation O 0 1.4785205282308311e-09
of O 0 7.23646476075146e-09
nuclear O 0 8.886857472134579e-07
BARD1 O 0 1.3837351389156538e-06
polypeptides O 0 2.175166180506949e-08
into O 0 1.164766683103835e-08
BRCA1 O 0 2.5772058620532334e-07
nuclear O 0 1.903892894006276e-06
dots O 0 3.263042174239672e-07
. O 0 6.605286984040504e-08

This O 0 8.469132062316476e-09
cell O 0 2.2426948476095276e-07
cycle O 0 1.9790197924862696e-08
- O 0 1.5511586459737714e-09
dependent O 0 1.4811369908329652e-09
colocalization O 0 9.685440005569035e-08
of O 0 7.143966485045894e-08
BARD1 O 0 4.0100847400026396e-05
and O 0 7.264565837772352e-09
BRCA1 O 0 3.980023421945589e-09
indicates O 0 1.8375968524608766e-09
a O 0 3.558860151020582e-10
role O 0 5.656330404057996e-10
for O 0 5.800038782588501e-10
BARD1 O 0 9.315654097008519e-06
in O 0 1.475919759741373e-07
BRCA1 O 0 2.251189926028019e-06
- O 0 1.1033713235519826e-05
mediated O 0 0.00040844958857633173
tumor B-Disease 0 0.000272497592959553
suppression O 0 0.040727753192186356
. O 0 3.006373162861564e-06

Ethnic O 0 2.237909058067089e-07
differences O 0 5.761925763181353e-07
in O 0 2.6070883230033814e-09
the O 0 5.849725592810273e-09
HFE O 0 8.087525316113897e-07
codon O 0 4.8708240996120367e-08
282 O 0 9.354616281598283e-08
( O 0 1.905275048841304e-08
Cys O 0 0.00019620770763140172
/ O 0 5.836705440742662e-06
Tyr O 0 3.1544818739348557e-06
) O 0 1.5435333011737384e-08
polymorphism O 0 6.145623956399504e-07
. O 0 4.917690716865764e-07

Recent O 0 1.0482426482383289e-08
studies O 0 5.064775709939795e-09
have O 0 8.520972816228323e-11
shown O 0 2.060273063264617e-09
that O 0 6.473809488483084e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 3.154116711812094e-05
HH B-Disease 0 0.12084988504648209
) O 0 6.991730749916769e-09
is O 0 6.549629727459205e-10
likely O 0 4.92100193927314e-10
to O 0 6.387442658128961e-11
be O 0 1.8262819034831068e-10
caused O 0 8.105565663107939e-10
by O 0 4.832782438124461e-11
homozygosity O 0 2.7657893753030294e-08
for O 0 9.882735740873727e-10
a O 0 3.1982401171859465e-09
Cys282Tyr O 0 1.1027037061239753e-07
mutation O 0 3.605573617448954e-10
in O 0 5.054100471468814e-10
the O 0 3.012134319746451e-09
HFE O 0 1.2078596682840725e-06
gene O 0 2.3453303299447725e-08
located O 0 1.7498506110769085e-07
4 O 0 5.329202849679859e-06
. O 0 1.1009904028469464e-06

5 O 0 1.2964032066520303e-05
Mb O 0 4.041631109430455e-05
telomeric O 0 1.3016732737014536e-05
to O 0 1.1684553413715548e-07
HLA O 0 9.339887037640437e-05
- O 0 4.770149644173216e-06
A O 0 1.3436856534099206e-06
. O 0 1.9241801396674418e-07

Population O 0 4.37424887977933e-11
studies O 0 5.558153381990394e-10
of O 0 3.319836627824202e-10
this O 0 1.0882573488191216e-11
polymorphism O 0 8.093360981398234e-10
are O 0 1.948237361368288e-12
facilitated O 0 2.63912051934323e-11
by O 0 1.6149237979865005e-12
the O 0 2.6980390144260014e-11
fact O 0 3.6703511757663065e-11
that O 0 2.3323263893121338e-12
the O 0 1.0501346320301863e-10
Cys282Tyr O 0 7.092766907135228e-08
mutation O 0 1.6180772277607502e-09
creates O 0 7.188810879910079e-09
a O 0 1.1842877789547401e-08
Rsal O 0 8.415528327532229e-07
restriction O 0 8.28406498953882e-08
site O 0 7.432787185734924e-08
. O 0 6.453506529169317e-08

We O 0 6.454417444956562e-08
have O 0 3.94105026391145e-10
studied O 0 1.7365206161912283e-08
the O 0 4.947844356451014e-10
codon O 0 2.0091219798956672e-09
282 O 0 1.841450369965969e-08
( O 0 5.633829847084826e-09
Cys O 0 3.281178942415863e-05
/ O 0 6.046561225048208e-07
Tyr O 0 3.537114707796718e-07
) O 0 3.6607608611127773e-10
polymorphism O 0 9.226738817424973e-10
in O 0 5.997231877774567e-11
different O 0 4.2771515496031753e-11
ethnic O 0 6.805576657775703e-10
groups O 0 4.0551234592456353e-10
. O 0 1.4393680025648337e-08

In O 0 4.115343088528789e-08
agreement O 0 3.801716630391638e-08
with O 0 1.7441501021231431e-10
previous O 0 1.6772856437086148e-09
observations O 0 2.882587502028855e-09
the O 0 5.382535528397625e-10
Tyr O 0 1.9986009291983464e-08
allele O 0 2.0797852329224042e-09
appeared O 0 7.822961833880981e-09
to O 0 1.6378555456331156e-10
be O 0 1.3595455317094718e-10
rare O 0 6.536338692519905e-10
or O 0 3.0529678785029546e-10
absent O 0 6.9088903487113384e-09
in O 0 1.235465507676281e-09
Asiatic O 0 9.19864540094295e-09
( O 0 2.1587832216285463e-11
Indian O 0 3.682538649019129e-11
, O 0 2.9176095567295945e-11
Chinese O 0 3.5145078514098316e-10
) O 0 2.6114303428026453e-11
populations O 0 2.7001909388979506e-11
. O 0 3.721206676132738e-09

The O 0 1.4623721789064348e-08
highest O 0 3.167032414097548e-09
allele O 0 1.5870825487152018e-10
frequency O 0 3.1418228019219896e-09
( O 0 6.220133436096731e-11
7 O 0 6.935014784659188e-10
. O 0 1.5958239937829966e-11
5 O 0 6.330392876563451e-10
% O 0 4.5436345658123045e-11
) O 0 3.3615447231349904e-11
was O 0 2.0483770235557586e-09
found O 0 2.862211023746397e-10
in O 0 6.751842418495357e-10
Swedes O 0 8.710649694876338e-07
. O 0 5.961538249721343e-07

Saamis O 0 1.7236205167137086e-05
( O 0 3.6936302905132834e-08
2 O 0 1.9625559843916562e-07
% O 0 9.024974101379257e-10
) O 0 1.4309574358772892e-10
and O 0 2.2221430251434526e-10
Mordvinians O 0 1.3960899991616316e-07
( O 0 3.536105297463621e-10
1 O 0 5.712495365628456e-09
. O 0 4.8705192656761653e-11
8 O 0 3.4030158690967482e-09
% O 0 1.1220664675182235e-10
) O 0 3.763667155709527e-11
had O 0 3.262238812418161e-10
significantly O 0 2.608215865507191e-10
lower O 0 3.21623727650433e-09
frequencies O 0 1.067295762879894e-08
of O 0 4.4968757606511645e-09
the O 0 2.9495561548742444e-09
Tyr O 0 9.177039714813873e-07
allele O 0 8.925147909621955e-08
. O 0 1.9490967417823413e-07

Comparisons O 0 4.7096865074536254e-08
with O 0 4.5844469886979766e-10
allele O 0 1.8728469886042376e-09
frequencies O 0 9.608707607355882e-09
based O 0 3.4239003299241233e-10
on O 0 9.840450676534829e-10
prevalence O 0 2.494471518232899e-09
estimates O 0 1.1200351063278546e-10
of O 0 1.906939051110612e-09
HH B-Disease 0 2.0875198970315978e-05
showed O 0 2.5948344273274415e-07
some O 0 3.199104869899827e-10
disagreements O 0 2.8271580632122095e-08
with O 0 8.192289902009264e-11
the O 0 1.9919770000154102e-10
RFLP O 0 6.01959637691607e-09
data O 0 3.8835479276855267e-10
, O 0 1.1061589838545771e-10
particularly O 0 5.155434967818451e-10
in O 0 2.0811821155319876e-09
Finns O 0 5.421497348834237e-07
. O 0 1.408713927730787e-07

The O 0 3.8730078699700243e-07
newly O 0 1.5504074326599948e-06
described O 0 7.380981514870655e-07
HFE O 0 1.2065439477737527e-05
marker O 0 4.5694622485825676e-07
provides O 0 8.386412453376124e-09
a O 0 1.064440757758689e-09
new O 0 5.458097307453613e-10
approach O 0 1.2496188528388075e-09
to O 0 5.6903922546203134e-11
the O 0 5.7113126727958985e-11
screening O 0 1.0209328937804685e-09
of O 0 5.538176583996801e-09
HH B-Disease 0 1.8832180330718984e-06
as O 0 1.313897657340135e-09
well O 0 8.343135904365084e-11
as O 0 1.9262348660564754e-11
studies O 0 1.5646066386931778e-10
of O 0 8.46615666461048e-10
the O 0 6.849540934439347e-10
relationship O 0 1.6658280088677202e-08
between O 0 3.426987404964166e-08
the O 0 3.8673175772885315e-09
HFE O 0 7.037086788841407e-07
Tyr O 0 7.812229796400061e-08
allele O 0 2.6032074273985017e-09
and O 0 6.520039508295383e-10
different O 0 4.853018964467992e-08
disorders O 1 0.9999954700469971
including O 0 3.259582399550709e-06
cancer B-Disease 1 0.9999977350234985

Autosomal B-Disease 1 0.999996542930603
dominant I-Disease 1 0.9999995231628418
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9784164428710938
associated O 0 1.0625710729073035e-06
with O 0 5.710861117336208e-09
a O 0 2.1832713414937643e-08
missense O 0 3.465109088551799e-08
mutation O 0 2.577268953807277e-10
encoding O 0 7.695129866647221e-09
Gly23 O 0 3.936722805519821e-06
- O 0 1.0315521876691491e-06
- O 0 6.395400191649969e-07
> O 0 2.787120934044651e-07
Val O 0 1.037824972627277e-06
in O 0 2.294661172186352e-08
neurophysin O 0 3.106773510808125e-05
II O 1 0.9999831914901733
. O 0 1.1235837519052438e-05

Autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 6.103342684582458e-07
ADNDI B-Disease 0 0.002140536205843091
) O 0 1.515084613323836e-09
is O 0 1.6600663899080104e-10
an O 0 2.6365973848641033e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 8.785432146396488e-05
by O 0 2.009386435020133e-09
progressive O 1 0.9999890327453613
degeneration O 1 0.9999996423721313
of O 0 0.0001548219588585198
the O 0 1.3049144627075293e-06
magnocellular O 0 1.553334732307121e-05
neurons O 0 2.118635933356927e-07
of O 0 1.4454913355166354e-07
the O 0 3.12157517612377e-08
hypothalamus O 0 7.919619804397371e-08
leading O 0 1.343415600985054e-08
to O 0 1.7138343522127286e-10
decreased O 0 1.4218067612148388e-08
ability O 0 5.029079375162837e-10
to O 0 1.928643911242034e-10
produce O 0 5.636084376980932e-10
the O 0 9.18751119627359e-09
hormone O 0 3.615948784840839e-08
arginine O 0 2.1058444588106795e-07
vasopressin O 0 2.5122863007709384e-06
( O 0 7.243124144906687e-08
AVP O 0 1.1872041795868427e-05
) O 0 1.1318007153704457e-07
. O 0 4.250917129411391e-07

Affected O 0 4.548635956780345e-08
individuals O 0 1.762862633647444e-10
are O 0 3.701403766820377e-11
not O 0 2.477144357693195e-11
symptomatic O 0 3.607419030160486e-09
at O 0 6.140242980734456e-09
birth O 0 8.404407170203854e-10
, O 0 2.3960814235501893e-11
but O 0 1.7247075295712122e-11
usually O 0 3.769639322914742e-10
develop O 0 1.567186274087362e-07
diabetes B-Disease 1 0.9999887943267822
insipidus I-Disease 0 0.00025696554803289473
at O 0 6.896328704897314e-05
1 O 0 6.891851808177307e-05
- O 0 6.791363489355717e-07
6 O 0 1.239471430380945e-06
yr O 0 6.598414074687753e-06
of O 0 7.629557075006232e-08
age O 0 1.6459359812870389e-06
. O 0 9.327977181783353e-07

The O 0 2.455396952427691e-08
genetic O 0 1.770662194644501e-08
locus O 0 9.857362925913549e-09
of O 0 2.7852603778910634e-08
the O 0 2.001942966955994e-08
disease O 0 6.340010827443621e-07
is O 0 4.1328326871870047e-10
the O 0 1.745919142592811e-08
AVP O 0 0.00010038665641332045
- O 0 1.9445385987637565e-05
neurophysin O 0 0.00020704299095086753
II O 1 0.9999996423721313
( O 0 8.325946510012727e-08
NPII O 0 2.1294213183864485e-06
) O 0 4.942449227662848e-10
gene O 0 9.431573300133778e-10
, O 0 2.2621535200606502e-10
and O 0 1.813245248394324e-10
mutations O 0 3.0212137236418357e-09
that O 0 2.8694535636475393e-10
cause O 0 3.597540043642766e-08
ADNDI B-Disease 0 2.979156306537334e-06
have O 0 8.389540451236854e-11
been O 0 4.1652927634805437e-11
found O 0 6.301522671725568e-12
in O 0 2.9061557847709363e-12
both O 0 5.946552712049469e-12
the O 0 4.404001122115808e-11
signal O 0 3.768354517319494e-09
peptide O 0 1.763613477478998e-09
of O 0 5.741398023673128e-09
the O 0 4.748795578990439e-09
prepro O 0 1.1477422049210873e-05
- O 0 5.138778760738205e-06
AVP O 0 2.0167604816379026e-05
- O 0 4.6088248950582056e-07
NPII O 0 9.343208148493432e-06
precursor O 0 2.674562153970328e-07
and O 0 2.0653250221158714e-09
within O 0 2.6577241740710633e-08
NPII O 0 2.340198443562258e-05
itself O 0 1.1424913282098714e-07
. O 0 1.3981032509491342e-07

An O 0 1.1118632414763852e-07
affected O 0 1.512680682935752e-07
girl O 0 2.3178698427273048e-07
who O 0 8.776601667648265e-10
presented O 0 2.6157100929680155e-09
at O 0 1.5125674934779454e-08
9 O 0 7.860774253742875e-09
months O 0 8.560693265380337e-10
of O 0 1.5064082203863904e-09
age O 0 4.804406650293913e-09
and O 0 2.3265395165950054e-10
her O 0 2.1602257482822296e-10
similarly O 0 2.8985966404881935e-10
affected O 0 1.8123670619818455e-10
younger O 0 2.9477957852463987e-09
brother O 0 2.2101490415593616e-08
and O 0 1.327920773341873e-09
father O 0 4.18330863283245e-08
were O 0 3.999314213132266e-09
all O 0 8.605791773641513e-11
found O 0 7.928101924958852e-11
to O 0 1.9352979288567163e-11
have O 0 1.0851648572784978e-11
a O 0 8.495705527966635e-11
novel O 0 8.560950559566294e-11
missense O 0 8.392905259668737e-10
mutation O 0 4.7436308353576706e-11
( O 0 9.523181548898307e-11
G1758 O 0 1.3261648668105863e-08
- O 0 1.9797596451098798e-08
- O 0 1.4929252500905932e-08
> O 0 4.669816089375445e-09
T O 0 3.055754316250159e-09
) O 0 6.087048833730568e-12
encoding O 0 2.0865469074760057e-10
the O 0 6.813057895627139e-10
amino O 0 4.117052032626134e-09
acid O 0 3.222789368706458e-09
substitution O 0 2.17399942492591e-09
Gly23 O 0 2.2161903245887515e-07
- O 0 5.347798648358548e-08
- O 0 2.5873832854017564e-08
> O 0 3.926588121316854e-08
Val O 0 8.1734320644955e-08
within O 0 2.9323983241624774e-08
NPII O 0 6.302842666627839e-05
. O 0 6.126418270469003e-07

The O 0 1.739675781209371e-07
mutation O 0 3.0438815912248174e-09
was O 0 7.62508722829125e-09
confirmed O 0 3.8521064116281423e-10
by O 0 1.668012949984643e-11
restriction O 0 1.5536221198431122e-09
endonuclease O 0 6.162561305700365e-08
analysis O 0 3.791513591977491e-08
. O 0 9.04812935687005e-08

A O 0 4.332904063630849e-05
T1 O 0 0.00023899521329440176
- O 0 2.7327638818519517e-08
weighted O 0 1.5015889642810976e-09
magnetic O 0 3.5910048268306127e-09
resonance O 0 3.4890221822792e-09
imaging O 0 1.3796356768125406e-07
of O 0 9.902739961376028e-09
the O 0 3.8291961601544244e-08
fathers O 0 2.727458650042536e-07
pituitary O 0 1.663766283854784e-06
gland O 0 1.173769874185382e-06
demonstrates O 0 6.30002659818274e-07
an O 0 1.9743897183843728e-08
attenuated O 0 2.634219754327205e-06
posterior O 0 1.1098795766883995e-05
pituitary O 0 0.001457108766771853
bright O 0 2.0552897694869898e-05
spot O 0 1.6452202544314787e-05
. O 0 4.729562590455316e-07

This O 0 1.1688862322500881e-08
mutation O 0 8.286652253275406e-09
may O 0 8.349029245735551e-10
be O 0 6.280312381257147e-11
valuable O 0 8.632444203904299e-10
for O 0 3.390094108213226e-11
developing O 0 5.386119883432627e-10
models O 0 2.582939195860945e-09
of O 0 2.227692448286689e-07
dominantly B-Disease 1 0.9994884729385376
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 3.560174022254614e-08
as O 0 2.435041335235866e-10
the O 0 5.754175261274419e-11
early O 0 1.5897494431982295e-09
age O 0 3.1329787653078256e-09
of O 0 1.0774160230653251e-08
onset O 0 8.009609882719815e-05
of O 0 7.3131964200001676e-06
symptoms O 0 0.003131316741928458
suggests O 0 3.2177223108220687e-09
that O 0 5.51615610827616e-12
this O 0 1.2920911736380436e-11
mutation O 0 1.22350060638432e-10
may O 0 9.852935828336129e-11
be O 0 4.880227472137122e-11
particularly O 0 1.321393827691253e-10
deleterious O 0 9.337393080954826e-09
to O 0 9.828483582552394e-10
the O 0 7.04382596694586e-09
magnocellular O 0 2.4624494017189136e-06
neuron O 0 5.189704666008765e-07
. O 0 1.096677237910626e-08
. O 0 1.7099644367135625e-07

Frequent O 0 3.881057182297809e-07
inactivation O 0 1.4867843674437609e-05
of O 0 9.742309885041323e-06
PTEN O 0 0.009717750363051891
/ O 0 0.0002482426352798939
MMAC1 O 0 0.016135672107338905
in O 0 5.755609890911728e-07
primary O 1 0.9999903440475464
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3871450126171112

Sporadic B-Disease 1 0.9999967813491821
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.0082081871587434e-06
the O 0 1.9467627510039165e-08
most O 0 3.9897882220252257e-10
common O 0 4.42915171205982e-09
male B-Disease 0 8.545851137853333e-09
cancer I-Disease 0 1.4308339757462818e-07
in O 0 4.133638764614034e-09
the O 0 4.267086595177716e-08
Western O 0 2.751704073489236e-07
world O 0 1.4742037590664836e-09
, O 0 3.640496584744746e-11
yet O 0 2.5964510055875856e-11
many O 0 1.7726456153638326e-12
of O 0 3.0602541334356914e-11
the O 0 2.8639788457462956e-11
major O 0 2.088035855329906e-10
genetic O 0 3.878351806374525e-10
events O 0 1.8031641457749714e-10
involved O 0 5.793371893325627e-10
in O 0 1.3294278178310748e-10
the O 0 3.8853409378702963e-10
progression O 0 1.8846235150249413e-07
of O 0 3.5297610168072424e-08
this O 0 1.7917795025468308e-09
often O 0 2.632127689139452e-07
fatal O 0 0.0007496821344830096
cancer B-Disease 0 2.047608904831577e-05
remain O 0 8.572969818487763e-07
to O 0 3.1641524955716704e-09
be O 0 2.0907638287326336e-08
elucidated O 0 8.243345655500889e-05
. O 0 7.581973591186397e-07

Numerous O 0 7.089385434255746e-08
cytogenetic O 0 8.461193829134572e-06
and O 0 4.345804160976741e-09
allelotype O 0 6.724499712618126e-07
studies O 0 3.2634603908121562e-09
have O 0 1.4019044605739772e-11
reported O 0 1.484785072669581e-10
frequent O 0 5.7569855133055015e-11
loss O 0 2.9931304657004887e-10
of O 0 1.2818325956232002e-08
heterozygosity O 0 0.00016097132174763829
on O 0 2.0725907234009355e-05
chromosomal O 0 0.06894257664680481
arm O 0 0.0001164409113698639
10q O 0 9.992781997425482e-06
in O 0 5.112964913678297e-07
sporadic B-Disease 1 0.9999958276748657
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0028615989722311497

Deletion O 0 5.10455095081852e-07
mapping O 0 3.65548316949571e-07
studies O 0 1.4170959516945913e-08
have O 0 1.280345690579665e-10
unambiguously O 0 2.202346305324454e-09
identified O 0 8.394570594205675e-10
a O 0 3.81563891593828e-10
region O 0 4.213680515618989e-09
of O 0 2.9355994968227606e-08
chromosome O 0 1.2751405620292644e-07
10q23 O 0 6.458604673298396e-08
to O 0 1.7130565022061006e-10
be O 0 9.473324902309344e-11
the O 0 8.610536589293005e-11
minimal O 0 5.408752912217096e-08
area O 0 3.855783692330306e-09
of O 0 2.1524915183590565e-08
loss O 0 9.326677741228195e-07
. O 0 1.3223327641753713e-06

A O 0 1.579248873895267e-06
new O 0 2.625322892413351e-08
tumor B-Disease 0 1.4112056589965505e-07
suppressor O 0 3.2865969501472136e-07
gene O 0 6.0494556919366e-08
, O 0 5.434273475657392e-08
PTEN O 0 4.143824480706826e-05
/ O 0 2.2205020286492072e-05
MMAC1 O 0 0.004259154666215181
, O 0 2.6285949417115262e-08
was O 0 2.7997270990454126e-07
isolated O 0 1.6879155850801908e-08
recently O 0 8.60207460817719e-09
at O 0 6.629783833034253e-09
this O 0 1.4506769917266293e-11
region O 0 1.4470749043482556e-09
of O 0 2.7511193323448424e-09
chromosome O 0 2.3049212316550438e-08
10q23 O 0 4.1551103890924423e-08
and O 0 2.8392654893849567e-10
found O 0 1.32940505825907e-10
to O 0 9.907373532680452e-12
be O 0 3.5195288523859336e-12
inactivated O 0 1.0199981137493097e-10
by O 0 2.3188818486924445e-12
mutation O 0 1.5265269603936815e-10
in O 0 8.481672031379617e-10
three O 0 5.041146664552798e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.999995231628418
lines O 0 0.00021741628006566316
. O 0 8.897577004063351e-07

We O 0 7.829309112139526e-08
screened O 0 7.539396165157086e-07
80 O 0 1.2951348935530405e-06
prostate B-Disease 0 0.0012035375693812966
tumors I-Disease 1 0.9999977350234985
by O 0 4.569346678806596e-09
microsatellite O 0 1.777166005467734e-07
analysis O 0 2.6467854574718785e-09
and O 0 3.8474362584750565e-10
found O 0 2.769671991753597e-10
chromosome O 0 3.0144102769469328e-09
10q23 O 0 5.1572275339140106e-09
to O 0 4.007678910955548e-11
be O 0 3.5586072283377845e-11
deleted O 0 9.9924035712462e-10
in O 0 1.85173293365537e-10
23 O 0 2.3573138108190506e-08
cases O 0 5.194068730673962e-09
. O 0 2.2182451431262962e-08

We O 0 1.0966881092144831e-07
then O 0 8.543537433070014e-09
proceeded O 0 3.7114602502441585e-09
with O 0 9.627092525943404e-12
sequence O 0 9.634849862383277e-11
analysis O 0 1.1883821704472552e-10
of O 0 1.4330878150836668e-10
the O 0 3.5671987586027853e-10
entire O 0 8.489157465874086e-08
PTEN O 0 3.1474589832214406e-06
/ O 0 4.772315378431813e-07
MMAC1 O 0 3.3254186746489722e-06
coding O 0 2.5617366645747097e-06
region O 0 1.5286532573099976e-07
and O 0 6.164178056877745e-10
tested O 0 1.0814837914097097e-09
for O 0 1.2412376682036097e-10
homozygous O 0 4.889267324337254e-10
deletion O 0 2.4103992135593444e-09
with O 0 5.832673927175236e-11
new O 0 3.265638037763807e-10
intragenic O 0 8.372239790332969e-08
markers O 0 6.9886909592753454e-09
in O 0 4.884420645723253e-10
these O 0 5.2123045463092765e-11
23 O 0 6.527061113814625e-09
cases O 0 3.261728664938346e-10
with O 0 2.391133957502234e-10
10q23 O 0 4.0699435999158595e-07
loss O 0 1.3257647424325114e-06
of O 0 1.125503422372276e-05
heterozygosity O 1 0.7253590822219849
. O 0 2.0050776583957486e-05

The O 0 3.787384628139989e-09
identification O 0 2.2586796877277493e-09
of O 0 3.3652816089357884e-09
the O 0 2.958631950544799e-10
second O 0 3.3004743382747392e-09
mutational O 0 2.055360148744967e-08
event O 0 1.0385146076430374e-09
in O 0 1.4821939231524084e-09
10 O 0 7.354629794065204e-09
( O 0 5.643614464645452e-10
43 O 0 8.403036133586284e-08
% O 0 1.2656180103931547e-07
) O 0 2.023210981860757e-06
tumors B-Disease 1 1.0
establishes O 0 0.003914533648639917
PTEN O 1 0.5731975436210632
/ O 0 0.00022345662000589073
MMAC1 O 0 0.00027850797050632536
as O 0 1.4291204664118595e-08
a O 0 2.8599314028099343e-09
main O 0 5.248092627141432e-09
inactivation O 0 4.0436351156358796e-08
target O 0 2.6286588461488236e-09
of O 0 9.976639958608757e-09
10q O 0 4.897360099676007e-07
loss O 0 3.8549663372577925e-07
in O 0 2.9688334279853734e-07
sporadic B-Disease 1 0.9999985694885254
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.476860224007396e-06
. O 0 2.5826434466580395e-06

Risk O 0 1.1305347697998513e-06
reversals O 0 4.7015279847073543e-07
in O 0 1.1306389158249885e-09
predictive O 0 3.960661842938862e-08
testing O 0 3.218613642275159e-08
for O 0 2.0371906828131614e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.536117194220424e-05

The O 0 2.8133966267773758e-09
first O 0 4.745859816246423e-10
predictive O 0 5.531335833808271e-09
testing O 0 7.355808406828146e-09
for O 0 7.25379720734054e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.396241397117365e-09
HD B-Disease 0 6.458247412410856e-07
) O 0 1.3621463679225343e-10
was O 0 5.701215610720567e-10
based O 0 1.4990177502061108e-11
on O 0 7.57616608337841e-11
analysis O 0 7.78410669255436e-11
of O 0 5.800747104878212e-10
linked O 0 6.865632062869054e-09
polymorphic O 0 3.295448358642261e-09
DNA O 0 3.6760159360937905e-09
markers O 0 2.592736914053262e-09
to O 0 1.8402827872687766e-10
estimate O 0 4.2734349392503646e-10
the O 0 1.8049879646486744e-10
likelihood O 0 6.277623754158412e-09
of O 0 2.1779476000460818e-08
inheriting O 0 7.468513985031677e-08
the O 0 5.401265656956866e-09
mutation O 0 1.6271700653547327e-09
for O 0 2.6391231422451256e-09
HD B-Disease 0 4.595470818458125e-05
. O 0 2.1830876448802883e-06

Limits O 0 8.758766512073635e-08
to O 0 6.610095804049365e-10
accuracy O 0 6.206203106984276e-09
included O 0 2.5321100771691363e-10
recombination O 0 2.4218973493361773e-09
between O 0 2.3185975361883493e-09
the O 0 3.484252331098503e-10
DNA O 0 1.2540097849012e-09
markers O 0 6.953398967723956e-10
and O 0 2.6419508941666336e-11
the O 0 1.34408831287125e-10
mutation O 0 1.188855958123014e-10
, O 0 1.5751583370970934e-10
pedigree O 0 1.328462784222495e-09
structure O 0 9.837640924104107e-09
, O 0 3.1151067836354684e-10
and O 0 5.783200654474463e-11
whether O 0 6.031589117050373e-11
DNA O 0 9.72452188219286e-11
samples O 0 3.303966822354454e-11
were O 0 1.2164749242649098e-11
available O 0 2.818867188281171e-11
from O 0 6.419996756434898e-10
family O 0 1.0172281905695968e-09
members O 0 1.1681545730723997e-09
. O 0 9.590620919652793e-08

With O 0 2.9553168801044194e-09
direct O 0 2.22667528859688e-09
tests O 0 1.905193086626511e-10
for O 0 2.3123373008027137e-11
the O 0 9.534450312598253e-11
HD B-Disease 0 2.1662485494289285e-07
mutation O 0 1.073116179250988e-10
, O 0 4.3705542657201946e-11
we O 0 2.060381032453762e-11
have O 0 1.1909564046758137e-12
assessed O 0 6.094987015092812e-11
the O 0 4.909362846805543e-12
accuracy O 0 4.358253202774165e-10
of O 0 6.679290454059128e-11
results O 0 1.0828222866965387e-11
obtained O 0 6.054526324739129e-11
by O 0 2.2891757933685142e-11
linkage O 0 3.9204941515436076e-09
approaches O 0 6.50886056163813e-09
when O 0 1.2024644613362057e-09
requested O 0 4.580105184004424e-09
to O 0 1.0088925250784087e-09
do O 0 3.999769682128118e-10
so O 0 4.298595160379115e-11
by O 0 9.567745901106761e-12
the O 0 3.2274672517873526e-11
test O 0 3.6297378991356766e-10
individuals O 0 6.951445669090006e-11
. O 0 4.3036305186205936e-08

For O 0 2.790103970085056e-08
six O 0 3.78338471662687e-09
such O 0 1.0524526389277256e-10
individuals O 0 7.591061459977233e-12
, O 0 2.5796184632831398e-11
there O 0 2.731405206179982e-11
was O 0 1.69856595455542e-09
significant O 0 2.341614679934878e-09
disparity O 0 2.985778024822139e-08
between O 0 1.6322871942975326e-08
the O 0 7.954071179483435e-09
tests O 0 2.4564885237055023e-08
. O 0 1.5689861854184528e-08

Three O 0 1.0459163490850187e-07
went O 0 1.1826877255316504e-07
from O 0 1.8968797643736934e-09
a O 0 5.295116012327128e-10
decreased O 0 4.788378582532005e-09
risk O 0 1.609764960219806e-10
to O 0 1.4209425303057799e-11
an O 0 7.1824130844222456e-12
increased O 0 1.5559523114383467e-10
risk O 0 2.4293460576529924e-09
, O 0 3.327334241465252e-11
while O 0 1.9110198146155e-10
in O 0 9.38255098614782e-11
another O 0 1.372929270271328e-10
three O 0 6.601726110222472e-11
the O 0 1.9892698599477399e-10
risk O 0 8.57458815062273e-09
was O 0 1.0794074967179768e-07
decreased O 0 7.592479391860252e-07
. O 0 1.9122803962545731e-07

Knowledge O 0 1.5316666122089373e-06
of O 0 1.1116300413505087e-07
the O 0 2.0926300692281075e-09
potential O 0 5.897942134680534e-10
reasons O 0 6.193617285710218e-10
for O 0 9.721011322294526e-12
these O 0 2.169290788667233e-12
changes O 0 8.181514493665887e-11
in O 0 5.638446654021578e-11
results O 0 3.435869991297302e-11
and O 0 1.3495464294688286e-11
impact O 0 8.718721855593969e-10
of O 0 5.607090902692846e-10
these O 0 5.824580401325719e-11
risk O 0 2.0545283252459967e-09
reversals O 0 1.0117429560807523e-08
on O 0 7.956438174971936e-09
both O 0 8.397100237367283e-10
patients O 0 1.1331517946189251e-09
and O 0 1.2384211711680138e-10
the O 0 1.2595686715854981e-09
counseling O 0 7.695422965525722e-09
team O 0 3.5147224020093404e-10
can O 0 3.5975757095574323e-11
assist O 0 6.517229533820057e-10
in O 0 1.7287198061932685e-10
the O 0 3.615586718908048e-10
development O 0 1.5628713878612643e-09
of O 0 1.4772556511388757e-08
strategies O 0 2.181717473348499e-09
for O 0 1.1552054451913207e-10
the O 0 3.341314447347088e-10
prevention O 0 8.168366605332267e-08
and O 0 6.303714494837465e-11
, O 0 2.6416990123179218e-11
where O 0 1.5169776546031244e-10
necessary O 0 5.918680656691322e-09
, O 0 4.3185177656113183e-10
management O 0 1.2348607469903072e-08
of O 0 5.30984713975613e-08
a O 0 1.2701408813597936e-08
risk O 0 2.0585929405569914e-08
reversal O 0 1.6240361944142023e-08
in O 0 3.377690904748931e-10
any O 0 1.7996355794469565e-10
predictive O 0 3.1308697856502476e-09
testing O 0 1.1623182416542477e-09
program O 0 4.857329538587862e-10
. O 0 1.7172700761403092e-10
. O 0 7.1727863648618495e-09

A O 0 2.498526043837046e-07
novel O 0 8.951108299015686e-09
common O 0 2.427632095347576e-09
missense O 0 2.437850810110831e-08
mutation O 0 2.1117826931593697e-10
G301C O 0 8.059629408307956e-09
in O 0 2.910185703530743e-10
the O 0 1.0796145089031484e-09
N O 0 1.1312864671708667e-06
- O 0 1.5451746548933443e-07
acetylgalactosamine O 0 1.2579771464515943e-06
- O 0 3.8788186884630704e-07
6 O 0 2.3320524178416235e-06
- O 0 1.2317184427956818e-07
sulfate O 0 2.82040247157056e-07
sulfatase O 0 1.9228041310270783e-06
gene O 0 8.892557445960847e-08
in O 0 9.027409220152549e-08
mucopolysaccharidosis B-Disease 0 0.0003018933057319373
IVA I-Disease 1 0.9998993873596191
. O 0 1.678597072896082e-05

Mucopolysaccharidosis B-Disease 0 0.004688747227191925
IVA I-Disease 1 0.9999940395355225
( O 0 0.00021913823729846627
MPS B-Disease 1 0.9999955892562866
IVA I-Disease 1 1.0
) O 0 3.3553295253341275e-08
is O 0 6.070857150319853e-10
an O 0 3.2479483547120935e-09
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.00015318216173909605
by O 0 1.0106836478840364e-09
a O 0 1.410371481824768e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.478448651454528e-07
N O 0 0.001274687354452908
- O 0 1.5799494121893076e-06
acetylgalactosamine O 0 1.3973749446449801e-05
- O 0 1.9473220618237974e-06
6 O 0 3.809136978816241e-05
- O 0 1.6878951782928198e-06
sulfate O 0 1.9653464278235333e-06
sulfatase O 0 9.682864401838742e-06
( O 0 3.806868420497267e-08
GALNS O 0 1.8396674931864254e-05
) O 0 1.8959800840434582e-08
. O 0 4.327600322540093e-08

In O 0 3.4765488265975364e-08
previous O 0 1.769770996418174e-08
studies O 0 3.2608595823546693e-09
, O 0 1.197554277965196e-10
we O 0 7.576455435254204e-11
have O 0 5.632274160949358e-12
found O 0 3.9907430658681076e-12
two O 0 1.2927018396696743e-12
common O 0 2.7609886599222477e-11
mutations O 0 8.572371285042735e-11
in O 0 4.809629916557867e-10
Caucasians O 0 3.5799672115643943e-09
and O 0 2.8321420209032055e-10
Japanese O 0 9.827648739246797e-08
, O 0 6.17791429124992e-10
respectively O 0 5.559133953170203e-08
. O 0 4.767839456576439e-08

To O 0 4.9344947683493956e-08
characterize O 0 6.220420232239121e-07
the O 0 1.7269879748482708e-08
mutational O 0 7.542489015577303e-07
spectrum O 0 6.813076680600716e-08
in O 0 1.7085469150579513e-10
various O 0 1.358000933926462e-10
ethnic O 0 1.6261514357296392e-10
groups O 0 7.768855003753572e-12
, O 0 7.049594848845819e-12
mutations O 0 1.089808972232209e-11
in O 0 1.2883955013975879e-10
the O 0 9.685505730772093e-10
GALNS O 0 6.032691430846171e-07
gene O 0 4.262659114573353e-09
in O 0 3.5494187589080184e-09
Colombian O 0 2.0107770524191437e-06
MPS B-Disease 1 0.9999979734420776
IVA I-Disease 1 1.0
patients O 0 7.237833870021859e-07
were O 0 6.848482891896879e-10
investigated O 0 1.7449295341975812e-09
, O 0 6.078567770656518e-12
and O 0 8.001564688608909e-12
genetic O 0 1.6060112961735484e-10
backgrounds O 0 2.508536156575758e-10
were O 0 6.079151071425315e-11
extensively O 0 1.9896256517326627e-11
analyzed O 0 3.8680808556179613e-11
to O 0 4.851528467159083e-12
identify O 0 1.3301761081496721e-10
racial O 0 2.383602204503177e-10
origin O 0 3.415862037670081e-11
, O 0 3.970880482068173e-12
based O 0 9.029338908506102e-12
on O 0 2.069077686961407e-10
mitochondrial O 0 6.420302622878182e-10
DNA O 0 4.168712319785328e-10
( O 0 5.721889281828929e-11
mtDNA O 0 2.8408797536627617e-10
) O 0 1.1481722239636838e-09
lineages O 0 2.0865131844516327e-08
. O 0 1.9908173953808728e-07

Three O 0 5.194894114879389e-08
novel O 0 4.702146583213107e-08
missense O 0 5.617206397801056e-07
mutations O 0 1.3926002573327878e-08
never O 0 4.712910062210085e-09
identified O 0 7.243780575372227e-10
previously O 0 1.104637381565965e-09
in O 0 7.641342419928421e-11
other O 0 1.3475247827299253e-11
populations O 0 1.8621545277985874e-12
and O 0 1.2681830412197836e-11
found O 0 7.371376425924225e-11
in O 0 2.453353353804033e-10
16 O 0 4.66760807782407e-09
out O 0 1.1755657558509824e-10
of O 0 1.3169592527617624e-08
19 O 0 1.2771279500611854e-07
Colombian O 0 3.383011971891392e-06
MPS B-Disease 1 0.9999227523803711
IVA I-Disease 1 1.0
unrelated O 0 3.2437328627565876e-06
alleles O 0 1.917545455754066e-09
account O 0 5.584059326046997e-10
for O 0 1.7748440495068962e-09
84 O 0 4.5985427732375683e-07
. O 0 3.3830141887847276e-07

2 O 0 2.356761797273066e-06
% O 0 1.3252823727327723e-08
of O 0 4.404325348872362e-09
the O 0 3.657996960892973e-10
alleles O 0 1.1092330526318861e-10
in O 0 1.1585992581997218e-10
this O 0 3.547113991420048e-11
study O 0 2.3869974885570855e-09
. O 0 1.0184867171858514e-08

The O 0 1.5362323324552563e-07
G301C O 0 7.08024344930891e-07
and O 0 2.7582860440134027e-09
S162F O 0 7.583854255699407e-08
mutations O 0 5.138393044390455e-10
account O 0 2.818540678628523e-10
for O 0 3.76818887204422e-09
68 O 0 1.3151867506167036e-06
. O 0 1.1059829603254911e-06

4 O 0 3.873857167491224e-06
% O 0 4.356595084686887e-08
and O 0 1.8675185842198516e-08
10 O 0 1.2616303024515219e-07
. O 0 1.495446753096985e-07

5 O 0 8.603758487879531e-07
% O 0 7.704263893515417e-09
of O 0 1.535007498887353e-08
mutations O 0 7.707846583215883e-10
, O 0 2.2701930613155952e-10
respectively O 0 3.1124833821394304e-09
, O 0 2.2620152972940843e-10
whereas O 0 8.533207473959692e-10
the O 0 1.908518232340839e-09
remaining O 0 1.477453537290785e-07
F69V O 0 1.6582473563175881e-06
is O 0 1.9952242635845607e-10
limited O 0 9.528795807955959e-11
to O 0 8.824704855747711e-11
a O 0 6.671437846605954e-10
single O 0 7.341885988054742e-10
allele O 0 3.263200554215473e-08
. O 0 2.914352990046609e-07

The O 0 2.9352857922049225e-08
skewed O 0 4.101120865129815e-08
prevalence O 0 3.5252799790441713e-08
of O 0 2.0454178351059227e-09
G301C O 0 1.5170776634931826e-08
in O 0 1.3662913855849723e-10
only O 0 2.647267648148155e-11
Colombian O 0 2.8001201357596983e-09
patients O 0 1.0432430613827037e-10
and O 0 9.59067634337396e-12
haplotype O 0 2.0853216375904537e-10
analysis O 0 5.408414341379064e-11
by O 0 7.380953487290398e-12
restriction O 0 1.1348816331135936e-10
fragment O 0 1.9571892717618056e-10
length O 0 3.681290272616877e-10
polymorphisms O 0 8.452505917411202e-10
in O 0 2.583243619014297e-10
the O 0 1.1314910119963884e-09
GALNS O 0 7.07367632912792e-07
gene O 0 5.167132499650506e-09
suggest O 0 9.46401068624425e-10
that O 0 1.7424634651819204e-11
G301C O 0 3.945429760676689e-09
originated O 0 2.202606763646031e-09
from O 0 5.306793893211648e-10
a O 0 2.701902868107453e-10
common O 0 7.579871175167341e-10
ancestor O 0 4.5076120613884996e-08
. O 0 1.0466706612533017e-07

Investigation O 0 3.569111868273467e-07
of O 0 1.8333897955358225e-08
the O 0 7.054309358878186e-10
genetic O 0 1.0256209215242507e-09
background O 0 1.7984344569121902e-10
by O 0 7.0836951755748334e-12
means O 0 4.704402423172382e-10
of O 0 2.5140747261787055e-09
mtDNA O 0 1.6449193118717176e-09
lineages O 0 1.301824092969639e-09
indicate O 0 1.5516675722082596e-09
that O 0 4.5011102484115995e-11
all O 0 9.473867523812629e-11
our O 0 6.80352607584922e-10
patients O 0 2.2898231921697487e-10
are O 0 2.728571058333018e-12
probably O 0 7.647217581396859e-11
of O 0 4.036449230415684e-10
native O 0 2.7704711857978737e-09
American O 0 2.491489965450455e-07
descent O 0 0.0002170778316212818

Low O 0 4.5176565777182986e-07
frequency O 0 3.094124565450329e-07
of O 0 9.684239898888336e-08
BRCA1 O 0 9.59010861834031e-08
germline O 0 8.454997413309684e-08
mutations O 0 7.371676047362996e-10
in O 0 4.897349747956525e-10
45 O 0 4.488479987685423e-08
German O 1 0.999047577381134
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.413019607658498e-05
. O 0 1.0921538887487259e-05

In O 0 1.1949520484222376e-08
this O 0 1.0846459841395983e-10
study O 0 1.3744254345748885e-10
we O 0 1.089083771083077e-11
investigated O 0 4.851922197346425e-10
45 O 0 2.241401730884718e-09
German O 0 0.0005834986222907901
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.348853650995352e-08
for O 0 8.546308549739479e-09
germline O 0 9.806150274016545e-07
mutations O 0 2.2987207692892753e-09
in O 0 8.913571547530807e-10
the O 0 1.0642505543501102e-08
BRCA1 O 0 1.1518628184603585e-07
gene O 0 2.9143475899218174e-07
. O 0 5.903451665290049e-07

We O 0 1.1487029105694546e-08
identified O 0 3.564874617723035e-09
four O 0 3.0817894902668286e-09
germline O 0 4.397125508148747e-08
mutations O 0 1.8003094570673284e-09
in O 0 1.3054692882263907e-09
three O 0 9.952692892056803e-09
breast B-Disease 0 0.0005068738246336579
cancer I-Disease 0 0.0001591150794411078
families O 0 1.4324839925361488e-10
and O 0 2.4725588243512675e-09
in O 0 1.4087813724472653e-06
one O 1 0.9999877214431763
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9998055100440979
. O 0 4.869224135006789e-09
among O 0 2.7404538707753723e-11
these O 0 8.269998401366774e-12
were O 0 2.1430060503924153e-10
one O 0 7.060874801512185e-11
frameshift O 0 8.93543194990798e-09
mutation O 0 6.330586055369736e-10
, O 0 1.952212003164533e-10
one O 0 4.3499484569942126e-10
nonsense O 0 5.809743797158262e-08
mutation O 0 6.912986294516088e-10
, O 0 2.4105495377568786e-10
one O 0 1.0105404707472232e-10
novel O 0 4.354754890023571e-10
splice O 0 1.3500788043074863e-08
site O 0 1.612211808499353e-09
mutation O 0 4.475840253981289e-10
, O 0 3.431889772365082e-10
and O 0 8.561673037199569e-10
one O 0 1.1189067450345647e-08
missense O 0 8.221577445510775e-06
mutation O 0 6.757400115020573e-07
. O 0 1.266668846255925e-06

The O 0 1.6041200012750778e-07
missense O 0 3.8298688309623685e-07
mutation O 0 5.876072073363048e-09
was O 0 9.195439076847833e-08
also O 0 5.870378072536653e-10
found O 0 5.850548379093823e-10
in O 0 2.102399587755599e-09
2 O 0 3.5476687116897665e-06
. O 0 5.088409125164617e-07

8 O 0 2.315487108717207e-06
% O 0 8.772070181350955e-09
of O 0 1.3978160851024768e-08
the O 0 6.729445889419594e-10
general O 0 1.560762297181384e-09
population O 0 8.27474720688226e-12
, O 0 4.83077362833928e-11
suggesting O 0 2.010405175667529e-10
that O 0 4.060583466691803e-12
it O 0 3.1353231642883284e-12
is O 0 1.4469464688915412e-11
not O 0 5.4804192434199095e-11
disease O 0 2.800473986042107e-08
associated O 0 8.596879297328996e-08
. O 0 3.020999770342314e-07

The O 0 2.675561461273901e-08
average O 0 1.3815460997435025e-09
age O 0 4.915498230673165e-09
of O 0 9.005495904546024e-09
disease O 0 2.489065025201853e-07
onset O 0 2.1491774759851978e-07
in O 0 8.47229453260212e-10
those O 0 3.02646629979364e-10
families O 0 4.684451090919417e-11
harbouring O 0 3.8437214300302e-08
causative O 0 2.477734284411781e-08
mutations O 0 1.6075849984531487e-08
was O 0 4.728904059447814e-07
between O 0 1.7777775838112575e-06
32 O 0 6.150716671982082e-06
. O 0 1.056532482834882e-06

3 O 0 2.3286533178179525e-05
and O 0 2.0194835315123782e-07
37 O 0 7.593857844767626e-06
. O 0 7.953253202686028e-07

4 O 0 6.1079763327143155e-06
years O 0 3.3256199571951583e-08
, O 0 9.372038700661278e-10
whereas O 0 1.557746709401897e-09
the O 0 1.0563023788989767e-09
family O 0 1.2235759072609653e-09
harbouring O 0 7.115178135563838e-08
the O 0 4.585533730505631e-09
missense O 0 4.767530015215016e-08
mutation O 0 1.8018208036707506e-09
had O 0 5.917232259733396e-10
an O 0 1.2517071580619987e-11
average O 0 6.318905815261289e-11
age O 0 1.3329095605030261e-09
of O 0 1.2794266091020745e-08
onset O 0 1.2602306014741771e-05
of O 0 5.182670065551065e-06
51 O 0 7.339475268963724e-05
. O 0 5.684765710611828e-06

2 O 0 0.0001713561941869557
years O 0 2.575017106209998e-06
. O 0 9.907446383294882e-07

These O 0 2.194002979294396e-09
findings O 0 3.1090836571934233e-09
show O 0 1.6472866404271258e-09
that O 0 4.390606975213096e-11
BRCA1 O 0 6.971725419191444e-10
is O 0 7.908468324657747e-11
implicated O 0 2.360943662793602e-09
in O 0 3.850431362639739e-10
a O 0 2.978971791467444e-10
small O 0 6.454950463030684e-11
fraction O 0 3.139840165644614e-09
of O 0 6.699008372379467e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.02530237820065e-08
suggesting O 0 5.66284263925354e-09
the O 0 2.693731349090456e-10
involvement O 0 3.1415112733412798e-09
of O 0 4.114508733721323e-09
another O 0 1.0853481446915225e-09
susceptibility O 0 1.897810797402144e-08
gene O 0 1.5416560472658603e-08
( O 0 4.099626949027879e-08
s O 0 2.921344957940164e-06
) O 0 1.1035785973945167e-06

Paternal O 0 0.00035466282861307263
transmission O 1 0.999848484992981
of O 1 0.9999891519546509
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9993401169776917

We O 0 5.99235789877639e-08
report O 0 1.1869487615001617e-09
a O 0 1.1803716337688286e-10
rare O 0 7.755623226968211e-11
case O 0 1.2597722864882144e-10
of O 0 4.28544444375234e-09
paternally O 1 0.9999998807907104
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8710204362869263
DM B-Disease 1 1.0
) O 0 7.67571634696651e-07
. O 0 3.252007729770412e-07

The O 0 1.7396939711034065e-07
proband O 0 4.144008926232345e-06
is O 0 1.4694004901727453e-09
a O 0 4.2666506439026364e-10
23 O 0 3.84803966468894e-09
year O 0 3.9970393661548087e-10
old O 0 1.486921883042669e-05
, O 0 2.073308678518515e-06
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 1 0.9999423027038574
who O 0 0.23268046975135803
suffers O 1 0.9999998807907104
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 0.045487500727176666

He O 0 7.312362271250095e-08
presented O 0 6.78771883144691e-08
with O 0 5.353429699539447e-09
respiratory O 1 0.9995040893554688
and O 0 1.4701917905313167e-08
feeding O 0 8.619257840791761e-08
difficulties O 0 3.444843741817749e-06
at O 0 1.1642518074950203e-05
birth O 0 9.872114787867758e-07
. O 0 2.458675680827582e-07

His O 0 2.682582817215007e-06
two O 0 2.7729288376576733e-06
sibs O 1 0.7251504063606262
suffer O 0 1.4500324141408782e-05
from O 0 7.356806577263342e-07
childhood O 1 0.9109681248664856
onset O 1 0.9999990463256836
DM B-Disease 1 1.0
. O 0 0.00022536067990586162

Their O 0 2.5922638258180086e-08
late O 0 5.41740155313164e-06
father O 0 9.153162494612843e-08
had O 0 7.617088626510338e-10
the O 0 6.219231379889223e-11
adult O 0 1.922107056850919e-10
type O 0 4.21450874199536e-09
of O 0 3.6655720236922207e-07
DM B-Disease 1 1.0
, O 0 5.1526161115589275e-09
with O 0 5.124514146359616e-10
onset O 0 1.396281186316628e-05
around O 0 1.690512618779394e-08
30 O 0 4.275852916180156e-08
years O 0 1.7997882295617273e-08
. O 0 5.367777689002651e-08

Only O 0 1.7053579881576297e-08
six O 0 1.19817167298919e-09
other O 0 7.018281789061831e-12
cases O 0 6.352351804295164e-12
of O 0 6.344749725606391e-11
paternal O 0 7.524707257289265e-08
transmission O 0 0.4678654372692108
of O 1 0.993224024772644
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 9.672532996773953e-07
been O 0 4.183689394920975e-09
reported O 0 6.168082711255352e-10
recently O 0 2.0429964386892152e-09
. O 0 3.6133755987322047e-09

We O 0 1.8595212480931878e-08
review O 0 1.2975999164055452e-09
the O 0 2.918746633273628e-10
sex O 0 2.819142697063626e-10
related O 0 1.404549393457799e-10
effects O 0 7.3425199254018025e-09
on O 0 2.8431811571749677e-08
transmission O 0 0.0001225688902195543
of O 0 6.72195601509884e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.33456432819366455

Decreased O 0 6.052341063877975e-07
fertility O 0 1.5282248000403342e-07
of O 0 5.162660077218106e-09
males O 0 1.886746731072364e-10
with O 0 8.027847137048738e-11
adult O 0 2.106740453200473e-07
onset O 0 0.000692137866280973
DM B-Disease 1 1.0
and O 0 8.368580495243805e-09
contraction O 0 1.2072012722796899e-08
of O 0 3.794094372011614e-09
the O 0 2.1741808353681336e-10
repeat O 0 3.9220032777009806e-10
upon O 0 3.5670763565143204e-10
male O 0 1.2552733297255259e-09
transmission O 0 5.9807088170771294e-09
contribute O 0 8.46639425233775e-11
to O 0 5.0055352224243066e-11
the O 0 2.0056252492128834e-10
almost O 0 2.445327551559018e-10
absent O 0 9.036618120461526e-10
occurrence O 0 5.454434126583863e-10
of O 0 6.681969422217549e-10
paternal O 0 1.0598532185213116e-07
transmission O 0 0.00011445609561633319
of O 0 0.0005195561680011451
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.2252751588821411

Also O 0 5.7964943067645436e-08
the O 0 9.05553321217667e-09
fathers O 0 1.4350697519205369e-08
of O 0 2.524270570347653e-09
the O 0 1.5953994791928494e-09
reported O 0 1.565396168246025e-08
congenitally O 0 4.249448011250934e-06
affected O 0 1.609888666820325e-09
children O 0 2.248800312631971e-10
showed O 0 2.056849357501278e-09
, O 0 7.675494267944671e-11
on O 0 3.762845590671304e-09
average O 0 2.2180282055472844e-09
, O 0 7.163868387394245e-10
shorter O 0 5.514705136988596e-08
CTG O 0 4.3016697759412637e-07
repeat O 0 1.8727693174014348e-08
lengths O 0 1.2512154512478446e-07
and O 0 1.662065485241726e-10
hence O 0 2.915587549168208e-09
less O 0 4.58130200442497e-09
severe O 0 1.5057260327466793e-07
clinical O 0 1.758724295086722e-07
symptoms O 0 1.352720175873401e-07
than O 0 3.222914990441694e-11
the O 0 1.9328641465143903e-10
mothers O 0 2.2264831645024685e-10
of O 0 1.668250093622703e-09
children O 0 2.118484943025578e-09
with O 0 1.539243044135219e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9983903169631958

We O 0 7.193710160890987e-08
conclude O 0 6.284263065481355e-08
that O 0 1.3468522130910543e-10
paternal O 0 1.1398674359952565e-07
transmission O 0 1.1539596016518772e-05
of O 0 0.00015116354916244745
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.1526994967425708e-06
rare O 0 1.0539240591356247e-08
and O 0 6.186979401023862e-11
preferentially O 0 1.3466673609574542e-10
occurs O 0 6.237050459434457e-11
with O 0 9.845735338132044e-12
onset O 0 3.301219635432062e-07
of O 0 1.4127584790912806e-06
DM B-Disease 1 1.0
past O 0 2.0163794545169367e-07
30 O 0 1.1003564281963918e-08
years O 0 2.5027246941533576e-10
in O 0 3.935902298524141e-11
the O 0 3.749532351271512e-10
father O 0 7.523254907937371e-09
. O 0 1.749038247567114e-09
. O 0 3.641849488644766e-08

The O 0 5.430086957858293e-07
RB1 O 0 7.1424660745833535e-06
gene O 0 2.499607276718052e-08
mutation O 0 4.2601069338843445e-09
in O 0 1.7171005728400246e-09
a O 0 1.493813961417345e-08
child O 0 1.72353182392726e-07
with O 0 1.3098889439788763e-07
ectopic B-Disease 1 0.9999996423721313
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.005066039506345987

The O 0 6.098193807702046e-07
RB1 O 0 5.65254595130682e-06
gene O 0 2.6567308353264707e-08
mutation O 0 1.3205655458037313e-09
was O 0 7.319588046783565e-09
investigated O 0 1.4963006833568215e-08
in O 0 8.824136976670616e-10
a O 0 2.329924475574785e-09
child O 0 3.30035625495384e-08
with O 0 2.5059417652073535e-08
ectopic B-Disease 1 0.8848926424980164
intracranial I-Disease 1 0.9999332427978516
retinoblastoma I-Disease 0 0.06581772118806839
using O 0 1.4800928482827658e-08
DNA O 0 2.33365593516055e-09
obtained O 0 2.3852497754717206e-09
from O 0 1.9933223127654998e-10
both O 0 8.268156992397024e-11
the O 0 3.3855485082057157e-09
pineal B-Disease 0 5.067544407211244e-05
and I-Disease 0 5.4192537390918e-07
retinal I-Disease 1 0.9999966621398926
tumours I-Disease 1 1.0
of O 1 0.6229352951049805
the O 0 1.6778336430434138e-05
patient O 0 0.00021801369439344853
. O 0 8.547279435333621e-07

A O 0 2.8028096039633965e-06
nonsense O 0 7.424555406032596e-07
mutation O 0 8.025666353717043e-09
in O 0 6.147742759310404e-09
exon O 0 3.2223582024926145e-07
17 O 0 5.4048545194973485e-08
( O 0 7.964815473826548e-10
codon O 0 1.8329937567784782e-09
556 O 0 1.1487161444279081e-08
) O 0 9.383988031075319e-10
of O 0 1.9597649725255906e-08
the O 0 1.511214975380426e-08
RB1 O 0 4.395584255689755e-06
gene O 0 5.862864327355055e-08
was O 0 8.480627116114192e-07
found O 0 2.915765406896753e-09
to O 0 1.0853392490295377e-10
be O 0 7.609359670146532e-11
present O 0 3.3444197411469645e-10
homozygously O 0 1.8656464817468077e-07
in O 0 1.5325258839737899e-09
both O 0 1.0855033538703651e-09
the O 0 5.715024009589342e-09
retinal B-Disease 0 4.9847454647533596e-05
and I-Disease 0 1.1986470838110108e-07
the I-Disease 0 3.39158555107133e-06
pineal I-Disease 1 0.999957799911499
tumours I-Disease 1 1.0
. O 0 0.00014925631694495678

The O 0 2.7412525582803937e-08
same O 0 1.3113814478771246e-09
mutation O 0 3.4698807716004865e-10
was O 0 3.795904035541753e-09
present O 0 4.1675357609349817e-10
heterozygously O 0 1.7423097631308337e-08
in O 0 2.1399018668155634e-10
the O 0 7.239742833009544e-11
DNA O 0 2.665844212046409e-10
from O 0 1.080130915265265e-10
the O 0 6.481821329673565e-11
constitutional O 0 1.3952217159385327e-08
cells O 0 8.67424743145051e-11
of O 0 2.5483908316914494e-09
the O 0 2.7422539239374544e-10
patient O 0 4.361398797669835e-09
, O 0 2.345466876274571e-10
proving O 0 4.2478389694622365e-09
it O 0 1.4132823383805615e-11
to O 0 2.2389297013591936e-11
be O 0 1.6395027002680251e-10
of O 0 4.546543586059215e-09
germline O 0 2.687376650101214e-07
origin O 0 3.472598919529446e-08
. O 0 1.1227231766497425e-07

The O 0 4.238937734157844e-08
initial O 0 3.626819067292786e-09
mutation O 0 7.41451455787967e-10
was O 0 8.577302423873334e-09
shown O 0 6.166024357767697e-10
to O 0 8.455468963886048e-11
have O 0 2.356002025416526e-11
occurred O 0 5.083367060620958e-09
in O 0 5.1193924099912635e-11
the O 0 4.174536827328268e-10
paternally O 0 1.0236871617053112e-07
derived O 0 3.031015793908409e-08
RB1 O 0 3.559832066457602e-06
allele O 0 5.598856773758598e-07
. O 0 5.88384068578307e-07

The O 0 5.618809240104383e-08
mutation O 0 1.388763992693498e-09
is O 0 1.7722079359572263e-10
in O 0 1.139675576133925e-10
an O 0 1.043147079132778e-11
area O 0 5.447405859726473e-10
of O 0 2.4114890084803164e-09
the O 0 8.155189301639609e-10
gene O 0 2.2846406710907985e-10
that O 0 4.4205552413023597e-11
encodes O 0 2.0827099767029011e-10
the O 0 6.68883004539822e-10
protein O 0 3.5749518900729527e-09
- O 0 1.5129592023654936e-09
binding O 0 2.7622346632227845e-09
region O 0 1.7786708994549372e-08
known O 0 1.6307679651106355e-09
as O 0 5.975642758393462e-10
the O 0 4.162199473967121e-09
pocket O 0 0.00021044816821813583
region O 0 9.4401855221804e-08
and O 0 9.106103648903741e-10
has O 0 5.517589857229055e-11
been O 0 1.9339288850894754e-11
detected O 0 4.945164833181082e-10
in O 0 1.1199405985928834e-11
other O 0 6.20278568091992e-12
cases O 0 7.699144100037358e-11
of O 0 6.6037477708391634e-09
retinoblastoma B-Disease 0 5.13086069986457e-06
. O 0 1.5265285924215277e-08
. O 0 3.0721253096999135e-07

Low O 0 6.022005436534528e-07
levels O 0 2.2194384996510053e-08
of O 0 4.082644888825371e-09
beta O 0 1.9626678948725385e-08
hexosaminidase O 0 7.779858179901566e-08
A O 0 3.2850873132872493e-09
in O 0 5.28083410333835e-10
healthy O 0 7.953187552978136e-10
individuals O 0 4.6654021791658895e-12
with O 0 2.5442470352743385e-10
apparent O 0 3.822462531388737e-05
deficiency O 1 0.8676429390907288
of O 0 8.592478479840793e-06
this O 0 1.737149979419428e-08
enzyme O 0 4.6241547124736826e-07
. O 0 4.033444724882429e-07

Appreciable O 0 6.491879503300879e-06
beta O 0 4.204881861369358e-06
hexosaminidase O 0 1.8386432202532887e-05
A O 0 1.6727598222132656e-06
( O 0 3.1990454729680096e-09
hex O 0 1.18479768218549e-07
A O 0 1.2633226909031237e-08
) O 0 5.78367527481749e-11
activity O 0 5.034991312768966e-10
has O 0 2.1640848835158266e-11
been O 0 5.283803602984527e-11
detected O 0 1.9220640634642905e-09
in O 0 2.472765325833848e-10
cultured O 0 2.3900874168703012e-08
skin O 0 2.3721119291053583e-08
fibroblasts O 0 3.3552336020648e-08
and O 0 1.0712931874934384e-08
melanoma B-Disease 0 5.578599484579172e-06
tissue O 0 1.4509537038520648e-07
from O 0 4.080514059978668e-08
healthy O 0 2.213894623182e-09
individuals O 0 2.8744682415565714e-12
previously O 0 1.2612804134448652e-09
reported O 0 3.6790373525441566e-10
as O 0 1.9087575964249481e-10
having O 0 4.307020073923695e-09
deficiency B-Disease 0 1.2952020369993988e-05
of I-Disease 0 8.473904017591849e-06
hex I-Disease 0 1.5519754015258513e-06
A I-Disease 0 1.1876649885778079e-08
activity O 0 9.21776766027449e-10
indistinguishable O 0 1.3242532626023262e-09
from O 0 1.3968571958844489e-11
that O 0 8.535034658196938e-13
of O 0 1.1702504243427114e-10
patients O 0 1.2127069348721875e-09
with O 0 1.5436767171195243e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.887594645377249e-05
TSD B-Disease 1 0.9165055155754089
) O 0 2.003838517339318e-07
. O 0 3.826349654900696e-07

Identification O 0 8.136102280786872e-08
and O 0 1.2865402965189787e-08
quantitation O 0 0.00014025579730514437
of O 0 3.1217473406286445e-06
hex O 0 8.011987119971309e-06
A O 0 7.258211098815082e-07
, O 0 2.0262900246592608e-09
amounting O 0 8.576059862264174e-09
to O 0 3.384354352320429e-09
3 O 0 7.222953399832477e-07
. O 0 2.6006935627265193e-07

5 O 0 5.9127532949787565e-06
% O 0 2.38104945537998e-07
- O 0 1.2156785942352144e-06
6 O 0 2.279764657941996e-06
. O 0 2.5881936949190276e-07

9 O 0 1.6162787233042764e-06
% O 0 1.1633346730377525e-08
of O 0 1.0854003917870614e-08
total O 0 8.80275519143936e-10
beta O 0 5.051965601410302e-08
hexosaminidase O 0 4.11491889451554e-08
activity O 0 1.1519936116144436e-09
, O 0 4.0650260935137794e-11
has O 0 1.7192085428885395e-12
been O 0 1.864027378631339e-12
obtained O 0 1.1809339964252707e-11
by O 0 3.8151783815498774e-11
cellulose O 0 1.0976883402236126e-07
acetate O 0 5.983837780831891e-08
gel O 0 6.86819532802474e-07
electrophoresis O 0 4.818284651264548e-07
, O 0 4.70492800275224e-08
DEAE O 0 0.0002833666221704334
- O 0 3.578177938834415e-06
cellulose O 0 1.6171565221156925e-05
ion O 0 0.00015918973076622933
- O 0 3.960722949614137e-07
exchange O 0 1.1119709597551264e-06
chromatography O 0 5.590678483713418e-06
, O 0 1.3268928178433725e-09
radial O 0 6.88769645762477e-08
immunodiffusion O 0 3.741353111763601e-07
, O 0 1.3467090775876045e-09
and O 0 1.7829975273997434e-09
radioimmunoassay O 0 1.1461900612630416e-05
. O 0 7.19532920356869e-07

Previous O 0 4.0092533026836463e-07
family O 0 2.6058765811853846e-08
studies O 0 2.7014248615842007e-09
suggested O 0 1.438253072194584e-09
that O 0 5.76777601374312e-12
these O 0 5.010757433976387e-12
individuals O 0 5.068652962625375e-12
may O 0 2.7447866202123805e-10
be O 0 6.510616351595999e-11
compound O 0 3.304764240041891e-09
heterozygotes O 0 9.432653547136738e-10
for O 0 5.854084578205132e-11
the O 0 2.0186431692881257e-10
common O 0 7.880375241242632e-10
mutant O 0 1.0727080557160207e-08
TSD B-Disease 0 6.023814762556867e-07
gene O 0 3.5809981646650613e-09
and O 0 1.0513637738185366e-09
a O 0 1.5563923483341568e-09
rare O 0 2.0640726905440943e-09
( O 0 2.0550952606335215e-10
allelic O 0 9.62556523376179e-09
) O 0 1.8630705866939934e-09
mutant O 0 6.345098313431663e-08
gene O 0 1.2429937612523645e-07
. O 0 2.8360028636598145e-07

Thus O 0 5.998830943099165e-07
, O 0 7.240703148170269e-09
the O 0 2.227163786727715e-09
postulated O 0 9.94076287952339e-08
rate O 0 9.446486259889753e-09
mutant O 0 2.701868062615631e-09
gene O 0 6.103924587996801e-10
appears O 0 5.162243965628477e-10
to O 0 1.754385352270571e-11
code O 0 4.6057949121269814e-11
for O 0 1.3610911876738019e-11
the O 0 2.691059701465104e-11
expression O 0 2.5970961492483013e-10
of O 0 2.128375253818149e-09
low O 0 5.4605160393350616e-09
amounts O 0 9.693249536368853e-10
of O 0 1.3979600588243102e-08
hex O 0 6.3311898657048e-07
A O 0 6.230329177014937e-07
. O 0 1.0651851312104554e-07

Heterozygotes O 0 2.1499413378478494e-06
for O 0 1.5220310345398502e-08
the O 0 4.565408939782856e-09
rare O 0 4.549831178479735e-09
mutant O 0 4.009288900874708e-09
may O 0 1.7879558944500218e-09
be O 0 1.696907198089903e-10
indistinguishable O 0 4.091071481582276e-09
from O 0 2.090857487146991e-10
heterozygotes O 0 1.1214850159646517e-09
for O 0 8.559513514638795e-11
the O 0 5.695922622450666e-10
common O 0 3.3140448607582584e-08
TSD B-Disease 0 1.5597888705087826e-05
mutant O 0 7.855813919377397e-07
. O 0 3.5025303191105195e-07

However O 0 5.977928196898574e-08
, O 0 2.7362834220667764e-09
direct O 0 3.930032743681977e-09
visualization O 0 1.1094164875657953e-07
and O 0 3.584073260398668e-09
quantitation O 0 0.001351705053821206
of O 0 1.622622221475467e-05
hex O 0 6.197964466991834e-06
A O 0 1.7998981860500862e-08
by O 0 1.9768247802587346e-11
the O 0 9.357672969834141e-11
methods O 0 6.450083578357635e-09
described O 0 1.6544690062403333e-09
may O 0 3.331597220324056e-10
prevent O 0 3.1451730109210985e-10
false O 0 3.4287492289841737e-10
- O 0 7.303184168527821e-10
positive O 0 6.334895108484062e-11
prenatal O 0 4.790509322560865e-08
diagnosis O 0 2.248304831198311e-08
of O 0 3.684293403694028e-08
TSD B-Disease 0 5.8790119510376826e-05
in O 0 7.889331499200125e-08
fetuses O 0 5.682775849891186e-08
having O 0 4.810751796924251e-09
the O 0 1.205930244552178e-09
incomplete O 0 2.629261786069037e-08
hex B-Disease 0 1.7496716964160441e-06
A I-Disease 0 1.1863380677823443e-06
deficiency I-Disease 0 0.00014576900866813958
of O 0 1.2271545983821852e-06
the O 0 3.2360652824081626e-08
type O 0 5.944376084698888e-07
described O 0 1.840769137118059e-08
in O 0 4.329247238477052e-10
the O 0 6.64685151363642e-09
four O 0 4.3373098890242545e-08
healthy O 0 1.0206417755398434e-07
individuals O 0 9.072479656424548e-08

The O 0 1.2173256891401252e-07
tumor B-Disease 0 9.380592587149295e-07
suppressor O 0 1.0967880825774046e-06
gene O 0 1.3531742126815516e-07
Smad4 O 0 1.015777434076881e-05
/ O 0 7.932649168651551e-07
Dpc4 O 0 1.146356453318731e-06
is O 0 2.6623483972976203e-10
required O 0 2.351572270242741e-10
for O 0 6.022024545693228e-11
gastrulation O 0 1.1389118093063644e-08
and O 0 7.972898036223697e-11
later O 0 9.478534623852397e-10
for O 0 1.1127146426481715e-10
anterior O 0 3.223707167876455e-08
development O 0 3.4787905889288595e-08
of O 0 4.172193541762681e-07
the O 0 5.733521746265069e-08
mouse O 0 9.367167308482749e-08
embryo O 0 1.2424491657725412e-08
. O 0 7.172159399715383e-08

Mutations O 0 6.410714803450901e-08
in O 0 1.2835426943524908e-08
the O 0 3.447014407242932e-08
SMAD4 O 0 9.760839748196304e-05
/ O 0 4.549496679828735e-06
DPC4 O 0 6.6172806327813305e-06
tumor B-Disease 0 1.3066050996712875e-07
suppressor O 0 8.66352891648603e-08
gene O 0 1.706203889284552e-08
, O 0 3.1120086507741007e-09
a O 0 4.922224849934764e-09
key O 0 5.636261448671576e-07
signal O 0 4.923490450892132e-07
transducer O 0 2.579330384833156e-07
in O 0 8.659526429255493e-09
most O 0 6.069850178036518e-10
TGFbeta O 0 4.461317359982786e-07
- O 0 7.86659359874875e-09
related O 0 9.382416621406264e-09
pathways O 0 1.3900466333538475e-09
, O 0 5.1770615572266365e-11
are O 0 2.101073655336183e-12
involved O 0 4.467615860592744e-11
in O 0 2.89056781982433e-11
50 O 0 2.5213160448345207e-09
% O 0 2.268658683135527e-08
of O 0 0.00014739549078512937
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0004401402547955513

Homozygous O 0 6.359022336255293e-06
Smad4 O 0 6.53701281407848e-05
mutant O 0 4.011768396594562e-06
mice O 0 6.621286843255803e-07
die O 0 1.5878207193509297e-07
before O 0 2.153136158256075e-08
day O 0 3.236941736872723e-08
7 O 0 2.1905442793013208e-07
. O 0 5.390328183807469e-08

5 O 0 1.2153066563769244e-05
of O 0 2.643977268235176e-06
embryogenesis O 0 0.00017518542881589383
. O 0 5.207590220379643e-06

Mutant O 0 3.079640862324595e-07
embryos O 0 1.45854199828932e-08
have O 0 3.5488822991425195e-10
reduced O 0 6.538370955766482e-10
size O 0 4.666635411432196e-10
, O 0 2.1199104971447724e-10
fail O 0 1.3271054255525883e-09
to O 0 2.2422172452074562e-10
gastrulate O 0 1.3590172898148012e-07
or O 0 3.6951435244958475e-09
express O 0 1.3995653525000762e-09
a O 0 5.611327513754816e-10
mesodermal O 0 3.159853889656006e-08
marker O 0 7.515814104408491e-08
, O 0 1.2660381631945938e-09
and O 0 5.973705974327004e-10
show O 0 5.395440538791263e-08
abnormal O 0 9.449766480429389e-07
visceral O 0 2.6812658688868396e-06
endoderm O 0 9.336750736110844e-06
development O 0 3.895466988979024e-07
. O 0 4.1612977952354413e-07

Growth B-Disease 1 0.9999936819076538
retardation I-Disease 1 1.0
of O 0 1.5842548236832954e-05
the O 0 4.095095107459201e-07
Smad4 O 0 0.00031529017724096775
- O 0 1.2634717450055177e-06
deficient O 0 1.665275846107761e-07
embryos O 0 4.3035772168131814e-10
results O 0 8.540042978344431e-11
from O 0 1.140441005520465e-10
reduced O 0 1.2541316873893038e-09
cell O 0 3.839901729918438e-09
proliferation O 0 2.871622939437657e-09
rather O 0 3.350662455825493e-11
than O 0 1.062980953259185e-11
increased O 0 2.2353593975843467e-10
apoptosis O 0 4.704335410110616e-08
. O 0 4.646443230171826e-08

Aggregation O 0 1.7910342364757526e-07
of O 0 1.7187339551583136e-07
mutant O 0 1.5816198128959513e-07
Smad4 O 0 4.087699835508829e-06
ES O 0 3.677883739783283e-07
cells O 0 1.671170424266677e-09
with O 0 3.4018457495399446e-10
wild O 0 1.090602275155561e-09
- O 0 3.018529870502107e-09
type O 0 2.660148368249793e-08
tetraploid O 0 1.5622143791915732e-06
morulae O 0 7.932596417958848e-06
rescues O 0 8.835216931402101e-07
the O 0 6.426593301966932e-08
gastrulation B-Disease 0 6.972107803449035e-05
defect I-Disease 0 0.00010971491428790614
. O 0 2.035195620919694e-06

These O 0 7.4394934657107115e-09
results O 0 3.8342076180697404e-09
indicate O 0 3.0126283689924094e-09
that O 0 7.001679097617952e-11
Smad4 O 0 2.8831278697794005e-08
is O 0 5.7396844221901944e-11
initially O 0 1.30738739279046e-10
required O 0 8.06155836530209e-11
for O 0 1.8596178416596665e-11
the O 0 4.3326564558299197e-11
differentiation O 0 1.1611527295229962e-09
of O 0 1.577625496906876e-08
the O 0 6.260679974445793e-09
visceral O 0 2.531973279928934e-07
endoderm O 0 4.7526401658615214e-07
and O 0 7.050852124379503e-10
that O 0 5.475361830598047e-11
the O 0 4.735136172051568e-10
gastrulation B-Disease 0 1.2213781985792593e-07
defect I-Disease 0 3.353557431751142e-08
in O 0 1.5247934026518806e-09
the O 0 3.8196530383061145e-09
epiblast O 0 2.086170297843637e-06
is O 0 3.034032192150704e-10
secondary O 0 1.3522694075618347e-08
and O 0 7.508671462375105e-10
non O 0 1.1881904811161803e-06
- O 0 1.3508665688277688e-06
cell O 0 2.894489853133564e-06
autonomous O 0 1.5233950989568257e-06
. O 0 4.0958684621728025e-07

Rescued O 0 9.97621682472527e-05
embryos O 0 1.0490886097613839e-06
show O 0 2.729295545123023e-07
severe O 0 2.9245672976685455e-06
anterior O 0 4.738140432891669e-06
truncations O 1 0.8757191300392151
, O 0 1.9021813457698045e-08
indicating O 0 3.00344460413271e-08
a O 0 1.228392942920209e-09
second O 0 1.184497055994882e-09
important O 0 4.684542753707888e-10
role O 0 2.4612145654856477e-09
for O 0 1.0390633908841096e-09
Smad4 O 0 2.0776590190507704e-06
in O 0 2.7263553192824475e-08
anterior O 0 1.0523650416871533e-05
patterning O 0 0.0023735123686492443
during O 0 0.0005781947402283549
embryogenesis O 0 0.00020773131109308451
. O 0 2.5213569188053953e-06

Prevalence O 0 1.2450086614990141e-06
of O 0 3.3094210039052996e-08
p16 O 0 1.8230285547815583e-07
and O 0 5.021088433920795e-09
CDK4 O 0 2.390352892689407e-05
germline O 0 1.6568531009397702e-06
mutations O 0 8.274049889678281e-09
in O 0 9.741517814632061e-09
48 O 0 5.942130883340724e-06
melanoma B-Disease 1 0.9989780187606812
- O 0 0.00737857585772872
prone O 0 0.00031321245478466153
families O 0 5.854343676503504e-10
in O 0 1.364180945984117e-08
France O 0 1.5980002672222327e-06
. O 0 3.094782528023643e-07

The O 0 1.5139896447635692e-07
French O 0 0.00016973218589555472
Familial B-Disease 1 0.8429218530654907
Melanoma I-Disease 1 0.9973932504653931
Study O 0 2.3138217386531323e-07
Group O 0 5.4225015588826864e-08
. O 0 2.602608901725034e-07

Germline O 0 3.245459447498433e-05
mutations O 0 9.748230667128155e-08
in O 0 8.742872203981733e-09
the O 0 5.671652480998546e-09
p16 O 0 6.068952274063122e-08
and O 0 1.2361160983687114e-09
CDK4 O 0 3.892305812769337e-06
genes O 0 1.6618317832950424e-09
have O 0 8.020424602239729e-11
been O 0 3.2886509487850546e-11
reported O 0 3.5270637105400127e-11
in O 0 5.5361722151037185e-12
a O 0 4.989397783816685e-11
subset O 0 3.53002871378294e-09
of O 0 1.2107850011489063e-07
melanoma B-Disease 0 1.1441368769737892e-05
pedigrees O 0 4.570848588514309e-08
, O 0 3.045912966292974e-10
but O 0 1.3252727040780066e-11
their O 0 5.252440843372952e-12
prevalence O 0 7.467980123188056e-10
is O 0 5.5529977317780865e-12
not O 0 1.040863489149002e-11
well O 0 1.5502320260818436e-10
known O 0 3.6338956288517466e-09
. O 0 4.271695530633224e-08

We O 0 1.1797044230377196e-08
searched O 0 1.4829016237172254e-08
for O 0 8.215463725980143e-11
such O 0 4.800334435506315e-11
germline O 0 1.951592132343194e-08
mutations O 0 9.926278687899526e-10
in O 0 3.134556392225818e-09
48 O 0 9.115484544963692e-07
French O 0 0.08857684582471848
melanoma B-Disease 1 0.9999958276748657
- O 0 0.10861941426992416
prone O 0 0.0002348909038119018
families O 0 7.379381133931773e-11
selected O 0 4.2455847171218863e-10
according O 0 5.6222949906814534e-11
to O 0 2.7723818032954206e-11
two O 0 3.802668249730523e-11
major O 0 4.536778452912671e-10
criteria O 0 5.005368119981313e-09
families O 0 9.395547707902185e-12
with O 0 2.4215067451205385e-11
at O 0 2.140643040604573e-08
least O 0 3.895601549674943e-11
three O 0 1.8105140650592766e-11
affected O 0 1.4852149024524586e-11
members O 0 1.9263193470897555e-11
( O 0 3.2246857961659714e-11
n O 0 4.175255252647503e-09
= O 0 5.071097319842011e-09
20 O 0 3.2557136986355317e-09
) O 0 4.09213669894104e-11
or O 0 1.541301808405393e-10
families O 0 8.47881660714922e-12
with O 0 8.432594900131818e-12
two O 0 3.888215444058929e-11
affected O 0 8.182138994117238e-11
members O 0 2.3650517308460017e-11
, O 0 2.396767159740243e-11
one O 0 2.1362958277371114e-11
of O 0 5.606128339330496e-10
them O 0 2.1875863967513176e-11
affected O 0 2.817421469736292e-11
before O 0 1.4063185338475392e-10
the O 0 7.61255294912111e-11
age O 0 7.726775885785742e-10
of O 0 1.8097875420508558e-09
50 O 0 1.4724276242716883e-09
( O 0 8.079382995962447e-11
n O 0 5.982237816226643e-09
= O 0 6.236152927385774e-09
28 O 0 4.707377954105141e-08
) O 0 4.3179659847680796e-10
, O 0 3.402196024904214e-10
and O 0 1.1800249666293894e-10
one O 0 5.229112975957406e-11
additional O 0 2.2734385207723307e-10
minor O 0 1.3239626639460766e-07
criterion O 0 0.00026729897945187986
. O 0 2.2606559468840715e-06

Sixteen O 0 1.0912781363003887e-06
different O 0 1.3704322121554924e-08
p16 O 0 4.809006668438087e-07
germline O 0 4.2799447896868514e-07
mutations O 0 2.8411792918348056e-09
were O 0 8.851597232961694e-10
found O 0 8.940537893353806e-11
in O 0 7.913930621938903e-11
21 O 0 2.380618591146799e-09
families O 0 1.173821977118461e-11
, O 0 6.49941281349875e-11
while O 0 8.126029849009342e-10
one O 0 2.6954533050016494e-10
germline O 0 2.0775541287321175e-08
mutation O 0 2.628953166272652e-10
, O 0 2.799723508584151e-10
Arg24His O 0 7.64352563464854e-08
, O 0 5.948997960913971e-10
was O 0 6.5395466819495596e-09
detected O 0 9.73642766410876e-09
in O 0 5.239009226443159e-10
the O 0 3.573751961027938e-09
CDK4 O 0 1.6731966752558947e-05
gene O 0 1.7443822741824988e-07
. O 0 2.1744448019944684e-07

The O 0 1.3871154003197717e-08
frequency O 0 5.30769028728173e-08
of O 0 4.317827873023816e-09
p16 O 0 4.9708130944736695e-09
gene O 0 3.8978259508937185e-10
mutation O 0 8.239300214318845e-11
in O 0 4.0876902557274164e-11
our O 0 3.839963763629939e-11
sample O 0 1.247674186188874e-11
( O 0 1.0741478019549167e-11
44 O 0 2.386550124189313e-10
% O 0 1.1402713495645145e-10
) O 0 8.416947694378507e-11
is O 0 5.972449618196762e-11
among O 0 6.380875862410651e-12
the O 0 9.275116091833624e-11
highest O 0 3.853416252752595e-09
rates O 0 1.7978318833655749e-09
yet O 0 8.572355325586756e-11
reported O 0 1.230692908693598e-10
and O 0 1.2797127073305159e-11
the O 0 2.697145007335422e-10
CDK4 O 0 2.3310398944431654e-07
mutation O 0 2.2054388870706987e-10
is O 0 2.6228815994122634e-11
the O 0 7.162402615445984e-11
second O 0 3.4039551732867324e-10
mutation O 0 3.732690545543704e-11
detected O 0 1.435953245199073e-09
in O 0 6.165162824700587e-11
this O 0 1.8972287282870148e-11
gene O 0 2.8550641850699776e-09
worldwide O 0 7.140980251563178e-09
. O 0 1.582731812277416e-07

In O 0 1.9819138685761573e-07
summary O 0 2.413214815533138e-06
, O 0 1.3773232554470383e-09
our O 0 3.07733560855894e-10
results O 0 1.7465336121791353e-10
show O 0 3.488248578875641e-10
frequent O 0 1.3324920333790402e-10
involvement O 0 9.228851016729323e-10
of O 0 1.2769367785381291e-09
the O 0 9.544316448284462e-10
p16 O 0 2.5903064582166735e-08
gene O 0 1.928149373497945e-08
in O 0 2.4784904795183138e-08
familial B-Disease 0 0.00020930473692715168
melanoma I-Disease 0 0.004189840983599424
and O 0 6.79452982765838e-09
confirm O 0 4.996840718973772e-09
the O 0 5.313184892052902e-10
role O 0 3.553510374842972e-09
of O 0 2.116050623612864e-08
the O 0 5.8792894996884115e-09
CDK4 O 0 7.5050511441077106e-06
gene O 0 6.618173120642723e-09
as O 0 5.036338457387046e-09
a O 0 5.036744710196217e-08
melanoma B-Disease 0 0.011819050647318363
- O 0 6.471906999649946e-06
predisposing O 0 6.368064987327671e-06
gene O 0 7.468634066754021e-07
. O 0 2.2141115607610118e-07
. O 0 2.1297300918377005e-06

Progression O 0 2.2052867279853672e-05
of O 0 8.24604467197787e-06
somatic O 0 1.2984794011572376e-05
CTG O 0 1.3501682587957475e-05
repeat O 0 2.4230168094163673e-08
length O 0 1.3136169929595098e-09
heterogeneity O 0 3.529786463118967e-09
in O 0 8.409951207655197e-11
the O 0 8.743030605051771e-11
blood O 0 1.2451364383991859e-09
cells O 0 6.998161161675398e-09
of O 0 0.00016557381604798138
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.840740978717804
. O 0 3.807678467637743e-06

The O 0 6.166956278974567e-09
genetic O 0 1.3708530310907463e-08
basis O 0 4.6757455152146576e-07
of O 1 0.9937589168548584
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.03556381165981293
DM B-Disease 1 1.0
) O 0 4.295501732087814e-09
is O 0 1.672926935869512e-10
the O 0 8.941595380784761e-11
expansion O 0 3.5166285439203193e-09
of O 0 1.1756656093098172e-08
an O 0 4.519093543819963e-09
unstable O 0 0.00011140974675072357
CTG O 0 1.4923245544196106e-05
repeat O 0 4.332679992558042e-08
in O 0 2.375406760179999e-09
the O 0 5.162345217968323e-09
34 O 0 3.656514735439487e-08
UTR O 0 2.322699401702266e-06
of O 0 1.4587540420052392e-07
the O 0 9.297410485942237e-08
DM B-Disease 1 0.9999994039535522
protein O 0 4.626523661954707e-07
kinase O 0 3.744861842847058e-08
gene O 0 7.909231491964874e-09
on O 0 2.50281857461232e-07
chromosome O 0 7.520634426327888e-06
19 O 0 9.887539818009827e-06
. O 0 1.259392320207553e-06

One O 0 2.8394795847930254e-08
of O 0 3.948171567458303e-08
the O 0 6.243221939428167e-09
principal O 0 1.4924761160273192e-07
features O 0 2.821392675045331e-09
of O 0 6.247464767739075e-08
the O 0 5.013181407775846e-07
DM B-Disease 1 1.0
mutation O 0 1.836346896766372e-08
is O 0 3.5962330335870263e-10
an O 0 8.671418444405887e-11
extraordinarily O 0 8.73805472423328e-09
high O 0 1.1578072722784327e-08
level O 0 2.0405252598720836e-07
of O 0 1.7616787317820126e-07
somatic O 0 9.513025815977016e-07
mosaicism O 0 9.8071914180764e-06
, O 0 3.699704709259066e-10
due O 0 1.8663852685563143e-09
to O 0 6.997860624302632e-11
an O 0 1.6278917450152086e-11
extremely O 0 6.790743523055198e-10
high O 0 1.5380428042277572e-09
degree O 0 7.236468491100823e-08
of O 0 4.652187080012027e-09
somatic O 0 1.2010694661057641e-07
instability O 0 9.695328628822608e-08
both O 0 8.147151286941323e-10
within O 0 9.754751451040988e-10
and O 0 4.254012767046511e-11
between O 0 1.1666360100193174e-09
different O 0 6.671119767709399e-10
tissues O 0 5.295414240436003e-08
. O 0 5.6700002915022196e-08

This O 0 9.925587107773026e-08
instability O 0 1.114244878408499e-05
appears O 0 3.1669070921225284e-08
to O 0 2.8183147482430115e-10
be O 0 6.482266112772805e-11
biased O 0 9.661352828871372e-10
towards O 0 3.0235067227657453e-10
further O 0 5.319347046173206e-11
expansion O 0 1.7571794019843878e-10
and O 0 4.1444663673173565e-11
continuous O 0 1.5345089643403753e-09
throughout O 0 1.58556986984415e-10
the O 0 3.04162250941431e-10
life O 0 2.870165216606324e-10
of O 0 1.5936658659398972e-09
an O 0 2.7002631033945512e-11
individual O 0 1.8369363322112697e-11
, O 0 1.0588232374209028e-10
features O 0 1.1611349659546022e-09
that O 0 7.960058306943907e-11
could O 0 3.26831756103374e-10
be O 0 3.187822575356769e-11
associated O 0 5.086021603872837e-10
with O 0 1.3553401456700698e-11
the O 0 8.705162701794222e-10
progressive O 0 4.458409421204124e-06
nature O 0 2.3384737701803715e-08
of O 0 9.410163670509064e-08
the O 0 1.0414751017151502e-07
disease O 0 0.0002988540509250015
. O 0 2.0395194155753416e-07

Although O 0 2.2441918545723638e-08
increasing O 0 5.590648388675845e-09
measured O 0 4.4977848112637275e-09
allele O 0 1.5322627611169537e-09
size O 0 6.25965324019262e-09
between O 0 2.3505789314981484e-08
patients O 0 2.5971964578985762e-09
clearly O 0 1.9938861672841313e-09
correlates O 0 1.008617300790604e-09
with O 0 5.0470049146877916e-12
an O 0 8.080222688860994e-13
increased O 0 1.6448328810092505e-11
severity O 0 1.1279620792947753e-08
of O 0 2.8482545211261368e-09
symptoms O 0 1.0579078058015057e-08
and O 0 4.7284006571279846e-11
an O 0 8.077498739322841e-12
earlier O 0 6.826116893954293e-10
age O 0 3.751794874773395e-09
of O 0 9.35950339453484e-09
onset O 0 2.5615946697143954e-07
, O 0 7.454215023017241e-11
this O 0 6.112597841084755e-12
correlation O 0 3.76122188949779e-10
is O 0 1.2115242836729934e-11
not O 0 3.022494581006452e-12
precise O 0 5.011212000916032e-10
and O 0 5.278133138886254e-11
measured O 0 5.775047107192677e-10
allele O 0 2.560003875551331e-10
length O 0 7.234957077884019e-10
cannot O 0 5.227540067487269e-10
be O 0 1.578800284951498e-11
used O 0 1.4707167775296348e-11
as O 0 3.0716204319630735e-12
an O 0 2.3485083235769144e-12
accurate O 0 1.9869312861686694e-09
predictor O 0 1.5515743712057883e-07
of O 0 1.238169744510742e-08
age O 0 9.590746685717022e-07
of O 0 4.988595719623845e-06
onset O 0 0.2585645616054535
. O 0 3.079008365602931e-06

In O 0 2.9754993136066332e-08
order O 0 4.8560537813102655e-09
to O 0 1.6335875707707004e-10
further O 0 3.1254387966583863e-10
characterize O 0 9.866993444518357e-09
the O 0 2.5870512398995515e-09
dynamics O 0 4.357265879662009e-06
of O 0 2.4602064513601363e-05
DM B-Disease 1 1.0
CTG O 0 0.18359054625034332
repeat O 0 5.307079845806584e-06
somatic O 0 4.482740678213304e-06
instability O 0 1.2912156535094255e-06
, O 0 2.1948567408003328e-09
we O 0 2.7535435043191114e-10
have O 0 7.941189372751012e-12
studied O 0 8.379468785513211e-10
repeat O 0 1.9253360017401633e-10
length O 0 2.9227561343381225e-11
changes O 0 1.812075663132351e-11
over O 0 1.98301427362102e-11
time O 0 1.2024981010938518e-10
in O 0 8.705876020087544e-10
111 O 0 0.00020809289708267897
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.500695674394592e-07
with O 0 3.6913658241211067e-10
varying O 0 9.432442382717454e-09
clinical O 0 1.229864068363895e-07
severity O 0 2.5670138370514906e-07
and O 0 1.0356779878151201e-09
CTG O 0 3.0807424877821177e-07
repeat O 0 3.0037980991437507e-09
size O 0 3.705537821030447e-10
over O 0 3.4152644601270765e-10
time O 0 3.208539822718848e-10
intervals O 0 1.5508214712411927e-09
of O 0 1.613491451557536e-09
1 O 0 9.272263667980951e-08
- O 0 3.1114641529939036e-08
7 O 0 1.7661011497693835e-07
years O 0 6.637630889372303e-08
. O 0 1.460788041640626e-07

We O 0 4.7912315892517654e-08
have O 0 1.9229724756986144e-10
found O 0 1.343204159010014e-10
a O 0 3.409509133356359e-11
direct O 0 4.955321569743987e-11
progression O 0 1.3062115833406551e-09
of O 0 2.907768248405773e-09
the O 0 8.900286618818143e-10
size O 0 9.758212016208745e-10
heterogeneity O 0 3.846748697355906e-09
over O 0 6.733837376593499e-10
time O 0 5.319167328821095e-10
related O 0 6.545732844642771e-10
to O 0 1.0427815555491549e-10
initial O 0 1.2533474258447086e-09
CTG O 0 2.487645929249993e-07
repeat O 0 3.238348034173555e-09
size O 0 5.741898623234931e-10
and O 0 8.12335962385724e-11
the O 0 4.9612227520645646e-11
time O 0 2.586221237166342e-10
interval O 0 1.6496353172357203e-09
and O 0 5.917884238204607e-11
always O 0 1.3274059629253543e-10
biased O 0 3.236660384153822e-10
towards O 0 2.476900351489064e-10
further O 0 4.518341534254233e-10
expansion O 0 1.3939262188955581e-08
. O 0 7.4499183710941e-08

Attempts O 0 3.4510412660893053e-07
to O 0 3.4256262271270543e-09
mathematically O 0 2.8264464546623458e-08
model O 0 5.288638860179162e-09
the O 0 4.3814174510714565e-09
dynamics O 0 7.920985808596015e-06
have O 0 3.923546376682907e-09
proved O 0 1.090206112053238e-07
only O 0 9.383015892039381e-11
partially O 0 1.9021730857105013e-09
successful O 0 9.662312061564649e-10
suggesting O 0 3.5204922310683173e-10
that O 0 1.0378159919985364e-12
individual O 0 9.776621786444784e-13
specific O 0 6.310182844998513e-12
genetic O 0 2.7555713266735893e-10
and O 0 1.9754312075015434e-10
/ O 0 6.634188309817546e-08
or O 0 2.494072059988639e-09
environmental O 0 7.301767190881492e-09
factors O 0 6.293172205573683e-09
also O 0 4.629003291789502e-10
play O 0 4.531004016428142e-09
a O 0 1.4150478566676838e-09
role O 0 2.0688190716100507e-08
in O 0 1.647230973844671e-08
somatic O 0 6.15643557466683e-07
mosaicism O 0 2.9709353839280084e-05
. O 0 3.6681733206478384e-08
. O 0 3.381394719781383e-07

Aspartylglucosaminuria B-Disease 1 0.9999735355377197
among O 0 8.483974411888084e-09
Palestinian O 0 1.3782930352590483e-07
Arabs O 0 2.8587803058144345e-07
. O 0 1.7030151866492815e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.998145341873169
AGU B-Disease 1 1.0
) O 0 3.605969212117088e-08
is O 0 1.2914123104224018e-09
a O 0 1.0482060774918978e-09
rare O 0 2.5317416429970763e-07
disorder B-Disease 1 0.9999946355819702
of I-Disease 1 0.9978088736534119
glycoprotein I-Disease 1 0.9999397993087769
metabolism I-Disease 1 0.9999827146530151
caused O 0 6.003220960337785e-07
by O 0 1.7580208122591756e-10
the O 0 1.5191741198350428e-08
deficiency B-Disease 0 0.1948137730360031
of I-Disease 0 1.535876617708709e-05
the I-Disease 0 1.1386422329451307e-06
lysosomal I-Disease 0 0.009275845251977444
enzyme I-Disease 0 1.1877288841333211e-07
aspartylglucosaminidase I-Disease 0 9.924383448378649e-06
( O 0 1.1602413252376209e-08
AGA O 0 2.3452039386029355e-06
) O 0 3.152768002223638e-08
. O 0 2.1205441669280845e-07

AGU B-Disease 1 1.0
is O 0 1.0232903377982439e-06
inherited O 0 8.881865505827591e-05
as O 0 3.3293069634510175e-08
an O 0 3.2099691793519014e-08
autosomal O 1 0.9232645630836487
recessive O 0 0.0008575360989198089
trait O 0 7.648022801731713e-07
and O 0 2.9793367772867896e-09
occurs O 0 1.222101753128868e-09
with O 0 3.6442134032643736e-11
a O 0 1.3556200606501534e-10
high O 0 2.3783128799692577e-09
frequency O 0 7.272218827125698e-09
in O 0 6.03352534600532e-10
Finland O 0 1.1099685615079125e-08
because O 0 3.0602440026505917e-10
of O 0 7.83105402746287e-09
a O 0 1.2716874664420175e-08
founder O 0 1.0690176566185983e-07
effect O 0 2.1582269482678385e-07
. O 0 2.3070373345035478e-07

While O 0 1.2575281971294316e-07
very O 0 1.4365348910416742e-08
few O 0 4.295272137966322e-09
patients O 0 7.135343871311761e-09
with O 0 1.2003407157124002e-08
AGU B-Disease 1 1.0
have O 0 2.917323271844907e-09
been O 0 6.185837397865157e-10
reported O 0 1.5757745108757604e-10
from O 0 6.695106274934304e-11
non O 0 2.3116342173779003e-09
- O 0 2.5543606119171613e-10
Finnish O 0 3.4967263218277367e-07
origin O 0 9.479552254276769e-09
, O 0 3.5466965475627887e-10
we O 0 2.1841564668001467e-10
diagnosed O 0 7.388545952835557e-08
the O 0 1.4564118799853532e-09
disorder O 0 1.1132292456750292e-06
in O 0 7.148908132137421e-10
8 O 0 1.2814072469780058e-08
patients O 0 2.3111303149025986e-10
originating O 0 4.905483241834929e-10
from O 0 7.147326619438843e-10
3 O 0 1.9546432028505478e-08
unrelated O 0 3.9362539894227666e-08
families O 0 2.143896345174756e-11
, O 0 9.617035466591428e-12
all O 0 5.7292252539364874e-12
Palestinian O 0 5.820585124993727e-10
Arabs O 0 1.496912732656952e-10
from O 0 4.253022933831119e-11
the O 0 4.375491982622215e-11
region O 0 8.159141140495763e-10
of O 0 2.7137623259676502e-09
Jerusalem O 0 5.568758751905989e-07
. O 0 3.0796877581451554e-07

The O 0 5.650868928341879e-08
clinical O 0 5.00677333548083e-06
diagnosis O 0 0.44770318269729614
of O 1 0.6998670697212219
AGU B-Disease 1 1.0
is O 0 2.8057948497917096e-07
often O 0 1.164515150975376e-09
difficult O 0 9.488881902441904e-10
, O 0 5.437787806844563e-12
in O 0 4.329936582891936e-12
particular O 0 1.4100621711921058e-11
early O 0 3.488860866873722e-10
in O 0 2.3844787255811184e-11
the O 0 2.9941124579657696e-10
course O 0 3.3968097223890936e-09
of O 0 2.0132149280982503e-09
the O 0 1.5687728893709618e-09
disease O 0 2.1970317121144944e-08
, O 0 2.3383720307301736e-11
and O 0 2.6032844283041534e-11
most O 0 3.2762795948437784e-11
of O 0 3.2399789517967292e-09
the O 0 6.948762010239307e-09
patients O 0 4.548462584352819e-08
are O 0 1.5194333291557172e-10
diagnosed O 0 2.174937918653086e-08
after O 0 3.6004899062191953e-09
the O 0 3.553888017204798e-10
age O 0 6.447020695077299e-09
of O 0 2.0621296670242373e-08
5 O 0 1.0369380021302277e-07
years O 0 3.269293102903248e-08
. O 0 7.85300002803524e-08

However O 0 1.159860048005612e-07
, O 0 3.164406070510495e-09
since O 0 1.0764767965909527e-09
these O 0 1.25623067503966e-10
patients O 0 2.3052222630770558e-10
excrete O 0 2.2421968726149544e-09
early O 0 5.937843550185562e-10
large O 0 4.21859006061176e-11
amounts O 0 1.2894869894086725e-10
of O 0 9.919371990463333e-10
aspartylglucosamine O 0 4.617447757482296e-08
in O 0 3.061388087477468e-10
urine O 0 3.1236865871697717e-10
, O 0 2.272951792059441e-11
biochemical O 0 5.62568769346683e-10
screening O 0 9.090675989753549e-10
is O 0 7.744802715814458e-11
easy O 0 3.433814899089782e-10
by O 0 4.529513569773158e-11
urine O 0 1.282443262695665e-09
chromatography O 0 7.216054314085341e-07
. O 0 2.5699085526298404e-08
. O 0 2.1779419512313325e-07

Detection O 0 6.639491516580165e-07
of O 0 4.697413658050209e-08
heterozygous O 0 3.037861295851485e-09
carriers O 0 5.304375272352502e-10
of O 0 6.507966610058702e-09
the O 0 4.771660542246536e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.281874445652647e-07
ATM O 0 1.1513939170981757e-05
) O 0 1.3159140443974593e-09
gene O 0 4.812970577638964e-10
by O 0 1.0482335138783938e-10
G2 O 0 6.984308242863335e-07
phase O 0 7.2901543717307504e-06
chromosomal O 0 0.0001608437014510855
radiosensitivity O 0 2.1030535208410583e-05
of O 0 1.428713744644483e-06
peripheral O 0 0.03881649300456047
blood O 0 9.446898729947861e-06
lymphocytes O 0 1.210659775097156e-06
. O 0 7.930970014058403e-07

In O 0 0.000731503707356751
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999806880950928
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.086371311970652e-08
patients O 0 4.1346561729938e-09
, O 0 5.2666489225305924e-11
mutations O 0 1.3644085861130861e-10
in O 0 2.263586262873929e-10
a O 0 4.95769703068305e-10
single O 0 2.6669735864182087e-10
gene O 0 9.407608025924219e-10
, O 0 8.261114570196071e-10
ATM O 0 1.2542727745312732e-07
, O 0 1.8636524268256238e-10
result O 0 2.249212066596229e-10
in O 0 5.419631965430938e-10
an O 0 2.830633718531317e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.9100221493317804e-07
embraces O 0 4.340421710935516e-08
a O 0 5.760931731657593e-10
variety O 0 4.870912007071126e-10
of O 0 1.2381690117635458e-09
clinical O 0 2.9329227935193103e-09
features O 0 1.2450509512262897e-09
and O 0 4.22172324876513e-10
manifests O 0 1.3322392966585994e-08
extreme O 0 1.4493606670384906e-07
radiosensitivity O 0 7.869408591432148e-07
and O 0 3.4148035510384034e-09
a O 0 5.407450487382448e-09
strong O 0 3.4555636130306766e-09
pre O 0 8.829869329929352e-06
- O 0 7.556729428870312e-07
disposition O 0 1.4616272210332681e-06
to O 0 1.1424516443980792e-08
malignancy B-Disease 0 6.204604869708419e-05
. O 0 4.6531837938346143e-07

Heterozygotes O 0 1.3071452258373029e-06
for O 0 9.277707491150977e-09
the O 0 1.4856477825730963e-08
ATM O 0 5.532372142624808e-07
gene O 0 2.8554945075143223e-09
have O 0 6.830515320022101e-11
no O 0 5.5537841686659206e-11
clinical O 0 3.8293967996594347e-10
expression O 0 3.620803934456518e-10
of O 0 2.2955382519285195e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.6482868403500106e-08
may O 0 6.404699437467798e-09
be O 0 1.5664646246804637e-09
cancer B-Disease 0 6.107342187533504e-08
prone O 0 1.2162841400709112e-08
with O 0 1.0191580218643637e-10
a O 0 2.0805313027949524e-09
moderate O 0 1.290280504662178e-08
increase O 0 1.3370191620509786e-09
in O 0 8.336940027220408e-09
in O 0 3.5205225401568896e-08
vitro O 0 1.4460223383139237e-06
radiosensitivity O 0 1.004926161840558e-05
. O 0 5.845573696205975e-07

We O 0 2.42258231253345e-08
performed O 0 7.411806990376135e-08
a O 0 1.2690753337096794e-08
blind O 0 1.4783216784053366e-07
chromosomal O 0 6.229206519492436e-07
analysis O 0 8.543737095578763e-08
on O 0 2.7154629833603394e-07
G2 O 0 8.812571650196332e-07
- O 0 5.253410595429386e-09
phase O 0 1.8052549677349816e-08
lymphocytes O 0 4.86734597071603e-10
from O 0 1.3820125044361475e-09
7 O 0 6.369312188780896e-08
unrelated O 0 2.040688059423701e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.127303789871803e-06
, O 0 3.4528362391483824e-09
13 O 0 1.707587671262445e-08
obligate O 0 6.400867391676002e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
T I-Disease 1 0.9999998807907104
heterozygotes O 0 8.264350981335156e-07
( O 0 1.9481129209797388e-10
parents O 0 1.0753387763573485e-11
of O 0 3.4875283216884156e-11
the O 0 3.1145350187777865e-11
patients O 0 2.5843806261693913e-11
) O 0 3.3941363174888606e-12
, O 0 1.0869256016066142e-11
and O 0 6.943535330039552e-11
14 O 0 4.202355796678603e-09
normal O 0 1.1200234517616536e-08
controls O 0 1.4702450812364987e-08
following O 0 1.1260419263692256e-09
X O 0 1.1958758250329993e-07
- O 0 5.0891202363345656e-09
irradiation O 0 1.3756455974345272e-09
with O 0 1.4855951191439232e-10
1 O 0 3.358473676939866e-08
Gy O 0 3.441043361362972e-08
in O 0 1.2391276893453096e-10
order O 0 6.752921138941659e-11
to O 0 2.357229168803432e-11
evaluate O 0 1.1107516018071806e-09
this O 0 6.966590498924674e-11
cytogenetic O 0 9.956265500932204e-08
method O 0 1.511442704327237e-08
as O 0 4.511546691787771e-10
a O 0 3.2921673720487377e-10
tool O 0 3.848876772849508e-09
for O 0 1.7106729921501085e-10
detection O 0 7.120988954056884e-08
of O 0 7.502494270283933e-08
ATM O 0 1.9311697542434558e-05
carriers O 0 6.273789949773345e-07
. O 0 3.083849264839955e-07

Both O 0 2.024257128141471e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999979734420776
T I-Disease 1 1.0
homozygotes O 0 5.038425570091931e-06
and O 0 1.2050059838841776e-09
heterozygotes O 0 7.493080822484899e-09
showed O 0 5.1110826682077e-10
significantly O 0 2.8745027191856565e-11
increased O 0 5.662585851606838e-12
levels O 0 1.2253127679162645e-10
of O 0 5.804111080642826e-10
radiation O 0 3.260915036662482e-05
- O 0 2.127305265275936e-07
induced O 0 2.7977759486930154e-07
chromatid O 0 1.639545735088177e-05
damage O 0 1.8212210761703318e-06
relative O 0 2.1713159981118224e-07
to O 0 5.207437814291893e-10
that O 0 1.156687037817683e-10
of O 0 5.831922944565804e-09
normal O 0 4.699411988440261e-07
controls O 0 5.559416422329377e-06
. O 0 3.325502859752305e-07

These O 0 5.901129807028838e-09
results O 0 2.705271340275317e-09
show O 0 6.183375145241143e-09
that O 0 4.534198363992381e-11
the O 0 7.339351348889522e-10
G2 O 0 1.5170725475854852e-07
- O 0 1.2719712394471117e-08
phase O 0 1.3394503639574395e-07
chromosomal O 0 2.8728089773721877e-07
radiosensitivity O 0 1.0793478111281729e-07
assay O 0 4.594288061099405e-09
can O 0 4.796289407305032e-11
be O 0 2.46368255657492e-11
used O 0 9.501332012828989e-12
for O 0 1.643279804765252e-12
the O 0 1.7872993016143646e-11
detection O 0 1.2270681359893842e-08
of O 0 2.3291975992378866e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00019793906540144235
. O 0 1.6565148825975484e-06

In O 0 8.893422176470267e-08
combination O 0 1.4220080402083113e-07
with O 0 1.0204890266152233e-09
molecular O 0 1.3956628208688926e-06
genetic O 0 4.4269320653711475e-08
analyses O 0 6.3881437917245876e-09
, O 0 1.0474381084701889e-10
this O 0 9.761348847281415e-12
test O 0 1.5547300946661124e-10
may O 0 7.888160957758572e-11
be O 0 9.93416807149039e-12
of O 0 7.114218242287862e-11
value O 0 7.99304233911613e-11
in O 0 2.517181255101697e-11
studies O 0 1.289541112781123e-10
of O 0 6.817737485675934e-10
familial B-Disease 0 1.1476850403369099e-07
and I-Disease 0 1.0123588189969723e-08
sporadic I-Disease 0 4.888638159172842e-06
cancers I-Disease 0 1.3155945453036111e-05
aimed O 0 9.573204096113841e-08
at O 0 1.1819953726899257e-07
determination O 0 5.017144033558907e-09
of O 0 5.6517173163683765e-09
the O 0 2.943636723262699e-10
potential O 0 4.738451853114611e-10
involvement O 0 6.0403686497068065e-09
of O 0 5.060758478947491e-09
ATM O 0 5.832587703480385e-06
mutations O 0 1.7157788079202874e-08
in O 0 4.66941552090816e-09
tumor B-Disease 0 3.1583861073158914e-06
risk O 0 5.940743221799494e-07
or O 0 4.750516868767818e-09
development O 0 3.0251651850221606e-08
. O 0 9.495639829992797e-09
. O 0 6.715988121186456e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
telangiectasia I-Disease 1 1.0
: O 0 1.9090288461143246e-08
identification O 0 3.493470623894268e-09
and O 0 1.7895926407440754e-10
detection O 0 1.5479652404337685e-07
of O 0 1.8085310671267507e-07
founder O 0 4.9646464503894094e-06
- O 0 4.4505611640488496e-08
effect O 0 1.513623004711917e-07
mutations O 0 1.827171303148134e-09
in O 0 2.901993367832034e-10
the O 0 6.521917450541537e-10
ATM O 0 1.6137745717514917e-07
gene O 0 5.851508166898611e-10
in O 0 5.560284455086162e-10
ethnic O 0 1.7803535312665986e-09
populations O 0 6.103714755845147e-10
. O 0 2.8573046151336712e-08

To O 0 4.753271998225728e-09
facilitate O 0 1.1589805559708566e-08
the O 0 4.265356956523192e-10
evaluation O 0 8.743706203517831e-09
of O 0 1.3512639007728922e-08
ATM O 0 4.2494215790611634e-07
heterozygotes O 0 3.200438314365783e-08
for O 0 7.677122826343918e-10
susceptibility O 0 3.8833150028949603e-08
to O 0 4.789563745610792e-10
other O 0 1.1319486459271388e-09
diseases O 0 0.0012071944074705243
, O 0 1.252883075064659e-10
such O 0 6.08706640647938e-10
as O 0 2.489055646037741e-07
breast B-Disease 1 0.999764621257782
cancer I-Disease 1 0.9997804760932922
, O 0 2.854456511158787e-07
we O 0 1.772419366830036e-08
have O 0 2.2139357014339112e-10
attempted O 0 1.6502615940439114e-09
to O 0 1.5464896724326493e-11
define O 0 1.0384413329234121e-09
the O 0 1.296110163639952e-10
most O 0 1.2697950330098351e-11
common O 0 2.417888458894346e-11
mutations O 0 4.8056458985812345e-12
and O 0 1.860283845370181e-12
their O 0 3.538483308446194e-12
frequencies O 0 5.451566309488953e-09
in O 0 2.020017006998387e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 1.0
( O 0 0.012412679381668568
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 3.7218028658969615e-09
homozygotes O 0 7.066947915745914e-08
from O 0 6.416263076403084e-10
10 O 0 9.8633390344105e-10
ethnic O 0 1.3966633405360085e-10
populations O 0 2.876961446851567e-10
. O 0 1.8456699280022804e-08

Both O 0 1.704688123993492e-08
genomic O 0 6.161244670011001e-08
mutations O 0 3.604935905343609e-09
and O 0 8.716339455761002e-11
their O 0 3.6352233723224714e-11
effects O 0 2.503615270654791e-08
on O 0 1.685367756465439e-08
cDNA O 0 4.969801636889315e-08
were O 0 8.903923820469117e-09
characterized O 0 4.583673529623411e-08
. O 0 6.683198705559334e-08

Protein O 0 1.2842132264268002e-06
- O 0 2.8704418397751397e-08
truncation O 0 1.8446111482717242e-07
testing O 0 6.983120748316196e-09
of O 0 2.2717969727636955e-09
the O 0 3.712350149509547e-10
entire O 0 3.3109346375681525e-09
ATM O 0 2.0331469841039507e-08
cDNA O 0 3.4027951567594528e-09
detected O 0 4.149018018040351e-09
92 O 0 8.172882814960758e-09
( O 0 2.1043322639968665e-10
66 O 0 4.39106351279861e-09
% O 0 1.628529117114752e-10
) O 0 5.875887276740599e-11
truncating O 0 1.1135246502647078e-08
mutations O 0 1.4453370722478098e-09
in O 0 9.12648290274376e-10
140 O 0 4.97916374797569e-09
mutant O 0 7.45436423699175e-09
alleles O 0 5.95396176805707e-09
screened O 0 3.279029954228463e-07
. O 0 2.023977714316061e-07

The O 0 2.683457545060719e-08
haplotyping O 0 3.4477361623430625e-06
of O 0 1.9199312362161436e-07
patients O 0 1.9317667465656996e-09
with O 0 1.28847404967658e-10
identical O 0 2.0670837486136406e-08
mutations O 0 3.140427029535431e-09
indicates O 0 3.461619657585402e-09
that O 0 3.4289175665502825e-11
almost O 0 1.628355089655642e-10
all O 0 8.947561441763341e-12
of O 0 5.93628896039533e-11
these O 0 9.17030123712137e-13
represent O 0 1.8733381165758622e-11
common O 0 5.11330318364589e-11
ancestry O 0 4.9141715002809505e-11
and O 0 2.996013506728623e-11
that O 0 9.263583823637678e-12
very O 0 6.338653907311809e-11
few O 0 1.6015146153680604e-10
spontaneously O 0 1.537978189247724e-09
recurring O 0 9.591517624585322e-08
ATM O 0 7.395521151920548e-06
mutations O 0 8.242613347420047e-08
exist O 0 1.6930205504195328e-07
. O 0 4.301641070014739e-07

Assays O 0 2.1731597144025727e-07
requiring O 0 7.052671779916864e-09
minimal O 0 8.455609901147909e-08
amounts O 0 5.898709964924365e-09
of O 0 1.1144525302597685e-09
genomic O 0 3.835370687710338e-09
DNA O 0 1.6878375364015596e-09
were O 0 8.193726946936764e-11
designed O 0 2.247486745321492e-11
to O 0 2.069288750766729e-12
allow O 0 1.039865329260925e-11
rapid O 0 4.74268346817297e-10
screening O 0 2.40714975729972e-10
for O 0 3.207485665956966e-11
common O 0 1.5176615519862935e-09
ethnic O 0 1.1623521700698802e-08
mutations O 0 5.1693533009711246e-08
. O 0 1.1607751559949975e-07

These O 0 3.7190779345053215e-09
rapid O 0 2.3615484678884968e-08
assays O 0 6.157353737989979e-09
detected O 0 1.9532111483755443e-09
mutations O 0 5.447278392245458e-11
in O 0 5.989184148624815e-11
76 O 0 5.025964977534159e-09
% O 0 3.27410737410716e-10
of O 0 1.2908664359656541e-08
Costa O 0 1.2831482081310241e-06
Rican O 0 5.409946425061207e-06
patients O 0 1.2958697936937824e-07
( O 0 3.124699388123986e-10
3 O 0 2.2376598352025212e-09
) O 0 8.578271773473922e-12
, O 0 4.869253437955745e-12
50 O 0 5.424199631121063e-11
% O 0 9.224090241621852e-12
of O 0 3.416671667810789e-10
Norwegian O 0 8.402152502640092e-07
patients O 0 1.573064345450348e-08
( O 0 1.4968586092845015e-10
1 O 0 4.469836500931024e-09
) O 0 1.1481799018497885e-11
, O 0 1.2373320250336217e-11
25 O 0 2.3455920539205977e-10
% O 0 5.7766413180670995e-11
of O 0 1.846334418686979e-09
Polish O 0 3.078594318139949e-06
patients O 0 2.9572806425903764e-08
( O 0 1.4820744631549587e-10
4 O 0 3.848091179037283e-09
) O 0 1.2536569005128229e-11
, O 0 7.373580912517497e-12
and O 0 7.638029965451043e-12
14 O 0 7.864938700308244e-10
% O 0 1.4838281992002322e-10
of O 0 1.325327758650019e-08
Italian O 0 0.0004767210048157722
patients O 0 1.3788556429972232e-07
( O 0 4.784413976111068e-10
1 O 0 4.7656296686682253e-08
) O 0 4.9658804845975624e-11
, O 0 2.452047072332153e-11
as O 0 2.249588362812638e-11
well O 0 2.1304728814453e-11
as O 0 3.138280260661652e-11
in O 0 1.1130499993905474e-10
patients O 0 5.802008318234186e-10
of O 0 1.0878854261875404e-08
Amish O 0 6.062623469915707e-08
/ O 0 3.4486387079368797e-08
Mennonite O 0 1.3406868504262093e-08
and O 0 1.504030511245702e-10
Irish O 0 1.3159398015716306e-08
English O 0 2.5766226485757215e-08
backgrounds O 0 7.594914563924249e-08
. O 0 4.849447421406694e-08

Additional O 0 5.8639269440163844e-08
mutations O 0 1.8014496561136184e-09
were O 0 4.0261766143245836e-10
observed O 0 8.713235688517784e-10
in O 0 7.533456497510471e-11
Japanese O 0 6.606166724765217e-09
, O 0 1.2351350497930014e-10
Utah O 0 1.0881967327236453e-08
Mormon O 0 6.950203190747573e-10
, O 0 2.4489854588694016e-11
and O 0 3.026967218544563e-11
African O 0 7.1813284208133155e-09
American O 0 4.192542846226388e-08
patients O 0 2.869424520213215e-07
. O 0 2.3561770490232448e-07

These O 0 6.563561361083714e-10
assays O 0 1.395604187770516e-09
should O 0 2.4662449166212852e-11
facilitate O 0 3.520987321148361e-11
screening O 0 6.490930015701224e-10
for O 0 1.1475329575461046e-09
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9996906518936157
T I-Disease 1 0.9999995231628418
heterozygotes O 0 2.017754781036274e-07
in O 0 4.121371299792287e-10
the O 0 1.1684726797245304e-10
populations O 0 1.5564978125826023e-11
studied O 0 3.17955528572611e-09
. O 0 6.493331983215e-10
. O 0 1.1973613212035161e-08

The O 0 2.277000703543308e-06
von B-Disease 1 0.9970875382423401
Hippel I-Disease 1 0.9982826709747314
- I-Disease 1 0.9715905785560608
Lindau I-Disease 0 0.0015192355494946241
tumor I-Disease 0 1.3936598861619132e-06
suppressor O 0 5.04097840803297e-07
gene O 0 7.211277797125604e-09
is O 0 2.6710667011542455e-10
required O 0 7.202888840929234e-10
for O 0 1.0951047846319284e-09
cell O 0 8.883877455900802e-08
cycle O 0 4.973876421843215e-09
exit O 0 4.256257124524154e-09
upon O 0 3.6782250578681897e-09
serum O 0 4.396194697164901e-08
withdrawal O 0 5.684033155262114e-08
. O 0 1.562857931958206e-07

The O 0 2.4239225737687775e-08
inactivation O 0 8.552954682272684e-07
of O 0 1.0610121137233364e-07
the O 0 6.334408908514888e-08
von B-Disease 1 0.9997215867042542
Hippel I-Disease 1 0.9995384216308594
- I-Disease 1 0.9999282360076904
Lindau I-Disease 1 0.9996122717857361
( I-Disease 0 1.0024136827269103e-06
VHL I-Disease 0 9.246449189959094e-05
) I-Disease 0 5.084678633693329e-08
tumor I-Disease 0 2.7285198029858293e-06
suppressor O 0 6.621042757615214e-06
gene O 0 7.61625187806203e-07
predisposes O 0 1.872303414529597e-06
affected O 0 1.3082817496012922e-08
individuals O 0 2.0109410664437277e-11
to O 0 1.0597001054435395e-10
the O 0 1.0232844793733875e-08
human O 1 0.6288005113601685
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.6339304898547198e-09
is O 0 7.345173774764291e-11
associated O 0 1.5201704339773414e-09
with O 0 9.77956493564136e-10
sporadic B-Disease 1 0.999993085861206
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 0.001321549410931766
RCC B-Disease 1 0.9997524619102478
) O 0 1.6923796408718772e-07
and O 0 2.1880556744235946e-07
brain B-Disease 1 0.9992152452468872
hemangioblastomas I-Disease 0 0.0016911582788452506
. O 0 1.24799726108904e-06

VHL O 0 0.000596849073190242
- O 0 3.319119969091844e-06
negative O 0 3.4239167945315785e-08
786 O 0 6.082933850848349e-06
- O 0 1.0242353710054886e-05
0 O 0 2.514155710287014e-07
RCC B-Disease 0 4.406521838973276e-06
cells O 0 1.3113614638626814e-09
are O 0 1.0502668873479948e-10
tumorigenic O 0 1.22832148008456e-07
in O 0 8.47996162178788e-09
nude O 0 1.438350500393426e-05
mice O 0 6.351758230493942e-08
which O 0 2.5073115805795965e-10
is O 0 3.8191172446744304e-11
suppressed O 0 5.386959281428183e-11
by O 0 4.22733506186268e-12
the O 0 1.1133259592011058e-10
reintroduction O 0 5.453896001483827e-09
of O 0 2.752874017630802e-08
VHL B-Disease 0 2.520358430047054e-05
. O 0 1.1344670838298043e-06

Remarkably O 0 9.260522347176448e-06
, O 0 9.028503500374541e-10
this O 0 1.8424171910336185e-11
occurs O 0 1.2275373773018572e-10
without O 0 6.699846233360063e-11
affecting O 0 5.650051954075863e-11
the O 0 1.3451031954936354e-11
growth O 0 2.2219299317116636e-11
rate O 0 4.5787054703261276e-10
and O 0 2.2257475376652458e-11
cell O 0 2.0099384379079765e-09
cycle O 0 2.0323852323311797e-10
profile O 0 5.827580779049768e-11
of O 0 4.266870468061512e-10
these O 0 1.2513706217076592e-11
cells O 0 4.758056795783894e-11
in O 0 7.893067449638025e-11
culture O 0 1.3282760669142135e-08
. O 0 2.6048281753787705e-08

The O 0 3.5019425581594987e-07
786 O 0 5.157155101187527e-06
- O 0 1.7655399915383896e-06
0 O 0 6.454614975837103e-08
cell O 0 6.434676436128939e-08
line O 0 1.36144127083071e-08
, O 0 1.2380456382299343e-10
like O 0 5.410911302350385e-11
many O 0 3.08681032124003e-11
cancer B-Disease 0 6.370111993447836e-09
cells O 0 6.878657643483166e-10
, O 0 6.208141778429876e-10
fails O 0 5.418786752642291e-09
to O 0 4.673190723281095e-10
exit O 0 5.8226568455665983e-08
the O 0 7.74708563966442e-09
cell O 0 6.14626785022665e-08
cycle O 0 1.8418286895638403e-09
upon O 0 1.003277572131367e-09
serum O 0 1.289409645721662e-08
withdrawal O 0 3.1752296791864865e-08
. O 0 1.164120888574871e-07

Here O 0 2.6124664600502e-06
, O 0 5.194187302492992e-09
it O 0 6.383971129508836e-11
is O 0 1.6526476367961784e-11
shown O 0 1.7068652047314004e-11
that O 0 2.6420202831056727e-12
reintroduction O 0 6.085209558470694e-10
of O 0 1.0130807304165046e-09
the O 0 9.214849994165775e-10
wild O 0 4.1288323870958266e-09
- O 0 1.7212396841159716e-08
type O 0 7.296758752772803e-08
VHL B-Disease 0 1.4864889408272575e-06
gene O 0 1.2651263148200087e-08
restores O 0 3.7118514484291154e-08
the O 0 8.452441524475773e-10
ability O 0 9.322920213605812e-10
of O 0 1.52317284118908e-07
VHL O 0 0.19825807213783264
- O 0 0.00036805079434998333
negative O 0 5.087895260658115e-07
RCC B-Disease 1 0.9938185811042786
cancer I-Disease 0 6.653356194874505e-06
cells O 0 4.3392500703731685e-10
to O 0 2.505413654319e-10
exit O 0 1.2944068039644208e-08
the O 0 2.1195880606228457e-09
cell O 0 3.417672544969719e-08
cycle O 0 8.872472201382209e-10
and O 0 9.460468519684184e-11
enter O 0 7.432189086387098e-09
G0 O 0 3.998296961071901e-06
/ O 0 2.3674185456457053e-07
quiescence O 0 8.322484177369915e-07
in O 0 1.7120228790190595e-08
low O 0 5.542733561014757e-07
serum O 0 2.583118998700229e-07
. O 0 5.582467821341197e-08

Both O 0 3.219159225409385e-06
VHL O 0 0.0006076966528780758
- O 0 2.135858494511922e-06
positive O 0 8.405805829170276e-09
and O 0 1.243053660004989e-08
VHL O 0 0.00012939408770762384
- O 0 1.3939243217464536e-06
negative O 0 1.3603459692035358e-08
RCC B-Disease 0 4.6736888180021197e-05
cells O 0 4.376197626498879e-09
exit O 0 2.5194040631504322e-08
the O 0 6.570199384547948e-10
cell O 0 1.4813467785756984e-08
cycle O 0 4.1660574989776933e-10
by O 0 1.864928003691979e-11
contact O 0 1.7783825967399025e-08
inhibition O 0 3.6748579645973223e-07
. O 0 2.672246921520127e-07

The O 0 8.657166858938581e-07
cyclin O 0 2.4685165044502355e-05
- O 0 1.6160921632035752e-06
dependent O 0 1.6146857717558305e-07
kinase O 0 2.7256803036834754e-07
inhibitor O 0 2.0126158517541626e-07
, O 0 2.1494341861938437e-09
p27 O 0 3.130280958885123e-07
, O 0 1.6030771154973422e-09
accumulates O 0 4.779546092237297e-09
upon O 0 1.9362154102253726e-09
serum O 0 3.14167314385827e-09
withdrawal O 0 9.715127591292116e-10
, O 0 7.66794336359844e-11
only O 0 1.7514599146006837e-11
in O 0 3.6479479159634565e-11
the O 0 5.1745541879144596e-11
presence O 0 1.0279593842810186e-09
of O 0 1.4350607102642243e-07
VHL B-Disease 0 2.232072984043043e-05
, O 0 5.320671903064067e-09
as O 0 4.925622132390117e-10
a O 0 3.212312083000768e-10
result O 0 2.9695546022168173e-10
of O 0 3.065678599867283e-09
the O 0 1.3373100404834304e-09
stabilization O 0 5.554798576667963e-07
of O 0 3.716059779890202e-07
the O 0 1.3223714745436155e-07
protein O 0 1.4806795434196829e-06
. O 0 3.0449055543613213e-07

We O 0 4.538756570582336e-08
propose O 0 1.2818325956232002e-08
that O 0 1.0104209829941979e-10
the O 0 2.805908838610094e-10
loss O 0 7.535907009526e-09
of O 0 6.580439304570973e-08
wild O 0 4.254568697348304e-09
- O 0 1.4213431320797554e-08
type O 0 2.0049656157539175e-08
VHL B-Disease 0 1.0820516536114155e-06
gene O 0 2.0411854428914467e-09
results O 0 4.858756730286018e-10
in O 0 2.363195195087542e-10
a O 0 5.236818270693e-11
specific O 0 2.583637748188039e-10
cellular O 0 9.688642421679106e-07
defect O 0 2.5497590172562923e-07
in O 0 3.674095250261189e-09
serum O 0 2.9778497889765276e-08
- O 0 9.830869451832314e-09
dependent O 0 1.1374551078802142e-08
growth O 0 1.9908499293563864e-09
control O 0 2.116197720170021e-06
, O 0 6.355606041452688e-10
which O 0 5.894475185730386e-11
may O 0 9.047206872558888e-10
initiate O 0 8.181632260573224e-09
tumor B-Disease 0 3.586465595617483e-07
formation O 0 4.135875769861741e-06
. O 0 3.1415904686582508e-06

This O 0 3.4353559996702643e-09
is O 0 6.96624924412248e-10
corrected O 0 1.6352157405918888e-09
by O 0 9.717082173621439e-12
the O 0 1.5536570641128122e-10
reintroduction O 0 1.3712341262461791e-09
of O 0 4.652071616817466e-09
wild O 0 2.8510536154158217e-09
- O 0 6.86881804767836e-08
type O 0 1.547723059047712e-06
VHL B-Disease 0 0.2069544494152069
, O 0 5.739062771681347e-07
implicating O 0 0.0012983906781300902
VHL B-Disease 0 0.0002737811882980168
as O 0 1.535218174808506e-08
the O 0 2.4970232548326976e-09
first O 0 1.3226376660568917e-09
tumor B-Disease 0 5.372332800845925e-09
suppressor O 0 4.0436887616124295e-08
involved O 0 4.474391079867246e-09
in O 0 4.1347095192101335e-10
the O 0 1.2728151865815107e-09
regulation O 0 1.2823197437228373e-07
of O 0 1.0930856575441794e-07
cell O 0 1.263813828700222e-06
cycle O 0 2.0525629196299633e-08
exit O 0 9.880175788623546e-09
, O 0 5.059095919968115e-10
which O 0 9.257370564563772e-11
is O 0 8.061988576724133e-11
consistent O 0 1.0467177125050853e-09
with O 0 2.913122174041938e-11
its O 0 9.918590254676118e-11
gatekeeper O 0 2.3201161880592736e-08
function O 0 3.314101704177119e-08
in O 0 6.355426851456514e-09
the O 0 3.66655754646672e-08
kidney O 0 0.01471731811761856
. O 0 7.140874203059866e-08
. O 0 7.697876753809396e-07

Piebaldism B-Disease 1 1.0
with O 0 0.00753162382170558
deafness B-Disease 1 1.0
: O 0 6.252936657347163e-08
molecular O 0 8.386016503436622e-08
evidence O 0 2.2251129827566274e-09
for O 0 1.2111854574836656e-10
an O 0 2.749806493618223e-10
expanded O 0 1.3969039400762995e-06
syndrome O 1 0.9999681711196899
. O 0 7.442749392794212e-06

In O 0 6.954452658192167e-08
a O 0 2.3391429238017736e-08
South O 0 1.4555127769710907e-08
African O 0 7.49233830532603e-09
girl O 0 1.8851297411970336e-08
of O 0 3.2483960410445434e-08
Xhosa O 0 7.873914000811055e-06
stock O 0 1.2005193283926019e-08
with O 0 1.3050455160978913e-10
severe O 0 2.8910170613016817e-07
piebaldism B-Disease 0 5.335345576895634e-06
and O 0 1.821599937557039e-07
profound O 1 0.9999980926513672
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.2090974905731855e-06
identified O 0 9.136797984865552e-09
a O 0 4.1415446072612383e-10
novel O 0 1.445761010909763e-10
missense O 0 2.258141229560806e-09
substitution O 0 2.710772051273125e-09
at O 0 6.403077179584216e-08
a O 0 1.8518893085683885e-09
highly O 0 4.323580160559004e-09
conserved O 0 1.3103044871343172e-08
residue O 0 3.8989675488210196e-08
in O 0 7.251134137575832e-10
the O 0 5.872662911521331e-10
intracellular O 0 1.560840523495699e-08
kinase O 0 2.8575827926147213e-08
domain O 0 2.6410077680338873e-08
of O 0 9.729247096856852e-08
the O 0 4.3756656964433205e-08
KIT O 0 0.00025117912446148694
proto O 0 0.0002987643238157034
- O 0 1.8850274727810756e-06
oncogene O 0 7.556074024250847e-07
, O 0 9.924372434966244e-09
R796G O 0 1.0353743391533499e-06
. O 0 1.965502320899759e-07

Though O 0 2.7820911441267526e-07
auditory B-Disease 0 3.2985284633468837e-05
anomalies I-Disease 0 8.173653441190254e-06
have O 0 7.009802460711256e-11
been O 0 2.2564297652571952e-11
observed O 0 8.218409980331742e-11
in O 0 2.7389174261926996e-11
mice O 0 2.532095644269816e-10
with O 0 1.8189537376311904e-10
dominant O 0 8.99521546671167e-06
white O 0 3.9346929270323017e-07
spotting O 0 2.9797995011904277e-05
( O 0 3.578146134941562e-08
W O 0 1.588970008015167e-05
) O 0 9.67485203062779e-10
due O 0 4.4041762237156945e-08
to O 0 1.9262405004383254e-09
KIT O 0 0.037190284579992294
mutations O 0 9.959102499124128e-06
, O 0 4.228346369927749e-06
deafness B-Disease 1 1.0
is O 0 4.474666681630879e-08
not O 0 4.2788672605098554e-10
typical O 0 8.170887078051692e-09
in O 0 5.870612884706361e-10
human O 0 1.0063061495202419e-08
piebaldism B-Disease 0 2.5269778234360274e-06
. O 0 2.2134615562663384e-07

Thus O 0 1.646584451009403e-07
, O 0 9.852770821439094e-10
the O 0 2.2159465928872635e-10
occurrence O 0 8.22213408468997e-09
of O 0 1.1264924069109838e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 6.07847539413342e-07
this O 0 4.859071478513499e-10
patient O 0 3.745659782339317e-09
extends O 0 2.0960243263257183e-10
considerably O 0 2.814984079169136e-10
the O 0 2.6676945374948247e-11
phenotypic O 0 1.0383605975050614e-08
range O 0 7.154286052468706e-09
of O 0 1.617315059654345e-09
piebaldism B-Disease 0 1.7187169021326554e-08
due O 0 7.729035189640854e-09
to O 0 2.1956511608856033e-10
KIT O 0 3.7764945659546356e-07
gene O 0 4.437657796785288e-09
mutation O 0 1.053071518875015e-09
in O 0 1.5208955206347241e-09
humans O 0 2.3425261730380953e-09
and O 0 3.011868532354356e-10
tightens O 0 3.0163598285781745e-09
the O 0 1.6702644822785828e-10
clinical O 0 3.343362697805219e-09
similarity O 0 5.204540798331436e-09
between O 0 2.313995395297752e-08
piebaldism B-Disease 0 2.3863483988861844e-07
and O 0 4.448042975613298e-11
the O 0 8.310794760713058e-12
various O 0 1.256879496314145e-11
forms O 0 9.412148838094936e-10
of O 0 7.070331093927962e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999794960021973
. O 0 1.207316699947114e-07
. O 0 1.1762631402234547e-06

Cycloheximide O 0 3.965662472182885e-06
facilitates O 0 1.954628281453097e-08
the O 0 1.7434824695072848e-09
identification O 0 3.054693831217037e-09
of O 0 1.6145573766834787e-08
aberrant O 0 1.3460856429503565e-08
transcripts O 0 4.079969428971708e-08
resulting O 0 4.1549736984336505e-09
from O 0 1.3830858680563551e-09
a O 0 5.830196325717907e-10
novel O 0 4.333567948933137e-10
splice O 0 1.2428782447670983e-08
- O 0 2.1035908570610218e-09
site O 0 3.304062856646084e-10
mutation O 0 1.1555271323127059e-10
in O 0 5.224888299792951e-10
COL17A1 O 0 7.300778634089511e-06
in O 0 6.479231817735354e-09
a O 0 2.608271820747632e-09
patient O 0 2.148820321679068e-08
with O 0 6.031273258599867e-09
generalized O 1 0.9991375207901001
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9998480081558228
. O 0 1.9468989194137976e-05

Patients O 0 1.5652653928555083e-07
with O 0 1.1718104708791088e-08
generalized O 1 0.7477616667747498
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9996781349182129
often O 0 5.095783350839156e-09
show O 0 1.2651497627302888e-09
decreased O 0 1.5968911748487358e-09
expression O 0 1.9254102756605107e-09
of O 0 3.908227963478339e-09
type O 0 2.1146431095075968e-07
XVII O 0 4.914985038340092e-05
collagen O 0 3.8176199268491473e-07
, O 0 1.1918517728304323e-08
a O 0 3.544184323800437e-08
transmembrane O 0 1.875096700132417e-07
hemidesmosomal O 0 5.677899821421306e-07
protein O 0 3.33433405330652e-08
encoded O 0 1.258061477216188e-08
by O 0 5.306159511775377e-09
COL17A1 O 0 4.771412204718217e-05
. O 0 8.92646596639679e-07

This O 0 6.981575761955128e-09
report O 0 3.6543861270388334e-09
documents O 0 1.2534842497302634e-08
a O 0 1.6516502610031125e-09
novel O 0 2.7016977544036536e-09
splice O 0 5.483385834281762e-08
- O 0 9.832088032624142e-09
site O 0 1.3029891610116806e-09
mutation O 0 7.281596992037009e-10
in O 0 1.0645362369388067e-09
COL17A1 O 0 2.714113361435011e-05
in O 0 1.614852962461555e-08
a O 0 6.233655369669577e-09
patient O 0 3.14820098878954e-08
with O 0 5.8662399382569674e-09
generalized O 1 0.9927719235420227
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9997418522834778
, O 0 3.660268532712507e-08
and O 0 1.10440767642217e-09
applies O 0 4.6187489388671565e-09
a O 0 2.224246203885727e-10
new O 0 3.511343646400711e-11
methodology O 0 3.790837088679666e-10
to O 0 4.7034133532353195e-11
define O 0 9.328314121148651e-09
and O 0 6.004376995605298e-10
characterize O 0 2.3575250196472552e-08
the O 0 3.3019036393966417e-09
resulting O 0 1.6619331466571907e-09
mRNA O 0 1.2663359250097983e-08
splice O 0 1.2020663575640356e-07
variants O 0 1.600332240059288e-07
. O 0 2.9449435601236473e-07

Mutational O 0 1.580732350703329e-05
analysis O 0 1.4714338192334253e-07
of O 0 1.2537704208170908e-07
COL17A1 O 0 4.277213884051889e-05
identified O 0 1.506731592826327e-07
a O 0 4.254619767607437e-08
maternally O 0 2.876745668345393e-07
inherited O 0 6.912840490258532e-06
G O 0 1.838208299886901e-05
- O 0 2.8035719878971577e-07
to O 0 3.479374655057654e-08
- O 0 1.4315343150883564e-06
T O 0 5.775877980340738e-07
transversion O 0 3.6756816257366154e-07
at O 0 9.311110460430427e-08
the O 0 1.0773579806055977e-09
- O 0 1.5983966372701275e-09
1 O 0 6.057732537811944e-09
position O 0 6.321250634044873e-09
of O 0 3.2833600727144585e-08
exon O 0 4.948698801854334e-07
32 O 0 1.115333361667581e-06
. O 0 4.2639868524929625e-07

This O 0 2.4706226398052422e-08
acceptor O 0 1.48144287948071e-08
splice O 0 8.355989393749041e-07
- O 0 2.3753219835498385e-08
site O 0 6.685185294230678e-09
mutation O 0 8.320287792074055e-10
led O 0 8.621633962313524e-10
to O 0 1.1206291450349681e-10
the O 0 6.592002499417049e-10
formation O 0 5.336244512932353e-08
of O 0 1.3044914339843672e-06
aberrant O 0 2.2345096795106656e-07
transcripts O 0 6.257100721995812e-07
present O 0 4.08514750915856e-08
at O 0 1.0177622016271926e-06
extremely O 0 2.0921686427755048e-07
low O 0 2.037281916500433e-07
levels O 0 2.104776370970285e-07
. O 0 1.538854235150211e-07

Based O 0 5.642134581762548e-08
on O 0 4.92876601754233e-08
our O 0 1.6527753610162677e-09
recent O 0 1.1739928473808448e-10
finding O 0 3.4941149973377605e-10
that O 0 1.761870163652368e-11
cycloheximide O 0 1.2684026273745985e-08
stabilized O 0 4.5527806946665805e-07
mutant O 0 1.9346806823250517e-08
COL17A1 O 0 2.54246003805747e-07
transcripts O 0 2.228452444796858e-08
in O 0 3.114702940010261e-10
keratinocytes O 0 3.549621929721525e-09
homozygous O 0 1.7992245471276647e-09
for O 0 4.3077899580801216e-10
a O 0 2.799489973170921e-09
frameshift O 0 6.045488021300116e-08
mutation O 0 7.569671001128597e-10
, O 0 2.187458270075382e-10
the O 0 5.397349234215199e-10
effects O 0 2.1945268144918373e-06
of O 0 3.440801208398625e-07
the O 0 1.880694533440419e-08
splice O 0 8.41394154349473e-08
- O 0 1.4688484872849017e-09
site O 0 2.04020342287059e-10
mutation O 0 1.391135383971287e-11
on O 0 8.634074566415961e-10
splicing O 0 1.4805982218035751e-08
of O 0 2.7159853033253967e-08
COL17A1 O 0 1.0608729326122557e-06
transcripts O 0 1.2682519923146174e-07
were O 0 7.412139235718485e-10
determined O 0 1.2222760303881586e-10
using O 0 7.917191902073739e-11
reverse O 0 2.0991781646273466e-09
transcriptase O 0 6.676367458879895e-09
polymerase O 0 8.725330680192656e-09
chain O 0 3.0047320187520654e-09
reaction O 0 2.561214851315441e-10
of O 0 3.5106775264637236e-09
total O 0 5.379076628564405e-10
RNA O 0 5.681374926069793e-09
from O 0 1.0606914235822273e-09
keratinocytes O 0 5.572709405043952e-09
incubated O 0 6.813684727546843e-09
for O 0 9.404055312245418e-10
2 O 0 2.8203834290252416e-07
. O 0 7.22864612612284e-08

5 O 0 9.88500232779188e-07
h O 0 1.3191117886890424e-07
in O 0 1.1089353879611963e-09
the O 0 2.589478909076348e-10
presence O 0 4.914792461896411e-10
or O 0 6.6848887536608e-10
absence O 0 3.40881207705479e-08
of O 0 1.0247849502320605e-07
10 O 0 1.1228688379105733e-07
microg O 0 1.189920908473141e-06
cycloheximide O 0 9.360502986055508e-07
per O 0 1.603795709570477e-07
ml O 0 1.5380661579911248e-06
. O 0 2.2846653280339524e-07

Using O 0 1.5547140463922915e-08
this O 0 1.746353756049146e-10
approach O 0 3.6552088023000806e-09
, O 0 2.1402854488705714e-10
an O 0 6.84303377851414e-11
abnormally O 0 1.0881386458549969e-08
spliced O 0 4.011647192214696e-08
transcript O 0 2.3709637275715068e-07
was O 0 1.4669341297235405e-08
identified O 0 8.890491814961266e-11
that O 0 1.1946715318400525e-12
contains O 0 3.1543977499493003e-12
an O 0 3.3426753118931396e-12
extra O 0 4.424640098754651e-10
264 O 0 1.0796248339772774e-09
bases O 0 9.141151169345108e-10
upstream O 0 5.2984625575902555e-09
from O 0 3.731114084359888e-09
exon O 0 4.453669433246432e-08
32 O 0 2.2617330230900734e-08
, O 0 1.902346197235616e-10
resulting O 0 1.1605482130860878e-09
in O 0 1.6194944274516843e-09
a O 0 4.59925075801948e-09
premature O 0 1.0657009497094805e-08
termination O 0 1.5493705873836916e-08
codon O 0 3.52140894221975e-08
27 O 0 1.148931687566801e-06
bp O 0 6.130942438176135e-07
downstream O 0 1.5830427457785845e-07
from O 0 2.3790127201550604e-08
the O 0 2.799448672874405e-08
cryptic O 0 6.398096275006537e-07
splice O 0 1.452382775823935e-06
site O 0 3.492064024612773e-07
. O 0 3.8789036693742673e-07

Three O 0 2.985709812719506e-08
other O 0 7.270883339849377e-10
splice O 0 1.6572997196817596e-08
variants O 0 1.584905318097185e-09
, O 0 3.6308178685828807e-10
including O 0 1.5717491197442257e-10
one O 0 3.73236302975144e-11
derived O 0 9.841947395949902e-11
from O 0 1.0142833239967786e-09
the O 0 1.6388594925587086e-09
skipping O 0 3.4440901686139114e-08
of O 0 5.491403243240711e-08
exon O 0 1.642655576006291e-07
32 O 0 1.0007995854266483e-07
, O 0 3.0452522725710196e-09
were O 0 2.484670913460718e-09
also O 0 1.5202342718012574e-09
identified O 0 2.0698413649711256e-08
. O 0 6.983416511729956e-08

These O 0 4.743671677687189e-09
results O 0 3.901078127199753e-09
indicate O 0 1.4468541920109601e-09
the O 0 1.3613567217962697e-10
usefulness O 0 6.219854853384277e-09
of O 0 1.6736265706640552e-09
cycloheximide O 0 1.2714837183125383e-08
treatment O 0 1.6618919573829771e-09
in O 0 4.999915065306837e-11
evaluating O 0 3.7092076632383453e-10
the O 0 1.6703728678013618e-10
abnormal O 0 1.1114679177026687e-09
processing O 0 9.996412586588121e-09
of O 0 1.982868980121566e-09
mRNA O 0 3.983234020399351e-10
due O 0 7.701927984271606e-09
to O 0 6.752332026849217e-10
splice O 0 4.878810955233348e-08
- O 0 3.642570023387748e-09
site O 0 9.596321515203954e-10
mutations O 0 2.947816990506169e-10
, O 0 4.01818245343577e-10
because O 0 2.8300808363468377e-09
( O 0 4.1241023929217135e-09
i O 0 5.474127817706176e-08
) O 0 2.608247173796485e-09
aberrant O 0 2.6494639371321682e-08
splicing O 0 9.524139699124134e-08
often O 0 1.4683050331143477e-09
generates O 0 1.0596076238655883e-09
a O 0 1.874487232100819e-09
premature O 0 5.083435006270065e-09
termination O 0 2.095329909579391e-09
codon O 0 3.028576056607335e-09
, O 0 1.1703580327093732e-09
( O 0 5.020568405456061e-10
ii O 0 7.443235290338635e-07
) O 0 1.487030387714583e-09
transcripts O 0 3.726969310946515e-08
with O 0 1.1920399112241853e-09
premature O 0 4.090589911243114e-08
termination O 0 1.3862399228514732e-08
codons O 0 4.836586686707278e-09
can O 0 1.8020467063006862e-10
occur O 0 2.0832313651908407e-09
at O 0 3.0331442246733786e-08
low O 0 2.786280539623931e-08
or O 0 3.239655765874261e-10
undetectable O 0 2.1912144987368265e-08
levels O 0 1.1006056066520387e-09
due O 0 5.56957457931162e-09
to O 0 5.731154439914121e-10
nonsense O 0 1.745226718696813e-08
- O 0 1.2735316134993013e-09
mediated O 0 3.038000295774168e-09
mRNA O 0 7.522490408362614e-10
decay O 0 4.3733880517038415e-08
, O 0 9.164400488481661e-11
and O 0 4.220344559935363e-11
( O 0 2.8081828529202824e-11
iii O 0 5.205278696962523e-08
) O 0 1.149398701216775e-10
the O 0 9.204902812198767e-11
levels O 0 1.1917261621974262e-09
of O 0 2.068226256923822e-09
these O 0 3.82888373784418e-11
transcripts O 0 3.6156710958579197e-09
can O 0 7.820145572767778e-12
be O 0 8.464209368119757e-12
increased O 0 1.108498536017688e-11
by O 0 3.644769555610772e-11
cycloheximide O 0 1.9389869976293994e-07
. O 0 8.969638543021574e-08

A O 0 8.253679197878228e-07
deletion O 0 9.911304488241512e-08
mutation O 0 2.281841604556689e-09
in O 0 7.219517761392069e-10
COL17A1 O 0 1.5312680261558853e-06
in O 0 4.102065354061324e-09
five O 0 1.6335137686951384e-09
Austrian O 0 2.510487604467926e-07
families O 0 1.001449340121141e-10
with O 0 1.2585408271093002e-09
generalized O 0 0.009347076527774334
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999991655349731
bullosa I-Disease 1 0.9642982482910156
represents O 0 1.0324738752842677e-07
propagation O 0 1.880845701407452e-07
of O 0 2.8803576412883558e-08
an O 0 1.0829204200035747e-09
ancestral O 0 6.756486214953838e-08
allele O 0 4.050973245739442e-07
. O 0 2.0895124919206864e-07

Patients O 0 8.781764790910529e-07
with O 0 3.228297273949465e-08
generalized O 1 0.884719967842102
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999972939491272
, O 0 6.939863794741541e-08
a O 0 6.8275136655415736e-09
usually O 0 1.0839330544243353e-09
nonlethal O 0 2.161028049840752e-07
form O 0 7.105885213576357e-09
of O 0 2.8914244012412382e-06
junctional B-Disease 1 0.9999935626983643
epidermolysis I-Disease 1 0.9999740123748779
bullosa I-Disease 1 0.6688546538352966
, O 0 7.842936966540037e-09
have O 0 5.527716062658783e-10
generalized O 0 7.126546108793264e-08
blistering B-Disease 0 2.3604749799233105e-07
, O 0 6.569628396846383e-08
nail B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999996423721313
, O 0 2.958372078865068e-06
patchy B-Disease 1 0.9999876022338867
alopecia I-Disease 1 1.0
, O 0 1.5343480299634393e-06
and O 0 3.152258796035312e-05
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9989907145500183

Skin B-Disease 0 0.26134583353996277
fragility I-Disease 0 0.02569134533405304
in O 0 1.0772763125999063e-08
most O 0 5.0509756099881287e-11
cases O 0 2.431819155768178e-11
is O 0 1.8004645083863346e-12
due O 0 4.292622507451327e-11
to O 0 5.439571969939605e-12
mutations O 0 4.488764568377768e-11
in O 0 8.654035821287209e-11
the O 0 3.716948415721788e-10
gene O 0 5.34084165781934e-10
encoding O 0 7.238883625859671e-08
type O 0 1.4982852917455602e-05
XVII O 0 0.16060197353363037
collagen O 0 5.217448779148981e-05
( O 0 1.483482208186615e-07
COL17A1 O 0 3.4902455809060484e-05
) O 0 8.74524488381212e-08
. O 0 2.350512460225218e-07

Recently O 0 1.137192384703667e-06
, O 0 5.6588906893750845e-09
we O 0 3.7049724399551565e-10
reported O 0 3.9817604768899173e-10
five O 0 5.0848651678148116e-11
Austrian O 0 2.3327714870902128e-08
families O 0 1.8787627703575893e-11
with O 0 2.9898780673498493e-10
generalized O 0 0.00044973473995923996
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999948740005493
who O 0 3.320552934837906e-07
share O 0 1.6746140474310778e-08
the O 0 6.20059426026387e-09
same O 0 3.1348154294619235e-08
COL17A1 O 0 2.6674431865103543e-05
mutation O 0 1.3709752977320022e-07
. O 0 1.0676992445723954e-07

Affected O 0 6.846908462421197e-08
individuals O 0 4.981839940576549e-10
in O 0 1.4098537892692775e-09
three O 0 4.5238174317674407e-10
families O 0 2.161873631500999e-11
are O 0 3.5837533027965884e-12
homozygous O 0 2.4936651701890078e-11
for O 0 6.305637956227628e-11
4003delTC O 0 3.739563769755705e-09
, O 0 6.804456997855368e-11
whereas O 0 1.740205757272406e-10
those O 0 3.6993498542248204e-11
in O 0 7.658398915033615e-11
two O 0 2.937786403034437e-10
others O 0 4.657582652889403e-10
are O 0 5.4273249089353826e-11
compound O 0 4.185806901091382e-08
heterozygotes O 0 8.819600338938471e-07
. O 0 4.6893123339941667e-07

To O 0 1.197233814309584e-07
determine O 0 1.4962897409986908e-07
if O 0 1.1797892662812615e-09
the O 0 1.6823727133630229e-10
occurrence O 0 9.54770262850957e-10
of O 0 1.1575703728894382e-09
4003delTC O 0 7.353255337960718e-09
in O 0 9.853780985613625e-11
these O 0 1.2039892520465667e-11
unrelated O 0 5.801277791483983e-10
families O 0 7.623937288772642e-13
signifies O 0 3.169972617733663e-11
propagation O 0 1.5121888186087062e-09
of O 0 2.8398465801160455e-09
an O 0 1.7842756439012675e-10
ancestral O 0 8.448996169363454e-09
allele O 0 1.889633161056281e-08
or O 0 1.1325971271958224e-08
a O 0 1.8690936798293478e-08
mutational O 0 1.0575809028523508e-06
hot O 0 7.446885206263687e-07
spot O 0 2.116543669217208e-07
, O 0 6.001137364819442e-10
haplotypes O 0 6.229673221724852e-09
were O 0 3.332976394876397e-10
determined O 0 3.842244022944641e-10
for O 0 1.5767155636670083e-10
polymorphisms O 0 5.497510446872411e-09
both O 0 2.531705511898963e-09
within O 0 9.911342147006508e-08
and O 0 7.043519900662432e-08
flanking O 0 5.718655665987171e-05
COL17A1 O 1 0.9261617064476013
. O 0 6.570483037648955e-06

Five O 0 5.700932774743706e-07
intragenic O 0 2.7840017082780832e-06
polymorphisms O 0 1.1789197174039145e-07
were O 0 3.3541569521844394e-09
chosen O 0 2.1067749766956467e-09
based O 0 1.090968537731385e-09
on O 0 1.3413902877346118e-08
their O 0 3.6359062427493427e-09
informativeness O 0 4.514337433647597e-06
. O 0 1.4860195562960143e-07

One O 0 4.034328782154262e-08
of O 0 3.987327445997835e-08
these O 0 1.702483293231083e-10
, O 0 5.291337160095999e-11
not O 0 9.171775318395081e-12
previously O 0 2.1554720508465408e-10
reported O 0 2.135250032342384e-10
, O 0 3.5317693214409474e-11
was O 0 1.634960788976514e-08
2988 O 0 1.2662144399655517e-07
A O 0 8.470654222492158e-08
or O 0 3.925702429796729e-09
C O 0 1.055895836543641e-06
that O 0 1.2310803765291922e-10
introduces O 0 7.890181286107634e-10
a O 0 7.173408395066971e-11
new O 0 1.9499856590554643e-11
restriction O 0 5.259100099852532e-11
site O 0 1.0569427277840049e-10
for O 0 2.097543944090674e-10
Eco0109 O 0 1.1562143953369741e-07
I O 0 2.02989417630306e-06
. O 0 2.147651088080238e-07

All O 0 7.250100964029116e-09
the O 0 2.411958188730523e-09
4003delTC O 0 1.2700609453020206e-08
alleles O 0 2.5370119893786125e-10
showed O 0 4.6186934832270765e-10
the O 0 4.519537522007511e-11
same O 0 4.779313056424428e-11
haplotype O 0 8.899946890572608e-10
for O 0 1.0257299870586323e-10
these O 0 6.999249096972804e-11
five O 0 6.278662589842554e-10
polymorphic O 0 3.2308349773302325e-08
markers O 0 2.979822397719545e-07
. O 0 1.148379510595987e-06

Fourteen O 0 6.608048806810984e-06
microsatellite O 0 4.208010977890808e-06
polymorphisms O 0 1.7137371344233543e-07
were O 0 5.80181191978113e-09
selected O 0 1.1298283419947097e-09
based O 0 3.4017158534460634e-10
on O 0 3.7984966283488575e-09
their O 0 1.475029820507956e-10
high O 0 3.785465452210701e-08
heterozygosity O 0 4.209963151424745e-07
and O 0 5.865901098189852e-10
their O 0 1.8515174116107147e-10
location O 0 1.1148825862505873e-08
within O 0 6.192321322373573e-09
10q23 O 0 1.6411304670782556e-07
- O 0 3.920623470321516e-08
q25 O 0 3.5651012808557425e-07
near O 0 1.105963860936754e-06
COL17A1 O 0 6.610003038076684e-05
. O 0 5.244443173069158e-07

Three O 0 1.9276086504760315e-08
families O 0 4.5208670140794993e-10
shared O 0 7.052201045354423e-09
microsatellite O 0 7.148204872464703e-07
polymorphisms O 0 9.270459599974856e-08
covering O 0 4.77383593988634e-07
at O 0 1.0109001777891535e-06
most O 0 1.2452885389535595e-09
19 O 0 2.151051070597987e-08
cM O 0 1.1119816178961628e-08
, O 0 3.912574153552839e-10
whereas O 0 6.764371840439765e-10
the O 0 5.727624485807326e-10
others O 0 6.224669668597471e-10
shared O 0 1.0102365610720199e-09
smaller O 0 4.6513506934964255e-10
regions O 0 8.07726052709512e-10
consistent O 0 4.074492299110943e-09
with O 0 1.806258753678236e-10
cross O 0 5.760319776726419e-09
- O 0 1.4394495595482226e-09
over O 0 2.6282212517436676e-10
events O 0 6.70538138902721e-11
during O 0 2.4358312589178865e-10
passage O 0 4.883433102342849e-10
of O 0 1.5725708235603264e-10
this O 0 1.559977190826456e-12
mutation O 0 4.754716152050031e-12
through O 0 2.2958135392769918e-11
several O 0 2.0322030169772631e-10
generations O 0 7.96314836293277e-09
. O 0 5.217842868887601e-08

These O 0 3.977822515821572e-09
results O 0 3.326811048864897e-09
indicate O 0 1.7783172712171336e-09
that O 0 4.2044923098671916e-11
4003delTC O 0 4.696909083889977e-09
occurs O 0 1.3597374615148539e-10
on O 0 1.3114690444737676e-09
a O 0 1.3312649593810733e-10
single O 0 4.639953699037136e-11
ancestral O 0 9.344800488975125e-10
allele O 0 1.969905127907623e-09
. O 0 2.6157400689896804e-09
. O 0 3.366823975170519e-08

The O 0 1.335922945600032e-07
haptoglobin O 0 1.180660183308646e-05
- O 0 1.4357163991007837e-07
gene O 0 3.0083391333590725e-09
deletion O 0 4.986731738654271e-08
responsible O 0 4.699761646520528e-08
for O 0 2.634954832103631e-08
anhaptoglobinemia B-Disease 0 6.856382242403924e-05
. O 0 2.025477442657575e-06

We O 0 9.033834658112028e-08
have O 0 5.09980557783507e-10
found O 0 9.079858392935236e-11
an O 0 3.5600172983152323e-12
allelic O 0 1.4444827556303608e-09
deletion O 0 1.4424956340519657e-08
of O 0 2.9413778079856456e-08
the O 0 5.218240772819627e-08
haptoglobin O 0 2.08655656024348e-05
( O 0 1.4911437418163587e-08
Hp O 0 6.335218216690919e-08
) O 0 6.073833658248873e-10
gene O 0 8.267183049248672e-10
from O 0 1.4481958965362196e-09
an O 0 2.9073674023827323e-10
individual O 0 3.589174790707972e-10
with O 0 6.5650542779849275e-09
anhaptoglobinemia B-Disease 0 0.0006128892418928444
. O 0 3.6873348108201753e-06

The O 0 4.768384656017588e-07
Hp O 0 4.314356374379713e-07
gene O 0 1.4805635606407463e-09
cluster O 0 2.401304266541615e-09
consists O 0 2.367942952830049e-09
of O 0 8.192875711188208e-09
coding O 0 1.1693967962855822e-06
regions O 0 2.1168096608903397e-08
of O 0 4.874495118656341e-08
the O 0 4.41881464752214e-09
alpha O 0 2.3466061804811034e-07
chain O 0 2.8371935911764012e-09
and O 0 2.546687860593977e-11
beta O 0 1.6606886532599674e-08
chain O 0 9.301627912350341e-09
of O 0 3.959240046924606e-09
the O 0 4.972434908268042e-09
haptoglobin O 0 4.764003165291797e-07
gene O 0 4.830363664609649e-09
( O 0 1.3590588654466274e-09
Hp O 0 7.100154242323242e-09
) O 0 6.995591605996054e-11
and O 0 5.614194178993337e-11
of O 0 2.3947042127048235e-09
the O 0 2.2473862770766573e-09
alpha O 0 1.382024379381619e-07
chain O 0 3.119092095715814e-09
and O 0 7.395373202712108e-11
beta O 0 3.9772785953573475e-08
chain O 0 1.2974990859504487e-08
of O 0 4.281832666208629e-09
the O 0 4.892254601429613e-09
haptoglobin O 0 1.050303922056628e-06
- O 0 1.1698809920801523e-08
related O 0 1.1342120131985212e-08
gene O 0 3.3869760329707788e-09
( O 0 1.2957548367609206e-09
Hpr O 0 7.008222269178077e-08
) O 0 6.237398375574799e-10
, O 0 6.291416831949448e-10
in O 0 1.750319555959834e-09
tandem O 0 2.623701789161714e-07
from O 0 2.8501037974137944e-08
the O 0 5.0601919099335646e-08
5 O 0 6.018038334332232e-07
side O 0 5.801272209282615e-07
. O 0 4.249320113558497e-07

Southern O 0 2.435493570374092e-06
blot O 0 1.335184606432449e-06
and O 0 4.016559973507583e-09
PCR O 0 2.06706793903777e-08
analyses O 0 3.292131234289286e-09
have O 0 3.589405508930277e-11
indicated O 0 5.276806769316522e-10
that O 0 3.0168502244964923e-12
the O 0 1.472134046609508e-11
individual O 0 8.605372274136935e-13
with O 0 6.7838360796879105e-12
anhaptoglobinemia B-Disease 0 7.364525878017503e-09
was O 0 1.7190602275007905e-09
homozygous O 0 6.25012680499637e-11
for O 0 9.697973327171816e-12
the O 0 6.25026974621079e-11
gene O 0 1.1342195238572828e-10
deletion O 0 8.973052856298125e-10
and O 0 5.82927109360476e-11
that O 0 9.68422130681601e-12
the O 0 1.0926756721651998e-10
gene O 0 1.806313848495833e-10
deletion O 0 1.328004994860521e-08
was O 0 1.552755080069801e-08
included O 0 8.382218252833695e-10
at O 0 2.515433195071637e-08
least O 0 2.7428920246208577e-10
from O 0 3.61726981701338e-10
the O 0 1.230245350036796e-09
promoter O 0 9.347869308840018e-06
region O 0 1.8979141032104963e-06
of O 0 1.32162676891312e-05
Hp O 0 4.97886185257812e-06
to O 0 5.322054974499224e-08
Hpr O 0 2.1781943360110745e-06
alpha O 0 8.446911579085281e-07
but O 0 9.334931716509232e-10
not O 0 1.8008579349970688e-10
to O 0 7.03759162057338e-10
Hpr O 0 2.587976268841885e-07
beta O 0 4.3653210468619363e-07
( O 0 8.73500471954003e-09
Hpdel O 0 9.532523108646274e-07
) O 0 1.9133887363409485e-08
. O 0 1.3964668710286787e-07

In O 0 2.2066277693966185e-08
addition O 0 2.4572228696229104e-09
, O 0 4.723733626477156e-10
we O 0 7.745807467651744e-11
found O 0 2.3133696347432675e-11
seven O 0 6.247858567315356e-12
individuals O 0 1.225647594483778e-13
with O 0 3.4243669098238394e-12
hypohaptoglobinemia B-Disease 0 6.719858447468141e-08
in O 0 2.0892001462158305e-09
three O 0 8.700414833029413e-10
families O 0 7.937252417822283e-12
, O 0 8.469216647433164e-12
and O 0 1.1338858671439134e-11
the O 0 3.036660645161504e-10
genotypes O 0 1.1883176220806035e-08
of O 0 3.997111974740619e-08
six O 0 2.6315583045999347e-09
of O 0 1.9970613607256382e-08
the O 0 3.35908656445838e-09
seven O 0 1.2224654621917352e-09
individuals O 0 1.4889587826583117e-11
were O 0 1.0284770812774013e-09
found O 0 5.18667109261628e-10
to O 0 1.0820816465084704e-10
be O 0 4.005336950996252e-09
Hp2 O 0 9.48993238125695e-06
/ O 0 1.0470243068994023e-05
Hpdel O 0 7.930325955385342e-05
. O 0 1.0786413895402802e-06

The O 0 8.770702208948933e-08
phenotypes O 0 1.5130211750147282e-07
and O 0 1.7320143097521168e-09
genotypes O 0 1.9967909992146815e-08
in O 0 7.579408212166072e-10
one O 0 1.1811621125623617e-10
of O 0 1.2076519784187667e-09
these O 0 1.8495717110655896e-11
three O 0 2.2949213362988274e-10
families O 0 8.904182946523065e-12
showed O 0 5.954980952793676e-10
the O 0 4.4878423199889994e-10
father O 0 3.737367748612996e-09
to O 0 1.8192382322812506e-10
be O 0 9.675701351241628e-10
hypohaptoglobinemic B-Disease 0 1.1001658606346609e-07
( O 0 9.168146242188868e-10
Hp2 O 0 5.9113954620215736e-08
) O 0 2.9018715208550816e-10
and O 0 9.41967281953282e-10
Hp2 O 0 1.0780655657072202e-06
/ O 0 3.6071870113119076e-07
Hpdel O 0 1.312052290813881e-06
, O 0 6.500692761868265e-10
the O 0 2.3906516766203367e-09
mother O 0 2.671011634092224e-09
to O 0 1.3430914713730147e-10
be O 0 7.629040177370428e-10
Hp2 O 0 2.409610431186593e-07
- O 0 2.1789322346421613e-08
1 O 0 3.1192364247090154e-08
and O 0 5.758701848712633e-10
Hp1 O 0 4.354485270141595e-07
/ O 0 4.631648664599197e-08
Hp2 O 0 3.9301139054259693e-07
, O 0 2.9791874522899775e-10
one O 0 4.633620917515735e-11
of O 0 8.45755354639266e-10
the O 0 1.072196220697208e-09
two O 0 4.0732786588115744e-10
children O 0 4.0791071909129784e-11
to O 0 3.8840201888046266e-11
be O 0 5.549466997045727e-10
hypohaptoglobinemic B-Disease 0 1.6739505781515618e-07
( O 0 1.0270735373296702e-09
Hp2 O 0 8.471688772715424e-08
) O 0 1.9737478318404555e-10
and O 0 3.7605332736667663e-10
Hp2 O 0 4.4360228912410093e-07
/ O 0 1.4681104687497282e-07
Hpdel O 0 7.742390266685106e-07
, O 0 2.4026730605086755e-10
and O 0 2.473202545538733e-11
the O 0 7.042313954208623e-11
other O 0 4.163632633114034e-11
child O 0 9.218928398446735e-10
to O 0 5.2641880438075717e-11
be O 0 5.451022966340702e-10
Hp1 O 0 1.593834468849309e-07
and O 0 2.05799910446558e-09
Hp1 O 0 2.127213065250544e-06
/ O 0 4.124038071040559e-07
Hpdel O 0 8.796232009444793e-07
, O 0 3.3809394173189844e-10
showing O 0 3.655011848735512e-10
an O 0 3.901647060988722e-11
anomalous O 0 8.655039351879168e-08
inheritance O 0 2.1882163991904235e-07
of O 0 7.040980563033372e-07
Hp O 0 1.473530346629559e-07
phenotypes O 0 1.6382884382437624e-08
in O 0 1.2316070385764988e-09
the O 0 4.182652446615975e-09
child O 0 1.1895239460102403e-08
with O 0 2.736445070539162e-09
Hp1 O 0 4.781314783031121e-05
. O 0 1.0874725830944953e-06

The O 0 2.586061782494653e-07
Hp2 O 0 2.4439123080810532e-05
/ O 0 2.103260612784652e-06
Hpdel O 0 1.3718465652345913e-06
individuals O 0 4.601178882346346e-10
had O 0 1.1158053370152743e-09
an O 0 6.190272600070656e-11
extremely O 0 5.359958255013453e-09
low O 0 1.2542137106663631e-08
level O 0 4.4869781845591206e-07
of O 0 5.758767542829446e-07
Hp O 0 1.622775016585365e-07
( O 0 6.233651927978201e-10
mean O 0 2.0016748258910866e-09
+ O 0 1.922735082260374e-09
/ O 0 7.875661012235469e-09
- O 0 2.4717479174540813e-09
SD O 0 2.6192410018666124e-08
= O 0 7.506327115436306e-09
0 O 0 1.7850730893442801e-09
. O 0 7.062653240019756e-11
049 O 0 1.1468224592192655e-08
+ O 0 3.768835910022972e-09
/ O 0 1.6057677854064423e-08
- O 0 7.2148829133311665e-09
0 O 0 2.0132111533399666e-09
. O 0 1.2762446655045778e-10
043 O 0 6.478839509327372e-08
mg O 0 1.219076466441038e-07
/ O 0 1.736951205089099e-08
ml O 0 9.55975210104043e-09
; O 0 3.899714717814362e-10
n O 0 8.420521169227868e-09
= O 0 4.18100931653953e-09
6 O 0 4.004008236080381e-09
) O 0 1.8749394398165364e-11
, O 0 7.158533748413687e-12
compared O 0 1.9328852754463277e-11
with O 0 8.790346922582515e-12
the O 0 2.257519865489499e-10
level O 0 1.0388820470552673e-07
( O 0 9.689325730644072e-11
1 O 0 1.0735344835310912e-09
. O 0 1.946477701242344e-11
64 O 0 1.302300822736413e-09
+ O 0 4.301372147352822e-09
/ O 0 2.6291013810464392e-08
- O 0 9.84426673511507e-09
1 O 0 1.751369005376091e-08
. O 0 1.7222821779849795e-10
07 O 0 1.6738157526674513e-08
mg O 0 5.152422488663433e-08
/ O 0 3.316661167929169e-09
ml O 0 1.2458634124357104e-09
) O 0 1.1509030707623769e-11
obtained O 0 2.852194591618229e-10
from O 0 4.5984588359360146e-10
52 O 0 2.360319051319948e-08
healthy O 0 3.1080342743905476e-09
volunteers O 0 7.327378703791965e-10
having O 0 2.384394903742759e-09
phenotype O 0 3.7836875854679874e-09
Hp2 O 0 2.434738064494013e-07
, O 0 5.563944305286839e-10
whereas O 0 9.969749470428724e-10
the O 0 7.811715163619226e-10
serum O 0 2.0551120805123446e-09
Hp O 0 4.196508474052507e-09
level O 0 2.9232289477931772e-08
of O 0 3.831400530174278e-09
an O 0 2.395222561957233e-11
individual O 0 1.441679241265259e-11
with O 0 4.62214849727971e-10
Hp1 O 0 1.301120732932759e-06
/ O 0 4.663890535994142e-07
Hpdel O 0 2.3547579530713847e-06
was O 0 1.0459796158102108e-06
0 O 0 2.5476492737652734e-07
. O 0 5.219575172077384e-08

50 O 0 6.009681328578154e-06
mg O 0 1.3807342838845216e-05
/ O 0 4.4714761315844953e-07
ml O 0 1.548598618228425e-07
, O 0 7.45925321510299e-10
which O 0 5.7040188544688064e-11
was O 0 2.2970290114443515e-09
approximately O 0 3.6606420672491424e-10
half O 0 6.503926563983242e-11
the O 0 3.0928332811486214e-11
level O 0 7.723936157333355e-09
of O 0 5.4059858811683625e-09
Hp O 0 7.0219612346988924e-09
in O 0 4.567531908250544e-10
control O 0 1.404398801696516e-07
sera O 0 5.257202673192296e-08
from O 0 6.819441122907222e-10
the O 0 8.397372242008316e-10
Hp1 O 0 3.35299468190442e-08
phenotype O 0 2.335386883878243e-10
( O 0 2.472020088628568e-10
1 O 0 5.859306817512788e-09
. O 0 1.4382303681337305e-10
26 O 0 6.718574141473255e-09
+ O 0 5.538472347410561e-09
/ O 0 2.7602506946777794e-08
- O 0 1.332948418308888e-08
0 O 0 1.7358640080900045e-09
. O 0 7.628832288109066e-11
33 O 0 1.1039385405808844e-08
mg O 0 4.7858971896630464e-08
/ O 0 5.8999929386516214e-09
ml O 0 5.409750869489471e-09
; O 0 1.1132877952846343e-10
n O 0 3.075470988989082e-09
= O 0 2.7995219475940303e-09
9 O 0 9.500767284009726e-09
) O 0 8.145049218422074e-11
, O 0 1.586047682078373e-10
showing O 0 2.785131236748839e-09
a O 0 2.560493594927493e-09
gene O 0 7.744426433475837e-09
- O 0 4.645397666536155e-08
dosage O 0 1.1698585922204074e-06
effect O 0 1.6957883417489938e-06
. O 0 3.200118783297512e-07

The O 0 6.861642276589919e-08
other O 0 1.691227713429555e-09
allele O 0 2.3336872434498446e-09
( O 0 4.781676721243855e-10
Hp2 O 0 4.114087204243333e-08
) O 0 1.8664911283217123e-10
of O 0 1.1766161378545803e-09
individuals O 0 2.8247066144460042e-11
with O 0 5.820529613842496e-10
Hp2 O 0 4.789468221133575e-06
/ O 0 3.886416379828006e-07
Hpdel O 0 2.3029429030430038e-06
was O 0 2.3254953873674822e-07
found O 0 3.6034422667974297e-10
to O 0 2.0932906449888655e-11
have O 0 7.826935280452751e-12
, O 0 3.792344910324985e-12
in O 0 1.6202374511498085e-11
all O 0 5.928752627726297e-11
exons O 0 9.813540202685545e-09
, O 0 1.456672282795779e-10
no O 0 1.26246388343354e-10
mutation O 0 3.318239780170096e-11
, O 0 8.65753215645304e-12
by O 0 6.126149067198217e-12
DNA O 0 1.9421333430358345e-09
sequencing O 0 1.6081401099654613e-08
. O 0 1.5429924360432778e-07

On O 0 1.3844517354755226e-07
the O 0 1.8160705161918145e-09
basis O 0 9.419965252277507e-09
of O 0 8.223148828534477e-10
the O 0 4.7491711951952453e-11
present O 0 3.718939392549636e-11
study O 0 2.788168827760895e-11
, O 0 1.1696510730449527e-12
the O 0 6.167464976225556e-12
mechanism O 0 3.5182654567478266e-09
of O 0 3.45254171918441e-08
anhaptoglobinemia B-Disease 0 2.569597938872903e-07
and O 0 1.8421159042603108e-10
the O 0 2.1485557777367603e-10
mechanism O 0 2.6586823409502358e-08
of O 0 2.919740715867647e-08
anomalous O 0 6.836520469732932e-07
inheritance O 0 5.210741846894962e-07
of O 0 5.833733780491457e-07
Hp O 0 4.143106195897417e-07
phenotypes O 0 9.737935613429727e-08
were O 0 1.359536661027505e-08
well O 0 5.567238225978599e-09
explained O 0 2.0317270355008077e-07
. O 0 8.34897377899324e-08

However O 0 1.0345496548325173e-07
, O 0 9.954586044358393e-10
the O 0 4.601441727647426e-10
mechanism O 0 9.372583065214712e-08
of O 0 2.067328175314742e-08
hypohaptoglobinemia B-Disease 0 8.60529689816758e-06
remains O 0 5.45539342056145e-06
unknown O 0 3.058471702388488e-05

ATM O 0 2.6246974812238477e-05
mutations O 0 4.2143579292996947e-08
and O 0 3.0920459526129207e-09
phenotypes O 0 6.874125233480299e-07
in O 0 8.48197396408068e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 9.648232435210957e-08
in O 0 8.334109402596823e-09
the O 0 3.006572324437684e-09
British O 0 7.131248480618524e-09
Isles O 0 7.414929115157065e-09
: O 0 6.08130473062074e-12
expression O 0 6.83758050179506e-11
of O 0 5.676324965619983e-10
mutant O 0 1.4470914466713225e-09
ATM O 0 2.2205311367429204e-08
and O 0 4.2459227106439457e-11
the O 0 8.115833005639672e-11
risk O 0 3.2655149695415275e-09
of O 0 2.7042932515541906e-07
leukemia B-Disease 1 1.0
, O 1 0.9855926632881165
lymphoma B-Disease 1 1.0
, O 0 0.00253715249709785
and O 0 0.02931983396410942
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9990150928497314

We O 0 7.301767190881492e-09
report O 0 1.5502350791951613e-10
the O 0 6.904786464811963e-11
spectrum O 0 3.974917728299943e-09
of O 0 1.0712108977628532e-09
59 O 0 6.482074876856814e-09
ATM O 0 8.294499309613457e-08
mutations O 0 6.832017729330175e-10
observed O 0 7.061986107004259e-09
in O 0 1.4470265341515187e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9997101426124573
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.7338068636927346e-08
patients O 0 3.206265697386357e-09
in O 0 1.445562419766233e-10
the O 0 8.660084316325367e-10
British O 0 3.9225234615969384e-08
Isles O 0 3.5858155911228096e-07
. O 0 1.108862335286176e-07

Of O 0 2.3380912352877203e-06
51 O 0 4.116562195122242e-06
ATM O 0 8.385906767216511e-06
mutations O 0 1.806729166276e-08
identified O 0 1.0429218377794314e-08
in O 0 1.7831470744411604e-09
families O 0 7.880927160863749e-11
native O 0 1.8366778931078187e-10
to O 0 3.491908151520562e-11
the O 0 5.269625291681734e-10
British O 0 7.150752878715139e-09
Isles O 0 3.376683110900558e-08
, O 0 3.7059336155387257e-10
11 O 0 4.9776254229527694e-09
were O 0 2.48893017307239e-09
founder O 0 8.199930334740202e-08
mutations O 0 1.5977199563366185e-09
, O 0 4.474610959537273e-10
and O 0 6.016012688014882e-10
2 O 0 3.2668566518623265e-07
of O 0 2.990742231645527e-08
these O 0 2.308200852674247e-10
11 O 0 4.725917435166593e-09
conferred O 0 1.7079230474337237e-08
a O 0 8.307380339189763e-10
milder O 0 7.725007855619026e-10
clinical O 0 5.175909145727076e-10
phenotype O 0 7.008118391160778e-11
with O 0 7.1963728379143e-12
respect O 0 5.485127907434162e-10
to O 0 6.2265465006206e-10
both O 0 1.2292342432829173e-07
cerebellar B-Disease 1 0.9999997615814209
degeneration I-Disease 1 0.9999994039535522
and O 0 2.3148369621139864e-07
cellular O 0 1.5170772712735925e-05
features O 0 6.584111247320834e-07
. O 0 2.430807910513977e-07

We O 0 1.2329755882944937e-08
report O 0 4.714840740049908e-10
, O 0 2.5124036531765093e-11
in O 0 7.121903067286439e-11
two O 0 7.627293796552692e-10
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.9998156428337097
T I-Disease 1 1.0
families O 0 1.4148528182378328e-10
, O 0 4.554549792867846e-11
an O 0 8.5824290382841e-12
ATM O 0 5.39039000102548e-08
mutation O 0 7.609798347019137e-10
( O 0 4.453418744887472e-10
7271T O 0 3.6896732780178354e-08
- O 0 4.0868542328098556e-08
- O 0 7.079319175318233e-08
> O 0 1.821292094916771e-08
G O 0 1.9090896330453688e-07
) O 0 1.9257913319581377e-10
that O 0 2.288363942781757e-11
may O 0 7.831165577121268e-11
be O 0 1.1465910686181413e-11
associated O 0 7.965571258150561e-11
with O 0 9.09879810384595e-13
an O 0 7.972220973651023e-13
increased O 0 8.805319667848366e-11
risk O 0 3.947477011934097e-09
of O 0 8.821420038884753e-08
breast B-Disease 0 4.388703382574022e-05
cancer I-Disease 0 1.2738646546495147e-06
in O 0 5.941143133014748e-09
both O 0 1.9541026574643183e-08
homozygotes O 0 1.3797368580981129e-07
and O 0 2.0149273916025834e-10
heterozygotes O 0 9.479189877481531e-09
( O 0 1.7691413611853335e-10
relative O 0 1.3520527808452698e-08
risk O 0 2.3313293517901457e-09
12 O 0 2.4042143831337626e-09
. O 0 9.882578783093621e-11
7 O 0 4.790799312814897e-09
; O 0 2.1972264285796683e-10
P O 0 1.8885546637648076e-07
= O 0 9.726552896438534e-09
. O 0 4.499198513752134e-10
0025 O 0 6.513221251225332e-08
) O 0 1.5370009431858733e-10
, O 0 7.973049998000192e-11
although O 0 3.522108993347928e-11
there O 0 6.60333732138696e-11
is O 0 5.203761727079481e-11
a O 0 3.6672181957797534e-10
less O 0 1.9054603228596534e-08
severe O 0 0.02103782445192337
A B-Disease 1 1.0
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999997615814209
phenotype O 0 1.4850859431092545e-09
in O 0 1.6577722528055006e-10
terms O 0 5.631227151248197e-10
of O 0 1.7081364100945962e-10
the O 0 7.434591831056991e-11
degree O 0 1.1585588310936146e-07
of O 0 2.200976894073392e-07
cerebellar B-Disease 1 0.9999910593032837
degeneration I-Disease 1 0.9999967813491821
. O 0 9.091270840144716e-06

This O 0 7.0352594860878526e-09
mutation O 0 4.5004622251099136e-09
( O 0 1.2753765821216234e-09
7271T O 0 5.376907452614432e-08
- O 0 1.7422932430122273e-08
- O 0 7.4081007994664105e-09
> O 0 3.0888276381091373e-09
G O 0 6.736962543385516e-09
) O 0 1.6005488601145146e-11
also O 0 6.373006723042751e-12
allows O 0 4.31390340116522e-12
expression O 0 5.909604749998465e-11
of O 0 9.471740058941691e-10
full O 0 7.051538242208721e-10
- O 0 8.005374141362154e-10
length O 0 5.085498133716726e-10
ATM O 0 5.1467846873265444e-08
protein O 0 3.4606293386474363e-09
at O 0 8.201084256143076e-09
a O 0 5.462492125296592e-10
level O 0 6.839909527656118e-09
comparable O 0 1.1317527359722135e-08
with O 0 4.408943349298866e-11
that O 0 2.757999210956097e-11
in O 0 1.6567450189519661e-10
unaffected O 0 1.299606910976081e-08
individuals O 0 4.105522866115763e-10
. O 0 5.911349987286485e-08

In O 0 1.275121785937472e-08
addition O 0 1.2649037373080319e-09
, O 0 1.9044991972361203e-10
we O 0 3.859694161501004e-11
have O 0 3.3209097364400586e-12
studied O 0 5.5348610139560606e-09
18 O 0 2.5444805373808776e-07
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999964237213135
T I-Disease 1 1.0
patients O 0 2.666264187212164e-08
, O 0 3.744692056439902e-11
in O 0 1.3316078795178043e-10
15 O 0 1.424645401648661e-09
families O 0 4.964239956606331e-12
, O 0 3.034852577576963e-11
who O 0 1.8756164676947407e-10
developed O 0 3.006657152582193e-06
leukemia B-Disease 1 1.0
, O 0 0.026867564767599106
lymphoma B-Disease 1 1.0
, O 0 8.726075975573622e-06
preleukemic O 1 0.935297429561615
T O 0 0.19185446202754974
- O 0 1.2927039279020391e-06
cell O 0 1.4015784017828992e-06
proliferation O 0 2.8707909223157912e-05
, O 0 1.472276078828827e-09
or O 0 6.751107548552682e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.8834592196981248e-07
mostly O 0 2.284898936721902e-09
in O 0 4.78540185255838e-09
childhood O 0 1.8391638150205836e-06
. O 0 1.8089365028117754e-07

A O 0 8.608247412666969e-07
wide O 0 4.188961355566789e-08
variety O 0 6.862542534236127e-09
of O 0 4.901744787844109e-09
ATM O 0 2.230362241562034e-07
mutation O 0 2.712560454032342e-10
types O 0 1.213882050432602e-10
, O 0 3.353763447511149e-11
including O 0 3.970912834661e-11
missense O 0 3.6292430394269104e-08
mutations O 0 2.1666723970525936e-09
and O 0 1.544710581669051e-09
in O 0 2.4853120450529786e-08
- O 0 7.931562606700027e-08
frame O 0 3.630757419159636e-05
deletions O 0 9.381543719655383e-08
, O 0 1.1773255703673158e-09
were O 0 1.0745874190476457e-09
seen O 0 2.3637733992387666e-09
in O 0 2.753112737785557e-10
these O 0 5.389736990046856e-10
patients O 0 2.3850601493791146e-08
. O 0 1.3502892670658184e-07

We O 0 2.90818018555683e-08
also O 0 7.075951491408716e-10
show O 0 2.9294214276553987e-10
that O 0 4.297298194372301e-12
25 O 0 2.1157056662168827e-10
% O 0 2.465026967268802e-11
of O 0 6.094594828809363e-10
all O 0 2.1024517682377564e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
patients O 0 8.902362402807285e-09
carried O 0 4.399369202268133e-10
in O 0 3.202718923400738e-10
- O 0 4.546673704197701e-09
frame O 0 1.0736705036151761e-07
deletions O 0 1.706968788539598e-08
or O 0 1.4135756565281099e-08
missense O 0 1.5139737286062882e-07
mutations O 0 4.744431958414452e-09
, O 0 2.8092875248297844e-10
many O 0 1.0871080077801132e-11
of O 0 2.535368581746411e-09
which O 0 3.047352648000157e-11
were O 0 5.973611882925667e-11
also O 0 3.7728652667323725e-12
associated O 0 1.400247539445898e-11
with O 0 3.9000903201413806e-12
expression O 0 9.041928317188308e-10
of O 0 6.080063741364938e-08
mutant O 0 7.264665669026726e-08
ATM O 0 6.013533948134864e-06
protein O 0 2.0199411210342078e-06
. O 0 1.5958239885094372e-07

The O 0 1.200676678081436e-07
DMPK O 0 2.012733239098452e-05
gene O 0 3.844081106763042e-07
of O 0 1.780397155926039e-06
severely O 1 0.9999994039535522
affected O 1 0.9999996423721313
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.20583990216255188
is O 0 2.894263140262865e-08
hypermethylated O 0 1.7492444612798863e-06
proximal O 0 4.0157735270440753e-07
to O 0 1.324465426222332e-09
the O 0 2.1395929472589614e-09
largely O 0 1.1718864989518352e-08
expanded O 0 7.51727391445911e-09
CTG O 0 4.147804702370195e-06
repeat O 0 6.916012011970452e-07
. O 0 3.349204860114696e-07

Using O 0 1.7175936761759658e-07
methylation O 0 6.831364771642257e-07
- O 0 9.269540157674783e-08
sensitive O 0 7.300879190097476e-08
restriction O 0 1.6949187608972238e-09
enzymes O 0 5.881607978430736e-10
, O 0 6.485605108519366e-11
we O 0 2.2887566841767182e-11
characterized O 0 4.102014214413252e-11
the O 0 1.377476865210836e-11
methylation O 0 1.627734946829662e-09
pattern O 0 1.0667461580737836e-08
on O 0 9.321094118774909e-09
the O 0 1.5438150757773883e-09
5 O 0 7.3854011795049246e-09
side O 0 4.650306362208312e-09
of O 0 2.0447167514703324e-08
the O 0 1.4035546058721593e-08
CTG O 0 1.7114143702201545e-06
repeat O 0 1.5592695135069334e-08
in O 0 4.630637262525994e-10
the O 0 5.331315389156543e-10
DMPK O 0 1.8232842080578848e-07
gene O 0 6.911891614613808e-10
of O 0 2.3184871800197016e-09
normal O 0 3.411088300708798e-08
individuals O 0 2.608990801178379e-11
and O 0 5.1662799038787455e-11
of O 0 1.7770704019426375e-08
patients O 0 7.092631904015434e-08
affected O 0 5.699677529946712e-08
with O 0 0.002837227191776037
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 3.653119762248025e-08
showing O 0 9.468926087663476e-09
expansions O 0 9.630229058643636e-09
of O 0 7.407620739030563e-09
the O 0 4.171434753175163e-09
repetitive O 0 2.5036208626261214e-06
sequence O 0 5.0237822790677455e-08
. O 0 1.9956036112489528e-07

The O 0 1.4989220176175877e-07
gene O 0 3.905807588466814e-08
segment O 0 3.01927975954186e-08
analyzed O 0 7.186425232674765e-09
corresponds O 0 4.8087702708699e-09
to O 0 3.740717458011744e-10
the O 0 1.325089482584474e-09
genomic O 0 4.546511078729054e-08
SacI O 0 4.219403308525216e-06
- O 0 2.153612754796086e-08
HindIII O 0 4.549260523845078e-08
fragment O 0 5.337198683008637e-09
carrying O 0 6.584629730355118e-09
exons O 0 8.207941704085897e-08
11 O 0 1.9655830385545414e-07
- O 0 1.2731064202853304e-07
15 O 0 1.190371037296245e-07
. O 0 8.678314600274462e-08

There O 0 4.388997609794387e-08
is O 0 2.391746356522617e-09
constitutive O 0 1.0656606974634997e-07
methylation O 0 4.309894450216234e-07
in O 0 9.761143360265123e-08
intron O 0 6.028232292010216e-06
12 O 0 1.6400790059378778e-07
at O 0 8.148977315158845e-08
restriction O 0 1.4022856209550127e-09
sites O 0 3.37178202025612e-10
of O 0 3.1499653996291954e-09
SacII O 0 9.122939559347287e-08
and O 0 7.430540627240134e-10
HhaI O 0 2.0980807846626703e-07
, O 0 5.859426277510238e-10
localized O 0 1.380293124242371e-08
1 O 0 2.076776297599281e-07
, O 0 4.3353290402059486e-10
159 O 0 3.6308474005153357e-09
- O 0 5.311961537302068e-09
1 O 0 3.378151802735374e-08
, O 0 2.359897832704405e-10
232 O 0 1.461228249510782e-09
bp O 0 2.3348992073124464e-08
upstream O 0 7.243397437406429e-09
of O 0 3.200646148115993e-08
the O 0 3.6284397708641336e-08
CTG O 0 1.4527232451655436e-05
repeat O 0 1.3226288331225078e-07
, O 0 1.7347452363480897e-09
whereas O 0 3.12180015171748e-09
most O 0 2.2136063815292317e-10
, O 0 5.970945959887786e-11
if O 0 3.4738392717947875e-11
not O 0 1.4551192716039107e-11
all O 0 1.7348560088503717e-11
, O 0 1.5411422138456032e-11
of O 0 7.925139017261884e-11
the O 0 2.0588961091583258e-11
other O 0 4.965367093184847e-12
sites O 0 5.788652543414763e-11
of O 0 7.621985820271959e-10
SacII O 0 7.966767867628732e-08
, O 0 6.014176934243665e-10
HhaI O 0 6.561438681274012e-08
, O 0 3.998579800601476e-10
and O 0 2.9208963026050583e-10
HpaII O 0 2.9429827463900438e-08
in O 0 2.1997675903051572e-10
this O 0 2.9015382110864074e-11
region O 0 1.3519076969004118e-09
are O 0 8.080350624717347e-12
unmethylated O 0 5.792966106810127e-09
, O 0 3.559788575024925e-11
in O 0 5.161926094898739e-11
normal O 0 1.6568478145018162e-08
individuals O 0 8.547273132319955e-12
and O 0 4.014090101978063e-11
most O 0 5.255289259320506e-11
of O 0 1.454263265365796e-09
the O 0 3.366642520319374e-09
patients O 0 6.731826829309284e-08
. O 0 5.8675073688618795e-08

In O 0 1.659745052506878e-08
a O 0 8.387703864798368e-10
number O 0 6.276515418512929e-11
of O 0 9.025013625318934e-09
young O 0 4.933560671105397e-09
and O 0 5.039682449137217e-09
severely O 0 0.02316814847290516
affected O 0 3.956343164190912e-08
patients O 0 1.0226191449191901e-08
, O 0 1.3598255854674335e-10
however O 0 1.5083397031379064e-10
, O 0 1.2288088081791049e-11
complete O 0 2.785507102753826e-10
methylation O 0 5.928352031503437e-09
of O 0 1.4030346884297273e-09
these O 0 2.391150992486768e-11
restriction O 0 5.643320533099683e-11
sites O 0 3.849445415204933e-11
was O 0 1.0233698333195207e-09
found O 0 4.311486931363184e-11
in O 0 2.2186606718488378e-11
the O 0 2.0887606921871082e-10
mutated O 0 7.754295539008638e-10
allele O 0 3.806766812886053e-08
. O 0 1.637450424141207e-07

In O 0 5.4437762742054474e-08
most O 0 2.0519903554117036e-09
of O 0 6.347032233122718e-09
these O 0 8.789864669456193e-11
patients O 0 2.0137479184167972e-10
, O 0 1.422583145033185e-11
the O 0 9.545567114521702e-11
onset O 0 1.4599052065022988e-06
of O 0 6.070619917863951e-08
the O 0 2.8015620046062395e-07
disease O 1 0.9924443364143372
was O 0 0.25432175397872925
congenital O 1 1.0
. O 0 0.0006204004166647792

Preliminary O 0 4.338973553785763e-07
in O 0 3.6845463569079584e-08
vivo O 0 1.3261972071632044e-06
footprinting O 0 3.048199232580373e-06
data O 0 1.0021038221452727e-08
gave O 0 2.611502569749291e-09
evidence O 0 2.5828013061612864e-09
for O 0 1.6065565544565175e-10
protein O 0 2.212307448345996e-09
- O 0 2.351528527455571e-09
DNA O 0 3.5389746688707646e-09
contact O 0 6.851128375728877e-08
in O 0 1.7800818596924728e-09
normal O 0 1.8083760267018079e-07
genes O 0 1.1921126308322982e-09
at O 0 3.4818771865730014e-08
an O 0 1.9323259659032033e-10
Sp1 O 0 2.9684816382768986e-08
consensus O 0 7.863113715700365e-09
binding O 0 2.082889638543861e-09
site O 0 3.2100226921016883e-09
upstream O 0 7.337115803807137e-09
of O 0 8.285135244534558e-09
the O 0 9.637211917379318e-09
CTG O 0 2.401059646217618e-06
repeat O 0 1.764839296924947e-08
and O 0 1.4580954499354704e-10
for O 0 3.8965452392458744e-11
a O 0 3.2253873183396564e-11
significant O 0 1.4080114678349798e-11
reduction O 0 2.3419364225674144e-09
of O 0 6.301123622876048e-09
this O 0 4.042764734091264e-11
interaction O 0 3.731547959517911e-09
in O 0 5.245148204657823e-10
cells O 0 8.237085319384718e-11
with O 0 9.006741186201594e-11
a O 0 2.7666691160277423e-09
hypermethylated O 0 2.119084570040286e-07
DMPK O 0 2.2528524823428597e-06
gene O 0 2.1337903888252185e-08
. O 0 8.866742007285211e-09
. O 0 8.322755462586429e-08

The O 0 9.96668495645281e-06
hemochromatosis B-Disease 1 1.0
gene O 0 7.915014066384174e-08
product O 0 8.610150814547524e-09
complexes O 0 2.6595902369308533e-08
with O 0 4.0084457975098076e-10
the O 0 3.6337988174039992e-09
transferrin O 0 1.2127428306030197e-07
receptor O 0 5.56110402172294e-09
and O 0 5.144257242406525e-10
lowers O 0 5.95757398968999e-09
its O 0 6.316134421036068e-11
affinity O 0 8.927387162849243e-10
for O 0 3.7130939989360456e-10
ligand O 0 1.0947423589868777e-07
binding O 0 2.818974280671682e-07
. O 0 5.444237558549503e-07

We O 0 7.597463991260156e-08
recently O 0 1.2294202988982761e-08
reported O 0 8.512416882489049e-10
the O 0 7.202322072075162e-11
positional O 0 5.139917291785423e-08
cloning O 0 2.063490045500771e-09
of O 0 9.035583947714088e-10
a O 0 5.326050156462259e-10
candidate O 0 4.446520485146266e-09
gene O 0 1.1506221397894478e-07
for O 0 1.5890031136223115e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999982118606567
HFE O 1 0.9998598098754883
. O 0 2.06584209081484e-05

The O 0 9.496856989699154e-08
gene O 0 6.732030044531712e-09
product O 0 2.116441244481848e-09
, O 0 3.2839517216665115e-10
a O 0 4.728168967460533e-10
member O 0 1.564094076478284e-09
of O 0 3.931946679358589e-08
the O 0 2.9652277078184852e-08
major O 0 5.418478963292728e-07
histocompatibility O 0 0.004441587254405022
complex O 1 0.5563114285469055
class O 0 1.1705470797096496e-06
I O 0 8.278097993752453e-06
- O 0 7.559390269307187e-08
like O 0 5.44269074254089e-10
family O 0 4.2538852995654963e-10
, O 0 1.1932357879551603e-10
was O 0 6.4893734830206995e-09
found O 0 2.530758103080899e-10
to O 0 8.102129384068846e-11
have O 0 4.634540320958003e-11
a O 0 5.240418099461408e-10
mutation O 0 6.94724416883119e-11
, O 0 8.742701007591336e-10
Cys O 0 3.5171512990928022e-06
- O 0 2.114645241135804e-07
282 O 0 1.8691619629862544e-07
- O 0 4.4098754869992263e-07
- O 0 1.98441611587441e-07
> O 0 2.1989810861100523e-08
Tyr O 0 6.959508880299836e-08
( O 0 1.2209688815545405e-10
C282Y O 0 1.248699144085208e-09
) O 0 8.177377178175682e-12
, O 0 3.194894002134241e-12
in O 0 5.263773791841508e-12
85 O 0 6.572555832917715e-10
% O 0 3.210351984250792e-10
of O 0 3.0541709605813594e-08
patient O 0 1.2342577520030318e-06
chromosomes O 0 2.9894845283706672e-06
. O 0 5.128005113874678e-07

This O 0 5.466925134811618e-09
mutation O 0 3.101946255412713e-09
eliminates O 0 2.028487244842836e-08
the O 0 1.5919615625747952e-09
ability O 0 2.730444315091063e-09
of O 0 4.797833952352448e-08
HFE O 0 3.597901468310738e-06
to O 0 8.438173715319408e-09
associate O 0 3.90697067587098e-07
with O 0 1.2935422732951452e-09
beta2 O 0 1.4800322787777986e-05
- O 0 2.0528273125819396e-06
microglobulin O 0 4.780742983712116e-06
( O 0 3.1615221551817285e-09
beta2m O 0 1.490777492563211e-07
) O 0 3.4875036192261177e-10
and O 0 3.698773232141406e-10
prevents O 0 5.914189582512108e-09
cell O 0 1.2180483963675215e-06
- O 0 3.7990854906411187e-08
surface O 0 5.100492330711859e-07
expression O 0 5.148169179847173e-07
. O 0 1.0818252604849476e-07

A O 0 1.7031270544975996e-06
second O 0 6.135082486480314e-08
mutation O 0 6.897550308693212e-10
that O 0 4.238608075635142e-11
has O 0 5.237887207298897e-11
no O 0 5.657029011896242e-11
effect O 0 1.2142623573296873e-09
on O 0 1.2874289190278887e-08
beta2m O 0 4.425294548582315e-07
association O 0 2.2736870164408174e-09
, O 0 3.6332700736885215e-10
H63D O 0 1.245971503749388e-07
, O 0 2.2759896745050412e-10
was O 0 1.2701936169534633e-09
found O 0 5.886610643379697e-11
in O 0 4.979975806729264e-11
eight O 0 9.698347680497932e-11
out O 0 1.0810208631029106e-11
of O 0 1.0029600483463241e-09
nine O 0 7.2787962324127875e-09
patients O 0 1.1099637875489066e-09
heterozygous O 0 9.643035259188082e-10
for O 0 8.165368381440885e-10
the O 0 1.206262201236541e-08
C282Y O 0 1.2293332929402823e-06
mutant O 0 7.097827392499312e-07
. O 0 2.653778778949345e-07

In O 0 7.049389960656072e-09
this O 0 8.102592902181627e-11
report O 0 9.753926832889448e-11
, O 0 1.4425622155145312e-11
we O 0 8.687173376487056e-12
demonstrate O 0 1.8755055841701562e-10
in O 0 2.0884181883840114e-10
cultured O 0 3.3215610262260498e-09
293 O 0 3.1329367988774948e-09
cells O 0 1.270576421852354e-09
overexpressing O 0 1.456009215416998e-07
wild O 0 8.378158167232641e-10
- O 0 1.4474917930940023e-09
type O 0 3.2631493063206563e-09
or O 0 2.213924155114455e-09
mutant O 0 1.371988300746807e-08
HFE O 0 4.045587616019475e-07
proteins O 0 4.476105042172662e-10
that O 0 1.7122260206892115e-11
both O 0 5.044216780381028e-11
the O 0 1.3025984457737394e-10
wild O 0 6.989257089751177e-11
- O 0 7.063945955954054e-11
type O 0 6.829763421478674e-10
and O 0 6.198345170460584e-10
H63D O 0 5.954434982413659e-06
HFE O 0 2.810223577398574e-06
proteins O 0 2.1313733000738466e-09
form O 0 3.0260123295988706e-09
stable O 0 6.558429390679521e-07
complexes O 0 8.530787631855219e-09
with O 0 2.6406526965061516e-10
the O 0 6.1816538554637646e-09
transferrin O 0 7.519771827446675e-08
receptor O 0 6.712554068144527e-09
( O 0 2.799318998825129e-09
TfR O 0 2.67242540985535e-07
) O 0 4.87706852680958e-09
. O 0 1.0299798702817498e-07

The O 0 2.6609811243361037e-07
C282Y O 0 1.9098831671726657e-06
mutation O 0 6.5994409936820375e-09
nearly O 0 3.974842233134268e-09
completely O 0 7.965670789644719e-09
prevents O 0 3.4282782168659764e-10
the O 0 2.0969841141305068e-10
association O 0 5.295964222717942e-10
of O 0 3.382508495519687e-09
the O 0 3.731270847850965e-09
mutant O 0 4.6413415333290686e-08
HFE O 0 7.2265338530996814e-06
protein O 0 8.76886261380605e-08
with O 0 1.441875951968541e-09
the O 0 4.51270487644706e-08
TfR O 0 2.31664798775455e-05
. O 0 2.8635142257371626e-07

Studies O 0 4.1546268647607576e-08
on O 0 6.781106520747926e-08
cell O 0 7.477436980707353e-08
- O 0 2.517731134688006e-09
associated O 0 1.9652890426158365e-09
transferrin O 0 7.208750218978821e-08
at O 0 3.1841818781686015e-07
37 O 0 6.641214866931477e-08
degrees O 0 1.181630750579643e-06
C O 0 2.68573671746708e-07
suggest O 0 6.021810272649475e-10
that O 0 6.98902654500122e-12
the O 0 6.985138856219208e-11
overexpressed O 0 1.0420772156294333e-07
wild O 0 8.845453813854931e-10
- O 0 4.386794483224321e-09
type O 0 3.0866264211226735e-08
HFE O 0 1.3395592759479769e-06
protein O 0 3.6489275601070403e-08
decreases O 0 2.6499376026833943e-09
the O 0 1.496978513371161e-10
affinity O 0 1.4949419480103643e-09
of O 0 5.565677696495186e-09
the O 0 3.05598746308533e-09
TfR O 0 3.5866295888808963e-07
for O 0 8.407842422286649e-09
transferrin O 0 1.9528902157617267e-06
. O 0 4.6914951212784217e-07

The O 0 2.2773003820475424e-06
overexpressed O 0 0.00023551097547169775
H63D O 0 0.0023069705348461866
protein O 0 1.8788857687468408e-06
does O 0 1.2390242165594145e-09
not O 0 2.974144541756374e-11
have O 0 6.713769622711252e-13
this O 0 2.467136466909742e-13
effect O 0 5.3209405631582385e-11
, O 0 6.278176763185872e-12
providing O 0 1.7034632385226622e-11
the O 0 1.2091235131184153e-11
first O 0 1.7015052561353272e-11
direct O 0 5.4980291153139405e-11
evidence O 0 1.9098793380134538e-10
for O 0 3.0318962618292034e-11
a O 0 1.8558840575444435e-10
functional O 0 3.4375474911030324e-07
consequence O 0 2.1993632515204808e-07
of O 0 5.2315751730702686e-08
the O 0 2.3801609572160487e-08
H63D O 0 5.454488564282656e-05
mutation O 0 3.821097749323599e-08
. O 0 1.6525025614555489e-07

Addition O 0 2.5946783921426686e-07
of O 0 1.069376139639644e-06
soluble O 0 1.0470531378814485e-05
wild O 0 8.102728799030956e-08
- O 0 1.338384123528158e-07
type O 0 9.573566330800531e-07
HFE O 0 0.001318716211244464
/ O 0 0.00012955718557350338
beta2m O 0 1.761411112966016e-05
heterodimers O 0 6.555923846462974e-06
to O 0 6.333621183074456e-09
cultured O 0 4.744886794583181e-08
cells O 0 5.380092482631937e-10
also O 0 3.858619673779984e-11
decreased O 0 9.562756142500461e-10
the O 0 1.5131573771753892e-10
apparent O 0 3.271081627786998e-09
affinity O 0 9.730111161232458e-10
of O 0 1.141922290059938e-08
the O 0 3.822918426266142e-09
TfR O 0 2.982442737220481e-08
for O 0 7.49925052612177e-11
its O 0 1.239304145417286e-11
ligand O 0 1.7713503996930058e-09
under O 0 1.215982692315265e-08
steady O 0 8.348560243121028e-08
- O 0 9.189084493321786e-10
state O 0 2.6522306920129246e-11
conditions O 0 5.87232651394487e-10
, O 0 1.2410523130002016e-11
both O 0 1.1992175481811973e-11
in O 0 1.1352150469656763e-10
293 O 0 1.1568597191313756e-09
cells O 0 1.52499332606304e-10
and O 0 6.597046797729433e-10
in O 0 5.0279114205409314e-09
HeLa O 0 4.5316244268178707e-07
cells O 0 2.4581195745554396e-08
. O 0 9.070367923413869e-08

Furthermore O 0 3.357804700954148e-07
, O 0 5.24996535133937e-09
at O 0 5.2367468583724985e-08
4 O 0 2.5731457853339634e-08
degrees O 0 1.0087709370054654e-06
C O 0 2.515695314286859e-07
, O 0 1.153628859107414e-10
the O 0 1.4270380710446062e-10
added O 0 1.7060923784839588e-09
soluble O 0 2.6800712760177703e-08
complex O 0 1.3115614194703085e-07
of O 0 1.9243086057940673e-07
HFE O 0 2.3415268515236676e-05
/ O 0 9.210330631503894e-07
beta2m O 0 1.0835103125828027e-07
inhibited O 0 1.3677757815244718e-09
binding O 0 2.4881803284415582e-09
of O 0 4.606484527158727e-09
transferrin O 0 6.274980535181385e-08
to O 0 3.1737747985260967e-09
HeLa O 0 1.9903369263829518e-07
cell O 0 7.20163129130924e-08
TfR O 0 1.9088693647972832e-07
in O 0 1.3206562510248432e-09
a O 0 2.307722235528331e-09
concentration O 0 8.516888669873879e-07
- O 0 6.204276559174104e-08
dependent O 0 1.1522182319367857e-08
manner O 0 1.0348534829063283e-07
. O 0 7.53591109514673e-08

Scatchard O 0 4.269312557880767e-05
plots O 0 4.298905764699157e-07
of O 0 2.9617176267038303e-08
these O 0 1.0914674719586515e-10
data O 0 6.809160457699193e-10
indicate O 0 6.728406720668545e-10
that O 0 1.848922577540879e-11
the O 0 1.878183164549796e-10
added O 0 5.8622799947727344e-09
heterodimer O 0 1.738038157839128e-08
substantially O 0 2.79644263301293e-09
reduced O 0 1.3821628286336818e-09
the O 0 7.995710343822182e-11
affinity O 0 1.0189816768146898e-09
of O 0 7.027883164312243e-09
TfR O 0 1.4892684419010038e-07
for O 0 7.96545762682399e-09
transferrin O 0 1.499668428550649e-06
. O 0 4.0366850839745894e-07

These O 0 2.1253163673407016e-09
results O 0 1.56364665659936e-09
establish O 0 9.919716603690176e-09
a O 0 3.4601541631928967e-09
molecular O 0 7.558021053455377e-08
link O 0 1.1298336488607674e-07
between O 0 3.269253170401498e-07
HFE O 0 2.391721136518754e-05
and O 0 2.2038769031951233e-08
a O 0 1.3423885114605127e-08
key O 0 9.9465455605241e-07
protein O 0 1.5575579936921713e-07
involved O 0 3.3823358336348974e-08
in O 0 1.6092201349238167e-08
iron O 0 0.0023288733791559935
transport O 0 1.3980512392208766e-07
, O 0 6.89497181571852e-10
the O 0 3.098143963597977e-09
TfR O 0 3.9256374861906806e-07
, O 0 3.6718514340172703e-10
and O 0 8.187572148043998e-11
raise O 0 1.8769691356723683e-10
the O 0 9.860963434693559e-11
possibility O 0 1.0206292477832335e-09
that O 0 1.1285349391099153e-11
alterations O 0 1.6422421200701365e-09
in O 0 7.508066390826684e-11
this O 0 8.19587973877045e-12
regulatory O 0 4.377967322000131e-09
mechanism O 0 6.34236357655027e-07
may O 0 1.2906276047885967e-08
play O 0 1.4275539861330344e-08
a O 0 1.0668229633026272e-09
role O 0 1.6922473422553708e-09
in O 0 4.893334626387968e-10
the O 0 3.1545710488245504e-09
pathogenesis O 0 0.3473416268825531
of O 0 0.42294925451278687
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00029345761868171394
. O 0 3.2300144994223956e-06

Genomic O 0 2.961150755709241e-07
organization O 0 2.0658855959254652e-08
of O 0 2.5661565317136592e-08
the O 0 3.913548241030185e-08
UBE3A O 0 0.00015811686171218753
/ O 0 2.423629666736815e-05
E6 O 0 5.899078132642899e-06
- O 0 3.1825121027395653e-07
AP O 0 3.620428117301344e-07
gene O 0 6.556878928698495e-10
and O 0 4.283094712231872e-11
related O 0 7.986817429639359e-09
pseudogenes O 0 3.7418882925521757e-07
. O 0 1.5950617182625138e-07

The O 0 3.0340416401486436e-07
UBE3A O 0 8.59464216773631e-06
gene O 0 2.0793777366634458e-08
encodes O 0 5.122748003572042e-09
the O 0 1.5971783895452063e-08
E6 O 0 1.3416919273367967e-06
- O 0 9.120292929765128e-07
AP O 0 6.398349341907306e-06
ubiquitin O 0 1.4705204876008793e-07
- O 0 2.3282375138933276e-08
protein O 0 9.327886907328775e-09
ligase O 0 4.267231012988759e-09
and O 0 2.513689534300312e-10
has O 0 6.516990419536128e-11
recently O 0 1.2614679301137244e-09
been O 0 2.1016928475336982e-10
shown O 0 3.902763529017861e-11
to O 0 2.0952228667325823e-12
be O 0 6.9061258448077645e-12
mutated O 0 7.15144499174869e-10
in O 0 2.7025651050394117e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.002039775950834155
who O 0 2.5403604553275727e-08
lack O 0 8.617318059123136e-08
15q11 O 0 4.508906101818866e-07
- O 0 3.315815177984405e-08
q13 O 0 4.6950130894174436e-08
deletions O 0 3.7336501890194995e-08
or O 0 3.858226182984481e-09
chromosome O 0 1.7918609955813736e-06
15 O 0 2.129697577402112e-06
paternal O 0 1.9514936866471544e-05
uniparental B-Disease 0 0.005162952467799187
disomy I-Disease 0 0.0005938932299613953
. O 0 4.40396388512454e-06

Previous O 0 1.8078463881465723e-06
UBE3A O 0 1.0618543456075713e-05
cDNA O 0 3.027722925708076e-07
analysis O 0 5.272885683638151e-09
has O 0 7.520263578530972e-11
shown O 0 9.751323359896702e-11
a O 0 8.98909904845091e-11
coding O 0 9.659589572663663e-09
region O 0 2.4344817717292244e-08
of O 0 2.889657224613984e-08
approximately O 0 1.270625471505582e-08
2 O 0 1.061015723280434e-06
. O 0 7.66448877698167e-08

6 O 0 2.9209912099759094e-05
kb O 0 3.2189815101446584e-05
and O 0 7.330390872084536e-08
a O 0 5.364246291605923e-08
3 O 0 5.875597821614065e-07
- O 0 2.9115323485484623e-08
untranslated O 0 1.8224534869659692e-05
region O 0 9.870009165524607e-08
( O 0 1.0914804615680396e-09
UTR O 0 2.2949419076212507e-07
) O 0 2.398067022735262e-10
of O 0 1.0553604212759637e-08
< O 0 1.9158014197273587e-07
50 O 0 2.715084157500769e-08
bp O 0 1.5753522930594954e-08
, O 0 1.0361832919469904e-10
whereas O 0 3.147459515240314e-10
Northern O 0 4.423880428650051e-10
analysis O 0 3.285142158304666e-10
has O 0 2.2341775998691027e-11
indicated O 0 8.768347853349567e-11
mRNA O 0 6.75761113733131e-11
sizes O 0 8.109679039414175e-10
of O 0 3.815822768871158e-09
5 O 0 9.281517066028755e-08
- O 0 7.80131514943605e-08
8 O 0 2.92402717150253e-07
kb O 0 1.7379294149577618e-05
. O 0 1.1561762676137732e-06

We O 0 7.048371486462202e-08
have O 0 8.420544123088902e-11
analyzed O 0 1.9198756473493006e-10
additional O 0 7.309535615673823e-11
cDNA O 0 4.145308540870474e-09
clones O 0 9.869962624975415e-10
and O 0 3.048724467324959e-11
provide O 0 4.435115122380928e-11
evidence O 0 3.0737337675112997e-10
for O 0 1.9646386947846928e-11
an O 0 2.7599251009591264e-11
additional O 0 1.3771420670494194e-09
0 O 0 2.7743095643018023e-07
. O 0 2.689986615678208e-07

5 O 0 6.016057795932284e-06
kb O 0 2.1814996216562577e-05
of O 0 2.386014557487215e-06
5 O 0 1.1526917660376057e-06
- O 0 8.38049984963618e-08
UTR O 0 1.8633327272254974e-06
and O 0 2.2251342990387e-09
> O 0 1.696433216125115e-08
2 O 0 6.229616644759517e-08
kb O 0 1.0610642675601412e-06
of O 0 3.388817049199133e-07
3 O 0 1.6916930690058507e-05
- O 0 2.8199901862535626e-06
UTR O 0 9.182325447909534e-05
. O 0 1.3747487628279487e-06

We O 0 3.0952456597788114e-08
have O 0 8.369274023811712e-11
established O 0 1.2186678055581268e-10
the O 0 2.990515474143862e-11
genomic O 0 7.309566840696391e-10
organization O 0 1.509692371115534e-10
of O 0 3.6738359021626366e-09
UBE3A O 0 4.4615470073949837e-07
and O 0 5.925477331025775e-10
the O 0 3.5623848315680107e-10
sequence O 0 3.3167371071840535e-09
of O 0 1.0017392071404174e-07
intron O 0 1.8154802091885358e-05
- O 0 3.2637287858960917e-06
exon O 0 4.360321327112615e-06
borders O 0 3.968644080032391e-07
. O 0 8.391230039705988e-07

We O 0 1.0768206948341685e-07
have O 0 9.200237793827171e-10
also O 0 1.3837844758946005e-10
mapped O 0 5.252947521405815e-10
two O 0 1.0851778503573328e-10
highly O 0 1.485253142696763e-09
homologous O 0 5.972763617023702e-09
processed O 0 9.587837190849768e-09
pseudogenes O 0 5.636734812242139e-08
, O 0 4.792908292472475e-10
UBE3AP1 O 0 1.7508571659163863e-07
and O 0 1.6483867604222269e-09
UBE3AP2 O 0 1.3176436368667055e-06
, O 0 6.557417386865438e-10
to O 0 1.5296894306793263e-10
chromosomes O 0 2.5288002802881238e-09
2 O 0 1.666838578273655e-08
and O 0 1.4398415792982178e-10
21 O 0 6.303648270034046e-09
, O 0 8.382693844621869e-11
respectively O 0 1.7500558779914854e-09
, O 0 4.3917463415921176e-11
and O 0 8.47180138541237e-12
determined O 0 6.680185293816976e-10
their O 0 1.0172567649346931e-10
genomic O 0 3.549677884961966e-08
organization O 0 1.3994647218851242e-08
. O 0 1.1088051365959473e-07

These O 0 6.499110138946662e-09
results O 0 1.5923654617111538e-09
will O 0 1.2921756720185584e-10
form O 0 2.0551374838029268e-11
the O 0 9.998475138106588e-12
basis O 0 8.827752417950308e-11
for O 0 4.1414614793122695e-12
studies O 0 2.8955672928820952e-11
of O 0 6.508083655321073e-11
mutation O 0 4.607885947804924e-11
and O 0 1.4633667888563906e-10
imprinting O 0 3.145464688714128e-07
of O 0 8.035592600208474e-07
UBE3A O 0 0.0037801633588969707
. O 0 5.332446107786382e-06

Mutation O 0 3.236207533063862e-07
spectrum O 0 1.4658596683148062e-06
and O 0 1.4253747515624582e-08
genotype O 0 1.2759481649027293e-07
- O 0 1.288962181433817e-08
phenotype O 0 6.255018725198624e-10
analyses O 0 1.182830944301827e-09
in O 0 1.8940841950421117e-10
Cowden B-Disease 0 0.0016878758324310184
disease I-Disease 0 2.4576561941103137e-07
and O 0 4.226116345762421e-09
Bannayan B-Disease 1 0.9999483823776245
- I-Disease 1 0.9999997615814209
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.2182373154701054e-07
two O 0 1.7016353126564354e-07
hamartoma B-Disease 1 0.9999822378158569
syndromes I-Disease 1 0.7962461113929749
with O 0 9.361820957565214e-06
germline O 1 0.9997530579566956
PTEN O 1 0.9640187621116638
mutation O 0 3.8113005302875536e-06
. O 0 9.937016329786275e-07

The O 0 5.247562512522563e-06
tumour B-Disease 1 0.9999997615814209
suppressor O 0 0.00010280269634677097
gene O 0 3.527036597006372e-06
PTEN O 0 4.6026289055589586e-05
, O 0 2.208771121559039e-08
which O 0 1.6756572518428214e-10
maps O 0 8.48342374126787e-09
to O 0 4.391750518806248e-09
10q23 O 0 4.221025392325828e-06
. O 0 5.176447643862048e-07

3 O 0 1.0826234984051553e-06
and O 0 2.033735624351607e-09
encodes O 0 2.6547537501642182e-09
a O 0 1.739788535459752e-09
403 O 0 4.071321058063404e-10
amino O 0 1.1948989575572e-09
acid O 0 2.7105240274494236e-09
dual O 0 5.2775671832705484e-08
specificity O 0 1.6623880583210848e-07
phosphatase O 0 2.440493153699208e-05
( O 0 1.3338079973834738e-08
protein O 0 1.4163047978854593e-07
tyrosine O 0 1.1516014097878724e-07
phosphatase O 0 5.467907158163143e-07
; O 0 2.21365836772236e-09
PTPase O 0 1.7447082711896655e-07
) O 0 6.433026333851899e-10
, O 0 3.388020974881556e-10
was O 0 1.061493470899677e-08
shown O 0 1.8724970463068757e-09
recently O 0 3.041693785732491e-09
to O 0 2.7133936764123234e-10
play O 0 2.4409775534195433e-08
a O 0 2.6248359041858293e-09
broad O 0 3.147022642480124e-09
role O 0 2.145715960466532e-08
in O 0 6.535531671403305e-09
human O 0 1.8981950233865064e-07
malignancy B-Disease 0 8.165610051946715e-05
. O 0 1.4137557400317746e-06

Somatic O 0 3.877227209159173e-05
PTEN O 0 2.7006100935977884e-05
deletions O 0 2.0648776910547895e-07
and O 0 1.2027556728355648e-09
mutations O 0 1.2599002952029537e-09
were O 0 8.615103075371167e-11
observed O 0 4.164103228898597e-10
in O 0 1.8250770339456324e-10
sporadic B-Disease 0 2.8431106784410076e-06
breast I-Disease 0 0.04618973657488823
, I-Disease 0 1.900328783221994e-07
brain I-Disease 1 0.9999996423721313
, I-Disease 0 1.6458135405628127e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9999854564666748
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.00014415521582122892
and O 0 1.018519157902631e-09
in O 0 3.9267714080359895e-10
several O 0 3.133305559455124e-10
primary O 0 1.201066424982855e-06
tumours B-Disease 1 1.0
such O 0 2.139896082553605e-08
as O 0 1.2959421837877017e-05
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999922513961792

In O 0 2.1401086769401445e-07
addition O 0 5.6382940982757646e-08
, O 0 1.6493718391075163e-08
PTEN O 0 2.1980265501042595e-06
was O 0 5.917847900605011e-08
identified O 0 4.1714027787520536e-09
as O 0 2.0763241126431353e-10
the O 0 1.0104980741054703e-10
susceptibility O 0 1.6403011171561843e-09
gene O 0 1.1103575836557411e-09
for O 0 2.0288966062764757e-09
two O 0 2.304027475474868e-07
hamartoma B-Disease 1 0.9999997615814209
syndromes I-Disease 1 0.9999997615814209
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9994577765464783
( O 0 2.397904808049134e-08
CD B-Disease 0 2.888558128688601e-06
; O 0 9.513859922094525e-09
MIM O 0 1.3776361811324023e-06
158350 O 0 8.101569903828931e-08
) O 0 1.2531077564492676e-10
and O 0 3.6337552411502827e-10
Bannayan B-Disease 0 3.0851604151393985e-06
- I-Disease 0 2.9576360702776583e-06
Zonana I-Disease 0 0.00013995973858982325
( I-Disease 0 1.938130367307167e-08
BZS I-Disease 0 1.1005035048583522e-05
) I-Disease 0 4.448275969792803e-09
or I-Disease 0 5.569638528157839e-09
Ruvalcaba I-Disease 0 2.8526108053483767e-06
- I-Disease 0 2.452788521623006e-06
Riley I-Disease 0 8.299078763229772e-05
- I-Disease 1 0.8904943466186523
Smith I-Disease 1 0.9889177083969116
syndrome I-Disease 1 0.9999946355819702
( O 0 1.7725299983339937e-07
MIM O 0 0.00010618972009979188
153480 O 0 1.0932397344731726e-05
) O 0 5.042242534614161e-08
. O 0 3.0846112508697843e-07

Constitutive O 0 1.9549138414731715e-06
DNA O 0 8.426018638374444e-08
from O 0 7.275548608021154e-09
37 O 0 1.0599436883751423e-08
CD B-Disease 0 6.012381703612846e-08
families O 0 1.9197622658229108e-10
and O 0 5.085701859641745e-10
seven O 0 6.385950879206348e-09
BZS B-Disease 0 5.808258720207959e-06
families O 0 1.86633458687524e-10
was O 0 6.218455084194829e-09
screened O 0 1.3494146244852345e-08
for O 0 1.1504745600632305e-08
germline O 0 1.9907420210074633e-05
PTEN O 0 0.00037089522811584175
mutations O 0 5.762405180576025e-06
. O 0 1.8250287894261419e-06

PTEN O 0 4.09458989452105e-05
mutations O 0 2.7080863773676356e-08
were O 0 3.414126537037987e-09
identified O 0 6.990260037476048e-10
in O 0 4.1773084991092446e-10
30 O 0 2.2865294102558664e-09
of O 0 1.0490506241467301e-08
37 O 0 3.6075032738835944e-08
( O 0 6.985115263979935e-10
81 O 0 1.4898360767290342e-08
% O 0 3.60437013569026e-10
) O 0 5.607131425833245e-11
CD B-Disease 0 2.131386622750142e-08
families O 0 6.38244943007571e-11
, O 0 4.984926707529702e-11
including O 0 1.0656368149009054e-10
missense O 0 5.385754775488749e-08
and O 0 5.623931098597268e-09
nonsense O 0 2.210154889326077e-06
point O 0 1.018337002278713e-06
mutations O 0 4.558952326760846e-09
, O 0 4.772146566800473e-10
deletions O 0 4.846790968571213e-09
, O 0 3.9091277437286465e-10
insertions O 0 7.588178085882191e-09
, O 0 7.3270151057514e-10
a O 0 2.168963231241605e-09
deletion O 0 1.2219700806781475e-07
/ O 0 7.645499522368482e-07
insertion O 0 1.9602292411491362e-07
and O 0 2.590331327212425e-08
splice O 0 2.2540600639331387e-06
site O 0 1.9123093863981921e-07
mutations O 0 1.9679161766816833e-07
. O 0 6.624817956435436e-07

These O 0 1.6648965539545202e-09
mutations O 0 2.6137052522301474e-09
were O 0 8.140301210879386e-10
scattered O 0 6.182570011503685e-10
over O 0 3.4377137247965095e-10
the O 0 2.1069909705850876e-10
entire O 0 2.1523223203701036e-09
length O 0 1.920957171108739e-09
of O 0 8.244338545182472e-09
PTEN O 0 1.7614905800655833e-07
, O 0 2.001101090387536e-10
with O 0 5.549990588632481e-12
the O 0 1.259966991851158e-10
exception O 0 2.7892552156849604e-10
of O 0 1.7834395071858467e-09
the O 0 5.196979513399924e-10
first O 0 1.0486980173141092e-09
, O 0 2.8216498582089855e-10
fourth O 0 9.874297823841971e-09
and O 0 6.749000913686132e-09
last O 0 5.103991043142742e-07
exons O 0 5.818004865432158e-06
. O 0 2.7668875191011466e-06

A O 0 7.528708010795526e-06
hot O 0 5.401038833952043e-06
spot O 0 3.4610906141097075e-07
for O 0 4.3604835298083344e-09
PTEN O 0 5.433392402665049e-07
mutation O 0 9.289248814603468e-10
in O 0 2.030792617402355e-10
CD B-Disease 0 8.847588617300062e-08
was O 0 5.168712746694837e-08
identified O 0 2.160709167142727e-09
in O 0 1.5182174406547233e-09
exon O 0 5.245183487545546e-08
5 O 0 1.156692608361709e-08
that O 0 4.977069797962308e-11
contains O 0 1.2547961281139663e-10
the O 0 2.3562010675881595e-10
PTPase O 0 6.283675446638881e-08
core O 0 5.9265456542334505e-08
motif O 0 4.194459890527469e-09
, O 0 4.311273213430944e-11
with O 0 7.077995741594512e-12
13 O 0 1.3473925308815637e-09
of O 0 6.173782818308382e-09
30 O 0 1.0814822815063962e-08
( O 0 2.415732336391585e-10
43 O 0 3.4960434547315344e-09
% O 0 3.320913266602332e-10
) O 0 1.3811080057379854e-10
CD B-Disease 0 5.021914262215432e-08
mutations O 0 4.15159862043879e-09
identified O 0 3.219662092490694e-09
in O 0 1.187759446352743e-09
this O 0 7.697856241328793e-10
exon O 0 2.44488796852238e-06
. O 0 7.977455425134394e-07

Seven O 0 2.3303996954382455e-07
of O 0 8.287541675144894e-08
30 O 0 4.305166001472571e-08
( O 0 4.831586797315879e-10
23 O 0 1.3576657131864067e-08
% O 0 3.1701249958437927e-10
) O 0 2.3032092899555323e-10
were O 0 7.167448856648662e-10
within O 0 1.013127137738934e-09
the O 0 7.144096425548696e-10
core O 0 7.801865820056264e-08
motif O 0 5.4672275595635256e-09
, O 0 1.3795468933874844e-10
the O 0 2.5494009681104046e-10
majority O 0 2.0919903309657428e-10
( O 0 8.916032495642767e-11
five O 0 3.8713451888661154e-10
of O 0 5.002380731866651e-09
seven O 0 2.224989970045499e-09
) O 0 3.5185302588169876e-11
of O 0 1.2127092663405392e-09
which O 0 6.536372831877912e-11
were O 0 3.766421396989017e-09
missense O 0 6.071267932838964e-08
mutations O 0 4.525985808356836e-09
, O 0 1.38255318304914e-09
possibly O 0 1.6281488157687818e-08
pointing O 0 2.2824650613983977e-08
to O 0 8.254306960164826e-11
the O 0 2.91870749791201e-10
functional O 0 1.0439531905603872e-07
significance O 0 3.972055040435407e-08
of O 0 2.3670500226558033e-08
this O 0 5.348854692499572e-10
region O 0 2.102164557982178e-07
. O 0 2.7033985361413215e-07

Germline O 0 0.0005898287636227906
PTEN O 0 5.005710409022868e-05
mutations O 0 3.91146599554304e-08
were O 0 2.71429567710868e-09
identified O 0 3.8317640727036917e-10
in O 0 6.837802546399985e-11
four O 0 8.7477511345746e-11
of O 0 2.731116000020961e-09
seven O 0 2.2622841377994973e-09
( O 0 1.6306987704606257e-10
57 O 0 1.3624491757013857e-08
% O 0 5.905216760027088e-09
) O 0 2.635618301383147e-08
BZS B-Disease 0 0.0002581606968306005
families O 0 1.5973917300016183e-08
studied O 0 1.0157464203075506e-05
. O 0 6.010719744153903e-07

Interestingly O 0 8.06379716777883e-07
, O 0 6.7015264448855305e-09
none O 0 3.134257520187589e-09
of O 0 1.0000450467728683e-09
these O 0 9.391283757598234e-12
mutations O 0 1.7429362120235936e-10
was O 0 2.594691128621207e-09
observed O 0 2.1537185368458722e-09
in O 0 5.22323406748626e-10
the O 0 2.294414880310569e-09
PTPase O 0 1.0507687875360716e-06
core O 0 4.039760369778378e-06
motif O 0 2.438447381791775e-06
. O 0 6.013482902744727e-07

It O 0 1.56497215186846e-08
is O 0 1.1837518743007536e-09
also O 0 1.0197024474800642e-10
worthy O 0 1.7218264591889465e-09
of O 0 3.6720775309362352e-09
note O 0 1.6811803060789998e-09
that O 0 3.364148890017127e-11
a O 0 4.024686972581293e-10
single O 0 2.388471642689183e-10
nonsense O 0 7.642242394467758e-08
point O 0 4.533219311042558e-08
mutation O 0 1.8598243778367163e-10
, O 0 1.0607920791771974e-10
R233X O 0 2.6368691674605316e-09
, O 0 6.076322778270082e-11
was O 0 1.2649519209873006e-09
observed O 0 6.092874538232707e-10
in O 0 7.608227936550804e-11
the O 0 3.5346486848553127e-10
germline O 0 5.461995300493072e-09
DNA O 0 2.058925696601932e-09
from O 0 6.65594468429731e-10
two O 0 9.0160920396265e-11
unrelated O 0 2.0982893200738317e-09
CD B-Disease 0 4.98884347166495e-08
families O 0 1.5611961723394074e-10
and O 0 1.4419502258888883e-09
one O 0 1.2070723087731494e-08
BZS B-Disease 0 0.0007106499979272485
family O 0 3.9831434150983114e-07
. O 0 6.028033112670528e-07

Genotype O 0 1.6531535038666334e-06
- O 0 9.609738071958418e-08
phenotype O 0 1.929748583151536e-09
studies O 0 2.767696904992789e-10
were O 0 4.24686258382323e-11
not O 0 1.1940997236142836e-12
performed O 0 9.275221563020963e-11
on O 0 1.445157188362245e-10
this O 0 4.778253313852954e-12
small O 0 6.109932004783047e-11
group O 0 2.1498758329130396e-10
of O 0 6.64557333607263e-08
BZS B-Disease 0 0.21176259219646454
families O 0 6.31124166261543e-08
. O 0 4.274845935015037e-07

However O 0 6.028825794146542e-08
, O 0 5.97259264267791e-09
genotype O 0 2.6132580543958284e-08
- O 0 3.840721962689031e-09
phenotype O 0 4.6562506628156086e-10
analysis O 0 1.0327820820776878e-09
inthe O 0 1.5395013974739413e-07
group O 0 1.6194665608537662e-09
of O 0 1.2286560213681241e-08
CD B-Disease 0 2.264443082822254e-06
families O 0 1.0658914861849667e-09
revealed O 0 9.952294099946357e-09
two O 0 5.286152765515695e-11
possible O 0 6.331041940699222e-11
associations O 0 1.222905023773313e-11
worthy O 0 2.0117179033718458e-09
of O 0 3.655257652113164e-09
follow O 0 1.0440398545696894e-09
- O 0 1.6449507311833145e-09
up O 0 6.797766793908977e-10
in O 0 2.915880870091314e-10
independent O 0 3.371410706165534e-09
analyses O 0 3.0048827426298885e-08
. O 0 7.289371950491841e-08

The O 0 1.6950674819327105e-07
first O 0 8.988147115474021e-09
was O 0 1.5027817212853734e-08
an O 0 4.32477179068691e-11
association O 0 1.0546469947358972e-10
noted O 0 2.2803132992965658e-10
in O 0 4.765159100639238e-11
the O 0 1.9165134756971014e-10
group O 0 1.187550474623933e-10
of O 0 6.970598764866054e-09
CD B-Disease 0 0.00025488928076811135
families O 0 4.592115132595609e-09
with O 0 1.88509261533909e-07
breast B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 9.169314580503851e-05

A O 0 2.492545263521606e-07
correlation O 0 5.422553073231029e-08
was O 0 2.3996296505401915e-08
observed O 0 1.826944928673413e-09
between O 0 5.312009165869824e-10
the O 0 4.5715039392879575e-11
presence O 0 4.681094956104914e-10
/ O 0 1.3540555343638516e-08
absence O 0 5.1513218579657405e-08
of O 0 6.425392484743497e-08
a O 0 2.287407419032661e-08
PTEN O 0 8.460988283331972e-07
mutation O 0 1.0408703898789895e-09
and O 0 7.968337101260659e-11
the O 0 1.0183147380882218e-10
type O 0 2.9787985411644513e-08
of O 0 3.8321337569868774e-07
breast O 0 0.16859428584575653
involvement O 0 0.024394378066062927
( O 0 3.2199960742218536e-07
unaffected O 0 3.4130534913856536e-05
versus O 1 0.9981551766395569
benign O 1 0.9949657320976257
versus O 1 0.9060056209564209
malignant O 0 0.015342985279858112
) O 0 7.076983621345789e-08
. O 0 2.8322889988885436e-07

Specifically O 0 1.4124631775302987e-07
and O 0 3.152538008421857e-09
more O 0 6.072707614546147e-11
directly O 0 6.617033032618735e-10
, O 0 2.753357958296121e-11
an O 0 3.001092083176893e-11
association O 0 5.460138452484387e-10
was O 0 2.4073633753118884e-08
also O 0 9.164714820375508e-11
observed O 0 9.56844936617074e-10
between O 0 7.366193766067397e-10
the O 0 7.238334931436441e-11
presence O 0 1.688467837768215e-10
of O 0 1.6571440886181676e-09
a O 0 7.701883575350621e-09
PTEN O 0 8.644126501167193e-05
mutation O 0 2.2901321017343435e-07
and O 0 7.526572858296277e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
. O 0 7.792362157488242e-05

Secondly O 0 1.42392727866536e-05
, O 0 3.031802364716896e-08
there O 0 2.604304993880646e-09
appeared O 0 6.1065361656176265e-09
to O 0 3.4301537304992635e-11
be O 0 2.589783942852364e-11
an O 0 2.6238922493093675e-11
interdependent O 0 1.5662389785120467e-07
association O 0 1.4123198610604959e-08
between O 0 3.6397563007994904e-07
mutations O 0 1.570276531026593e-08
upstream O 0 3.312287688572724e-08
and O 0 9.36846489274501e-10
within O 0 3.1696851809925874e-09
the O 0 2.424762834962735e-09
PTPase O 0 8.329678280460939e-07
core O 0 4.973879867975484e-07
motif O 0 1.4208795917625139e-08
, O 0 1.072604643992392e-10
the O 0 2.8571003896082914e-10
core O 0 2.4754054805953274e-08
motif O 0 7.567649840112267e-10
containing O 0 1.1428318014150562e-10
the O 0 5.148141288269237e-11
majority O 0 1.0515877751915426e-10
of O 0 1.3650554464561537e-08
missense O 0 7.740560192814883e-08
mutations O 0 1.8448101934964711e-09
, O 0 1.858852655134413e-10
and O 0 5.896139826377933e-11
the O 0 2.025454248766323e-10
involvement O 0 1.0145527085114736e-08
of O 0 1.5549154852578795e-08
all O 0 1.9333212808447797e-10
major O 0 8.258109751579923e-09
organ O 1 0.981888473033905
systems O 1 0.999997615814209
( O 0 0.00020479531667660922
central O 1 0.9999818801879883
nervous O 1 0.9995253086090088
system O 1 0.999980092048645
, O 0 0.00019875472935382277
thyroid O 1 1.0
, O 0 0.07110412418842316
breast O 1 1.0
, O 0 0.3554579019546509
skin O 1 1.0
and O 1 0.9999991655349731
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.0004421006597112864
. O 0 4.954136602464132e-05

However O 0 1.1495670548811177e-07
, O 0 1.3285996747214313e-09
these O 0 3.844764090432662e-11
observations O 0 2.58932209007412e-09
would O 0 2.4756627303723633e-10
need O 0 3.1267802236278897e-10
to O 0 2.8304018850899837e-11
be O 0 2.059642387197691e-11
confirmed O 0 4.055245375611527e-11
by O 0 3.4438860183755304e-12
studying O 0 1.1600281846213534e-09
a O 0 4.9168901589125014e-11
larger O 0 1.9441179568979727e-11
number O 0 4.13423392742196e-11
of O 0 3.824872862878692e-09
CD B-Disease 0 1.3255094017949887e-06
families O 0 1.5615075454888938e-08
. O 0 1.7155669240764837e-07

Molecular O 0 0.2511500418186188
defects O 1 0.9992647767066956
leading O 0 9.736428410178632e-07
to O 0 2.6906414873906215e-09
human O 0 3.842028206690884e-08
complement B-Disease 0 4.072978754265932e-06
component I-Disease 1 0.9999998807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.831703475678296e-08
an O 0 5.947148884466458e-10
African O 0 1.0376755454899467e-08
- O 0 3.502733036953032e-08
American O 0 1.734951382559302e-08
family O 0 1.563850204888695e-08
. O 0 7.980379024274953e-08

Complement B-Disease 0 9.162757487501949e-05
component I-Disease 1 0.9999959468841553
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.466842031230044e-07
C6D B-Disease 0 7.908532097644638e-06
) O 0 1.7193915180513386e-09
was O 0 6.722588352658931e-08
diagnosed O 0 5.079173774902301e-07
in O 0 4.571909961725851e-09
a O 0 4.962278588038771e-09
16 O 0 2.6198557989687288e-08
- O 0 1.7937695773184714e-09
year O 0 6.452860468186827e-10
- O 0 4.933127684125793e-09
old O 0 4.59158364662926e-08
African O 0 1.1607282246473005e-08
- O 0 4.92955321007571e-09
American O 0 8.075674573504443e-10
male O 0 1.7563727139346952e-09
with O 0 3.315486551969116e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 9.635649576011929e-07

The O 0 3.4429675110914104e-07
patients O 0 1.4550818150382838e-07
father O 0 1.753756748712476e-07
and O 0 1.3230521567209053e-08
two O 0 2.3183247321867384e-08
brothers O 0 4.371378281575744e-07
also O 0 5.172121841923172e-09
had O 0 7.482130826019784e-08
C6D B-Disease 0 0.0001283958408748731
, O 0 8.384968830377204e-10
but O 0 1.0100548869518278e-10
gave O 0 1.6607187847128557e-10
no O 0 5.866704344548168e-11
history O 0 2.040040081308092e-10
of O 0 1.419804096514099e-08
meningitis B-Disease 1 0.9999994039535522
or O 0 3.0119964300467927e-09
other O 0 1.940322791327276e-09
neisserial B-Disease 0 3.152817953377962e-05
infection I-Disease 0 2.0391145881148987e-05
. O 0 3.6432152228371706e-07

By O 0 1.7208350300279562e-09
using O 0 3.6074738751779023e-09
exon O 0 4.498825134646722e-08
- O 0 8.896433589811181e-10
specific O 0 8.55357312756766e-11
polymerase O 0 2.0333215999812637e-08
chain O 0 4.614284510040534e-09
reaction O 0 3.0859639843505704e-10
( O 0 7.313524091889789e-11
PCR O 0 6.904736782331611e-10
) O 0 1.087763976115319e-10
/ O 0 9.83369607965301e-10
single O 0 6.485212367124404e-10
- O 0 1.7026789977947487e-09
strand O 0 2.924575581708666e-10
conformation O 0 1.525490705978072e-10
polymorphism O 0 4.2233097574673195e-10
as O 0 4.8647443712246385e-11
a O 0 1.9366789422159414e-11
screening O 0 1.031785351601755e-10
step O 0 1.523199760766758e-10
and O 0 2.0694041966140553e-11
nucleotide O 0 1.7285152476009813e-10
sequencing O 0 6.710029198941925e-10
of O 0 6.982348477180267e-09
target O 0 5.266754588006961e-09
exons O 0 7.447091832091246e-08
, O 0 1.452660991496657e-09
we O 0 4.4310755065168905e-10
determined O 0 7.534667334496703e-10
that O 0 1.2194135458332145e-11
the O 0 1.5923463936307058e-10
proband O 0 5.251519752391687e-08
was O 0 2.7829820226088486e-08
a O 0 1.8178898386622677e-09
compound O 0 2.415062105853849e-08
heterozygote O 0 1.074774900189368e-07
for O 0 5.4089150935965336e-09
two O 0 7.845468985578918e-08
C6 O 0 0.03385728970170021
gene O 0 3.388969844309031e-06
mutations O 0 9.89815248431114e-07
. O 0 1.122214143833844e-06

The O 0 6.11308763609486e-08
first O 0 6.486478021372477e-09
, O 0 6.82827905329475e-10
1195delC O 0 1.2630239965005785e-08
located O 0 4.525813057654204e-09
in O 0 2.531015175222251e-09
exon O 0 1.5592492275118275e-07
7 O 0 2.9907772614024e-07
, O 0 1.5793438778999302e-09
is O 0 1.572660751625321e-10
a O 0 2.5231139400005986e-10
novel O 0 8.503309167906536e-11
mutation O 0 3.594351899449677e-11
, O 0 2.3679856686609213e-11
while O 0 5.6736153969394465e-11
the O 0 3.4881819654941637e-10
second O 0 1.6986179129929724e-09
, O 0 2.030792617402355e-10
1936delG O 0 1.0709172215683793e-08
in O 0 4.454839608314387e-09
exon O 0 1.5547307441465819e-07
12 O 0 7.172953075951227e-08
, O 0 8.303324139369295e-10
has O 0 1.489027789958186e-10
been O 0 1.7360683723932624e-10
described O 0 4.945863163463571e-10
before O 0 7.553676018012823e-10
to O 0 2.1956050866300814e-10
cause O 0 4.795745578434207e-09
C6D B-Disease 0 5.303521106725384e-07
in O 0 1.247190017927835e-09
an O 0 1.2969014751007535e-10
unrelated O 0 5.594128538177756e-08
African O 0 3.638266932171064e-08
- O 0 2.17742002206478e-08
American O 0 5.8046012441081984e-09
individual O 0 2.1905739444605388e-09
. O 0 1.7629997728363378e-07

Both O 0 3.3110623576249054e-08
mutations O 0 1.7136986940613497e-08
result O 0 1.0846946452147677e-08
in O 0 9.26836918324625e-09
premature O 0 1.0693459273625194e-07
termination O 0 8.599963052802195e-08
codons O 0 8.42495850861269e-08
and O 0 5.7954668619686345e-08
C6 O 0 5.134561433806084e-05
null O 0 2.2161018932820298e-05
alleles O 0 7.447176244568254e-07
. O 0 1.1017940551028005e-06

Allele O 0 1.2863714005106885e-07
- O 0 1.0611533873827739e-08
specific O 0 3.269258752602866e-10
PCR O 0 1.2930613246808775e-09
indicated O 0 4.743940795748358e-10
that O 0 5.206230845739013e-12
the O 0 8.002423723674212e-11
probands O 0 6.845628774954093e-08
two O 0 1.0191196775366507e-09
brothers O 0 1.8450714733830864e-08
also O 0 2.0321952454160908e-10
inherited O 0 3.9159601783467224e-08
the O 0 4.027061795142117e-09
1195delC O 0 5.6737974318821216e-08
mutation O 0 3.649765767388402e-10
from O 0 6.920823358846917e-10
their O 0 1.8880318142233676e-10
heterozygous O 0 2.2850950021080507e-09
mother O 0 1.3148001576368529e-09
and O 0 7.924141204318502e-11
the O 0 3.3695574108705273e-10
1936delG O 0 9.497649777756578e-09
mutation O 0 2.98314511981701e-10
from O 0 8.249652072578328e-10
their O 0 1.7010745589907117e-10
homozygous O 0 6.065906443808444e-09
father O 0 2.5633779543454693e-08
. O 0 3.4758440570215043e-09
. O 0 7.4247672898764e-08

PAX6 O 0 0.005598604213446379
mutations O 0 7.406461008940823e-06
reviewed O 0 9.381448762724176e-06
. O 0 2.8948209092050092e-06

Mutations O 0 3.294900920991495e-07
in O 0 2.974336155148194e-08
PAX6 O 0 1.7027150533976965e-05
are O 0 5.562883487186809e-10
responsible O 0 2.2816979416973027e-09
for O 0 3.220078093058021e-10
human O 0 1.1654938703031803e-07
aniridia B-Disease 1 1.0
and O 0 8.453477917669261e-09
have O 0 8.9481637377542e-11
also O 0 1.2479145321264706e-11
been O 0 1.0819469452305608e-11
found O 0 1.1891410599262908e-11
in O 0 7.894207856851132e-12
patients O 0 5.012184764452421e-11
with O 0 2.9137683932312086e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.4270794913027203e-07
with O 0 0.015359356068074703
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.01149447076022625
with O 0 6.930677773198113e-05
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 0.9999996423721313
, O 0 8.25177970398272e-09
and O 0 1.4258688674217979e-09
with O 0 3.338712417644274e-08
isolated B-Disease 1 0.9999991655349731
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.8841841816902161

No O 0 1.8669528856207762e-07
locus O 0 4.53763142616026e-08
other O 0 6.30084373565154e-10
than O 0 2.0023839530924903e-10
chromosome O 0 1.0933793426204375e-08
11p13 O 0 5.9075627945048836e-08
has O 0 2.871161641770925e-10
been O 0 5.975779870937004e-10
implicated O 0 4.889381788331093e-09
in O 0 4.357432192847455e-09
aniridia B-Disease 1 1.0
, O 0 5.794159374516994e-09
and O 0 2.0532431310726906e-09
PAX6 O 0 1.576195609231945e-05
is O 0 5.284061188604028e-09
clearly O 0 3.946332594040314e-09
the O 0 6.625798243398151e-10
major O 0 4.6042183399208625e-09
, O 0 3.6885297594047017e-10
if O 0 9.227561076352586e-11
not O 0 1.645789927950947e-11
only O 0 3.667726886091849e-11
, O 0 7.063393619999303e-11
gene O 0 1.814145500489417e-09
responsible O 0 6.448781419976513e-08
. O 0 2.587717347068974e-07

Twenty O 0 3.5767588997259736e-06
- O 0 1.1168729940891353e-07
eight O 0 6.454834000635401e-09
percent O 0 2.372563256969329e-09
of O 0 4.098655637108095e-09
identified O 0 1.5814094922461663e-08
PAX6 O 0 3.7261986562953098e-06
mutations O 0 1.041625719011563e-08
are O 0 5.250482826291147e-10
C O 0 9.120865797740407e-06
- O 0 3.875125003105495e-07
T O 0 1.438490215832644e-07
changes O 0 2.034534984929337e-09
at O 0 4.9765649379196475e-08
CpG O 0 2.3109608449090047e-08
dinucleotides O 0 1.8226716136382493e-08
, O 0 2.878471072609301e-10
20 O 0 1.3804714038556654e-09
% O 0 1.1954136291958406e-10
are O 0 2.1953442536082335e-11
splicing O 0 3.7008567321805685e-09
errors O 0 2.9470104578877e-08
, O 0 5.937152436352733e-10
and O 0 7.002853852355884e-11
more O 0 1.577346413206282e-11
than O 0 8.594747309687012e-12
30 O 0 2.708972213216754e-10
% O 0 4.947237758345935e-11
are O 0 1.3399716232431746e-11
deletion O 0 2.1755051093919064e-09
or O 0 7.356449893691774e-10
insertion O 0 1.2741931065818335e-08
events O 0 1.0823222318379067e-08
. O 0 9.29212760070186e-08

There O 0 1.0512623305203306e-07
is O 0 2.351685512991253e-09
a O 0 1.5412056075803093e-09
noticeably O 0 4.672197562172187e-08
elevated O 0 3.0946139872867207e-08
level O 0 5.95945266468334e-08
of O 0 3.2609217548440483e-09
mutation O 0 9.78866640521936e-11
in O 0 2.606520277392832e-10
the O 0 4.116696983302859e-10
paired O 0 1.6135468516864648e-09
domain O 0 4.236656359069002e-09
compared O 0 2.064698856329983e-09
with O 0 7.497419352020529e-11
the O 0 5.523952961716816e-10
rest O 0 4.585463564410475e-09
of O 0 5.157424709523184e-09
the O 0 7.029036019901014e-09
gene O 0 5.3785893072699764e-08
. O 0 2.0115240317863936e-07

Increased O 0 8.380755645021054e-08
mutation O 0 3.564275985468157e-09
in O 0 1.1083961526381358e-09
the O 0 1.1307769165469495e-09
homeodomain O 0 6.060704293986419e-08
is O 0 4.9253191802822727e-11
accounted O 0 1.9344612023353136e-10
for O 0 4.386371474374151e-11
by O 0 5.83719253488546e-11
the O 0 2.193751846846226e-09
hypermutable O 0 4.6288269572869467e-07
CpG O 0 4.3901661683776183e-07
dinucleotide O 0 9.97879169517546e-07
in O 0 1.5994647384331984e-08
codon O 0 2.3105558000224846e-07
240 O 0 7.772158596708323e-07
. O 0 3.8609192642979906e-07

Very O 0 1.2627702972167754e-07
nearly O 0 1.3157942291286417e-08
all O 0 2.66591054787213e-10
mutations O 0 9.093659159020717e-10
appear O 0 7.93497434425916e-10
to O 0 1.534997129404303e-10
cause O 0 1.3126902898008552e-09
loss O 0 3.4146017124925265e-09
of O 0 4.4858868619712666e-08
function O 0 2.10310304282757e-07
of O 0 1.5128624397675594e-07
the O 0 1.7999522983203065e-09
mutant O 0 5.884188691851477e-10
allele O 0 1.562679846633941e-10
, O 0 4.608958700802468e-11
and O 0 1.462172050104016e-11
more O 0 2.92005764186698e-12
than O 0 5.147058560611706e-12
80 O 0 7.818717895347049e-11
% O 0 2.2409634911624288e-11
of O 0 6.348288006385872e-10
exonic O 0 3.7711028966214144e-08
substitutions O 0 1.0821193940913076e-09
result O 0 4.4933409770742117e-10
in O 0 1.960429596437052e-09
nonsense O 0 7.883449626433503e-08
codons O 0 1.032202163742113e-07
. O 0 1.0778953196677321e-07

In O 0 7.326798368012533e-08
a O 0 1.7792206818967315e-08
gene O 0 1.3624900097042314e-09
with O 0 7.577467125985393e-11
such O 0 5.30963883971225e-10
extraordinarily O 0 4.776959983132656e-08
high O 0 8.236213488999056e-09
sequence O 0 5.279867099083901e-10
conservation O 0 1.7595101764467103e-10
throughout O 0 9.482906127011859e-11
evolution O 0 6.063150537194417e-10
, O 0 3.2608436784098416e-11
there O 0 2.930330977868323e-11
are O 0 1.1347252130977648e-11
presumed O 0 4.565454858607154e-08
undiscovered O 0 1.3227313502284233e-05
missense O 0 3.6702382999465044e-07
mutations O 0 5.0689119568403385e-09
, O 0 6.693960385995013e-10
these O 0 3.112539739835718e-11
are O 0 6.527075321199893e-12
hypothesized O 0 3.1779831544120896e-10
to O 0 2.5433188541312823e-11
exist O 0 3.5882438687018237e-10
in O 0 3.518827451642892e-10
as O 0 2.3576902652422405e-09
- O 0 3.26654436832996e-08
yet O 0 2.9946909396727506e-09
unidentified O 0 6.764906856915331e-08
phenotypes O 0 1.455168607833457e-08
. O 0 6.725856760425586e-09
. O 0 1.016274921994409e-07

Genetic O 0 2.540516277349525e-07
heterogeneity O 0 7.356385935963772e-07
and O 0 6.188850321109385e-09
penetrance O 0 2.0503586029008147e-07
analysis O 0 2.489623618373571e-09
of O 0 5.764067001479134e-09
the O 0 4.02157374068679e-09
BRCA1 O 0 1.4147085281024374e-08
and O 0 2.509446650478253e-09
BRCA2 O 0 1.8724049866136738e-08
genes O 0 3.840943918476114e-08
in O 0 3.0567881026399846e-07
breast B-Disease 1 0.9998218417167664
cancer I-Disease 1 0.9980541467666626
families O 0 1.333568064865176e-07
. O 0 2.6935394998872653e-06

The O 0 4.4000680645694956e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0006275246851146221
Consortium O 0 3.1727406621939735e-06
. O 0 3.3870881566144817e-07

The O 0 6.9441776773260244e-09
contribution O 0 2.9005907009604925e-08
of O 0 1.705975307686458e-07
BRCA1 O 0 5.4106926938857214e-08
and O 0 1.0091508073628574e-08
BRCA2 O 0 3.6691884020001453e-07
to O 0 1.1594170246098656e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.5008269548416138
assessed O 0 6.845184685744243e-08
by O 0 1.20870688458119e-10
linkage O 0 4.455383617596453e-09
and O 0 2.6015668785905888e-11
mutation O 0 1.6803258437447788e-11
analysis O 0 2.7154061985057432e-11
in O 0 3.108742430146805e-11
237 O 0 2.174346674932437e-10
families O 0 7.589787305584128e-12
, O 0 1.9838504103364407e-11
each O 0 7.839455647140614e-12
with O 0 3.738511583639692e-11
at O 0 3.672037252044902e-08
least O 0 1.3108231167180406e-10
four O 0 3.897496908544795e-11
cases O 0 1.2281932415536545e-10
of O 0 3.1734195715671376e-08
breast B-Disease 0 0.0007153722108341753
cancer I-Disease 0 4.498946509556845e-06
, O 0 4.0700168235652256e-10
collected O 0 1.2851630870613917e-10
by O 0 8.226423708901365e-11
the O 0 8.286875754492939e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.01923813670873642
Consortium O 0 2.0590662188624265e-06
. O 0 4.7001202574392664e-07

Families O 0 8.876539503432923e-09
were O 0 2.040597468777605e-09
included O 0 3.4853223085384855e-10
without O 0 1.6876017250311293e-10
regard O 0 5.144168979676067e-10
to O 0 1.9264296755028276e-11
the O 0 2.1401049335456612e-11
occurrence O 0 8.839116993897278e-09
of O 0 1.906060219880601e-06
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 0.01394767314195633
other I-Disease 0 6.020337241352536e-05
cancers I-Disease 1 0.9999997615814209
. O 0 5.0416401791153476e-05

Overall O 0 5.148561967871501e-07
, O 0 6.05596639502437e-08
disease O 0 3.2990146792144515e-06
was O 0 2.4057530367826985e-07
linked O 0 3.901429934671796e-08
to O 0 3.0264837858062776e-10
BRCA1 O 0 7.126227385967354e-10
in O 0 4.3274475669541346e-10
an O 0 7.413677310941225e-11
estimated O 0 1.6591736318183337e-10
52 O 0 1.2714200803287667e-09
% O 0 1.7924108031142083e-10
of O 0 1.0580207820964915e-08
families O 0 6.013543135674482e-11
, O 0 7.222090286918004e-11
to O 0 6.619479270275619e-11
BRCA2 O 0 5.241327927230088e-10
in O 0 6.953000952769628e-10
32 O 0 1.0576435727216449e-08
% O 0 9.418900104307681e-10
of O 0 2.3839595186814222e-08
families O 0 4.5777163310001256e-11
, O 0 6.527925422439296e-11
and O 0 1.6712133413254726e-11
to O 0 3.9732009349258135e-11
neither O 0 4.831918754000242e-10
gene O 0 3.716790764052291e-11
in O 0 2.422533840196195e-10
16 O 0 4.355346749917999e-09
% O 0 2.0027889069407223e-10
( O 0 9.991865668190769e-11
95 O 0 4.832676481214548e-09
% O 0 8.120684125145772e-10
confidence O 0 2.4192484460172636e-08
interval O 0 5.4504464941373953e-08
[ O 0 6.7215988330815435e-09
CI O 0 4.020306789698225e-07
] O 0 1.0511295833737222e-08
6 O 0 1.976616736953929e-08
% O 0 5.349956588851512e-10
- O 0 9.51414502736725e-10
28 O 0 2.946497268396797e-09
% O 0 1.3569394219370423e-10
) O 0 8.195884249051488e-11
, O 0 9.633233100103666e-11
suggesting O 0 1.3761468631301454e-09
other O 0 9.021394742347866e-10
predisposition O 0 8.385086402995512e-07
genes O 0 3.103942560755968e-07
. O 0 1.0663301281965687e-06

The O 0 4.179026191764024e-08
majority O 0 4.245020335247318e-09
( O 0 3.0613764301357094e-10
81 O 0 7.874819907272013e-09
% O 0 1.7434016730266677e-10
) O 0 5.662836519149117e-11
of O 0 4.867700909017003e-09
the O 0 5.869885626452742e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.145320069895206e-07
were O 0 5.787156975856078e-09
due O 0 4.8375394356980905e-08
to O 0 5.409820369450813e-10
BRCA1 O 0 4.4166637014342314e-10
, O 0 2.2689626219540848e-11
with O 0 4.359146290461302e-12
most O 0 9.314082144440405e-11
others O 0 9.610732348841466e-11
( O 0 1.918560449398754e-11
14 O 0 1.119514592140547e-09
% O 0 1.7247345218684984e-10
) O 0 1.1768086505270503e-10
due O 0 5.946655790012301e-08
to O 0 2.693903589090496e-08
BRCA2 O 0 6.063074806661461e-07
. O 0 7.379460953416128e-07

Conversely O 0 1.1577547098795549e-07
, O 0 4.919744611697752e-10
the O 0 1.5155375565623075e-10
majority O 0 5.396379176847432e-11
of O 0 1.3184061620208354e-09
families O 0 1.7820018464315135e-12
with O 0 1.1294953687623899e-11
male B-Disease 0 1.028401186431438e-08
and I-Disease 0 2.2662886678403993e-08
female I-Disease 0 9.494765981798992e-05
breast I-Disease 1 0.9995322227478027
cancer I-Disease 1 0.9999804496765137
were O 0 3.8788104575360194e-05
due O 0 0.16727681457996368
to O 0 1.1508481634336931e-07
BRCA2 O 0 1.2775952740184948e-08
( O 0 1.3048271352289476e-09
76 O 0 7.579588157113903e-08
% O 0 5.815505854656067e-09
) O 0 6.6812084753564704e-09
. O 0 1.3348035565741156e-07

The O 0 6.946353181547238e-08
largest O 0 1.271372163103024e-08
proportion O 0 6.799790175371356e-10
( O 0 8.270444051827752e-11
67 O 0 2.010360322657334e-09
% O 0 7.1798691991809e-11
) O 0 4.8549001624431654e-11
of O 0 1.7819911102279207e-09
families O 0 2.1496615251748175e-11
due O 0 3.0461411171245345e-09
to O 0 1.0118520604729397e-10
other O 0 3.456463240625318e-11
genes O 0 6.345306918786875e-11
was O 0 2.6865594193736797e-09
found O 0 1.499619040057354e-10
in O 0 8.656314554045252e-11
families O 0 3.236206658555063e-12
with O 0 2.042106241051389e-11
four O 0 6.815917275027061e-10
or O 0 2.2407209421260177e-10
five O 0 6.12451686587967e-11
cases O 0 1.4772681689034783e-10
of O 0 7.283242808853174e-08
female O 0 7.957671914482489e-05
breast B-Disease 1 0.999996542930603
cancer I-Disease 1 0.9999508857727051
only O 0 2.9233988243504427e-06
. O 0 2.8433809347916394e-05

These O 0 6.3316885068331885e-09
estimates O 0 6.0159011106009075e-09
were O 0 9.110099341569367e-10
not O 0 4.0634370868097847e-11
substantially O 0 2.722690295442476e-09
affected O 0 1.470883137510981e-10
either O 0 2.239503166245882e-10
by O 0 9.915464282972408e-12
changing O 0 1.0482700263381162e-09
the O 0 1.9521896599261623e-10
assumed O 0 5.686611181943135e-09
penetrance O 0 5.4245568037458725e-09
model O 0 9.163233505304902e-10
for O 0 3.736438936030595e-10
BRCA1 O 0 8.658135319805638e-10
or O 0 9.581739568442771e-11
by O 0 3.226802505751358e-11
including O 0 8.495045777934251e-10
or O 0 1.528556303753703e-08
excluding O 0 8.906762900551257e-07
BRCA1 O 0 1.554662674152496e-07
mutation O 0 1.3062820158893373e-08
data O 0 1.8383063604687777e-07
. O 0 4.623660743163782e-07

Among O 0 1.8846004756767343e-09
those O 0 2.4562188394305906e-10
families O 0 1.464114419980067e-11
with O 0 4.269652686961223e-11
disease O 0 1.0061683042295044e-07
due O 0 5.0259771455785085e-08
to O 0 1.595222953731934e-09
BRCA1 O 0 4.156281097067449e-09
that O 0 1.3355860861707924e-10
were O 0 4.0389597222301177e-10
tested O 0 8.776295662427103e-11
by O 0 1.5269884965848912e-12
one O 0 6.825954298322889e-12
of O 0 5.5838757229143e-11
the O 0 6.149566272872775e-11
standard O 0 1.7020004294820978e-09
screening O 0 2.1742141420588723e-10
methods O 0 3.535862436176984e-10
, O 0 1.3388347722131932e-11
mutations O 0 9.889814661656615e-12
were O 0 3.750159557891486e-11
detected O 0 3.898413258873745e-10
in O 0 2.5877692350073644e-11
the O 0 6.955371695260837e-11
coding O 0 7.406716129310098e-09
sequence O 0 1.6140577763223973e-09
or O 0 3.725906250195976e-10
splice O 0 2.44938980209497e-09
sites O 0 1.624000378619428e-10
in O 0 4.3262324278536823e-11
an O 0 1.5666542715897513e-11
estimated O 0 2.5051077878757155e-10
63 O 0 5.103292011199301e-09
% O 0 5.690633519961352e-10
( O 0 4.2695241786461224e-10
95 O 0 3.9521648176332747e-08
% O 0 7.103635901728467e-09
CI O 0 8.852887731336523e-06
51 O 0 3.558124603841861e-07
% O 0 7.571926197158518e-09
- O 0 2.6642865691428597e-08
77 O 0 3.997211095452258e-08
% O 0 4.254065988362754e-09
) O 0 3.739806242464283e-09
. O 0 2.837010981693311e-08

The O 0 1.9997029809815103e-08
estimated O 0 1.1771683627870289e-09
sensitivity O 0 2.4737381032480243e-09
was O 0 1.1731337012932386e-09
identical O 0 1.606077770777148e-11
for O 0 8.338041194988488e-12
direct O 0 3.070743659350228e-11
sequencing O 0 1.4556834904144722e-10
and O 0 1.9869074441292156e-10
other O 0 1.913518371532419e-10
techniques O 0 6.677413466604776e-07
. O 0 9.494031871781772e-08

The O 0 9.19696461210151e-08
penetrance O 0 2.9063669444440166e-06
of O 0 6.600406550205662e-07
BRCA2 O 0 2.613517224858697e-08
was O 0 2.958916844875148e-08
estimated O 0 1.6910559064164943e-10
by O 0 1.4054813736452676e-11
maximizing O 0 5.411855852344161e-09
the O 0 5.6142530624470055e-09
LOD O 0 9.701961062091868e-06
score O 0 3.728895947574529e-08
in O 0 7.383020861340128e-09
BRCA2 O 0 1.4540145087948986e-08
- O 0 1.8636471921240627e-08
mutation O 0 5.246338918851734e-10
families O 0 5.327226160201093e-11
, O 0 3.7855028139910374e-11
over O 0 3.592309436029062e-11
all O 0 1.562882601113813e-10
possible O 0 1.6783513467899525e-09
penetrance O 0 3.482960835299309e-07
functions O 0 8.986262969301606e-07
. O 0 1.5583142385366955e-06

The O 0 2.9660592204550085e-08
estimated O 0 2.550423428004933e-09
cumulative O 0 1.6584223772042606e-08
risk O 0 1.8332567464085514e-08
of O 0 5.1950326707128625e-08
breast B-Disease 0 4.811424787476426e-07
cancer I-Disease 0 3.728782260736807e-08
reached O 0 6.537902663694695e-08
28 O 0 1.423530449073951e-07
% O 0 6.315679645929606e-10
( O 0 1.5409254428000452e-10
95 O 0 1.3988429081734921e-08
% O 0 1.6724746032537041e-09
CI O 0 1.1024277455362608e-06
9 O 0 1.9836024023334176e-07
% O 0 2.051560032967359e-09
- O 0 2.1958030949065233e-09
44 O 0 4.300598210882356e-10
% O 0 1.4056475601542662e-11
) O 0 1.2669396781683773e-12
by O 0 2.5383501724152158e-12
age O 0 2.5810420467564654e-10
50 O 0 4.909002648822991e-10
years O 0 1.4399652303875854e-10
and O 0 3.0056575284209686e-11
84 O 0 1.135475602431768e-09
% O 0 1.4763668065853608e-10
( O 0 4.567512340569735e-11
95 O 0 2.9211539853690738e-09
% O 0 6.248532247177252e-10
CI O 0 5.177731168259925e-07
43 O 0 2.185100278495611e-08
% O 0 4.136776199370473e-10
- O 0 7.708964022690168e-10
95 O 0 1.2232188595362459e-09
% O 0 4.0039811743941556e-11
) O 0 4.6422882898911055e-12
by O 0 1.1577900096981786e-11
age O 0 7.499759036022624e-09
70 O 0 3.091127709353714e-08
years O 0 5.602874253440859e-08
. O 0 8.009214980120305e-08

The O 0 1.4905117495800368e-07
corresponding O 1 0.9996404647827148
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.009223107248544693
were O 0 2.489084351964266e-07
0 O 0 4.5020229322290106e-07
. O 0 3.076869248275216e-08

4 O 0 1.5284914525182103e-06
% O 0 6.5029532869687046e-09
( O 0 9.837223258202243e-10
95 O 0 2.2220774553716183e-08
% O 0 2.456435721498451e-09
CI O 0 8.643571618449641e-07
0 O 0 2.510299879077138e-08
% O 0 4.695885902350483e-10
- O 0 8.347548763332213e-10
1 O 0 2.3900954548849995e-09
% O 0 1.6821344664408322e-11
) O 0 1.7558140271572986e-12
by O 0 2.6855614086718216e-12
age O 0 3.5325861680313153e-10
50 O 0 4.460993241472977e-10
years O 0 8.752908120523983e-11
and O 0 4.139726061946902e-11
27 O 0 1.4543410919998223e-09
% O 0 4.966912992010464e-11
( O 0 3.9409878138663146e-11
95 O 0 7.546191227447707e-09
% O 0 1.8801304957349885e-09
CI O 0 1.0145478199774516e-06
0 O 0 2.7730155949257096e-08
% O 0 1.791895742897509e-09
- O 0 2.347553484938203e-09
47 O 0 4.9094732723631296e-09
% O 0 1.9960465225121737e-10
) O 0 1.427227780403939e-11
by O 0 2.0938016945248883e-11
age O 0 5.288830262628608e-09
70 O 0 1.6187138740519913e-08
years O 0 2.4880723259457227e-08
. O 0 5.4067619714714965e-08

The O 0 2.7337547336969692e-08
lifetime O 0 4.3340435240679653e-08
risk O 0 1.5802176278612023e-07
of O 0 7.730740207989584e-07
breast B-Disease 0 0.05919201672077179
cancer I-Disease 0 5.379366484703496e-06
appears O 0 1.0612667189491276e-08
similar O 0 6.333868152186284e-11
to O 0 6.905537253132366e-11
the O 0 2.14624695793475e-09
risk O 0 2.640081220306456e-08
in O 0 1.9827404162953144e-09
BRCA1 O 0 1.5507031214667677e-09
carriers O 0 2.710739965827713e-10
, O 0 8.058728684368077e-11
but O 0 1.2327572990189495e-11
there O 0 2.0998806860017538e-11
was O 0 4.208048354215066e-10
some O 0 5.378968537944617e-12
suggestion O 0 3.81986969832937e-10
of O 0 1.0423684138061162e-09
a O 0 1.0338957467936893e-09
lower O 0 3.4865891507251945e-08
risk O 0 1.8096745435514094e-08
in O 0 5.897405674915035e-09
BRCA2 O 0 2.041352642478955e-09
carriers O 0 2.6705482270017455e-09
< O 0 4.907828099476319e-08
50 O 0 3.971189599383251e-09
years O 0 8.975979959302549e-10
of O 0 6.337765867669987e-09
age O 0 3.88772150472505e-07
. O 0 4.3973605556857365e-07

Eye B-Disease 0 0.37362244725227356
movement I-Disease 0 8.893674930732232e-06
abnormalities I-Disease 0 0.0002096430689562112
correlate O 0 3.381142832381556e-08
with O 0 1.2335111820860334e-09
genotype O 0 1.3848863318344229e-06
in O 0 7.603770058040027e-08
autosomal O 1 0.9999830722808838
dominant O 1 0.9999959468841553
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999992847442627
I I-Disease 1 0.9999904632568359
. O 0 9.134289030043874e-06

We O 0 9.638961984137495e-08
compared O 0 8.541798024452874e-08
horizontal O 0 1.126507413573563e-06
eye O 0 5.942671123193577e-05
movements O 0 1.3751484573276684e-07
( O 0 3.4642748669710954e-09
visually O 0 1.0554328966350113e-08
guided O 0 1.2375716096357792e-07
saccades O 0 4.649754430374742e-07
, O 0 1.195309184964799e-09
antisaccades O 0 3.739537035585272e-08
, O 0 1.7247279993082287e-10
and O 0 5.5332509407701735e-11
smooth O 0 7.801296497689236e-09
pursuit O 0 2.790060182888965e-09
) O 0 1.002404322741901e-11
in O 0 1.4499688776037356e-11
control O 0 4.974768597065804e-09
subjects O 0 3.872390408332649e-08
( O 0 6.023518489550739e-11
n O 0 1.6789372114800472e-09
= O 0 2.329018089497481e-09
14 O 0 1.8299928239429164e-09
) O 0 5.5308872065618075e-11
and O 0 3.6189932994812324e-11
patients O 0 2.1011907491708115e-11
with O 0 3.625319662525772e-12
three O 0 4.019782770536828e-11
forms O 0 1.5862248403664125e-08
of O 0 1.9801012967946008e-05
autosomal O 1 0.9999885559082031
dominant O 1 0.99993896484375
cerebellar B-Disease 1 0.9999990463256836
ataxias I-Disease 0 0.10337258875370026
type I-Disease 0 0.0001483751111663878
I I-Disease 0 9.978024900192395e-05
spinocerebellar B-Disease 0 8.762173820286989e-05
ataxias I-Disease 0 5.495654022524832e-06
1 I-Disease 0 5.807848424410622e-07
and I-Disease 0 1.9136141560238684e-09
2 I-Disease 0 6.25077873905866e-08
( O 0 2.006849825209045e-10
SCA1 B-Disease 0 7.424682735290844e-08
, O 0 4.3874112676256516e-10
n O 0 5.6007234405797135e-09
= O 0 3.9763130565972915e-09
11 O 0 2.4234867446182307e-09
; O 0 6.696332377487124e-11
SCA2 B-Disease 0 3.944024484781039e-08
, O 0 2.3876792210053566e-10
n O 0 6.957753484471141e-09
= O 0 2.730147441454278e-09
10 O 0 1.4787658875192733e-09
) O 0 7.652266320601342e-11
and O 0 1.6356211940404819e-09
SCA3 B-Disease 1 1.0
/ O 0 0.0014278587186709046
Machado B-Disease 0 1.8095359337166883e-05
- I-Disease 0 1.3953907000541221e-05
Joseph I-Disease 0 0.0002895738580264151
disease I-Disease 0 2.069758193101734e-05
( O 0 1.3043798929857076e-08
MJD B-Disease 1 0.9999997615814209
) O 0 5.111475243069208e-09
( O 0 5.436445182915861e-10
n O 0 2.4563993505921644e-08
= O 0 2.007552524219136e-08
16 O 0 3.5161338729494673e-08
) O 0 2.890107708708456e-09
. O 0 4.6522426799811e-08

In O 0 4.978796255272755e-07
SCA1 B-Disease 0 2.1084713807795197e-05
, O 0 8.35381275265945e-09
saccade O 0 1.7756548231773195e-07
amplitude O 0 1.3978107560319586e-08
was O 0 2.9147979585530948e-09
significantly O 0 3.3571637136908805e-10
increased O 0 2.0017500157454293e-10
, O 0 4.573039169564197e-11
resulting O 0 1.7706403010464555e-10
in O 0 2.344242355789561e-09
hypermetria B-Disease 0 3.5561606637202203e-06
. O 0 2.4562734779465245e-07

The O 0 6.829091603322013e-07
smooth O 0 1.0137296158063691e-05
pursuit O 0 1.3257622413220815e-06
gain O 0 2.705835981942073e-07
was O 0 1.608834310218299e-07
decreased O 0 2.9570082915597595e-07
. O 0 5.6546316073990965e-08

In O 0 7.792724545652163e-07
SCA2 B-Disease 0 3.986817682744004e-05
, O 0 2.229047524338057e-08
saccade O 0 3.9180636690616666e-07
velocity O 0 1.7330768287138199e-07
was O 0 1.1001763766671502e-07
markedly O 0 2.4626487515888584e-07
decreased O 0 2.766367970252759e-07
. O 0 9.989820881628475e-08

The O 0 8.612224888793207e-08
percentage O 0 1.112279051085352e-07
of O 0 4.488171967409471e-08
errors O 0 5.092171591059014e-07
in O 0 4.821996135717654e-09
antisaccades O 0 6.81606536545587e-07
was O 0 2.083224437399167e-08
greatly O 0 5.788920454108393e-10
increased O 0 1.6707489558509536e-10
and O 0 1.484620065772546e-11
was O 0 2.957999678532275e-10
significantly O 0 2.0982233311928056e-11
correlated O 0 7.221318681915889e-11
with O 0 1.993165528457741e-11
age O 0 4.542393838846692e-08
at O 0 5.389224952523364e-06
disease O 0 6.162438512546942e-05
onset O 0 1.1025950698240194e-05
. O 0 4.1565698438716936e-07

In O 0 1.2059217624482699e-08
addition O 0 2.6796203034251675e-09
, O 0 1.742823246830838e-10
a O 0 1.3139521415350686e-10
correlation O 0 2.4016202360144234e-09
between O 0 2.076187399779883e-08
smooth O 0 4.1683276208459574e-07
pursuit O 0 3.5548680443753256e-08
gain O 0 3.593320752059981e-09
and O 0 6.967999788276558e-11
the O 0 4.896124131126278e-11
number O 0 2.0082781271302252e-10
of O 0 3.651810231986019e-08
trinucleotide O 0 1.925417109305272e-06
repeats O 0 8.95802898526199e-08
was O 0 2.107612573354345e-07
found O 0 3.948194304825847e-08
. O 0 8.651342398025008e-08

In O 0 1.7829266653279774e-05
SCA3 B-Disease 1 1.0
, O 0 1.8159453247790225e-06
gaze B-Disease 0 0.0003773147764150053
- I-Disease 0 4.637638994609006e-06
evoked I-Disease 0 1.6115629364321649e-07
nystagmus I-Disease 0 7.039369052108668e-07
was O 0 1.2860526510394266e-07
often O 0 7.343464725195759e-11
present O 0 1.0427258362311065e-10
as O 0 2.2215117245760752e-10
was O 0 8.381455529615778e-09
saccade O 0 7.442206850782895e-08
hypometria O 0 2.930643745457928e-07
and O 0 5.101910005578247e-09
smooth O 0 1.1693878150254022e-06
pursuit O 0 2.4761334316281136e-07
gain O 0 9.699545699959344e-08
was O 0 6.739136892974784e-08
markedly O 0 1.0660143345830875e-07
decreased O 0 1.4803602255142323e-07
. O 0 4.120731134094058e-08

Three O 0 7.278757863105056e-08
major O 0 1.745706157407767e-08
criteria O 0 7.237903787427058e-08
, O 0 4.8656589868301126e-09
saccade O 0 7.927614831260144e-08
amplitude O 0 2.3722114050883647e-08
, O 0 1.5525262186955047e-09
saccade O 0 2.5520892066310807e-08
velocity O 0 1.9034986920019037e-08
, O 0 3.435714768240672e-10
and O 0 4.6492198979564137e-11
presence O 0 9.44021305571141e-10
of O 0 1.2450117026219232e-07
gaze B-Disease 0 0.00023458006035070866
- I-Disease 0 1.5609141428285511e-06
evoked I-Disease 0 2.5806214054568954e-08
nystagmus I-Disease 0 3.175538765276542e-08
, O 0 5.240675254869487e-11
permitted O 0 7.010605290735938e-11
the O 0 2.826377500098065e-11
correct O 0 2.4243179685967675e-10
assignment O 0 1.0011366180506798e-09
of O 0 9.171469139701571e-10
90 O 0 3.0854006016767244e-09
% O 0 1.6254134149740196e-10
of O 0 5.209963571672915e-09
the O 0 3.312002005984027e-09
SCA1 B-Disease 0 3.7392521790025057e-07
, O 0 1.8948140279029246e-10
90 O 0 7.720293848656468e-10
% O 0 5.363378838274535e-11
of O 0 1.008696237647655e-09
the O 0 6.850429112859047e-10
SCA2 B-Disease 0 4.579985670716269e-07
, O 0 1.6077889020138514e-10
and O 0 2.0235455672201752e-11
93 O 0 9.121488009355971e-10
% O 0 1.0901234775984037e-10
of O 0 1.6873933361694071e-09
the O 0 1.2969466611778557e-09
patients O 0 1.3570022883158117e-09
with O 0 1.419383721668055e-09
SCA3 B-Disease 1 1.0
to O 0 1.9374419846229785e-09
their O 0 2.360924511446427e-10
genetically O 0 1.7663528972811093e-10
confirmed O 0 3.0266397721412375e-10
patient O 0 4.7980877049269566e-09
group O 0 6.111916528439565e-10
and O 0 4.591254876284978e-10
, O 0 4.824716737239498e-10
therefore O 0 6.461435830829032e-09
, O 0 1.3906407136943244e-09
may O 0 2.9261839618044405e-09
help O 0 4.620079430139867e-09
orient O 0 0.00010295239189872518
diagnoses O 0 3.458290166236111e-06
of O 0 1.5725805724287056e-06
SCA1 B-Disease 0 0.0007472021970897913
, O 0 1.6726604101791054e-08
SCA2 B-Disease 0 6.0646989368251525e-06
, O 0 2.0845907222621918e-09
and O 0 1.3945956611749466e-09
SCA3 B-Disease 1 1.0
at O 0 2.89420313492883e-07
early O 0 9.770880993187347e-09
clinical O 0 6.8883112547268865e-09
stages O 0 8.677846885518647e-09
of O 0 2.8569779431109055e-08
the O 0 3.443800977720457e-08
diseases O 0 0.0007949371356517076
. O 0 8.076495028319641e-09
. O 0 2.1460991206367908e-07

Genetic O 0 1.3260122955216502e-07
basis O 0 2.217466743559271e-08
and O 0 9.522636845726851e-11
molecular O 0 1.5946488574059003e-08
mechanism O 0 8.15149292066053e-07
for O 0 3.0018355801075813e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999973773956299

Ventricular B-Disease 1 0.9999920129776001
fibrillation I-Disease 1 1.0
causes O 0 0.0001700623397482559
more O 0 1.5089705041049228e-09
than O 0 2.1240428860203053e-10
300 O 0 2.249623959338365e-10
, O 0 3.081786215108906e-11
000 O 0 5.652868173555703e-10
sudden O 0 1.5292292987467704e-09
deaths O 0 1.5258748431445923e-10
each O 0 1.9624177283183997e-11
year O 0 6.516580330906407e-11
in O 0 2.7071850317028634e-10
the O 0 2.821564981658753e-09
USA O 0 3.3612032268592884e-08
alone O 0 7.547562574927724e-08
. O 0 9.286776503358851e-08

In O 0 1.7954961606392317e-07
approximately O 0 2.210714100669975e-08
5 O 0 3.765252287735166e-08
- O 0 3.3201930094151066e-09
12 O 0 1.2330407805904997e-09
% O 0 1.0088919283335329e-10
of O 0 2.6229129979071786e-10
these O 0 7.914621215354689e-12
cases O 0 1.456304868363567e-11
, O 0 1.5912427625552894e-12
there O 0 2.272586632767748e-12
are O 0 1.1198289474531609e-12
no O 0 7.515545130676315e-11
demonstrable O 0 2.574756479134521e-07
cardiac O 1 0.9920223951339722
or O 0 1.530270878902229e-06
non O 1 0.9995903372764587
- O 1 0.9999285936355591
cardiac O 1 1.0
causes O 0 3.7902771055087214e-06
to O 0 1.8392344314221987e-09
account O 0 5.730061425346378e-10
for O 0 8.633876946717578e-10
the O 0 1.056734078019872e-08
episode O 0 2.973337842604451e-08
, O 0 6.867432317259059e-11
which O 0 2.2017632942544774e-12
is O 0 1.7668868755246758e-12
therefore O 0 2.63228362717971e-11
classified O 0 5.412008063920837e-10
as O 0 6.501341687226159e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999959468841553
IVF B-Disease 1 1.0
) O 0 1.29525815850684e-07
. O 0 2.045868114919358e-07

A O 0 2.6352094550929905e-07
distinct O 0 1.4868950515278812e-08
group O 0 5.1654969190906286e-09
of O 0 4.9659438445814885e-06
IVF B-Disease 1 1.0
patients O 0 1.777303282324283e-07
has O 0 1.6171815275800583e-10
been O 0 2.5948482251791916e-10
found O 0 5.250851142779567e-11
to O 0 7.99079725999352e-12
present O 0 5.480523326828468e-11
with O 0 8.125110306789196e-11
a O 0 2.8359601333960427e-09
characteristic O 0 1.2612009925305756e-07
electrocardiographic O 0 5.9789090300910175e-06
pattern O 0 2.92924551104079e-06
. O 0 3.456756303421571e-07

Because O 0 6.984176081914484e-08
of O 0 5.2028166663831144e-08
the O 0 1.3607759363765126e-09
small O 0 1.4182517660277227e-10
size O 0 5.817410997366323e-10
of O 0 2.674779286948592e-09
most O 0 5.0360840497809534e-11
pedigrees O 0 1.6105121680709544e-09
and O 0 2.989808400855054e-11
the O 0 3.6834237049365726e-11
high O 0 4.390896535255706e-09
incidence O 0 4.8511495265302074e-08
of O 0 1.4122443658948214e-08
sudden B-Disease 0 2.7016271886282084e-08
death I-Disease 0 5.161636007500192e-09
, O 0 3.7311528866545984e-11
however O 0 4.957372706781982e-11
, O 0 8.476973463455995e-12
molecular O 0 8.350685698488292e-10
genetic O 0 4.5403969473056804e-10
studies O 0 2.4375799156928224e-09
of O 0 1.3331421655493614e-07
IVF B-Disease 1 0.999995231628418
have O 0 5.346365572478362e-10
not O 0 5.034432246087128e-11
yet O 0 2.9853536309687456e-10
been O 0 1.742308103347412e-10
done O 0 2.6605224690001705e-09
. O 0 6.138392905086221e-09

Because O 0 1.424201673216885e-05
IVF B-Disease 1 1.0
causes O 0 6.565488001797348e-05
cardiac O 1 0.9999969005584717
rhythm O 1 0.9999994039535522
disturbance O 1 0.9995150566101074
, O 0 1.118565329250032e-08
we O 0 1.6521386481116451e-09
investigated O 0 1.208894850890374e-08
whether O 0 1.6190651042080617e-09
malfunction O 0 1.706406874291133e-05
of O 0 1.2125966009080003e-08
ion O 0 3.389845915080514e-06
channels O 0 1.2148650512244785e-06
could O 0 6.0795390943724215e-09
cause O 0 2.480423422213107e-09
the O 0 2.7059665619333373e-10
disorder O 0 1.5916009843408574e-08
by O 0 6.8460857642616e-12
studying O 0 2.079832750467858e-09
mutations O 0 8.90328713532007e-11
in O 0 6.088375636981169e-11
the O 0 7.464605045193196e-10
cardiac O 0 0.00020594926900230348
sodium O 0 3.932242634618888e-06
channel O 0 6.42492977931397e-06
gene O 0 6.096728384363814e-07
SCN5A O 0 0.0002429950109217316
. O 0 2.4185439997381764e-06

We O 0 6.578883215979658e-08
have O 0 3.9580450028608993e-10
now O 0 1.508690672391566e-10
identified O 0 3.9495687276236424e-10
a O 0 6.899089077805343e-10
missense O 0 1.6132338132024415e-08
mutation O 0 4.974414768987856e-10
, O 0 6.434842658720186e-10
a O 0 2.8020219478008812e-09
splice O 0 6.638124716573657e-08
- O 0 1.0973802311298186e-08
donor O 0 9.610406914717373e-10
mutation O 0 6.132445107276396e-10
, O 0 4.808272668910263e-10
and O 0 3.170796403217935e-10
a O 0 8.24037726943061e-09
frameshift O 0 8.205186929899355e-08
mutation O 0 7.26240123594124e-10
in O 0 2.763598239141629e-10
the O 0 5.148900195095507e-10
coding O 0 1.6743881303682429e-07
region O 0 3.372563384118621e-08
of O 0 3.2404873451241656e-08
SCN5A O 0 3.870212367473869e-06
in O 0 1.7523213102776936e-08
three O 0 9.963883940145024e-08
IVF B-Disease 1 0.9999955892562866
families O 0 3.1383551313268754e-09
. O 0 6.40002468799139e-08

We O 0 4.7861075103128314e-08
show O 0 4.388183594272732e-09
that O 0 1.8469699727963196e-11
sodium O 0 1.7558592080302304e-10
channels O 0 7.320501843599558e-11
with O 0 1.522239799489622e-12
the O 0 1.167891200415383e-10
missense O 0 8.841967158446096e-09
mutation O 0 1.5800481756311768e-10
recover O 0 1.5101806027928433e-08
from O 0 8.744969748342157e-10
inactivation O 0 8.001000395552182e-08
more O 0 6.03607719362742e-11
rapidly O 0 4.258561003833705e-10
than O 0 3.6001566311449906e-11
normal O 0 6.04043370877605e-10
and O 0 1.9473096746214225e-11
that O 0 5.179419393375184e-12
the O 0 2.63748134443631e-10
frameshift O 0 7.835777893205886e-08
mutation O 0 8.355194869302807e-10
causes O 0 6.813447583908783e-10
the O 0 9.047793625427403e-10
sodium O 0 1.3279263910703776e-08
channel O 0 7.440075222575615e-09
to O 0 1.8563194037479747e-10
be O 0 6.465821211776301e-10
non O 0 1.1079045947326449e-07
- O 0 7.843808447205447e-08
functional O 0 5.708952812710777e-06
. O 0 7.280214617821912e-07

Our O 0 2.403990784216603e-08
results O 0 2.0118868793161937e-09
indicate O 0 7.764300313795047e-10
that O 0 8.28297413296708e-12
mutations O 0 4.362675498637003e-11
in O 0 1.0102282899104864e-10
cardiac O 0 1.33007051772438e-06
ion O 0 8.395813893002924e-06
- O 0 9.313770533481147e-06
channel O 0 5.303288617142243e-07
genes O 0 2.6206026237929336e-10
contribute O 0 8.317269095670099e-11
to O 0 3.629708339447646e-11
the O 0 6.596665574898353e-11
risk O 0 2.701507240132628e-09
of O 0 1.7754238967881975e-08
developing O 0 7.44664703233866e-06
IVF B-Disease 1 0.9999988079071045
. O 0 1.2054065301470018e-08
. O 0 4.211144144505852e-08

Molecular O 0 9.840805432759225e-06
heterogeneity O 0 2.3329419036599575e-06
in O 0 1.3446337732148095e-07
mucopolysaccharidosis B-Disease 0 5.989940746076172e-06
IVA I-Disease 0 0.00048215428250841796
in O 0 2.0221211372017933e-08
Australia O 0 1.2574995489345042e-09
and O 0 7.998837009415283e-11
Northern O 0 8.520945060652707e-10
Ireland O 0 2.0641277576061157e-09
: O 0 3.0923378441238825e-11
nine O 0 1.6996280771675032e-10
novel O 0 7.47388956279238e-11
mutations O 0 8.703630177686605e-11
including O 0 2.091312262253453e-10
T312S O 0 8.082045610535715e-08
, O 0 1.3103288454274775e-09
a O 0 8.25733370568571e-10
common O 0 4.5166265172369435e-10
allele O 0 9.8178032370555e-10
that O 0 1.1490874224362457e-10
confers O 0 5.003643011036729e-08
a O 0 2.5417030258267914e-08
mild O 0 1.892028649308486e-07
phenotype O 0 7.22700548294597e-08
. O 0 1.855141391615689e-07

Mucopolysaccharidosis B-Disease 0 0.012266699224710464
IVA I-Disease 1 0.9999973773956299
( O 0 0.0001161047475761734
MPS B-Disease 1 0.9999970197677612
IVA I-Disease 1 1.0
) O 0 4.017113752752266e-08
is O 0 5.075120323994042e-10
an O 0 1.5485750459731662e-09
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.000808999699074775
by O 0 3.098557854741557e-09
a O 0 3.8987374750831805e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 8.54932579841261e-07
N O 0 0.0024589274544268847
- O 0 2.67175778390083e-06
acetylgalactosamine O 0 2.6577437893138267e-05
- O 0 3.0032440463401144e-06
6 O 0 3.145694427075796e-05
- O 0 4.51524442723894e-07
sulfate O 0 7.683574381189828e-07
sulfatase O 0 7.039019237708999e-06
( O 0 1.8030284820724773e-08
GALNS O 0 8.03803777671419e-06
) O 0 8.448255428561424e-09
. O 0 3.180236163302652e-08

Previous O 0 1.5668240038735348e-08
studies O 0 6.553106501883121e-09
of O 0 6.848002609416426e-09
patients O 0 3.49012541089877e-10
from O 0 3.214543076168752e-10
a O 0 3.3463018467294603e-10
British O 0 2.916210384285023e-09
- O 0 2.676565635795214e-09
Irish O 0 3.62479268822824e-09
population O 0 1.9324420535982156e-12
showed O 0 5.96674515351836e-11
that O 0 3.868182683886001e-12
the O 0 5.6533396020075344e-11
I113F O 0 2.2103590069377788e-09
mutation O 0 3.7130708230304066e-11
is O 0 1.327453424959657e-11
the O 0 1.0686792596692474e-11
most O 0 2.658894805718237e-12
common O 0 1.4639831014129356e-11
single O 0 9.788737528881875e-12
mutation O 0 2.3983506847180536e-10
among O 0 4.0029599079893785e-10
MPS B-Disease 1 0.9998321533203125
IVA I-Disease 1 1.0
patients O 0 0.00019268662435933948
and O 0 5.121428614529577e-09
produces O 0 1.1615071127124565e-09
a O 0 1.5924778162812459e-09
severe O 0 3.4545976745903317e-07
clinical O 0 3.117648645911686e-07
phenotype O 0 2.2811732947047858e-07
. O 0 2.6397719921078533e-07

We O 0 9.2550713759465e-08
studied O 0 8.880266477717669e-07
mutations O 0 3.749162313937404e-09
in O 0 3.6600206199111085e-10
the O 0 1.7587026279741735e-09
GALNS O 0 1.6558122695187194e-07
gene O 0 1.2691715456369934e-09
from O 0 1.3817832433815624e-09
23 O 0 1.0946042294790459e-08
additional O 0 5.72249536645586e-09
MPS B-Disease 1 0.9529759287834167
IVA I-Disease 1 1.0
patients O 0 2.667653461685404e-06
( O 0 1.3908370011250781e-09
15 O 0 1.5003980280425822e-09
from O 0 1.1253607073991034e-10
Australia O 0 1.4488160671177752e-11
, O 0 5.716998922877803e-12
8 O 0 3.6630379285362835e-10
from O 0 8.188914824014404e-11
Northern O 0 8.050007327398134e-10
Ireland O 0 4.1400599615215583e-10
) O 0 1.6520361467708966e-11
, O 0 5.535823535685047e-12
with O 0 4.919824096727421e-12
various O 0 6.975768851447128e-10
clinical O 0 2.878013560803083e-07
phenotypes O 0 3.046108361104416e-07
( O 0 1.302960050963975e-08
severe O 0 1.6774581581557868e-06
, O 0 3.0224993619043516e-09
16 O 0 1.82848669538771e-08
cases O 0 6.805031538270612e-10
; O 0 4.779522611020326e-11
intermediate O 0 6.307725453069679e-09
, O 0 1.5253190377428893e-10
4 O 0 5.103623301749849e-09
cases O 0 3.0878480328233593e-10
; O 0 9.493674596461332e-11
mild O 0 1.3458930858689655e-08
, O 0 2.1862195387356564e-10
3 O 0 1.9944044638009473e-08
cases O 0 1.647223801803932e-09
) O 0 9.105044496138248e-10
. O 0 2.080016514582894e-08

We O 0 3.233911627376074e-08
found O 0 1.5319530088930833e-09
two O 0 3.892986974451951e-11
common O 0 8.461292777539597e-11
mutations O 0 1.3962577621873251e-11
that O 0 3.4527122914213004e-12
together O 0 1.6201198368981373e-11
accounted O 0 2.245003211109875e-10
for O 0 3.515377572371747e-11
32 O 0 1.8555804670583598e-09
% O 0 2.4880555948847416e-10
of O 0 2.8917288563690136e-09
the O 0 1.9034069875800697e-09
44 O 0 8.738237688987738e-09
unrelated O 0 4.093608119148939e-09
alleles O 0 2.7229588028809815e-10
in O 0 2.4966742562249067e-10
these O 0 2.339202997969636e-10
patients O 0 1.1102056163281304e-08
. O 0 3.633572021044529e-08

One O 0 4.2710031067372256e-08
is O 0 9.703108316827525e-10
the O 0 6.321862477953744e-10
T312S O 0 6.286744280714629e-08
mutation O 0 8.171132659384739e-10
, O 0 9.042545184856365e-11
a O 0 1.242085462260789e-10
novel O 0 1.051485495895399e-10
mutation O 0 4.5606175086421175e-11
found O 0 4.077045992478823e-11
exclusively O 0 6.921826445349666e-10
in O 0 1.3870591342168836e-09
milder O 0 1.7675519359272585e-07
patients O 0 4.736107683811497e-08
. O 0 2.2210420524970687e-07

The O 0 1.9318567012760468e-07
other O 0 3.138199478058823e-09
is O 0 1.0971321767749842e-10
the O 0 1.1429866081380524e-10
previously O 0 1.7077983471835978e-09
described O 0 9.071779438762917e-10
I113F O 0 1.1954923273549412e-08
that O 0 4.020403801541228e-11
produces O 0 4.3609638122887873e-10
a O 0 2.512233976403877e-09
severe O 0 1.3982111113364226e-07
phenotype O 0 1.5788258167503955e-07
. O 0 4.074320543168142e-07

The O 0 4.238776440956826e-08
I113F O 0 1.9398544282012153e-07
and O 0 5.935929525691108e-10
T312S O 0 9.039294646129292e-09
mutations O 0 9.079460100425152e-11
accounted O 0 4.3213191358582037e-10
for O 0 5.845660067116398e-11
8 O 0 4.309320900119928e-09
( O 0 4.7570405947716665e-11
18 O 0 1.6325357732327461e-09
% O 0 3.66930097417395e-11
) O 0 1.504635131766019e-11
and O 0 7.80584347159774e-11
6 O 0 1.1967768109855115e-08
( O 0 9.167581971336602e-11
14 O 0 1.5152984422783788e-09
% O 0 8.569560339122262e-11
) O 0 3.108742430146805e-11
of O 0 2.8813780250658283e-09
44 O 0 6.960169329772725e-09
unrelated O 0 1.5773698791576862e-08
alleles O 0 1.107979707981599e-09
, O 0 2.1332604571711045e-09
respectively O 0 1.6997165630527888e-07
. O 0 2.7797653956440627e-07

The O 0 1.3395768405644048e-07
relatively O 0 1.5273593589881784e-07
high O 0 8.912407167827041e-08
residual O 0 2.2934068510949146e-06
GALNS O 0 7.708912562520709e-06
activity O 0 1.5560518207280438e-08
seen O 0 1.5948030673840208e-09
when O 0 2.7914677513951602e-11
the O 0 4.2195396482425096e-11
T312S O 0 5.60243018643547e-10
mutant O 0 1.1320538256809343e-10
cDNA O 0 1.1321904525019022e-09
is O 0 1.0142556933212532e-10
overexpressed O 0 2.6335531089216602e-08
in O 0 1.5809864528648632e-09
mutant O 0 4.742857662165534e-09
cells O 0 1.6882874265267134e-10
provides O 0 5.30307776858141e-11
an O 0 5.11837447425556e-12
explanation O 0 1.114345699049224e-10
for O 0 2.4729336633999566e-11
the O 0 3.1457611515683936e-10
mild O 0 1.4338056963936197e-08
phenotype O 0 6.951170750113533e-10
in O 0 2.369703877569407e-10
patients O 0 5.338313471825451e-11
with O 0 9.890984732641162e-12
this O 0 5.2593606553186234e-11
mutation O 0 4.609279624645524e-09
. O 0 3.449112284670264e-08

The O 0 1.1989266468503956e-08
distribution O 0 4.985283297287424e-09
and O 0 8.05390407143669e-11
relative O 0 5.565040428479051e-09
frequencies O 0 9.714761439738595e-09
of O 0 8.831866349368056e-10
the O 0 1.9062544598380526e-10
I113F O 0 2.6054527424435037e-09
and O 0 9.039406723143628e-11
T312S O 0 7.318917916165901e-09
mutations O 0 2.8427171727685163e-10
in O 0 1.8086857012100666e-10
Australia O 0 1.9303073028886786e-10
corresponded O 0 3.7115222006889326e-10
to O 0 5.971174249497224e-11
those O 0 1.4034802833795545e-11
observed O 0 5.350507814583239e-10
in O 0 1.3956301392337167e-10
Northern O 0 1.5394017172098984e-09
Ireland O 0 1.862970888666382e-09
and O 0 1.2170232877029008e-10
are O 0 5.9043178332607305e-12
unique O 0 5.121179522116215e-11
to O 0 3.748229157607419e-11
these O 0 1.2695528656125887e-11
two O 0 3.610788404384557e-11
populations O 0 7.899690450396957e-12
, O 0 3.53044260492652e-11
suggesting O 0 1.6933894564363783e-10
that O 0 5.8368557383225994e-12
both O 0 6.982394523680213e-11
mutations O 0 2.2915359887409892e-10
were O 0 4.6498963013341665e-10
probably O 0 2.8155103248828084e-10
introduced O 0 4.863278529887438e-11
to O 0 6.115828329877893e-12
Australia O 0 2.7130749903625517e-12
by O 0 1.4652757089270163e-12
Irish O 0 1.620798495416409e-09
migrants O 0 1.9919084437436396e-10
during O 0 4.1124040284223895e-10
the O 0 6.648750439097739e-10
19th O 0 3.109055768391045e-08
century O 0 8.742043178244785e-08
. O 0 1.1755886930586712e-07

Haplotype O 0 6.477516762970481e-07
analysis O 0 5.6527124314698085e-08
using O 0 2.8782048744346866e-08
6 O 0 2.08974583415511e-07
RFLPs O 0 3.5571611078921705e-07
provides O 0 1.3906299445309855e-09
additional O 0 9.798492572876683e-11
data O 0 3.1102742603650313e-10
that O 0 4.621764776446824e-12
the O 0 9.365958703044797e-11
I113F O 0 3.469657672283688e-09
mutation O 0 1.1122329446333623e-10
originated O 0 1.3208023563748839e-09
from O 0 2.2037821567622018e-10
a O 0 6.188870527168433e-10
common O 0 2.247416253098322e-09
ancestor O 0 1.0886123646969281e-07
. O 0 1.7309460531578225e-07

The O 0 1.0764202329482941e-07
other O 0 1.9096362269266365e-09
9 O 0 1.3553680844324845e-08
novel O 0 2.2628006413061286e-10
mutations O 0 5.592284968436445e-11
identified O 0 8.840052301284373e-11
in O 0 4.397714484238868e-11
these O 0 8.169379235589691e-12
23 O 0 6.2474985185190235e-09
patients O 0 2.387214592669551e-10
were O 0 1.5814349829668117e-10
each O 0 1.0268334793561706e-11
limited O 0 3.2626228108068034e-11
to O 0 3.0255013772073625e-11
a O 0 5.289543802966534e-10
single O 0 2.1136978833879994e-09
family O 0 2.7395591573053935e-08
. O 0 1.5641104766928038e-07

These O 0 4.537421105510475e-09
data O 0 3.1392233257321323e-09
provide O 0 2.331488058171516e-10
further O 0 1.4653890600957453e-10
evidence O 0 2.6601557068239856e-10
for O 0 2.1268310029798343e-11
extensive O 0 7.235550492090681e-10
allelic O 0 1.5834832112204822e-08
heterogeneity O 0 6.231613269847003e-08
in O 0 4.97454344383641e-08
MPS B-Disease 1 0.981203019618988
IVA I-Disease 1 1.0
in O 0 4.979783696512641e-08
British O 0 1.3749793481565575e-07
- O 0 1.1445913550289788e-08
Irish O 0 2.253313757805131e-09
patients O 0 2.305920385192728e-11
and O 0 7.311818685240556e-12
provide O 0 2.972505575016271e-11
evidence O 0 2.891804573579293e-10
for O 0 4.947341494809798e-11
their O 0 3.474170257034004e-11
transmission O 0 6.608686931031116e-09
to O 0 3.080176044778504e-11
Australia O 0 9.202440025279923e-12
by O 0 5.867931574671248e-12
British O 0 1.972303875774628e-09
- O 0 1.626403678400834e-09
Irish O 0 3.600283848825825e-09
migrants O 0 6.789681039620632e-10
. O 0 2.992947834012938e-10
. O 0 1.6248508316607513e-08

Identification O 0 5.6107342771838375e-08
of O 0 9.588334393129117e-08
constitutional O 0 6.506760655611288e-06
WT1 O 0 5.251502443570644e-05
mutations O 0 2.4836770862179947e-08
, O 0 2.5322258179194534e-10
in O 0 2.502066054343999e-10
patients O 0 1.9280121943410222e-09
with O 0 2.141152144474745e-09
isolated O 1 0.9390704035758972
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 4.36806075754248e-08
and O 0 1.84290305238477e-10
analysis O 0 4.5128031866958906e-10
of O 0 7.072284979869892e-09
genotype O 0 3.9018910769073045e-08
/ O 0 5.4991385667335635e-08
phenotype O 0 1.6740703268069979e-09
correlations O 0 3.5074247950461768e-09
by O 0 1.5732810887403303e-11
use O 0 1.4197673592342142e-10
of O 0 1.6036580952061286e-09
a O 0 1.1850576076000152e-09
computerized O 0 1.061655865441935e-07
mutation O 0 2.465297521681009e-09
database O 0 3.5440155699006937e-08
. O 0 1.6386329093620589e-07

Constitutional O 0 4.856834038946545e-06
mutations O 0 4.6608310100282324e-08
of O 0 2.703967716399802e-08
the O 0 1.139315930487328e-08
WT1 O 0 3.820941856247373e-07
gene O 0 3.4619498379129254e-09
, O 0 3.170566309496081e-10
encoding O 0 2.3702847684603512e-08
a O 0 8.926050298896371e-08
zinc O 0 0.0009788181632757187
- O 0 2.154999310732819e-05
finger O 0 2.8021790058119223e-05
transcription O 0 3.419913809921127e-06
factor O 0 1.7105710981013544e-07
involved O 0 4.691083432817322e-08
in O 0 2.3705471363655306e-08
renal O 1 0.9999998807907104
and O 0 2.12716236092092e-06
gonadal O 1 0.9999994039535522
development O 0 0.030351990833878517
, O 0 1.2954590289382395e-08
are O 0 3.4687672872957265e-11
found O 0 5.0245606286747346e-11
in O 0 2.3372484503347835e-11
most O 0 1.2763048430619595e-11
patients O 0 9.99762217457345e-11
with O 0 7.224021936202973e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.896831342193764e-06
DDS B-Disease 1 1.0
) O 0 1.057903808998617e-08
, O 0 1.7266577057029053e-09
or O 0 2.3993962372514943e-08
diffuse B-Disease 1 0.9959083795547485
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.4768705770839006e-06
DMS B-Disease 0 0.00012047626660205424
) O 0 1.8790718980810084e-10
associated O 0 9.34636923410892e-10
with O 0 1.569364777020965e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.3480656352603546e-07
/ O 0 0.020067887380719185
or O 0 1.6243449181274627e-06
Wilms B-Disease 1 0.9999873638153076
tumor I-Disease 0 0.029322000220417976
( O 0 1.9251269804954063e-06
WT B-Disease 1 0.9999984502792358
) O 0 1.5338812886511732e-07
. O 0 1.9255054439781816e-07

Most O 0 3.2698652674412187e-09
mutations O 0 6.644722105875189e-09
in O 0 1.7758031489734094e-08
DDS B-Disease 1 1.0
patients O 0 3.1010363272798713e-06
lie O 0 2.5635642941779224e-06
in O 0 1.1050003578816359e-08
exon O 0 1.3548361721404945e-07
8 O 0 1.2979525365608424e-07
or O 0 5.931473534559473e-09
exon O 0 5.941270586617975e-08
9 O 0 4.2956514789693756e-08
, O 0 4.054195590352805e-10
encoding O 0 2.7528844981361544e-08
zinc O 0 0.00022954893938731402
finger O 0 0.0770929753780365
2 O 0 0.0009036972769536078
or O 0 3.297434432170121e-07
zinc O 0 0.007107568439096212
finger O 0 0.009754371829330921
3 O 0 1.3591031802206999e-06
, O 0 4.716117496528227e-10
respectively O 0 1.3555542466292536e-08
, O 0 1.583834868812417e-10
with O 0 1.523766390842951e-10
a O 0 7.307842331272241e-09
hot O 0 1.9011716290151526e-07
spot O 0 2.9456222350177086e-08
( O 0 2.3028140505587658e-10
R394W O 0 3.372504053800185e-09
) O 0 1.0620554435902818e-10
in O 0 1.4541856607763748e-09
exon O 0 3.636141059359943e-07
9 O 0 2.175781901314622e-06
. O 0 4.4997094050813757e-07

We O 0 2.4924707631157617e-08
analyzed O 0 2.4084473082552904e-08
a O 0 5.89767235048555e-10
series O 0 1.2405181049057745e-10
of O 0 1.068203414611446e-09
24 O 0 2.9239650700674247e-08
patients O 0 8.849689314693876e-10
, O 0 4.687062959973787e-10
10 O 0 3.5411282794939325e-09
with O 0 4.275981346779645e-09
isolated B-Disease 0 3.4461254472262226e-06
DMS I-Disease 1 0.650359570980072
( O 0 4.230570027630165e-08
IDMS B-Disease 0 5.709257948183222e-06
) O 0 3.4630063261431587e-09
, O 0 8.279413266087943e-10
10 O 0 2.183965674973365e-09
with O 0 3.0027252906350554e-10
DDS B-Disease 1 1.0
, O 0 8.750429714154961e-09
and O 0 8.8913443274663e-10
4 O 0 4.0792844657744354e-08
with O 0 1.5672954045697907e-09
urogenital B-Disease 1 0.9958946704864502
abnormalities I-Disease 1 0.9999996423721313
and O 0 2.5801355150179006e-05
/ O 1 0.9998691082000732
or O 0 0.22331561148166656
WT B-Disease 1 1.0
. O 0 7.551552698714659e-06

We O 0 2.455210221796733e-07
report O 0 3.087167854687323e-08
WT1 O 0 1.4314277905214112e-06
heterozygous O 0 1.8059367334899434e-08
mutations O 0 1.5659149532609717e-09
in O 0 1.6859971196936385e-09
16 O 0 5.052659446391772e-08
patients O 0 6.2845599835270605e-09
, O 0 6.312355638193878e-10
4 O 0 7.727932427314954e-08
of O 0 2.11963424590067e-07
whom O 0 1.4324585606573237e-07
presented O 0 1.6147875214755913e-07
with O 0 1.3524827124911099e-07
IDMS B-Disease 0 0.03582293912768364
. O 0 5.732051704399055e-06

One O 0 6.718589418142074e-08
male O 0 1.766880330933418e-08
and O 0 6.849645295403661e-10
two O 0 1.8150108083148098e-09
female O 0 1.5385460017114383e-07
IDMS B-Disease 1 0.9133862853050232
patients O 0 2.720522161325789e-06
with O 0 4.423041843892861e-07
WT1 O 1 0.9999865293502808
mutations O 0 0.0007099061622284353
underwent O 0 0.08393403142690659
normal O 0 0.0007123264367692173
puberty O 0 9.835474338615313e-05
. O 0 2.10919708365509e-07

Two O 0 9.609022555423508e-08
mutations O 0 3.321087405083745e-08
associated O 0 7.544065283582313e-08
with O 0 3.586425600943244e-09
IDMS B-Disease 0 7.785135676385835e-05
are O 0 1.0084879459304474e-10
different O 0 4.420909124891459e-11
from O 0 7.700143300759521e-11
those O 0 2.701592075049497e-11
described O 0 2.231973494914996e-09
in O 0 8.937239392992069e-09
DDS B-Disease 1 1.0
patients O 0 4.9206037147087045e-06
. O 0 4.543702232240321e-07

No O 0 1.5029786482045893e-06
WT1 O 0 2.0583536752383225e-05
mutations O 0 3.9294125286915005e-08
were O 0 4.264692154976046e-09
detected O 0 1.123099657718285e-08
in O 0 1.0424455049173886e-10
the O 0 2.356915496104506e-10
six O 0 1.91791849069034e-09
other O 0 1.861688803117545e-09
IDMS B-Disease 0 0.00678523862734437
patients O 0 1.744809736692332e-07
, O 0 6.935398366714196e-10
suggesting O 0 5.9559153164912004e-09
genetic O 0 7.422782388744054e-09
heterogeneity O 0 1.623388889981925e-08
of O 0 4.841010081690911e-08
this O 0 4.879245896205475e-09
disease O 0 0.0010632084449753165
. O 0 1.354803913500291e-07

We O 0 1.2610037458671286e-07
analyzed O 0 1.5602905989453575e-07
genotype O 0 1.788228303212236e-07
/ O 0 1.1532311816608853e-07
phenotype O 0 9.443729354075003e-09
correlations O 0 3.706439244410831e-08
, O 0 1.3605987170262068e-10
on O 0 3.370290435622536e-10
the O 0 6.305132804751423e-11
basis O 0 6.667532637116835e-10
of O 0 2.2391101472951647e-10
the O 0 8.034265613909852e-11
constitution O 0 4.959560540029884e-10
of O 0 3.980334728481694e-09
a O 0 2.8100501925365506e-09
WT1 O 0 8.788234850953813e-08
mutation O 0 2.5095603373159747e-10
database O 0 8.0712858618881e-10
of O 0 1.039764256915987e-07
84 O 0 9.331195542472415e-06
germ O 1 0.9986333250999451
- O 0 8.520613846485503e-06
line O 0 3.1491535423811e-07
mutations O 0 7.322670247944529e-10
, O 0 9.597286854123865e-11
to O 0 3.5942426118706905e-11
compare O 0 4.589871260840539e-10
the O 0 1.979350017222714e-10
distribution O 0 5.64078395104417e-10
and O 0 7.347555897041502e-11
type O 0 3.967663175785674e-08
of O 0 9.825755142855996e-08
mutations O 0 3.673920057067903e-09
, O 0 1.8678766866564445e-10
according O 0 2.0384764709557857e-10
to O 0 8.957708880208415e-11
the O 0 7.386354861083078e-10
different O 0 1.968921914397015e-08
symptoms O 0 2.0859475625911728e-05
. O 0 2.5957672278309474e-07

This O 0 7.765592613395711e-09
demonstrated O 0 4.618927462729516e-08
( O 0 5.898887489586002e-10
1 O 0 4.411159881811955e-09
) O 0 2.0197283082112882e-11
the O 0 6.503554639269993e-11
association O 0 2.195039844332669e-10
between O 0 9.154516034115545e-10
mutations O 0 3.548970284317221e-10
in O 0 5.064203500992903e-10
exons O 0 1.4063791908824896e-08
8 O 0 5.077206921555444e-08
and O 0 1.4342151910540224e-09
9 O 0 9.419968449719818e-08
and O 0 3.440601803461618e-09
DMS B-Disease 0 4.675902346207295e-06
; O 0 1.1777432362691798e-09
( O 0 2.716060154561717e-10
2 O 0 1.5225507965510587e-08
) O 0 7.501925469721726e-11
among O 0 2.0216321672261728e-11
patients O 0 2.422191613948854e-10
with O 0 3.5235825368573614e-10
DMS B-Disease 0 0.006862288806587458
, O 0 1.5968790734177674e-09
a O 0 2.2399815335916173e-10
higher O 0 5.467120089974742e-10
frequency O 0 2.4618906913076444e-09
of O 0 1.958060380502502e-09
exon O 0 2.0677028089721716e-08
8 O 0 6.8995014146366884e-09
mutations O 0 3.43855999229703e-10
among O 0 1.0430919322734766e-10
46 O 0 9.313486870610177e-09
, O 0 2.6916782136510164e-09
XY O 0 2.6400512069812976e-05
patients O 0 1.3462371661887573e-08
with O 0 2.6204727276990525e-10
female O 0 2.260688081179296e-09
phenotype O 0 3.940614223818528e-10
than O 0 9.099847958493612e-11
among O 0 6.023460896731336e-11
46 O 0 8.83869599732634e-09
, O 0 1.3474336091334749e-09
XY O 0 5.6588949519209564e-05
patients O 0 1.0897919899832686e-08
with O 0 2.562035861242151e-10
sexual O 0 3.1950467160868357e-08
ambiguity O 0 1.171374730546404e-08
or O 0 6.496788107490659e-10
male O 0 2.799541987119625e-10
phenotype O 0 1.0280529899597823e-10
; O 0 2.8360978496233535e-11
and O 0 9.280637369712963e-11
( O 0 7.205001179011461e-11
3 O 0 2.0738515349449926e-09
) O 0 1.6171623068439445e-11
statistically O 0 1.1107002123589282e-10
significant O 0 1.584063782922307e-11
evidence O 0 1.0363138125413229e-10
that O 0 5.07967626295347e-12
mutations O 0 6.56346990646206e-11
in O 0 3.930690495312916e-10
exons O 0 3.2004141559127675e-08
8 O 0 8.931006334478298e-08
and O 0 2.1467627675519907e-09
9 O 0 7.824547765267198e-08
preferentially O 0 1.0606211908736896e-08
affect O 0 1.9939328410600865e-08
amino O 0 3.729408248887012e-08
acids O 0 1.6107671862997108e-09
with O 0 1.9968984799056955e-11
different O 0 3.4550660943377665e-11
functions O 0 9.072250506392265e-09
. O 0 1.6858106022255015e-09
. O 0 4.566639333347666e-08

The O 0 4.164187714650325e-07
185delAG O 0 2.4467913135595154e-06
BRCA1 O 0 3.088487332547629e-08
mutation O 0 9.045154625297869e-10
originated O 0 4.0354178332258073e-10
before O 0 1.793063891808444e-10
the O 0 1.5430717467679322e-11
dispersion O 0 9.024974101379257e-10
of O 0 7.119814737777119e-10
Jews O 0 3.634273090802331e-11
in O 0 1.101207233039636e-11
the O 0 1.3671510104562579e-11
diaspora O 0 3.877905982441199e-11
and O 0 5.05854386156912e-11
is O 0 2.055772566067482e-11
not O 0 8.549148368397486e-12
limited O 0 1.8558697634230015e-10
to O 0 7.725626804955255e-10
Ashkenazim O 0 3.505695531202946e-06
. O 0 5.789599413219548e-07

The O 0 5.667070013259945e-08
185delAG O 0 2.382819133117664e-07
mutation O 0 3.0683111607032743e-09
in O 0 2.665571319226956e-09
BRCA1 O 0 2.936146659138217e-09
is O 0 1.1437346902898327e-10
detected O 0 9.614147256087335e-10
in O 0 6.002118246861698e-11
Ashkenazi O 0 2.193626391644443e-09
Jews O 0 9.556260643917014e-11
both O 0 6.845880112793523e-11
in O 0 2.429725753927414e-09
familial B-Disease 1 0.9986433386802673
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.15216064453125
in O 0 2.3482741084990266e-07
the O 0 3.100173273651308e-08
general O 0 2.826241640718763e-08
population O 0 2.544800203896358e-10
. O 0 2.5109894608021932e-08

All O 0 1.9592343747376617e-08
tested O 0 1.2118013259510008e-08
Ashkenazi O 0 1.2855787545618114e-08
mutation O 0 3.1895391883196567e-10
carriers O 0 2.1445188680413452e-10
share O 0 1.766036206163335e-10
the O 0 1.426684187455507e-10
same O 0 2.3780802327344475e-10
allelic O 0 5.490635945903932e-09
pattern O 0 2.974608470651674e-08
at O 0 9.63348441018752e-08
the O 0 1.2074867328237815e-08
BRCA1 O 0 3.3470840321569995e-08
locus O 0 1.335950940983821e-07
. O 0 3.9675882135270513e-07

Our O 0 8.31975555115605e-08
previous O 0 2.2425702184136753e-08
study O 0 9.723024607666275e-10
showed O 0 3.81563891593828e-10
that O 0 1.5003784889847105e-12
this O 0 1.603542385680834e-12
Ashkenazi O 0 2.33798091997528e-10
mutation O 0 2.6780180503727102e-11
also O 0 1.4425595266931435e-11
occurs O 0 3.137813273101919e-11
in O 0 3.2825346607534556e-11
Iraqi O 0 7.20423898314948e-09
Jews O 0 2.5025434502445876e-10
with O 0 2.055639339304527e-11
a O 0 1.4160515815486718e-10
similar O 0 1.1415726003383142e-10
allelic O 0 6.04943224402632e-08
pattern O 0 8.487666036671726e-07
. O 0 5.613789539893332e-07

We O 0 7.922626110712372e-08
extended O 0 1.492247747592046e-08
our O 0 8.237387438825294e-10
analysis O 0 6.884534609064019e-11
to O 0 2.168543122849087e-11
other O 0 3.944853471660181e-11
non O 0 4.210314319408326e-09
- O 0 2.3048187802743314e-09
Ashkenazi O 0 2.680990318637555e-09
subsets O 0 4.446248702549838e-09
354 O 0 1.5680250431415743e-09
of O 0 7.074736907419776e-10
Moroccan O 0 1.4357103950146666e-08
origin O 0 2.6554866638939245e-10
, O 0 3.2220913437353005e-11
200 O 0 1.8340454155385544e-10
Yemenites O 0 1.9733430889345982e-08
and O 0 1.282736139529561e-10
150 O 0 6.907582283943725e-10
Iranian O 0 5.117327894765822e-09
Jews O 0 7.228450282781296e-09
. O 0 1.960426665448267e-08

Heteroduplex O 0 4.975007414032007e-06
analysis O 0 2.50434109005937e-08
complemented O 0 5.469282360337502e-09
by O 0 3.613916804701134e-11
direct O 0 2.2043708525210093e-10
DNA O 0 3.584714192150784e-10
sequencing O 0 1.2288546846761506e-09
of O 0 3.1489142404694803e-09
abnormally O 0 7.804183965731681e-09
migrating O 0 2.94511914855633e-10
bands O 0 9.003486844960662e-09
were O 0 3.777096857504603e-09
employed O 0 6.065793201059932e-08
. O 0 6.981285594065412e-08

Four O 0 7.739409113582951e-08
of O 0 4.9552156156096316e-08
Moroccan O 0 1.980086921093971e-07
origin O 0 1.7847394673253802e-09
( O 0 3.879163310016587e-11
1 O 0 6.014199693815669e-10
. O 0 7.173732961829327e-12
1 O 0 5.572908245987662e-10
% O 0 1.48720202819419e-11
) O 0 7.573258860305021e-12
and O 0 4.150035176619937e-11
none O 0 8.641027338107676e-10
of O 0 1.2572165530855273e-09
the O 0 2.31595920219263e-09
Yemenites O 0 2.3455501718672167e-07
or O 0 1.764949519866832e-09
Iranians O 0 1.753999168130349e-09
was O 0 5.612208031635646e-09
a O 0 2.879135541089539e-10
carrier O 0 2.9770630405323573e-10
of O 0 8.267577733533926e-10
the O 0 1.22689436388157e-09
185delAG O 0 9.05343000567882e-08
mutation O 0 1.1281837686283325e-08
. O 0 8.635976911364196e-08

BRCA1 O 0 6.841255526524037e-07
allelic O 0 3.1934297339830664e-07
patterns O 0 1.8777194910057915e-08
were O 0 5.771908506702061e-10
determined O 0 6.417658071633525e-10
for O 0 1.6789130849459433e-11
four O 0 2.8666949022926325e-11
of O 0 8.501686854511803e-11
these O 0 3.6190466855962056e-12
individuals O 0 1.0797900117445747e-12
and O 0 2.2293248844174052e-11
for O 0 2.805935483962685e-10
12 O 0 5.849681183889288e-09
additional O 0 2.029678203285812e-09
non O 0 7.008194984337024e-07
- O 0 9.03800554397094e-08
Ashkenazi O 0 4.670493325420466e-09
185delAG O 0 7.486752551244535e-09
mutation O 0 5.69102431846602e-10
carriers O 0 7.550953196044929e-10
who O 0 1.6993728646497175e-09
had O 0 1.0997982826665975e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999443292617798

Six O 0 3.1924814720696304e-06
non O 0 1.0632081284711603e-05
- O 0 5.75536830638157e-07
Ashkenazi O 0 6.608979674638249e-08
individuals O 0 1.3052495195786662e-10
shared O 0 6.917180717103122e-10
the O 0 3.931050207572895e-10
common O 0 4.329618885634545e-10
Ashkenazi O 0 2.9671327617109e-09
haplotype O 0 2.4797767395057235e-08
, O 0 2.492887896110574e-09
four O 0 1.6295833571433604e-09
had O 0 2.5979693951683203e-09
a O 0 8.047919553000327e-10
closely O 0 3.270456128134924e-10
related O 0 1.3136470800034772e-09
pattern O 0 1.2585078756899293e-08
, O 0 8.176866128639659e-11
and O 0 4.88091650430178e-11
the O 0 1.1658419785121055e-09
rest O 0 1.7468785529217712e-08
( O 0 2.2270395250156838e-10
n O 0 1.1310881120607519e-08
= O 0 9.235159303955243e-09
6 O 0 2.0463474470489018e-08
) O 0 1.651186409823424e-10
displayed O 0 6.00001826001062e-09
a O 0 1.968966101273395e-09
distinct O 0 4.632052963415845e-09
BRCA1 O 0 5.206489817055626e-08
allelic O 0 8.242320745921461e-07
pattern O 0 2.266718183818739e-06
. O 0 1.0964074590447126e-06

We O 0 8.856012811975233e-08
conclude O 0 1.288124593656903e-07
that O 0 8.13252173936796e-11
the O 0 2.798025700023743e-10
185delAG O 0 1.0893471902306828e-08
BRCA1 O 0 5.97507321398183e-10
mutation O 0 3.261614936467261e-11
occurs O 0 2.8666949022926325e-11
in O 0 3.4172109586450006e-11
some O 0 1.9549386415240733e-11
non O 0 1.5574265432860557e-08
- O 0 5.431255445387251e-09
Ashkenazi O 0 2.232501516985508e-09
populations O 0 3.362981074173099e-11
at O 0 3.709796914108665e-09
rates O 0 1.074942024281711e-09
comparable O 0 9.447813642537994e-10
with O 0 1.8125457731943406e-11
that O 0 4.445082843473891e-11
of O 0 1.7234473403959782e-08
Ashkenazim O 0 2.1125720195414033e-06
. O 0 2.3175296348654228e-07

The O 0 5.90143649503716e-08
majority O 0 3.0602105294263993e-09
of O 0 1.771652158311099e-08
Jewish O 0 4.63177007858917e-09
185delAG O 0 5.530115032570393e-08
mutation O 0 2.647856156556827e-09
carriers O 0 5.484436793601333e-10
have O 0 3.045557209202521e-11
a O 0 7.694211934250461e-11
common O 0 1.0648078946351447e-10
allelic O 0 8.566610532056984e-09
pattern O 0 9.9816688248211e-08
, O 0 4.778121787119005e-10
supporting O 0 2.2168102908892706e-09
the O 0 1.2598672327612803e-08
founder O 0 2.639701506268466e-07
effect O 0 3.2371551128562714e-07
notion O 0 7.040524252488467e-08
, O 0 4.787316654208951e-10
but O 0 4.739886608207122e-11
dating O 0 1.6790461243587629e-09
the O 0 1.41513897822243e-10
mutations O 0 6.034857336079114e-11
origin O 0 7.234028653879676e-11
to O 0 3.101552695228271e-11
an O 0 1.156816656355808e-11
earlier O 0 5.114924594984416e-10
date O 0 1.5284543408711215e-08
than O 0 5.84973403050526e-10
currently O 0 1.7993618817158108e-09
estimated O 0 6.66041799490813e-09
. O 0 1.3342283011752443e-07

However O 0 1.1458368476269243e-07
, O 0 7.191220952051935e-10
the O 0 1.4687973060034665e-10
different O 0 3.4657516440050884e-11
allelic O 0 5.961200422177626e-09
pattern O 0 1.8476811192158493e-08
at O 0 4.9890815034814295e-08
the O 0 3.192584197009296e-09
BRCA1 O 0 1.3072334326125201e-09
locus O 0 9.376867060595373e-10
even O 0 5.257447810436133e-10
in O 0 1.4566806094684637e-10
some O 0 1.279627272199324e-11
Jewish O 0 1.1085181383929665e-10
mutation O 0 1.6528249602298928e-10
carriers O 0 3.7859237966841874e-10
, O 0 3.192679731700565e-10
might O 0 2.0162344016583233e-10
suggest O 0 1.5704397504645584e-10
that O 0 1.2031943366977438e-12
the O 0 2.6864031832385393e-11
mutation O 0 6.559214976720185e-11
arose O 0 5.281408088642081e-10
independently O 0 2.441515045692455e-10
. O 0 4.97980712221846e-10
. O 0 1.913111447038318e-08

Crystal O 0 0.0037946016527712345
structure O 0 2.7434516596258618e-05
of O 0 4.377434743219055e-05
the O 0 4.483417433220893e-05
hemochromatosis B-Disease 1 1.0
protein O 0 6.200661300681531e-05
HFE O 0 3.7003606848884374e-05
and O 0 3.0257696348456875e-09
characterization O 0 5.577593142902515e-08
of O 0 8.498452608307616e-09
its O 0 2.6195581814825175e-10
interaction O 0 4.511035101018024e-08
with O 0 3.871281073486443e-09
transferrin O 0 7.932875973892806e-07
receptor O 0 2.2503004970531038e-07
. O 0 3.923152291918086e-07

HFE O 0 0.0004913971642963588
is O 0 1.785612795401903e-07
an O 0 1.3736928927698955e-08
MHC O 0 1.9383765902603045e-05
- O 0 0.00010152202594326809
related O 0 2.7390440664021298e-05
protein O 0 3.242454056362476e-07
that O 0 1.8346578423145132e-10
is O 0 8.559709885336275e-11
mutated O 0 3.4204539200999307e-10
in O 0 3.1150534929302864e-10
the O 0 8.956214436750543e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999443292617798

HFE O 0 4.546259515336715e-05
binds O 0 1.154681683601666e-07
to O 0 3.0721015065182655e-08
transferrin O 0 4.183775672572665e-07
receptor O 0 1.8138212709573054e-08
( O 0 2.0549437707018114e-09
TfR O 0 1.0755808688145407e-07
) O 0 3.092575084906457e-10
and O 0 9.996402317025144e-11
reduces O 0 6.771446181552676e-10
its O 0 3.170667547958139e-11
affinity O 0 1.1192028415152322e-09
for O 0 8.386860095299653e-09
iron O 0 0.18359610438346863
- O 0 2.680297086499195e-07
loaded O 0 2.4234049433857763e-08
transferrin O 0 1.8478542074262805e-07
, O 0 3.530937764395503e-09
implicating O 0 1.1942465789616108e-06
HFE O 0 0.00044725293992087245
in O 0 3.7144125144550344e-06
iron O 1 0.9999996423721313
metabolism O 1 0.9733162522315979
. O 0 2.01458146875666e-06

The O 0 1.6294120541715529e-06
2 O 0 6.0127873439341784e-05
. O 0 1.1712450032064226e-06

6 O 0 0.0002925287699326873
A O 0 1.0537036359892227e-05
crystal O 0 0.19019107520580292
structure O 0 1.9433186025707982e-05
of O 0 1.5295168850570917e-05
HFE O 0 0.00014490645844489336
reveals O 0 2.774528340410143e-08
the O 0 2.644720276112622e-10
locations O 0 2.3612500843483986e-09
of O 0 2.496882416380686e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 4.3200299160162103e-07
and O 0 3.300211659507113e-08
a O 0 1.3562440415171295e-07
patch O 0 0.018346084281802177
of O 1 0.9950142502784729
histidines O 1 0.996911346912384
that O 0 1.4591143848718957e-09
could O 0 7.482937047775806e-10
be O 0 4.32130060901148e-11
involved O 0 2.2951840428220294e-10
in O 0 2.4897742201268613e-10
pH O 0 7.564271413684764e-07
- O 0 1.2080520264134975e-06
dependent O 0 3.8232053611864103e-07
interactions O 0 1.825961930990161e-06
. O 0 4.0328674799638975e-07

We O 0 6.13956601114296e-08
also O 0 1.230414325981144e-09
demonstrate O 0 4.456930380314361e-09
that O 0 4.405540932062024e-10
soluble O 0 9.766450403958515e-08
TfR O 0 6.342030474115745e-07
and O 0 1.0403648609269567e-08
HFE O 0 5.036379207012942e-06
bind O 0 5.264467262122707e-08
tightly O 0 2.7125352630719135e-07
at O 0 3.8063458163151154e-08
the O 0 2.7305363525798043e-10
basic O 0 6.985318989904954e-09
pH O 0 2.6595799340611848e-08
of O 0 1.3285851530042692e-08
the O 0 5.030251770676841e-09
cell O 0 3.125107994605969e-08
surface O 0 2.835236756482118e-08
, O 0 3.15703130304712e-10
but O 0 1.034623220430575e-10
not O 0 5.720077883575314e-11
at O 0 3.817832272545729e-09
the O 0 5.748714837494617e-10
acidic O 0 2.4550224964059453e-08
pH O 0 5.458112468659237e-07
of O 0 8.831349873617e-07
intracellular O 0 1.9355396943865344e-05
vesicles O 0 6.004936221870594e-05
. O 0 3.894630481227068e-06

TfR O 0 0.0003153584257233888
HFE O 0 9.89334293990396e-05
stoichiometry O 0 2.933674068117398e-06
( O 0 1.162126466169866e-07
2 O 0 8.447080972473486e-07
1 O 0 1.0145009099460367e-07
) O 0 1.6374682165753995e-10
differs O 0 1.1995894277916364e-09
from O 0 1.1981624581380856e-09
TfR O 0 1.9257162975350184e-08
transferrin O 0 6.867491908479906e-09
stoichiometry O 0 1.6114531931066267e-08
( O 0 1.4584354834923374e-09
2 O 0 4.788883600781446e-08
2 O 0 4.057773850263402e-08
) O 0 8.911051063709152e-11
, O 0 5.4632087048700484e-11
implying O 0 4.1386305493773534e-10
a O 0 6.113463901780136e-11
different O 0 1.1084098049118918e-11
mode O 0 1.0391134175335992e-08
of O 0 1.1259281285092015e-09
binding O 0 1.0393785832008007e-09
for O 0 5.285734516746743e-09
HFE O 0 2.7126413897349266e-06
and O 0 1.4023986416589196e-08
transferrin O 0 2.2922712616946228e-07
to O 0 5.045549755777756e-09
TfR O 0 3.9205045254675497e-07
, O 0 4.5234374579372627e-10
consistent O 0 2.0444816950515587e-09
with O 0 5.873779934661982e-11
our O 0 6.252132145334599e-10
demonstration O 0 1.5358323501857285e-09
that O 0 3.175600407634427e-11
HFE O 0 1.5709376555150811e-07
, O 0 1.5885310844510059e-09
transferrin O 0 4.546051712850385e-08
, O 0 9.070637019270578e-10
and O 0 5.270851533012433e-10
TfR O 0 4.758908573876397e-07
form O 0 1.3239002782938769e-08
a O 0 2.2898605678278727e-08
ternary O 0 1.8545644024925423e-06
complex O 0 0.00021472857042681426
. O 0 1.1644667665677844e-06

Identification O 0 4.2901530150629696e-07
of O 0 1.0216642465366021e-07
three O 0 1.8621113540007173e-09
novel O 0 1.2412570971065406e-09
mutations O 0 1.4534168313318219e-10
and O 0 1.0193679927938959e-10
a O 0 1.706123992084585e-10
high O 0 2.2669401911201703e-09
frequency O 0 1.7208884983688222e-08
of O 0 3.947522309033502e-09
the O 0 3.477725607492488e-10
Arg778Leu O 0 4.915528606375119e-08
mutation O 0 1.4783646529181738e-10
in O 0 1.3157777645211866e-10
Korean O 0 2.121243909414261e-07
patients O 0 1.0013428974886551e-09
with O 0 6.979095634740418e-10
Wilson B-Disease 0 6.297296749835368e-06
disease I-Disease 0 0.00026054464979097247
. O 0 4.972698661731556e-07

Four O 0 1.1234434396101278e-06
mutations O 0 4.354426863528715e-08
- O 0 8.05141198156889e-08
- O 0 2.0621495622208386e-08
R778L O 0 7.326295303755614e-08
, O 0 4.2336736894021954e-10
A874V O 0 8.590597566637825e-09
, O 0 2.1484000689575566e-10
L1083F O 0 4.4805146259818684e-09
, O 0 6.525087414832598e-11
and O 0 2.3046583738639548e-11
2304delC O 0 3.4952434280199896e-09
- O 0 9.578090542916584e-10
- O 0 3.420642935569873e-10
in O 0 1.2045411890149182e-10
the O 0 1.1486388507009337e-09
copper O 0 2.5013489448610926e-06
- O 0 8.04643462970489e-09
transporting O 0 4.557743960020844e-09
enzyme O 0 4.39174835387135e-10
, O 0 1.214461531340305e-09
P O 0 2.414174787190859e-06
- O 0 5.2122228311191066e-08
type O 0 4.156909838570755e-08
ATPase O 0 1.5759316340790974e-07
( O 0 1.437068464227309e-09
ATP7B O 0 1.6244953826571873e-07
) O 0 4.14723394515093e-11
, O 0 9.27433217029483e-12
were O 0 6.15782641891216e-12
identified O 0 3.688077621077923e-11
in O 0 5.951786979929707e-11
Korean O 0 2.6511477813073725e-07
Patients O 0 4.716443680052862e-09
with O 0 2.494604967040459e-09
Wilson B-Disease 0 2.0168028640910052e-05
disease I-Disease 0 0.023180613294243813
. O 0 2.1112327885930426e-06

Arg778Leu O 0 2.6621728466125205e-05
, O 0 1.3883965088723471e-08
the O 0 1.3467706949654712e-09
most O 0 5.800589175652959e-11
frequently O 0 5.4728770126910575e-11
reported O 0 9.200825865085527e-12
mutation O 0 4.219143263928249e-12
of O 0 1.4885052912472219e-10
this O 0 7.58682006107847e-12
enzyme O 0 5.1050979416045195e-11
, O 0 3.9233033488628166e-11
was O 0 1.1191303439517242e-09
found O 0 1.5101762895763926e-10
in O 0 6.748131914369182e-11
six O 0 2.412656185946105e-10
of O 0 6.4781571218475165e-09
eight O 0 5.489589227636316e-09
unrelated O 0 1.2622369638393138e-07
patients O 0 1.668612803484848e-09
studied O 0 7.896060338907773e-08
, O 0 7.518399097738993e-11
an O 0 9.622209279358529e-12
allele O 0 2.0688369073429413e-10
frequency O 0 1.5790345031518882e-08
of O 0 5.528301372237365e-08
37 O 0 9.598047654435504e-07
. O 0 2.9389897804321663e-07

5 O 0 2.0192919691908173e-06
% O 0 1.4962948213792515e-08
, O 0 9.220229579831596e-10
which O 0 8.225639613890223e-11
is O 0 1.9195634665125638e-11
considerably O 0 5.779013934059662e-10
higher O 0 7.997575379725674e-10
than O 0 6.800275620388874e-12
those O 0 1.8579718926575728e-12
in O 0 1.5714126180843557e-11
other O 0 2.2979600861061655e-11
Asian O 0 1.0334205713391498e-09
populations O 0 1.858062315118758e-10
. O 0 6.85666767807902e-09

The O 0 1.9261094053035777e-08
novel O 0 1.6035632821598256e-09
single O 0 1.9992431321558257e-10
nucleotide O 0 4.818962118235959e-09
deletion O 0 2.389827713500381e-08
, O 0 3.5300537493121453e-10
2304delC O 0 9.532659994704318e-09
, O 0 3.668190473593569e-10
was O 0 1.1244070563520836e-08
found O 0 6.001067975880403e-10
in O 0 8.128416273400774e-10
one O 0 1.487909906394691e-09
patient O 0 1.9031907072530885e-07
. O 0 2.97830524687015e-07

Since O 0 1.3781129837298067e-07
a O 0 1.146382899719356e-08
mutation O 0 2.0549111023893118e-10
at O 0 2.8021730713589932e-08
cDNA O 0 2.382804531464444e-08
nucleotide O 0 6.323858059431586e-08
2302 O 0 4.413718215801055e-06
( O 0 3.5297726963534615e-09
2302insC O 0 3.0456082100727144e-08
) O 0 6.805979113622129e-10
had O 0 3.056692898795177e-09
been O 0 4.1454964461173915e-10
previously O 0 3.4792666525618188e-09
described O 0 8.724427291717518e-10
, O 0 1.0411831119494508e-11
this O 0 6.236951927141021e-12
region O 0 9.5401297972586e-10
of O 0 2.5983659668327164e-09
the O 0 4.3018806294981005e-09
ATP7B O 0 1.6828751540742815e-05
gene O 0 3.0198787470681054e-08
may O 0 3.455379316008589e-09
be O 0 3.8681419178843157e-10
susceptible O 0 2.3007780125539057e-09
to O 0 9.226175379239976e-10
gene O 0 1.1691670351865469e-06
rearrangements O 0 0.3977583050727844
causing O 1 0.5951704382896423
Wilson B-Disease 1 0.9173247218132019
disease I-Disease 1 0.9684674143791199
. O 0 4.5378315007837955e-06

Disruption O 0 1.9327415429870598e-05
of O 0 9.317192279922892e-07
splicing O 0 3.9559742504025053e-07
regulated O 0 8.289596564736712e-08
by O 0 1.0527020366524198e-09
a O 0 8.414997587635753e-09
CUG O 0 2.207843863288872e-06
- O 0 2.685382582967577e-08
binding O 0 4.302145129031487e-08
protein O 0 7.85218580858782e-05
in O 0 1.5169383914326318e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0002187835198128596

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9992192983627319
DM B-Disease 1 1.0
) O 0 1.8896788844813273e-07
is O 0 2.4797328634917903e-09
caused O 0 2.6254669549530263e-09
by O 0 1.3066046855580993e-10
a O 0 2.4184350078115813e-09
CTG O 0 3.6372267686601845e-07
expansion O 0 1.3034944679191085e-08
in O 0 1.5699402888813552e-09
the O 0 2.4334827486427457e-09
3 O 0 6.516676620549333e-08
untranslated O 0 5.012373094359646e-06
region O 0 1.8161337322908366e-08
of O 0 1.2802053639404676e-08
the O 0 8.3945302264965e-08
DM B-Disease 1 1.0
gene O 0 2.1584010028163902e-06
. O 0 7.86913801675837e-07

One O 0 1.6113025580466456e-08
model O 0 1.015155106642851e-07
of O 0 3.6354342682898277e-06
DM B-Disease 1 1.0
pathogenesis O 1 0.9998795986175537
suggests O 0 1.674424794373408e-07
that O 0 2.6031862776498826e-10
RNAs O 0 1.0888984824930503e-08
from O 0 3.048813146389051e-10
the O 0 1.2285986117355208e-10
expanded O 0 8.092986003571667e-11
allele O 0 1.1150239759283309e-10
create O 0 1.8743004370769256e-10
a O 0 6.671934116297962e-10
gain O 0 4.809706410924264e-09
- O 0 2.734613868682345e-09
of O 0 2.55109640079354e-08
- O 0 2.441357782601017e-09
function O 0 1.4954411042822358e-09
mutation O 0 3.549577992645325e-11
by O 0 1.0169845868213123e-11
the O 0 1.8760852593668886e-10
inappropriate O 0 5.012820381011807e-09
binding O 0 4.754777460647119e-09
of O 0 4.0991110950017173e-08
proteins O 0 1.1287427659212312e-09
to O 0 2.1863246768560884e-09
the O 0 2.135806020930886e-08
CUG O 0 7.475136226275936e-05
repeats O 0 1.0829477332663373e-06
. O 0 2.2250128495215904e-07

Data O 0 1.1869701666000765e-07
presented O 0 9.274987888829855e-08
here O 0 9.339761852800166e-09
indicate O 0 7.88852649868943e-10
that O 0 1.931204848815149e-11
the O 0 1.7104512251009396e-10
conserved O 0 1.6494599464067505e-08
heterogeneous O 0 2.7158773718838347e-07
nuclear O 0 5.71792133996496e-06
ribonucleoprotein O 0 6.37255084257049e-07
, O 0 3.572498075143926e-09
CUG O 0 4.933548893859552e-07
- O 0 1.1267450084062602e-08
binding O 0 5.335325958810699e-09
protein O 0 5.4767699708691e-08
( O 0 2.230484019705159e-09
CUG O 0 5.4414472288044635e-06
- O 0 4.6351178184522723e-07
BP O 0 4.81842278077238e-07
) O 0 6.697919996412338e-10
, O 0 4.3927705917212734e-10
may O 0 1.6756356302494169e-09
mediate O 0 3.151566261294647e-07
the O 0 1.480450606550221e-07
trans O 0 8.084085493464954e-06
- O 0 2.2170486602135497e-07
dominant O 0 2.392701787812257e-07
effect O 0 1.223028647245883e-07
of O 0 3.781712720751784e-08
the O 0 8.326705547290203e-09
RNA O 0 1.7846269884103094e-07
. O 0 7.664839785093136e-08

CUG O 0 0.053393494337797165
- O 0 0.00013086672697681934
BP O 0 1.5158552741922904e-05
was O 0 1.680893433331221e-07
found O 0 6.893341453206858e-10
to O 0 4.19543219609686e-11
bind O 0 8.816747332218711e-11
to O 0 7.084319936234706e-11
the O 0 1.7846918387576238e-09
human O 0 1.4981017670834262e-07
cardiac O 1 0.9994394183158875
troponin O 0 0.0002814876788761467
T O 0 2.9711622119066305e-05
( O 0 3.802715919931643e-09
cTNT O 0 2.0395635402792323e-08
) O 0 2.0272784839736602e-10
pre O 0 3.8152279557834845e-08
- O 0 5.173128148072692e-09
messenger O 0 6.887808101652126e-10
RNA O 0 2.227839246415897e-09
and O 0 2.9923414440746754e-11
regulate O 0 2.6765742400236547e-10
its O 0 4.052144383925871e-11
alternative O 0 3.798743097860324e-09
splicing O 0 1.0409190309701444e-07
. O 0 6.364078330989287e-08

Splicing O 0 2.28735643759137e-06
of O 0 4.470640249110147e-07
cTNT O 0 2.7124704047309933e-06
was O 0 1.0246280908177141e-06
disrupted O 0 5.935023182246368e-06
in O 0 1.1602627125739673e-07
DM B-Disease 1 1.0
striated O 0 0.00014961083070375025
muscle O 0 4.880523647443624e-06
and O 0 1.4437398832001236e-08
in O 0 5.774300593230919e-09
normal O 0 2.378099281941104e-07
cells O 0 5.327076557648525e-10
expressing O 0 9.261720834707887e-10
transcripts O 0 1.5357132454596467e-08
that O 0 5.635522604130472e-11
contain O 0 1.3455176972598792e-09
CUG O 0 1.3280197208587197e-06
repeats O 0 3.108587520728179e-07
. O 0 8.136195361885257e-08

Altered O 0 9.83032961698882e-08
expression O 0 3.2933765936604686e-08
of O 0 4.415707977045713e-08
genes O 0 6.449197620383984e-09
regulated O 0 2.36491555227758e-08
posttranscriptionally O 0 5.354943510837984e-08
by O 0 8.80720552043357e-10
CUG O 0 0.0002732439897954464
- O 0 2.728067101998022e-06
BP O 0 7.492061513403314e-07
therefore O 0 7.710937666161044e-09
may O 0 6.527032248015985e-10
contribute O 0 9.617338037060108e-10
to O 0 1.7018811249158716e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9998260140419006
. O 0 1.704246699318901e-07
. O 0 4.0778735410640365e-07

Identification O 0 5.5731693038296726e-08
of O 0 3.6203310571636393e-08
a O 0 1.3722284419870334e-09
novel O 0 6.331394852843175e-10
nonsense O 0 7.068130969400954e-09
mutation O 0 1.7394424789429763e-10
and O 0 1.09111157609032e-10
a O 0 3.7893480020478876e-10
missense O 0 3.890578970100478e-09
substitution O 0 2.1200856625824827e-09
in O 0 1.1954802703328937e-09
the O 0 5.282469128786715e-09
vasopressin O 0 9.379253640418028e-08
- O 0 3.577163454338006e-08
neurophysin O 0 1.9320319211146852e-07
II O 0 0.009888535365462303
gene O 0 4.959505695012467e-09
in O 0 1.1734471172530903e-09
two O 0 1.9375444304525757e-10
Spanish O 0 1.0790530247106744e-08
kindreds O 0 2.599530262159533e-07
with O 0 1.2611847566290635e-08
familial B-Disease 1 0.9999958276748657
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999951124191284
. O 0 0.00011295441800029948

Familial B-Disease 1 0.9999997615814209
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 5.775421595899388e-05
FNDI B-Disease 1 1.0
) O 0 1.086858780752209e-08
is O 0 2.594328640803667e-10
an O 0 1.0056552257609042e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.2467062080977485e-05
by O 0 7.119682621237189e-09
deficiency O 1 0.8956704139709473
in O 0 1.7013528008646972e-07
the O 0 3.372677838342497e-06
antidiuretic O 0 7.614053629367845e-06
hormone O 0 2.702127517295594e-07
arginine O 0 5.817383339490334e-07
vasopressin O 0 7.293933208529779e-07
( O 0 1.0662701832586663e-08
AVP O 0 1.4458650809956453e-07
) O 0 1.0981161813194973e-10
encoded O 0 1.5886393589514824e-10
by O 0 1.0082110146747425e-10
the O 0 4.3863344068029164e-09
AVP O 0 6.760192718502367e-06
- O 0 7.353271485044388e-07
neurophysin O 0 9.082320502784569e-06
II O 1 0.9999948740005493
( O 0 2.2403027344353177e-07
AVP O 0 1.080443416867638e-05
- O 0 3.4777431778820755e-07
NPII O 0 4.387244700865267e-07
) O 0 7.452328198986891e-10
gene O 0 1.972860541599175e-09
on O 0 5.3694876100962574e-08
chromosome O 0 1.6077804048109101e-06
20p13 O 0 5.8461087064642925e-06
. O 0 6.806465080444468e-07

In O 0 1.3678234545011492e-08
this O 0 3.0353172753017077e-10
study O 0 3.5161842881770156e-10
, O 0 2.2499360013972236e-11
we O 0 2.4192909828246734e-11
analyzed O 0 1.9587764743533853e-10
two O 0 1.8801177628646748e-11
families O 0 9.78178909399885e-13
with O 0 2.1839844169257994e-11
FNDI B-Disease 1 0.999841570854187
using O 0 2.4734831960415704e-09
direct O 0 1.0043957887617694e-09
automated O 0 8.7301748052937e-09
fluorescent O 0 1.549455452831694e-09
, O 0 1.1971978963742913e-10
solid O 0 1.3698538969819651e-09
phase O 0 2.2068087801585534e-08
, O 0 1.699984736314164e-10
single O 0 8.493356712380162e-11
- O 0 5.368376299053068e-10
stranded O 0 2.711588176218527e-10
DNA O 0 3.0580253607137564e-11
sequencing O 0 1.44460873818808e-10
of O 0 1.7711206945492108e-09
PCR O 0 2.1449713116794555e-08
- O 0 8.536016338211994e-08
amplified O 0 5.212362452766683e-07
AVP O 0 4.0014660044107586e-05
- O 0 3.6123619793215767e-06
NPII O 0 1.8872935470426455e-05
DNA O 0 5.405792080637184e-07
. O 0 1.1201264271676337e-07

In O 0 2.319833036779073e-08
one O 0 1.0848886233816302e-09
of O 0 3.3617146844022727e-09
the O 0 7.52837514550464e-10
families O 0 3.685454719182246e-11
, O 0 1.7374587879537273e-11
affected O 0 1.166056400742077e-11
individuals O 0 3.665151515619414e-12
presented O 0 9.80694858654374e-10
a O 0 7.17727099974752e-10
novel O 0 3.8755415543434424e-10
nonsense O 0 4.606467207679543e-09
mutation O 0 9.518132809693824e-11
in O 0 6.007859765233547e-10
exon O 0 2.5264345282494105e-08
3 O 0 3.9602390700110846e-08
of O 0 5.3839857017123904e-09
the O 0 1.0466677524689771e-09
gene O 0 3.458819619606146e-10
, O 0 7.891742814791769e-11
consisting O 0 4.85781137538055e-10
in O 0 1.1397652821543147e-09
a O 0 1.122226045424668e-08
G O 0 1.3449765674522496e-06
to O 0 3.110342916556874e-08
T O 0 1.4758363249711692e-05
transition O 0 1.745099143590778e-05
at O 0 1.868266963356291e-06
nucleotide O 0 4.272885334444254e-08
2101 O 0 5.608422384284495e-07
, O 0 3.9933820139559373e-10
which O 0 1.283222486603286e-11
produces O 0 1.7551352732292358e-11
a O 0 6.035893312938967e-11
stop O 0 1.2507581081955266e-10
signal O 0 4.926564489693419e-09
in O 0 4.706107725738207e-10
codon O 0 5.402502001317089e-09
82 O 0 1.0853904797158975e-07
( O 0 5.2190443078359294e-09
Glu O 0 1.1481726005513337e-06
) O 0 8.446289889718628e-09
of O 0 3.545321192177653e-07
NPII O 0 0.002476274035871029
. O 0 2.355530568820541e-06

The O 0 4.963629862686503e-07
premature O 0 9.035874199980753e-07
termination O 0 9.397214029149836e-08
eliminates O 0 1.0756013324453306e-07
part O 0 2.7945978864352128e-09
of O 0 6.751318171183129e-09
the O 0 6.195062685065977e-09
C O 0 2.561365363362711e-06
- O 0 3.476964938187166e-09
terminal O 0 3.869597531291902e-09
domain O 0 1.7997188184182278e-09
of O 0 3.9742960034061525e-09
NPII O 0 5.683983772541978e-07
, O 0 4.402063713548898e-10
including O 0 1.7319343181831925e-10
a O 0 7.896324150102885e-10
cysteine O 0 2.535842424933321e-09
residue O 0 7.34147249659145e-08
in O 0 1.4537087089649958e-09
position O 0 5.4398221038809424e-08
85 O 0 6.673938202084173e-08
, O 0 7.886480357655046e-10
which O 0 3.5984406426825544e-11
could O 0 7.74022443361666e-11
be O 0 2.6399060021331522e-11
involved O 0 1.4482282040262362e-10
in O 0 5.7532971442508796e-11
the O 0 1.5512881257340183e-10
correct O 0 5.8952714709903375e-08
folding O 0 1.1926747447432717e-06
of O 0 1.3476596905093174e-07
the O 0 2.2963168078149465e-07
prohormone O 0 0.0002952649083454162
. O 0 1.1564366104721557e-06

In O 0 4.505652384523273e-08
the O 0 9.831113700897731e-09
second O 0 3.2549827722050395e-08
family O 0 5.763943211611888e-10
, O 0 1.2891722411811912e-10
a O 0 2.9145297286703453e-10
G279A O 0 2.9715616634007347e-09
substitution O 0 2.6247459761208347e-09
at O 0 5.2862006327814015e-08
position O 0 3.383865276873621e-08
- O 0 3.456051667072302e-09
1 O 0 8.609198687281605e-09
of O 0 1.3239223051186855e-09
the O 0 3.1231622843463924e-10
signal O 0 1.3454722669337116e-08
peptide O 0 3.6281871951260314e-10
was O 0 1.6149845905033544e-09
observed O 0 4.804825981530314e-10
in O 0 9.197373418423638e-11
all O 0 7.05427868896713e-11
affected O 0 1.0053022858613758e-09
individuals O 0 5.428197891177433e-10
. O 0 7.175334104658759e-08

This O 0 1.8587021699545403e-08
missense O 0 1.12717270894791e-06
mutation O 0 6.484746073454062e-09
, O 0 1.6861385621069758e-09
which O 0 7.066887630635676e-10
replaces O 0 1.1963246606683242e-06
Ala O 0 5.918321903664037e-07
with O 0 4.711579570937374e-09
Thr O 0 6.110878075560322e-06
, O 0 1.909913116548978e-09
is O 0 1.8200156659542444e-10
frequent O 0 7.254219447361265e-10
among O 0 9.126064903774989e-10
FNDI B-Disease 1 1.0
patients O 0 1.9395251001697034e-05
and O 0 2.037837099067019e-08
is O 0 1.7052009804174872e-09
thought O 0 6.274974984066262e-10
to O 0 2.739737776924489e-11
reduce O 0 5.397081670466264e-10
the O 0 1.3765950879207622e-10
efficiency O 0 9.0457286106016e-09
of O 0 2.7605704389088714e-09
cleavage O 0 3.777544055338922e-09
by O 0 4.062741532084857e-10
signal O 0 7.48973945974285e-07
peptidases O 0 2.1733512767241336e-06
. O 0 3.405043003112951e-08
. O 0 1.879464974763323e-07

Genetic O 0 4.805618800673983e-07
heterogeneity O 0 1.1295163631075411e-06
of O 0 2.4692433271411574e-06
Saethre B-Disease 1 0.9997547268867493
- I-Disease 1 0.999891996383667
Chotzen I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999967813491821
, O 0 1.0665829330847032e-09
due O 0 6.106608196887464e-08
to O 0 2.6564761501646217e-09
TWIST O 0 4.798640020453604e-06
and O 0 8.489477565376546e-09
FGFR O 0 0.00010176860814681277
mutations O 0 1.9865461808876717e-07
. O 0 1.7800513774091087e-07

Thirty O 0 0.0002639729646034539
- O 0 3.842043042823207e-06
two O 0 7.560512216286952e-09
unrelated O 0 1.8500584531011555e-07
patients O 0 3.2534522298455215e-10
with O 0 1.9681228868861922e-11
features O 0 1.976619534715951e-09
of O 0 1.4946625697120908e-06
Saethre B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.0525619809651516e-09
a O 0 5.5710192015112625e-09
common O 0 3.055954493902391e-07
autosomal B-Disease 0 0.17444981634616852
dominant I-Disease 0 0.05828605592250824
condition I-Disease 1 0.9894043207168579
of O 0 0.16631272435188293
craniosynostosis B-Disease 1 0.9999903440475464
and O 0 8.617151365797326e-07
limb B-Disease 1 0.8589444756507874
anomalies I-Disease 0 0.12473071366548538
, O 0 3.797815839590157e-09
were O 0 6.676517116943614e-10
screened O 0 4.977984136012026e-10
for O 0 8.556461095210466e-11
mutations O 0 5.691567772636574e-10
in O 0 2.394119569260056e-09
TWIST O 0 7.736396696600423e-07
, O 0 1.5255758878396364e-09
FGFR2 O 0 1.2573437970786472e-06
, O 0 2.056331549482593e-09
and O 0 5.481250120453751e-09
FGFR3 O 0 6.578473403351381e-05
. O 0 6.250313617783831e-07

Nine O 0 3.718860455137474e-07
novel O 0 1.4157127026237504e-08
and O 0 8.755751124134292e-10
three O 0 4.709798107072061e-10
recurrent O 0 1.8001803425704566e-07
TWIST O 0 3.5801878084384953e-07
mutations O 0 6.079675096692938e-10
were O 0 3.3888547523730495e-10
found O 0 7.546572394767637e-11
in O 0 2.208941640713391e-10
12 O 0 2.1327895893819004e-08
families O 0 1.2744598709701904e-09
. O 0 1.0985722553868982e-07

Seven O 0 4.701581985955272e-07
families O 0 7.530156498347651e-10
were O 0 2.270631460632444e-09
found O 0 2.0311412274320872e-10
to O 0 3.3794547021903654e-11
have O 0 1.70680674455026e-11
the O 0 2.877565130621207e-10
FGFR3 O 0 1.9346832402789005e-07
P250R O 0 1.2030683116392993e-08
mutation O 0 1.4011726501284016e-10
, O 0 5.1808744794268335e-11
and O 0 3.679077181795165e-11
one O 0 1.2660561835020623e-11
individual O 0 4.260677314432693e-12
was O 0 5.3128736965391e-09
found O 0 9.755490165685998e-11
to O 0 3.5303347051263145e-11
have O 0 1.4345584616048956e-11
an O 0 6.227873078357149e-11
FGFR2 O 0 4.861815909862344e-07
VV269 O 0 3.5855592273037473e-07
- O 0 1.543451588759126e-07
270 O 0 7.325638762267772e-08
deletion O 0 2.9685079994123953e-07
. O 0 1.8206569052381383e-07

To O 0 1.0798436811398915e-08
date O 0 6.743226066419084e-08
, O 0 2.687127187428473e-10
our O 0 9.935460787424688e-11
detection O 0 3.071338294802217e-09
rate O 0 3.386541325145487e-10
for O 0 4.9156151371576584e-11
TWIST O 0 3.398904624418719e-08
or O 0 1.3356147299248278e-09
FGFR O 0 4.144401941630349e-07
mutations O 0 4.377222195817154e-10
is O 0 8.002087881209263e-11
68 O 0 2.7327993201708978e-09
% O 0 2.949234190197103e-10
in O 0 2.7593791140922974e-10
our O 0 9.80493375379865e-09
Saethre B-Disease 0 0.002358662895858288
- I-Disease 0 0.009838259778916836
Chotzen I-Disease 1 0.999794065952301
syndrome I-Disease 1 0.9999873638153076
patients O 0 7.671095758610136e-09
, O 0 9.905828934897443e-11
including O 0 2.264925191841627e-10
our O 0 5.1741544382366556e-09
five O 0 2.720385472443354e-09
patients O 0 1.2421760287040229e-09
elsewhere O 0 1.3770816709168798e-09
reported O 0 3.6696529148727564e-10
with O 0 4.751529725233183e-10
TWIST O 0 3.928344540327089e-06
mutations O 0 1.3798461395708728e-07
. O 0 1.4153367544622597e-07

More O 0 1.11714957284903e-08
than O 0 9.41978051116621e-10
35 O 0 3.5001668230449923e-09
different O 0 3.3451405534457024e-10
TWIST O 0 4.0963829661677664e-08
mutations O 0 1.848246694580169e-10
are O 0 8.704556173078082e-12
now O 0 2.1918382039909368e-11
known O 0 1.531478242833284e-11
in O 0 3.9015356917415644e-11
the O 0 3.257873693041091e-10
literature O 0 1.1978936065304424e-08
. O 0 3.221506617023806e-08

The O 0 5.516377754588575e-08
most O 0 3.4639957569027047e-10
common O 0 1.0076995488050855e-10
phenotypic O 0 6.1014948649074086e-09
features O 0 1.076400746313766e-09
, O 0 3.762669342766145e-11
present O 0 8.432662901292076e-11
in O 0 2.0468607364598768e-10
more O 0 1.3644756331754326e-11
than O 0 9.381078379389063e-12
a O 0 2.7015716053124805e-11
third O 0 2.2139061417458805e-10
of O 0 3.7037590772115436e-09
our O 0 4.580900547779265e-09
patients O 0 2.794469988742776e-09
with O 0 3.800719738933367e-10
TWIST O 0 1.0385278983449098e-06
mutations O 0 3.6698020178249635e-09
, O 0 2.588491365695944e-10
are O 0 7.829014520011057e-11
coronal B-Disease 0 3.511132149469631e-07
synostosis I-Disease 0 1.0265040373269585e-06
, O 0 6.5092327083959844e-09
brachycephaly B-Disease 0 2.258793983855867e-06
, O 0 2.009253385892862e-08
low B-Disease 0 0.00023937739024404436
frontal I-Disease 1 0.9999991655349731
hairline I-Disease 1 1.0
, O 0 1.1894412637047935e-05
facial B-Disease 1 0.9999982118606567
asymmetry I-Disease 1 0.9999940395355225
, O 0 3.8838416571707057e-07
ptosis B-Disease 0 9.892126399790868e-05
, O 0 4.057216429487198e-08
hypertelorism B-Disease 0 7.588630251120776e-05
, O 0 1.883588041096118e-08
broad B-Disease 0 6.574266535608331e-07
great I-Disease 0 0.0002772458828985691
toes I-Disease 0 0.0065116873010993
, O 0 1.684114536715242e-08
and O 0 2.9070653440044225e-08
clinodactyly B-Disease 0 5.575727118412033e-05
. O 0 1.0557952236922574e-06

Significant O 0 6.744485858689586e-07
intra O 0 6.109728565206751e-05
- O 0 2.5946560526790563e-06
and O 0 6.0351745823084e-09
interfamilial O 0 4.961093509336933e-07
phenotypic O 0 1.2279811016924214e-06
variability O 0 8.498746524310263e-07
is O 0 4.0197156714327775e-10
present O 0 6.747642028459566e-11
for O 0 1.2116543879336916e-10
either O 0 5.439040773325132e-09
TWIST O 0 1.4477016065939097e-06
mutations O 0 1.2786435021894249e-08
or O 0 1.0014407969549666e-08
FGFR O 0 1.498699657531688e-05
mutations O 0 4.091160406005656e-07
. O 0 2.5485823584858736e-07

The O 0 3.906045975554662e-08
overlap O 0 4.091479510748286e-08
in O 0 8.301170861813034e-10
clinical O 0 2.1902397673301266e-09
features O 0 4.744972748049747e-10
and O 0 7.550834263403416e-11
the O 0 9.370264286712171e-11
presence O 0 8.477107210635992e-11
, O 0 2.6089510760107792e-11
in O 0 1.8279678118404696e-11
the O 0 4.4279978989036906e-11
same O 0 8.21391288319262e-11
genes O 0 5.990178492121245e-11
, O 0 4.0191083100493685e-11
of O 0 4.424808852654394e-10
mutations O 0 2.1027354857316993e-10
for O 0 3.563200290379598e-10
more O 0 8.988910310536724e-11
than O 0 1.7758758352748316e-10
one O 0 2.5361701627701905e-10
craniosynostotic B-Disease 0 1.0809939254841083e-07
condition I-Disease 0 3.806494987657061e-06
- O 0 1.6841273264844858e-08
such O 0 4.1789738336461824e-10
as O 0 3.5306346735097804e-09
Saethre B-Disease 0 2.3995439732971136e-06
- I-Disease 0 1.6904262167827255e-07
Chotzen I-Disease 0 1.0804225212268648e-06
, I-Disease 0 2.833062007212561e-09
Crouzon I-Disease 0 7.337887950598088e-07
, I-Disease 0 3.642021351168978e-09
and I-Disease 0 8.652196292757708e-09
Pfeiffer I-Disease 0 0.0061456975527107716
syndromes I-Disease 0 0.00010891829879255965
- O 0 6.485873882411397e-07
support O 0 9.563345670926537e-09
the O 0 4.368952488675859e-08
hypothesis O 0 1.4301130057958744e-08
that O 0 3.455876904090438e-11
TWIST O 0 7.822007042079804e-09
and O 0 6.098103272345057e-11
FGFRs O 0 1.383207948180143e-08
are O 0 6.383128400844207e-12
components O 0 8.823851094241775e-10
of O 0 1.0643271819432698e-09
the O 0 1.6285227333323604e-10
same O 0 2.4088767092145247e-10
molecular O 0 5.761253696334734e-09
pathway O 0 7.081865094349382e-10
involved O 0 1.762237300528824e-10
in O 0 2.405046647946385e-11
the O 0 4.95083418705633e-11
modulation O 0 3.516315061347086e-08
of O 0 9.042502711054112e-07
craniofacial O 1 0.9999995231628418
and O 0 6.657691301370505e-06
limb O 1 0.9912300109863281
development O 0 1.4929294593457598e-05
in O 0 3.1321050641963666e-07
humans O 0 9.184991967003953e-08
. O 0 1.4645682444580643e-09
. O 0 2.0406725198540698e-08

Mutation O 0 1.9550533636447653e-08
analysis O 0 7.000216850627794e-09
of O 0 2.1837420760562054e-08
UBE3A O 1 0.9575939178466797
in O 0 0.030253103002905846
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.33948633074760437
. O 0 3.2069945063994965e-06

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.28035616874694824
AS B-Disease 1 1.0
) O 0 4.4516457187171454e-09
is O 0 1.9409140961101912e-10
caused O 0 7.392063072764188e-10
by O 0 9.459278499379664e-11
chromosome O 0 9.95129241232462e-08
15q11 O 0 3.026836736808036e-07
- O 0 2.1959214890898693e-08
q13 O 0 2.9583073768435497e-08
deletions O 0 2.2090143048103528e-09
of O 0 1.3132086529310527e-09
maternal O 0 3.2005713634930544e-09
origin O 0 3.973134599100092e-10
, O 0 2.8283727790401336e-11
by O 0 4.698965522242915e-11
paternal O 0 1.805139930866062e-07
uniparental B-Disease 0 0.0008459222153760493
disomy I-Disease 0 0.0009330635657534003
( O 0 6.365681315401162e-07
UPD B-Disease 1 0.9999974966049194
) O 0 1.297669882660557e-08
15 O 0 3.032415207826489e-08
, O 0 1.6829568294518538e-10
by O 0 1.9415434537872756e-10
imprinting O 0 0.0005376422195695341
defects O 1 0.9744325280189514
, O 0 3.398799464093827e-09
and O 0 4.875801429271576e-10
by O 0 1.6010136272281983e-10
mutations O 0 3.799446091079517e-09
in O 0 5.711112027739773e-09
the O 0 7.827980397223655e-08
UBE3A O 0 0.0004005467635579407
gene O 0 3.5698510600923328e-06
. O 0 1.1082877335866215e-06

UBE3A O 0 0.00015254312893375754
encodes O 0 4.0101713238982484e-07
a O 0 4.319914523875923e-07
ubiquitin O 0 7.80001130351593e-07
- O 0 3.413181559608347e-07
protein O 0 3.289703798259325e-08
ligase O 0 2.0267856726263744e-08
and O 0 2.4384261276821917e-09
shows O 0 2.9644361632108485e-08
brain O 0 3.0324785257107578e-05
- O 0 2.7991070794541884e-08
specific O 0 1.1367935925932215e-08
imprinting O 0 1.1626352716120891e-05
. O 0 7.124669991753763e-07

Here O 0 8.71256020218425e-07
we O 0 8.768357595556608e-09
describe O 0 3.24314619604138e-08
UBE3A O 0 6.933658823982114e-06
coding O 0 1.4970611118769739e-05
- O 0 6.94457071404031e-07
region O 0 5.781257783610272e-08
mutations O 0 2.4083222083248756e-09
detected O 0 1.5691289378949591e-09
by O 0 4.1698793723510263e-11
SSCP O 0 6.579184486099621e-08
analysis O 0 6.05809846732086e-10
in O 0 2.848122848675416e-10
13 O 0 3.6748399878661075e-08
AS B-Disease 1 0.9997020363807678
individuals O 0 4.0650902088934515e-10
or O 0 2.3096609069739316e-08
families O 0 9.660985345050221e-10
. O 0 6.248656347906945e-08

Two O 0 2.0573453696215438e-07
identical O 0 9.449787086168726e-08
de O 0 5.477345894178143e-06
novo O 0 1.8028174508799566e-06
5 O 0 1.6157300706254318e-06
- O 0 2.4199042059080966e-07
bp O 0 1.3434981838145177e-07
duplications O 0 2.944443338037672e-07
in O 0 3.6982619633363356e-08
exon O 0 8.36535832604568e-07
16 O 0 4.5275680804479634e-07
were O 0 2.4624414507457004e-08
found O 0 1.9113134186454772e-08
. O 0 7.220529596452252e-08

Among O 0 4.241184292652633e-09
the O 0 1.760017909191447e-09
other O 0 5.4897194429193164e-11
11 O 0 4.674046705233081e-10
unique O 0 4.119514451783601e-11
mutations O 0 5.4729498710770486e-11
, O 0 5.1725117244938446e-11
8 O 0 5.638968847421211e-09
were O 0 5.893736609863254e-10
small O 0 2.14913781215742e-10
deletions O 0 3.8383567435573696e-09
or O 0 2.2393078502602748e-09
insertions O 0 4.162820843589543e-08
predicted O 0 1.5315119128445076e-07
to O 0 4.66624605621746e-09
cause O 0 2.5529394065415545e-07
frameshifts O 0 6.250681508390699e-06
, O 0 5.527159618878841e-09
1 O 0 3.071416472266719e-07
was O 0 4.073484305422426e-08
a O 0 1.0486099766282564e-09
mutation O 0 4.3457251686085385e-11
to O 0 6.711138589299281e-11
a O 0 6.36492247796383e-10
stop O 0 6.195189361513087e-10
codon O 0 7.298644466580129e-10
, O 0 5.782762602102309e-10
1 O 0 5.280356063508407e-08
was O 0 6.204454194858045e-08
a O 0 6.589504497611642e-09
missense O 0 3.3036691604593216e-08
mutation O 0 7.040840133143433e-10
, O 0 6.856861189952212e-10
and O 0 1.450180642237342e-09
1 O 0 4.093541008387547e-07
was O 0 2.0696013791621226e-07
predicted O 0 2.8747813018981105e-08
to O 0 4.3835304830430744e-10
cause O 0 5.224771726375366e-09
insertion O 0 1.1966147184239162e-08
of O 0 6.31958911867514e-08
an O 0 2.670955900896388e-09
isoleucine O 0 2.5897638806782197e-06
in O 0 3.72005892756988e-08
the O 0 5.065377450819142e-08
hect O 0 1.4200743407855043e-06
domain O 0 1.0952707185651889e-07
of O 0 1.9405852924592182e-07
the O 0 5.898623101074918e-08
UBE3A O 0 1.3771178601018619e-05
protein O 0 6.01047887016648e-08
, O 0 1.408745620157248e-10
which O 0 7.522539882676149e-12
functions O 0 8.69218808041694e-10
in O 0 1.9509474036283336e-09
E2 O 0 2.7941629809902224e-07
binding O 0 6.590309187259891e-09
and O 0 4.442264778248273e-09
ubiquitin O 0 2.1508587622065534e-07
transfer O 0 1.4675632655780646e-06
. O 0 6.13906308899459e-07

Eight O 0 6.343150005250209e-08
of O 0 7.126204071283837e-09
the O 0 4.089275584817642e-10
cases O 0 1.8297546811041343e-10
were O 0 1.913000174935675e-10
familial O 0 8.19582979261213e-09
, O 0 2.9343311114260473e-10
and O 0 2.059612064231331e-10
five O 0 1.0935977678983022e-09
were O 0 4.095326744391059e-09
sporadic O 0 5.402668534770783e-07
. O 0 9.508838161309541e-08

In O 0 9.285341917575352e-08
two O 0 1.4341940079987126e-08
familial O 0 1.7746775711202645e-06
cases O 0 7.807906321488645e-09
and O 0 3.8615738384706333e-10
one O 0 2.4244473095791363e-10
sporadic O 0 3.520482394492319e-08
case O 0 6.568724231215128e-09
, O 0 1.9569727782720037e-10
mosaicism O 0 3.162253676691762e-07
for O 0 2.930652387433952e-09
UBE3A O 0 5.047062131779967e-06
mutations O 0 3.566044126657175e-09
was O 0 8.27455526319909e-09
detected O 0 2.3580364327813186e-09
in O 0 6.993483570028047e-11
the O 0 3.19192478004382e-10
mother O 0 2.279236133162499e-09
of O 0 2.2302511837324346e-08
three O 0 3.441772022938494e-08
AS B-Disease 1 1.0
sons O 0 1.7597471924091224e-06
, O 0 3.6607467057692133e-10
in O 0 5.163622862625061e-10
the O 0 2.9014193270171518e-09
maternal O 0 8.997411100608588e-07
grandfather O 0 2.2325507416098844e-06
of O 0 1.8317942931389553e-06
two O 0 1.6114539391764993e-07
AS B-Disease 1 1.0
first O 0 2.668409422312834e-07
cousins O 0 3.2098654401124804e-08
, O 0 3.63408109160801e-10
and O 0 2.2686608147637344e-10
in O 0 9.35578614580379e-10
the O 0 7.343486263522436e-09
mother O 0 2.3358794010164274e-08
of O 0 2.2016381251432904e-07
an O 0 1.041281993963139e-08
AS B-Disease 1 1.0
daughter O 1 0.9258378148078918
. O 0 2.6713814804679714e-05

The O 0 2.5064151643050536e-08
frequencies O 0 9.054946126241248e-09
with O 0 6.017569775806919e-11
which O 0 1.3963856113075046e-11
we O 0 1.6512988892936065e-11
detected O 0 6.856857442949504e-11
mutations O 0 1.3319068938033585e-11
were O 0 1.5985360257708692e-10
5 O 0 1.0219070034622746e-09
( O 0 4.645372628231392e-11
14 O 0 8.645857363376308e-10
% O 0 5.48554326962325e-11
) O 0 3.5826067806832285e-11
of O 0 1.4897841849048632e-09
35 O 0 7.214290942414436e-09
in O 0 4.749182713759126e-10
sporadic O 0 1.3666134002221497e-08
cases O 0 1.2264000925910068e-10
and O 0 8.367869591685562e-11
8 O 0 3.7661624929796744e-09
( O 0 9.664058442382384e-11
80 O 0 6.576719169260059e-10
% O 0 5.710615660903251e-11
) O 0 2.6610678938165933e-11
of O 0 1.6356649368276521e-09
10 O 0 5.737544661599259e-09
in O 0 1.1971893476570017e-09
familial O 0 1.568131153817376e-07
cases O 0 5.767564204006703e-09
. O 0 2.2050026249331722e-09
. O 0 2.72734865802704e-08

The O 0 6.392921477527125e-06
hemochromatosis B-Disease 1 1.0
845 O 0 6.8304998421808705e-06
G O 0 4.5192309698904864e-06
- O 0 1.110070613208336e-07
- O 0 1.2537258342604218e-08
> O 0 3.1647682252611276e-09
A O 0 1.205796795744618e-09
and O 0 2.2070538105434245e-11
187 O 0 2.2100794805357538e-10
C O 0 3.8467799612362796e-08
- O 0 4.673389675247108e-09
- O 0 4.404047793116206e-09
> O 0 4.040934697968623e-09
G O 0 1.7362689064270853e-08
mutations O 0 1.264232607489646e-10
: O 0 1.816120517861286e-11
prevalence O 0 5.354673371371632e-10
in O 0 2.0552011481544952e-10
non O 0 2.8172732413622725e-07
- O 0 2.8254368089619675e-07
Caucasian O 0 1.6357583376702678e-07
populations O 0 2.35696617778558e-09
. O 0 5.602981190122591e-08

Hemochromatosis B-Disease 1 0.9998689889907837
, O 0 1.4458996133726032e-07
the O 0 3.0721125767740887e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.806013981171418e-07
leads O 0 2.962210032819712e-07
, O 0 5.009398673649912e-09
if O 0 1.4516872681724635e-07
untreated O 1 0.9999836683273315
, O 0 2.6393749408271105e-09
to O 0 1.4146086968480631e-08
progressive O 1 0.9999998807907104
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.000441538606537506
premature B-Disease 0 0.0007969133439473808
death I-Disease 0 1.4042974726180546e-05
. O 0 5.580257607107342e-07

The O 0 2.847516407200601e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.545060963006108e-06
, O 0 8.56347739386365e-08
HFE O 0 3.993529389845207e-05
, O 0 7.405388302572646e-09
recently O 0 1.1486328332921403e-08
has O 0 6.603211727407299e-11
been O 0 6.2063867933837e-11
identified O 0 1.4052246866125273e-10
, O 0 2.4862327474561852e-11
and O 0 3.5910423940022085e-11
characterization O 0 3.4875253795974004e-09
of O 0 8.644476245933674e-09
this O 0 1.682937678104679e-10
gene O 0 1.0798266725231542e-09
has O 0 1.1776572772514982e-10
shown O 0 2.5228576172597883e-11
that O 0 8.146858838584126e-13
it O 0 1.9416404790396913e-13
contains O 0 4.8887006639034e-13
two O 0 9.570132230088402e-13
mutations O 0 2.2774596878522013e-12
that O 0 1.6030501578945255e-12
result O 0 7.378508221078661e-11
in O 0 1.7335669011409038e-10
amino O 0 2.5155231231366315e-09
acid O 0 2.357892547877327e-09
substitutions O 0 1.8249178834750523e-09
- O 0 1.0733051114542036e-09
cDNA O 0 1.2178853481259466e-09
nucleotides O 0 2.1047458220735393e-10
845 O 0 6.648588346536144e-09
G O 0 4.844214984700557e-08
- O 0 1.0259306293392001e-08
- O 0 1.481736067177053e-09
> O 0 1.241361347048553e-09
A O 0 1.127333448813772e-09
( O 0 1.3453495262272241e-11
C282Y O 0 1.907112662236088e-10
) O 0 4.081050601623115e-12
and O 0 8.23046925751969e-12
187 O 0 3.8424052828389677e-10
C O 0 2.161810819245602e-08
- O 0 4.097826966642515e-09
- O 0 3.8233047838787115e-09
> O 0 7.637416032935107e-09
G O 0 2.1630384594573115e-07
( O 0 2.638111507025087e-09
H63D O 0 1.9387423435546225e-06
) O 0 7.949217284419774e-09
. O 0 9.244855903034477e-08

Although O 0 4.210475162835792e-05
hemochromatosis B-Disease 1 1.0
is O 0 1.811034877619022e-08
common O 0 7.619766151378826e-09
in O 0 5.4023989726204036e-09
Caucasians O 0 3.2887626844058104e-08
, O 0 7.981529326350767e-10
affecting O 0 4.3462931031967855e-09
> O 0 6.178848099835932e-09
= O 0 4.960432953282634e-09
1 O 0 2.2148713085812233e-08
/ O 0 2.216133720978064e-09
300 O 0 1.1356482421120973e-10
individuals O 0 2.8766951928188567e-12
of O 0 2.0527174404705306e-10
northern O 0 2.546533539593554e-10
European O 0 4.802901409917126e-10
origin O 0 5.371387223895852e-10
, O 0 2.2071927618938503e-11
it O 0 2.5307460120582714e-12
has O 0 2.241081886039664e-12
not O 0 7.60846626587236e-13
been O 0 2.9109323458620384e-12
recognized O 0 1.4140967043163588e-11
in O 0 5.76594189061197e-11
other O 0 5.302976807675108e-11
populations O 0 1.3412942978519027e-10
. O 0 2.1261730154265024e-08

The O 0 5.8321042217812646e-08
present O 0 2.031754542386466e-09
study O 0 6.365696164634116e-11
used O 0 9.329261321799898e-12
PCR O 0 1.1111430525678756e-10
and O 0 8.933476354500147e-12
restriction O 0 1.5992678015219752e-10
- O 0 1.6012823012001576e-10
enzyme O 0 1.7267746260651862e-11
digestion O 0 5.619317788863043e-10
to O 0 2.9805727330689535e-11
analyze O 0 3.258482650370098e-10
the O 0 8.113743704685206e-11
frequency O 0 4.4344430349951836e-09
of O 0 2.383121699978119e-09
the O 0 9.751067731045282e-10
845 O 0 7.462416462544752e-09
G O 0 8.053393685258925e-08
- O 0 9.796073285883722e-09
- O 0 3.2667859528601184e-09
> O 0 9.923383226251303e-10
A O 0 5.906926059395801e-10
and O 0 1.7147882072632292e-11
187 O 0 1.0141164297206018e-10
C O 0 1.147119998989865e-08
- O 0 1.2209182553846176e-09
- O 0 7.407616742227674e-10
> O 0 8.163094644686453e-10
G O 0 4.66950433875013e-09
mutations O 0 9.510601334250524e-11
in O 0 2.5401641901012795e-10
HLA O 0 5.942400793657043e-09
- O 0 8.071254775643411e-10
typed O 0 3.064876130665084e-10
samples O 0 1.1611123174048998e-10
from O 0 2.6407231956682153e-10
non O 0 1.700239415924898e-08
- O 0 3.438312301540236e-09
Caucasian O 0 3.0169065023955e-09
populations O 0 2.7974148605197646e-12
, O 0 5.821245829124022e-12
comprising O 0 1.1021233405072994e-11
Australian O 0 7.378676836200526e-11
Aboriginal O 0 1.2726549813990573e-09
, O 0 4.7763695776303905e-11
Chinese O 0 4.4913531227486203e-10
, O 0 4.5495489320313e-11
and O 0 1.0412552070571124e-10
Pacific O 0 6.951522379949893e-08
Islanders O 0 9.595833034836687e-07
. O 0 6.141205943777095e-08

Results O 0 4.05420024662817e-07
showed O 0 9.449408366890566e-08
that O 0 1.505353480757421e-10
the O 0 1.4990478858223355e-09
845 O 0 2.6200204672477412e-08
G O 0 4.0069826923172513e-07
- O 0 7.840472449061053e-08
- O 0 1.0052587207098895e-08
> O 0 2.27856666867865e-09
A O 0 7.040518168466292e-10
mutation O 0 1.3699727983984555e-11
was O 0 2.5793442381960574e-10
present O 0 1.9340726936656338e-11
in O 0 7.881735195058859e-12
these O 0 1.4286215439807126e-12
populations O 0 2.297694911938819e-13
( O 0 4.3487639162474723e-13
allele O 0 3.8381680646237815e-12
frequency O 0 4.771254502600186e-10
0 O 0 3.139197790602566e-10
. O 0 1.033064779554227e-11
32 O 0 7.824629277841666e-10
% O 0 5.930313878854676e-11
) O 0 3.8112291100844686e-11
, O 0 4.8251378587105265e-11
and O 0 1.191043791370916e-10
, O 0 9.150095264809366e-11
furthermore O 0 9.123871658189842e-10
, O 0 3.746584986696888e-11
it O 0 1.006773050343801e-11
was O 0 5.4452065079146905e-09
always O 0 3.3324359938191606e-10
seen O 0 1.3285889055580924e-10
in O 0 1.5108409315289784e-11
conjunction O 0 5.814590475772263e-11
with O 0 9.708713000211588e-11
HLA O 0 1.3706706170069083e-07
haplotypes O 0 1.0460698973702165e-07
common O 0 7.140830149410249e-09
in O 0 5.9850684408502275e-09
Caucasians O 0 4.0668624023965094e-08
, O 0 3.8255129619635397e-10
suggesting O 0 1.0613674383819216e-09
that O 0 6.712329303493192e-11
845 O 0 6.385841189171515e-09
G O 0 5.388477006817993e-07
- O 0 2.3384474445720116e-07
- O 0 2.552566797930922e-07
> O 0 1.067442738644786e-07
A O 0 6.933129270692007e-08
may O 0 1.6268939528885085e-09
have O 0 7.688662206906116e-12
been O 0 3.1319998677892258e-12
introduced O 0 2.822098891380742e-12
into O 0 8.037016148085274e-13
these O 0 1.95551081295757e-13
populations O 0 1.4782410863965756e-13
by O 0 8.916452645668649e-12
Caucasian O 0 1.9456045663446275e-08
admixture O 0 5.076122988612042e-07
. O 0 6.924089461790572e-07

187 O 0 1.4455384871325805e-06
C O 0 5.658554528054083e-06
- O 0 1.4061140518606408e-07
- O 0 1.1615608919157694e-08
> O 0 4.986215440538899e-09
G O 0 3.621277144816304e-08
was O 0 7.385133393711385e-09
present O 0 3.1299426939135344e-10
at O 0 1.5301074851592489e-09
an O 0 6.451992586031796e-12
allele O 0 2.96851675185561e-11
frequency O 0 7.175659622049579e-09
of O 0 2.5727725727620054e-08
2 O 0 1.6955360706560896e-06
. O 0 1.351377818537003e-07

68 O 0 3.3824314868979855e-06
% O 0 1.2154122153162916e-08
in O 0 1.2359463452682462e-09
the O 0 3.7227099181080803e-10
two O 0 4.658149213576657e-11
populations O 0 7.084137963742076e-13
analyzed O 0 4.138210260573594e-11
( O 0 3.640064378390706e-12
Australian O 0 6.123301865557096e-11
Aboriginal O 0 3.2174013453456496e-10
and O 0 5.53700904570853e-11
Chinese O 0 1.4909837808829707e-09
) O 0 7.673023882937002e-10
. O 0 9.003795931050718e-09

In O 0 2.0638413644746834e-08
the O 0 1.485749079321863e-09
Australian O 0 2.6358835114592694e-09
Aboriginal O 0 3.2012531514524767e-10
samples O 0 3.9358499098751665e-11
, O 0 2.06774302541346e-11
187 O 0 3.5519226448954555e-10
C O 0 5.713370043736177e-08
- O 0 1.219945833241809e-08
- O 0 9.81204273386993e-09
> O 0 6.41046771221454e-09
G O 0 1.0430137820094387e-07
was O 0 1.821775086341404e-08
found O 0 1.4551615468150203e-10
to O 0 1.3974700736885115e-11
be O 0 6.728656260640564e-12
associated O 0 1.4028386785547298e-10
with O 0 3.4949865918010303e-11
HLA O 0 1.6837813632264442e-07
haplotypes O 0 1.5747086479223071e-07
common O 0 3.754745847572849e-08
in O 0 1.003465666116199e-08
Caucasians O 0 3.240759482991962e-08
, O 0 3.232533130059778e-10
suggesting O 0 5.205699760146842e-10
that O 0 2.3830906865918156e-12
it O 0 1.1124694915265465e-12
was O 0 9.251564098144982e-11
introduced O 0 1.0594348315295932e-11
by O 0 5.465550755034965e-12
recent O 0 1.21473428538188e-10
admixture O 0 3.9146005548218454e-08
. O 0 1.316736160106302e-07

In O 0 3.622893984811526e-08
the O 0 6.890873649467721e-09
Chinese O 0 9.8239483214968e-10
samples O 0 3.984812479984612e-11
analyzed O 0 1.642535829571301e-10
, O 0 3.2641292446733416e-11
187 O 0 3.576027529650361e-10
C O 0 3.385266111877172e-08
- O 0 3.980676233084068e-09
- O 0 2.7407074387753028e-09
> O 0 3.3246922992447026e-09
G O 0 3.5181262347805387e-08
was O 0 7.056950579453769e-09
present O 0 9.077490426001589e-10
in O 0 1.0202555467131447e-09
association O 0 3.615407417889571e-10
with O 0 3.115901633932161e-11
a O 0 3.5121491825940154e-10
wide O 0 3.8272207625311694e-10
variety O 0 5.273556591411932e-10
of O 0 1.5466836700284148e-08
HLA O 0 2.1297046259860508e-07
haplotypes O 0 7.75951107812034e-08
, O 0 2.604765569902412e-10
showing O 0 3.093566236511691e-10
this O 0 5.09237443879762e-12
mutation O 0 1.171616536427278e-11
to O 0 8.15776352719455e-12
be O 0 2.5375430923180176e-11
widespread O 0 7.119865114146862e-11
and O 0 4.5609654941713984e-11
likely O 0 1.6175301376097906e-10
to O 0 1.024621290590666e-10
predate O 0 1.1186677362218234e-08
the O 0 1.0070737577194677e-09
more O 0 5.6816940041670705e-11
genetically O 0 4.352535346030528e-11
restricted O 0 1.105349076158113e-10
845 O 0 6.827526988217869e-09
G O 0 2.7074955255557143e-07
- O 0 7.478264052451777e-08
- O 0 4.238679451873395e-08
> O 0 2.2634678131794317e-08
A O 0 1.3710517166032332e-08
mutation O 0 6.219095460835433e-09
. O 0 2.5131122072252765e-08

Genotype O 0 3.526152113408898e-06
- O 0 7.546798315161141e-07
phenotype O 0 2.2030615554058386e-08
correlations O 0 6.95243613790808e-07
in O 0 1.5387543328415632e-07
attenuated B-Disease 1 0.9985363483428955
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
coli I-Disease 1 0.9999936819076538
. O 0 6.095720891607925e-06

Germ O 1 0.98675936460495
- O 0 2.6242470994475298e-05
line O 0 1.9322510524943937e-07
mutations O 0 2.2869610649678407e-09
of O 0 3.885943566928063e-09
the O 0 1.0232332758874918e-09
tumor B-Disease 0 8.674772544736697e-08
suppressor O 0 5.675003649230348e-07
APC O 0 8.053793010276422e-08
are O 0 4.4549225419743266e-10
implicated O 0 3.828904766578489e-07
in O 0 4.988187356502749e-07
attenuated B-Disease 1 0.9999985694885254
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.0010242125717923045
AAPC B-Disease 1 1.0
) O 0 1.7616006431353526e-08
, O 0 4.0762784814241115e-10
a O 0 3.6579270168424216e-10
variant O 0 1.1718036603269866e-06
of O 1 0.6715133786201477
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.158222393220058e-06
FAP B-Disease 0 2.597788125058287e-06
) O 0 6.636605576204602e-08
. O 0 3.128105277028226e-07

AAPC B-Disease 1 0.9999996423721313
is O 0 5.546668191414028e-08
recognized O 0 2.6766320271320865e-09
by O 0 3.9183076921966986e-11
the O 0 8.597211137439942e-11
occurrence O 0 8.913979554492357e-10
of O 0 6.833129173600128e-09
< O 0 1.579776096605201e-07
100 O 0 2.3974292773232264e-08
colonic B-Disease 0 9.752840242072125e-07
adenomas I-Disease 0 4.7163251792881056e-07
and O 0 2.8711999444652747e-10
a O 0 5.194799590491073e-10
later O 0 1.688788309195388e-08
onset O 0 0.029057659208774567
of O 1 0.9999849796295166
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.460083183246752e-07
age O 0 2.1917750814282044e-07
> O 0 2.9183819805211897e-08
40 O 0 5.571720862462826e-09
years O 0 1.540520710996418e-09
) O 0 8.674003737496605e-10
. O 0 1.3512432062157131e-08

The O 0 2.7973083405186117e-08
aim O 0 3.467403431045568e-08
of O 0 4.825289945387112e-09
this O 0 1.952240799574234e-11
study O 0 8.242617005604913e-11
was O 0 3.615062693640425e-10
to O 0 2.2357974846509698e-11
assess O 0 6.711862177155581e-09
genotype O 0 7.144184621665772e-08
- O 0 7.59278435680244e-08
phenotype O 0 1.1256194198949743e-08
correlations O 0 5.838236347699421e-07
in O 0 1.979118593453677e-07
AAPC B-Disease 1 1.0
families O 0 3.40967680756421e-08
. O 0 1.8679412505662185e-07

By O 0 1.635656232679139e-08
protein O 0 7.172543092792694e-08
- O 0 2.8349662173354773e-08
truncation O 0 8.492591518916015e-08
test O 0 1.0427945618118883e-08
( O 0 4.461291336355089e-10
PTT O 0 4.435857903217766e-08
) O 0 9.114630578066496e-11
assay O 0 1.4263448200324547e-09
, O 0 6.811676916962384e-11
the O 0 1.0197257621635814e-10
entire O 0 2.6408200071159627e-09
coding O 0 1.5659492191844038e-07
region O 0 5.0635804882404045e-08
of O 0 4.074883364069137e-08
the O 0 8.084324321089298e-09
APC B-Disease 0 9.866504946387522e-09
gene O 0 2.290200029619882e-09
was O 0 1.040601027568755e-08
screened O 0 3.2525422355433875e-09
in O 0 1.960940715362014e-10
affected O 0 1.3134535126191338e-10
individuals O 0 2.123021203281894e-11
from O 0 1.2339684829498765e-08
11 O 0 3.410124008951243e-06
AAPC B-Disease 1 1.0
kindreds O 0 9.59661410888657e-05
, O 0 3.4795719638935907e-09
and O 0 1.7561004039823302e-10
their O 0 1.036017313604809e-10
phenotypic O 0 1.1918198197236052e-06
differences O 0 9.112312113757071e-07
were O 0 7.742022489765077e-08
examined O 0 1.279931439057691e-06
. O 0 9.493669494986534e-08

Five O 0 6.136686465652019e-07
novel O 0 2.1794443227918237e-07
germ O 0 6.035409387550317e-05
- O 0 6.915800554452289e-07
line O 0 1.2262626114534214e-07
APC B-Disease 0 2.4330057968313668e-08
mutations O 0 2.8714204347579653e-09
were O 0 4.5474951582136214e-10
identified O 0 5.763580168682836e-10
in O 0 8.963268460782103e-10
seven O 0 4.3723453302391135e-08
kindreds O 0 6.0265765569056384e-06
. O 0 7.974511504471593e-07

Mutations O 0 7.808505131379206e-08
were O 0 5.49247980430323e-09
located O 0 2.2535586730043633e-09
in O 0 7.243582816895966e-11
three O 0 9.892644863007671e-12
different O 0 6.986267467312679e-12
regions O 0 7.999310241979529e-11
of O 0 1.7771439875247097e-09
the O 0 2.016796951664901e-09
APC B-Disease 0 3.35505911941425e-09
gene O 0 1.4463961139909998e-09
( O 0 8.510452342846975e-10
1 O 0 4.594377855937637e-08
) O 0 1.4543791171384157e-10
at O 0 4.721961488485249e-09
the O 0 5.457452267876306e-10
5 O 0 4.2031094160677185e-09
end O 0 8.390315997530706e-09
spanning O 0 5.034016936633634e-08
exons O 0 1.3000060583578943e-08
4 O 0 2.6077511705580037e-08
and O 0 8.85801487715554e-10
5 O 0 8.309586796428903e-09
, O 0 1.7769466453820826e-10
( O 0 7.177089478282994e-11
2 O 0 3.767369527452047e-09
) O 0 4.558530289355822e-11
within O 0 2.1135850847286974e-09
exon O 0 1.720038511621169e-08
9 O 0 5.450799989148436e-08
, O 0 5.836616190357802e-10
and O 0 3.7021610777010494e-10
( O 0 2.7971081006938903e-10
3 O 0 8.106280091624285e-09
) O 0 1.118899209395785e-10
at O 0 1.1762577578622313e-08
the O 0 2.3264785653509534e-09
3 O 0 9.784816512592442e-08
distal O 0 3.338222427373694e-07
end O 0 1.1131725585755703e-07
of O 0 7.618476161042054e-08
the O 0 1.8297356518814922e-08
gene O 0 1.9342165558100533e-07
. O 0 2.8288528142184077e-07

Variability O 0 4.8278243411914445e-06
in O 0 5.845687933714316e-09
the O 0 9.089063945921794e-10
number O 0 1.9690298280750085e-09
of O 0 0.0009057385614141822
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.00013083302474115044
most O 0 6.049357681447987e-10
apparent O 0 1.311875053033873e-08
in O 0 1.8645876509459924e-10
individuals O 0 2.6875444144452976e-12
with O 0 3.227430475649662e-11
mutations O 0 4.3633599511316845e-10
in O 0 3.5501908079993427e-09
region O 0 6.53679364859272e-07
1 O 0 5.018376396037638e-05
, O 0 3.989988339725414e-09
and O 0 1.1270609334701476e-08
upper O 1 0.9999927282333374
- O 1 0.8997113108634949
gastrointestinal O 1 0.9998393058776855
manifestations O 0 0.19282710552215576
were O 0 9.419716917591359e-08
more O 0 8.245776977888752e-11
severe O 0 8.975231224894742e-09
in O 0 2.4631999218094336e-10
them O 0 2.5429416905531355e-10
. O 0 1.4149784455241843e-08

In O 0 2.500694407103765e-08
individuals O 0 1.2018194772700497e-10
with O 0 7.117882672158515e-11
mutations O 0 4.5620118793721076e-10
in O 0 1.0251907101022084e-09
either O 0 1.441431241033797e-08
region O 0 2.4701094503143395e-07
2 O 0 1.0804760677274317e-06
or O 0 4.2043919457057655e-09
region O 0 4.121076813135005e-08
3 O 0 2.7281082282115676e-08
, O 0 5.2346613155229704e-11
the O 0 4.335062170346404e-11
average O 0 8.574890103529853e-11
number O 0 1.7708766397728226e-10
of O 0 1.4634073508545953e-08
adenomas B-Disease 0 1.37226527385792e-06
tended O 0 1.2902853896434863e-08
to O 0 5.758394316934812e-10
be O 0 4.966612676682303e-10
lower O 0 1.8119747480227488e-08
than O 0 2.914350358262929e-11
those O 0 4.819598279498516e-12
in O 0 3.234924828010577e-11
individuals O 0 8.966144341739091e-13
with O 0 1.095993868577283e-11
mutations O 0 1.35313482640953e-10
in O 0 5.809382974675259e-10
region O 0 1.0651257653648827e-08
1 O 0 3.306644558165317e-08
, O 0 4.831482783296259e-11
although O 0 1.099625251965719e-10
age O 0 2.4914854623858673e-09
at O 0 1.83501995820734e-08
diagnosis O 0 4.590331315057483e-08
was O 0 1.6493025611907797e-08
similar O 0 7.627879661242787e-09
. O 0 1.2018028883176157e-07

In O 0 1.380342609991203e-06
all O 0 1.2585506965478999e-06
AAPC B-Disease 1 0.9999998807907104
kindreds O 0 1.2523808436526451e-05
, O 0 2.6385040818865946e-09
a O 0 4.103299644508951e-10
predominance O 0 5.512790934858458e-08
of O 0 6.019949978508521e-07
right O 1 0.9999783039093018
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999912977218628
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9990290403366089
sparing O 0 1.2228331343067111e-06
was O 0 2.844532502876973e-07
observed O 0 6.164206922676385e-08
. O 0 6.669534968750668e-08

No O 0 1.2541066098492593e-05
desmoid B-Disease 1 0.9795821905136108
tumors I-Disease 1 1.0
were O 0 9.569625802896553e-08
found O 0 8.49870840369249e-10
in O 0 2.738688997805383e-10
these O 0 5.462585939142173e-10
kindreds O 0 1.2832999800593825e-06
. O 0 9.510488041541976e-08

Our O 0 9.137917089674374e-08
data O 0 1.5340971160071604e-08
suggest O 0 1.970517526928006e-09
that O 0 1.766854197671197e-11
, O 0 5.617814893832396e-11
in O 0 2.4316080260433637e-09
AAPC B-Disease 1 0.9999998807907104
families O 0 1.418392486796094e-10
, O 0 2.5278527535088635e-11
the O 0 3.689153843522419e-11
location O 0 3.1309295156489725e-09
of O 0 6.245175487862298e-09
the O 0 9.084631713562885e-09
APC B-Disease 0 4.4703293156089785e-07
mutation O 0 4.3826737794461224e-08
may O 0 1.868598253906839e-08
partially O 0 6.26629699240766e-08
predict O 0 9.953148527586109e-09
specific O 0 1.5741800085677937e-09
phenotypic O 0 3.038074282812886e-06
expression O 0 1.0305433306712075e-06
. O 0 1.3693683058590977e-06

This O 0 2.5365306299818258e-08
should O 0 2.8247850725193757e-09
help O 0 1.012524397658865e-09
in O 0 2.690137279603988e-10
the O 0 2.3225490974887464e-10
design O 0 2.6488121918077923e-08
of O 0 1.779397074130884e-08
tailored O 0 5.9260005791372805e-09
clinical O 0 1.2224583656461618e-07
- O 0 5.6572826423462175e-09
management O 0 3.908056100954127e-09
protocols O 0 2.8384678785187134e-07
in O 0 2.1320716026007602e-10
this O 0 8.3298697800549e-12
subset O 0 1.569826491021331e-09
of O 0 5.261392654887231e-09
FAP B-Disease 0 2.4605071757832775e-08
patients O 0 5.926995338967345e-09
. O 0 2.208395022407217e-09
. O 0 4.368785866404323e-08

Wilms B-Disease 1 0.9955474138259888
' I-Disease 0 1.1641019227681682e-05
tumor I-Disease 0 3.2350089895771816e-06
1 O 0 4.477707079786342e-06
and O 0 2.3621746336743854e-08
Dax O 0 0.4274326264858246
- O 0 7.381263458228204e-07
1 O 0 7.938524504425004e-08
modulate O 0 7.774085375444884e-09
the O 0 3.768023670858156e-09
orphan O 0 1.4707667972402305e-08
nuclear O 0 8.71337704211328e-08
receptor O 0 8.027866149618035e-10
SF O 0 3.1931099897519744e-07
- O 0 2.3392766834717804e-08
1 O 0 1.8857017280993205e-08
in O 0 1.9567227005357068e-10
sex O 0 3.304926332603486e-10
- O 0 1.9169145437647472e-11
specific O 0 8.384160553320807e-12
gene O 0 2.892157624501124e-10
expression O 0 4.072884252082076e-09
. O 0 9.00220271660146e-08

Products O 0 1.6961702442586102e-07
of O 0 1.362619883593652e-07
steroidogenic O 0 3.828126409644028e-06
factor O 0 2.341951557127686e-07
1 O 0 1.1689674010995077e-06
( O 0 5.985342443892705e-09
SF O 0 1.9119097487418912e-06
- O 0 2.707162707338284e-07
1 O 0 2.2853647863030346e-07
) O 0 3.9636124937736383e-10
and O 0 8.279760210783138e-10
Wilms B-Disease 0 3.436778933973983e-05
tumor I-Disease 0 1.5298857078960282e-06
1 O 0 7.434938652295386e-06
( O 0 2.9029580961292822e-09
WT1 O 0 1.8392886147466925e-07
) O 0 3.990747454718502e-10
genes O 0 1.6977456940292512e-10
are O 0 1.3275546460744803e-11
essential O 0 3.743579612969228e-10
for O 0 1.2862863552065562e-10
mammalian O 0 2.1778603809252672e-08
gonadogenesis O 0 2.7597960183811665e-07
prior O 0 1.6096713295610243e-08
to O 0 1.5639867179118028e-09
sexual O 0 2.830470968717691e-08
differentiation O 0 1.6831775440095953e-07
. O 0 2.5082354682126606e-07

In O 0 7.225682452371984e-08
males O 0 7.4400610117209e-09
, O 0 7.041555782905107e-09
SF O 0 5.570805569732329e-06
- O 0 2.513654635549756e-07
1 O 0 9.687491342447174e-08
participates O 0 5.108645728668648e-10
in O 0 1.1608687622288727e-10
sexual O 0 2.6205226877351606e-10
development O 0 3.182100069554217e-11
by O 0 1.211845641196918e-11
regulating O 0 1.791558190689102e-08
expression O 0 2.0540344980446434e-09
of O 0 6.698459564802306e-09
the O 0 7.603215834706134e-09
polypeptide O 0 4.1550003970769467e-07
hormone O 0 3.058122999277657e-08
Mullerian O 0 3.326283319893264e-07
inhibiting O 0 1.2120328563014482e-07
substance O 0 1.994645799641148e-06
( O 0 2.5499481637325516e-08
MIS O 0 5.952379524387652e-06
) O 0 4.036152745356958e-08
. O 0 2.0164446823400795e-07

Here O 0 4.837580718231038e-07
, O 0 5.334349406638239e-09
we O 0 8.31892332797679e-10
show O 0 2.3278854399677584e-09
that O 0 2.3280707917017196e-10
WT1 O 0 7.258058758452535e-07
- O 0 3.723516215359268e-07
KTS O 0 1.5991094187484123e-05
isoforms O 0 5.855555684775027e-08
associate O 0 2.648974657404324e-07
and O 0 6.271995145468168e-10
synergize O 0 2.988188327890384e-07
with O 0 4.772040096412411e-09
SF O 0 0.0001335464185103774
- O 0 1.1517796565385652e-06
1 O 0 4.886196052211744e-07
to O 0 1.505753299824164e-09
promote O 0 5.595932250912483e-08
MIS O 0 2.171913547499571e-05
expression O 0 9.459757279728365e-07
. O 0 5.692668878509721e-07

In O 0 5.6603511211505975e-08
contrast O 0 1.3178467384022952e-07
, O 0 1.4223682676117733e-08
WT1 O 0 1.897017500596121e-05
missense O 0 8.206045549741248e-07
mutations O 0 3.856769126286963e-09
, O 0 1.9186895128253667e-10
associated O 0 3.506327672653242e-09
with O 0 1.6729659879644032e-09
male B-Disease 0 2.0876233975286596e-05
pseudohermaphroditism I-Disease 1 1.0
in O 0 7.14220805093646e-05
Denys B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.327000115405099e-07
fail O 0 1.0506344096938847e-06
to O 0 9.394378608362786e-09
synergize O 0 5.311272161634406e-06
with O 0 7.639939525461159e-08
SF O 1 0.9988277554512024
- O 0 0.0004922940279357135
1 O 0 9.595845767762512e-05
. O 0 1.998321295104688e-07

Additionally O 0 4.4751106997864554e-07
, O 0 8.267771356429421e-09
the O 0 2.568926849022546e-09
X O 0 2.8732805731124245e-05
- O 0 8.740672683416051e-07
linked O 0 9.100850917320713e-08
, O 0 1.612318473176444e-10
candidate O 0 7.362373488639662e-10
dosage O 0 7.61135936500068e-08
- O 0 6.321889678417847e-09
sensitive O 0 9.860563210395412e-08
sex O 0 9.077356644127121e-09
- O 0 8.277075691509594e-10
reversal O 0 1.877066946320838e-09
gene O 0 8.530815498453137e-10
, O 0 2.09077088975107e-09
Dax O 0 0.0003441424632910639
- O 0 5.080811433799681e-07
1 O 0 4.790669549947779e-07
, O 0 1.8057636497204044e-09
antagonizes O 0 5.027396454693189e-08
synergy O 0 9.61918118491667e-08
between O 0 4.073559125572501e-07
SF O 0 3.82804028049577e-05
- O 0 5.636863420477312e-07
1 O 0 1.5491643523546372e-07
and O 0 7.315048011768965e-10
WT1 O 0 3.4090987810486695e-07
, O 0 6.478326208814167e-10
most O 0 4.702103290066262e-11
likely O 0 7.371066951256111e-11
through O 0 2.343775000468451e-11
a O 0 7.274292279646488e-11
direct O 0 8.752942121104113e-11
interaction O 0 1.3768688411630592e-09
with O 0 1.9631984926604673e-09
SF O 0 0.0001079630310414359
- O 0 3.6405758692126255e-06
1 O 0 6.592420049855718e-06
. O 0 2.590672920632642e-07

We O 0 5.377686917995561e-08
propose O 0 6.658362394773576e-08
that O 0 1.3530401243855295e-09
WT1 O 0 1.8538357835495844e-06
and O 0 3.577231666440639e-08
Dax O 0 0.07559133321046829
- O 0 1.4867640629745438e-06
1 O 0 2.1433072561194422e-07
functionally O 0 9.385280996809797e-09
oppose O 0 3.818660387899797e-10
each O 0 8.377351763677598e-12
other O 0 5.231285023221677e-12
in O 0 1.4347007956660995e-11
testis O 0 3.832116846069766e-09
development O 0 6.859136592041182e-10
by O 0 3.855634700400401e-10
modulating O 0 3.330838467263675e-07
SF O 0 0.00046226431732065976
- O 0 1.6744737877161242e-05
1 O 0 6.0778140323236585e-05
- O 0 2.0528375443973346e-07
mediated O 0 6.229379323485773e-07
transactivation O 0 8.597676242061425e-06
. O 0 3.9013851704794433e-08
. O 0 1.6992433415907726e-07

A O 0 7.783752380419173e-07
mouse O 0 2.5213942933532962e-08
model O 0 2.0836376180000116e-08
for O 0 6.361239002217189e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999752044677734
centre O 1 0.9974253177642822
mutations O 0 3.5899909107683925e-06
. O 0 3.6683277926385927e-07

Imprinting O 0 2.9312043352547335e-06
in O 0 4.683510823610959e-08
the O 0 2.1334892963409402e-08
15q11 O 0 4.032844458379259e-07
- O 0 7.557008352421235e-09
q13 O 0 1.349934652949969e-08
region O 0 9.939483680554417e-10
involves O 0 5.004334724389992e-10
an O 0 6.291125953516996e-11
imprinting O 0 1.0680923168138179e-07
centre O 0 2.0061379473190755e-06
( O 0 1.5506853578983737e-09
IC O 0 2.0872978723218694e-07
) O 0 3.7660602414391064e-10
, O 0 5.552237836159435e-11
mapping O 0 1.1964040869116843e-09
in O 0 3.926097225104286e-10
part O 0 7.912637212115214e-10
to O 0 3.180487817555644e-10
the O 0 4.0338958839925e-09
promoter O 0 1.004615751298843e-05
and O 0 2.83481349505621e-09
first O 0 1.4238258572163431e-08
exon O 0 1.1453161050667404e-06
of O 0 1.2851027122451342e-06
SNRPN O 0 0.004769712220877409
. O 0 5.999911536491709e-06

Deletion O 0 9.512335736872046e-07
of O 0 6.308870581506199e-08
this O 0 8.413324481537643e-10
IC O 0 5.891561727366934e-07
abolishes O 0 1.4581908658328757e-07
local O 0 2.584185976317599e-09
paternally O 0 2.414988564680698e-08
derived O 0 1.2000878069073906e-10
gene O 0 1.5217477278284264e-10
expression O 0 1.1771945918059856e-10
and O 0 2.5958370869494374e-11
results O 0 3.9179431920999264e-10
in O 0 1.3034228629749123e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999988079071045
PWS B-Disease 1 1.0
) O 0 9.519464583718218e-06
. O 0 9.015585646920954e-07

We O 0 2.949293254062013e-08
have O 0 2.2648646846867848e-10
created O 0 2.9665822576241396e-10
two O 0 7.994368361741166e-11
deletion O 0 3.87795440204286e-09
mutations O 0 2.415254440890635e-09
in O 0 5.114751733259482e-09
mice O 0 4.116214213922831e-08
to O 0 5.861408247653799e-09
understand O 0 8.69946143211564e-06
PWS B-Disease 1 1.0
and O 0 6.468032776041355e-09
the O 0 8.399871354036748e-10
mechanism O 0 5.6656762836837515e-08
of O 0 6.82959733211419e-09
this O 0 3.105496415578557e-10
IC O 0 5.611265351035399e-06
. O 0 1.9106232684862334e-07

Mice O 0 5.4262072808342054e-06
harbouring O 0 3.6128856208961224e-06
an O 0 6.060644874850141e-09
intragenic O 0 1.0062602768812212e-06
deletion O 0 1.0742563461008103e-07
in O 0 8.550058439027453e-09
Snrpn O 0 4.406294920045184e-06
are O 0 6.346302927617842e-10
phenotypically O 0 1.2821415111829992e-06
normal O 0 2.1500426328202593e-07
, O 0 1.3024294143182402e-10
suggesting O 0 1.0439597103450993e-10
that O 0 9.724994247395369e-13
mutations O 0 1.8841312190986947e-11
of O 0 1.1391133591942548e-09
SNRPN O 0 4.111146267860022e-07
are O 0 7.787938349768098e-11
not O 0 2.5528397104568334e-11
sufficient O 0 3.1042899362176968e-09
to O 0 2.883005389975324e-09
induce O 0 2.9469820219674148e-06
PWS B-Disease 1 1.0
. O 0 3.096725049545057e-05

Mice O 0 2.4703263079572935e-07
with O 0 1.3557914790851555e-09
a O 0 2.533961707129606e-09
larger O 0 5.229873756285031e-10
deletion O 0 2.8395987783369492e-08
involving O 0 8.339261725609504e-09
both O 0 1.4439153206424749e-09
Snrpn O 0 5.217484613240231e-07
and O 0 1.3850420810257447e-09
the O 0 5.581463735637726e-09
putative O 0 8.617217304163205e-07
PWS O 1 0.9999995231628418
- O 0 1.399231905452325e-06
IC O 0 1.85462090485089e-06
lack O 0 1.630218271486683e-08
expression O 0 9.249451204951242e-10
of O 0 1.551235584429378e-09
the O 0 1.0132101824211759e-09
imprinted O 0 3.318977315203142e-09
genes O 0 1.2155646489375727e-09
Zfp127 O 0 2.1073894629353163e-07
( O 0 8.599085332683387e-10
mouse O 0 4.952274590408479e-09
homologue O 0 1.1368590691063218e-07
of O 0 1.0748773604518647e-07
ZNF127 O 0 5.884654456167482e-05
) O 0 2.8590930511995793e-08
, O 0 2.230987128370998e-08
Ndn O 0 2.88093474409834e-06
and O 0 2.7412145886529515e-09
Ipw O 0 1.6096611261673388e-06
, O 0 2.5730511055144234e-09
and O 0 2.2268016597326579e-10
manifest O 0 2.6735666125432545e-08
several O 0 9.54475276593314e-10
phenotypes O 0 8.778016535870847e-08
common O 0 4.96418337547766e-08
to O 0 6.912998173902452e-07
PWS B-Disease 1 1.0
infants O 1 0.9998675584793091
. O 0 6.24770154900034e-06

These O 0 3.2155134110922745e-09
data O 0 3.2878388900314803e-09
demonstrate O 0 5.456747054211064e-09
that O 0 2.6517451429119987e-11
both O 0 2.9716382132782826e-11
the O 0 1.5982737355813015e-10
position O 0 3.2921689818721234e-09
of O 0 9.89929915817811e-10
the O 0 3.045140251067835e-10
IC O 0 1.5328014413285018e-08
and O 0 4.0341379542452316e-11
its O 0 1.2673536699259191e-11
role O 0 2.469630888679575e-10
in O 0 5.013771342543549e-11
the O 0 2.627979257818769e-11
coordinate O 0 4.779370232910196e-10
expression O 0 1.244970126990097e-09
of O 0 1.084669776219016e-08
genes O 0 7.80971898262095e-10
is O 0 8.7109382207462e-11
conserved O 0 8.609100099477018e-09
between O 0 1.225875134736043e-08
mouse O 0 5.3229656238329426e-09
and O 0 1.5604698089255464e-10
human O 0 6.326844048665237e-10
, O 0 4.7086910759386313e-11
and O 0 2.4335172765788116e-11
indicate O 0 1.6250167877984723e-10
that O 0 1.2288978862295963e-11
the O 0 2.4103749551862563e-10
mouse O 0 1.0832799102189483e-09
is O 0 2.4408060642078233e-11
a O 0 5.35234183363098e-11
suitable O 0 4.6500203687571684e-10
model O 0 1.1338892047518812e-09
system O 0 9.532313605120635e-09
in O 0 4.720266399971251e-10
which O 0 1.544214062176863e-11
to O 0 1.1538835859026264e-11
investigate O 0 5.557739823913721e-10
the O 0 2.2939138435984496e-11
molecular O 0 2.023910594672884e-09
mechanisms O 0 5.972754024696769e-08
of O 0 1.763056189929557e-08
imprinting O 0 1.0604051681184501e-07
in O 0 5.377353562430187e-10
this O 0 3.059349648615317e-11
region O 0 1.5974853662115152e-09
of O 0 1.1411944722539147e-09
the O 0 5.931560798089208e-10
genome O 0 9.36553390396e-10
. O 0 2.9545113022777514e-09
. O 0 4.546935983285039e-08

Mutations O 0 1.1587587778194575e-07
of O 0 4.232603956211278e-08
the O 0 2.4768351813975187e-09
ATM O 0 2.216097385598914e-07
gene O 0 1.7521166739697946e-09
detected O 0 7.122589629204867e-09
in O 0 9.446409210411844e-10
Japanese O 1 0.9264169335365295
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0004932800075039268
: O 0 3.303962103906599e-10
possible O 0 1.942215055450447e-09
preponderance O 0 9.124138387051062e-07
of O 0 1.954468054066183e-08
the O 0 2.717367220128608e-09
two O 0 2.5603714703947844e-09
founder O 0 2.4008528498598025e-07
mutations O 0 4.046302404248081e-09
4612del165 O 0 2.0770536934833217e-07
and O 0 4.0123737221620104e-08
7883del5 O 0 4.5539327402366325e-06
. O 0 8.95985522220144e-07

The O 0 2.9570082915597595e-07
ATM O 0 5.056933150626719e-05
( O 0 2.4405831027252134e-06
A O 1 1.0
- O 1 0.9999432563781738
T O 1 0.9999997615814209
, O 0 9.673006839960863e-10
mutated O 0 8.701307036007577e-11
) O 0 2.473009297343509e-11
gene O 0 1.9104257065194474e-10
on O 0 2.2384194497959697e-09
human O 0 4.963972788374349e-09
chromosome O 0 6.866793569315632e-07
11q22 O 0 2.0608340491889976e-06
. O 0 2.915092238708894e-07

3 O 0 1.2198886906844564e-05
has O 0 1.8975601090431837e-09
recently O 0 8.520993910465791e-10
been O 0 3.303072051985545e-11
identified O 0 2.4111969365581132e-11
as O 0 4.621667631932169e-12
the O 0 8.487295068138057e-12
gene O 0 1.2168484969654614e-11
responsible O 0 8.733896939006058e-11
for O 0 3.706101397993322e-11
the O 0 3.741953857883118e-09
human O 1 0.9906833171844482
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999998807907104
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.09005598512158e-07
. O 0 2.7878121500179986e-07

In O 0 3.0214575730269644e-08
order O 0 3.626984934612665e-09
to O 0 9.209960571965325e-11
define O 0 1.2733833987255139e-09
the O 0 2.1844395736714262e-10
types O 0 6.2597722561008595e-09
of O 0 1.2709556074241846e-07
disease O 0 0.0001464492961531505
- O 0 5.10712148127368e-08
causing O 0 9.4816501317041e-09
ATM O 0 2.224554549457025e-07
mutations O 0 8.20552348290704e-10
in O 0 3.966494077634053e-10
Japanese O 0 1.008736126095755e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 1.4763648437110533e-07
as O 0 9.715460658199504e-10
well O 0 1.7599197099649189e-10
as O 0 1.7436876942333868e-10
to O 0 3.8983889033561425e-11
look O 0 1.0874819100781252e-10
for O 0 3.579041923940096e-11
possible O 0 6.419286213699138e-10
mutational O 0 3.323717479020161e-08
hotspots O 0 2.1265421423777298e-08
, O 0 6.275573394276535e-10
reverse O 0 6.268410679410863e-09
- O 0 4.4389953934853565e-09
transcribed O 0 3.024609895874164e-09
RNA O 0 1.4567451689373456e-09
derived O 0 2.2516501163583058e-10
from O 0 1.9287764441155986e-10
ten O 0 2.357230244331987e-10
patients O 0 6.814925707088193e-11
belonging O 0 3.396231351704415e-10
to O 0 1.1006660166623661e-10
eight O 0 4.219125049331751e-09
unrelated O 0 2.6841135536415095e-07
Japanese O 0 0.00030260623316280544
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
families O 0 3.1474536865694347e-10
was O 0 1.5242148654337484e-09
analyzed O 0 6.821766762588055e-11
for O 0 2.8110001305814425e-12
mutations O 0 6.448581360736505e-13
by O 0 5.669434106209126e-13
the O 0 1.033736984901168e-11
restriction O 0 1.725056902879274e-10
endonuclease O 0 2.0450159343710084e-09
fingerprinting O 0 1.748582079130756e-08
method O 0 5.2674703709953974e-08
. O 0 5.9539420504961527e-08

As O 0 9.249141896816582e-08
has O 0 1.0547922535408816e-09
been O 0 6.940198415961163e-11
reported O 0 3.296513756412267e-11
by O 0 3.510645116625022e-12
others O 0 3.913228768803734e-11
, O 0 1.3020464047219793e-11
mutations O 0 4.033430187067033e-11
that O 0 3.8257005202657623e-11
lead O 0 2.2674160327085247e-09
to O 0 4.023031241473518e-09
exon O 0 2.6770935619424563e-06
skipping O 0 1.4287014664660092e-06
or O 0 8.746562940586955e-08
premature O 0 2.623596628836822e-07
protein O 0 5.4458844545024476e-08
truncation O 0 4.172209457919962e-07
were O 0 1.2018436024163748e-08
also O 0 4.1284209384429005e-10
predominant O 0 1.3340421212149067e-08
in O 0 8.425111164278576e-10
our O 0 5.6319175989472114e-09
mutants O 0 8.789106686890591e-08
. O 0 5.6206207688092036e-08

Six O 0 2.971421508846106e-08
different O 0 2.8849128641539323e-10
mutations O 0 1.5904524919285734e-10
were O 0 7.796588374908708e-11
identified O 0 1.2664770621118038e-10
on O 0 1.3166396861663543e-09
12 O 0 2.2081085848668636e-09
of O 0 1.2264124160665801e-09
the O 0 1.612429967323692e-09
16 O 0 4.208197168509287e-08
alleles O 0 7.732558593431804e-09
examined O 0 1.8085517012877972e-06
. O 0 5.586898055298661e-07

Four O 0 2.1734518895755173e-07
were O 0 1.7531872842369012e-08
deletions O 0 2.9271845392031537e-08
involving O 0 8.29358199894159e-08
a O 0 7.724716866164272e-09
loss O 0 5.8304138406128914e-08
of O 0 5.196489496483991e-07
a O 0 2.836199364253389e-08
single O 0 3.2959386331299356e-09
exon O 0 1.7315717570909328e-07
exon O 0 1.6355618015495565e-07
7 O 0 1.49211032862695e-07
, O 0 6.881915926015836e-09
exon O 0 1.4946796511594584e-07
16 O 0 1.4191616060088563e-07
, O 0 1.186944764697273e-08
exon O 0 1.0212331744696712e-06
33 O 0 1.135814841290994e-06
or O 0 2.6194365432274935e-07
exon O 0 1.3408718587015755e-05
35 O 0 1.0046846909972373e-05
. O 0 2.4091377781587653e-06

The O 0 8.644398263868425e-08
others O 0 6.0958882386330515e-09
were O 0 1.8889836361779544e-09
minute O 0 2.684050093293422e-09
deletions O 0 3.7700417787611684e-10
, O 0 6.446239375623719e-11
4649delA O 0 3.2262212901201792e-09
in O 0 1.7693514431371682e-09
exon O 0 6.399670837708982e-08
33 O 0 5.149219717281994e-08
and O 0 1.9182113675242363e-09
7883del5 O 0 9.087563768161999e-08
in O 0 1.5687259491414807e-08
exon O 0 1.6702141465430032e-06
55 O 0 1.6484965499330428e-06
. O 0 5.484023972712748e-07

The O 0 9.264113742801783e-08
mutations O 0 8.254913197447422e-09
4612del165 O 0 6.151698528356064e-08
and O 0 2.988327363340204e-10
7883del5 O 0 1.0628225410869163e-08
were O 0 3.5854799684820193e-10
found O 0 7.209056962498295e-11
in O 0 2.7034170041462247e-11
more O 0 1.6619560545480527e-12
than O 0 1.1737004597389689e-12
two O 0 2.617817638009279e-12
unrelated O 0 8.715259069980164e-11
families O 0 6.627835758520051e-13
; O 0 2.4717441635124793e-12
44 O 0 1.6572855587870805e-10
% O 0 1.1465697835610911e-10
( O 0 8.048513938652135e-11
7 O 0 1.4157289562888309e-08
of O 0 2.2730853643793125e-08
16 O 0 3.1303102332458366e-08
) O 0 1.7242247907223174e-10
of O 0 8.878312529603249e-10
the O 0 1.2325393483614278e-10
mutant O 0 2.4787244479185233e-10
alleles O 0 6.728634316388593e-11
had O 0 8.644109317224036e-10
one O 0 4.283519372538791e-11
of O 0 2.1843146735811558e-10
the O 0 3.008664706261044e-10
two O 0 4.00870558969757e-10
mutations O 0 6.1048242017136545e-09
. O 0 7.526071499341924e-08

The O 0 5.549070181132265e-08
4612del165 O 0 2.239758032374084e-07
mutations O 0 7.366629528604562e-10
in O 0 8.581680505104217e-11
three O 0 3.67052638283738e-11
different O 0 2.4442722151851726e-11
families O 0 1.6204535976949153e-11
were O 0 1.2869390275671577e-10
all O 0 2.3079356134547702e-11
ascribed O 0 1.0517027249079547e-09
to O 0 3.203408024954335e-11
the O 0 3.3075372996016483e-10
same O 0 9.653769339479368e-09
T O 0 6.744139113834535e-07
- O 0 2.3650914116046806e-08
- O 0 6.539571550945311e-09
> O 0 6.679561348477137e-10
A O 0 2.7069990693462387e-10
substitution O 0 7.489230069435138e-11
at O 0 4.1033465514317413e-10
the O 0 5.2567734887265516e-11
splice O 0 9.237339226864094e-10
donor O 0 1.1982122238851645e-10
site O 0 3.1550764223453598e-09
in O 0 9.97888527365376e-09
intron O 0 1.5150444596656598e-05
33 O 0 2.6482739485800266e-05
. O 0 5.508935373654822e-06

Microsatellite O 0 9.158461034530774e-05
genotyping O 0 1.8431408534524962e-05
around O 0 1.4854599328373297e-07
the O 0 1.0975728770290516e-08
ATM O 0 5.81717245040636e-07
locus O 0 4.5880732102432376e-08
also O 0 1.4496329692192944e-09
indicated O 0 1.8586693295574719e-09
that O 0 1.740742792966099e-11
a O 0 2.5142074533412995e-10
common O 0 2.896435868926517e-10
haplotype O 0 2.7146077385964418e-08
was O 0 5.2076917000931644e-08
shared O 0 1.0639475966911505e-09
by O 0 2.2344291347731193e-11
the O 0 1.0390491245182432e-10
mutant O 0 1.4745973331287132e-09
alleles O 0 4.580688328648108e-10
in O 0 2.0546300216750524e-09
both O 0 1.229598467489268e-08
mutations O 0 1.6473730113375495e-07
. O 0 4.85969792407559e-07

This O 0 6.34163521695541e-09
suggests O 0 5.096424615658179e-09
that O 0 2.88410788307214e-11
these O 0 2.0872942263494565e-11
two O 0 1.9243226456744367e-10
founder O 0 3.201745002456846e-08
mutations O 0 1.6710461903102214e-09
may O 0 1.6305066186106387e-09
be O 0 4.514421891865794e-10
predominant O 0 5.854349538481074e-08
among O 0 1.7776041749684168e-10
Japanese O 0 6.209047143101998e-08
ATM O 0 7.425340982081252e-07
mutant O 0 9.58778585413711e-08
alleles O 0 7.272235791333514e-08
. O 0 2.8909784077768563e-07

W474C O 0 5.269548182695871e-06
amino O 0 1.0119904914063227e-07
acid O 0 1.4877064025142772e-08
substitution O 0 2.3120221293027043e-09
affects O 0 2.1920443238343523e-10
early O 0 3.300120177129884e-10
processing O 0 1.7572908683760602e-09
of O 0 5.836093275313203e-10
the O 0 2.7264146496008834e-10
alpha O 0 6.354930359719901e-09
- O 0 3.788249436365021e-10
subunit O 0 1.990762443782046e-09
of O 0 7.0629559978385714e-09
beta O 0 3.0069125500631344e-07
- O 0 4.413518439605468e-08
hexosaminidase O 0 4.394635055859908e-08
A O 0 3.2565459218147907e-09
and O 0 3.206005599887263e-11
is O 0 3.9404898614925354e-12
associated O 0 2.9006266832887206e-10
with O 0 7.49369177821535e-10
subacute O 0 0.0010456263553351164
G B-Disease 1 0.7512401938438416
( I-Disease 0 1.8113153998911002e-07
M2 I-Disease 0 1.5113904737518169e-05
) I-Disease 0 4.354244254045625e-08
gangliosidosis I-Disease 0 8.853191502566915e-06
. O 0 2.146846327377716e-07

Mutations O 0 3.865903508426527e-08
in O 0 5.635786060054215e-09
the O 0 1.5548918597119155e-08
HEXA O 0 7.89440889548132e-07
gene O 0 1.0687191132063845e-09
, O 0 7.714284766535684e-11
encoding O 0 5.032245731229068e-10
the O 0 1.4077954357816225e-09
alpha O 0 2.513131214243458e-08
- O 0 1.3544525501174576e-09
subunit O 0 2.7075890418615245e-09
of O 0 8.724848399310758e-09
beta O 0 4.466268137548468e-07
- O 0 9.994319327688572e-08
hexosaminidase O 0 5.158332783139485e-07
A O 0 1.3558586431372532e-07
( O 0 5.289997884183606e-10
Hex O 0 2.7234031918510482e-08
A O 0 1.362625923206906e-08
) O 0 8.64611715556407e-11
, O 0 2.8314278005536764e-11
that O 0 9.018839494667752e-12
abolish O 0 1.1537136579420348e-08
Hex O 0 1.9656798855294255e-08
A O 0 2.0256252231121152e-09
enzyme O 0 1.3185094127621255e-09
activity O 0 9.704208991934138e-08
cause O 1 0.9988571405410767
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.7825803979576449e-06
TSD B-Disease 0 0.01199729647487402
) O 0 3.266449555283657e-09
, O 0 5.197316466087898e-10
the O 0 4.390577679203034e-09
fatal O 0 7.05119309714064e-05
infantile B-Disease 0 1.084440100385109e-06
form I-Disease 0 3.193864728245899e-08
of I-Disease 0 0.006513482891023159
G I-Disease 0 0.4174302816390991
( I-Disease 0 2.011465838336335e-08
M2 I-Disease 0 3.2557531426391506e-07
) I-Disease 0 1.960803519551746e-09
gangliosidosis I-Disease 0 1.335205865871103e-07
, I-Disease 0 1.1389416076923453e-09
Type I-Disease 0 2.9539602763861694e-08
1 I-Disease 0 1.829189727686753e-06
. O 0 1.343544226983795e-07

Less O 0 8.470486136502586e-06
severe O 0 0.0010136546334251761
, O 0 1.6052187845616572e-07
subacute O 0 0.04588746279478073
( O 0 2.4314985580531356e-07
juvenile O 0 0.02966916188597679
- O 0 8.945417562244984e-07
onset O 0 0.00031969876727089286
) O 0 9.549364854422038e-09
and O 0 8.428815334582396e-08
chronic O 1 1.0
( O 0 6.59828600646506e-08
adult O 0 7.089533369253331e-07
- O 0 1.4189072317094542e-07
onset O 0 6.350201147142798e-07
) O 0 1.1745572570109886e-10
variants O 0 5.292268845380477e-10
are O 0 6.810452375660692e-12
characterized O 0 6.454876216865912e-11
by O 0 1.0158543277405396e-11
a O 0 3.2490801715745476e-10
broad O 0 1.6043035788726456e-09
spectrum O 0 7.405631663459644e-08
of O 0 1.9280268492849473e-09
clinical O 0 4.5046357755040844e-09
manifestations O 0 4.4505079621615096e-09
and O 0 6.414448833202968e-11
are O 0 1.4658543476264718e-12
associated O 0 4.352584959121941e-11
with O 0 9.077238960486511e-12
residual O 0 2.282592731717159e-06
levels O 0 1.7664409597273334e-06
of O 0 6.773220206923725e-07
Hex O 0 8.22136712486099e-07
A O 0 3.6433707606420285e-08
enzyme O 0 6.2351297458462795e-09
activity O 0 7.304807070340757e-08
. O 0 8.941744056301104e-08

We O 0 2.378455405960267e-07
identified O 0 6.25764968731346e-08
a O 0 1.971800678290947e-08
1422 O 0 2.4203645807574503e-06
G O 0 1.86797660717275e-06
- O 0 2.1571960928667977e-07
- O 0 3.834216855125305e-08
> O 0 7.989742201175432e-09
C O 0 1.5267461606072175e-07
( O 0 1.1004476496712101e-10
amino O 0 3.3578295699498995e-10
acid O 0 2.4952459543037264e-10
W474C O 0 6.330634350071307e-10
) O 0 4.8994380601186105e-12
substitution O 0 7.83878725818532e-11
in O 0 2.52687887974945e-11
the O 0 4.013439233729876e-11
first O 0 6.583995154629818e-11
position O 0 1.1167085922636488e-08
of O 0 1.875994115607682e-08
exon O 0 5.820102444431541e-08
13 O 0 6.538863317473442e-08
of O 0 1.9379849902634305e-07
HEXA O 0 0.0001256694959010929
of O 0 1.3313268709680415e-06
a O 0 9.982278470488382e-08
non O 0 1.4751882417840534e-06
- O 0 7.53284936649834e-08
Jewish O 0 4.790205565541328e-09
proband O 0 2.0158267943770625e-06
who O 0 3.0171598552897194e-09
manifested O 0 1.5334826741764118e-08
a O 0 6.617251635532284e-09
subacute O 0 5.444595672088326e-07
variant O 0 1.1966939439389535e-07
of O 0 1.1158759662066586e-05
G B-Disease 0 0.03946903720498085
( I-Disease 0 4.5669619197497013e-08
M2 I-Disease 0 5.963544936093967e-06
) I-Disease 0 6.279601905134768e-08
gangliosidosis I-Disease 0 1.0085418580274563e-05
. O 0 3.2192406251851935e-07

On O 0 1.3363999187276931e-06
the O 0 2.6441529854537293e-08
second O 0 7.938054835676667e-08
maternally O 0 5.202251713853911e-07
inherited O 0 5.507566811502329e-07
allele O 0 1.0675970329998563e-08
, O 0 2.835309487192461e-10
we O 0 5.0386205624475267e-11
identified O 0 9.334391593007751e-11
the O 0 2.898994932998278e-10
common O 0 2.3672718896250444e-07
infantile O 1 0.9988970756530762
disease O 1 0.9967725872993469
- O 0 5.683280051016482e-06
causing O 0 1.4469852430920582e-05
4 O 0 0.002954567549750209
- O 0 3.162186203553574e-06
bp O 0 1.005784611152194e-07
insertion O 0 5.750231402146255e-09
, O 0 7.453394013090531e-10
+ O 0 1.9417935703813782e-08
TATC O 0 3.1933705031406134e-06
1278 O 0 7.4733611654664855e-06
, O 0 3.34949024072273e-09
in O 0 3.3237919083717316e-09
exon O 0 5.948186867499317e-07
11 O 0 4.7462174279644387e-07
. O 0 2.1210497891388513e-07

Pulse O 0 0.0003367655735928565
- O 0 6.252871003198379e-07
chase O 0 1.4290631789037889e-08
analysis O 0 4.746421033985371e-10
using O 0 5.801653601977819e-10
proband O 0 6.990812551066483e-08
fibroblasts O 0 7.642705135424421e-09
revealed O 0 9.48950162893425e-09
that O 0 1.5090812280349475e-11
the O 0 8.857368311021574e-11
W474C O 0 1.0967937669192906e-09
- O 0 1.1485155881896247e-10
containing O 0 3.0789190641478115e-11
alpha O 0 1.4877169496330112e-09
- O 0 2.60140936569897e-10
subunit O 0 1.7865376955583656e-09
precursor O 0 1.3048725655551152e-08
was O 0 1.8426870695975595e-08
normally O 0 3.6024114247190653e-10
synthesized O 0 7.730578954756595e-10
, O 0 6.256435647333802e-11
but O 0 2.3768185336559e-11
not O 0 6.444674655048388e-12
phosphorylated O 0 2.69751054826628e-10
or O 0 2.449827840589336e-10
secreted O 0 1.944133742881604e-10
, O 0 1.0149136392412217e-10
and O 0 8.52025741626683e-11
the O 0 1.7991491629842926e-09
mature O 0 4.514874163419336e-08
lysosomal O 0 9.349349056719802e-06
alpha O 0 3.14759722641611e-06
- O 0 8.204623469509897e-08
subunit O 0 8.89802009851337e-08
was O 0 2.693673195608426e-07
not O 0 1.2967116269635426e-09
detected O 0 9.6615281108825e-08
. O 0 4.964230981840956e-08

When O 0 6.282333941953766e-08
the O 0 8.107022608783154e-09
W474C O 0 5.4710067587393496e-08
- O 0 3.1881906004116445e-09
containing O 0 3.281240834596133e-10
alpha O 0 1.2825221773482554e-08
- O 0 1.4087248034755362e-09
subunit O 0 2.1276781225765262e-08
was O 0 2.415019082491199e-07
transiently O 0 2.621615919906617e-07
co O 0 5.981361539397767e-08
- O 0 8.818971664048547e-10
expressed O 0 4.865264094378041e-11
with O 0 1.0878298262184671e-11
the O 0 1.477304806263291e-10
beta O 0 5.504182887250408e-09
- O 0 4.044355961241308e-10
subunit O 0 3.2635644187095636e-10
to O 0 9.140484202863064e-11
produce O 0 2.836845758302786e-10
Hex O 0 4.6169631673365075e-08
A O 0 4.231506167684529e-08
( O 0 2.570489099351647e-10
alphabeta O 0 1.7546559760717173e-08
) O 0 6.092433224580418e-10
in O 0 6.396397633778861e-09
COS O 0 2.5240480681532063e-05
- O 0 8.024725843824854e-07
7 O 0 1.0457068810865167e-07
cells O 0 4.755491556096558e-10
, O 0 1.645950875595048e-10
the O 0 3.424030781129517e-10
mature O 0 1.3483180127948913e-09
alpha O 0 3.879435794829078e-08
- O 0 1.0905191194510166e-09
subunit O 0 1.1659642140671167e-09
was O 0 1.2307763697094742e-08
present O 0 4.15054407509885e-10
, O 0 8.576541560278983e-11
but O 0 1.4361079166136381e-11
its O 0 7.686492935199407e-12
level O 0 1.0169376452040524e-08
was O 0 1.0396744798413238e-08
much O 0 1.0831538999056534e-09
lower O 0 5.254072288352063e-09
than O 0 2.631284599929895e-11
that O 0 2.2640331449885753e-12
from O 0 4.8490329807027166e-11
normal O 0 1.251192927043121e-09
alpha O 0 5.944022163362206e-09
- O 0 3.002124104867221e-10
subunit O 0 4.1416001184124696e-10
transfections O 0 8.782148341879292e-09
, O 0 4.4744891819492594e-11
although O 0 3.768142048388157e-11
higher O 0 2.611033333987933e-10
than O 0 6.161303672119756e-12
in O 0 1.4900554748398243e-11
those O 0 1.6144316786204094e-11
cells O 0 1.1838522349927327e-11
transfected O 0 5.168115935205719e-10
with O 0 7.954924045872058e-12
an O 0 2.098287342489069e-11
alpha O 0 3.151391325673103e-08
- O 0 6.328416457535013e-09
subunit O 0 2.3052509234844365e-08
associated O 0 2.786597406156943e-07
with O 0 8.77610730753986e-08
infantile O 1 0.8783382177352905
TSD B-Disease 0 0.07414732873439789
. O 0 4.764875484397635e-06

Furthermore O 0 8.908588711165066e-07
, O 0 5.024115345975133e-09
the O 0 1.026899232314804e-09
precursor O 0 6.339724745174635e-09
level O 0 1.691564044392635e-08
of O 0 7.3514323517542834e-09
the O 0 1.7058254808688389e-09
W474C O 0 1.119367798452231e-08
alpha O 0 1.9317603516810777e-08
- O 0 8.696532938223811e-10
subunit O 0 1.215393119480268e-09
was O 0 1.4204894149827396e-08
found O 0 9.872669348709451e-11
to O 0 2.5657413693647158e-11
accumulate O 0 3.844105866956937e-10
in O 0 1.347545963703567e-10
comparison O 0 3.168813267340198e-10
to O 0 2.2716831193925202e-10
the O 0 2.791188391526589e-09
normal O 0 4.759280614052841e-07
alpha O 0 1.2760507388520637e-06
- O 0 5.531011737502922e-08
subunit O 0 6.901846916207433e-08
precursor O 0 6.201768201208324e-07
levels O 0 2.89271866904528e-07
. O 0 1.7356040871163714e-07

We O 0 1.644105367404336e-07
conclude O 0 1.2440978025551885e-07
that O 0 1.9837644027465018e-10
the O 0 1.5166717881598402e-09
1422 O 0 1.2897744454676285e-06
G O 0 2.8192105219204677e-06
- O 0 2.5804990855249343e-07
- O 0 3.826436412168732e-08
> O 0 1.3320765823721104e-08
C O 0 2.3775845647833194e-07
mutation O 0 3.3451599823486333e-10
is O 0 1.5883296414220816e-11
the O 0 4.396297215158995e-11
cause O 0 2.3198760690235076e-09
of O 0 2.5615253917976588e-08
Hex B-Disease 0 3.741139153135009e-06
A I-Disease 0 2.7415790100349113e-05
enzyme I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 2.3694107653682295e-07
the O 0 1.1041579739412555e-07
proband O 0 3.9953654777491465e-05
. O 0 3.3171630775541416e-07

The O 0 3.475428300703243e-08
resulting O 0 8.94342910839896e-09
W474C O 0 5.7866966329811476e-08
substitution O 0 3.4923113290119545e-09
clearly O 0 8.578808774473146e-09
interferes O 0 4.144581122744739e-09
with O 0 2.1825488638604895e-10
alpha O 0 3.2145216266599164e-08
- O 0 1.6315675477329705e-09
subunit O 0 2.7937183677551047e-09
processing O 0 2.2857326698044744e-08
, O 0 1.5270744391226998e-10
but O 0 1.2759885162361151e-11
because O 0 9.278950871549618e-12
the O 0 5.084322199366831e-11
base O 0 2.966837053808291e-10
substitution O 0 1.6343987274680671e-09
falls O 0 2.2469672344982428e-08
at O 0 1.6159685145566982e-08
the O 0 3.973407436408394e-10
first O 0 3.4383368374690804e-10
position O 0 9.6564578555558e-09
of O 0 6.093600291023904e-08
exon O 0 3.216239576886437e-07
13 O 0 1.0174133535656438e-07
, O 0 5.3615227812997546e-09
aberrant O 0 2.9223478748008347e-08
splicing O 0 1.7187095124882035e-07
may O 0 4.06713382972157e-08
also O 0 1.2048221309512996e-09
contribute O 0 2.8936046891914202e-09
to O 0 5.966421579017833e-09
Hex B-Disease 0 1.975018676603213e-05
A I-Disease 0 1.894976412586402e-05
deficiency I-Disease 0 0.0009607266983948648
in O 0 1.6400267810467994e-08
this O 0 1.7902012094950237e-09
proband O 0 7.472074798897665e-07
. O 0 5.9220228720846535e-09
. O 0 4.215684512587359e-08

Two O 0 4.2049396853371945e-08
frequent O 0 1.5107950446235918e-07
missense O 0 6.1982364059076644e-06
mutations O 0 1.2089498113709851e-06
in O 0 3.891355390805984e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0006191110005602241

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.5744998904665408e-07
an O 0 2.9300386813702062e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9712970852851868
by O 0 2.395727394244318e-09
early O 0 0.011244842782616615
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999070167541504
goiter B-Disease 1 1.0
. O 1 0.9714704155921936

A O 0 4.4969550572204753e-07
century O 0 4.7765137622945986e-08
after O 0 8.931082540186708e-10
its O 0 6.213252568693095e-12
recognition O 0 3.416437133196837e-10
as O 0 1.3586208824634127e-09
a O 0 2.2261584575744564e-08
syndrome O 0 1.2971568708053383e-07
by O 0 1.3744594351550177e-10
Vaughan O 0 2.4420373279099294e-07
Pendred O 0 7.15421322183829e-07
, O 0 9.53958467775351e-10
the O 0 4.1608023693129326e-09
disease O 0 2.1321566237020306e-06
gene O 0 2.4306169521537413e-08
( O 0 2.15175273154955e-08
PDS O 0 2.306747774127871e-06
) O 0 1.881138356196743e-09
was O 0 2.429027468053846e-08
mapped O 0 2.2283919154375553e-09
to O 0 1.325246246075551e-09
chromosome O 0 6.337937747957767e-07
7q22 O 0 7.666997589694802e-06
- O 0 1.9070694179390557e-06
q31 O 0 3.951482540287543e-06
. O 0 4.155618569257058e-07

1 O 0 5.656666417053202e-06
and O 0 6.559209175804881e-09
, O 0 8.598724510200384e-10
recently O 0 2.3685571282072715e-09
, O 0 7.438222954236906e-11
found O 0 2.263887514952767e-11
to O 0 1.450107135064771e-11
encode O 0 1.658509996005364e-09
a O 0 1.4145196125525672e-08
putative O 0 1.0095552624989068e-06
sulfate O 0 0.0001155198915512301
transporter O 0 0.002214314416050911
. O 0 4.929894203087315e-06

We O 0 9.388861244019608e-09
performed O 0 6.338273905726055e-09
mutation O 0 2.088673262123919e-10
analysis O 0 1.749480976753759e-10
of O 0 1.0779787062986657e-09
the O 0 1.3259364717299604e-09
PDS B-Disease 0 4.0591365291220427e-07
gene O 0 2.069674653881748e-09
in O 0 1.8313581762186004e-09
patients O 0 1.0680343276447957e-09
from O 0 6.343180425361084e-10
14 O 0 8.564552622658539e-09
Pendred B-Disease 0 5.768997723976099e-08
families O 0 1.5638717751342845e-11
originating O 0 1.518735137651106e-10
from O 0 1.2999129550550492e-10
seven O 0 9.01825905619269e-11
countries O 0 7.441483193537657e-12
and O 0 3.633670447866777e-11
identified O 0 7.520740141764293e-10
all O 0 4.0974026949136544e-10
mutations O 0 1.8209584951023317e-08
. O 0 6.9700291760455e-08

The O 0 2.7108356448479753e-08
mutations O 0 2.075188909600456e-09
include O 0 1.0680037965116185e-09
three O 0 3.280358207291556e-10
single O 0 3.433474060621222e-10
base O 0 7.92387755410573e-09
deletions O 0 1.2276393235310934e-08
, O 0 9.288610991475821e-10
one O 0 1.944927413566333e-10
splice O 0 1.2924357584154222e-08
site O 0 1.3813300503429105e-09
mutation O 0 3.379095614430838e-10
and O 0 1.8969268378299375e-09
10 O 0 1.7798426199533424e-07
missense O 0 4.306860319047701e-06
mutations O 0 8.851704933476867e-07
. O 0 1.4848851606075186e-06

One O 0 1.868272647698177e-07
missense O 0 4.813246619050915e-07
mutation O 0 2.892633466089478e-09
( O 0 9.008945256461232e-10
L236P O 0 3.1967594793513854e-08
) O 0 3.6477826315106654e-10
was O 0 6.344091474375091e-09
found O 0 1.930925974669151e-10
in O 0 8.426553899099076e-11
a O 0 1.1836429059108866e-10
homozygous O 0 1.6982314166025247e-10
state O 0 1.3251166830485772e-10
in O 0 2.1554556750569276e-10
two O 0 4.801362640804996e-10
consanguineous O 0 3.463884183929622e-07
families O 0 2.3166458334999973e-11
and O 0 3.49450642034288e-11
in O 0 2.062229970123397e-10
a O 0 2.8128907536562053e-10
heterozygous O 0 1.1439593716744412e-10
state O 0 1.474374511367671e-10
in O 0 8.013573832288401e-11
five O 0 9.604684408914821e-11
additional O 0 4.893866978328276e-10
non O 0 1.3013986972509883e-06
- O 0 8.285505828098394e-06
consanguineous O 0 0.00023658110876567662
families O 0 3.639106438413364e-08
. O 0 4.3407283101259964e-07

Another O 0 9.678493597675697e-07
missense O 0 1.5740239405204193e-06
mutation O 0 3.8772811628007275e-09
( O 0 2.0279680157386792e-09
T416P O 0 6.641899119586014e-08
) O 0 3.2441449526743327e-10
was O 0 1.3491804118359596e-08
found O 0 2.7327196061577297e-10
in O 0 3.714948140776109e-11
a O 0 5.392448640395564e-11
homozygous O 0 6.713020417326021e-11
state O 0 1.083711315130742e-10
in O 0 2.0662853372765966e-10
one O 0 1.554563977546053e-10
family O 0 5.6314390650680224e-11
and O 0 3.08039947716221e-11
in O 0 1.7696948073631091e-10
a O 0 5.156093885183566e-10
heterozygous O 0 3.5519226448954555e-10
state O 0 9.154377256237467e-10
in O 0 1.1126408683281852e-09
four O 0 3.3532614462927768e-09
families O 0 5.715544149076379e-10
. O 0 2.8803356144635472e-08

Pendred B-Disease 0 0.00013924716040492058
patients O 0 9.306049975066344e-08
in O 0 2.125125853069676e-09
three O 0 1.1297895952111503e-09
non O 0 3.7634615068782296e-07
- O 0 6.032104238329339e-07
consanguineous O 0 1.550123306515161e-05
families O 0 1.2423626016833111e-10
were O 0 3.9784503469419974e-10
shown O 0 1.9606379020320475e-10
to O 0 2.4552901378704917e-11
be O 0 7.284024772236108e-11
compound O 0 2.2296502422136655e-09
heterozygotes O 0 7.1959718184189114e-09
for O 0 6.263423668606549e-10
L236P O 0 9.844627157917785e-08
and O 0 7.866472806483671e-09
T416P O 0 1.4998830693002674e-06
. O 0 1.8112876887244056e-07

In O 0 8.816726193572322e-08
total O 0 3.906282408649986e-09
, O 0 8.899607717438585e-10
one O 0 5.763665933411488e-11
or O 0 4.0384338234611405e-11
both O 0 2.7712452124739606e-11
of O 0 7.26204096856975e-10
these O 0 1.300076019061791e-11
mutations O 0 2.9030382264760846e-11
were O 0 7.874166596533172e-11
found O 0 3.6448736390193304e-11
in O 0 3.9682174213240273e-11
nine O 0 7.307420224478278e-10
of O 0 2.1946977568632065e-09
the O 0 2.7511404265823103e-09
14 O 0 9.411886736643282e-08
families O 0 1.5845599832253754e-10
analyzed O 0 8.467004164458558e-08
. O 0 1.776454467972144e-07

The O 0 4.920882812342597e-09
identification O 0 7.142941793603086e-09
of O 0 1.3475113469496591e-08
two O 0 1.3336520776618954e-09
frequent O 0 7.892789533059386e-09
PDS B-Disease 0 8.702445484232157e-07
mutations O 0 1.5982258849689401e-09
will O 0 5.200646163716627e-11
facilitate O 0 3.5431688694131935e-09
the O 0 2.2280390865603295e-09
molecular O 0 1.6923503380894545e-06
diagnosis O 0 0.0006999585893936455
of O 0 0.0013614108320325613
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00037135957973077893

Insertional O 0 8.349645213456824e-06
mutation O 0 1.0372045444739797e-08
by O 0 7.258911249863331e-10
transposable O 0 8.416071068495512e-06
element O 0 4.758522607062332e-07
, O 0 4.5924393177187994e-09
L1 O 0 2.226350943601574e-06
, O 0 9.455133342939348e-10
in O 0 1.7138972463470736e-09
the O 0 2.3901696621919655e-08
DMD B-Disease 1 0.9999998807907104
gene O 0 7.589045836198238e-09
results O 0 3.878671606116768e-09
in O 0 9.576853088333337e-09
X B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999988079071045
linked I-Disease 1 0.9999097585678101
dilated I-Disease 1 0.9999905824661255
cardiomyopathy I-Disease 1 1.0
. O 1 0.9504680037498474

X B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999997615814209
linked I-Disease 1 0.9999934434890747
dilated I-Disease 1 0.9999932050704956
cardiomyopathy I-Disease 1 1.0
( O 0 0.000367303699022159
XLDCM B-Disease 1 0.9739915132522583
) O 0 2.0641277576061157e-09
is O 0 1.9251339411496815e-10
a O 0 1.3587263258951765e-10
clinical O 0 3.929043312922431e-09
phenotype O 0 4.540243292439072e-09
of O 0 9.614705476224117e-08
dystrophinopathy B-Disease 0 4.573618298309157e-06
which O 0 2.351760453045415e-10
is O 0 8.965738741706364e-12
characterized O 0 3.075080814984865e-11
by O 0 4.5697404194022795e-12
preferential O 0 5.415948223230771e-08
myocardial B-Disease 0 0.04454721882939339
involvement I-Disease 0 2.954912581287772e-08
without O 0 7.381130706640704e-10
any O 0 1.5075400650044202e-10
overt O 0 5.772957223371122e-09
clinical O 0 1.9949789376028093e-08
signs O 0 1.4088954003455e-07
of O 0 0.0005003652186132967
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9991164803504944

To O 0 9.000345357890183e-09
date O 0 6.141182495866815e-08
, O 0 7.494502934912717e-11
several O 0 1.1283283335439265e-11
mutations O 0 1.9940143980434755e-10
in O 0 1.0580445408692185e-09
the O 0 7.512023148592561e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 2.5290697521995753e-05
, O 0 3.7354564028646564e-06
DMD O 1 1.0
, O 0 2.998960635380854e-09
have O 0 5.040674908723952e-12
been O 0 2.4648657680897967e-12
identified O 0 8.02527055226987e-12
in O 0 1.3653034432181688e-11
patients O 0 3.353027924757335e-11
with O 0 7.969704757249119e-11
XLDCM B-Disease 0 0.010616333223879337
, O 0 1.2417070704984212e-09
but O 0 6.925890416731306e-11
a O 0 3.049573440994102e-11
pathogenic O 0 7.948709745964067e-11
correlation O 0 4.015547061531066e-10
of O 0 4.767689021356603e-10
these O 0 4.877733633668058e-11
cardiospecific O 0 4.853037438579122e-08
mutations O 0 1.796662929542947e-09
in O 0 7.55862306078825e-09
DMD O 1 0.9999970197677612
with O 0 2.4368547180131372e-09
the O 0 2.257758957568967e-08
XLDCM B-Disease 0 1.6029338439693674e-05
phenotype O 0 2.1019596729843215e-08
has O 0 1.7668221330424672e-09
remained O 0 1.4371492795817176e-07
to O 0 9.015494462083495e-10
be O 0 2.808549837141072e-09
elucidated O 0 7.900978744146414e-06
. O 0 6.564630439243047e-07

We O 0 2.437385759890276e-08
report O 0 1.4279317728238539e-09
here O 0 2.0243882958848047e-10
the O 0 1.2813807306888414e-11
identification O 0 1.1000825250739865e-10
of O 0 1.318793518834127e-09
a O 0 7.641637322919337e-10
unique O 0 2.9800186762685144e-09
de O 0 2.8269425911275903e-06
novo O 0 2.0118284282943932e-06
L1 O 0 2.5759504751476925e-06
insertion O 0 1.6172533889857732e-07
in O 0 1.990433240450784e-08
the O 0 1.7279962349903144e-08
muscle O 0 1.3333479387256375e-07
exon O 0 2.7743070063479536e-07
1 O 0 4.665821222715749e-07
in O 0 1.5509701967175715e-08
DMD O 1 0.9999998807907104
in O 0 8.086791680739225e-09
three O 0 2.9073135010548867e-09
XLDCM B-Disease 0 2.011302512983093e-06
patients O 0 1.59808566380093e-09
from O 0 5.352324139451525e-10
two O 0 1.7733846335854508e-10
unrelated O 0 2.799801279707026e-08
Japanese O 0 7.500619858546997e-08
families O 0 4.775515538568698e-10
. O 0 1.945656791235706e-08

The O 0 1.2477980249059328e-07
insertion O 0 2.295642360650163e-07
was O 0 1.0241093377771904e-06
a O 0 1.49109826708127e-08
5 O 0 2.0803179623385404e-08
- O 0 8.03586308606441e-10
truncated O 0 6.162215182570208e-10
form O 0 2.4335974901923407e-10
of O 0 1.1046020098604004e-08
human O 0 5.593720153740378e-09
L1 O 0 1.4427217820411897e-07
inversely O 0 2.2929505405500095e-08
integrated O 0 1.5713011336515592e-08
in O 0 3.1001642919470385e-10
the O 0 7.280124836306356e-10
5 O 0 1.1597102833604822e-08
- O 0 4.213672522013212e-09
untranslated O 0 1.7585660998520325e-06
region O 0 9.494498520723482e-09
in O 0 5.947852210752558e-10
the O 0 7.454705297504916e-09
muscle O 0 5.114071655043517e-08
exon O 0 1.5692367583142186e-07
1 O 0 1.8588286820886424e-07
, O 0 1.676542793482838e-10
which O 0 6.776994763979527e-12
affected O 0 1.6343409264818476e-11
the O 0 5.096818106453682e-11
transcription O 0 8.974336274114592e-10
or O 0 3.7857939005903063e-10
the O 0 8.652835670197589e-10
stability O 0 9.81028506430448e-07
of O 0 1.2232665369538154e-07
the O 0 6.57363674605449e-09
muscle O 0 1.4145332016823886e-08
form O 0 6.546585940014893e-09
of O 0 9.03135060070781e-07
dystrophin O 0 8.810848157736473e-07
transcripts O 0 1.1522747911385522e-07
but O 0 9.512542836764837e-11
not O 0 6.6225692464672026e-12
that O 0 2.232877077679163e-12
of O 0 2.2470424132503553e-10
the O 0 2.861715753255112e-09
brain O 0 0.0001255557144759223
or O 0 1.3095267092921858e-07
Purkinje O 0 1.2653728845180012e-05
cell O 0 2.9446248390740948e-06
form O 0 8.874105361655893e-08
, O 0 2.652385200363483e-09
probably O 0 2.1890411705527413e-09
due O 0 4.495777528035205e-09
to O 0 7.993926354199488e-11
its O 0 4.022772132766805e-12
unique O 0 3.304773468770783e-11
site O 0 5.423168025764369e-10
of O 0 3.0678370954717593e-09
integration O 0 2.3999646714401024e-07
. O 0 7.142984941310715e-07

We O 0 2.6539660780144914e-07
speculate O 0 4.620548921252521e-08
that O 0 4.504158851448281e-11
this O 0 5.325516503479344e-12
insertion O 0 5.659546165048823e-10
of O 0 1.412017391899667e-09
an O 0 1.473545035990398e-10
L1 O 0 2.2934476362479472e-07
sequence O 0 6.2811329470946475e-09
in O 0 2.9831252135181785e-08
DMD O 1 1.0
is O 0 1.7247354655580693e-09
responsible O 0 8.6293333589893e-10
for O 0 2.4779383406281497e-11
some O 0 4.230932444670987e-12
of O 0 1.4020976046857925e-10
the O 0 3.7822262682896124e-11
population O 0 1.1208097167383912e-12
of O 0 3.6419081639316175e-10
Japanese O 0 5.350921128410846e-08
patients O 0 7.855733286099564e-10
with O 0 1.916491410014487e-10
XLDCM B-Disease 0 7.626568276464241e-06
. O 0 5.471901154407988e-09
. O 0 5.2706159436866074e-08

Severe O 0 0.0012958105653524399
early O 0 0.03263447433710098
- O 1 0.9997102618217468
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.1750933228759095e-05
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9998563528060913
red O 0 0.20505820214748383
hair O 1 0.5053703784942627
pigmentation O 0 0.046218618750572205
caused O 0 3.56743413476579e-07
by O 0 1.2983524255716361e-09
POMC O 0 8.538329711882398e-05
mutations O 0 2.749589000927699e-08
in O 0 6.257826701272506e-09
humans O 0 4.2597839922109415e-08
. O 0 3.778814416932619e-08

Sequential O 0 2.78134280051745e-06
cleavage O 0 1.2132128404118703e-06
of O 0 1.656832608887271e-07
the O 0 1.3726897840626862e-08
precursor O 0 4.887463234126699e-08
protein O 0 1.6114746870243835e-08
pre O 0 1.1158780353071052e-06
- O 0 6.312150730991561e-07
pro O 0 2.5551256840117276e-05
- O 0 1.1976510450040223e-06
opiomelanocortin O 0 1.2025266187265515e-06
( O 0 2.8853928135674778e-09
POMC O 0 2.270182903885143e-07
) O 0 1.9180054766643195e-10
generates O 0 1.1457871457176694e-10
the O 0 2.956273836840495e-10
melanocortin O 0 2.0314770665663673e-07
peptides O 0 9.201466255603918e-10
adrenocorticotrophin O 0 4.6508585427318394e-08
( O 0 3.149164817806138e-10
ACTH O 0 8.90732199110289e-09
) O 0 2.7506666389065515e-10
, O 0 9.677620926851205e-10
melanocyte O 0 5.657598194375169e-07
- O 0 9.746889872985776e-07
stimulating O 0 3.3462484338997456e-07
hormones O 0 3.1548314183282855e-08
( O 0 1.5461815161543768e-09
MSH O 0 1.605786934533171e-07
) O 0 4.0689068780963566e-10
alpha O 0 1.0142470863172548e-08
, O 0 9.949151918986487e-11
beta O 0 1.1164780211458947e-09
and O 0 4.862953789652735e-11
gamma O 0 3.097340606217358e-09
as O 0 8.051661420926948e-11
well O 0 1.9450972083001616e-11
as O 0 1.4192090211362363e-11
the O 0 8.713563204310049e-11
opioid O 0 5.6411550986013026e-08
- O 0 2.3727682929575167e-08
receptor O 0 2.7582753858723663e-09
ligand O 0 1.864212890723138e-07
beta O 0 1.8895030734711327e-05
- O 0 4.064585937157972e-06
endorphin O 0 8.84056953509571e-06
. O 0 2.469209903210867e-07

While O 0 1.254374524251034e-07
a O 0 5.248242729294361e-09
few O 0 1.386820380755438e-10
cases O 0 2.838177193265068e-10
of O 0 9.820880997324366e-09
isolated O 0 2.1708410713472404e-06
ACTH B-Disease 0 0.0006789121543988585
deficiency I-Disease 1 0.9971522092819214
have O 0 1.897719315024915e-09
been O 0 1.0461248534099354e-09
reported O 0 6.315245548726978e-10
( O 0 9.106759096821904e-11
OMIM O 0 1.0489549850944968e-07
201400 O 0 4.221018912176078e-08
) O 0 5.23754040138158e-10
, O 0 4.034878819947352e-10
an O 0 1.8245698285568324e-09
inherited O 1 0.999009370803833
POMC O 1 0.9999915361404419
defect O 1 0.9993983507156372
has O 0 4.1337671063956805e-08
not O 0 6.963724596964482e-10
been O 0 7.587016015442316e-10
described O 0 2.670517584846266e-09
so O 0 2.61207916407713e-10
far O 0 2.7070676811291605e-09
. O 0 7.743658159142797e-09

Recent O 0 6.097702343055289e-09
studies O 0 1.0019198803945528e-09
in O 0 2.035943080791469e-10
animal O 0 9.847430509912769e-11
models O 0 1.553301515189176e-10
elucidated O 0 4.22455457282922e-08
a O 0 8.287533437290051e-10
central O 0 4.071027959184903e-09
role O 0 2.5634105949023933e-09
of O 0 4.533790232130741e-08
alpha O 0 2.4420078261755407e-06
- O 0 1.9045960186758748e-07
MSH O 0 4.818527941097273e-07
in O 0 2.57668886227691e-10
the O 0 1.5202045178241974e-10
regulation O 0 3.277007998292447e-09
of O 0 6.002739416643976e-10
food O 0 1.0339248207591467e-10
intake O 0 1.8393729248056268e-11
by O 0 7.656258439736607e-13
activation O 0 6.608406599717398e-10
of O 0 1.7261186258110683e-08
the O 0 4.1931663474770176e-08
brain O 0 0.0001799886958906427
melanocortin O 0 3.057480716961436e-05
- O 0 6.511892820526555e-07
4 O 0 6.278901309997309e-07
- O 0 1.2545869232383211e-08
receptor O 0 4.4743209137720896e-10
( O 0 8.49413817061162e-10
MC4 O 0 1.0643153700584662e-06
- O 0 1.6678522740676271e-07
R O 0 5.494854917742487e-07
; O 0 1.1552809819903587e-09
refs O 0 1.4921288027380797e-07
3 O 0 4.274915355040321e-08
- O 0 1.0626192148421865e-09
5 O 0 4.191578750756264e-10
) O 0 4.212428583033612e-12
and O 0 6.813726666221598e-12
the O 0 6.264520152621245e-11
linkage O 0 3.7760692350730096e-08
of O 0 2.1706942021637587e-08
human O 0 6.69970120270591e-07
obesity B-Disease 1 0.9999998807907104
to O 0 2.084725947426591e-09
chromosome O 0 1.1683918899052514e-07
2 O 0 2.880078397993202e-07
in O 0 3.0467801614975087e-09
close O 0 8.942119222865585e-08
proximity O 0 5.314629447639163e-08
to O 0 3.4813112392839685e-09
the O 0 3.708659690460081e-08
POMC O 0 3.263439111833577e-06
locus O 0 1.196019638882717e-07
, O 0 5.499041666467974e-09
led O 0 2.3088493339429306e-09
to O 0 1.3527118314371478e-10
the O 0 2.8715013700164604e-10
proposal O 0 1.2436126572978878e-09
of O 0 2.10485495699686e-09
an O 0 3.6630518063240913e-10
association O 0 3.294537087583649e-09
of O 0 3.3758237805159297e-07
POMC O 0 0.003988658078014851
with O 0 3.9283941077883355e-07
human O 1 0.9988194108009338
obesity B-Disease 1 1.0
. O 0 2.1278392523527145e-05

The O 0 1.897195467392976e-08
dual O 0 8.143258867221448e-08
role O 0 9.638648634791025e-08
of O 0 3.9537187035421084e-07
alpha O 0 1.9057139070355333e-05
- O 0 1.2163478686488816e-06
MSH O 0 1.0214445865130983e-05
in O 0 6.099644789259173e-09
regulating O 0 3.4830668482754845e-07
food O 0 5.906624966911522e-09
intake O 0 4.475851245189233e-09
and O 0 1.1138873157179319e-09
influencing O 0 2.3392578896164196e-06
hair O 0 2.5228482627426274e-06
pigmentation O 0 4.4990838432568125e-06
predicts O 0 1.681707040290803e-08
that O 0 2.4356116082313584e-11
the O 0 2.0810303480445214e-10
phenotype O 0 7.688201186795141e-10
associated O 0 3.618893185119987e-09
with O 0 2.0922935606293436e-10
a O 0 1.0577363873665035e-08
defect O 0 3.1767081054567825e-07
in O 0 1.610620437020316e-08
POMC O 0 4.797084329766221e-06
function O 0 3.4157312711613486e-07
would O 0 5.0434905141116815e-09
include O 0 7.060750562004614e-08
obesity B-Disease 1 1.0
, O 0 3.118627800446916e-09
alteration O 0 3.92964830098208e-06
in O 0 2.494055024726549e-07
pigmentation O 1 0.9956204295158386
and O 0 6.4911614572338294e-06
ACTH B-Disease 1 0.7594849467277527
deficiency I-Disease 1 0.9999449253082275
. O 0 3.6501255635812413e-06

The O 0 5.337618702583313e-08
observation O 0 5.963618605164811e-06
of O 0 5.006115699757174e-08
these O 0 3.5824651578586497e-10
symptoms O 0 2.550958129177161e-07
in O 0 7.258800227560869e-10
two O 0 5.948703196700933e-10
probands O 0 1.5114838447516377e-07
prompted O 0 2.2064206017802235e-09
us O 0 2.781742614033078e-10
to O 0 5.283773418796045e-11
search O 0 9.56002166319081e-10
for O 0 2.7294377868969377e-10
mutations O 0 6.257169893331138e-09
within O 0 2.823623113101803e-08
their O 0 5.0047407995634785e-08
POMC O 0 0.00015745728160254657
genes O 0 1.2127709396736464e-06
. O 0 1.5040325251902686e-06

Patient O 0 7.2139810072258115e-06
1 O 0 7.5392408689367585e-06
was O 0 2.976025257339643e-07
found O 0 3.617311172821047e-10
to O 0 4.132215750130008e-11
be O 0 3.734484943507255e-11
a O 0 6.298354199296696e-11
compound O 0 1.2625223089202109e-09
heterozygote O 0 7.33373006767124e-09
for O 0 2.4619034588724276e-10
two O 0 1.4111391222204617e-10
mutations O 0 2.1908320990693397e-10
in O 0 2.8854589828597454e-09
exon O 0 2.1479461054241256e-07
3 O 0 2.1354848911414592e-07
( O 0 1.2221856859895297e-09
G7013T O 0 6.752067349680146e-08
, O 0 7.382425226687417e-10
C7133delta O 0 3.611075882758996e-08
) O 0 1.5794726637707868e-10
which O 0 9.268497427883382e-12
interfere O 0 3.5504327255964085e-10
with O 0 5.974577169803874e-12
appropriate O 0 3.5973027334712526e-10
synthesis O 0 4.48572201605657e-09
of O 0 2.0893486052386834e-08
ACTH O 0 2.8313792199696763e-07
and O 0 3.46815056673222e-08
alpha O 0 4.2674113501561806e-05
- O 0 2.588514871604275e-05
MSH O 0 0.0002542996371630579
. O 0 6.74109060128103e-07

Patient O 0 1.6516296454938129e-06
2 O 0 1.0234933824904147e-06
was O 0 3.053087738180693e-08
homozygous O 0 6.569648158816221e-10
for O 0 4.756459462407214e-11
a O 0 2.548204980357127e-10
mutation O 0 4.1778323855989896e-11
in O 0 1.1922581810708266e-09
exon O 0 1.8796264100728877e-07
2 O 0 5.789859187643742e-07
( O 0 3.523880076627961e-09
C3804A O 0 6.820839359988895e-08
) O 0 1.0096855573848984e-09
which O 0 2.0176127435433955e-09
abolishes O 0 1.0424444099044194e-06
POMC O 0 3.4284570574527606e-05
translation O 0 3.168513330820133e-06
. O 0 1.8431214812153485e-06

These O 0 4.512641815779261e-09
findings O 0 3.1687483748044087e-09
represent O 0 1.0961365148887126e-10
the O 0 5.0547243474197145e-11
first O 0 3.554482749801302e-11
examples O 0 2.5053417673781553e-10
of O 0 4.8900719029632e-09
a O 0 1.1259463406076975e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.294482899538707e-06
the O 0 6.145776154653504e-08
POMC O 0 3.3227779567823745e-06
gene O 0 6.280989062190656e-09
and O 0 3.5332467507309673e-10
define O 0 1.7304039090504375e-08
a O 0 2.770920382033637e-09
new O 0 6.293775101084975e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.999970555305481
resulting O 0 2.0217509444364623e-08
in O 0 1.983349262602019e-09
early O 0 1.542764402984176e-05
- O 0 0.14375261962413788
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 0 3.077377914451063e-05
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999604225158691
red O 1 0.640082836151123
hair O 0 0.025743260979652405
pigmentation O 0 0.0002778677153401077
. O 0 2.4144590327068727e-08
. O 0 1.2581040209624916e-07

A O 0 3.493139786314714e-07
European O 0 5.66071776120225e-08
multicenter O 0 4.505662218434736e-06
study O 0 1.5701955291547165e-08
of O 0 1.2320820133027155e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 1.17364908902573e-08
classification O 0 4.1998099220563745e-08
of O 0 6.648895123362308e-08
105 O 0 2.090317821057397e-07
mutations O 0 9.602015849097256e-10
and O 0 2.9005767232526125e-10
a O 0 1.9362994541083367e-10
general O 0 4.3746600786320755e-10
system O 0 1.583932207616101e-09
for O 0 4.882707016484744e-10
genotype O 0 7.589118666828654e-09
- O 0 4.329934633062749e-09
based O 0 6.124730167478276e-10
prediction O 0 3.698184514178138e-08
of O 0 4.2835914371153194e-08
metabolic O 0 0.0004504422249738127
phenotype O 0 4.932330170959176e-07
. O 0 5.180773996471544e-07

Phenylketonuria B-Disease 0 0.0026839894708245993
( O 0 1.0114788437931566e-06
PKU B-Disease 0 6.588311225641519e-05
) O 0 3.714967533596791e-08
and O 0 2.3378582625355193e-08
mild B-Disease 0 0.09742391854524612
hyperphenylalaninemia I-Disease 1 1.0
( O 0 2.78077077382477e-05
MHP B-Disease 1 1.0
) O 0 6.041704914139245e-09
are O 0 2.0004752021574035e-10
allelic B-Disease 0 1.1161910151713528e-05
disorders I-Disease 1 0.9999451637268066
caused O 0 2.0738879058512794e-08
by O 0 6.342088659794243e-11
mutations O 0 2.3212382016524202e-10
in O 0 2.6089225224623647e-10
the O 0 7.567029225441502e-10
gene O 0 3.5119567254326967e-09
encoding O 0 1.3581686175712093e-07
phenylalanine O 0 6.8068361542827915e-06
hydroxylase O 0 0.00013505791139323264
( O 0 4.665630228828377e-07
PAH O 0 0.000602245912887156
) O 0 1.1592256896619801e-06
. O 0 2.6409381916892016e-06

Previous O 0 4.999807856620464e-07
studies O 0 1.198761339082921e-07
have O 0 2.68345984322238e-10
suggested O 0 5.547371451086747e-10
that O 0 5.826885740405074e-13
the O 0 1.1091753383818403e-11
highly O 0 7.878601659960793e-10
variable O 0 9.943551049218513e-08
metabolic O 0 0.0003395381791051477
phenotypes O 0 3.1194497296382906e-06
of O 0 0.0005701539921574295
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999927282333374
correlate O 0 3.525625288602896e-05
with O 0 3.846989329758799e-06
PAH O 1 0.999929666519165
genotypes O 0 0.000592973839957267
. O 0 5.1442807489365805e-06

We O 0 1.2965516660301546e-08
identified O 0 2.5336377440510205e-09
both O 0 3.173894203012395e-10
causative O 0 1.592232656832948e-08
mutations O 0 6.897576398934291e-10
in O 0 1.848473152321617e-09
686 O 0 1.750705393988028e-07
patients O 0 4.5788411284775066e-08
from O 0 1.649632963562908e-08
seven O 0 2.305000457170081e-08
European O 0 9.731083849828792e-08
centers O 0 5.126401561028615e-07
. O 0 1.8454538519563357e-07

On O 0 1.8839244830815005e-07
the O 0 2.3905695201165145e-09
basis O 0 6.350217240935763e-09
of O 0 4.213043802714367e-10
the O 0 3.017456076670477e-11
phenotypic O 0 8.952167007691969e-09
characteristics O 0 3.6927267910158434e-09
of O 0 2.357336192915227e-08
297 O 0 3.909653401024116e-08
functionally O 0 3.3149746059280005e-07
hemizygous O 0 1.2267942111066077e-06
patients O 0 5.326764362934e-09
, O 0 3.9358818981760635e-10
105 O 0 8.58999182895559e-09
of O 0 4.074244053242637e-09
the O 0 2.019029388122817e-09
mutations O 0 5.571038075302681e-10
were O 0 7.295290482822736e-10
assigned O 0 1.7108565675272303e-09
to O 0 1.63235425176822e-10
one O 0 1.1242343861406212e-10
of O 0 1.985158482042948e-09
four O 0 6.938957741731144e-10
arbitrary O 0 4.035481282471665e-09
phenotype O 0 6.719009792988118e-09
categories O 0 1.426633104983921e-07
. O 0 3.2105396030601696e-07

We O 0 2.0064998551561075e-08
proposed O 0 8.717960575665984e-09
and O 0 2.7742505515071514e-10
tested O 0 1.1132330612895203e-09
a O 0 5.522454368800389e-11
simple O 0 2.4775698853618522e-11
model O 0 3.129630929410432e-11
for O 0 8.545285139216485e-12
correlation O 0 3.588079555694179e-10
between O 0 5.6291038497136014e-09
genotype O 0 7.707527061029396e-09
and O 0 5.644109624114435e-10
phenotypic O 0 5.576273451879388e-07
outcome O 0 1.982432877412066e-06
. O 0 5.275343255561893e-07

The O 0 6.473502622839078e-08
observed O 0 2.5810003023707395e-08
phenotype O 0 1.4960430672061875e-09
matched O 0 3.412349069975562e-09
the O 0 2.7696561710754963e-10
predicted O 0 1.9012518226446673e-09
phenotype O 0 1.5173191869610747e-10
in O 0 1.6596547747216306e-10
79 O 0 4.444163259620382e-09
% O 0 3.1775287956392617e-10
of O 0 4.4963779366469225e-09
the O 0 7.995012984984839e-10
cases O 0 2.551667765970933e-10
, O 0 1.244024241259245e-11
and O 0 1.1439391968404156e-11
in O 0 5.60937754578994e-11
only O 0 2.02443339869518e-11
5 O 0 1.4081605881344217e-09
of O 0 4.872902970021187e-09
184 O 0 5.321199481045369e-09
patients O 0 1.0706103781288334e-09
was O 0 4.2393564214648904e-09
the O 0 2.528625364650594e-10
observed O 0 1.1137470945499217e-09
phenotype O 0 3.9264622803125704e-11
more O 0 3.916123935548965e-12
than O 0 4.507946967102772e-12
one O 0 2.590291479573348e-12
category O 0 7.332267432103023e-11
away O 0 2.3853033437326587e-10
from O 0 2.7800242663467145e-10
that O 0 3.706228726696459e-11
expected O 0 1.1874226046870717e-08
. O 0 5.140936920611239e-08

Among O 0 6.361114746056273e-09
the O 0 2.017143119203979e-09
seven O 0 9.679578250043619e-10
contributing O 0 2.739154181252701e-10
centers O 0 1.95945273895326e-10
, O 0 5.5248743947855505e-12
the O 0 7.463658163731068e-12
proportion O 0 1.44917605693351e-10
of O 0 5.103934164196744e-09
patients O 0 8.363246761788901e-10
for O 0 4.771309458639905e-10
whom O 0 1.7453855027937948e-09
the O 0 4.137186426778072e-10
observed O 0 1.079645373103233e-09
phenotype O 0 7.416958019978992e-11
did O 0 6.709794525550095e-11
not O 0 4.537223895206832e-12
match O 0 3.3159638923585533e-10
the O 0 3.369157383636967e-11
predicted O 0 1.1088459317409871e-10
phenotype O 0 1.7390967138597446e-11
was O 0 1.29116606295554e-09
4 O 0 3.07522474152222e-09
% O 0 3.822945571219094e-10
- O 0 3.2605920186057347e-09
23 O 0 2.5808429171547687e-08
% O 0 3.941247328498321e-09
( O 0 4.538823095145972e-09
P O 0 3.370256990820053e-06
< O 0 6.67364545847704e-08
. O 0 7.308466054567475e-10
0001 O 0 1.1708965530488058e-06
) O 0 6.074911129694271e-10
, O 0 6.558552312352361e-11
suggesting O 0 1.2989562203635785e-10
that O 0 1.9277741295647965e-12
differences O 0 2.6009430720286275e-10
in O 0 2.8004699254013943e-11
methods O 0 3.4536776216675946e-10
used O 0 2.310080425560468e-11
for O 0 1.3360898325209813e-11
mutation O 0 5.715584949772534e-11
detection O 0 1.2405312332930407e-08
or O 0 6.368274241275174e-10
phenotype O 0 1.9184454025378272e-09
classification O 0 2.953339128808352e-09
may O 0 8.018959940514492e-10
account O 0 2.4080393928871402e-11
for O 0 2.6570204370024442e-11
a O 0 4.9339320823404975e-11
considerable O 0 2.0988326354665077e-10
proportion O 0 4.6193809888350756e-10
of O 0 1.3959191136336813e-08
genotype O 0 7.113372930689366e-07
- O 0 1.2146518884037505e-06
phenotype O 0 3.876713705608381e-08
inconsistencies O 0 3.967932684645348e-07
. O 0 1.4102462841947272e-07

Our O 0 9.45885787473344e-08
data O 0 1.9559260877599627e-08
indicate O 0 4.788780483266919e-09
that O 0 9.718495452837317e-11
the O 0 3.4399521009476075e-09
PAH O 0 2.449488965794444e-05
- O 0 2.039190718505779e-07
mutation O 0 6.378193528888687e-10
genotype O 0 3.0412934393098112e-09
is O 0 3.176854612707558e-11
the O 0 5.174682557451682e-11
main O 0 1.0902030389559059e-09
determinant O 0 3.264183945361765e-08
of O 0 2.0259353306073535e-08
metabolic O 0 2.700455479498487e-05
phenotype O 0 9.911508058735308e-09
in O 0 2.0898975883199e-09
most O 0 3.239200463411862e-09
patients O 0 1.6035251348966995e-07
with O 0 2.396502623014385e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9778187274932861

In O 0 4.040597190169137e-08
the O 0 1.3244351171337598e-09
present O 0 3.1955676993433713e-10
study O 0 4.05634345557182e-11
, O 0 3.329262429976887e-12
the O 0 6.608021855397661e-12
classification O 0 4.3793269011160874e-10
of O 0 2.971755996838965e-08
105 O 0 7.003463906585239e-06
PAH O 0 0.002266703872010112
mutations O 0 3.855182484358011e-08
may O 0 6.3610663403324e-09
allow O 0 3.006003224115261e-10
the O 0 6.241968608655668e-10
prediction O 0 1.0485945445282141e-08
of O 0 2.7079198883228628e-09
the O 0 1.0107299441841633e-09
biochemical O 0 1.2526978565574609e-08
phenotype O 0 7.182762717938829e-10
in O 0 1.1528376031577636e-09
> O 0 1.4449959451212635e-08
10 O 0 3.476878340791245e-09
, O 0 1.2181634867491908e-10
000 O 0 5.776900735554591e-09
genotypes O 0 3.189524377944508e-08
, O 0 9.661833555441035e-10
which O 0 7.97709606703556e-11
may O 0 2.731114501219878e-10
be O 0 1.8306614904539664e-11
useful O 0 5.4532350857172673e-11
for O 0 6.817730408004152e-12
the O 0 1.3648146501843428e-10
management O 0 1.838242802421064e-08
of O 0 1.4665793912627123e-07
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.1057381925638765e-06
newborns O 0 2.7292278446111595e-06
. O 0 4.3282281581014104e-07

Somatic O 0 1.5629308109055273e-05
instability O 0 9.582806342223193e-06
of O 0 3.149532119550713e-07
the O 0 2.7979005778888677e-08
CTG O 0 6.3242714531952515e-06
repeat O 0 1.0261032201697162e-07
in O 0 6.859964152283737e-09
mice O 0 2.8880466906855418e-09
transgenic O 0 4.2637648967058794e-09
for O 0 1.0512173354015886e-09
the O 0 4.4324540795059875e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.006094794720411301
is O 0 2.3908384161330787e-09
age O 0 1.4449078378220293e-08
dependent O 0 2.621064032481968e-09
but O 0 2.8732200646475192e-11
not O 0 3.0818433742474394e-12
correlated O 0 4.3762850981954315e-11
to O 0 9.245790764944584e-12
the O 0 1.0550513934726169e-10
relative O 0 3.947185334141068e-08
intertissue O 0 1.7130933827047556e-07
transcription O 0 1.1138521216480513e-07
levels O 0 6.118745687899718e-08
and O 0 1.3345229810113324e-08
proliferative O 0 0.00013210823817644268
capacities O 0 2.4169334210455418e-05
. O 0 1.411248945260013e-06

A O 0 4.002710193162784e-05
( O 0 1.6686526294051873e-07
CTG O 0 5.835369393025758e-06
) O 0 4.561318434070927e-09
nexpansion O 0 1.1212636508162177e-07
in O 0 1.2067999932696694e-09
the O 0 4.549675303167078e-09
3 O 0 2.414565187791595e-07
- O 0 3.1481288687018605e-08
untranslated O 0 1.6777728887973353e-05
region O 0 8.747296931232995e-08
( O 0 6.245184369646495e-10
UTR O 0 2.8119129069636983e-07
) O 0 4.932955710579279e-10
of O 0 8.549014829384305e-09
the O 0 8.899666426032127e-08
DM O 1 1.0
protein O 0 2.9092427666910226e-06
kinase O 0 1.0076067979980508e-07
gene O 0 1.9182159860520187e-08
( O 0 2.5979745021942335e-09
DMPK O 0 4.3717116682273627e-07
) O 0 1.7634176063818785e-10
is O 0 2.2265118568287612e-11
responsible O 0 7.298365800600948e-10
for O 0 3.849186924753667e-08
causing O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9990164041519165
DM B-Disease 1 1.0
) O 0 6.047794727237488e-07
. O 0 2.9123219746907125e-07

Major O 0 9.481565030000638e-06
instability O 0 0.0006199098424986005
, O 0 7.673935265017917e-09
with O 0 2.880305161045982e-10
very O 0 3.2370123248526284e-10
large O 0 1.236594299180993e-10
expansions O 0 8.70124472474032e-10
between O 0 9.519467880636512e-09
generations O 0 1.0360968749623112e-09
and O 0 1.5108417295017773e-10
high O 0 4.325114488779036e-09
levels O 0 7.546177016592992e-09
of O 0 1.3514778629541979e-08
somatic O 0 3.4136016324737284e-07
mosaicism O 0 2.712059313125792e-06
, O 0 2.4125917930106766e-10
is O 0 1.9267015066715132e-11
observed O 0 5.642107336889524e-10
in O 0 9.462404193527618e-10
patients O 0 1.1553608736392107e-08
. O 0 3.6931794511474436e-08

There O 0 9.258372557496841e-08
is O 0 4.593937230623624e-09
a O 0 1.663664872531001e-09
good O 0 6.333714108741617e-10
correlation O 0 1.8571455484561739e-09
between O 0 9.559734337472037e-09
repeat O 0 4.350880100645327e-09
size O 0 2.9140085899825863e-09
( O 0 4.629886474205591e-10
at O 0 6.062020219133046e-09
least O 0 9.819633994823107e-11
in O 0 1.4501411182976653e-10
leucocytes O 0 1.652287551223708e-08
) O 0 1.2361579815323154e-10
, O 0 6.454802664590531e-11
clinical O 0 2.5068680464812587e-09
severity O 0 6.81999381413334e-08
and O 0 8.461765177436575e-10
age O 0 5.106235079210819e-08
of O 0 3.029100525964168e-07
onset O 0 0.004490021616220474
. O 0 1.5845879488551873e-06

The O 0 1.1466910336821456e-06
trinucleotide O 0 0.0009349590982310474
repeat O 0 1.8783267705657636e-06
instability O 0 7.617278242832981e-06
mechanisms O 0 5.002921625418821e-06
involved O 0 2.298866519367948e-08
in O 0 1.1839873970131976e-08
DM B-Disease 1 1.0
and O 0 1.0437338104907212e-08
other O 0 4.2596357552326936e-09
human O 0 0.10986704379320145
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.3542716947867461e-09
unknown O 0 3.7141890629754926e-07
. O 0 3.011624727378148e-08

We O 0 3.543643956049891e-08
studied O 0 8.298216584989859e-07
somatic O 0 2.0112304355279775e-07
instability O 0 1.5264907560208485e-08
by O 0 1.162401910836941e-10
measuring O 0 2.250787787261288e-07
the O 0 1.103142910352517e-08
CTG O 0 8.728611078367976e-07
repeat O 0 4.596005798163105e-09
length O 0 1.1212070161192855e-09
at O 0 1.6880759012849467e-09
several O 0 1.2150557469892131e-11
ages O 0 1.4859069530359648e-10
in O 0 8.179233332294977e-12
various O 0 6.940621688489301e-11
tissues O 0 2.668165466346295e-09
of O 0 6.742119751379505e-08
transgenic O 0 2.984707592190716e-08
mice O 0 3.895709532741876e-09
carrying O 0 1.847535568977321e-09
a O 0 3.241907631235108e-09
( O 0 4.5783302149438043e-10
CTG O 0 1.765705377465565e-07
) O 0 9.08644659514124e-10
55expansion O 0 7.572363358576695e-08
surrounded O 0 1.1641293262698582e-08
by O 0 9.77877639973812e-11
45 O 0 4.17538270625073e-09
kb O 0 1.0320894716642215e-06
of O 0 7.88161500508977e-08
the O 0 9.946734103039034e-09
human O 0 2.37489004462077e-07
DM B-Disease 1 1.0
region O 0 1.2643668867440283e-07
, O 0 1.481492289956421e-10
using O 0 3.2805086425113927e-10
small O 0 7.429123982660712e-10
- O 0 6.562337784288275e-09
pool O 0 3.582571395099876e-08
PCR O 0 9.496910990947072e-08
. O 0 5.044609352466978e-08

These O 0 3.390151093185523e-08
mice O 0 5.3678490985475946e-08
have O 0 1.23877311186682e-10
been O 0 2.990948808068161e-11
shown O 0 1.0779446779629609e-11
to O 0 3.6671867799376034e-12
reproduce O 0 9.917303783746334e-11
the O 0 1.0828703905785275e-10
intergenerational O 0 8.202929890899213e-09
and O 0 1.3286148847768686e-09
somatic O 0 1.672457017320994e-07
instability O 0 5.19739671744901e-07
of O 0 4.032743916582149e-08
the O 0 1.519333459043537e-08
55 O 0 3.513051183290372e-07
CTG O 0 3.2972659482766176e-06
repeat O 0 2.6806745268004306e-08
suggesting O 0 5.777252898298002e-09
that O 0 3.23285218040148e-11
surrounding O 0 3.0516639215605323e-10
sequences O 0 3.76907116628189e-10
and O 0 5.093523866572802e-11
the O 0 8.178987348506084e-11
chromatin O 0 2.2457291137811808e-08
environment O 0 1.0436103536903829e-08
are O 0 2.6960326332536866e-11
involved O 0 4.869648573269103e-10
in O 0 7.010555469477708e-10
instability O 0 1.3837827737006592e-06
mechanisms O 0 6.498763104900718e-05
. O 0 1.3158517049305374e-06

As O 0 3.393023462194833e-08
observed O 0 1.3242386742717827e-08
in O 0 2.4074162108256303e-10
some O 0 1.3373952986728277e-11
of O 0 2.8101451721163073e-10
the O 0 1.3632796280749204e-10
tissues O 0 7.605768459484352e-09
of O 0 2.649957195899333e-06
DM B-Disease 1 1.0
patients O 0 9.9626277005882e-07
, O 0 2.529242926208042e-10
there O 0 3.7338437897105337e-11
is O 0 2.438172580498943e-11
a O 0 4.3661053938937044e-11
tendency O 0 2.917754579612186e-11
for O 0 6.032337129813214e-11
repeat O 0 5.392944979476511e-10
length O 0 8.834662446055574e-10
and O 0 3.3165453716677007e-10
somatic O 0 1.1340951289184886e-08
mosaicism O 0 1.1340588912389649e-07
to O 0 7.714608812880996e-11
increase O 0 3.519362579140761e-11
with O 0 1.0795042811040378e-11
the O 0 2.3607985011331323e-10
age O 0 1.1649667008839515e-08
of O 0 5.716342954542597e-09
the O 0 2.5475259679552664e-09
mouse O 0 3.883670629534208e-08
. O 0 3.706135487391293e-08

Furthermore O 0 4.0592644268144795e-07
, O 0 2.676601384976607e-09
we O 0 1.790138870472191e-10
observed O 0 3.0740443524024386e-10
no O 0 2.5555337360150254e-11
correlation O 0 1.5773531092388993e-10
between O 0 1.8035803406313278e-10
the O 0 1.3684586797069187e-10
somatic O 0 4.988098822877873e-09
mutation O 0 2.616517003062313e-10
rate O 0 1.3824345002078076e-09
and O 0 3.341716348082002e-10
tissue O 0 4.715807477850831e-08
proliferation O 0 4.170413376414217e-06
capacity O 0 7.660834171474562e-07
. O 0 1.9721998967270338e-07

The O 0 8.586752642258944e-08
somatic O 0 4.0780716403787665e-07
mutation O 0 2.636507012709899e-09
rates O 0 1.4551677640639582e-09
in O 0 3.869438797154956e-11
different O 0 1.5659612495610986e-11
tissues O 0 4.500631811676925e-10
were O 0 2.2695004209261072e-10
also O 0 4.391065202419275e-12
not O 0 1.4969770215089717e-12
correlated O 0 3.371490933656851e-11
to O 0 1.9219447214280372e-11
the O 0 3.747687438160341e-10
relative O 0 2.9892707971157506e-06
inter O 1 0.9629733562469482
- O 0 7.417251879360265e-08
tissue O 0 9.938371015039138e-09
difference O 0 4.5188112807181824e-08
in O 0 2.2102100705190253e-10
transcriptional O 0 1.618058687036239e-09
levels O 0 1.423629547581129e-09
of O 0 1.7978387667483275e-09
the O 0 2.0774293396641497e-10
three O 0 1.5758526428211184e-10
genes O 0 1.4018596006248885e-10
( O 0 1.3715840962991166e-10
DMAHP O 0 1.503483275655526e-07
, O 0 9.758752694821737e-10
DMPK O 0 6.51870266210608e-07
and O 0 1.66796998435359e-09
59 O 0 3.075443189004545e-08
) O 0 4.946089648960594e-10
surrounding O 0 6.896895943242498e-09
the O 0 3.947793203451511e-09
repeat O 0 2.4529160924657845e-08
. O 0 3.014042349036572e-09
. O 0 8.091978997981641e-08

A O 0 2.0010730850117397e-07
novel O 0 1.3747597726876393e-08
missense O 0 8.19905423554701e-08
mutation O 0 2.690133449334553e-09
in O 0 9.84240244861212e-10
patients O 0 2.21653118082088e-09
from O 0 6.489794479591637e-09
a O 0 5.83629962136456e-08
retinoblastoma B-Disease 0 0.0009715228225104511
pedigree O 0 4.5428399175762024e-07
showing O 0 2.2317914627478785e-08
only O 0 5.51605650045417e-10
mild O 0 1.0312552589653023e-08
expression O 0 1.1300136382175197e-09
of O 0 1.2320986897407238e-08
the O 0 3.448906715775024e-09
tumor B-Disease 0 6.194733970232846e-08
phenotype O 0 2.0238111630987987e-08
. O 0 8.750183155825653e-08

We O 0 3.201714804390576e-08
have O 0 7.950907987552824e-11
used O 0 6.418352654913306e-11
single O 0 4.3517633940837186e-11
strand O 0 2.986720315512059e-10
conformation O 0 3.190354647131244e-10
polymorphism O 0 8.822100272531941e-10
analysis O 0 4.164691091990136e-10
to O 0 7.354692549421671e-11
study O 0 2.545348654070523e-10
the O 0 2.751558703106838e-10
27 O 0 3.326254116586824e-08
exons O 0 4.114197338367376e-08
of O 0 1.799019599957319e-08
the O 0 1.2508595048643656e-08
RB1 O 0 3.294237558293389e-07
gene O 0 1.4365040268415896e-09
in O 0 4.5485273880707666e-10
individuals O 0 1.7047406888903716e-11
from O 0 3.1471729666776582e-09
a O 0 9.571886394610374e-09
family O 0 2.0970571945611027e-09
showing O 0 1.0670230032872041e-08
mild O 0 5.545779302451592e-08
expression O 0 1.3500840445601625e-08
of O 0 1.8290836578671588e-07
the O 0 1.246741732074952e-07
retinoblastoma B-Disease 0 6.28359048278071e-05
phenotype O 0 2.3917618818813935e-07
. O 0 1.4546836268891639e-07

In O 0 3.448415242246483e-08
this O 0 9.622953545118662e-10
family O 0 3.2095393009967665e-09
affected O 0 3.4482144917191704e-10
individuals O 0 3.4225011713573394e-11
developed O 0 4.954251835442847e-07
unilateral B-Disease 0 0.0002523413859307766
tumors I-Disease 1 1.0
and O 0 2.4586077529420436e-07
, O 0 1.589619214037441e-09
as O 0 1.0872827638230831e-10
a O 0 1.1184511650164097e-10
result O 0 2.520257058602482e-10
of O 0 9.418779534087207e-09
linkage O 0 3.429092743090223e-08
analysis O 0 1.6822068182875682e-09
, O 0 9.530995437323497e-11
unaffected O 0 1.329826693208247e-09
mutation O 0 7.917629746279076e-11
carriers O 0 1.4428849781644715e-10
were O 0 2.4747090487942103e-10
also O 0 2.4118590805088935e-11
identified O 0 2.1634832814143579e-10
within O 0 5.856353735289588e-10
the O 0 9.458308580789776e-10
pedigree O 0 1.8734837681222416e-08
. O 0 4.026349387231676e-08

A O 0 3.485356785404292e-07
single O 0 3.0343403345511888e-09
band O 0 2.7500348664943886e-08
shift O 0 1.7304895294500966e-08
using O 0 2.3995965214851367e-09
SSCP O 0 2.7080304221271945e-07
was O 0 1.1714350378611016e-08
identified O 0 1.6053014473271787e-09
in O 0 1.3092995576613475e-09
exon O 0 5.925166846054708e-08
21 O 0 9.348708474021805e-09
which O 0 6.802017282758754e-11
resulted O 0 7.148417413560537e-10
in O 0 4.626099503468595e-10
a O 0 1.8527300804649371e-09
missense O 0 2.955498956680458e-08
mutation O 0 1.44209322261446e-09
converting O 0 1.2904705215532886e-07
a O 0 1.1307768232882154e-07
cys O 0 6.521608884213492e-05
- O 0 2.59789226220164e-06
- O 0 6.928224252078508e-07
> O 0 7.484842257099444e-08
arg O 0 1.0112664483585831e-08
at O 0 5.451330409300681e-08
nucleotide O 0 1.1372923935937251e-08
position O 0 5.343496312093521e-08
28 O 0 8.328424172532323e-08
in O 0 2.8488631453882363e-09
the O 0 2.672149435056781e-08
exon O 0 2.772381321847206e-06
. O 0 7.496113880733901e-07

The O 0 9.087857932854604e-08
mutation O 0 7.072959107290444e-09
destroyed O 0 9.929412669862359e-08
an O 0 9.747869178511337e-10
NdeI O 0 4.350168580913305e-07
restriction O 0 3.561919470485009e-08
enzyme O 0 4.5759865230365904e-08
site O 0 1.6669251579060074e-07
. O 0 2.3432740192674828e-07

Analysis O 0 4.2110556819352496e-08
of O 0 7.81553808337776e-08
all O 0 2.209330274283161e-09
family O 0 7.029273829672888e-10
members O 0 1.2941086570406046e-11
demonstrated O 0 1.0688999685370959e-10
that O 0 2.8449163597815685e-12
the O 0 6.612072001033198e-11
missense O 0 1.1169578151282167e-08
mutation O 0 2.413909738763209e-09
co O 0 8.529699471182539e-07
- O 0 1.0934855936284293e-06
segregated O 0 1.444336561462478e-07
with O 0 1.6449569484322524e-09
patients O 0 6.341752509797516e-07
with O 0 8.266322311101248e-07
tumors B-Disease 1 1.0
or O 1 0.9999539852142334
who O 0 3.351612349433708e-06
, O 0 1.420540240992807e-09
as O 0 3.0646482573892797e-10
a O 0 3.020002303788516e-10
result O 0 8.381291216608133e-10
of O 0 5.685551229817065e-08
linkage O 0 1.0064965749734256e-07
analysis O 0 5.098631739031134e-09
had O 0 2.457532177757571e-09
been O 0 3.876325371798828e-10
predicted O 0 9.502031383945564e-10
to O 0 1.6951206063819946e-11
carry O 0 6.393634927048808e-11
the O 0 1.977108615713874e-10
predisposing O 0 2.2947341449253145e-07
mutation O 0 8.185460131926448e-08
. O 0 7.290574330909294e-07

These O 0 1.2242675317963858e-08
observations O 0 1.5732450719951885e-07
point O 0 9.629609110106685e-08
to O 0 2.745750016241999e-10
another O 0 2.6543323095040705e-10
region O 0 2.7397719648547536e-09
of O 0 4.8434363186800056e-09
the O 0 6.177269362694915e-09
RB1 O 0 8.957599675341044e-07
gene O 0 5.665986346770069e-09
where O 0 2.5201620790227253e-09
mutations O 0 2.2627574813860463e-10
only O 0 4.234212633291712e-11
modify O 0 1.3902209938798649e-10
the O 0 6.145603470564254e-11
function O 0 1.6068760766430046e-09
of O 0 5.95017013438337e-09
the O 0 1.0087096713462529e-09
gene O 0 2.9048730088021557e-10
and O 0 8.851559069045223e-11
raise O 0 4.2766457042375805e-11
important O 0 8.04303498802561e-11
questions O 0 1.422033185649596e-10
for O 0 4.952902671329085e-11
genetic O 0 9.069425765950712e-10
counseling O 0 1.387342241088163e-09
in O 0 1.2979012309344284e-10
families O 0 8.082338617820817e-12
with O 0 1.2515639566390568e-11
these O 0 4.7254079121872294e-11
distinctive O 0 1.3259895403905375e-09
phenotypes O 0 1.2687172201708563e-08
. O 0 7.588785599921266e-09
. O 0 1.4305186368801515e-07

Maternal B-Disease 0 1.3021091035625432e-05
disomy I-Disease 0 0.0004542907699942589
and O 0 2.190756276831962e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.0006960585014894605
with O 0 1.5362552119313477e-08
gamete O 0 8.348303026650683e-07
complementation O 0 8.625801228845376e-07
in O 0 6.996155321736808e-10
a O 0 4.745570048036996e-10
case O 0 9.595974015397246e-10
of O 0 3.170749662828598e-09
familial O 0 1.1228387108985771e-07
translocation O 0 1.9469565870622318e-07
( O 0 3.604365250708952e-09
3 O 0 8.066106715887145e-08
; O 0 3.34162697512852e-10
15 O 0 5.116986390163447e-09
) O 0 1.4871658071680116e-10
( O 0 2.423578004950855e-10
p25 O 0 2.4972196754902143e-08
; O 0 2.0681464873995026e-10
q11 O 0 1.9164129838600275e-08
. O 0 3.597035447278074e-10
2 O 0 3.5633807016210994e-08
) O 0 1.1191046977998553e-09
. O 0 2.497848505811362e-08

Maternal B-Disease 0 0.001722431741654873
uniparental I-Disease 1 0.9509578943252563
disomy I-Disease 0 0.2891780436038971
( I-Disease 0 4.077211087860633e-06
UPD I-Disease 1 0.9999781847000122
) I-Disease 0 1.071652810935575e-08
for I-Disease 0 2.999292592065217e-09
chromosome I-Disease 0 1.800238749183336e-07
15 I-Disease 0 2.2708146474315072e-08
is O 0 9.542927559280656e-11
responsible O 0 2.761511574966846e-10
for O 0 2.044877461804262e-11
an O 0 6.813869347227497e-12
estimated O 0 5.171505237933083e-11
30 O 0 5.266148628280121e-10
% O 0 3.0474803236479886e-11
of O 0 2.248748826039204e-10
cases O 0 1.7968102561383148e-09
of O 0 0.0013765246840193868
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997081160545349
PWS B-Disease 1 1.0
) O 0 7.319087558244064e-07
. O 0 2.1747497669366567e-07

We O 0 8.001764228993125e-08
report O 0 2.6369293415484663e-09
on O 0 1.55128887513456e-09
an O 0 1.2047335351539346e-11
unusual O 0 1.977930874641487e-10
case O 0 2.330412252060654e-10
of O 0 8.572555443286944e-10
maternal B-Disease 0 3.315644647727822e-08
disomy I-Disease 0 1.2049960105287028e-06
15 I-Disease 0 1.222336010187064e-07
in O 0 8.764331482780108e-08
PWS B-Disease 1 1.0
that O 0 9.806088163699656e-10
is O 0 5.919826434608311e-11
most O 0 6.175387024659473e-12
consistent O 0 7.196046536428469e-11
with O 0 5.909985174856747e-12
adjacent O 0 1.5896616245569817e-09
- O 0 6.291540177727484e-09
1 O 0 1.1291485435549475e-07
segregation O 0 7.60513358954995e-08
of O 0 6.7901768652234296e-09
a O 0 2.2594637272277396e-09
paternal O 0 8.98675889260403e-09
t O 0 1.2573729613052365e-08
( O 0 1.423569179204165e-10
3 O 0 4.633449179891613e-09
; O 0 9.925762989304587e-11
15 O 0 2.422345435348916e-09
) O 0 6.818345194004038e-11
( O 0 7.646022009977216e-11
p25 O 0 5.885606224609319e-09
; O 0 7.021337677937112e-11
q11 O 0 3.0530105110671e-09
. O 0 2.8626680886878475e-11
2 O 0 5.717190054710386e-10
) O 0 1.828510867024624e-12
with O 0 3.3475496680202e-12
simultaneous O 0 3.716225660532757e-10
maternal O 0 3.592452202383356e-08
meiotic O 0 4.605398089552182e-07
nondisjunction O 0 4.1869247979775537e-07
for O 0 1.9951881924384907e-08
chromosome O 0 4.343330601841444e-06
15 O 0 3.724024281837046e-06
. O 0 7.80869754635205e-07

The O 0 5.652474328599055e-07
patient O 0 7.692548820159573e-07
( O 0 2.18263318529921e-09
J O 0 8.347476665448994e-08
. O 0 1.3257031583613355e-10
B O 0 5.50672440979838e-09
. O 0 1.1865627404239465e-11
) O 0 5.0469281531739796e-12
, O 0 7.057155207434995e-12
a O 0 1.187813319925013e-10
17 O 0 6.452298251247157e-09
- O 0 5.074716202813079e-09
year O 0 6.022031318053678e-09
- O 0 1.3645055219058122e-07
old O 0 7.949219025249477e-07
white O 0 4.472207049133203e-09
male O 0 2.2400425958579717e-09
with O 0 2.6224240556871337e-09
PWS B-Disease 1 1.0
, O 0 1.758921541750169e-08
was O 0 6.331920587854256e-08
found O 0 3.502322043491546e-10
to O 0 1.3288625755336625e-10
have O 0 8.066310119847486e-11
47 O 0 7.30307636587213e-09
chromosomes O 0 2.655219599745351e-09
with O 0 3.467704179360709e-10
a O 0 9.47329770184524e-09
supernumerary O 0 1.365245225315448e-06
, O 0 6.3279093076573645e-09
paternal O 0 3.5379275686864275e-07
der O 0 0.00010137422214029357
( O 0 3.078064914063816e-09
15 O 0 3.823866556729172e-09
) O 0 3.4571952939321804e-11
consisting O 0 3.767698375511941e-10
of O 0 7.829440207274274e-09
the O 0 1.2271524241214138e-08
short O 0 1.4156208649751534e-08
arm O 0 1.859005891446941e-07
and O 0 1.1325251847438267e-09
the O 0 1.0474171752150596e-08
proximal O 0 6.079054583096877e-05
long O 0 1.489132159804285e-07
arm O 0 4.789458785126044e-07
of O 0 1.8977860349878029e-07
chromosome O 0 2.3404957971706608e-07
15 O 0 1.0579869069715642e-07
, O 0 1.9076011881224986e-09
and O 0 5.344105158400225e-09
distal O 0 0.00020830886205658317
chromosome O 0 0.003274594433605671
arm O 1 0.685710072517395
3p O 0 0.25404709577560425
. O 0 1.2976871403225232e-05

The O 0 2.5535118766129017e-06
t O 0 1.7651797179496498e-06
( O 0 6.811345709678562e-09
3 O 0 2.3523057279817294e-08
; O 0 2.7882232633835713e-10
15 O 0 1.961772300163034e-09
) O 0 5.6039235751814687e-11
was O 0 8.627276115724669e-10
present O 0 1.589233328269657e-10
in O 0 1.879968125617637e-10
the O 0 2.466161441727621e-10
balanced O 0 2.1111908055093664e-10
state O 0 5.221867035998251e-11
in O 0 3.1806134115353046e-11
the O 0 1.3163500844903808e-10
patients O 0 1.9095525161105797e-09
father O 0 1.2998275344955346e-08
and O 0 6.4219594086978304e-09
a O 0 7.495142284597023e-08
sister O 0 4.718426225736039e-06
. O 0 3.570392436813563e-06

Fluorescent O 0 4.660298031922139e-07
in O 0 4.483977189551069e-09
situ O 0 9.97717748418836e-08
hybridization O 0 2.23950014088814e-09
analysis O 0 5.413247072816318e-10
demonstrated O 0 3.162123340949563e-10
that O 0 1.1189392294663758e-11
the O 0 5.5507687335421e-10
PWS B-Disease 1 0.9999822378158569
critical O 0 1.3605085769086145e-07
region O 0 1.789526038464828e-08
resided O 0 3.32374270328728e-08
on O 0 1.0759332980114777e-08
the O 0 6.076232850205088e-10
derivative O 0 1.4538869663738296e-08
chromosome O 0 2.1873312050502136e-08
3 O 0 3.281093796658752e-08
and O 0 1.6637496935700824e-10
that O 0 4.259127425743081e-11
there O 0 6.93284180064424e-11
was O 0 8.769155401822104e-10
no O 0 2.715540813047479e-11
deletion O 0 7.935246348900193e-10
of O 0 2.3476967037083796e-09
the O 0 6.0531935019980665e-09
PWS B-Disease 1 1.0
region O 0 3.2538349614696926e-07
on O 0 8.403709017557048e-08
the O 0 3.1778333298149164e-09
normal O 0 3.475189558344027e-08
pair O 0 1.3424269695860858e-08
of O 0 2.417111399921623e-09
15s O 0 2.644885057634383e-07
present O 0 1.756149181630917e-08
in O 0 2.821168187949752e-08
J O 0 0.00015742274990770966
. O 0 6.330579935820424e-07

B O 0 0.0021630299743264914
. O 0 1.4636618288932368e-05

Methylation O 0 7.019713166300789e-07
analysis O 0 5.8506660849388936e-08
at O 0 7.230134428937163e-07
exon O 0 3.1154701218838454e-07
alpha O 0 1.9026280995149136e-07
of O 0 6.577151623332611e-08
the O 0 1.02731112505694e-08
small O 0 2.000225407527978e-08
nuclear O 0 3.444988351475331e-06
ribonucleoprotein O 0 6.536544105983921e-07
- O 0 4.914766815744542e-09
associated O 0 5.9646465544460625e-09
polypeptide O 0 6.325570467424768e-08
N O 0 5.760948056376947e-07
( O 0 8.122899575191411e-10
SNRPN O 0 9.68314992633168e-08
) O 0 2.963274070566513e-10
gene O 0 1.145625927456706e-09
showed O 0 4.261553776530036e-09
a O 0 3.5574010404104683e-10
pattern O 0 6.653916528875925e-09
characteristic O 0 9.85191128677343e-09
of O 0 1.6094595878257678e-08
only O 0 1.4480901200375484e-10
the O 0 6.444632050239818e-10
maternal O 0 2.5604363074194225e-08
chromosome O 0 3.5588161750865765e-08
15 O 0 9.063364814210217e-08
in O 0 3.532973735786982e-08
J O 0 0.00012308714212849736
. O 0 1.516684847047145e-06

B O 0 0.0031210335437208414
. O 0 2.549261989770457e-05

Maternal B-Disease 0 1.3521707842301112e-05
disomy I-Disease 0 8.366096153622493e-06
was O 0 1.62165804340475e-07
confirmed O 0 2.4833253231548724e-09
by O 0 3.3281846029131756e-11
polymerase O 0 4.980094558959536e-09
chain O 0 3.27410737410716e-10
reaction O 0 2.2391519194364662e-11
analysis O 0 8.816108260090161e-11
of O 0 3.7651139983552184e-09
microsatellite O 0 7.527263079509794e-08
repeats O 0 1.1547483858009855e-08
at O 0 2.3183778452562365e-08
the O 0 1.4624746969005287e-09
gamma O 0 3.055103832139139e-07
- O 0 4.7562309646309586e-08
aminobutyric O 0 2.1407291228570102e-07
acid O 0 1.8400038825916454e-08
receptor O 0 1.2562678897154456e-08
beta3 O 0 5.966355729469797e-07
subunit O 0 1.303146888176343e-07
( O 0 8.672519591357286e-09
GABRB3 O 0 1.9090637124463683e-06
) O 0 5.410122128068906e-09
locus O 0 1.6086178789009864e-07
. O 0 6.621470447498723e-07

A O 0 2.6204006644547917e-05
niece O 0 1.732440614432562e-05
( O 0 1.0820869533745281e-08
B O 0 6.094588655969346e-08
. O 0 1.360930951266326e-10
B O 0 3.768548584304199e-09
. O 0 1.2261538138991224e-11
) O 0 2.9146047554606813e-12
with O 0 2.0924602328609154e-11
45 O 0 8.988760846762034e-10
chromosomes O 0 1.3633687512282222e-09
and O 0 3.221994893110036e-10
the O 0 5.525481183710212e-10
derivative O 0 1.0030753117007407e-08
3 O 0 6.884278924701448e-09
but O 0 4.7045978224247165e-11
without O 0 2.1557765295110443e-10
the O 0 5.454392493220439e-10
der O 0 4.7391345106007066e-06
( O 0 3.479941890205396e-10
15 O 0 1.4534674575017448e-09
) O 0 5.188973903336169e-11
demonstrated O 0 5.867691887928572e-10
a O 0 8.647539351258615e-10
phenotype O 0 5.79458703242608e-10
consistent O 0 2.3665340798117995e-09
with O 0 4.344987217241858e-11
that O 0 1.2324704624921967e-11
reported O 0 4.570396491820894e-11
for O 0 4.0806791973269085e-11
haploinsufficiency O 0 3.5711643420199835e-08
of O 0 2.1711522890655033e-07
distal O 0 0.00015938446449581534
3 O 0 0.001072827959433198
p O 0 0.0011066014412790537
. O 0 3.3611058825044893e-06

Uniparental B-Disease 1 0.9999995231628418
disomy I-Disease 1 0.9999669790267944
associated O 0 1.0925996321020648e-06
with O 0 4.279881782309758e-09
unbalanced O 0 1.2604746189026628e-05
segregation O 0 7.468010608135955e-06
of O 0 2.2475595073956356e-07
non O 0 2.2534670733875828e-06
- O 0 1.8525602740737668e-07
Robertsonian O 0 6.628009145970282e-07
translocations O 0 2.7457272722131165e-07
has O 0 9.8464592035441e-10
been O 0 2.3608343058256764e-10
reported O 0 1.7941141627897395e-10
previously O 0 9.866180095130517e-10
but O 0 4.1309945048029206e-11
has O 0 1.9980718468648462e-11
not O 0 5.79731184932597e-12
, O 0 8.861453237862804e-12
to O 0 7.753696122658749e-12
our O 0 1.6025962501498014e-10
knowledge O 0 5.0980384358467745e-09
, O 0 5.2339226702668995e-11
been O 0 1.079277812954249e-11
observed O 0 9.8204215592812e-11
in O 0 5.130771155159586e-11
a O 0 4.625499427923785e-10
case O 0 7.667614987383331e-09
of O 0 2.8280570063543564e-07
PWS B-Disease 1 1.0
. O 0 1.5150936633290257e-05

Furthermore O 0 8.496951522829477e-06
, O 0 5.912184875001003e-08
our O 0 6.448951594961727e-09
findings O 0 7.127695655917421e-10
are O 0 4.321215694297331e-12
best O 0 7.688193831567602e-12
interpreted O 0 1.7744935729147038e-11
as O 0 7.192410556022821e-11
true O 0 1.6222861942694067e-09
gamete O 0 5.134538128004351e-08
complementation O 0 4.935436095365731e-07
resulting O 0 1.4271211767891145e-08
in O 0 2.5987292318063737e-08
maternal B-Disease 0 0.00015584084030706435
UPD I-Disease 1 1.0
15 I-Disease 0 0.0003145399095956236
and O 0 2.9375958547461778e-05
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9983217120170593
- I-Disease 1 0.9999443292617798
Jampel I-Disease 1 0.9999971389770508
syndrome I-Disease 1 0.9999995231628418
type I-Disease 0 0.0003023137978743762
2 I-Disease 0 0.00161144626326859
and O 0 1.1284268630618044e-08
Stuve B-Disease 1 0.9998109936714172
- I-Disease 1 0.999983549118042
Wiedemann I-Disease 1 0.9999978542327881
syndrome I-Disease 1 0.999975323677063
: O 0 1.248408709741966e-09
a O 0 6.765468185676582e-10
case O 0 7.548217606512253e-10
for O 0 9.613537743646816e-11
" O 0 1.0342132705787321e-09
lumping O 0 1.193004894872729e-08
" O 0 2.4963769718056028e-08
. O 0 5.3313208070449036e-08

Recent O 0 6.187575785077115e-09
studies O 0 1.589822273828645e-09
demonstrated O 0 4.700546063496347e-10
the O 0 1.0244943088322245e-10
existence O 0 9.00763907907276e-10
of O 0 3.302684792316768e-09
a O 0 8.645890670067047e-10
genetically O 0 1.9572676812629197e-10
distinct O 0 1.0278549539277648e-10
, O 0 3.434756298825725e-11
usually O 0 8.923292660334425e-12
lethal O 0 1.1095906832236935e-10
form O 0 6.087455626385685e-12
of O 0 3.4719196961852106e-10
the O 0 1.3585041980235246e-09
Schwartz B-Disease 0 0.00018261995865032077
- I-Disease 0 0.05304327234625816
Jampel I-Disease 1 0.9679386019706726
syndrome I-Disease 1 0.9997636675834656
( O 0 1.4471776665914149e-08
SJS B-Disease 0 0.00028993107844144106
) O 0 9.642543652432778e-09
of O 0 1.982198455152684e-06
myotonia B-Disease 1 0.9999998807907104
and O 0 0.0015943325124680996
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.931419658125378e-06
which O 0 1.1864061733035669e-08
we O 0 8.841427145966918e-09
called O 0 1.0229805269545977e-07
SJS B-Disease 0 0.010867524892091751
type I-Disease 0 9.719452646095306e-05
2 I-Disease 0 0.0002675011637620628
. O 0 5.880441449335194e-07

This O 0 1.0109004477953931e-07
disorder O 1 0.8279526233673096
is O 0 4.12340206423778e-09
reminiscent O 0 1.8165583242080174e-06
of O 0 6.300405175352353e-08
another O 0 2.012285893471244e-09
rare O 0 4.268093434234288e-09
condition O 0 2.85879650618881e-07
, O 0 5.84742476661404e-10
the O 0 3.0747142609754974e-09
Stuve B-Disease 1 0.9997681975364685
- I-Disease 1 0.9999994039535522
Wiedemann I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 1.1294178392518006e-07
SWS B-Disease 0 3.6424025893211365e-06
) O 0 8.798726192082995e-10
, O 0 1.0567410835271573e-10
which O 0 1.3234539332496187e-11
comprises O 0 5.598627117464616e-10
campomelia B-Disease 0 3.7385675000223273e-07
at O 0 1.0555615972407395e-06
birth O 0 2.0018194391013822e-07
with O 0 4.6427757638412004e-08
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.734756662903237e-06
contractures B-Disease 1 0.6188804507255554
, O 0 2.132358467576978e-08
and O 0 9.830246616715499e-10
early B-Disease 0 5.539319545277976e-07
death I-Disease 0 9.491059245192446e-07
. O 0 1.0608684419821657e-07

To O 0 4.720430712978896e-09
test O 0 7.523897060934814e-10
for O 0 2.2101036278865394e-11
possible O 0 4.632677852445255e-10
nosologic O 0 3.530993453182418e-08
identity O 0 3.323867847626616e-09
between O 0 5.680250581008295e-08
these O 0 1.174280006566164e-09
disorders O 0 0.000312412332277745
, O 0 2.588294023553317e-10
we O 0 4.645470119690742e-11
reviewed O 0 3.3212868566501186e-10
the O 0 2.454644126848038e-11
literature O 0 4.1555796997938543e-11
and O 0 4.110831466896947e-12
obtained O 0 8.200372325628535e-11
a O 0 7.063272883245375e-11
follow O 0 3.840732940019187e-11
- O 0 1.0760307922463852e-10
up O 0 7.865234852300063e-11
of O 0 3.6221992072427156e-10
the O 0 6.692502108052167e-11
only O 0 2.5814494639120333e-11
two O 0 1.256661996684727e-10
surviving O 0 1.0204097122823441e-08
patients O 0 1.0282927842553136e-09
, O 0 2.4930293940350623e-10
one O 0 3.0856109334287396e-10
with O 0 3.380773661021408e-09
SJS B-Disease 0 0.010076160542666912
type I-Disease 0 5.255329961073585e-05
2 I-Disease 0 1.5476949556614272e-05
at O 0 3.802478829584288e-07
age O 0 3.2794918780609805e-08
10 O 0 2.9395650358310377e-09
years O 0 2.3344337574116025e-10
and O 0 1.6669379418465802e-11
another O 0 5.0746143398505694e-11
with O 0 1.533723981150814e-10
SWS B-Disease 0 6.709356057399418e-07
at O 0 4.3055686660409265e-07
age O 0 1.4076087495595857e-07
7 O 0 5.316880447026051e-07
years O 0 1.1245384001767889e-07
. O 0 2.572243431586685e-07

Patients O 0 4.1870882228067785e-07
reported O 0 7.998952611387722e-09
as O 0 1.0762570834543794e-09
having O 0 8.298167486486818e-09
either O 0 7.817034770596365e-07
neonatal O 1 0.9999841451644897
SJS B-Disease 1 0.9999630451202393
or O 0 8.400245974371501e-07
SWS B-Disease 0 2.537417458370328e-06
presented O 0 6.783212658234561e-09
a O 0 4.140075782199659e-10
combination O 0 2.8789610695412193e-09
of O 0 7.574613825056531e-09
a O 0 2.9988465044539225e-09
severe O 0 4.6236169737312593e-07
, O 0 3.007461391035804e-09
prenatal O 0 0.04229669272899628
- O 1 0.5794602036476135
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.8119216065315413e-06
with O 0 5.381999017117778e-06
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999998807907104
contractures I-Disease 1 1.0
, O 0 0.0023103358689695597
respiratory O 1 1.0
and O 0 0.00043991481652483344
feeding O 0 0.00013924305676482618
difficulties O 0 0.29159826040267944
, O 0 7.764630716167176e-09
tendency O 0 2.4148305577398332e-09
to O 0 9.791024657701541e-10
hyperthermia B-Disease 1 0.9998747110366821
, O 0 4.1178985221712594e-10
and O 0 8.480794538856529e-11
frequent O 0 5.68416869128896e-10
death O 0 1.793770465496891e-08
in O 0 9.767043174235823e-09
infancy O 0 7.948589768602687e-07
) O 0 1.2439584085033317e-10
with O 0 4.650302018460728e-11
a O 0 1.0320810872599395e-09
distinct O 0 6.589454315530929e-09
campomelic B-Disease 0 0.26809942722320557
- I-Disease 1 0.9858306050300598
metaphyseal I-Disease 1 0.9995750784873962
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.0011848481371998787

The O 0 1.24363710440889e-08
similarity O 0 4.356811444949926e-08
of O 0 2.596990000824917e-08
the O 0 2.3470876353570702e-09
clinical O 0 2.851974301165683e-08
and O 0 2.2444036906765774e-10
radiographic O 0 2.0880383999610785e-07
findings O 0 1.371433078212192e-09
is O 0 7.671995677638321e-11
so O 0 7.594218656703511e-12
extensive O 0 7.339043262000189e-10
that O 0 1.9765647452096857e-11
these O 0 2.4643276308466966e-10
disorders O 0 0.011078841052949429
appear O 0 1.2123352988169245e-08
to O 0 1.2619005840264208e-10
be O 0 1.2716545871871432e-10
a O 0 2.597462800402184e-10
single O 0 3.918496638277702e-10
entity O 0 2.7109862799079565e-07
. O 0 3.700601610034937e-06

The O 0 2.6076497761096107e-07
follow O 0 3.323298969348798e-08
- O 0 4.638931461187212e-09
up O 0 2.101235990759065e-10
observation O 0 3.6547437076706046e-08
of O 0 1.0050952292672832e-09
an O 0 6.792187472182132e-12
identical O 0 4.117911914236494e-11
and O 0 1.3189280397007952e-11
unique O 0 3.125736891540498e-10
pattern O 0 1.2284021977393422e-07
of O 0 3.925271812477149e-05
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 3.0683793283969862e-06
the O 0 6.671074288533418e-07
two O 0 1.1012114242703319e-07
patients O 0 5.4103725943832615e-08
( O 0 4.6265763442576713e-10
one O 0 4.0542266765974944e-10
with O 0 1.1979842673426333e-09
SJS B-Disease 0 0.0005684515926986933
type I-Disease 0 3.153400757582858e-05
2 I-Disease 0 9.547539775667246e-06
, O 0 4.442406720261971e-10
one O 0 1.09770366407691e-10
with O 0 7.758201303609269e-10
SWS B-Disease 0 7.807639690327051e-07
) O 0 3.2494231749780056e-09
surviving O 0 6.038868036739586e-07
beyond O 0 3.6872293094347697e-06
infancy O 0 1.5501885854973807e-06
adds O 0 2.993760128688905e-09
to O 0 1.2454635933689673e-10
the O 0 1.601801608019926e-10
evidence O 0 9.651187626857904e-10
in O 0 3.36677422052567e-11
favor O 0 2.14355089234175e-09
of O 0 6.457776979829077e-09
identity O 0 5.2082775425787986e-08
. O 0 2.365340208143607e-07

The O 0 1.9896384628736996e-07
hypothesis O 0 1.5850247336857137e-07
that O 0 2.0368178255125713e-09
SWS B-Disease 0 4.452957455214346e-06
and O 0 2.9711950233490825e-08
SJS B-Disease 0 0.0025522399228066206
type I-Disease 0 8.75884961715201e-06
2 I-Disease 0 2.4538248908356763e-06
are O 0 6.329593099652087e-11
the O 0 2.304910151629258e-10
same O 0 1.6228563382014727e-08
disorder O 0 9.510154086456168e-06
should O 0 6.019605369722569e-10
be O 0 6.307466354771307e-11
testable O 0 5.128992786040953e-10
by O 0 7.043922303079375e-12
molecular O 0 5.1438964199235215e-09
methods O 0 1.1021754175999376e-08
. O 0 1.4045179463906265e-09
. O 0 2.024760981100826e-08

A O 0 3.810937698744965e-07
mouse O 0 1.5042441958712516e-08
model O 0 1.506839986120667e-08
of O 0 1.7824449116687902e-07
severe O 1 0.9999945163726807
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 4.377251025289297e-05
defects O 1 0.9996650218963623
in O 0 7.805086283951823e-07
hemostasis O 1 0.9999697208404541
and O 0 8.961564890341833e-05
thrombosis B-Disease 1 0.9999946355819702
. O 0 7.034229201963171e-05

von B-Disease 1 0.5785026550292969
Willebrand I-Disease 1 0.5513448119163513
factor I-Disease 0 1.545519262435846e-05
( I-Disease 0 1.676979877629492e-06
vWf I-Disease 0 0.0033724799286574125
) I-Disease 0 0.0002569709322415292
deficiency I-Disease 1 1.0
causes O 1 0.9999880790710449
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.008686757646501064
humans O 0 3.129243850708008e-05
. O 0 3.524144460698153e-07

We O 0 1.3646129559674591e-08
generated O 0 5.204230935085263e-10
a O 0 2.430925183372068e-10
mouse O 0 2.0827099767029011e-10
model O 0 2.490714579028719e-10
for O 0 4.729862335128843e-11
this O 0 2.1325991320098048e-11
disease O 0 3.542275361922975e-10
by O 0 5.742374891565261e-12
using O 0 3.347048749269277e-10
gene O 0 2.5960376071054725e-09
targeting O 0 6.088210113830428e-08
. O 0 1.2431797813405865e-07

vWf B-Disease 0 0.00784558616578579
- I-Disease 1 0.9929927587509155
deficient I-Disease 0 0.047904159873723984
mice O 0 1.6480846625199774e-06
appeared O 0 2.1229278956980124e-07
normal O 0 1.3151023381396953e-07
at O 0 2.8223036352414965e-08
birth O 0 3.6967981453805976e-10
; O 0 1.0600472756527868e-11
they O 0 7.266300842273532e-12
were O 0 1.66495289777302e-10
viable O 0 1.8408313762208195e-09
and O 0 3.5717739876872656e-10
fertile O 0 5.77855665540028e-08
. O 0 9.012511270611867e-08

Neither O 0 3.074441701755859e-05
vWf O 0 0.000111504559754394
nor O 0 1.4268116501625627e-05
vWf O 0 3.955996726290323e-05
propolypeptide O 0 4.8978556151269004e-05
( O 0 2.0550157842080807e-07
von B-Disease 0 4.798305963049643e-05
Willebrand I-Disease 0 3.6785961583518656e-06
antigen O 0 2.335839255351857e-08
II O 0 0.006811917293816805
) O 0 2.8491347059400596e-09
were O 0 1.1812122391319235e-09
detectable O 0 2.436437540609404e-08
in O 0 3.3545263788958835e-10
plasma O 0 2.2239937891299633e-08
, O 0 2.473831417493244e-10
platelets O 0 3.09820902266722e-09
, O 0 1.7028503607185996e-10
or O 0 7.818091313227526e-11
endothelial O 0 6.311067224373801e-10
cells O 0 1.4861392672038676e-10
of O 0 3.1070741535188517e-09
the O 0 2.6367030780960476e-09
homozygous O 0 3.746790611103279e-08
mutant O 0 1.878667603705253e-07
mice O 0 2.5871671027744014e-07
. O 0 8.623599256907255e-08

The O 0 2.1588076037915016e-07
mutant O 0 2.5136453132290626e-06
mice O 0 1.7464329005179025e-07
exhibited O 0 2.527845026634168e-07
defects O 0 0.00010021564230555668
in O 0 1.7932915596929888e-08
hemostasis O 0 4.3202620872762054e-05
with O 0 5.818334702922812e-09
a O 0 1.1309903413803113e-07
highly O 0 0.0002212764520663768
prolonged O 1 0.9702296853065491
bleeding O 1 0.883162796497345
time O 0 2.1288640539296466e-07
and O 0 3.788988234276758e-09
spontaneous O 0 1.6174423578263486e-08
bleeding O 0 8.560682545066811e-07
events O 0 6.635776927943482e-10
in O 0 4.888885407616783e-10
approximately O 0 3.427899075703067e-10
10 O 0 5.522499124666069e-10
% O 0 1.274126221195715e-10
of O 0 1.1442071290446165e-08
neonates O 0 9.752635605764226e-07
. O 0 4.6957026711424987e-07

As O 0 4.561598743180184e-08
in O 0 4.3206704880560665e-09
the O 0 2.4814501564662805e-09
human O 0 3.557011041266378e-08
disease O 0 6.340742686461454e-08
, O 0 4.697388658603252e-11
the O 0 1.8084028718945433e-10
factor O 0 6.292016907494258e-10
VIII O 0 3.881964119045733e-07
level O 0 8.569766123400768e-07
in O 0 3.2824190032698652e-09
these O 0 1.2663635418075359e-10
mice O 0 1.4785910273928948e-09
was O 0 3.1410620771055164e-09
reduced O 0 4.134772524366781e-10
strongly O 0 1.450611297748594e-10
as O 0 4.3225700796512e-11
a O 0 2.440182257645862e-11
result O 0 8.137502477412184e-11
of O 0 5.351865062230843e-10
the O 0 1.5117554430510438e-10
lack O 0 3.0829887531780287e-09
of O 0 1.4687251415068658e-09
protection O 0 2.4131916465108816e-09
provided O 0 4.462508140790078e-10
by O 0 4.3097625468391243e-10
vWf O 0 2.5071883555938257e-06
. O 0 1.2483899354265304e-06

Defective O 1 0.848999559879303
thrombosis B-Disease 1 0.5897966623306274
in O 0 6.21099502495781e-07
mutant O 0 8.195917757802818e-07
mice O 0 7.96546117953767e-08
was O 0 1.044869080146782e-08
also O 0 1.114507305888246e-10
evident O 0 4.2407047318171465e-10
in O 0 3.309264667850087e-11
an O 0 3.36509661282014e-12
in O 0 4.394763025716841e-11
vivo O 0 8.76417693973508e-09
model O 0 2.4992925062861104e-08
of O 0 4.409649591252673e-06
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999998807907104
. O 0 0.0006218694616109133

In O 0 2.1128927940594622e-08
this O 0 3.1536248612518136e-10
model O 0 2.7602649055324946e-09
, O 0 1.8732175532942819e-10
the O 0 4.808144438150919e-10
exteriorized O 0 2.548961504089675e-07
mesentery O 0 2.9468751563399564e-06
was O 0 2.6739141389953147e-07
superfused O 0 6.380742547662521e-07
with O 0 6.543626973609662e-09
ferric O 0 6.725117418682203e-05
chloride O 0 1.9177605281583965e-06
and O 0 7.1307995064273655e-09
the O 0 1.582441377934174e-08
accumulation O 0 2.300227833984536e-06
of O 0 4.904571142105851e-06
fluorescently O 0 1.4748838111700024e-05
labeled O 0 3.9993771849822224e-08
platelets O 0 3.735487652534175e-08
was O 0 2.9093007114511238e-08
observed O 0 2.9305236015630953e-09
by O 0 3.7451222678619445e-10
intravital O 0 3.446380958394002e-07
microscopy O 0 1.481347567278135e-06
. O 0 3.451995667091978e-07

We O 0 1.5027822541924252e-07
conclude O 0 2.0120073429552576e-07
that O 0 1.8323251249618977e-10
these O 0 5.7247491469514244e-11
mice O 0 1.6966589244660213e-09
very O 0 1.5954533527651193e-10
closely O 0 4.893589533594422e-09
mimic O 0 8.993173423732514e-07
severe O 0 0.0010766058694571257
human O 0 0.06578437983989716
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 4.23388001991043e-07
will O 0 3.373147094976048e-09
be O 0 1.9757062652558943e-10
very O 0 3.426812306139837e-11
useful O 0 7.411994629169527e-11
for O 0 9.546891922840306e-12
investigating O 0 3.6155659022263364e-10
the O 0 2.8260647294553465e-11
role O 0 7.588419892456955e-10
of O 0 7.369163057546757e-09
vWf O 0 4.6703799938541124e-08
in O 0 1.2181966546620515e-09
normal O 0 3.516245214996161e-07
physiology O 0 1.7850645406269905e-07
and O 0 9.203814099745244e-11
in O 0 2.8704058574469116e-10
disease O 0 3.1603222261367137e-09
models O 0 7.200952056862775e-10
. O 0 7.777372634798496e-10
. O 0 1.5229515426540274e-08

Oral O 0 0.0004973725299350917
contraceptives O 0 2.588460483821109e-05
and O 0 1.8089756081973718e-10
the O 0 5.83877612925221e-10
risk O 0 3.049218264550291e-07
of O 0 0.0772118866443634
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999864101409912

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999988079071045
Clinical O 0 0.004132684785872698
Study O 0 2.2931129706194042e-07
Group O 0 4.880784132410554e-08
. O 0 1.8660432488104561e-07

BACKGROUND O 0 4.088105015398469e-06
Women O 0 2.0921671062268388e-09
with O 0 1.9707195597629124e-10
mutations O 0 7.389356349030152e-10
in O 0 5.441372352699148e-10
either O 0 2.6005773090531648e-09
the O 0 3.963970041098719e-09
BRCA1 O 0 4.637533468354604e-09
or O 0 2.0640216202849615e-09
the O 0 5.183419915510967e-09
BRCA2 O 0 3.160629757914535e-09
gene O 0 1.487234668751114e-09
have O 0 1.2358374046339549e-10
a O 0 2.170592594552545e-10
high O 0 1.0164877828344743e-08
lifetime O 0 6.954861131447387e-09
risk O 0 9.060552770279173e-07
of O 1 0.9873308539390564
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7270154356956482

Oral O 1 0.9938187003135681
contraceptives O 1 0.9999500513076782
protect O 0 0.00011411977902753279
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.7723627686500549
general O 0 0.0001029887207550928
, O 0 8.555588237868506e-09
but O 0 2.3193262588261376e-10
it O 0 1.881484551491397e-11
is O 0 1.4063608784475878e-11
not O 0 6.435179646102629e-12
known O 0 7.08961916950912e-11
whether O 0 8.232451526035689e-11
they O 0 1.8686595673611528e-11
also O 0 1.5348762191780274e-11
protect O 0 6.150152609407655e-11
against O 0 4.582823009968706e-09
hereditary B-Disease 1 0.9999396800994873
forms I-Disease 1 0.9125787019729614
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9937013387680054

METHODS O 0 1.2872027355115279e-06
We O 0 6.274570640840693e-09
enrolled O 0 1.741343069738832e-08
207 O 0 1.310509478713584e-08
women O 0 2.5040139406407036e-10
with O 0 4.783430984645065e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.5058329811145086e-06
161 O 0 1.8578820970560628e-07
of O 0 5.470150199471391e-07
their O 0 5.6351519006625495e-09
sisters O 0 2.5128629843607087e-08
as O 0 4.053298807704664e-10
controls O 0 1.4113645363522664e-07
in O 0 3.3710505498163457e-09
a O 0 8.064395373708066e-09
case O 0 3.034289974834792e-08
- O 0 9.439317771864353e-09
control O 0 1.5356317817349918e-07
study O 0 1.927189607897617e-08
. O 0 3.503989276509856e-08

All O 0 6.744509839506918e-09
the O 0 2.449399127968377e-09
patients O 0 3.1913466314037464e-10
carried O 0 2.897749575014874e-11
a O 0 9.017669423683206e-12
pathogenic O 0 1.9800324574381634e-11
mutation O 0 6.74520682364399e-12
in O 0 8.745865837100908e-11
either O 0 7.452398698148954e-10
BRCA1 O 0 2.8882712888034234e-10
( O 0 1.5658424556974637e-10
179 O 0 1.980374531029838e-09
women O 0 7.802390677991156e-11
) O 0 8.631781400758598e-11
or O 0 5.242887790579687e-10
BRCA2 O 0 4.0975143278387804e-09
( O 0 1.4340456599981621e-09
28 O 0 4.035703398130863e-07
women O 0 4.758732963239254e-09
) O 0 6.678965824846728e-09
. O 0 9.719231286453578e-08

The O 0 1.1365631280568778e-07
control O 0 1.1424383501434932e-06
women O 0 7.454190598110699e-10
were O 0 3.487410360492049e-10
enrolled O 0 6.68135768933098e-10
regardless O 0 3.343360865937228e-10
of O 0 6.613967151736233e-10
whether O 0 1.6271071989759633e-10
or O 0 1.604009008948637e-10
not O 0 2.0489457353001228e-11
they O 0 1.3586219822780965e-11
had O 0 3.2625624424298394e-10
either O 0 4.925810315192791e-10
mutation O 0 2.1020547524841504e-09
. O 0 1.5583804469088136e-08

Lifetime O 0 1.2018937241009553e-06
histories O 0 6.544465804836364e-07
of O 0 2.620236045913771e-07
oral O 0 8.279882422357332e-06
- O 0 3.120271685475018e-08
contraceptive O 0 4.825345012449134e-09
use O 0 1.6598732111017256e-10
were O 0 3.3439844643323724e-11
obtained O 0 9.144390106241573e-11
by O 0 1.0185784507510398e-11
interview O 0 8.378525651053792e-10
or O 0 1.079496041167527e-11
by O 0 8.605077371146019e-13
written O 0 3.034040683622119e-12
questionnaire O 0 2.908340668988929e-12
and O 0 5.417600396073752e-12
were O 0 4.238980000348391e-11
compared O 0 8.517564986654236e-10
between O 0 2.7991870155119614e-08
patients O 0 4.063355873995533e-09
and O 0 5.487010845683926e-10
control O 0 2.305337693542242e-05
women O 0 1.7202541613414724e-09
, O 0 5.263896957208303e-11
after O 0 2.2932236665162975e-10
adjustment O 0 6.32602681349681e-09
for O 0 8.460630807061165e-11
year O 0 7.634830267999604e-11
of O 0 5.591586749176258e-09
birth O 0 1.6209199316108425e-08
and O 0 1.1975166636091217e-08
parity O 0 1.4306157936516684e-05
. O 0 5.053440190749825e-07

RESULTS O 0 2.6899073191088974e-07
The O 0 1.0443410580762702e-08
adjusted O 0 1.1057512949719239e-07
odds O 0 3.3312832670162607e-07
ratio O 0 7.688912262437952e-08
for O 0 6.927623417141149e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 9.119665264734067e-06
with O 0 1.1110482533993604e-09
any O 0 2.396138842897244e-09
past O 0 3.850857410725439e-10
use O 0 6.579325279032489e-11
of O 0 1.8223926812055424e-09
oral O 0 6.317160909929953e-07
contraceptives O 0 7.650065754205571e-07
was O 0 1.7368989801980206e-07
0 O 0 1.3792936215395457e-07
. O 0 6.12653465736912e-08

5 O 0 6.819641953370592e-07
( O 0 9.130316946937e-09
95 O 0 1.0390068894139404e-07
percent O 0 2.1435438313233135e-08
confidence O 0 4.932038777383241e-08
interval O 0 4.308320455947978e-08
, O 0 1.182916653519328e-09
0 O 0 9.757727958970008e-10
. O 0 4.272495898738349e-11
3 O 0 1.9246320093202485e-09
to O 0 2.1838272856733454e-10
0 O 0 2.2504833552261516e-09
. O 0 2.5490701216490663e-10
8 O 0 4.1474773837535395e-08
) O 0 6.436441601920251e-09
. O 0 1.0822358831319434e-07

The O 0 1.3564962841883244e-07
risk O 0 3.476887044939758e-08
decreased O 0 3.2851750209061947e-09
with O 0 2.386567159173847e-11
increasing O 0 1.435790930592873e-10
duration O 0 3.778228396811301e-09
of O 0 1.9538064222057727e-10
use O 0 6.24574073015971e-11
( O 0 3.848505888970344e-11
P O 0 1.3180247115940347e-08
for O 0 1.5109137552204999e-10
trend O 0 2.2036572566719315e-09
, O 0 1.4096003531083312e-10
< O 0 2.4787161212458386e-09
0 O 0 6.579027322928255e-10
. O 0 3.733601622313287e-11
001 O 0 3.3893672313212164e-09
) O 0 3.221108449413812e-11
; O 0 1.3029978138123788e-11
use O 0 4.510976661653565e-11
for O 0 1.2302822649523648e-10
six O 0 9.744597351257767e-10
or O 0 2.2572917146579385e-10
more O 0 7.900504903068928e-12
years O 0 1.3445985991289433e-10
was O 0 1.1847592906732984e-09
associated O 0 2.866849535543281e-10
with O 0 1.6576543956925427e-11
a O 0 4.760601357567396e-10
60 O 0 2.2359019080653297e-09
percent O 0 2.1113126802418947e-09
reduction O 0 2.109948837869524e-08
in O 0 2.700056001003759e-08
risk O 0 1.5839593743294245e-06
. O 0 5.442534529720433e-07

Oral O 0 0.00028462675982154906
- O 0 6.578205216101196e-07
contraceptive O 0 6.385064210689961e-08
use O 0 3.047593732929954e-09
protected O 0 8.243065167334862e-06
against O 1 0.9999939203262329
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.6291808435653365e-07
for O 0 1.2872465315894033e-09
carriers O 0 2.1295842866919656e-10
of O 0 2.9860158790029345e-09
the O 0 1.9296015896230756e-09
BRCA1 O 0 9.134528133891706e-10
mutation O 0 1.5247403339913035e-10
( O 0 1.0581448911528568e-10
odds O 0 1.0427586794037325e-08
ratio O 0 1.234947255568386e-09
, O 0 1.9338081136410779e-10
0 O 0 5.140294301320125e-10
. O 0 2.3277990646164426e-11
5 O 0 6.59385102075305e-10
; O 0 3.121076314061e-11
95 O 0 7.087679776418554e-09
percent O 0 6.277108610674986e-09
confidence O 0 2.353320027737027e-08
interval O 0 3.17581729802896e-08
, O 0 4.766270711442644e-10
0 O 0 4.826888888587177e-10
. O 0 1.230837914228955e-11
3 O 0 7.039335780945066e-10
to O 0 9.959518626478925e-11
0 O 0 1.1671946742453088e-09
. O 0 2.074340005320252e-11
9 O 0 1.692760598359655e-09
) O 0 3.094745293363843e-11
and O 0 2.5192851277333617e-11
for O 0 5.754153403758622e-11
carriers O 0 1.9714978261031746e-10
of O 0 6.631314164451396e-09
the O 0 9.444108606260215e-09
BRCA2 O 0 4.8723824974672425e-09
mutation O 0 1.107603564420856e-09
( O 0 3.3432845381042853e-10
odds O 0 2.0074605089348552e-08
ratio O 0 5.362136512587767e-09
, O 0 2.812311494793107e-10
0 O 0 6.910310101915229e-10
. O 0 2.4635838508091368e-11
4 O 0 2.234580520621421e-09
; O 0 3.263232739580957e-11
95 O 0 4.166869960187114e-09
percent O 0 4.8218122827847765e-09
confidence O 0 1.5248524221078696e-08
interval O 0 3.9731233414386224e-08
, O 0 5.103114597559966e-10
0 O 0 6.076904535134986e-10
. O 0 8.093572340106547e-11
2 O 0 5.164944916202785e-09
to O 0 4.154266375344662e-10
1 O 0 2.976231705531518e-08
. O 0 9.775015241686447e-10
1 O 0 1.1671868804796759e-07
) O 0 5.053678364674852e-09
. O 0 8.612519764028548e-08

CONCLUSIONS O 0 3.3540420645294944e-06
Oral O 0 2.6213105229544453e-05
- O 0 1.0330313671147451e-07
contraceptive O 0 8.198706602513539e-09
use O 0 1.512384245616616e-10
may O 0 1.0621931806342744e-10
reduce O 0 2.0136595169084615e-10
the O 0 1.8984423755252777e-10
risk O 0 5.433215619632392e-07
of O 1 0.9939861297607422
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.07417745818384e-06
women O 0 3.22645937744781e-10
with O 0 2.630828020711018e-11
pathogenic O 0 1.093768853266397e-09
mutations O 0 3.422790106899498e-10
in O 0 4.53494436447599e-10
the O 0 7.534556090149636e-09
BRCA1 O 0 2.2238376118366432e-07
or O 0 5.298253427099553e-07
BRCA2 O 0 4.221653398417402e-06
gene O 0 0.00013052400026936084

A O 0 1.3735838138018153e-06
Japanese O 0 3.1092981771507766e-06
family O 0 1.228733292890638e-08
with O 0 4.314798740523429e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.343202242296229e-09
a O 0 1.1731747129317682e-08
codon O 0 5.291645344129847e-09
291 O 0 1.2799945547925518e-09
deletion O 0 3.4056537145943366e-08
: O 0 3.582635854648686e-10
a O 0 3.414899751863487e-10
clinical O 0 7.768393039953025e-09
, O 0 5.81751091743854e-10
biochemical O 0 3.190863537838595e-07
, O 0 2.308699675879211e-09
pathological O 0 0.0011704480275511742
, O 0 3.0433242592664556e-09
and O 0 1.6269280367353645e-09
genetic O 0 6.337781144338805e-08
report O 0 2.465129433915081e-08
. O 0 1.3994919356719038e-07

We O 0 1.8393722100995546e-08
report O 0 1.3144716426438663e-09
a O 0 2.7581162354017863e-10
Japanese O 0 8.072151835847308e-09
family O 0 4.976484224705757e-10
with O 0 1.1848231729061354e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.1361777978891041e-05
ALD B-Disease 1 1.0
) O 0 2.9738580487048694e-09
with O 0 4.825011501452536e-10
a O 0 3.6020970650696427e-09
three O 0 5.080204590335313e-10
base O 0 1.0316250076414235e-08
pair O 0 1.1447490066984756e-07
deletion O 0 6.68128734560014e-08
( O 0 2.2149675427129978e-09
delGAG O 0 6.451463718804007e-08
291 O 0 2.8389040007681388e-09
) O 0 4.814788567841788e-10
in O 0 1.6207459818673442e-09
the O 0 1.205351765065643e-07
ALD B-Disease 1 1.0
gene O 0 1.6551961380173452e-05
. O 0 2.797250090225134e-06

A O 0 1.2861040943334956e-07
variety O 0 9.405064282930198e-09
of O 0 4.082255866677542e-09
phenotypes O 0 4.9267052659729416e-09
were O 0 3.977206342042905e-10
observed O 0 1.566339169478681e-09
within O 0 4.958945476474241e-10
this O 0 9.054073463188317e-11
family O 0 1.7134886842740116e-09
. O 0 1.950487060753403e-08

While O 0 1.530712978592419e-07
the O 0 6.040566091769506e-08
proband O 0 7.245828783197794e-06
( O 0 4.974892053866142e-09
patient O 0 1.4843448248313962e-08
1 O 0 3.043297454041749e-07
) O 0 2.4796040221097826e-10
was O 0 7.766230325501056e-09
classified O 0 1.4197085729250603e-09
as O 0 1.2280221284299841e-10
having O 0 3.1115321430519316e-10
a O 0 7.442636784649181e-11
rare O 0 5.47788966964724e-11
intermediate O 0 5.313184892052902e-10
type O 0 1.6565120386502485e-09
of O 0 2.180603786428037e-08
adult O 0 8.103390882752137e-07
cerebral O 0 0.19620224833488464
and O 0 1.6504701605413175e-08
cerebello O 0 0.2754910886287689
- O 0 2.065684566332493e-05
brain O 0 1.3203795788285788e-05
stem O 0 4.028053002258503e-09
forms O 0 2.0205239703585676e-09
, O 0 1.8387109890216635e-10
his O 0 1.43940570573875e-09
younger O 0 1.9169467790902672e-08
brother O 0 1.0926229521146524e-07
( O 0 4.839740275208726e-10
patient O 0 4.7505803735248264e-09
2 O 0 6.950315878384572e-08
) O 0 1.3774592577675548e-10
and O 0 1.4722029151315041e-09
nephew O 0 1.0113039934367407e-05
( O 0 3.295410611059424e-09
patient O 0 8.673317353213861e-08
3 O 0 8.259891615125525e-07
) O 0 3.605644005588715e-09
had O 0 1.4112137591837381e-07
a O 0 1.9187926625363616e-07
childhood O 1 0.5783517360687256
ALD B-Disease 1 1.0
type O 1 0.7848015427589417
. O 0 7.160873337852536e-06

Another O 0 2.0091113128728466e-06
nephew O 0 0.00013040905469097197
( O 0 2.2151841250206417e-08
patient O 0 1.019664992440994e-07
4 O 0 1.3534207710108603e-07
) O 0 6.390870055383857e-10
of O 0 2.8605819935023646e-08
patient O 0 8.407348417449612e-08
1 O 0 1.8785990505421069e-06
was O 0 6.181243605851705e-08
classified O 0 5.387372770115917e-10
as O 0 9.560673086550509e-11
having O 0 2.073684418624211e-10
an O 0 1.0628416202695945e-10
adolescent O 0 5.4592689480159606e-08
form O 0 2.2117390585663088e-08
. O 0 5.405709657679836e-07

The O 0 1.3104987317547057e-07
tau O 0 1.3479068456945242e-06
level O 0 8.470159968965163e-07
in O 0 5.662421642682602e-09
the O 0 1.6866348317989832e-08
cerebrospinal O 0 2.2439611711888574e-05
fluid O 0 0.00010776802082546055
( O 0 4.6637747885824865e-08
CSF O 0 2.3082238840288483e-05
) O 0 1.3588254965668511e-09
in O 0 1.7601421431479025e-09
patient O 0 1.7833043486348288e-08
1 O 0 2.248125525738942e-07
was O 0 3.531485148755564e-08
as O 0 2.8460156453746777e-10
high O 0 2.835592205485682e-09
as O 0 1.2670322256658206e-11
that O 0 3.218895636147856e-12
of O 0 1.1667917743096723e-09
patients O 0 2.5600539466097416e-09
with O 0 1.4744125920174156e-08
Alzheimers B-Disease 1 1.0
disease I-Disease 0 0.011750645004212856
( O 0 1.659684056853905e-09
AD B-Disease 0 3.5903081396782e-08
) O 0 4.194236069565704e-09
. O 0 2.7722961704057525e-08

His O 0 9.473352520217304e-07
brain O 0 3.4489955851313425e-06
magnetic O 0 7.772017625029548e-07
resonance O 0 5.046788942308922e-07
image O 0 2.1306263420228788e-08
( O 0 2.509205898615363e-10
MRI O 0 4.130930335577432e-07
) O 0 3.4898722800491555e-10
showed O 0 9.54370182881803e-09
abnormalities B-Disease 0 3.2321870548912557e-06
in I-Disease 0 9.046930982137269e-10
the I-Disease 0 8.518365568477293e-09
bilateral I-Disease 1 0.9999817609786987
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 0 0.12858791649341583
and O 0 1.166483514225547e-07
brain O 0 0.0002085191081278026
stem O 0 1.9566725129038787e-08
, O 0 1.2007517202761164e-10
but O 0 6.910184230379812e-12
not O 0 9.830648448061474e-12
in O 0 1.3582185376392886e-10
the O 0 1.642408098412318e-09
cerebral O 0 0.0002189394144807011
white O 0 1.7310442856910413e-08
matter O 0 3.7459688684293724e-08
, O 0 3.078666488409709e-11
where O 0 1.089811140636554e-11
marked O 0 2.5112394802517812e-11
reductions O 0 3.5910510676195884e-10
of O 0 6.430769250442836e-10
the O 0 1.352789880115779e-09
cerebral O 0 1.379672085022321e-05
blood O 0 1.3362396522609288e-08
flow O 0 1.788765224830513e-08
and O 0 3.559907479910862e-09
oxygen O 0 4.716752144418024e-08
metabolism O 0 1.6832113658438175e-07
were O 0 1.0051661725185568e-09
clearly O 0 2.479301486335572e-10
demonstrated O 0 3.57931462247052e-11
by O 0 3.0348972033383825e-12
positron O 0 1.8532462231490854e-09
emission O 0 8.627670800009923e-10
tomography O 0 1.1793831333761773e-07
( O 0 1.9807708806496294e-09
PET O 0 4.551916887862717e-08
) O 0 2.9058830897099597e-09
. O 0 6.049720724377039e-08

In O 0 5.914247935834283e-07
patients O 0 1.9459392319731705e-07
2 O 0 1.2116854577470804e-06
and O 0 6.157494958358711e-09
3 O 0 5.453607698768792e-08
, O 0 4.68237844331032e-11
the O 0 2.5355014962591405e-11
autopsy O 0 1.0761056934427415e-08
findings O 0 5.587426077369173e-10
showed O 0 4.3946748462531104e-09
massive O 0 5.884295717351051e-08
demyelination B-Disease 1 1.0
of I-Disease 0 0.002269719261676073
the I-Disease 0 2.0904801203869283e-05
cerebral I-Disease 1 0.9999103546142578
white I-Disease 0 2.7967054450073192e-08
matter I-Disease 0 1.779346270325277e-08
with O 0 2.519342720552764e-11
sparing O 0 5.520266466163548e-10
of O 0 3.095373957151537e-09
the O 0 1.7988067924079587e-08
U O 1 0.5503007769584656
- O 0 7.826658475096337e-06
fibers O 0 9.396407563144749e-08
, O 0 2.7320110063122627e-10
compatible O 0 2.548050881401309e-09
with O 0 2.538603181834187e-11
the O 0 7.664156809195077e-11
findings O 0 2.423411749052917e-10
of O 0 1.3428724798814073e-08
childhood O 0 0.00046569740516133606
ALD B-Disease 1 1.0
. O 0 1.6078774933703244e-05

Oleic O 0 0.0011625498300418258
and O 0 2.452374474160024e-06
erucic O 0 0.01583043672144413
acids O 0 1.1185566108906642e-06
( O 0 9.162398839634989e-09
Lorenzos O 0 6.459836754402204e-07
Oil O 0 3.3239011543173547e-08
) O 0 5.685097878571632e-11
were O 0 8.44774736274978e-11
administered O 0 9.480627394253816e-11
to O 0 5.688199911091374e-11
patients O 0 7.024020254320362e-10
1 O 0 5.553792448154127e-08
and O 0 8.333120304904185e-10
4 O 0 2.9533349987787005e-08
, O 0 7.624817444096266e-11
but O 0 1.4678610757434818e-11
sufficient O 0 3.394948766555217e-10
effectiveness O 0 1.3461826098293272e-09
was O 0 6.894988580086192e-09
not O 0 1.2732030707507391e-10
obtained O 0 7.250612554798863e-09
. O 0 2.4404700482705266e-08

The O 0 3.212143795394695e-08
findings O 0 2.0075399120855764e-09
in O 0 2.704841628453636e-10
this O 0 6.168197896894156e-11
family O 0 2.3397561665916555e-10
suggest O 0 1.572960789397726e-10
that O 0 3.4153391920144216e-12
delGAG291 O 0 5.373826383880953e-10
is O 0 1.8366280718495887e-11
part O 0 7.834795312522402e-11
of O 0 1.432634899600771e-09
the O 0 7.452342076774698e-10
cause O 0 1.0372757763832396e-08
of O 0 4.4012118394221034e-08
Japanese O 0 2.1208295947872102e-05
ALD B-Disease 1 1.0
with O 0 3.3538756216699994e-09
phenotypic O 0 6.121983915363671e-06
variations O 0 2.076280452456558e-06
. O 0 5.184688802728488e-07

Moreover O 0 4.420536754423665e-07
, O 0 2.8624580483693762e-09
although O 0 2.517067387852734e-10
the O 0 1.8163535953075183e-10
scale O 0 2.8530173779017787e-09
of O 0 1.1105439901015757e-09
the O 0 2.3595289611044734e-10
study O 0 2.8428785367462517e-11
is O 0 2.552103493813629e-12
limited O 0 1.1269260698221206e-11
, O 0 1.6815699874217493e-11
there O 0 4.926991453713114e-11
is O 0 3.4335510129546165e-11
a O 0 1.3988708802425975e-10
possibility O 0 1.1010067302308357e-09
that O 0 1.6713130879253413e-10
PET O 0 9.207686169077078e-09
can O 0 1.0011132201004358e-10
detect O 0 4.681778165149808e-08
an O 0 1.3785138586186463e-09
insidious B-Disease 0 1.4617205579270376e-06
lesion I-Disease 0 1.0176051546295639e-05
which O 0 6.011608433276194e-10
is O 0 7.796990136865745e-11
undetectable O 0 3.7471177272152545e-09
by O 0 6.23419284945248e-12
computed O 0 1.1548078049372634e-08
tomogram O 0 3.00015557286315e-07
( O 0 1.5575327694250518e-09
CT O 0 1.2563538120957674e-06
) O 0 3.3865546478217823e-10
or O 0 1.934055277041935e-10
MRI O 0 4.550041978745867e-07
analysis O 0 6.404015095995419e-09
, O 0 1.1957670964513056e-10
and O 0 2.0924602328609154e-11
that O 0 2.7953292892207715e-12
the O 0 4.32453274579192e-11
higher O 0 7.335796969876185e-10
level O 0 5.989670537331904e-09
of O 0 1.8617419828004245e-09
tau O 0 4.707995326924674e-09
reflects O 0 5.988727569405938e-11
the O 0 1.2337829542741208e-11
process O 0 3.0980068510544356e-10
of O 0 5.627966093157966e-09
neuronal B-Disease 0 1.561869794386439e-05
degeneration I-Disease 1 0.9983616471290588
in O 0 8.798884664429352e-06
ALD B-Disease 1 1.0
. O 0 3.6563687899615616e-05

Lorenzos O 0 0.0007151648751460016
Oil O 0 2.2770182113163173e-06
should O 0 2.117765740550226e-09
be O 0 3.604760240305538e-11
given O 0 1.4747364787681683e-11
in O 0 4.692460829625045e-12
the O 0 1.4573663456585173e-11
early O 0 4.851736790101313e-10
stage O 0 2.8583226896472524e-09
. O 0 6.208532021823032e-10
. O 0 1.815039318842082e-08

Nonsense O 0 5.677798071701545e-06
mutation O 0 1.3020880373915134e-08
in O 0 1.0060086985674843e-08
exon O 0 8.65830656948674e-07
4 O 0 3.467265230483463e-07
of O 0 8.123170402996038e-08
human O 0 3.2295289997819054e-08
complement O 0 2.371090204178472e-07
C9 O 0 3.374987136339769e-05
gene O 0 2.610259208779553e-08
is O 0 3.13266607099294e-10
the O 0 1.4424281213898382e-10
major O 0 3.745167287405593e-09
cause O 0 2.3405887006333614e-08
of O 0 5.0014293151434686e-08
Japanese O 0 2.1830728655913845e-05
complement B-Disease 0 4.8683930799597874e-05
C9 I-Disease 1 0.9995672106742859
deficiency I-Disease 1 0.9995118379592896
. O 0 1.843696372816339e-05

Deficiency B-Disease 1 0.9934214949607849
of I-Disease 0 2.0891207896056585e-05
the I-Disease 0 3.1282095847018354e-07
ninth I-Disease 0 7.067978344821313e-07
component I-Disease 0 2.0805568112791661e-07
of I-Disease 0 2.2093362872510625e-07
human I-Disease 0 4.9857998618563215e-08
complement I-Disease 0 1.3577529500707897e-07
( O 0 1.6205859765250352e-08
C9 O 0 5.082079042040277e-06
) O 0 8.28273005737401e-10
is O 0 5.15033120318531e-11
the O 0 7.665004742030135e-11
most O 0 6.893968729215771e-11
common O 0 1.4665648251366292e-08
complement B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 2.114195467584068e-07
Japan O 0 4.7784361356661975e-08
but O 0 8.476379320665473e-11
is O 0 1.0546907097674918e-11
rare O 0 2.7106971181578565e-11
in O 0 1.871523769292338e-11
other O 0 1.0855379789509456e-10
countries O 0 8.815305707621235e-10
. O 0 6.667995933185011e-08

We O 0 3.4442347640606386e-08
studied O 0 1.6516392520316003e-07
the O 0 1.7728367385227983e-10
molecular O 0 5.5242193042204235e-09
basis O 0 1.4435553197245099e-08
of O 0 2.4657172303932384e-08
C9 B-Disease 0 0.004759741947054863
deficiency I-Disease 0 0.0001742052991176024
in O 0 1.3733759018919045e-08
four O 0 9.798465150367974e-09
Japanese O 0 2.438705450913403e-06
C9 B-Disease 1 0.9989268183708191
- I-Disease 0 0.029787305742502213
deficient I-Disease 0 0.13516175746917725
patients O 0 6.794545697630383e-06
who O 0 5.532288227527715e-08
had O 0 1.6064975625340594e-06
suffered O 1 0.9999135732650757
from O 0 0.006778602488338947
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 7.216150947897404e-07

Direct O 0 8.43019876128892e-08
sequencing O 0 3.866781028705191e-08
of O 0 6.473651126270852e-08
amplified O 0 1.8634860055044555e-07
C9 O 0 3.362846882737358e-06
cDNA O 0 1.1778465136558225e-07
and O 0 2.1983761477883945e-09
DNA O 0 6.431312371546483e-09
revealed O 0 1.1764372587208527e-08
a O 0 1.4761958322395685e-09
nonsense O 0 4.032657763275438e-09
substitution O 0 1.4866220476861258e-09
( O 0 4.949798348974355e-10
CGA O 0 2.020113356593356e-07
- O 0 1.97581382366252e-08
- O 0 5.248643741850856e-09
> O 0 4.372134654317961e-09
TGA O 0 2.062023618520925e-08
) O 0 9.50162656887521e-11
at O 0 1.6515463441280076e-09
codon O 0 6.661558527021327e-10
95 O 0 3.736098985740455e-09
in O 0 9.614551377268299e-10
exon O 0 1.161015390493958e-07
4 O 0 5.475119735365297e-08
in O 0 2.605224258545036e-09
the O 0 2.4685688160275276e-08
four O 0 2.545368715800578e-07
C9 B-Disease 0 0.025272110477089882
- I-Disease 0 0.00018335014465264976
deficient I-Disease 0 2.283809953951277e-05
individuals O 0 2.5466576403232466e-08
. O 0 4.946641070091573e-07

An O 0 4.762855887463502e-09
allele O 0 1.2404507643282159e-08
- O 0 3.857210550961554e-09
specific O 0 3.568178530422017e-10
polymerase O 0 3.5988986013535396e-08
chain O 0 3.6792495716753137e-09
reaction O 0 1.417321537910965e-10
system O 0 1.2438926555446983e-09
designed O 0 2.8663043050158876e-09
to O 0 1.0479576928457135e-10
detect O 0 4.4689159039990045e-09
exclusively O 0 1.6866757990285919e-09
only O 0 7.808643315287966e-11
one O 0 3.404738990742118e-11
of O 0 3.871751530493128e-10
the O 0 1.621054124267829e-10
normal O 0 4.516336193916004e-09
and O 0 4.2388668963777576e-11
mutant O 0 1.110301989237783e-10
alleles O 0 1.3358223381609857e-11
indicated O 0 3.956407146343821e-10
that O 0 2.8959965935743126e-12
all O 0 5.872790968808328e-12
the O 0 5.7240941153668956e-11
four O 0 6.777179512029718e-11
patients O 0 2.3463423912128967e-11
were O 0 3.511745408357747e-11
homozygous O 0 2.6366551303391716e-11
for O 0 1.4037693750468261e-11
the O 0 4.9163648846439756e-11
mutation O 0 5.976882877511969e-11
in O 0 4.772401918096136e-10
exon O 0 4.74821852947116e-08
4 O 0 9.966578673470394e-09
and O 0 1.0680439865851099e-10
that O 0 1.1788523282540986e-11
the O 0 1.8625792574944455e-10
parents O 0 1.2843691388209066e-10
of O 0 1.5732825042746867e-09
patient O 0 3.581082097525723e-08
2 O 0 1.169035499515303e-06
were O 0 4.594325275775191e-08
heterozygous O 0 1.3631409956360585e-07
. O 0 1.347833062936843e-07

The O 0 4.767975525510337e-08
common O 0 1.174034292006354e-08
mutation O 0 8.27186819041259e-10
at O 0 9.872829664914207e-09
codon O 0 2.2209747374546396e-09
95 O 0 1.944788508012607e-08
in O 0 7.396932844017101e-09
exon O 0 6.342877441056771e-07
4 O 0 1.8540006863076997e-07
might O 0 2.5237600898009305e-09
be O 0 1.3373348262124551e-10
responsible O 0 2.583726566030009e-10
for O 0 1.6416400183683066e-10
most O 0 6.350153181067242e-10
Japanese O 0 3.821116479230113e-06
C9 B-Disease 1 0.9961536526679993
deficiency I-Disease 0 0.007344651501625776
. O 0 4.007937448591292e-08
. O 0 1.0509776871003851e-07

BRCA1 O 0 1.978007162506401e-07
required O 0 2.022263956291681e-08
for O 0 3.252188518487742e-09
transcription O 0 1.8641432006916148e-06
- O 0 1.185449150398199e-06
coupled O 0 7.816237257429748e-07
repair O 0 0.002137842820957303
of O 0 3.939817815989954e-06
oxidative O 0 0.00016433425480499864
DNA O 0 7.164057024056092e-06
damage O 0 0.0005621740710921586
. O 0 8.797103987490118e-07

The O 0 1.0716180440795142e-06
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9999948740005493
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999159574508667
gene O 0 5.117455657455139e-06
BRCA1 O 0 2.7656926704366924e-07
encodes O 0 2.238847862656712e-08
a O 0 2.0378688248001708e-07
zinc O 0 0.00019453118147794157
finger O 0 9.054955444298685e-05
protein O 0 1.2030037623844692e-06
of O 0 2.871921083169582e-07
unknown O 0 1.5280892284863512e-06
function O 0 1.7391345181749784e-06
. O 0 3.06719556419921e-07

Association O 0 2.9689354619222286e-07
of O 0 2.7534076707524946e-07
the O 0 3.7338637071115954e-08
BRCA1 O 0 2.920860175947837e-08
protein O 0 8.150092156711253e-09
with O 0 2.434470403045452e-10
the O 0 2.7656295031874834e-09
DNA O 0 7.453728301243245e-08
repair O 0 1.1744902622012887e-05
protein O 0 2.2990032277903083e-07
Rad51 O 0 5.235987714513612e-07
and O 0 3.930817615849236e-10
changes O 0 4.6285356103403785e-10
in O 0 1.5430252908732456e-10
the O 0 1.0215830265059012e-10
phosphorylation O 0 1.26817456536088e-09
and O 0 5.286154847183866e-10
cellular O 0 2.752779337811262e-08
localization O 0 5.886619192096987e-07
of O 0 6.781714745329737e-08
the O 0 1.4513101831425956e-08
protein O 0 3.792236569211127e-08
after O 0 1.5617457549410574e-08
exposure O 0 1.2820042627481598e-07
to O 0 1.2252526770950567e-09
DNA O 0 7.047053429687367e-08
- O 0 2.1640756742158374e-08
damaging O 0 1.1013811196391998e-08
agents O 0 5.183318219081912e-10
are O 0 4.109263710555533e-12
consistent O 0 3.466148201791697e-11
with O 0 2.7187215152768562e-12
a O 0 8.103396426095699e-11
role O 0 4.0564077097293705e-10
for O 0 1.670921734309161e-09
BRCA1 O 0 1.55281725255918e-08
in O 0 4.198255965093267e-08
DNA O 0 2.2191945845406735e-06
repair O 1 0.5092462301254272
. O 0 3.6595538404071704e-06

Here O 0 3.844227762783703e-07
, O 0 1.1267853317065146e-09
it O 0 1.4131692344099278e-11
is O 0 3.2623723601049592e-12
shown O 0 1.444401282607588e-11
that O 0 8.3639241366118e-12
mouse O 0 6.553928511010554e-10
embryonic O 0 3.17216497514039e-09
stem O 0 5.525357060776059e-09
cells O 0 1.540320981874288e-09
deficient B-Disease 0 2.709631985453598e-07
in I-Disease 0 5.931699575967286e-09
BRCA1 I-Disease 0 4.034188538781791e-09
are O 0 7.743694574458004e-11
defective O 0 1.3427291278844677e-08
in O 0 2.1171869812874888e-10
the O 0 1.4091514066727484e-10
ability O 0 3.2680913530924727e-11
to O 0 1.8396079798366216e-11
carry O 0 7.747905095278895e-11
out O 0 1.1434330045301255e-11
transcription O 0 9.271056811144263e-09
- O 0 1.5776496553598918e-08
coupled O 0 5.407370551324675e-08
repair O 0 1.3714823580812663e-05
of O 0 9.666354117143783e-07
oxidative O 0 4.890046056971187e-06
DNA O 0 2.740725619787554e-07
damage O 0 3.2506628485862166e-05
, O 0 1.5847422263348676e-09
and O 0 9.738744255471943e-10
are O 0 1.970580504329078e-10
hypersensitive O 0 1.799998443630102e-07
to O 0 8.779468707587057e-09
ionizing O 0 0.07958384603261948
radiation O 1 0.6709996461868286
and O 0 9.266424960685526e-09
hydrogen O 0 6.302171584593452e-08
peroxide O 0 3.5330253922438715e-07
. O 0 1.0837024433385523e-07

These O 0 5.15195752726072e-09
results O 0 3.163754147550435e-09
suggest O 0 2.7360589349711972e-09
that O 0 1.7129160589934855e-10
BRCA1 O 0 2.398049980811834e-09
participates O 0 9.515052079578368e-10
, O 0 1.4020494487620994e-10
directly O 0 5.776765732434797e-10
or O 0 2.874992188761638e-10
indirectly O 0 6.988820078213109e-10
, O 0 3.708066839691604e-11
in O 0 1.8310393479215037e-10
transcription O 0 2.5769676881282066e-07
- O 0 7.349177622018033e-07
coupled O 0 7.827143235772382e-07
repair O 0 0.06446162611246109
of O 0 2.910125294874888e-05
oxidative O 0 0.00016566715203225613
DNA O 0 3.1508918709732825e-06
damage O 0 1.2944994523422793e-05
. O 0 1.774320246283878e-08
. O 0 1.441467532004026e-07

Truncation O 0 1.5577819794998504e-05
mutations O 0 8.964062914174065e-08
in O 0 4.8480393033401015e-09
the O 0 6.028558985349264e-09
transactivation O 0 4.220856226311298e-06
region O 0 5.7649277351856654e-08
of O 0 8.71158221116275e-08
PAX6 O 0 9.493073775956873e-06
result O 0 2.570084944863993e-08
in O 0 1.563772755730497e-08
dominant O 0 1.2883920135209337e-05
- O 0 2.90856377205273e-07
negative O 0 1.1286399370646905e-08
mutants O 0 1.8631838827332103e-07
. O 0 7.649490640915246e-08

PAX6 O 0 0.00010321563604520634
is O 0 2.6512585904470143e-08
a O 0 2.91781843131389e-09
transcription O 0 6.995718671021223e-09
factor O 0 3.590011843357388e-09
with O 0 2.4396437647844493e-10
two O 0 3.2434643859602375e-10
DNA O 0 8.774659332466683e-10
- O 0 4.4149287004024984e-10
binding O 0 5.091350119279525e-10
domains O 0 9.693531310972503e-09
( O 0 5.388246515636297e-10
paired O 0 3.6075153975190233e-09
box O 0 9.15578226567959e-08
and O 0 3.4674412230373264e-09
homeobox O 0 8.60112692180337e-08
) O 0 5.275739844989857e-10
and O 0 1.622159295777692e-09
a O 0 2.9623391739619365e-08
proline O 0 2.8460840439947788e-06
- O 0 2.1734799702244345e-06
serine O 0 1.1043281347156153e-06
- O 0 3.158883998821693e-07
threonine O 0 1.6387282641971979e-07
( O 0 4.2822820844889975e-09
PST O 0 1.6934991435846314e-05
) O 0 1.1656778653446054e-08
- O 0 3.603562603871069e-08
rich O 0 5.489002585790104e-09
transactivation O 0 1.2148615269325092e-06
domain O 0 1.2902924027002882e-06
. O 0 2.9725052286266873e-07

PAX6 O 0 0.0016743578016757965
regulates O 0 4.3828340494656e-06
eye O 0 8.626281669421587e-06
development O 0 3.3332526072626933e-08
in O 0 2.883896232930283e-09
animals O 0 1.6495999011212348e-10
ranging O 0 1.9865760592097104e-08
from O 0 3.887030974869532e-10
jellyfish O 0 1.3689442635023141e-10
to O 0 2.765712658892028e-10
Drosophila O 0 1.5897079208571085e-08
to O 0 7.627821929645506e-09
humans O 0 1.1454139325905999e-07
. O 0 1.1665903087987317e-07

Heterozygous O 0 1.9994193678485317e-07
mutations O 0 6.969096411069131e-09
in O 0 5.959980842185075e-10
the O 0 1.2339442800879397e-09
human O 0 4.8129180640898994e-09
PAX6 O 0 1.0730190069807577e-06
gene O 0 4.1764263158938775e-09
result O 0 2.275305277521511e-09
in O 0 1.647160047246743e-10
various O 0 3.0318397792328255e-10
phenotypes O 0 4.143703602466076e-09
, O 0 1.0767903929620459e-10
including O 0 7.409623470344684e-10
aniridia B-Disease 1 1.0
, O 0 2.3841509744215728e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.2407238045852864e-06
autosomal B-Disease 1 0.9841916561126709
dominant I-Disease 1 0.9891505837440491
keratitis I-Disease 1 0.999991774559021
, O 0 9.237893294766764e-08
and O 0 4.397981570036791e-07
familial B-Disease 1 0.9999957084655762
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.35711562633514404

It O 0 1.7129146101524384e-08
is O 0 3.6131067027156405e-09
believed O 0 3.768548584304199e-09
that O 0 7.40334356319483e-12
the O 0 2.962927819760708e-11
mutated O 0 2.206490962164409e-10
allele O 0 3.487206079455518e-09
of O 0 2.0058951832879757e-08
PAX6 O 0 3.657286242741975e-06
produces O 0 4.657354502057842e-09
an O 0 3.295069495035108e-10
inactive O 0 8.455416633523782e-08
protein O 0 4.533392257144442e-07
and O 0 4.033359601862685e-08
aniridia B-Disease 1 1.0
is O 0 1.7642840077769506e-08
caused O 0 7.097476384387846e-08
due O 0 1.708554293600173e-07
to O 0 5.462516217136226e-09
genetic O 0 2.0781632770194847e-07
haploinsufficiency O 0 6.666643457720056e-06
. O 0 4.0786784438751056e-07

However O 0 1.425410545152772e-07
, O 0 2.4156183719981072e-09
several O 0 2.413401978262897e-10
truncation O 0 3.3956130351953107e-08
mutations O 0 1.0497547275889474e-09
have O 0 7.028599924296941e-11
been O 0 7.496103737736348e-11
found O 0 9.19770249546703e-12
to O 0 1.9884369758388365e-12
occur O 0 2.7654687567713054e-11
in O 0 7.719700573227684e-11
the O 0 1.7976330424218645e-09
C O 0 0.00011032443580916151
- O 0 1.9450801858056366e-07
terminal O 0 3.31507891360161e-07
half O 0 2.6674529252090906e-09
of O 0 2.5851079055172477e-09
PAX6 O 0 3.2196919619309483e-07
in O 0 6.507838712366265e-10
patients O 0 1.34151689756834e-10
with O 0 1.686697448377572e-10
Aniridia B-Disease 1 0.9999980926513672
resulting O 0 1.735040733308324e-08
in O 0 1.3319743086270819e-09
mutant O 0 1.6216302745064581e-09
proteins O 0 6.519115802738895e-11
that O 0 2.1682371176279247e-11
retain O 0 9.65656332674314e-10
the O 0 4.184246005234371e-10
DNA O 0 1.3920524732924378e-09
- O 0 2.517245023536674e-10
binding O 0 2.611033333987933e-10
domains O 0 2.5271670978099792e-08
but O 0 1.0271088424218533e-09
have O 0 1.7638414340215292e-10
lost O 0 6.0373506194366655e-09
most O 0 1.9658719097037647e-11
of O 0 2.5324867203302404e-10
the O 0 1.0148677453969412e-09
transactivation O 0 9.700264627099386e-07
domain O 0 1.238802497027791e-06
. O 0 6.445553708545049e-07

It O 0 8.500268044997483e-09
is O 0 5.152407389630298e-10
not O 0 3.0900736830430375e-11
clear O 0 1.8813742230783248e-10
whether O 0 2.0531706543258643e-11
such O 0 7.11181669110772e-11
mutants O 0 1.609944710878608e-08
really O 0 8.647148774798552e-09
behave O 0 2.659030995388889e-09
as O 0 5.520414125825823e-10
loss O 0 1.096484858464919e-08
- O 0 1.7670927832114103e-08
of O 0 1.164023188948704e-07
- O 0 3.4989071195923316e-08
function O 0 6.854278211676501e-08
mutants O 0 1.9819813346089177e-08
as O 0 1.0565521790795174e-09
predicted O 0 6.7538294956648315e-09
by O 0 1.707837538056367e-09
haploinsufficiency O 0 8.45840168040013e-06
. O 0 6.580187346116873e-07

Contrary O 0 4.106875053366821e-07
to O 0 1.154514372991855e-09
this O 0 9.061571631940879e-11
theory O 0 8.908204840452072e-09
, O 0 3.43293553306534e-11
our O 0 5.4342651906180706e-11
data O 0 2.778105523404406e-10
showed O 0 2.989684333432052e-10
that O 0 1.3791823585962426e-12
these O 0 9.851516304115737e-13
mutants O 0 2.57446841622766e-10
are O 0 6.485602419697978e-12
dominant O 0 3.2567946117723068e-09
- O 0 3.4968619666564393e-10
negative O 0 5.4815898348214986e-11
in O 0 8.909403076406974e-11
transient O 0 3.465345566056044e-09
transfection O 0 8.40878833230363e-09
assays O 0 4.7346957465776995e-09
when O 0 2.5618501764412827e-10
they O 0 4.1818104534740996e-11
are O 0 8.303759589656234e-12
coexpressed O 0 1.0163947017360897e-08
with O 0 4.790002283705519e-10
wild O 0 1.3918965535708594e-08
- O 0 1.1329064619758356e-07
type O 0 3.587502760638017e-06
PAX6 O 0 0.0012078833533450961
. O 0 2.405450686637778e-06

We O 0 1.0178927567494611e-07
found O 0 2.26155072446943e-09
that O 0 1.4338144387060492e-11
the O 0 2.2902862939488955e-10
dominant O 0 3.648259649935426e-08
- O 0 1.2633172286058425e-09
negative O 0 7.080537545167687e-11
effects O 0 9.448288373903324e-09
result O 0 1.6508872047182876e-10
from O 0 4.844447759611015e-11
the O 0 1.9557740843501037e-11
enhanced O 0 2.750708827381487e-10
DNA O 0 2.0571699899107898e-10
binding O 0 8.881662072468544e-11
ability O 0 2.9141852819769554e-10
of O 0 1.1881945427560936e-09
these O 0 1.7312670741453928e-10
mutants O 0 5.78054084598989e-08
. O 0 3.811002713405287e-08

Kinetic O 0 7.274967970261059e-07
studies O 0 1.2546060190743447e-08
of O 0 4.404274722702439e-09
binding O 0 2.5497375322203197e-09
and O 0 5.040737827144426e-10
dissociation O 0 5.2072413048165345e-09
revealed O 0 7.365646426116257e-10
that O 0 3.2727429707252176e-12
various O 0 2.3378280214481073e-11
truncation O 0 5.545131465112263e-09
mutants O 0 7.374857613484664e-09
have O 0 1.5728766900036106e-10
3 O 0 8.37448865809165e-09
- O 0 1.1691710932737465e-09
5 O 0 1.9768495729266533e-09
- O 0 3.346589116937082e-10
fold O 0 2.3092268375268787e-10
higher O 0 5.81137804545051e-10
affinity O 0 5.398891056440647e-11
to O 0 2.4187972805234104e-11
various O 0 9.983749243991369e-11
DNA O 0 2.034793999960982e-10
- O 0 2.7674102592856187e-11
binding O 0 1.8372445925729508e-11
sites O 0 2.955432426565707e-11
when O 0 3.128693484844014e-11
compared O 0 1.2597459186913795e-10
with O 0 2.3966393106200634e-11
the O 0 1.1689526013825002e-09
wild O 0 5.377847944743053e-09
- O 0 2.6456564938825977e-08
type O 0 1.5170783740359184e-07
PAX6 O 0 5.4869335144758224e-05
. O 0 1.9263814010628266e-06

These O 0 4.303111200698595e-09
results O 0 9.67643853932998e-10
provide O 0 8.126990747037155e-10
a O 0 4.438637790649125e-10
new O 0 1.3177217650373052e-10
insight O 0 8.791093408788697e-10
into O 0 1.0202706041129161e-10
the O 0 6.415843550877653e-11
role O 0 1.5299790323552998e-09
of O 0 5.783162393413477e-09
mutant O 0 8.800764561556207e-08
PAX6 O 0 1.6466912711621262e-05
in O 0 6.897214888113012e-08
causing O 0 2.193018417528947e-06
aniridia B-Disease 1 0.9999998807907104
. O 0 1.528440520814911e-07
. O 0 3.649439577202429e-07

Reversal O 0 1.2556216461234726e-05
of O 0 6.444799964810954e-06
severe O 1 0.9999629259109497
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 2.9381393687799573e-05
excellent O 0 7.058628398226574e-06
neuropsychologic O 0 1.5979476302163675e-05
outcome O 0 7.760856419736228e-07
in O 0 4.601690140049186e-09
very B-Disease 0 7.506069543694593e-09
- I-Disease 0 5.8969806815412085e-08
long I-Disease 0 2.4800225872922965e-08
- I-Disease 0 1.5653459684017434e-07
chain I-Disease 0 2.924885222910234e-08
acyl I-Disease 0 8.272628804206761e-09
- I-Disease 0 2.9068603524251557e-08
coenzyme I-Disease 0 2.622245176553406e-08
A I-Disease 0 4.699842975242063e-06
dehydrogenase I-Disease 0 0.00012028365745209157
deficiency I-Disease 1 0.8028587102890015
. O 0 3.0988396702014143e-06

Very B-Disease 0 6.958186986594228e-07
- I-Disease 0 4.312038527132245e-06
long I-Disease 0 4.411414806781977e-07
- I-Disease 0 1.6310448813783296e-07
chain I-Disease 0 1.2958494721715397e-08
acyl I-Disease 0 2.112061636694307e-09
- I-Disease 0 4.671381614862469e-10
coenzyme I-Disease 0 2.3504420632036727e-10
A I-Disease 0 7.69151942137114e-09
dehydrogenase I-Disease 0 1.208290800747136e-08
( I-Disease 0 7.326204642943424e-10
VLCAD I-Disease 0 9.577424862072803e-06
) I-Disease 0 1.680539973847317e-08
deficiency I-Disease 0 1.2117259757360443e-05
is O 0 2.4746442672807234e-09
a O 0 4.154777144549371e-08
disorder O 1 0.9999842643737793
of O 0 0.004245357122272253
fatty O 0 0.00028909469256177545
acid O 0 1.168623043668049e-06
beta O 0 1.2914447324874345e-06
oxidation O 0 1.233667603628419e-07
that O 0 4.904360806357033e-10
reportedly O 0 6.01023542046164e-09
has O 0 9.909508109917642e-12
high O 0 9.472349293826454e-11
rates O 0 3.086222943871064e-10
of O 0 1.6882133191398196e-10
morbidity O 0 2.0075333395652706e-08
and O 0 5.602921460123866e-10
mortality O 0 1.5839307820897375e-07
. O 0 4.570089728872517e-08

We O 0 4.328401459474662e-08
describe O 0 1.7741680125027415e-08
the O 0 1.141533978454845e-09
outcome O 0 1.7077992353620175e-08
of O 0 8.25651902403024e-09
a O 0 1.7317698386420943e-09
5 O 0 5.4950364258843365e-09
- O 0 2.2911437191908135e-09
year O 0 6.651502681975785e-10
- O 0 1.9233999282164405e-08
old O 0 1.4556509597696277e-07
girl O 0 2.4412381449678833e-08
with O 0 4.183156931958365e-08
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.6795467672636732e-05
was O 0 3.465173449512804e-06
first O 0 6.494883741936519e-09
seen O 0 4.331247804856275e-09
at O 0 1.2669688409516766e-08
5 O 0 9.216080121277059e-10
months O 0 1.1207275385505255e-10
of O 0 3.7164665789291007e-10
age O 0 6.82323042511257e-09
with O 0 4.166003986227906e-09
severe O 1 0.9999657869338989
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999995231628418
encephalopathy B-Disease 1 0.9999948740005493
, O 0 1.592549097040319e-07
and O 0 1.3604714013126795e-06
hypotonia B-Disease 1 0.9997283816337585
. O 0 3.8655281969113275e-05

Biochemical O 0 1.9674558643600903e-05
studies O 0 8.51292668357928e-07
indicated O 0 0.0007467106333933771
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.00016889847756829113
by O 0 2.0887140905756496e-09
a O 0 2.3546130378804264e-08
stable O 0 2.5091617317229975e-06
yet O 0 9.804839606886162e-09
inactive O 0 1.5832029021112248e-07
enzyme O 0 1.6105074962524668e-07
. O 0 2.0738630723826645e-07

Molecular O 0 2.8349663807603065e-06
genetic O 0 4.531317543410296e-08
analysis O 0 1.8555885716864395e-08
of O 0 1.5575788836486026e-07
her O 0 2.8714495670101314e-08
VLCAD O 0 6.37965276837349e-05
gene O 0 3.1919405785174604e-08
revealed O 0 3.372448418303975e-07
a O 0 1.0396289162883932e-08
T1372C O 0 6.807244545825597e-08
( O 0 1.149083717066901e-09
F458L O 0 5.807649827715977e-08
) O 0 1.948686323416382e-09
missense O 0 1.3750015170899132e-07
mutation O 0 4.518817764420646e-09
and O 0 3.6973712980170603e-09
a O 0 1.196469128217359e-07
1668 O 0 0.00015072929090820253
ACAG O 0 0.00252903182990849
1669 O 0 0.00034032060648314655
splice O 0 2.2970551071921363e-05
site O 0 6.834382020315388e-07
mutation O 0 4.573844307742547e-07
. O 0 6.039161348780908e-07

After O 0 3.492652567160803e-08
initial O 0 5.3854338766257115e-09
treatment O 0 6.795789175839673e-08
with O 0 1.1535723487554606e-09
intravenous O 0 1.4434803006224683e-06
glucose O 0 1.5783440403538407e-06
and O 0 2.843938862184814e-09
carnitine O 0 3.789034508372424e-07
, O 0 3.10228787103739e-10
the O 0 2.818949240701585e-10
patient O 0 2.816268995786686e-09
has O 0 4.253899316131182e-11
thrived O 0 1.7536746499402511e-09
on O 0 1.3695456990703292e-09
a O 0 2.980767577209775e-10
low O 0 2.434755863589544e-08
- O 0 1.1242998532168258e-08
fat O 0 4.925408969569389e-09
diet O 0 1.07526140769032e-10
supplemented O 0 5.5867199755255115e-11
with O 0 3.098028777959172e-11
medium O 0 1.524399380059549e-07
- O 0 2.1180213138904946e-08
chain O 0 1.717003250689686e-08
triglyceride O 0 4.123577213022145e-08
oil O 0 2.431906054312094e-08
and O 0 5.707547767741517e-10
carnitine O 0 6.097204874322415e-08
and O 0 6.228910165440027e-10
avoidance O 0 2.0752629552589497e-06
of O 0 4.712467500667117e-07
fasting O 0 6.477720830844191e-07
. O 0 4.537042741503683e-08

Her O 0 1.033412991091609e-05
ventricular O 0 0.22956165671348572
hypertrophy O 0 0.07975568622350693
resolved O 0 3.996447776444256e-05
significantly O 0 2.7877209873850006e-08
over O 0 7.101102816875482e-09
1 O 0 1.0150191798175001e-08
year O 0 1.0050736631850299e-10
, O 0 5.162034688588335e-11
and O 0 1.2378803537771432e-10
cognitively O 0 2.412213007119135e-07
, O 0 4.284780030783253e-10
she O 0 2.8240618177299837e-10
is O 0 3.9804978757551623e-11
in O 0 5.8451472828569e-11
the O 0 4.2305497993666563e-10
superior O 0 2.2035770541606325e-07
range O 0 8.726046551998934e-09
for O 0 2.0535722011771895e-09
age O 0 5.51748200905422e-07
. O 0 5.121265758134541e-07

Clinical O 0 1.0576454769761767e-06
recognition O 0 8.850446988617477e-07
of O 1 0.9998584985733032
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 4.822408300242387e-06
important O 0 5.5411170762909023e-08
because O 0 2.0332342753892618e-10
it O 0 4.711635595566754e-12
is O 0 8.577977737844744e-12
one O 0 6.487086909312545e-12
of O 0 1.5250545271072724e-10
the O 0 1.9636356429764135e-10
few O 0 4.504289996543065e-10
directly O 0 1.689757445078044e-09
treatable O 0 5.4500746045960113e-05
causes O 0 1.8259772360806892e-08
of O 0 2.8254683002160164e-06
cardiomyopathy B-Disease 1 1.0
in O 0 0.00012662903463933617
children O 0 1.8076224250762607e-07
. O 0 1.2614445488168258e-08
. O 0 9.310506499105031e-08

Cloning O 0 2.3053129893924051e-07
of O 0 5.339899900036471e-08
a O 0 1.9177284205085243e-09
novel O 0 1.2949098460168784e-09
member O 0 1.6530024016248035e-09
of O 0 3.2687552664611985e-09
the O 0 3.761596811813206e-09
low O 0 1.5194369780147099e-06
- O 0 3.9226804915415414e-08
density O 0 7.538652369021293e-09
lipoprotein O 0 1.457573716834304e-06
receptor O 0 3.039810678728827e-07
family O 0 3.845199216812034e-07
. O 0 4.733271623535984e-07

A O 0 8.749538551455771e-07
gene O 0 1.6345804709771983e-08
encoding O 0 1.0899108104922561e-07
a O 0 3.4439651130924176e-08
novel O 0 8.709800880524199e-09
transmembrane O 0 7.652452183037894e-08
protein O 0 1.0792651217172988e-08
was O 0 4.81188067169569e-09
identified O 0 1.2698876672434523e-10
by O 0 2.2228148141567594e-12
DNA O 0 3.487601527019102e-11
sequence O 0 2.473759218302174e-11
analysis O 0 3.7494875260168925e-11
within O 0 6.004774455448114e-11
the O 0 5.300391237028634e-10
insulin B-Disease 0 0.19667334854602814
- I-Disease 1 0.9995928406715393
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.0339198297515395e-06
IDDM B-Disease 0 1.163835622719489e-05
) O 0 6.698443466568449e-10
locus O 0 3.899924827521772e-09
IDDM4 O 0 5.88002649237751e-07
on O 0 4.1663000160951924e-08
chromosome O 0 4.825112682738109e-07
11q13 O 0 2.6185825845459476e-06
. O 0 2.2421517087423126e-07

Based O 0 6.856866718862875e-08
on O 0 2.5223467758905826e-08
its O 0 5.072139375172924e-10
chromosomal O 0 4.830034754377266e-07
position O 0 2.1454135890053294e-07
, O 0 3.9204475776877246e-10
this O 0 8.26924119456951e-12
gene O 0 1.8569923376787756e-10
is O 0 9.553818847152229e-11
a O 0 8.484968977429119e-11
candidate O 0 6.005794472851989e-11
for O 0 2.3517560121533165e-10
conferring O 0 3.31479100168508e-07
susceptibility O 0 9.559640602674335e-06
to O 0 3.942581088267616e-07
diabetes B-Disease 1 0.9999985694885254
. O 0 2.933206269517541e-05

The O 0 1.1884154815788861e-07
gene O 0 1.0021707907981181e-08
, O 0 1.092419821269175e-09
termed O 0 1.962349749362602e-08
low O 0 1.9085489100234554e-07
- O 0 7.732087858869363e-09
density O 0 7.234211563122983e-10
lipoprotein O 0 2.2320639558870425e-08
receptor O 0 3.3654998787824297e-09
related O 0 1.1590671533667773e-07
protein O 0 7.740531060562716e-08
5 O 0 3.4041470087231573e-08
( O 0 1.8673637636190676e-10
LRP5 O 0 4.3631398938259736e-08
) O 0 5.5984109709195096e-11
, O 0 2.7773146629717083e-11
encodes O 0 8.202702406201468e-11
a O 0 7.323927575519917e-10
protein O 0 1.3948917576556141e-08
of O 0 1.1223827556250399e-07
1615 O 0 5.167113340576179e-05
amino O 0 2.787982396057487e-07
acids O 0 1.3365099249540435e-08
that O 0 7.712062932707653e-11
contains O 0 8.413191671108322e-11
conserved O 0 5.541597736247184e-10
modules O 0 1.9529355910208324e-09
which O 0 5.77883140645552e-12
are O 0 5.354480964517294e-13
characteristic O 0 6.394731966175016e-11
of O 0 2.9667010514877745e-10
the O 0 3.791314484580255e-10
low O 0 1.2524307635430887e-07
- O 0 4.48661197083311e-09
density O 0 3.2213065548347686e-10
lipoprotein O 0 1.5557186827663827e-07
( O 0 9.944210788148666e-09
LDL O 0 3.434555821968388e-07
) O 0 1.5412915388424153e-08
receptor O 0 1.5861996871535666e-07
family O 0 1.9991506405858672e-07
. O 0 1.7283694830894092e-07

These O 0 1.231156065983896e-09
modules O 0 3.233159162618904e-08
include O 0 7.768240495309442e-10
a O 0 1.3638784546188276e-09
putative O 0 6.5720824338200146e-09
signal O 0 2.8195113799256433e-08
peptide O 0 3.0263584971379487e-09
for O 0 5.422919890918365e-10
protein O 0 2.567898338412533e-09
export O 0 4.89602625108887e-09
, O 0 5.319299445361025e-10
four O 0 3.131405690304234e-10
epidermal O 0 1.9394386097104643e-09
growth O 0 7.916727828849446e-10
factor O 0 3.335706377782799e-09
( O 0 5.59834956170846e-10
EGF O 0 8.437949006179224e-09
) O 0 4.1573577913567306e-10
repeats O 0 4.2725081250694075e-09
with O 0 1.736767257787264e-10
associated O 0 3.9357356484970296e-08
spacer O 0 1.4701463442179374e-06
domains O 0 2.8644731742133445e-07
, O 0 2.4590056213469325e-08
three O 0 2.215281114104073e-08
LDL O 0 1.2774279412042233e-06
- O 0 1.2221477163620875e-06
receptor O 0 2.34592985037807e-08
( O 0 4.920770457772505e-09
LDLR O 0 1.1583682635318837e-06
) O 0 8.801932516178113e-10
repeats O 0 4.375496409636526e-09
, O 0 1.9673844497969384e-10
a O 0 2.685215938491581e-10
single O 0 6.960338971850888e-10
transmembrane O 0 5.247484935466673e-08
spanning O 0 1.8697198811423732e-07
domain O 0 1.3228304851509165e-07
, O 0 2.69379962780647e-09
and O 0 1.3947952792747742e-09
a O 0 5.522280410730218e-09
cytoplasmic O 0 2.3732575016310875e-07
domain O 0 1.7078308474083315e-06
. O 0 1.700804432402947e-06

The O 0 2.3430484930031525e-07
encoded O 0 6.849077038850737e-08
protein O 0 1.0489309687500281e-07
has O 0 2.9714300464611654e-10
a O 0 7.783453742638002e-11
unique O 0 5.706434630381452e-11
organization O 0 1.1649277376069023e-10
of O 0 1.3077977811803976e-08
EGF O 0 1.3778658569663094e-07
and O 0 1.0134136196882082e-08
LDLR O 0 2.4701412257854827e-05
repeats O 0 8.852817146021152e-09
; O 0 1.027500098893519e-10
therefore O 0 8.00502275577486e-10
, O 0 2.863215775583683e-10
LRP5 O 0 4.124167958252656e-07
likely O 0 7.300068549653815e-09
represents O 0 1.2824995510030135e-09
a O 0 1.8993442929549076e-10
new O 0 8.738228890470268e-11
category O 0 2.991579650668541e-09
of O 0 1.6801747548811363e-08
the O 0 1.305948149621372e-08
LDLR O 0 0.0008556837565265596
family O 0 9.05524331074048e-08
. O 0 2.018738314291113e-07

Both O 0 2.13633811085856e-07
human O 0 2.982397262485392e-08
and O 0 2.774844576336477e-09
mouse O 0 1.4819288907119699e-08
LRP5 O 0 2.364984538871795e-06
cDNAs O 0 1.5047126566969382e-07
have O 0 7.037667670850567e-11
been O 0 4.885908691520946e-11
isolated O 0 3.869910988885117e-11
and O 0 1.2459381616702903e-11
the O 0 4.124821664786005e-11
encoded O 0 1.7208702518534125e-10
mature O 0 2.8886512626336014e-10
proteins O 0 3.272732432280101e-11
are O 0 5.2712487152994925e-12
95 O 0 2.70007904923375e-10
% O 0 3.7872576602593355e-11
identical O 0 2.6925089935403435e-10
, O 0 5.6792130026517285e-11
indicating O 0 5.208669606737715e-10
a O 0 3.095986245149618e-10
high O 0 9.602753259230212e-09
degree O 0 1.3176557445149228e-07
of O 0 3.1333728944815675e-09
evolutionary O 0 3.2116578285723563e-09
conservation O 0 4.4667319842872644e-10
. O 0 2.110248642495094e-10
. O 0 8.076772139986588e-09

The O 0 1.7043703337549232e-07
APC B-Disease 0 1.2553067563203513e-07
variants O 0 1.6858885842907512e-08
I1307K O 0 1.0504786018827872e-07
and O 0 4.54732196342178e-10
E1317Q O 0 1.696533580286541e-08
are O 0 2.8883302000126676e-11
associated O 0 1.9136047058054828e-07
with O 1 0.8436234593391418
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.00182191317435354
but O 0 2.582210223422976e-09
not O 0 3.1979213721555766e-10
always O 0 6.901379467905144e-10
with O 0 6.007432745702701e-11
a O 0 3.2562352814125006e-09
family O 0 1.0199324718129787e-09
history O 0 1.8363785159181134e-08
. O 0 5.596946195396413e-08

Classical O 1 0.9999991655349731
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.616407280380372e-05
FAP B-Disease 0 8.1618782132864e-07
) O 0 5.648969292337824e-09
is O 0 3.3018013323449225e-10
a O 0 1.944468586145831e-09
high O 0 0.0005746823153458536
- O 1 0.9993079900741577
penetrance O 1 0.9999996423721313
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9996358156204224
that O 0 3.5055502944913997e-10
predisposes O 0 6.81437395400053e-09
to O 0 1.2515168068549798e-10
hundreds O 0 1.0804359490412807e-10
or O 0 6.190674362027693e-11
thousands O 0 2.786777197893997e-10
of O 0 0.05221467465162277
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 1.0
and O 0 2.447836209285015e-07
that O 0 9.983407156521906e-11
results O 0 1.955954009869032e-10
from O 0 4.4476550220551303e-10
truncating O 0 3.479215493484844e-08
mutations O 0 6.447177236523771e-10
in O 0 9.947791479447687e-10
the O 0 8.932109274439881e-09
APC B-Disease 0 3.6124407643001177e-07
gene O 0 5.529028044293227e-07
. O 0 1.053182586474577e-06

A O 0 1.4852474805593374e-07
variant O 0 9.740256956547455e-08
of O 0 4.5178719432215075e-08
FAP B-Disease 0 3.276375935001852e-07
is O 0 8.722472699673745e-08
attenuated B-Disease 1 0.9370397925376892
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.99997878074646
coli I-Disease 1 0.9995167255401611
, O 0 6.296702714791991e-09
which O 0 2.8485233269370802e-11
results O 0 4.823373367379702e-10
from O 0 1.0087697788208061e-08
germ O 0 0.00048718281323090196
- O 0 1.1323124482487401e-07
line O 0 4.596444114213227e-09
mutations O 0 1.0299646552303088e-10
in O 0 5.245995651770308e-11
the O 0 3.2736266475374975e-10
5 O 0 2.2818851252992545e-09
and O 0 1.4591165775623693e-10
3 O 0 5.280977877220039e-09
regions O 0 1.7479175884460574e-09
of O 0 2.373845475744929e-08
the O 0 7.400619495001592e-08
APC B-Disease 0 1.2071560604454135e-06
gene O 0 1.4746467513759853e-06
. O 0 1.000522615868249e-06

Attenuated B-Disease 1 0.9999964237213135
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 1.0628810969137703e-06
have O 0 6.819581011008324e-11
" O 0 2.473255766854976e-10
multiple O 0 1.4474454523849545e-08
" O 0 0.000592576339840889
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 2.0692085911377944e-07
typically O 0 1.447941766485883e-09
fewer O 0 6.698299553908882e-11
than O 0 1.63561959115599e-11
100 O 0 5.362600988267907e-11
) O 0 3.6091201641857973e-12
without O 0 2.6695168645063383e-11
the O 0 6.76949191147358e-11
florid O 0 7.818606206910772e-09
phenotype O 0 2.882415695015794e-10
of O 0 4.2518109033551355e-09
classical O 0 3.076070470342529e-06
FAP B-Disease 0 5.130083877702418e-07
. O 0 1.87456564049171e-07

Another O 0 6.140842856439122e-08
group O 0 6.409868635870453e-09
of O 0 4.9832706849883834e-08
patients O 0 6.619207848501674e-09
with O 0 5.868161512267989e-10
multiple O 0 6.358339987855288e-07
adenomas B-Disease 0 0.0007258871337398887
has O 0 6.517257844507185e-09
no O 0 1.4229617484318169e-09
mutations O 0 2.597695669681599e-10
in O 0 3.8610803443361874e-10
the O 0 2.2980588543219937e-09
APC B-Disease 0 5.641055622618296e-09
gene O 0 1.557274309504919e-09
, O 0 5.371080247229543e-10
and O 0 1.4422905925126628e-10
their O 0 5.013867099279423e-11
phenotype O 0 5.92141002897506e-10
probably O 0 4.566756417467843e-10
results O 0 7.066910945319194e-11
from O 0 2.4114141239373055e-10
variation O 0 3.735001641302915e-09
at O 0 3.4948318017313795e-08
a O 0 7.8119394286702e-10
locus O 0 3.2747257683318765e-10
, O 0 1.8751085406609747e-10
or O 0 1.730817988931932e-10
loci O 0 1.1905402219625216e-09
, O 0 4.710831724707987e-10
elsewhere O 0 2.2251129827566274e-09
in O 0 4.614643112077488e-10
the O 0 1.659016257704593e-09
genome O 0 1.519463843635549e-08
. O 0 1.0509977244055335e-07

Recently O 0 5.224545134296932e-07
, O 0 2.5448743112832517e-09
however O 0 1.0168692554657355e-09
, O 0 1.9877829937620106e-10
a O 0 6.515390449379765e-10
missense O 0 1.5082260773624512e-08
variant O 0 1.371114510817506e-08
of O 0 1.0543221833358984e-06
APC B-Disease 0 4.4482831640380027e-07
( O 0 9.944571388587065e-09
I1307K O 0 8.237835658064796e-08
) O 0 3.9967193443679605e-10
was O 0 5.289707782907271e-09
described O 0 3.276144078245835e-10
that O 0 1.0921203177916006e-12
confers O 0 8.105019433379823e-11
an O 0 1.6359525496431604e-12
increased O 0 2.8248589578616645e-10
risk O 0 6.96511222031404e-08
of O 1 0.9995354413986206
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.1054756214434747e-05
including O 0 2.735449733393125e-08
multiple O 0 3.4199008496216265e-06
adenomas B-Disease 1 0.9875530004501343
, O 0 1.1237600716640372e-07
in O 0 6.007682031849981e-07
Ashkenazim O 0 0.02136530727148056
. O 0 6.006552666804055e-06

We O 0 8.04149777877683e-08
have O 0 1.7002538266197575e-10
studied O 0 6.470438851380322e-09
a O 0 6.423582499248681e-11
set O 0 1.5135125097653912e-10
of O 0 2.1168680697236653e-10
164 O 0 2.9683782098999245e-09
patients O 0 7.975304860963206e-10
with O 0 6.794034224100187e-10
multiple O 1 0.9999992847442627
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9996161460876465
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9235395789146423
carcinoma I-Disease 1 1.0
and O 0 3.7580031175821205e-07
analyzed O 0 3.516906019740418e-07
codons O 0 3.2001331362607743e-08
1263 O 0 8.470595957987825e-07
- O 0 4.7104411038390026e-08
1377 O 0 9.9926762686664e-07
( O 0 4.811449461072925e-09
exon O 0 6.080620096327038e-08
15G O 0 1.8505278376323986e-07
) O 0 2.2148310963032714e-10
of O 0 2.9389368716437048e-09
the O 0 3.578813467797204e-09
APC B-Disease 0 3.094909217793429e-08
gene O 0 6.8060996838426036e-09
for O 0 2.9761917375026314e-08
germ O 0 0.022344255819916725
- O 0 1.3900985322834458e-06
line O 0 3.035827376152156e-07
variants O 0 9.090978636550062e-08
. O 0 9.639641973535618e-08

Three O 0 1.2953212547017756e-07
patients O 0 1.9616452906490167e-09
with O 0 8.142687912826574e-11
the O 0 8.680623442280933e-10
I1307K O 0 9.795624755781773e-09
allele O 0 6.043937017530254e-10
were O 0 1.7134094143500533e-10
detected O 0 8.278465690736425e-10
, O 0 7.33190157892194e-12
each O 0 2.952748939452632e-12
of O 0 8.548162733212905e-10
Ashkenazi O 0 3.6886810050873464e-08
descent O 0 1.1502571624077973e-06
. O 0 3.303915434571536e-07

Four O 0 9.130353078035114e-07
patients O 0 3.793579139710346e-07
had O 0 1.030677481139719e-07
a O 0 2.6820041298947217e-08
germ O 0 5.964075171505101e-05
- O 0 1.8342717567065847e-07
line O 0 3.6040646023138834e-08
E1317Q O 0 2.8472783242250443e-08
missense O 0 7.017034064915606e-09
variant O 0 8.151413766199767e-09
of O 0 4.777087525553725e-08
APC O 0 3.212143795394695e-08
that O 0 3.2798513904808146e-10
was O 0 4.180977342116421e-09
not O 0 1.2642270910689923e-11
present O 0 2.1871233990555794e-11
in O 0 4.856252552865037e-11
controls O 0 5.249584322797318e-09
; O 0 3.20556532706906e-11
one O 0 3.418038768687737e-11
of O 0 4.3275383276863977e-10
these O 0 3.1352049428834405e-11
individuals O 0 1.0974246685002687e-11
had O 0 1.28419097578103e-09
an O 0 3.543983162490605e-11
unusually O 0 1.2325793163903143e-10
large O 0 1.5182622520315547e-11
number O 0 6.031335847422881e-11
of O 0 3.056677044810385e-08
metaplastic B-Disease 0 1.20664517453406e-05
polyps I-Disease 0 1.2076546909156605e-06
of I-Disease 0 5.082071083961637e-07
the I-Disease 0 1.5901012773156253e-07
colorectum I-Disease 0 0.00011957121023442596
. O 0 1.3829568388246116e-06

There O 0 2.1182032128308492e-08
is O 0 3.0160535180456804e-10
increasing O 0 1.600116150690667e-10
evidence O 0 6.600621160757214e-10
that O 0 5.501152051251568e-12
there O 0 2.6536980946012534e-11
exist O 0 3.744915211267852e-10
germ O 0 1.0003434169902903e-07
- O 0 5.243947498456691e-10
line O 0 1.1802432642316063e-10
variants O 0 1.0306720754638121e-10
of O 0 1.1985648029622098e-09
the O 0 1.3229605189124527e-09
APC B-Disease 0 9.825152247344704e-09
gene O 0 3.370960399706746e-09
that O 0 1.0859066423840602e-10
predispose O 0 3.5018363764294236e-09
to O 0 5.861156004982604e-11
the O 0 1.2238296487332434e-10
development O 0 4.170320533347649e-09
of O 0 1.3416330375548569e-06
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 8.300067975142156e-07
but O 0 1.698251761439451e-09
without O 0 1.164452978485997e-09
the O 0 7.414981406661525e-10
florid O 0 4.758990002073915e-08
phenotype O 0 4.515403884131075e-10
of O 0 2.5462045805113576e-09
classical O 0 7.956439844747365e-07
FAP B-Disease 0 7.289744807792431e-09
, O 0 9.941374806698988e-11
and O 0 7.096379907312045e-12
possibly O 0 4.095463204678573e-11
with O 0 2.9331140381089194e-12
importance O 0 8.410556517901568e-08
for O 0 0.001847778563387692
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.8934851884841919
in O 0 6.947026065518003e-09
the O 0 5.108782286100677e-10
general O 0 1.200637228526702e-10
population O 0 1.955153920707442e-12
. O 0 1.1575698732890771e-10
. O 0 5.243740552884901e-09

Genomic O 0 2.1041191757831257e-06
structure O 0 3.6734530795001774e-07
of O 0 7.247891176120902e-08
the O 0 1.5805115083367127e-07
human O 1 0.9999960660934448
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9992309808731079
CLD B-Disease 1 0.9999885559082031
) O 0 1.9192850686522434e-07
gene O 0 2.6444865852681687e-07
. O 0 2.1140986916634574e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9984437823295593
CLD B-Disease 1 0.9999932050704956
) O 0 3.2841803943028935e-08
is O 0 9.129337286140071e-10
caused O 0 5.005432734961346e-10
by O 0 8.854594141238792e-12
mutations O 0 4.738460734898808e-10
in O 0 5.434662164738313e-10
a O 0 1.5711444367738636e-09
gene O 0 9.26702159453896e-10
which O 0 2.641649954338021e-10
encodes O 0 2.4909010409857046e-09
an O 0 3.2562974539018796e-09
intestinal O 0 0.0004509210120886564
anion O 0 5.401685484685004e-05
transporter O 0 0.00826583057641983
. O 0 5.444904672913253e-06

We O 0 2.472927995711416e-08
report O 0 1.2833143436807859e-09
here O 0 2.691867007076354e-10
the O 0 2.2784859068925023e-11
complete O 0 9.817368445963481e-11
genomic O 0 6.406125629965231e-10
organization O 0 4.877324238927727e-11
of O 0 1.875757105196385e-09
the O 0 3.729278219566368e-09
human O 0 3.7749529724351305e-08
CLD B-Disease 0 6.458903499151347e-06
gene O 0 8.362038173004294e-09
which O 0 1.5176383483250788e-09
spans O 0 1.4993460695222893e-08
approximately O 0 7.185489425687308e-10
39kb O 0 4.00725745919317e-08
, O 0 1.929107429354815e-10
and O 0 1.5738099712336862e-10
comprises O 0 4.1084078361564025e-09
21 O 0 5.603557156064198e-07
exons O 0 6.234221018530661e-06
. O 0 1.6977332961687353e-06

All O 0 2.509841010578384e-07
exon O 0 8.152992450050078e-06
/ O 0 3.061618599531357e-06
intron O 0 1.8061799664792488e-06
boundaries O 0 9.341186490985365e-09
conform O 0 2.0358905672424044e-08
to O 0 3.0369864401080804e-09
the O 0 1.5610847725611166e-08
GT O 0 4.625928795576328e-06
/ O 0 1.3776880223304033e-05
AG O 0 0.00010715953976614401
rule O 0 1.5823892454136512e-06
. O 0 8.743324428905908e-07

An O 0 5.148067749871643e-09
analysis O 0 9.072129714127186e-09
of O 0 1.2347077138485929e-08
the O 0 5.253671275795568e-09
putative O 0 1.1080609851887857e-07
promoter O 0 7.040059699647827e-06
region O 0 5.3857650783584177e-08
sequence O 0 7.22405335551457e-09
shows O 0 1.6345554243457627e-08
a O 0 1.093777690641673e-08
putative O 0 1.1674729449850929e-07
TATA O 0 1.8947166608995758e-06
box O 0 1.4917375210643513e-06
and O 0 3.2218614443024762e-09
predicts O 0 1.2304618657310584e-08
multiple O 0 3.3538369859087425e-09
transcription O 0 4.917572837825901e-08
factor O 0 1.8241671284613403e-08
binding O 0 2.9721753946887475e-08
sites O 0 5.143987635847225e-08
. O 0 3.307023632714845e-07

The O 0 4.85537050565199e-08
genomic O 0 3.7972526456542255e-08
structure O 0 6.979474420631959e-08
was O 0 1.4240376877694416e-08
determined O 0 4.50335380097755e-10
using O 0 6.03319963432547e-11
DNA O 0 7.820775971278948e-11
from O 0 2.3295755949281904e-11
several O 0 3.5874053293943886e-12
sources O 0 9.247294596725908e-11
including O 0 4.672669369487625e-12
multiple O 0 2.6385782447846395e-10
large O 0 4.901940631185653e-09
- O 0 1.412961694313708e-07
insert O 0 1.0910985537293527e-07
libaries O 0 1.392249032505788e-06
and O 0 1.7562654663905164e-09
genomic O 0 2.8831994569600283e-08
DNA O 0 2.328837034326625e-08
from O 0 1.204138122545828e-08
Finnish O 0 0.0007164427079260349
CLD B-Disease 1 0.9994128942489624
patients O 0 3.9122798511925794e-07
and O 0 1.7883216685277148e-08
controls O 0 4.682664439314976e-05
. O 0 7.296396233869018e-07

Exon O 0 1.1110763807664625e-05
- O 0 3.713437379815332e-08
specific O 0 4.85927575955003e-10
primers O 0 4.459872915418828e-09
developed O 0 4.847796608586918e-10
in O 0 2.4226525299764212e-11
this O 0 1.902163105846344e-12
study O 0 6.050944034025063e-12
will O 0 1.0937546441464052e-12
facilitate O 0 4.8225343857177805e-11
mutation O 0 3.908082191195206e-11
screening O 0 3.0313249133051556e-10
studies O 0 9.034860637413544e-10
of O 0 8.200516377065981e-10
patients O 0 2.0517974819167506e-10
with O 0 9.38706196107475e-11
the O 0 3.796615288820249e-08
disease O 0 0.000418843817897141
. O 0 2.4992576186377846e-07

Genomic O 0 1.3076723348603991e-07
sequencing O 0 8.732776279885002e-08
of O 0 7.963734560689772e-07
a O 0 1.230088514603267e-06
BAC O 1 0.970615804195404
clone O 0 2.320769453945104e-05
H O 1 0.9999998807907104
_ O 0 2.0566346847772365e-08
RG364P16 O 0 5.43031539734784e-08
revealed O 0 3.471345433325723e-09
the O 0 1.1805877109249963e-10
presence O 0 2.888144723378616e-10
of O 0 4.299353761894054e-09
another O 0 2.465700699172402e-10
, O 0 8.730498962661315e-11
highly O 0 4.900359007464772e-10
homologous O 0 1.1001208832794873e-09
gene O 0 3.347088828320466e-09
3 O 0 1.6177716588572366e-07
of O 0 1.719711235637078e-07
the O 0 1.581601623001916e-07
CLD B-Disease 0 7.545104745076969e-05
gene O 0 3.606801612932031e-08
, O 0 5.178851791853845e-10
with O 0 7.379423461184587e-11
a O 0 2.0275105205858068e-10
similar O 0 1.717486153296477e-10
genomic O 0 1.099185986674911e-08
structure O 0 3.879376464510642e-08
, O 0 1.1633734947613661e-10
recently O 0 1.1990947124118634e-10
identified O 0 4.55913917729589e-11
as O 0 4.445226825522397e-11
the O 0 1.9334523315706065e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 4.095694748684764e-06
( O 0 1.4676413684355794e-07
PDS B-Disease 0 6.73434487907798e-06
) O 0 4.81424944354103e-09
. O 0 5.058181873351941e-09
. O 0 1.1551828293931976e-07

The O 0 2.182838869657644e-07
APCI1307K O 0 1.8347373043070547e-05
allele O 0 1.6669807223479438e-07
and O 0 7.178972527555061e-09
cancer B-Disease 0 6.343379936879501e-07
risk O 0 2.3438456508984018e-08
in O 0 3.980289431382289e-09
a O 0 2.27153251763923e-09
community O 0 1.1588688342278886e-10
- O 0 1.645910074898893e-10
based O 0 2.8460034676158763e-11
study O 0 6.992950662976227e-11
of O 0 1.3984046143278306e-09
Ashkenazi O 0 4.4836543366955084e-08
Jews O 0 2.8343768221361643e-08
. O 0 4.706399536757999e-08

Mutations O 0 2.21654119059167e-07
in O 0 2.3045870989335526e-08
APC O 0 1.9311973176172614e-07
are O 0 1.555714862488955e-10
classically O 0 2.1204915867656382e-07
associated O 0 1.0310624247722444e-06
with O 0 6.43897510599345e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.554124178772327e-06
FAP B-Disease 0 3.6805221270697075e-07
) O 0 1.8030447135330974e-09
, O 0 1.3287561329011766e-10
a O 0 4.682506049569213e-10
highly O 0 2.745965502981562e-06
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.6105376482009888
by O 0 5.493747678997352e-09
multiple O 0 1.2390577239784761e-06
intestinal O 1 0.9999082088470459
polyps B-Disease 0 7.170598109951243e-06
and O 0 3.897025369070661e-09
, O 0 3.928876390890679e-10
without O 0 6.0943303736848975e-09
surgical O 0 0.46623867750167847
intervention O 0 1.1236524187552277e-05
, O 0 1.8495302511745138e-10
the O 0 6.506870597888792e-10
development O 0 4.1101895931205945e-07
of O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0002990273351315409
CRC B-Disease 0 6.875716644572094e-05
) O 0 2.0388673860338713e-08
. O 0 1.0341648959411032e-07

APC B-Disease 0 6.683646461169701e-06
is O 0 5.7305701517407215e-08
a O 0 5.601666330790067e-08
tumour O 1 1.0
- O 0 4.398884357215138e-06
suppressor O 0 2.2705619073803973e-07
gene O 0 1.4775937806632555e-08
, O 0 1.879051358955053e-09
and O 0 2.101846252600126e-09
somatic O 0 8.174614549716352e-07
loss O 0 5.698633458450786e-07
occurs O 0 8.072068453657266e-07
in O 0 2.0633394797187066e-06
tumours B-Disease 1 1.0
. O 0 0.0001657638349570334

The O 0 4.259599336364772e-06
germline O 0 2.0536794181680307e-05
T O 0 1.1432228347985074e-05
- O 0 6.651064410334584e-08
to O 0 2.8969182608307165e-09
- O 0 3.6407641346158925e-09
A O 0 2.329035853065875e-09
transversion O 0 2.3390402503764562e-08
responsible O 0 1.476713973325161e-09
for O 0 2.2239579622329586e-10
the O 0 1.1476862793458054e-09
APC O 0 7.94845966822777e-09
I1307K O 0 3.4448390806574025e-08
allele O 0 1.152525408443239e-09
converts O 0 2.7038837835391405e-09
the O 0 1.1749385908643717e-09
wild O 0 6.209538994106367e-10
- O 0 2.0270080058892859e-10
type O 0 1.6311341166641569e-10
sequence O 0 2.953934874483366e-10
to O 0 5.177844264458997e-10
a O 0 7.571724580657246e-09
homopolymer O 0 1.4055569408810697e-05
tract O 0 3.965416181017645e-05
( O 0 3.6231977418310635e-08
A8 O 0 5.001343765798083e-07
) O 0 7.673931490259633e-10
that O 0 9.868301314996941e-11
is O 0 4.0221700969844676e-10
genetically O 0 9.199400352599696e-09
unstable O 0 2.825341471179854e-05
and O 0 2.4734939430004488e-08
prone O 0 3.004186282851151e-06
to O 0 1.0440005304701572e-08
somatic O 0 4.604677997122053e-06
mutation O 0 1.2037780550144817e-07
. O 0 2.5564915517861664e-07

The O 0 1.4520777824600373e-07
I1307K O 0 2.7600933094618085e-07
allele O 0 6.912910688328111e-09
was O 0 4.195638325654727e-08
found O 0 2.1431951768846602e-09
in O 0 1.5119178131683952e-09
6 O 0 4.5156579631111526e-07
. O 0 1.7581457711912662e-07

1 O 0 3.672594857562217e-06
% O 0 2.3421964812087026e-08
of O 0 1.9409345242138443e-08
unselected O 0 1.8422693756292574e-05
Ashkenazi O 0 2.838159218754299e-07
Jews O 0 2.8524351769476652e-09
and O 0 9.338933099067859e-11
higher O 0 1.0781534554027417e-09
proportions O 0 1.244246150555739e-09
of O 0 4.659931107653392e-09
Ashkenazim O 0 3.500455392213553e-08
with O 0 3.666686676506714e-10
family O 0 4.2480069462058623e-10
or O 0 4.021993571523552e-10
personal O 0 1.5391909968798245e-08
histories O 0 4.983708024042244e-08
of O 0 1.9810192952718353e-06
CRC B-Disease 0 5.474452700582333e-05
( O 0 3.0794051752991436e-08
ref O 0 3.610232965911564e-07
. O 0 2.025262180183063e-09
2 O 0 3.483253294689348e-07
) O 0 1.0647297266075384e-08
. O 0 9.658599253725697e-08

To O 0 1.0507327452558002e-08
evaluate O 0 1.1439322378237193e-08
the O 0 6.697868926153205e-10
role O 0 7.691989267755162e-09
of O 0 3.844696649935031e-08
I1307K O 0 4.159694526606472e-07
in O 0 1.7113567452042844e-08
cancer B-Disease 0 2.3870356358202116e-07
, O 0 1.9332264677984767e-09
we O 0 3.5762885985946014e-09
genotyped O 0 3.6301295835983183e-07
5 O 0 4.6723133806381156e-08
, O 0 6.20177775800812e-09
081 O 0 1.1543760365384514e-06
Ashkenazi O 0 3.912219881385681e-08
volunteers O 0 5.783085121890963e-09
in O 0 8.206024193491146e-10
a O 0 1.4078276322493366e-09
community O 0 3.857091035452953e-10
survey O 0 4.494808969468522e-09
. O 0 5.0231694359581525e-08

Risk O 0 1.64554671755468e-06
of O 0 2.010704292843002e-06
developing O 1 0.9953031539916992
colorectal B-Disease 1 1.0
, I-Disease 0 1.5065065781527665e-05
breast I-Disease 1 0.7976679801940918
and I-Disease 0 2.606332145660417e-07
other I-Disease 0 1.4460457009590755e-07
cancers I-Disease 1 0.9999922513961792
were O 0 1.5616332404988498e-07
compared O 0 1.5547975351637433e-07
between O 0 3.339241629873868e-07
genotyped O 0 2.436891577417555e-07
I1307K O 0 5.664128277516056e-09
carriers O 0 1.0364798602724434e-10
and O 0 1.8941735333011245e-11
non O 0 1.2163161589029414e-09
- O 0 1.7819018482967408e-10
carriers O 0 1.6339575525936567e-11
and O 0 9.488619091835293e-12
their O 0 5.54161317528612e-12
first O 0 1.7311085898086276e-10
- O 0 2.9915567800742338e-09
degree O 0 2.6045282197628694e-07
relatives O 0 1.5031258016051652e-08
. O 0 4.043233658990175e-08

Sperm O 0 2.219688433058309e-08
DNA O 0 5.9011182607093815e-09
analysis O 0 1.4643225521027148e-09
in O 0 9.332652428639676e-10
a O 0 1.133954619092492e-08
Friedreich B-Disease 0 0.00043369928607717156
ataxia I-Disease 0 0.3632722795009613
premutation O 0 0.00018159201135858893
carrier O 0 2.2920883111510193e-06
suggests O 0 1.8139135704586806e-07
both O 0 6.293136234347685e-09
meiotic O 0 2.2577262370759854e-06
and O 0 2.386806308152245e-09
mitotic O 0 4.8005340147483366e-08
expansion O 0 9.702021408486416e-09
in O 0 2.1880308676003324e-09
the O 0 4.662402464106208e-09
FRDA B-Disease 0 1.4888105397403706e-05
gene O 0 2.754968022600224e-07
. O 0 4.4928103193342395e-07

Friedreich B-Disease 1 0.9999580383300781
ataxia I-Disease 1 0.9999991655349731
is O 0 2.0098300410609227e-06
usually O 0 3.012733529317302e-08
caused O 0 4.109544260444409e-09
by O 0 9.375462212135588e-12
an O 0 2.160603813916584e-11
expansion O 0 8.326482614506858e-09
of O 0 6.577891440429084e-07
a O 0 4.0666691347723827e-07
GAA O 0 3.733860694410396e-06
trinucleotide O 0 3.3849030387500534e-06
repeat O 0 4.0939543310969384e-08
in O 0 1.989841003080528e-08
intron O 0 1.2372015589789953e-06
1 O 0 9.338515383205959e-07
of O 0 9.868841743809753e-08
the O 0 4.429761801816312e-08
FRDA B-Disease 0 0.0001154494020738639
gene O 0 4.946188596477441e-07
. O 0 6.545714086314547e-07

Occasionally O 0 9.454210498915927e-07
, O 0 1.293523332890345e-08
a O 0 1.568431828857797e-09
fully O 0 2.710131230543311e-09
expanded O 0 2.805903287494971e-10
allele O 0 5.263176561243199e-10
has O 0 3.26467741729175e-11
been O 0 3.524441155589031e-11
found O 0 1.7043798664073684e-11
to O 0 1.3575884340311095e-11
arise O 0 8.942929730082483e-10
from O 0 7.257056622300695e-10
a O 0 6.914251948764161e-10
premutation O 0 6.336680513641113e-08
of O 0 8.002832174724972e-08
100 O 0 5.397210856017409e-08
or O 0 1.7338397384492055e-08
less O 0 6.32412380241476e-08
triplet O 0 2.968096396216424e-06
repeats O 0 7.833281188140973e-07
. O 0 3.7020384979769005e-07

We O 0 1.3769660256457428e-07
have O 0 3.367745526894339e-10
examined O 0 2.688148592611128e-09
the O 0 9.165501690944211e-11
sperm O 0 8.32037910791783e-11
DNA O 0 8.077276070217465e-10
of O 0 2.521152620005296e-09
a O 0 5.295916594150185e-09
premutation O 0 1.0282509492753888e-06
carrier O 0 1.3224311032900005e-06
. O 0 5.95464598518447e-07

This O 0 1.3597362347184117e-08
mans O 0 1.6749548876759945e-06
leucocyte O 0 4.6300721123770927e-07
DNA O 0 1.4979654849867075e-08
showed O 0 8.723250566333718e-09
one O 0 1.503032420746564e-10
normal O 0 1.3523874242693523e-09
allele O 0 1.5409078180095293e-10
and O 0 3.959976097034357e-11
one O 0 6.988133162411092e-12
allele O 0 5.390022109197368e-11
of O 0 6.69674427022926e-10
approximately O 0 4.1109923798465786e-10
100 O 0 8.802137685393063e-09
repeats O 0 2.3612152233454253e-08
. O 0 3.1162155522679313e-08

His O 0 2.841135540165851e-07
sperm O 0 9.466615047415416e-09
showed O 0 2.4902313544572507e-09
an O 0 7.560514714288757e-12
expanded O 0 8.98861887699276e-11
allele O 0 3.673777948520751e-10
in O 0 5.194700225530369e-10
a O 0 1.8496228992859187e-09
tight O 0 4.715250057074627e-08
range O 0 1.1857093973333122e-08
centering O 0 6.156132936752101e-09
on O 0 1.3102589013769261e-09
a O 0 1.3726884906528625e-10
size O 0 1.6614981612761426e-10
of O 0 1.405659699749151e-09
approximately O 0 5.642282197015902e-09
320 O 0 4.727885283273281e-08
trinucleotide O 0 4.616003934643231e-06
repeats O 0 5.543452061829157e-07
. O 0 5.187952751839475e-07

His O 0 2.7495714221004164e-06
affected O 0 3.414356797293294e-07
son O 0 4.046693447889993e-06
has O 0 8.242526661206284e-10
repeat O 0 1.1916739817152688e-09
sizes O 0 3.1425722024636116e-09
of O 0 2.4124195974195572e-08
1040 O 0 2.0168987191482302e-07
and O 0 1.8727265072016053e-08
540 O 0 5.723621825381997e-07
. O 0 2.5269389425375266e-07

These O 0 5.616180853706965e-09
data O 0 4.537923370406816e-09
suggest O 0 5.26809762479985e-10
that O 0 2.3240888380460234e-12
expansion O 0 8.479533047944798e-11
occurs O 0 5.6031540518475254e-11
in O 0 2.7514315478760487e-11
two O 0 1.4096829606402572e-11
stages O 0 4.891804739060035e-10
, O 0 1.8204592347470516e-11
the O 0 1.1565783920863826e-11
first O 0 2.974025192781227e-11
during O 0 1.008482630737717e-09
meiosis O 0 2.1803945315923556e-09
followed O 0 4.2040851355729103e-10
by O 0 5.6700671935416835e-11
a O 0 1.0822885920802605e-09
second O 0 1.2151596173737289e-08
mitotic O 0 2.2943291355659312e-07
expansion O 0 1.1229581104998942e-06
. O 0 1.088204953703098e-06

We O 0 1.1544427280796299e-07
also O 0 2.2279329492391753e-09
show O 0 1.0652146942291552e-09
that O 0 1.2100301663431345e-11
in O 0 3.529863554230239e-11
all O 0 4.85938407568387e-11
informative O 0 9.590008787085935e-10
carrier O 0 1.5031822453437371e-09
father O 0 3.0269935447080343e-09
to O 0 2.2698422308398136e-10
affected O 0 1.3126827402842878e-09
child O 0 5.58642732073622e-09
transmissions O 0 3.0543692020046365e-08
, O 0 4.37163846789268e-11
with O 0 3.999033309359801e-12
the O 0 3.0639393799880565e-11
notable O 0 6.62310414845102e-11
exception O 0 1.8742610241595514e-10
of O 0 2.833829615411787e-09
the O 0 6.610098690629229e-09
premutation O 0 5.996485583636968e-07
carrier O 0 1.8795971001850376e-08
, O 0 2.0677677625702273e-10
the O 0 1.6511673972541274e-10
expansion O 0 2.571888035873826e-09
size O 0 2.0960093660704615e-09
decreases O 0 1.1567147240043596e-08
. O 0 4.1433483310981956e-09
. O 0 8.134566087392159e-08

The O 0 1.3264359211007104e-07
R496H O 0 8.614300099907268e-07
mutation O 0 1.798172100109241e-08
of O 0 4.580238766038747e-08
arylsulfatase O 0 8.276124390249606e-06
A O 0 1.841601715568686e-07
does O 0 1.6041934447486028e-09
not O 0 1.2345092725851714e-09
cause O 0 2.942157379948185e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 8.87058467924362e-06

Deficiency B-Disease 1 0.9485479593276978
of I-Disease 0 0.0002998426789417863
arylsulfatase I-Disease 1 0.8928890824317932
A I-Disease 0 7.984596595633775e-05
( O 0 2.947499311289903e-08
ARSA O 0 1.0251745152345393e-05
) O 0 8.263888462423097e-10
enzyme O 0 2.745946403592825e-08
activity O 0 1.039617458786779e-07
causes O 0 4.4096701458329335e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.0906593161053024e-05
MLD B-Disease 1 0.9999998807907104
) O 0 2.3331659804171068e-07
. O 0 2.606946054584114e-07

A O 0 7.970354687358849e-08
number O 0 5.681981996019658e-09
of O 0 9.660883648621166e-08
ARSA O 0 8.675936987856403e-05
gene O 0 1.6857784146395716e-07
mutations O 0 3.1284596246905494e-08
responsible O 0 6.447650235941182e-08
for O 0 6.95343160828088e-08
MLD B-Disease 1 1.0
have O 0 8.750129509849103e-09
been O 0 1.5711084655478658e-09
identified O 0 7.807042123886276e-09
. O 0 2.459531245335711e-08

Recently O 0 5.570564667323197e-07
, O 0 3.3111116071182778e-09
the O 0 1.8553256708742083e-09
R496H O 0 5.562528215818929e-08
mutation O 0 1.1009311240428588e-09
of O 0 1.819583594908636e-08
ARSA O 0 2.9700855520786718e-05
was O 0 1.7448131472974637e-07
proposed O 0 5.014465731534301e-09
to O 0 3.4949215743651507e-10
be O 0 5.407055914119496e-10
a O 0 1.17363285756511e-09
cause O 0 1.483569356253156e-08
of O 0 2.523406237742165e-06
MLD B-Disease 1 1.0
( O 0 1.2354006173609378e-07
Draghia O 0 1.8677059188121348e-06
et O 0 9.247030448022997e-07
al O 0 5.9485842029971536e-08
. O 0 5.247359213811364e-10
, O 0 3.177286211908381e-10
1997 O 0 2.289104017449972e-09
) O 0 6.468070079534982e-09
. O 0 1.4028044859060174e-07

We O 0 8.265629958259524e-08
have O 0 3.294824413302422e-10
investigated O 0 1.589937514978601e-09
the O 0 4.0053484834379205e-11
R496H O 0 1.0031016017819638e-09
mutation O 0 1.2454297142194815e-11
and O 0 3.924753317480212e-12
found O 0 8.002327966938338e-12
this O 0 1.1095430130225736e-12
mutation O 0 9.880142710916306e-12
at O 0 2.5180288965032105e-09
a O 0 1.3861908843004755e-10
relatively O 0 8.241815563359012e-11
high O 0 9.396520367355166e-11
frequency O 0 1.0124041188719346e-10
in O 0 1.1918931119847542e-11
an O 0 4.7962961727265885e-12
African O 0 1.1220836065861661e-10
American O 0 6.048501283162366e-11
population O 0 1.7319819623634602e-12
( O 0 2.807154682316071e-11
f O 0 1.703277519027324e-08
= O 0 9.34277277764295e-09
0 O 0 5.8693734317216695e-09
. O 0 1.3785578234504214e-10
09 O 0 1.0022051633029605e-08
, O 0 1.2518612813039454e-09
n O 0 6.563654864066848e-08
= O 0 8.081305935547789e-08
61 O 0 1.798411233266961e-07
subjects O 0 3.6372475165080687e-07
) O 0 2.0203131612106517e-08
. O 0 6.136148300583955e-08

The O 0 2.225653759069246e-07
ARSA O 0 3.441537046455778e-05
enzyme O 0 1.3251281849591123e-08
activity O 0 8.507892168552189e-09
in O 0 3.728060082863749e-10
subjects O 0 6.920324757686558e-09
with O 0 1.9534289116829306e-11
and O 0 2.6610625161738177e-11
without O 0 1.0927964783080668e-10
the O 0 5.45418155084576e-11
R496H O 0 2.2941566424350412e-09
mutation O 0 4.965899566555798e-11
was O 0 1.8865065065654107e-09
determined O 0 2.6357678262201034e-09
and O 0 2.3637045099000886e-10
found O 0 2.351715766568674e-10
to O 0 1.343457844971141e-10
be O 0 1.6917470757604747e-09
normal O 0 7.011604452600295e-07
. O 0 1.8780210098157113e-07

It O 0 1.1512297781735015e-08
is O 0 9.368696929357156e-10
therefore O 0 1.4022266681124052e-09
concluded O 0 1.2853035302740068e-09
that O 0 2.319748776749564e-12
the O 0 1.9340615914353876e-11
R496H O 0 8.211425428505947e-10
mutation O 0 5.925225587954941e-11
of O 0 3.650436175561822e-09
ARSA O 0 1.1258673566771904e-06
does O 0 3.23625903853042e-10
not O 0 1.782431147123731e-11
negatively O 0 9.079113849619347e-11
influence O 0 6.612869696276391e-10
the O 0 6.853523304428677e-11
activity O 0 6.923991380247685e-10
of O 0 2.0881723017396325e-09
ARSA O 0 3.5737855341722025e-06
and O 0 1.4587081542671854e-09
is O 0 2.618474326254727e-10
not O 0 1.3587056479913429e-10
a O 0 2.53474952138788e-09
cause O 0 2.591537793250609e-07
of O 0 7.944396929815412e-05
MLD B-Disease 1 1.0

Down O 0 1.126083134295186e-05
- O 0 1.6244644029939082e-07
regulation O 0 5.526899116148343e-08
of O 0 2.5211537746372414e-08
transmembrane O 0 7.265566068781482e-07
carbonic O 0 0.00046426168410107493
anhydrases O 0 3.6534416722133756e-05
in O 0 6.065290563128656e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999984622001648
lines O 0 2.0567587455389003e-07
by O 0 1.465646076725946e-10
wild O 0 3.1475391182311796e-09
- O 0 1.6700591132234877e-08
type O 0 8.21570665721083e-06
von B-Disease 1 0.9999362230300903
Hippel I-Disease 1 0.9999493360519409
- I-Disease 1 0.9999533891677856
Lindau I-Disease 1 0.997738242149353
transgenes O 0 0.001194774522446096
. O 0 4.442722456587944e-06

To O 0 7.091644249612727e-08
discover O 0 5.531507341061115e-08
genes O 0 4.7016506243835465e-09
involved O 0 6.38289421317495e-09
in O 0 1.667703664054443e-08
von B-Disease 1 0.9751001596450806
Hippel I-Disease 1 0.9999066591262817
- I-Disease 1 0.9999961853027344
Lindau I-Disease 1 0.9999827146530151
( O 0 2.6220011477562366e-06
VHL B-Disease 0 0.0026827226392924786
) O 0 7.29981366021093e-07
- O 0 8.379511200473644e-06
mediated O 0 4.520269430940971e-05
carcinogenesis O 1 0.9445018172264099
, O 0 4.483669435728643e-09
we O 0 1.1076416450706006e-09
used O 0 7.444634775310988e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999997615814209
lines O 0 7.667861063964665e-05
stably O 0 1.634927320992574e-05
transfected O 0 1.1199555416396834e-07
with O 0 5.752817111570607e-10
wild O 0 3.932769665482283e-09
- O 0 1.053526155203599e-08
type O 0 2.410784816220257e-07
VHL O 0 0.00021034404926467687
- O 0 5.498889095179038e-06
expressing O 0 9.165881209582949e-08
transgenes O 0 1.6953106751316227e-05
. O 0 2.841539128439763e-07

Large O 0 2.741402340689092e-07
- O 0 1.0688300733363576e-07
scale O 0 1.309032313656644e-07
RNA O 0 2.959159672855094e-08
differential O 0 5.315116169413159e-08
display O 0 1.5586085755359136e-09
technology O 0 3.517675262187936e-09
applied O 0 6.13527617598919e-10
to O 0 2.955268668669575e-11
these O 0 4.758308764368779e-12
cell O 0 1.3279409794009212e-09
lines O 0 1.0323227689346126e-10
identified O 0 4.10481613977165e-11
several O 0 1.025882157001945e-11
differentially O 0 2.3625204015331747e-09
expressed O 0 1.443743874451897e-10
genes O 0 1.0256986926471257e-10
, O 0 2.6955854215415798e-11
including O 0 1.2973857231590724e-11
an O 0 9.826117003397528e-11
alpha O 0 1.7343544413961354e-06
carbonic O 0 0.0005477303639054298
anhydrase O 0 0.000492097286041826
gene O 0 2.1629168145409494e-07
, O 0 2.1617942991269956e-08
termed O 0 1.5143622249524924e-06
CA12 O 0 0.0003901903983205557
. O 0 1.6252978412012453e-06

The O 0 1.3396739007021097e-07
deduced O 0 7.350902109237722e-08
protein O 0 7.025095616342014e-09
sequence O 0 6.18117890205383e-10
was O 0 3.525426395256659e-09
classified O 0 8.95385321442177e-10
as O 0 9.06215935625454e-11
a O 0 7.630379106338125e-10
one O 0 8.786165683893898e-10
- O 0 4.418740928713305e-08
pass O 0 4.875834136441881e-08
transmembrane O 0 9.193718710776011e-07
CA O 0 2.260500878037419e-06
possessing O 0 2.644592598244344e-07
an O 0 1.538107308185488e-09
apparently O 0 1.715726583029209e-08
intact O 0 3.3776554886344456e-08
catalytic O 0 4.2263035737732935e-08
domain O 0 6.576938460511883e-08
in O 0 4.93677942969839e-09
the O 0 7.756785436185964e-09
extracellular O 0 1.910820537887048e-05
CA O 0 0.00040829391218721867
module O 0 0.00037406120100058615
. O 0 5.985544248687802e-06

Reintroduced O 0 1.1979698228969937e-06
wild O 0 1.4414428051168215e-07
- O 0 9.064868322639086e-08
type O 0 6.234834870610939e-08
VHL B-Disease 0 4.781112693308387e-06
strongly O 0 1.3012638078180316e-08
inhibited O 0 4.449608237422353e-09
the O 0 8.145566443573671e-10
overexpression O 0 8.149393160294949e-09
of O 0 2.286790978800468e-09
the O 0 7.247649702613046e-10
CA12 O 0 1.1997964577403764e-07
gene O 0 2.4143873011972516e-10
in O 0 1.0321553334247113e-10
the O 0 1.5023138288938753e-09
parental O 0 4.676758635469014e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.00926316250115633
. O 0 1.9279932530480437e-06

Similar O 0 9.337393080954826e-09
results O 0 2.0844754811122357e-09
were O 0 4.987534829581364e-10
obtained O 0 7.207424101984827e-10
with O 0 1.6512682887714902e-10
CA9 O 0 2.1560742879955797e-06
, O 0 5.186888696329106e-10
encoding O 0 1.7981619748752564e-08
another O 0 5.598430163900048e-08
transmembrane O 0 1.9043104657612275e-06
CA O 0 8.592434141974081e-07
with O 0 1.3574811275063325e-09
an O 0 9.941701906157618e-10
intact O 0 2.9319406280592375e-07
catalytic O 0 4.691396497946698e-07
domain O 0 1.7939538565769908e-06
. O 0 7.36091976705211e-07

Although O 0 5.414781156787285e-08
both O 0 3.6187068896964547e-09
domains O 0 8.230485093463358e-08
of O 0 1.2966474116637983e-07
the O 0 1.2780550662228052e-07
VHL B-Disease 0 3.9977057895157486e-05
protein O 0 1.213762175211741e-07
contribute O 0 6.482210768155028e-09
to O 0 1.6553339809988188e-09
regulation O 0 2.1356355262014404e-07
of O 0 9.21561351674427e-08
CA12 O 0 1.329003043792909e-05
expression O 0 2.3522696679378896e-08
, O 0 6.228493831805793e-10
the O 0 3.369480250370316e-10
elongin O 0 1.4651948099242418e-08
binding O 0 4.467108905004125e-09
domain O 0 8.334335888093847e-08
alone O 0 1.8458564454704174e-08
could O 0 1.2237392210678877e-09
effectively O 0 3.3344104366506144e-08
regulate O 0 3.0741799150746374e-07
CA9 O 0 0.0005033037159591913
expression O 0 1.475078533985652e-06
. O 0 7.325645015043847e-07

We O 0 1.7082919612221303e-07
mapped O 0 3.5155278510501375e-07
CA12 O 0 1.9129136489937082e-05
and O 0 5.9134364960300445e-08
CA9 O 0 8.653677650727332e-05
loci O 0 7.549347458279954e-08
to O 0 3.1971056912993845e-09
chromosome O 0 4.970693225914147e-07
bands O 0 4.682680412315676e-07
15q22 O 0 1.1218684221603326e-06
and O 0 2.5621165633538112e-08
17q21 O 0 3.2866669243958313e-06
. O 0 8.377559623795605e-08

2 O 0 4.284557689970825e-06
respectively O 0 1.353056831021604e-07
, O 0 3.050943941929063e-09
regions O 0 4.780028817208404e-09
prone O 0 1.8319704864211417e-08
to O 0 6.691863729813008e-11
amplification O 0 7.090142872812066e-08
in O 0 1.4631721390045982e-09
some O 0 7.406514845875733e-10
human O 0 4.998911435905029e-07
cancers B-Disease 1 0.7254598140716553
. O 0 1.4173601812217385e-06

Additional O 0 2.839782808905511e-08
experiments O 0 3.0597334443882573e-08
are O 0 1.9330474720913315e-11
needed O 0 3.05793917965147e-10
to O 0 3.15890300028876e-11
define O 0 3.436882778373729e-09
the O 0 1.7395629381411482e-09
role O 0 6.298062515952552e-08
of O 0 1.7062565120795625e-06
CA O 0 1.6448344467789866e-05
IX O 0 0.00011864827683893964
and O 0 1.9797754191586137e-07
CA O 0 9.055248710865271e-07
XII O 0 1.4657478004664881e-06
enzymes O 0 1.529824489310272e-09
in O 0 6.392223417250875e-10
the O 0 4.65807170613175e-10
regulation O 0 6.241150707353427e-09
of O 0 1.9863173328360517e-09
pH O 0 3.1453801341285725e-08
in O 0 1.5542861442341405e-09
the O 0 8.785461247384774e-10
extracellular O 0 4.01434121499733e-08
microenvironment O 0 7.21405939430042e-08
and O 0 2.537970111848864e-10
its O 0 2.5493995803316238e-11
potential O 0 4.0600148243363776e-10
impact O 0 1.1113137077245483e-08
on O 0 1.0212527286057593e-06
cancer B-Disease 0 6.583353297173744e-06
cell O 0 2.150269438061514e-06
growth O 0 1.1785870412950317e-07
. O 0 2.487923609351128e-07

A O 0 2.1533709571031068e-07
gene O 0 8.891738900729251e-09
encoding O 0 6.46950368832222e-08
a O 0 7.72078720956415e-08
transmembrane O 0 1.3873635396066675e-07
protein O 0 3.438904272456966e-08
is O 0 3.840264217735978e-11
mutated O 0 2.5560714655981087e-10
in O 0 9.556297420054705e-11
patients O 0 1.1621903439618109e-08
with O 0 1.2345576578809414e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 4.696248936397751e-07
. O 0 2.2248048026085598e-07

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.3734552264213562
WFS B-Disease 1 0.9938914775848389
; O 0 3.835698692000733e-07
OMIM O 0 2.882661465264391e-05
222300 O 0 2.3459304543393955e-07
) O 0 1.1818292178222833e-10
is O 0 2.8761205222993524e-11
an O 0 1.2558839523890697e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
defined O 0 2.855695697689953e-07
by O 0 1.3474181770334326e-09
young O 0 5.025114546697296e-08
- O 0 1.376286149934458e-06
onset O 1 0.9999511241912842
non O 1 0.999998927116394
- O 1 0.9999951124191284
immune O 1 0.9998617172241211
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999985694885254
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.0009190469281747937

Linkage O 0 1.0735659998317715e-05
to O 0 7.905644139327705e-08
markers O 0 2.7688355430655065e-07
on O 0 5.633391992887482e-07
chromosome O 0 2.0761340238095727e-06
4p O 0 5.073356078355573e-05
was O 0 1.2220888834235666e-07
confirmed O 0 6.2359504227060825e-09
in O 0 1.3977327073533274e-09
five O 0 3.3626510465012416e-09
families O 0 3.5821715038686364e-10
. O 0 4.992384816659978e-08

On O 0 9.314769755519592e-08
the O 0 1.32558253262971e-09
basis O 0 6.7821002147638865e-09
of O 0 1.0212937162634717e-08
meiotic O 0 5.794775461254176e-06
recombinants O 0 2.885081630665809e-05
and O 0 2.7413362246875295e-08
disease O 0 1.0035337254521437e-05
- O 0 1.5640651440662623e-08
associated O 0 7.205712648783447e-08
haplotypes O 0 3.0361371727849473e-07
, O 0 3.2218243628534537e-09
the O 0 1.5661905550246047e-08
WFS B-Disease 0 2.6148367396672256e-05
gene O 0 9.834189462765153e-09
was O 0 1.3864982406630588e-07
localized O 0 5.31142738680046e-08
to O 0 2.438658608383548e-09
a O 0 4.474103221241421e-08
BAC O 0 0.00036841820110566914
/ O 0 3.5526994679457857e-07
P1 O 0 2.4888663574529346e-06
contig O 0 5.420059778771247e-07
of O 0 1.3146427946253425e-08
less O 0 4.65970018126427e-09
than O 0 4.391915997548068e-10
250 O 0 5.2107789194622e-09
kb O 0 2.206669250881532e-06
. O 0 3.0239456805247755e-07

Mutations O 0 7.026384452046841e-08
in O 0 1.019089079790092e-08
a O 0 1.3871120918551583e-09
novel O 0 3.782733570822927e-10
gene O 0 6.124379892114007e-10
( O 0 3.25293098013546e-10
WFS1 O 0 2.0732757377572852e-07
) O 0 9.17976472614157e-10
encoding O 0 5.0746994162409464e-08
a O 0 5.879639886074983e-08
putative O 0 2.841463526692678e-07
transmembrane O 0 3.7071714587000315e-07
protein O 0 4.814976861666764e-08
were O 0 8.300521936455141e-10
found O 0 9.497350822451622e-11
in O 0 1.7490829964939003e-11
all O 0 1.50012190169857e-11
affected O 0 6.067034374890312e-11
individuals O 0 3.4494080768804336e-12
in O 0 4.752182536371663e-10
six O 0 2.7904341948215006e-08
WFS B-Disease 0 8.900344255380332e-06
families O 0 3.4984765084900005e-10
, O 0 9.719421795173488e-11
and O 0 1.9960718841693925e-11
these O 0 7.657343509270831e-12
mutations O 0 1.1220108175891141e-10
were O 0 8.99009339194734e-11
associated O 0 1.2058060105957225e-09
with O 0 1.4406877080208602e-10
the O 0 3.9794791462099965e-08
disease O 0 6.110812682891265e-05
phenotype O 0 8.835210962843121e-08
. O 0 3.3903717167049763e-07

WFS1 O 0 0.00012321914255153388
appears O 0 8.420974495493283e-08
to O 0 2.2507311292496723e-10
function O 0 4.440875667199862e-09
in O 0 1.3577322599545028e-09
survival O 0 1.4745143062100396e-07
of O 0 2.620865124924876e-08
islet O 0 6.690009399790142e-07
beta O 0 7.758527317491826e-06
- O 0 5.172509531803371e-07
cells O 0 1.0495905256036053e-09
and O 0 5.344938380780206e-10
neurons O 0 2.1282870577010726e-08
. O 0 3.289030825470718e-09
. O 0 3.239436807689344e-08

Stable O 0 1.8711516531766392e-05
interaction O 0 3.458770834185998e-07
between O 0 2.966036660723148e-08
the O 0 4.720023261128858e-10
products O 0 3.9135145124546966e-10
of O 0 4.183112745081985e-10
the O 0 5.017858906164463e-10
BRCA1 O 0 2.0730723804263107e-09
and O 0 8.974473941769645e-10
BRCA2 O 0 2.18680851205022e-09
tumor B-Disease 0 1.9376201976228913e-08
suppressor O 0 1.2300505147777585e-07
genes O 0 6.960169329772725e-09
in O 0 6.034840627222593e-09
mitotic O 0 3.9154602404778416e-07
and O 0 5.089151855486307e-08
meiotic O 0 5.847515421919525e-05
cells O 0 2.914995036462642e-07
. O 0 4.609475183769973e-07

BRCA1 O 0 1.911198523885105e-06
and O 0 1.224225520957134e-08
BRCA2 O 0 7.466146811907493e-09
account O 0 1.138498045838432e-10
for O 0 1.5898084931853518e-11
most O 0 3.646568724063881e-12
cases O 0 2.167224212590302e-11
of O 0 5.901971134036899e-10
familial O 0 6.218861159368316e-08
, O 0 3.73691660948694e-10
early O 0 7.71635626506395e-08
onset O 1 0.9637969136238098
breast B-Disease 0 0.003853283589705825
and I-Disease 0 0.0017819673521444201
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.00330308265984e-05
encode O 0 5.499705224565332e-08
products O 0 1.608692379306831e-08
that O 0 3.618510005520825e-11
each O 0 5.5058999026691424e-11
interact O 0 4.973874090374863e-10
with O 0 3.25754451191429e-10
hRAD51 O 0 2.981220177389332e-07
. O 0 6.535658769735164e-08

Results O 0 1.6686263037968274e-08
presented O 0 8.272948548437853e-08
here O 0 2.4291107791896138e-08
show O 0 4.03111188873595e-09
that O 0 5.542693734539306e-11
BRCA1 O 0 3.2441840325247995e-09
and O 0 7.388060163648902e-10
BRCA2 O 0 8.279480212536328e-09
coexist O 0 2.274538246638258e-08
in O 0 2.3030348739183637e-09
a O 0 2.4347595051210646e-09
biochemical O 0 1.1012912182195578e-07
complex O 0 6.033577051312022e-07
and O 0 1.7882014757830689e-09
colocalize O 0 4.667392374813062e-07
in O 0 5.64270230540842e-09
subnuclear O 0 1.0647092949511716e-06
foci O 0 1.775320924934931e-06
in O 0 3.734546005773609e-09
somatic O 0 2.33629791068779e-08
cells O 0 3.609288978800862e-10
and O 0 7.342456503911521e-11
on O 0 5.768111543957843e-10
the O 0 4.017015886592645e-11
axial O 0 2.2365578833394295e-10
elements O 0 1.9287256236566463e-09
of O 0 2.1092276814016486e-09
developing O 0 4.828054400718429e-08
synaptonemal O 0 9.67144387686858e-07
complexes O 0 2.7675474711941206e-07
. O 0 3.538018802373699e-07

Like O 0 1.8667709582587122e-06
BRCA1 O 0 1.3151566236047074e-06
and O 0 7.09183325398044e-08
RAD51 O 0 0.00010987194400513545
, O 0 3.539442161581974e-08
BRCA2 O 0 1.7132053997670482e-08
relocates O 0 1.2310187003095052e-07
to O 0 4.3722594433859285e-09
PCNA O 0 1.3393600966082886e-06
+ O 0 1.0587072551970778e-08
replication O 0 5.417709059152287e-10
sites O 0 5.635823405181206e-11
following O 0 1.0228035085546594e-10
exposure O 0 4.364912697951695e-08
of O 0 5.8564715743614215e-08
S O 0 1.5899253185125417e-06
phase O 0 1.4837809203527286e-06
cells O 0 5.204580322271113e-09
to O 0 9.384922172728238e-09
hydroxyurea O 0 2.8843849122495158e-06
or O 0 3.188629804640186e-08
UV O 0 2.08865476452047e-05
irradiation O 0 1.7613238014746457e-06
. O 0 1.1810647038146271e-07

Thus O 0 6.027147492204676e-07
, O 0 3.345029142565181e-08
BRCA1 O 0 1.0029872932193484e-08
and O 0 1.150379680403546e-09
BRCA2 O 0 1.4436867257217045e-09
participate O 0 1.4825275451713082e-09
, O 0 2.1800608540623045e-10
together O 0 1.2314371744537311e-10
, O 0 5.7104848627531624e-11
in O 0 1.335501986776677e-10
a O 0 5.641515588017398e-10
pathway O 0 1.8207180207951978e-09
( O 0 3.865206765762963e-10
s O 0 5.183657059149027e-09
) O 0 1.8471356388882754e-11
associated O 0 1.9460184852437834e-10
with O 0 1.9808332057946743e-11
the O 0 1.7186232992294492e-10
activation O 0 3.9782324101622635e-09
of O 0 3.3645257246917026e-08
double O 0 2.6806539210610936e-08
- O 0 2.932802090072073e-07
strand O 0 1.1636098307121756e-08
break O 0 2.9430166748056763e-08
repair O 0 1.3837325241183862e-06
and O 0 5.265548885802218e-09
/ O 0 2.0326856429164764e-06
or O 0 1.2357159739906365e-08
homologous O 0 3.818952620804339e-07
recombination O 0 3.561770824944688e-07
. O 0 3.606884604323568e-07

Dysfunction O 1 0.9978316426277161
of O 0 1.3700520867132582e-05
this O 0 1.1354760687254384e-08
pathway O 0 1.46441593074087e-07
may O 0 6.098504812257488e-09
be O 0 1.2194188714342857e-10
a O 0 6.349641645808646e-11
general O 0 1.104320732081554e-10
phenomenon O 0 1.6703506633408693e-10
in O 0 1.8995607170557705e-11
the O 0 2.7328016585781434e-11
majority O 0 1.1137629880864086e-11
of O 0 1.0153241442045768e-10
cases O 0 2.367047668982991e-10
of O 0 1.5185136703621538e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 0.9999991655349731
and I-Disease 1 0.9997639060020447
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.98439621925354
. O 0 0.00010844117059605196

A O 0 3.694529482345388e-07
novel O 0 1.029576779387753e-08
Arg362Ser O 0 1.0144815121293504e-07
mutation O 0 2.4507063045575705e-10
in O 0 2.1469991062783578e-10
the O 0 6.537348440360802e-10
sterol O 0 1.9523330507809078e-08
27 O 0 2.49307049671188e-07
- O 0 4.9129980084217095e-08
hydroxylase O 0 8.878524937472321e-08
gene O 0 9.990312577201621e-09
( O 0 5.294614080497695e-09
CYP27 O 0 1.290024215450103e-06
) O 0 7.013537528521852e-10
: O 0 2.0933185740368287e-11
its O 0 3.911257168837112e-12
effects O 0 3.2773141978026388e-09
on O 0 6.203031865936737e-09
pre O 0 4.891128568829117e-08
- O 0 8.199703138700443e-10
mRNA O 0 2.1530273397463162e-10
splicing O 0 1.3365271112064647e-09
and O 0 9.287100255495062e-11
enzyme O 0 1.4261870573406554e-09
activity O 0 1.9513503701773516e-08
. O 0 5.718843354429737e-08

A O 0 8.104875064418593e-07
novel O 0 2.174315838487928e-08
C O 0 4.2913521269838384e-07
to O 0 1.4523617863915206e-09
A O 0 4.031157629924564e-09
mutation O 0 8.294835651678767e-11
in O 0 1.235693630752266e-10
the O 0 8.883936919446e-10
sterol O 0 3.1335058991999176e-08
27 O 0 1.9695045239132014e-07
- O 0 1.0286605345299904e-07
hydroxylase O 0 2.39369910559617e-07
gene O 0 1.415882788791123e-08
( O 0 5.542139192016293e-09
CYP27 O 0 1.138176571657823e-06
) O 0 4.656872665265155e-10
was O 0 3.781941426694857e-09
identified O 0 7.867306112130379e-11
by O 0 6.21167657241517e-12
sequencing O 0 8.123363648415705e-10
amplified O 0 1.354507439543795e-08
CYP27 O 0 4.254619909715984e-07
gene O 0 3.2276059602764917e-09
products O 0 5.378689049706509e-09
from O 0 2.1268331540369445e-09
a O 0 1.1784465625552798e-09
patient O 0 1.82245614155363e-08
with O 0 2.5208075626892423e-08
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.5159184840740636e-06
CTX B-Disease 0 0.00017842213856056333
) O 0 6.465235458108509e-08
. O 0 2.622868748858309e-07

The O 0 5.741554431892837e-08
mutation O 0 2.307968705039798e-09
changed O 0 4.717667589915209e-09
the O 0 2.4994342151529736e-09
adrenodoxin O 0 7.813927993538528e-08
cofactor O 0 4.704189482396259e-09
binding O 0 1.2848580865920667e-08
residue O 0 4.166118117154838e-07
362Arg O 0 2.718911957799719e-07
to O 0 6.025984156110553e-09
362Ser O 0 7.023081707302481e-07
( O 0 2.5646395229728114e-08
CGT O 0 3.0457206321443664e-06
362Arg O 0 2.2059992943468387e-07
to O 0 7.764733744863861e-09
AGT O 0 7.411025308101671e-06
362Ser O 0 2.0546238488350355e-07
) O 0 5.26711341208852e-10
, O 0 1.2235472357513544e-10
and O 0 2.2912288386023327e-11
was O 0 1.7664785190163457e-09
responsible O 0 2.362042783587981e-09
for O 0 1.3080665439701988e-09
deficiency O 0 6.389844929799438e-05
in O 0 1.3151699818081397e-07
the O 0 2.623038710680703e-07
sterol O 0 6.20096955117333e-07
27 O 0 6.022602860866755e-07
- O 0 2.174398794352328e-08
hydroxylase O 0 7.12473848807349e-08
activity O 0 2.266490772839802e-09
, O 0 3.638587695031781e-11
as O 0 4.365353564739216e-12
confirmed O 0 3.783561311476724e-11
by O 0 4.7806693499741204e-12
expression O 0 4.499138284153048e-10
of O 0 3.214078558855249e-09
mutant O 0 5.991533047478015e-09
cDNA O 0 3.4699638717938797e-08
into O 0 5.747767062302955e-08
COS O 0 7.36873407731764e-05
- O 0 1.106634840652987e-06
1 O 0 8.051317763602128e-07
cells O 0 2.576775059992542e-08
. O 0 7.438886484578688e-08

Quantitative O 0 7.396335490739148e-07
analysis O 0 4.6661060792985154e-08
showed O 0 8.973621845598245e-09
that O 0 1.4008139266608044e-11
the O 0 3.522102401398719e-11
expression O 0 1.6349903375623143e-10
of O 0 3.4178924135375155e-09
CYP27 O 0 8.902366488428015e-08
gene O 0 2.564813084138251e-10
mRNA O 0 9.01533958597156e-10
in O 0 5.056520757662497e-10
the O 0 7.868390383691803e-10
patient O 0 2.8121750261789202e-08
represented O 0 4.120982310951149e-08
52 O 0 2.930614755314309e-06
. O 0 9.5374616648769e-07

5 O 0 8.250632959061477e-07
% O 0 1.1541142264093196e-08
of O 0 2.1030503560837133e-08
the O 0 1.0777222669844377e-08
normal O 0 1.218842044181656e-06
level O 0 4.020942014903994e-06
. O 0 1.370545135159773e-07

As O 0 7.418338388021084e-09
the O 0 3.27565197189017e-09
mutation O 0 7.600717832900727e-10
occurred O 0 2.2811248001630702e-08
at O 0 6.364913485157331e-09
the O 0 3.025219796892742e-10
penultimate O 0 1.1318088688483385e-08
nucleotide O 0 2.6789250817671473e-09
of O 0 1.0585860188427887e-08
exon O 0 5.373821565513026e-08
6 O 0 2.635433133946208e-07
( O 0 3.6419309790147736e-09
- O 0 6.793687390427294e-09
2 O 0 3.598116293801468e-08
position O 0 5.7502454353652865e-08
of O 0 3.6805784020543797e-07
exon O 0 7.467886007361813e-07
6 O 0 7.533340067311656e-06
- O 0 7.638881811544707e-07
intron O 0 6.143374093880993e-07
6 O 0 1.7979361643938319e-07
splice O 0 3.173528284605709e-08
site O 0 3.919664592899608e-09
) O 0 8.544881469063625e-11
of O 0 1.8713723903829305e-09
the O 0 2.1628985269472878e-09
gene O 0 8.159736886170776e-09
, O 0 1.2873644372746185e-09
we O 0 2.4990995384222003e-10
hypothesized O 0 5.35507138632596e-10
that O 0 6.693545023805925e-12
the O 0 1.353630540990025e-10
mutation O 0 2.7363600274554756e-10
may O 0 9.293448788305625e-10
partially O 0 1.0488245827389164e-08
affect O 0 4.713979873116614e-09
the O 0 1.0666458827301994e-09
normal O 0 1.685663519879199e-08
splicing O 0 3.963531725048597e-09
efficiency O 0 2.735860649138999e-09
in O 0 5.082346765661327e-10
exon O 0 3.1096249131223885e-08
6 O 0 1.2973927709936106e-08
and O 0 1.5938353414846063e-10
cause O 0 6.460298962451816e-10
alternative O 0 1.4853296370631597e-09
splicing O 0 1.027207296999677e-08
elsewhere O 0 9.118252264350701e-10
, O 0 3.6947663678565945e-11
which O 0 2.9607742039333695e-12
resulted O 0 2.9305613491459326e-10
in O 0 1.420390333128907e-10
decreased O 0 1.1605997940478119e-08
transcript O 0 8.955893804341031e-08
in O 0 5.235902267308745e-10
the O 0 1.6779927447529985e-09
patient O 0 7.626675824212725e-08
. O 0 1.1396424071108413e-07

Transfection O 0 1.0110667972185183e-05
of O 0 3.9953445707396895e-07
constructed O 0 6.522676585518639e-07
minigenes O 0 2.1607841063087108e-06
, O 0 3.3875491300960903e-10
with O 0 4.780781326374495e-11
or O 0 3.3222311013325623e-10
without O 0 6.742177927065995e-10
the O 0 1.8087065178917783e-10
mutation O 0 5.269422051479289e-11
, O 0 1.4515855184527027e-10
into O 0 5.539201541893135e-09
COS O 0 4.8186895583057776e-05
- O 0 7.394467047561193e-07
1 O 0 2.4780328544693475e-07
cells O 0 1.7368302629439114e-10
confirmed O 0 4.564884581448325e-10
that O 0 1.09935836475894e-11
the O 0 7.406637803075711e-11
mutant O 0 2.4206410209615115e-09
minigene O 0 7.071559338100997e-08
was O 0 9.647143528468405e-09
responsible O 0 2.4318491664843123e-09
for O 0 2.024527351318639e-10
a O 0 1.966169171918608e-10
mRNA O 0 1.7019573250731668e-10
species O 0 2.0677814929065397e-12
alternatively O 0 1.576313302109611e-09
spliced O 0 1.592375475922836e-08
at O 0 4.141050879979957e-08
an O 0 6.080452807921688e-10
activated O 0 1.0910527237228962e-07
cryptic O 0 6.853559142427912e-08
5 O 0 4.170768619360388e-08
splice O 0 8.470525614256985e-08
site O 0 3.7927865292886054e-08
88 O 0 2.1247527115519915e-07
bp O 0 2.276565851389023e-07
upstream O 0 7.956047198831584e-08
from O 0 8.280411911698593e-09
the O 0 7.2480408341846214e-09
3 O 0 8.25932602310786e-08
end O 0 6.643571026643258e-08
of O 0 1.787534671393587e-07
exon O 0 1.1536012607393786e-06
6 O 0 5.138651431479957e-06
. O 0 7.20396656106459e-07

Our O 0 1.8481979680018412e-07
data O 0 2.2727862258875575e-08
suggest O 0 1.3591779923771696e-09
that O 0 1.215623695455248e-11
the O 0 5.5557659167648765e-11
C O 0 1.4461209119076557e-08
to O 0 1.1809368760662409e-10
A O 0 2.009125754653951e-09
mutation O 0 7.528688089619706e-11
at O 0 7.117238798315384e-09
the O 0 5.399862224031438e-10
penultimate O 0 1.650300163191787e-08
nucleotide O 0 6.5700773710375415e-09
of O 0 1.1702871560714811e-08
exon O 0 7.526716672145994e-08
6 O 0 1.638479716348229e-07
of O 0 2.6778025130624883e-08
the O 0 8.329040568355595e-09
CYP27 O 0 5.431166755442973e-06
gene O 0 3.525627789713326e-09
not O 0 5.51769852030759e-10
only O 0 2.9081051455825957e-10
causes O 0 2.0852111148883523e-09
the O 0 3.6745018139328067e-09
deficiency B-Disease 0 2.617848622321617e-06
in I-Disease 0 1.665885029922265e-08
the I-Disease 0 3.727274844322892e-08
sterol I-Disease 0 2.6610166514728917e-07
27 I-Disease 0 2.7331140017849975e-07
- I-Disease 0 7.776843169438052e-09
hydroxylase I-Disease 0 1.1350694961720365e-07
activity I-Disease 0 1.251675652014228e-08
, O 0 2.939585797001598e-10
but O 0 1.0282254908622335e-10
also O 0 1.879964517392807e-10
partially O 0 6.628127380281512e-09
leads O 0 6.63227195385474e-10
to O 0 5.398458763350433e-11
alternative O 0 5.120703860939102e-10
pre O 0 4.069555004093672e-08
- O 0 1.169460972505476e-09
mRNA O 0 7.660564960154659e-10
splicing O 0 9.808562850821545e-09
of O 0 2.659061193455159e-09
the O 0 3.081989108366656e-09
gene O 0 3.5492853101004584e-08
. O 0 1.4616296084568603e-07

To O 0 9.937085110323096e-08
our O 0 2.7795765689120344e-08
knowledge O 0 7.014547520611814e-08
, O 0 9.366422915046968e-11
this O 0 7.902222279310145e-12
is O 0 6.002779003033698e-12
the O 0 3.1677889478221033e-12
first O 0 7.096298375308674e-12
report O 0 6.0243546262661596e-12
regarding O 0 1.4593085073677514e-10
effects O 0 4.1313530374509355e-09
on O 0 1.0281364204445254e-08
pre O 0 4.9346169816999463e-08
- O 0 4.683113341563683e-10
mRNA O 0 1.5653289775485746e-10
splicing O 0 1.8551276070866152e-09
of O 0 9.927831889910976e-10
a O 0 3.02873587321173e-10
mutation O 0 3.091883693517872e-11
at O 0 1.2748154532005174e-08
the O 0 3.891543531864272e-09
- O 0 7.86443266065362e-09
2 O 0 2.8423514208952838e-08
position O 0 2.2679968125771666e-08
of O 0 9.035299086690429e-08
a O 0 3.6560685146014293e-08
5 O 0 1.8250482014536829e-07
splice O 0 6.882521574880229e-07
site O 0 2.477342491147283e-07
. O 0 4.784081397701812e-07

ATM O 0 0.00024151841353159398
germline O 0 1.1136201464978512e-05
mutations O 0 1.115380712235492e-07
in O 0 3.406290360885578e-08
classical O 1 0.9999998807907104
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.00030818142113275826
in O 0 1.1082085471514347e-08
the O 0 6.232347526946569e-09
Dutch O 0 3.2266189009533264e-06
population O 0 2.715939625974606e-11
. O 0 6.277923070285851e-09

Germline O 0 5.498949394677766e-05
mutations O 0 1.5796344143836905e-07
in O 0 9.798539757355229e-09
the O 0 4.242381557162389e-09
ATM O 0 3.962948369462538e-07
gene O 0 8.404054119282023e-10
are O 0 1.7737684151336586e-12
responsible O 0 2.3253138997647582e-11
for O 0 2.5315534391001648e-11
the O 0 1.3717649380851071e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999942779541016
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.708622658559761e-07
. O 0 3.0245485049817944e-07

In O 0 1.804028357810239e-07
our O 0 2.8615753322469573e-08
study O 0 2.3818766958783044e-09
, O 0 1.2041276309382454e-10
we O 0 6.119694334616455e-11
have O 0 2.32383166529071e-12
determined O 0 3.73189291968945e-11
the O 0 1.7798221230158617e-11
ATM O 0 2.6647173356764142e-09
mutation O 0 3.949039012463018e-11
spectrum O 0 2.210923888412708e-09
in O 0 2.411322252982018e-10
19 O 0 1.7440520139189175e-08
classical O 0 0.0004418032185640186
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 5.917148371281655e-08
, O 0 5.370052666431313e-11
including O 0 1.8891692030176266e-11
some O 0 3.3587867730167087e-12
immigrant O 0 4.5945462712193574e-11
populations O 0 9.985339378265623e-13
, O 0 1.847349747133298e-12
as O 0 9.6967902457612e-12
well O 0 1.4768701886436197e-11
as O 0 4.72239816695641e-11
12 O 0 3.734586806469764e-10
of O 0 6.113385353501144e-10
Dutch O 0 1.6705728000943054e-07
ethnic O 0 1.1138830968704383e-09
origin O 0 5.2342175038688765e-09
. O 0 2.1249405790513265e-08

Both O 0 1.6687050674590864e-07
the O 0 4.7772516609256854e-08
protein O 0 3.847777563237287e-08
truncation O 0 1.3140002863565314e-07
test O 0 2.3561943507388605e-08
( O 0 5.398152480573515e-10
PTT O 0 3.5252263330676215e-08
) O 0 8.445459609429662e-11
and O 0 6.024093029965982e-11
the O 0 8.056592892824455e-11
restriction O 0 3.055612984859124e-10
endonuclease O 0 3.420298710921088e-09
fingerprinting O 0 2.008414234921929e-08
( O 0 6.222022896906765e-10
REF O 0 2.3653440095472433e-08
) O 0 7.124416334658434e-11
method O 0 1.6848720196804834e-09
were O 0 7.805069784927454e-11
used O 0 4.2405166184034115e-11
and O 0 1.4663948874615862e-11
compared O 0 1.0720421772525413e-10
for O 0 2.7091310098037447e-11
their O 0 5.928387988851647e-12
detection O 0 5.706938255300997e-10
efficiency O 0 1.3166615020487882e-10
, O 0 9.313295794288745e-12
identifying O 0 3.460785824582757e-10
76 O 0 1.0512258619144177e-08
% O 0 2.5648030921310294e-10
and O 0 1.8920189026605527e-10
60 O 0 2.0961934410479444e-09
% O 0 5.714235751241858e-10
of O 0 2.9276019386514918e-09
the O 0 2.4165032197487335e-09
mutations O 0 7.708802485240085e-10
, O 0 1.1828219514953275e-09
respectively O 0 9.294307545815172e-08
. O 0 2.5068555942198145e-07

Most O 0 3.5844987422706254e-08
patients O 0 3.5345443905043794e-08
were O 0 9.042519621971223e-09
found O 0 4.75635364427518e-10
to O 0 1.307312591514176e-10
be O 0 4.679113208005958e-10
compound O 0 1.0952854267998191e-07
heterozygote O 0 5.834423518535914e-06
. O 0 2.997664410031575e-07

Seventeen O 0 4.658423051751015e-07
mutations O 0 6.356688064812488e-09
were O 0 5.673618241885947e-10
distinct O 0 7.481334995951272e-11
, O 0 3.477339249879918e-11
of O 0 4.5684031557691185e-10
which O 0 8.249883415301085e-11
10 O 0 1.3931628073393654e-09
were O 0 2.864395387547347e-10
not O 0 7.861861162083983e-11
reported O 0 1.4398450209895941e-09
previously O 0 1.7558612341872504e-08
. O 0 4.533132980100163e-08

Mutations O 0 3.47539923950535e-07
are O 0 9.010285295651954e-10
small O 0 6.213875525240553e-10
deletions O 0 3.130536896378544e-08
or O 0 1.960954065793885e-08
point O 0 3.0826370220893295e-06
mutations O 0 1.869528709619317e-08
frequently O 0 9.159831115823636e-09
affecting O 0 1.9480369317648183e-08
splice O 0 3.137624275950657e-07
sites O 0 3.090037026254322e-08
. O 0 1.7394847873219987e-07

Moreover O 0 2.1970122361381073e-06
, O 0 4.336383696568191e-08
a O 0 5.893247845278893e-08
16 O 0 5.694998321814637e-07
. O 0 1.6707718941688654e-07

7 O 0 1.2441490071068984e-05
- O 0 4.3648546466101834e-07
kb O 0 9.024601013152278e-07
genomic O 0 7.934406909271274e-08
deletion O 0 1.1414044820412528e-07
of O 0 3.833990547263966e-08
the O 0 6.2840563863630905e-09
3 O 0 4.741177761502513e-08
end O 0 7.927022593889888e-09
of O 0 4.7319059781614214e-09
the O 0 5.318659956898841e-10
gene O 0 1.817150596661321e-10
, O 0 6.409801162066131e-11
most O 0 3.529713630753828e-12
likely O 0 4.1340132705958155e-11
a O 0 5.59185857340605e-11
result O 0 3.556926142511685e-10
of O 0 7.386034450718171e-09
recombination O 0 8.677416118985093e-09
between O 0 4.8729241086675756e-08
two O 0 3.1757367846552143e-09
LINE O 0 1.6255802393061458e-07
elements O 0 3.3658352549537085e-08
, O 0 5.212048570513161e-10
was O 0 1.6958475512751647e-08
identified O 0 1.4814260040907357e-08
. O 0 5.2910223757862695e-08

The O 0 8.270171036883767e-08
most O 0 4.846465451180393e-10
frequently O 0 1.3248992181136288e-10
found O 0 1.382926152065922e-11
mutation O 0 2.6666860993701524e-12
, O 0 4.924518258453414e-12
identified O 0 6.31137780926494e-11
in O 0 1.0025846125527593e-10
three O 0 6.698558374651498e-10
unrelated O 0 3.922089675256757e-08
Turkish O 0 2.6319069093005965e-06
A B-Disease 1 1.0
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
individuals O 0 1.0344303191800464e-09
, O 0 1.1910308295171035e-09
was O 0 3.028640804814131e-08
previously O 0 1.1332107696659932e-08
described O 0 1.2016870831743631e-09
to O 0 3.739602377761386e-11
be O 0 1.1705048041932287e-10
a O 0 7.530501222596797e-10
Turkish O 0 3.2188967225010856e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
founder O 0 0.0004154892230872065
mutation O 0 7.019097836291621e-08
. O 0 1.4668815140339575e-07

The O 0 3.265865444745941e-08
presence O 0 1.924541237485755e-08
of O 0 6.282752451625129e-08
a O 0 1.8843245186417334e-08
founder O 0 5.872623987102088e-08
mutation O 0 1.0103655689874813e-09
among O 0 5.021676824368271e-11
relatively O 0 2.8742519475599693e-10
small O 0 1.1758678232498543e-11
ethnic O 0 1.6150476789267287e-11
population O 0 5.589016120570445e-13
groups O 0 9.535876862448722e-13
in O 0 3.7412579978468585e-11
Western O 0 1.4976874185279598e-09
Europe O 0 1.0665177629931577e-09
could O 0 8.6911887409169e-11
indicate O 0 1.2833969997849692e-10
a O 0 7.062396500945312e-11
high O 0 2.5062690811594734e-10
carrier O 0 7.79438805165178e-11
frequency O 0 7.489976971974954e-10
in O 0 5.304676142792175e-11
such O 0 4.137878928389682e-11
communities O 0 2.0187665428217372e-10
. O 0 1.8654182198929448e-08

In O 0 7.880743169152993e-08
patients O 0 1.0545434747655236e-08
of O 0 1.1239374764215881e-08
Dutch O 0 6.410142759705195e-06
ethnic O 0 1.87377224847296e-09
origin O 0 2.515531394298165e-10
, O 0 7.020396850659916e-12
however O 0 1.8371850915577248e-11
, O 0 3.04320934771396e-12
no O 0 1.075851647353021e-11
significant O 0 3.2650027126379655e-10
founder O 0 9.385856714061447e-08
effect O 0 2.6957854970532935e-07
could O 0 7.303856630613836e-09
be O 0 3.1408344813854683e-09
identified O 0 7.337133212104163e-08
. O 0 4.1767311387275186e-08

The O 0 3.2773471048130887e-08
observed O 0 2.743716365216642e-08
genetic O 0 6.4800227406180966e-09
heterogeneity O 0 8.180212063280123e-09
including O 0 3.7497968619071287e-10
the O 0 3.873605325388496e-10
relative O 0 1.1116173226355386e-07
high O 0 2.6577146172712673e-07
percentage O 0 1.5275363196565195e-08
of O 0 2.50637217646954e-08
splice O 0 2.735802979714208e-07
- O 0 2.833350087882991e-08
site O 0 5.9669451601962464e-09
mutations O 0 2.1273931505305654e-09
had O 0 5.4868882770620075e-09
no O 0 1.1215662842900542e-09
reflection O 0 6.501044147455559e-09
on O 0 2.6730008428899055e-08
the O 0 4.288453592238284e-09
phenotype O 0 3.887153710024904e-08
. O 0 1.3425004397049634e-07

All O 0 1.0731787014606198e-08
patients O 0 3.0309854626153765e-09
manifested O 0 4.254065988362754e-09
classical O 0 4.13297166232951e-05
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.7931700944900513
T I-Disease 1 0.9999918937683105
and O 0 1.1838512392614575e-09
increased O 0 3.250588687109257e-09
cellular O 0 1.4054157304599357e-07
radioresistant O 0 7.360961973290614e-08
DNA O 0 9.709796522372471e-09
synthesis O 0 7.102107701939531e-08
. O 0 3.4055300801583144e-08

Determination O 0 1.3801372915622778e-06
of O 0 1.077258175996576e-07
the O 0 5.537880820583041e-09
genomic O 0 4.686603105596987e-08
structure O 0 4.571885980908519e-08
of O 0 4.3815955308446064e-08
the O 0 2.508202534556858e-09
COL4A4 O 0 8.072968853412021e-07
gene O 0 7.602457552380315e-10
and O 0 3.3949797834109674e-11
of O 0 1.2903488277871134e-09
novel O 0 3.3109614605564275e-08
mutations O 0 2.7642932764138095e-05
causing O 0 0.0032431986182928085
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.001342685311101377

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.324391973867023e-07
a O 0 1.5290250132693473e-07
progressive O 1 0.9998062252998352
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.2607928514480591
by O 0 9.89802373396742e-08
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9999996423721313
membrane I-Disease 1 0.6782633662223816
abnormalities I-Disease 1 0.9999626874923706
and O 0 2.5601221143034536e-09
associated O 0 3.9564337583897213e-08
with O 0 3.8803790736174903e-10
mutations O 0 1.7706014432405937e-08
in O 0 1.1171303881951644e-08
either O 0 2.5347654641905137e-08
the O 0 4.2898381735767543e-08
COL4A3 O 0 6.564467184944078e-05
or O 0 5.613386200309378e-09
the O 0 3.469882603468477e-09
COL4A4 O 0 6.351624506351072e-07
gene O 0 1.6523434842596885e-09
, O 0 2.7082902587238777e-10
which O 0 2.1748932516052477e-11
encode O 0 5.754529075474579e-10
the O 0 1.6326914265007986e-09
alpha3 O 0 1.7671912644345866e-07
and O 0 3.132859083265771e-09
alpha4 O 0 2.046271447397885e-06
type O 0 1.877751674328465e-05
IV O 1 0.9999998807907104
collagen O 0 0.08667690306901932
chains O 0 1.9556542611098848e-05
, O 0 1.1047810666298119e-08
respectively O 0 1.2306212511248305e-06
. O 0 4.0402358081337297e-07

To O 0 8.70307470535181e-09
date O 0 5.787281409652678e-08
, O 0 2.14799039666147e-10
mutation O 0 2.2131407817482796e-11
screening O 0 4.498983963152625e-10
in O 0 2.4280755184236114e-10
the O 0 5.857638818440591e-10
two O 0 1.1959888635004745e-09
genes O 0 1.550212291867581e-09
has O 0 2.1307298980755007e-10
been O 0 3.337995713170727e-10
hampered O 0 9.310254789340888e-09
by O 0 1.8153483924421288e-11
the O 0 7.747032876315174e-11
lack O 0 3.8129708279655006e-09
of O 0 3.4176250718331858e-09
genomic O 0 1.6183372864020384e-08
structure O 0 7.069294127859393e-08
information O 0 3.2038709463222403e-08
. O 0 1.062847232446984e-07

We O 0 6.949507280751277e-08
report O 0 5.89128923422777e-09
here O 0 1.5797747554557873e-09
the O 0 6.698912952129987e-11
complete O 0 7.635329035693417e-10
characterization O 0 5.140120773461376e-09
of O 0 3.012122773426995e-09
the O 0 1.851239384009773e-09
48 O 0 2.7940236790868767e-08
exons O 0 6.31260235195441e-08
of O 0 7.83126594683381e-08
the O 0 2.1600385480269324e-08
COL4A4 O 0 8.396110388275702e-06
gene O 0 6.709328204124176e-09
, O 0 1.2643248670229923e-09
a O 0 1.1561361867862274e-09
comprehensive O 0 3.5744609494514634e-09
gene O 0 1.121121417924087e-09
screen O 0 1.0063487110301139e-07
, O 0 9.6036634200658e-10
and O 0 4.6269443138013955e-11
the O 0 5.909740058429591e-11
subsequent O 0 5.928572216484795e-11
detection O 0 1.2530079196437782e-09
of O 0 2.1834774266427104e-10
10 O 0 1.0833165614565488e-10
novel O 0 3.691582456388787e-11
mutations O 0 8.194399325756052e-11
in O 0 9.277380252914469e-11
eight O 0 1.028587526263891e-08
patients O 0 3.5814214243146125e-06
diagnosed O 1 0.9946751594543457
with O 0 0.004530438221991062
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 9.171045530820265e-05

Furthermore O 0 3.046176971110981e-06
, O 0 2.590953940284635e-08
we O 0 2.8891817827059185e-09
identified O 0 3.4344844745959335e-09
a O 0 1.2487872957933632e-09
glycine O 0 3.4924378944367618e-09
to O 0 1.9395225703267016e-10
alanine O 0 3.860640251929226e-09
substitution O 0 6.468662050451712e-09
in O 0 3.087013311642295e-09
the O 0 4.907319883784567e-09
collagenous O 0 9.339833582089341e-07
domain O 0 1.6907060640392046e-08
that O 0 9.125972200152432e-11
is O 0 5.309616288307062e-11
apparently O 0 1.0129609373521475e-09
silent O 0 2.3172403995630475e-09
in O 0 6.134945329527852e-11
the O 0 1.3026978107344434e-10
heterozygous O 0 2.1105867054060923e-10
carriers O 0 2.377091579131019e-10
, O 0 1.9453282040782227e-10
in O 0 1.456900822205398e-09
11 O 0 1.268283540412085e-07
. O 0 3.2516015835426515e-07

5 O 0 3.6825412053076434e-07
% O 0 3.904748080429954e-09
of O 0 6.50243281441476e-09
all O 0 1.279322758840351e-10
control O 0 1.1020514278925475e-08
individuals O 0 2.2697880901201284e-12
, O 0 9.995652743011174e-12
and O 0 1.30549295332405e-11
in O 0 2.3350663069798827e-10
one O 0 8.250843064327995e-11
control O 0 7.485424724507084e-09
individual O 0 4.141700524207259e-11
homozygous O 0 3.91172344516022e-10
for O 0 1.1647145747861742e-10
this O 0 1.429465296132193e-10
glycine O 0 6.45577173941092e-08
substitution O 0 1.0552782470085731e-07
. O 0 1.6861352492014703e-07

There O 0 2.980463520430021e-08
has O 0 4.592025648619824e-10
been O 0 1.4862017172490027e-10
no O 0 2.1972083874555182e-11
previous O 0 5.845927908421089e-11
finding O 0 5.624228860412472e-10
of O 0 1.3017198430276267e-09
a O 0 9.516721855007404e-10
glycine O 0 1.0302682262874896e-08
substitution O 0 4.865834846157213e-09
that O 0 2.289845119074485e-10
is O 0 3.729417122344536e-11
not O 0 3.274759803606475e-12
associated O 0 8.801944589853505e-11
with O 0 3.904369882956615e-12
any O 0 9.756755819934071e-11
obvious O 0 7.402843338333298e-10
phenotype O 0 3.542166837622318e-10
in O 0 5.1838722203712e-10
homozygous O 0 5.017909643356688e-09
individuals O 0 1.2806882221383376e-09
. O 0 1.6432525740128767e-07

Founder O 0 0.00033392407931387424
BRCA1 O 0 1.893311377898499e-06
and O 0 1.802825444485734e-08
BRCA2 O 0 2.192845194315396e-08
mutations O 0 1.3552071687072953e-09
in O 0 3.341180943028377e-10
French O 0 5.342141093933606e-07
Canadian O 0 0.00019524754316080362
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9104990363121033
. O 0 0.0001877327886177227

We O 0 3.878533050283295e-08
have O 0 1.4592502206589586e-10
identified O 0 1.8323881301185452e-10
four O 0 3.352222319175091e-11
mutations O 0 1.01312222500205e-11
in O 0 7.997841972029462e-12
each O 0 6.011578821546459e-12
of O 0 4.860066127321261e-09
the O 0 7.145452229906368e-08
breast B-Disease 1 0.993517279624939
cancer I-Disease 1 0.9989913105964661
- O 0 0.0741906613111496
susceptibility O 0 0.007125546224415302
genes O 0 2.838137618255132e-07
, O 0 2.0704455039322056e-08
BRCA1 O 0 9.400688227856335e-09
and O 0 1.3758766348459517e-09
BRCA2 O 0 1.0009342243932906e-09
, O 0 2.4650880295351563e-11
in O 0 3.1989688675793104e-11
French O 0 1.3786821284611506e-07
Canadian O 0 2.1470343199325725e-05
breast B-Disease 1 0.9999943971633911
cancer I-Disease 1 0.9999911785125732
and O 1 0.9999938011169434
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00012618183973245323
from O 0 6.394939191523008e-06
Quebec O 0 0.00017375624156557024
. O 0 1.1955946774833137e-06

To O 0 6.255215367900746e-08
identify O 0 8.17527734398027e-07
founder O 0 8.719046491023619e-06
effects O 0 0.02806873805820942
, O 0 1.4791051050622173e-08
we O 0 9.11682618287557e-10
examined O 0 3.034369422394434e-09
independently O 0 2.3264107307241488e-10
ascertained O 0 2.783952179896687e-09
French O 0 1.8959791514561175e-09
Canadian O 0 3.793667158191738e-09
cancer B-Disease 0 7.480871921927701e-09
families O 0 2.4453063272172892e-12
for O 0 4.7636027067365916e-12
the O 0 2.498707317444282e-11
distribution O 0 3.530349901303964e-10
of O 0 1.1279550626852597e-09
these O 0 4.4025651180223946e-11
eight O 0 3.168851181456489e-09
mutations O 0 6.286945630762375e-09
. O 0 4.2539788580597815e-08

Mutations O 0 6.363556082078503e-08
were O 0 5.29210986144335e-09
found O 0 7.916561850507264e-10
in O 0 3.4255592806786694e-10
41 O 0 1.3750900862419257e-08
of O 0 1.5071908165964487e-08
97 O 0 7.94492962086224e-07
families O 0 1.1613305872515411e-08
. O 0 1.5681850129567465e-07

Six O 0 7.317510863913412e-08
of O 0 3.853381258522859e-08
eight O 0 5.7210658432893524e-09
mutations O 0 3.5552169541652745e-10
were O 0 4.1240133530351386e-10
observed O 0 2.7046160866461832e-09
at O 0 2.002603771700251e-08
least O 0 1.0108263115427008e-09
twice O 0 2.5425320515637395e-08
. O 0 4.6436966272267455e-08

The O 0 6.20198647993675e-07
BRCA1 O 0 1.9669613493533689e-07
C4446T O 0 9.245137988500574e-08
mutation O 0 1.6578711736769947e-09
was O 0 5.791253698816945e-09
the O 0 2.553215971978773e-10
most O 0 3.272645002216912e-11
common O 0 1.8044750416112976e-10
mutation O 0 5.817330298030221e-11
found O 0 1.527884485597042e-10
, O 0 3.517711816281022e-11
followed O 0 6.254896600665916e-11
by O 0 4.3080098516279364e-11
the O 0 4.531125252782431e-09
BRCA2 O 0 6.470195046404115e-08
8765delAG O 0 7.344721666413534e-07
mutation O 0 1.2995342046906444e-07
. O 0 2.69099245997495e-07

Together O 0 2.140728838639916e-08
, O 0 5.31042876339427e-10
these O 0 1.0927480274813828e-11
mutations O 0 4.102381975790159e-11
were O 0 6.362273902160709e-11
found O 0 9.008592483095157e-12
in O 0 1.4284315917600932e-11
28 O 0 2.8608098112670177e-09
of O 0 7.61874918708827e-09
41 O 0 4.094438210699991e-08
families O 0 3.41635747469482e-11
identified O 0 5.748331255439609e-10
to O 0 2.3017512895684433e-10
have O 0 1.606728083913822e-10
a O 0 5.853766360530699e-09
mutation O 0 1.7141434938139355e-08
. O 0 1.649212180154791e-07

The O 0 7.968713333639244e-08
odds O 0 2.9281264346536773e-07
of O 0 2.6685522680480744e-09
detection O 0 7.072068708424695e-09
of O 0 1.1706303704173138e-09
any O 0 1.6527272606037258e-10
of O 0 5.378186784810168e-09
the O 0 4.361282002207645e-09
four O 0 1.3911666485455498e-08
BRCA1 O 0 1.1578316083671325e-08
mutations O 0 3.943518844806704e-09
was O 0 6.822634190939425e-07
18 O 0 3.7365823573054513e-06
. O 0 1.3233621984909405e-06

7x O 0 0.0024851830676198006
greater O 0 1.8512776023271726e-06
if O 0 1.8163623494160674e-08
one O 0 4.947919851616689e-10
or O 0 4.514643520137085e-11
more O 0 1.402098814655417e-12
cases O 0 1.806031296736066e-10
of O 0 2.783157697194838e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.5016208837769227e-06
also O 0 3.8308139993503687e-10
present O 0 3.259576775160866e-10
in O 0 5.892387688888334e-10
the O 0 8.481402247184633e-09
family O 0 2.2079456485357696e-08
. O 0 6.561251097991772e-08

The O 0 1.1882862338552513e-07
odds O 0 9.551077937430819e-07
of O 0 5.963258775665281e-09
detection O 0 3.16637560615618e-08
of O 0 1.8644674693035768e-09
any O 0 3.048766794577773e-10
of O 0 9.211936990993763e-09
the O 0 3.304663431791255e-09
four O 0 1.0274542106003537e-08
BRCA2 O 0 3.7094998184272754e-09
mutations O 0 2.785641273206352e-09
was O 0 5.778594527328096e-07
5 O 0 1.5953963838910568e-06
. O 0 3.415626963487739e-07

3x O 0 7.847126107662916e-05
greater O 0 1.8272878321567987e-07
if O 0 3.4895812905944013e-09
there O 0 3.562955486202668e-10
were O 0 2.158528911166968e-10
at O 0 9.587101112984442e-10
least O 0 1.0631696044371974e-11
five O 0 1.192748243922237e-11
cases O 0 4.0262970041338164e-11
of O 0 4.72696282116658e-09
breast B-Disease 0 2.4675608074176125e-05
cancer I-Disease 0 3.0193776183295995e-05
in O 0 3.859781827486586e-07
the O 0 8.309965778607875e-06
family O 0 1.1225148455196177e-06
. O 0 3.9343814250969444e-07

Interestingly O 0 2.6166750899392355e-07
, O 0 1.6869203811609168e-09
the O 0 3.0829755415240356e-10
presence O 0 2.069718174624313e-09
of O 0 7.704340987402247e-08
a O 0 1.4923294600066583e-07
breast B-Disease 0 2.8532413125503808e-05
cancer I-Disease 0 6.900786502228584e-06
case O 0 3.2745236921982723e-07
< O 0 1.1856408832500165e-07
36 O 0 1.767396007323896e-08
years O 0 9.254850774631507e-10
of O 0 3.3819602673901272e-09
age O 0 4.759177940627524e-09
was O 0 2.9981142013468798e-09
strongly O 0 3.712822757573342e-11
predictive O 0 3.275725246609795e-10
of O 0 4.324683389178574e-10
the O 0 1.4695819561261203e-10
presence O 0 2.4720295255242775e-10
of O 0 1.1858716231216704e-09
any O 0 2.420288969240403e-10
of O 0 5.138307113128349e-09
the O 0 3.3832117107834847e-09
eight O 0 1.0736537880973174e-08
mutations O 0 2.7274928982023994e-09
screened O 0 2.4847037138897576e-07
. O 0 3.3078973160627356e-07

Carriers O 0 3.2869881039232496e-08
of O 0 2.0826524504968802e-08
the O 0 4.721968371868002e-10
same O 0 1.3043885416230694e-10
mutation O 0 5.967163395348418e-12
, O 0 1.9065289711545086e-12
from O 0 5.6337785998838985e-12
different O 0 5.353789026690814e-12
families O 0 2.1629820330659744e-12
, O 0 7.575685738447913e-12
shared O 0 4.385292823316789e-11
similar O 0 3.3825629797146206e-11
haplotypes O 0 3.3376856833911006e-09
, O 0 3.0422958596787453e-10
indicating O 0 9.774455689282036e-10
that O 0 2.455468120499127e-11
the O 0 2.332969373242122e-10
mutant O 0 8.080003888188969e-10
alleles O 0 3.923918689974215e-10
were O 0 2.2878947625315504e-09
likely O 0 2.805924659288195e-10
to O 0 1.361413239087117e-11
be O 0 1.1037790473289455e-11
identical O 0 2.7234665911368694e-11
by O 0 2.0877719691947405e-11
descent O 0 3.5464413628005786e-09
for O 0 1.3418469113624099e-10
a O 0 3.1923999554983595e-10
mutation O 0 1.0327560334699726e-10
in O 0 2.658126774246483e-10
the O 0 3.4119715941471895e-09
founder O 0 2.1042083631073183e-07
population O 0 4.175332857236924e-10
. O 0 1.2592106202191644e-07

The O 0 5.24706189608537e-09
identification O 0 1.1396897647841797e-08
of O 0 2.1076763445648794e-08
common O 0 4.9806288870968274e-08
BRCA1 O 0 3.1610774442469847e-08
and O 0 9.63877422321957e-09
BRCA2 O 0 1.1596085869314265e-08
mutations O 0 5.534404046159125e-10
will O 0 4.238155312807912e-11
facilitate O 0 2.936223486571521e-10
carrier O 0 1.1264070787220248e-09
detection O 0 1.5034354206022726e-08
in O 0 1.8787062183722725e-10
French O 0 4.6619160798400117e-07
Canadian O 0 3.050528175663203e-05
breast B-Disease 1 0.9999978542327881
cancer I-Disease 1 0.999998927116394
and O 1 0.9999853372573853
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.7859611511230469
. O 0 2.6916624847217463e-05

Are O 0 3.613080679087943e-08
Dp71 O 0 1.0519043826207053e-05
and O 0 2.7203507002582228e-08
Dp140 O 0 1.03812271845527e-05
brain O 0 4.628262831829488e-05
dystrophin O 0 1.8773955616779858e-06
isoforms O 0 9.9542148745968e-08
related O 0 1.1510496555899863e-08
to O 0 3.8142053404577325e-10
cognitive B-Disease 0 0.008642228320240974
impairment I-Disease 1 0.9999996423721313
in O 1 0.9999706745147705
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.6965084075927734

Molecular O 0 5.634036597257364e-07
study O 0 5.386491697123574e-09
and O 0 9.067501610671158e-11
neuropsychological O 0 4.383281737574407e-09
analysis O 0 8.039538479387431e-11
were O 0 1.0759091534362497e-11
performed O 0 5.547347650680656e-11
concurrently O 0 9.403583467459953e-11
on O 0 1.517725278787907e-09
49 O 0 1.7829361809162947e-07
patients O 0 6.40382893379865e-07
with O 1 0.9654024839401245
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5018301010131836
DMD B-Disease 1 1.0
) O 0 1.0639557013192302e-09
in O 0 4.53492486618412e-11
order O 0 3.750195640139786e-11
to O 0 9.350851690181905e-12
find O 0 5.602940333915285e-11
a O 0 2.849762266443623e-11
molecular O 0 7.163868387394245e-10
explanation O 0 9.53426781968858e-11
for O 0 2.297618345581398e-11
the O 0 3.420662364472804e-10
cognitive B-Disease 0 1.604779936315026e-05
impairment I-Disease 0 5.164496906218119e-05
observed O 0 3.5113622232074704e-08
in O 0 2.4785364871604543e-09
most O 0 1.5586213208962363e-08
DMD B-Disease 1 1.0
patients O 0 1.3464909898175392e-06
. O 0 1.4029450312591507e-07

Complete O 0 1.4122772995506239e-07
analysis O 0 1.5052602719833885e-08
of O 0 1.7062886215057915e-08
the O 0 6.480789682683508e-09
dystrophin O 0 4.736184280318412e-07
gene O 0 1.8285319924871146e-08
was O 0 3.4324438047406147e-07
performed O 0 2.5028368710877658e-08
to O 0 9.450409343969568e-10
define O 0 2.2352294237748538e-08
the O 0 5.5407021193332184e-09
localization O 0 2.991552264575148e-06
of O 0 2.3576870233910086e-08
deletions O 0 3.177215157634805e-09
and O 0 3.8713526828715317e-10
duplications O 0 1.8295681414315368e-08
in O 0 1.03467889811526e-09
relation O 0 2.3402808579930934e-08
to O 0 4.031655564951109e-10
the O 0 2.6674022990391677e-09
different O 0 8.011186025669303e-08
DMD B-Disease 1 1.0
promoters O 0 6.905371265020221e-05
. O 0 1.4310810456663603e-06

Qualitative O 0 6.604606710425287e-07
analysis O 0 3.0151248608945025e-08
of O 0 2.189998582480257e-08
the O 0 4.038006817808082e-09
Dp71 O 0 5.043219744038652e-07
transcript O 0 2.53827785456906e-08
and O 0 5.7900989558490323e-11
testing O 0 3.1332800937144967e-11
for O 0 4.062582301816997e-12
the O 0 4.892882106422025e-12
specific O 0 6.332487485771754e-12
first O 0 1.0687653539953601e-10
exon O 0 8.004492180191392e-09
of O 0 7.847171801245167e-09
Dp140 O 0 5.959225291007897e-08
were O 0 1.8418356839688954e-09
also O 0 2.0790665022918375e-10
carried O 0 2.54003346134013e-10
out O 0 2.2603592608749778e-10
. O 0 6.503003469049418e-09

Neuropsychological O 0 4.6517907321685925e-06
analysis O 0 5.4233805002468216e-08
assessed O 0 1.3887891725516965e-07
verbal O 0 2.768407796338579e-07
and O 0 1.3758247874307017e-08
visuospatial O 0 1.1156503205711488e-05
intelligence O 0 5.5489536521236005e-08
, O 0 1.1075148576011884e-09
verbal O 0 1.779329217299619e-08
memory O 0 1.1836962585221045e-05
, O 0 8.83369022375291e-09
and O 0 6.445016520473246e-09
reading O 0 2.27683995035477e-06
skills O 0 9.564219362800941e-05
. O 0 1.318234353675507e-06

Comparison O 0 1.1197931826245622e-07
of O 0 7.123950496179532e-08
molecular O 0 1.3402413401308877e-07
and O 0 9.030484693361984e-10
psychometric O 0 2.646810628448293e-07
findings O 0 2.215132299809852e-09
demonstrated O 0 1.63914404271992e-09
that O 0 2.6976582426230244e-11
deletions O 0 1.3596992420872311e-09
and O 0 1.6160406346443779e-10
duplications O 0 1.4173229700986667e-08
that O 0 6.698210042177521e-11
were O 0 3.5531289022117107e-10
localized O 0 8.039822141370223e-09
in O 0 2.0131842859427707e-09
the O 0 2.6965807364831562e-09
distal O 0 2.976496489281999e-07
part O 0 1.1398854304900397e-08
of O 0 1.4950617810427502e-07
the O 0 4.5062968467846076e-08
gene O 0 3.412455029661032e-08
seemed O 0 1.7525260886941396e-07
to O 0 1.369853258603726e-10
be O 0 5.2967599056819026e-11
preferentially O 0 4.3616124600909245e-10
associated O 0 1.0115056348070084e-08
with O 0 5.388999468891598e-09
cognitive B-Disease 1 0.9940416216850281
impairment I-Disease 1 0.9999217987060547
. O 0 2.8916949304402806e-05

Two O 0 8.634214765379511e-08
altered O 0 3.009552074217936e-07
Dp71 O 0 3.0660889933642466e-06
transcripts O 0 3.4935862913698656e-07
and O 0 7.3885109141969e-10
two O 0 1.7984619349320496e-10
deleted O 0 2.32573316161222e-09
Dp140 O 0 5.102902544962262e-09
DNA O 0 4.5739137477518454e-10
sequences O 0 4.2165165803353943e-10
were O 0 9.203567769011656e-11
found O 0 2.8776625179971482e-11
in O 0 2.724713683843749e-11
four O 0 3.3721292425070715e-10
patients O 0 2.9997271333570552e-09
with O 0 1.9676642537547195e-08
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.0037830937653779984

These O 0 2.0623804886099606e-09
findings O 0 1.3742662563487329e-09
suggest O 0 3.4179231667152976e-10
that O 0 9.717688893157161e-13
some O 0 9.941725177473049e-13
sequences O 0 5.146491913188278e-11
located O 0 1.5150000698405108e-10
in O 0 6.441237127008392e-11
the O 0 9.033344072761906e-10
distal O 0 2.6972924160872935e-07
part O 0 8.579642774009244e-09
of O 0 5.821523885174429e-08
the O 0 2.953040700859333e-09
gene O 0 3.89450416360404e-10
and O 0 1.6825814352916524e-10
, O 0 4.277624782167422e-11
in O 0 8.811333607194882e-11
particular O 0 7.536536394958659e-10
, O 0 1.5700772626470183e-10
some O 0 1.1861718551831046e-10
DMD B-Disease 1 0.9989509582519531
isoforms O 0 4.3206643596249705e-08
expressed O 0 3.565799211457943e-09
in O 0 3.053138630804142e-09
the O 0 1.2311755170912875e-08
brain O 0 6.719654629705474e-05
may O 0 5.446183060087151e-09
be O 0 9.206833906372225e-11
related O 0 2.893647543800171e-10
to O 0 2.7388235776526493e-11
the O 0 1.4233146883313452e-09
cognitive B-Disease 0 0.0001564075646456331
impairment I-Disease 0 0.02054428867995739
associated O 0 2.1292027668096125e-05
with O 0 1.176774730993202e-06
DMD B-Disease 1 1.0
. O 0 2.271462875569341e-07
. O 0 3.09899405692704e-07

I1307K O 0 1.6876450899871998e-05
APC O 0 1.0577978173387237e-06
and O 0 7.907813071028613e-09
hMLH1 O 0 8.107026161496833e-08
mutations O 0 3.0313382914926024e-09
in O 0 5.510357170557256e-10
a O 0 1.7447532307812708e-09
non O 0 1.1019152879043759e-07
- O 0 2.222069106494473e-08
Jewish O 0 9.709051340678343e-10
family O 0 1.0445851128526584e-10
with O 0 1.5423486099397365e-10
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999951124191284

We O 0 1.827757856176504e-08
describe O 0 4.109920404005152e-09
a O 0 4.2771944319675015e-10
French O 0 9.136659429032079e-09
Canadian O 0 8.952460461841838e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999086856842041
HNPCC B-Disease 1 0.9999332427978516
) O 0 3.951305416194373e-08
kindred O 0 1.133446289713902e-06
which O 0 5.842853978421658e-10
carries O 0 5.437232886151833e-10
a O 0 8.926583083823658e-11
novel O 0 1.00427645366441e-10
truncating O 0 8.766384063108035e-09
mutation O 0 1.6087529086661334e-09
in O 0 3.3658080766940657e-09
hMLH1 O 0 1.1560947541511268e-06
. O 0 4.734626202207437e-07

Interestingly O 0 3.5351652627468866e-07
, O 0 5.40501687851247e-09
the O 0 1.466234023084212e-09
I1307K O 0 6.532493301847353e-08
APC O 0 1.8232002574336548e-08
polymorphism O 0 1.7594885548533057e-08
, O 0 1.3810765031596617e-10
associated O 0 1.1575168601396513e-10
with O 0 1.489026350137701e-12
an O 0 6.1385709883288175e-12
increased O 0 2.654682917935247e-09
risk O 0 9.812421012611594e-06
of O 1 0.9999985694885254
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.534393727022689e-06
is O 0 1.2269832927458424e-09
also O 0 1.7214800765441574e-11
present O 0 9.502278824902177e-11
in O 0 1.8077270236283027e-10
this O 0 2.5799840042139977e-10
family O 0 6.831708532217817e-09
. O 0 4.338170711548628e-08

The O 0 2.1008298745073262e-07
I1307K O 0 5.288157467475685e-07
polymorphism O 0 6.561538867799754e-08
has O 0 2.6580862511060843e-10
previously O 0 5.31932942138269e-10
only O 0 7.2217691896026e-12
been O 0 1.865919745103195e-12
identified O 0 4.2285285516141524e-12
in O 0 1.4556542820079454e-12
individuals O 0 5.128750072205812e-13
of O 0 3.814767612908554e-09
self O 0 1.981016310992345e-07
- O 0 8.535234741202657e-08
reported O 0 9.327246530688171e-09
Ashkenazi O 0 1.3596869408161183e-08
Jewish O 0 1.459587561924991e-09
origins O 0 1.3871338744309014e-08
. O 0 2.630179629647955e-08

In O 0 6.613910130681688e-08
addition O 0 1.1640582719962822e-08
, O 0 4.726509739150231e-10
in O 0 3.334336973193075e-10
this O 0 1.4199841302797722e-10
family O 0 6.781527006616273e-10
, O 0 1.6832843452441182e-10
there O 0 1.1067372018835897e-10
appears O 0 6.021901866049006e-10
to O 0 5.7315884677278106e-11
be O 0 2.8784544192639316e-10
no O 0 9.065984629685886e-10
relationship O 0 4.094201866422509e-09
between O 0 2.768453244428315e-09
the O 0 3.5266820019863587e-10
I1307K O 0 3.3546687649987916e-09
polymorphism O 0 1.2912252378427524e-09
and O 0 1.2090012151133589e-11
the O 0 2.4122962308248397e-11
presence O 0 8.553801417177098e-11
or O 0 1.1300266278269078e-09
absence O 0 9.792452715373656e-08
of O 0 3.026672175110434e-07
cancer B-Disease 0 4.293453912396217e-06
. O 0 2.503873020032188e-08
. O 0 4.3427655782579677e-07

Identification O 0 1.2631677748231596e-07
of O 0 9.584933735595769e-08
a O 0 1.3274674692809185e-09
novel O 0 1.3915606167369532e-10
mutation O 0 1.6628708132682135e-10
of O 0 5.702240901683808e-09
the O 0 3.418785698983129e-09
CPO O 0 9.294892322486703e-08
gene O 0 1.1406243727307697e-09
in O 0 1.4524753622069397e-09
a O 0 6.328452872850221e-09
Japanese O 0 3.127549462078605e-06
hereditary B-Disease 1 0.9999960660934448
coproporphyria I-Disease 1 0.9988886713981628
family O 0 1.9668107142933877e-06
. O 0 9.237961648977944e-07

Hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999901056289673
( O 0 1.6933587176026776e-05
HCP B-Disease 1 0.8675229549407959
) O 0 9.99378091393055e-09
is O 0 6.985808043147301e-10
an O 0 2.590665681978521e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
characterized O 0 1.2363859980268899e-07
by O 0 4.72640149240533e-10
a O 0 2.0004010892193946e-08
deficiency B-Disease 0 0.0005861457902938128
of I-Disease 0 0.0018307561986148357
coproporphyrinogen I-Disease 0 0.0003885511832777411
oxidase I-Disease 0 7.611022034836878e-09
( O 0 4.340847681305604e-10
CPO O 0 1.0534016325891571e-08
) O 0 4.313699397684445e-11
caused O 0 5.226300989202848e-11
by O 0 3.6589494455119276e-12
a O 0 7.333121609942594e-11
mutation O 0 9.709157089421439e-11
in O 0 5.165977090548779e-10
the O 0 7.222882292268196e-09
CPO O 0 4.77263438369846e-06
gene O 0 1.7641148986058397e-07
. O 0 2.779813144115906e-07

Only O 0 8.659828409918191e-08
11 O 0 1.2542572846996336e-07
mutations O 0 7.3179129422840106e-09
of O 0 1.3402215337521284e-08
the O 0 1.4752078447699546e-09
gene O 0 1.1186224169179582e-09
have O 0 4.271933501387437e-11
been O 0 1.651466741137142e-10
reported O 0 3.597934172816508e-10
in O 0 3.075881771508193e-09
HCP B-Disease 1 0.9939117431640625
patients O 0 3.8900863728486e-05
. O 0 5.486845566338161e-06

We O 0 2.0842657377784235e-08
report O 0 1.1488623385957908e-09
another O 0 3.7620379034208895e-11
mutation O 0 5.17154444268364e-11
in O 0 1.4805233428116793e-10
a O 0 3.0822007168751497e-09
Japanese O 0 5.246334353614657e-07
family O 0 3.113209601224298e-08
. O 0 4.590120994407698e-08

Polymerase O 0 6.4778037085488904e-06
chain O 0 1.1433578350761309e-07
reaction O 0 1.086060463784122e-09
- O 0 9.09305242213776e-10
single O 0 4.842599932164404e-11
strand O 0 3.742608722934193e-10
conformational O 0 2.5923549418216396e-10
polymorphism O 0 9.391615263254494e-10
and O 0 2.3258372658374604e-11
direct O 0 7.626737436039477e-11
sequence O 0 1.6634513211322144e-10
analyses O 0 1.0158147656369465e-09
demonstrated O 0 2.36749575499573e-09
a O 0 1.2186963660454353e-09
C O 0 3.0654700111654165e-08
to O 0 3.708040818839464e-10
T O 0 1.1391964704898783e-08
substitution O 0 1.445303987601676e-09
in O 0 9.345709761632293e-10
exon O 0 2.3337328514116962e-08
1 O 0 3.633024192595258e-08
of O 0 6.227903526223599e-09
the O 0 3.678849447297239e-09
CPO O 0 9.637822273589336e-08
gene O 0 9.810953160993563e-10
at O 0 9.253991350988144e-09
nucleotide O 0 1.8905912391176116e-09
position O 0 1.7849513866963207e-08
85 O 0 2.5184432317360006e-08
, O 0 6.089203585801783e-10
which O 0 9.774450693278425e-11
lies O 0 1.0047885856678818e-09
in O 0 7.811055968698355e-11
the O 0 2.4788901487049486e-10
putative O 0 2.460712522633912e-09
presequence O 0 2.0181140314434742e-08
for O 0 5.216265197560688e-10
targeting O 0 6.585107126255707e-09
to O 0 6.3923852877678655e-09
mitochondria O 0 4.520225047599524e-07
. O 0 5.387870487538748e-07

This O 0 8.497735848322918e-10
mutation O 0 1.7636765659023723e-10
changes O 0 1.0781591591735307e-10
the O 0 2.0945535583738462e-10
codon O 0 1.0634525482444701e-09
for O 0 3.1616531614986343e-10
glutamine O 0 3.2373104197347402e-09
to O 0 3.322484509737933e-10
a O 0 1.9964052633270057e-09
termination O 0 2.341329974342443e-08
codon O 0 4.1769144587533447e-08
at O 0 1.0214201893177233e-06
amino O 0 5.699774305867322e-07
acid O 0 6.798557024012553e-07
position O 0 9.864406820270233e-07
29 O 0 1.6238496755249798e-05
. O 0 1.0700147186071263e-06

MaeI O 0 4.568574240693124e-06
restriction O 0 7.064266327461155e-08
analysis O 0 1.5147355370004334e-08
showed O 0 8.177060806247027e-09
two O 0 1.7257414941518334e-10
other O 0 3.8126033580221375e-11
carriers O 0 9.19856690817511e-11
in O 0 3.523595859533657e-10
the O 0 5.640818923069446e-09
family O 0 1.853307018961914e-08
. O 0 7.368323196033089e-08

The O 0 8.225178476095607e-07
C O 0 0.011752136051654816
- O 0 4.651720246329205e-06
T O 0 1.4144353599476744e-07
mutation O 0 7.048468753101389e-11
is O 0 1.8510326951770573e-11
located O 0 3.1790806098719315e-10
within O 0 2.6261168240004906e-10
a O 0 1.8251467004404276e-10
recently O 0 1.5140581843819945e-10
proposed O 0 1.0205566947085742e-10
putative O 0 3.790201208442312e-10
alternative O 0 1.6393120194635458e-10
translation O 0 3.388596347964068e-10
initiation O 0 4.754539539852942e-10
codon O 0 1.8570853743682392e-09
( O 0 2.3557258366224687e-09
TIC O 0 2.755312209501426e-07
- O 0 3.3343656724582615e-08
1 O 0 4.963691324633146e-08
) O 0 8.235529619371462e-11
, O 0 1.314959946485672e-10
supporting O 0 6.446660427705808e-10
that O 0 6.5046618091813e-10
TIC O 0 1.1962927146669244e-06
- O 0 9.334191020116123e-08
1 O 0 6.18755393588799e-08
is O 0 4.284737148418927e-11
the O 0 1.9865586953216052e-10
real O 0 3.185247976489336e-07
TIC O 0 5.815896884087124e-07
rather O 0 8.798378026142473e-09
than O 0 1.3687675437523694e-09
TIC O 0 3.9212298474922136e-07
- O 0 3.050753605293721e-08
2 O 0 4.0341902263207885e-08
. O 0 6.866467394672782e-10
. O 0 1.259876825088213e-08

Human B-Disease 0 2.6248974549503146e-08
complement I-Disease 0 2.25988159741064e-07
factor I-Disease 0 2.3356900783255696e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999274015426636
associated O 0 0.0008122451254166663
with O 0 0.38348719477653503
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.999980092048645

This O 0 1.881482747378982e-09
study O 0 1.0506981951152738e-09
reports O 0 3.0480340473815204e-10
on O 0 6.419249576339325e-10
six O 0 8.905036430473245e-11
cases O 0 4.883495691165862e-11
of O 0 2.377686936227974e-09
deficiency B-Disease 0 3.37455685439636e-06
in I-Disease 0 6.522481221793441e-09
the I-Disease 0 4.323736924050081e-09
human I-Disease 0 1.9534420747646664e-09
complement I-Disease 0 3.340468568424626e-09
regulatory I-Disease 0 6.202856894788056e-08
protein I-Disease 0 7.099372112406854e-08
Factor I-Disease 0 1.0653598536691788e-07
H I-Disease 1 0.9999678134918213
( O 0 3.969371942247335e-09
FH O 0 2.5567468142639882e-08
) O 0 3.919682980968453e-11
in O 0 9.503724196502361e-12
the O 0 4.780577843310763e-12
context O 0 5.039564876518909e-10
of O 0 5.424823368294085e-10
an O 0 1.4020341554399351e-09
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9870763421058655

Five O 0 1.923561399053142e-08
of O 0 6.665234142388954e-09
the O 0 7.705402982338683e-11
cases O 0 2.923810152322126e-11
were O 0 2.405646428588204e-12
observed O 0 1.6313325690298086e-11
in O 0 2.7460301827569866e-12
children O 0 1.228517721579836e-12
presenting O 0 7.581775485210329e-11
with O 0 2.1587410969914345e-08
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999992847442627
HUS B-Disease 1 1.0
) O 0 2.4344195480807684e-05
. O 0 4.13432599088992e-06

Two O 0 2.0561364166837848e-08
of O 0 2.842161705984836e-08
the O 0 2.34717734137746e-09
children O 0 4.3478246003481047e-10
exhibited O 0 6.390851581272727e-08
a O 0 7.056589623744003e-08
homozygous O 0 6.354799211294448e-07
deficiency O 0 0.06842202693223953
characterized O 0 1.7763223070232925e-07
by O 0 8.210501722949459e-10
the O 0 9.649866683503205e-09
absence O 0 7.298261550658935e-08
of O 0 2.761256290284564e-08
the O 0 1.5370280603832498e-09
150 O 0 2.217757533173881e-09
- O 0 1.8172129079285781e-10
kD O 0 1.528403958950264e-09
form O 0 1.0296307556556528e-10
of O 0 7.305486882103196e-09
Factor O 0 2.1856878973380844e-08
H O 1 0.9999946355819702
and O 0 1.8993235872954983e-09
the O 0 5.363033905858572e-10
presence O 0 3.1370131492458597e-10
, O 0 3.999066008897323e-11
upon O 0 2.336866256058556e-10
immunoblotting O 0 1.8794143130662633e-08
, O 0 2.726232850580601e-10
of O 0 7.732938733795436e-10
the O 0 9.090849739656903e-10
42 O 0 1.2395732440495522e-08
- O 0 3.291666716975783e-09
kD O 0 2.1778438608066608e-08
Factor O 0 1.9728238598304415e-08
H O 1 0.9999479055404663
- O 0 3.5237616202721256e-07
like O 0 1.6464133389959557e-09
protein O 0 1.7915924743761025e-08
1 O 0 4.5949917648613336e-07
( O 0 1.368407165358576e-09
FHL O 0 1.4370806411534431e-07
- O 0 1.848579955776586e-08
1 O 0 2.4883904714556593e-08
) O 0 2.5201212644487825e-11
and O 0 2.4645238974607686e-11
other O 0 6.554638082301167e-11
FH O 0 1.2165260443453008e-07
- O 0 2.2971571311813932e-08
related O 0 1.931605631000366e-08
protein O 0 1.9007451612651494e-08
( O 0 7.734679563498048e-10
FHR O 0 5.166012329027581e-07
) O 0 2.110636110330688e-09
bands O 0 2.0524343824490643e-07
. O 0 2.606282407668914e-07

Southern O 0 9.851423783402424e-07
blot O 0 3.323381747577514e-07
and O 0 2.781779806504403e-10
PCR O 0 1.1148947320904767e-09
analysis O 0 9.486054303176061e-11
of O 0 1.1639283981068616e-10
DNA O 0 4.5702858164631266e-10
of O 0 1.2609002730812335e-09
one O 0 3.0696384323292136e-10
patient O 0 4.080636717418429e-09
with O 0 3.2397937665962218e-09
homozygous O 0 8.596688303441624e-07
deficiency O 0 0.20476286113262177
ruled O 0 8.3162367445766e-06
out O 0 2.9646535226746096e-10
the O 0 1.667549431871862e-10
presence O 0 1.5230428029866516e-10
of O 0 1.3659898767670597e-09
a O 0 3.922975833070552e-10
large O 0 1.037464766873164e-10
deletion O 0 6.894186554973203e-09
of O 0 1.4656728275497244e-08
the O 0 7.774529464654734e-09
FH O 0 7.380587589977949e-07
gene O 0 3.143699078833606e-09
as O 0 3.272240811647009e-10
the O 0 1.304429009252317e-09
underlying O 0 3.2218194974120706e-05
defect O 0 6.343927907437319e-06
for O 0 8.930627792835821e-09
the O 0 1.1574295513128163e-06
deficiency O 1 0.9999972581863403
. O 0 0.0003343894786667079

The O 0 1.6060987206856225e-08
other O 0 2.945625132699803e-10
four O 0 2.778158536553832e-10
children O 0 1.1127904153696022e-11
presented O 0 6.997036283706848e-10
with O 0 1.8612448249299973e-09
heterozygous O 0 3.7028254951110284e-07
deficiency O 0 0.0025817377027124166
and O 0 1.7487788994685616e-08
exhibited O 0 1.2021183692922932e-06
a O 0 3.533423553747639e-09
normal O 0 9.65931761243155e-08
immunoblotting O 0 9.130147304858838e-08
pattern O 0 8.186986200087176e-09
of O 0 1.3000971410548345e-09
proteins O 0 1.3106932206241595e-10
of O 0 3.7090046589582926e-09
the O 0 1.6046532991254026e-08
FH O 0 8.103962500172202e-06
family O 0 3.937199721804063e-08
. O 0 8.508934712381233e-08

Factor B-Disease 0 0.057630449533462524
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999285936355591
is O 0 1.6374949396436023e-08
the O 0 6.158552334767364e-09
only O 0 1.3958125322233172e-08
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
associated O 0 0.0013307012850418687
with O 0 2.5803217340580886e-06
HUS B-Disease 1 1.0
. O 0 5.295213122735731e-05

These O 0 5.850439688259712e-09
observations O 0 3.1159956392912136e-08
suggest O 0 2.201644866417496e-09
a O 0 2.4343821403149946e-10
role O 0 1.4324573749391334e-09
for O 0 2.3899038303909492e-09
FH O 0 1.6530841548956232e-06
and O 0 2.1685298889906335e-08
/ O 0 4.591216566041112e-06
or O 0 4.110981066673958e-08
FH O 0 3.1889743468127563e-07
receptors O 0 3.876697185489775e-09
in O 0 2.651058539360207e-10
the O 0 7.756573716655168e-10
pathogenesis O 0 4.380783502710983e-05
of O 0 5.382652830121515e-07
idiopathic O 1 0.9870226979255676
HUS B-Disease 1 0.9999997615814209
. O 0 2.8646724103964516e-07
. O 0 5.142280770087382e-07

Further O 0 2.326124537432861e-08
evidence O 0 1.1814427658407567e-08
for O 0 5.924671864221409e-11
a O 0 1.5077213089131902e-10
major O 0 7.390879019908425e-10
ancient O 0 5.823311539643328e-07
mutation O 0 7.450205885106698e-06
underlying O 1 0.9999555349349976
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.3345176057555364e-06
linkage O 0 3.7182153391768225e-06
disequilibrium O 0 1.709822299744701e-06
studies O 0 1.707824326402374e-09
in O 0 7.796380208091591e-11
the O 0 5.0964100994921324e-11
Japanese O 0 1.0909274372750133e-08
population O 0 3.360448377898173e-11
. O 0 8.052315259021725e-09

The O 1 0.9483793377876282
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0014623543247580528
DM B-Disease 1 1.0
) O 0 1.5496572913775708e-08
mutation O 0 7.739283658381169e-10
is O 0 6.501234967037917e-11
an O 0 4.130373820743216e-10
unstable O 0 0.00011694007844198495
( O 0 2.4306725521228145e-08
CTG O 0 4.018714662379352e-06
) O 0 2.489898731639073e-09
n O 0 4.006783527188418e-08
repeat O 0 9.552552526770342e-09
, O 0 2.47687176324618e-10
present O 0 2.8563318377194946e-10
at O 0 7.208293961724621e-09
a O 0 6.698069876520663e-11
copy O 0 2.700743517713988e-10
number O 0 1.105652722155348e-10
of O 0 5.308527839531507e-09
5 O 0 2.706604362856524e-08
- O 0 1.1144169143051386e-08
37 O 0 4.243676521298312e-09
repeats O 0 1.2113730019081004e-09
on O 0 3.9982159805163064e-09
normal O 0 5.003431002847947e-09
chromosomes O 0 3.69402147759601e-10
but O 0 5.6454740188227603e-11
amplified O 0 2.4435228840324896e-10
to O 0 7.264448070865015e-11
50 O 0 1.7701549115400894e-09
- O 0 1.4586852559173025e-10
3000 O 0 7.35596930589999e-11
copies O 0 9.03589425504947e-10
on O 0 1.5796857155692123e-07
DM B-Disease 1 0.9999860525131226
chromosomes O 0 3.82534199161455e-06
. O 0 6.076852514524944e-07

Previous O 0 1.7338198432526042e-08
findings O 0 2.532729581616877e-09
in O 0 6.295330368111252e-10
Caucasian O 0 5.709183792390604e-09
populations O 0 7.345901664734811e-11
of O 0 3.126383774088026e-08
a O 0 1.3044467550571426e-06
DM B-Disease 1 1.0
founder O 1 0.9967507123947144
chromosome O 0 8.174620234058239e-06
raise O 0 3.402900716764634e-08
a O 0 5.1597068839726035e-09
question O 0 1.6293533189326581e-09
about O 0 1.4399232674267015e-11
the O 0 1.2263386486854877e-11
molecular O 0 7.013042924164381e-10
events O 0 8.389779843076539e-11
involved O 0 2.379196561985708e-10
in O 0 9.233635384076067e-11
the O 0 6.866755497547672e-10
expansion O 0 4.081938698163867e-08
mutation O 0 1.5719725965368525e-08
. O 0 1.6630666266337357e-07

To O 0 2.622870631796559e-08
investigate O 0 6.3288297269537e-08
whether O 0 1.6137352787382042e-08
a O 0 1.0985404585994729e-08
founder O 0 6.880816272314405e-08
chromosome O 0 2.2623542150768117e-08
for O 0 4.714519441506582e-09
the O 0 9.741557960296632e-08
DM B-Disease 1 1.0
mutation O 0 2.004609145345171e-09
exists O 0 2.0879402373719103e-10
in O 0 2.5976496995094855e-11
the O 0 1.0203323429214262e-11
Japanese O 0 2.1373890157772024e-10
population O 0 4.249337427070232e-13
, O 0 2.992567998960638e-12
we O 0 1.8491201625447928e-11
genotyped O 0 2.753880901096295e-09
families O 0 6.5216746933383085e-12
using O 0 8.77460465398272e-11
polymorphic O 0 1.7714754108055786e-09
markers O 0 2.1842543773686884e-08
near O 0 2.1383337411862158e-07
the O 0 1.1377589537175936e-08
( O 0 2.148417665992497e-09
CTG O 0 6.207341698427626e-07
) O 0 1.5927906771295852e-09
n O 0 6.020609788492948e-08
repeat O 0 6.245367956125847e-08
region O 0 3.278072213674932e-08
and O 0 2.06849848360946e-09
constructed O 0 2.1202571076628374e-07
haplotypes O 0 3.2883253879845142e-06
. O 0 1.4089023352426011e-06

Six O 0 5.4313723296672833e-08
different O 0 1.172328456533478e-09
haplotypes O 0 3.6216984966586097e-08
were O 0 2.2897808094057837e-09
found O 0 1.017620210319592e-09
and O 0 6.942743602245116e-10
DM B-Disease 1 0.999995231628418
alleles O 0 1.628782442253396e-08
were O 0 8.698262554673875e-09
always O 0 9.025925784555966e-09
haplotype O 0 5.976081496328334e-08
A O 0 2.1322125576261897e-07
. O 0 1.9061188538671558e-07

To O 0 1.3379000129987162e-08
find O 0 3.3812250777032204e-09
an O 0 2.1441867378846347e-11
origin O 0 2.490553041578636e-10
of O 0 2.6224391547202686e-09
the O 0 1.3844503321536195e-09
( O 0 4.3701064988965754e-10
CTG O 0 1.2933831783357164e-07
) O 0 4.886918092417147e-10
n O 0 4.112612117523895e-08
repeat O 0 1.1752530504338665e-08
mutation O 0 4.735876690808993e-10
and O 0 8.058637090968546e-11
to O 0 9.617553975438398e-11
investigate O 0 3.4001479409795365e-09
the O 0 5.406746161895626e-10
mechanism O 0 4.599217717782267e-08
of O 0 9.21274523335569e-09
the O 0 3.463202780107366e-10
expansion O 0 5.971928507264579e-10
mutation O 0 2.7040871278249945e-11
in O 0 1.6360501495227275e-11
the O 0 1.3599520815033017e-11
Japanese O 0 4.156976984859284e-10
population O 0 2.2692805479781336e-13
we O 0 1.4250237274915367e-12
have O 0 2.3652615781764863e-13
studied O 0 1.5253685814453632e-10
90 O 0 6.898813187383723e-10
Japanese O 0 2.2190322468418344e-08
DM B-Disease 1 0.9984229803085327
families O 0 1.0227332869483519e-10
comprising O 0 2.8899299620022134e-10
190 O 0 6.145594588780057e-10
affected O 0 1.0133024280767344e-10
and O 0 2.57580429208204e-10
130 O 0 1.2196829324295777e-08
unaffected O 0 1.4047792262772418e-07
members O 0 7.566960391613975e-09
. O 0 6.071117297778983e-08

The O 0 1.1503950503310989e-07
results O 0 1.3708320700800414e-08
suggest O 0 3.632925738017434e-09
that O 0 1.7996415122012444e-11
a O 0 6.570183286314091e-11
few O 0 2.9942309048847093e-11
common O 0 7.57927401395797e-11
ancestral O 0 9.753002849777204e-10
mutations O 0 3.1018143609173876e-10
in O 0 2.493281414661652e-10
both O 0 1.3804082321655642e-09
Caucasian O 0 6.251279671687371e-08
and O 0 8.320605315859098e-10
Japanese O 0 4.579802137527622e-08
populations O 0 6.733624942356631e-12
have O 0 1.7424292260773133e-12
originated O 0 2.7125007968920034e-12
by O 0 1.0292520958785079e-13
expansion O 0 2.88693131900164e-11
of O 0 2.1587388820965003e-10
an O 0 2.7321448922701386e-11
ancestral O 0 9.18342513145376e-10
n O 0 1.9614029511672015e-08
= O 0 7.532917400965289e-09
5 O 0 7.530303491876111e-09
repeat O 0 2.6933217878166715e-09
to O 0 5.803070801668753e-10
n O 0 4.91228568932911e-08
= O 0 1.56930255457155e-07
19 O 0 5.551272010961839e-07
- O 0 5.265832925260838e-08
37 O 0 3.512413826456395e-08
copies O 0 1.4361211775337779e-08
. O 0 1.5628923222266167e-07

These O 0 1.957716655454078e-09
data O 0 1.5538889064359296e-09
support O 0 1.0297485780741411e-10
multistep O 0 1.146684613928528e-08
models O 0 4.576411694046101e-09
of O 0 6.767668736529231e-08
triplet O 0 1.821082150854636e-06
repeat O 0 5.237625444465266e-08
expansion O 0 1.466254406778944e-08
that O 0 5.4520808007163524e-11
have O 0 5.7141097409285635e-12
been O 0 2.3914414285647334e-12
proposed O 0 4.732522099898384e-12
for O 0 8.48409016651619e-12
both O 0 1.3727886605252593e-09
DM B-Disease 1 1.0
and O 0 5.022259870202106e-07
Friedreichs B-Disease 0 0.3687319755554199
ataxia I-Disease 0 0.0445047989487648
. O 0 6.762714122032776e-08
. O 0 6.29430928711372e-07

The O 0 1.380198355604989e-08
molecular O 0 3.70681476624668e-07
basis O 0 4.7054572860361077e-07
of O 0 0.007196502760052681
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.6417686522536314e-08
the O 0 1.890584133690254e-09
western O 0 7.1254562250544495e-09
Cape O 0 1.4418190197318381e-08
, O 0 3.215301636050327e-11
South O 0 4.4031134294186813e-10
Africa O 0 1.4470749043482556e-09
. O 0 1.2745673849678951e-08

Deficiency B-Disease 1 0.9777942299842834
of I-Disease 0 1.4289345926954411e-05
the I-Disease 0 1.3259059983283805e-07
sixth I-Disease 0 1.3571664680966933e-07
component I-Disease 0 7.157987624850648e-08
of I-Disease 0 8.558922104384692e-08
human I-Disease 0 1.3303321999558193e-08
complement I-Disease 0 8.427240061337216e-08
( O 0 2.5577907791785037e-08
C6 O 0 1.238647769241652e-06
) O 0 7.296417914304243e-10
has O 0 8.927467792796406e-11
been O 0 1.691748650889391e-11
reported O 0 1.6402714256291695e-11
in O 0 2.8522676841918893e-12
a O 0 1.5995652068515054e-12
number O 0 1.6590138551125788e-12
of O 0 1.916425629300278e-10
families O 0 1.3655735613474218e-12
from O 0 4.623539051618053e-11
the O 0 8.192945627483184e-11
western O 0 3.1923161891711516e-09
Cape O 0 2.8850587696638286e-08
, O 0 1.314192782375656e-10
South O 0 2.4684592148105367e-09
Africa O 0 4.7341450759574855e-09
. O 0 2.6453637502754646e-08

Meningococcal B-Disease 1 0.9984496831893921
disease I-Disease 0 0.00011064620048273355
is O 0 2.0133685829648584e-09
endemic O 0 5.739840269747276e-10
in O 0 1.9581265775503454e-10
the O 0 5.390107249425569e-10
Cape O 0 5.3581825198989463e-08
and O 0 5.2509410014556224e-11
almost O 0 7.485474046164953e-11
all O 0 8.1730577167205e-12
pedigrees O 0 5.676086267669689e-10
of O 0 8.740134171958402e-10
total O 0 3.67923064459319e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.170951288211654e-07
C6Q0 O 0 1.8009881387115456e-05
) O 0 5.032476102506678e-10
have O 0 1.2001923760385225e-11
been O 0 6.762249180752855e-12
ascertained O 0 5.327178143055278e-10
because O 0 3.579260152153374e-11
of O 0 2.2014263745262497e-09
recurrent O 0 6.165919330669567e-05
disease O 0 0.001726343878544867
. O 0 6.823337344030733e-07

We O 0 3.236237944292952e-08
have O 0 4.162997377377131e-11
sequenced O 0 2.0994171678889728e-10
the O 0 1.4127117531348432e-10
expressed O 0 1.3055682923646117e-10
exons O 0 5.042942063937517e-09
of O 0 4.161992972484541e-09
the O 0 3.273515902790791e-09
C6 O 0 1.0429536132505746e-06
gene O 0 8.266441975379735e-10
from O 0 4.4329775961138296e-10
selected O 0 1.4387682711891614e-10
cases O 0 9.464005967796396e-11
and O 0 2.76296416301669e-11
have O 0 8.854492659915447e-12
found O 0 6.023208320993234e-11
three O 0 8.741329882155924e-11
molecular O 0 1.5793136753927683e-06
defects O 1 0.8454340696334839
leading O 0 7.633609584445367e-07
to O 0 1.8405653889885798e-08
total O 0 2.996709326907876e-06
deficiency O 1 0.9999997615814209
879delG O 0 0.08479298651218414
, O 0 1.1018917334126854e-08
which O 0 9.687661783885915e-11
is O 0 2.7465606178278534e-11
the O 0 6.977894650983529e-11
common O 0 3.4525926562167797e-09
defect O 0 2.812534205531847e-08
in O 0 8.554588148967923e-10
the O 0 3.1148650325718563e-09
Cape O 0 1.191053442539669e-07
and O 0 2.28346425101833e-10
hitherto O 0 1.5583299983745746e-08
unreported O 0 3.288447292248975e-09
, O 0 1.967023419147118e-11
and O 0 8.206829313350816e-12
1195delC O 0 7.113203914776989e-10
and O 0 9.118403948571441e-11
1936delG O 0 1.0321131505008907e-08
, O 0 8.077903623782134e-11
which O 0 8.35647783609117e-12
have O 0 3.2376141698153837e-12
been O 0 8.868165750353096e-12
previously O 0 4.5013676813754344e-11
reported O 0 3.6797509483932345e-11
in O 0 3.155181671488094e-11
African O 0 3.5781988483307714e-09
- O 0 3.6600521724494683e-08
Americans O 0 4.2638950148443655e-09
. O 0 1.5309927547946245e-08

We O 0 2.1791406368265598e-07
also O 0 2.7532927049378486e-09
show O 0 7.173685534489493e-10
that O 0 2.5625562869585616e-12
the O 0 2.2831452006766284e-11
879delG O 0 4.45954118077907e-09
and O 0 2.3684385008770903e-10
1195delC O 0 1.2232747792495502e-07
defects O 0 1.315706072091416e-06
are O 0 2.5994241481530622e-11
associated O 0 3.580042262640859e-09
with O 0 1.9841970289036226e-09
characteristic O 1 0.996485710144043
C6 O 1 0.9999991655349731
/ O 1 0.9838752746582031
C7 O 0 0.00045008730376139283
region O 0 1.217816247844894e-08
DNA O 0 2.2249178055488983e-09
marker O 0 1.7689060216596886e-09
haplotypes O 0 2.4556581212920037e-09
, O 0 4.646382931183801e-11
although O 0 3.9919706429358826e-11
small O 0 9.632681458038306e-11
variations O 0 1.2258090098526964e-09
were O 0 3.5743927817577514e-09
observed O 0 4.9581274197407765e-08
. O 0 5.227585120337608e-08

The O 0 4.1905161651811795e-07
1936delG O 0 7.736788575130049e-06
defect O 0 3.5134974041284295e-06
was O 0 2.892106181207055e-07
observed O 0 1.149658590549052e-08
only O 0 1.8762784381731734e-10
once O 0 8.219229186146038e-10
in O 0 9.810199180781964e-11
the O 0 3.6006253534281996e-10
Cape O 0 4.5839268381087095e-08
, O 0 2.0872066228139197e-11
but O 0 2.055532393602233e-12
its O 0 1.7603274523811385e-12
associated O 0 4.1364606184757235e-10
haplotype O 0 7.891359565803668e-09
could O 0 3.6087608457080478e-09
be O 0 1.8400133638962757e-09
deduced O 0 9.871327222299442e-08
. O 0 8.519669592033097e-08

The O 0 2.1372201786107325e-08
data O 0 5.734383190514336e-09
from O 0 5.281126647105339e-10
the O 0 2.1888439671879922e-10
haplotypes O 0 3.1863180982583117e-09
indicate O 0 9.464155015237452e-10
that O 0 6.386172406863677e-12
these O 0 1.0880145742686587e-11
three O 0 8.915386484620313e-11
molecular O 0 1.6988964546271745e-07
defects O 0 7.65561196658382e-07
account O 0 4.6203152415102977e-10
for O 0 1.0306530073833642e-09
the O 0 5.206489817055626e-08
defects O 0 0.00830752868205309
in O 0 1.5295304578444302e-08
all O 0 1.3210996741008785e-09
the O 0 4.3351242595690564e-09
38 O 0 6.415069719878375e-08
unrelated O 0 4.588720869946883e-08
C6Q0 O 0 4.892812626167142e-07
individuals O 0 4.6366889494553476e-11
we O 0 2.7579585837322895e-10
have O 0 2.361301605635635e-11
studied O 0 1.9133805650994873e-09
from O 0 8.627271119721058e-11
the O 0 3.1102387332282433e-10
Cape O 0 1.4117709667971212e-07
. O 0 1.7037908861539108e-08

We O 0 3.083825461658307e-08
have O 0 1.4996820452140014e-10
also O 0 1.719537359723411e-11
observed O 0 5.469235134225592e-11
the O 0 7.210775726518293e-11
879delG O 0 7.490537079490878e-09
defect O 0 1.1648755737780903e-08
in O 0 1.960870799067038e-09
two O 0 2.708944002449698e-08
Dutch O 1 0.9999997615814209
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.013168775476515293
, O 0 1.8502863685654347e-09
but O 0 6.006676406267175e-11
the O 0 2.3976920449086947e-10
879delG O 0 2.5184672125533325e-08
defect O 0 4.374631146220054e-08
in O 0 5.474070086108895e-10
the O 0 4.0591494609998335e-09
Cape O 0 1.622353920538444e-06
probably O 0 2.002709775794642e-09
did O 0 3.0788266380810114e-10
not O 0 2.8470892310394902e-11
come O 0 3.569470066744351e-11
from O 0 4.2316209564186025e-11
The O 0 9.302861259108397e-11
Netherlands O 0 1.1285646195346999e-08
. O 0 1.3260983422469508e-09
. O 0 1.8390563738535093e-08

Complement B-Disease 1 0.9999880790710449
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.2007957650439494e-07
seven O 0 3.5280629528955387e-09
further O 0 1.2674684635172184e-09
molecular O 0 1.1634676866378868e-06
defects O 0 9.163903087028302e-06
and O 0 7.770374343962771e-10
their O 0 1.8169980797733132e-10
associated O 0 8.674673779296427e-08
marker O 0 4.083582609837322e-07
haplotypes O 0 6.190013664308935e-06
. O 0 3.934365850000177e-06

Seven O 0 1.6325682850037992e-07
further O 0 5.112586354272253e-09
molecular O 0 5.2734115740804555e-08
bases O 0 2.4770018924868964e-08
of O 0 0.008054228499531746
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.819280511967008e-08
described O 0 5.490648504746787e-07
. O 0 5.579114770171145e-08

All O 0 3.3856002445986633e-09
these O 0 1.4870182862836145e-10
new O 0 3.9818284780501756e-10
molecular O 0 9.394704392207132e-08
defects O 0 1.3896237760491204e-07
involve O 0 2.0439396841709367e-09
single O 0 7.124691947524298e-10
- O 0 5.169715322494994e-09
nucleotide O 0 2.866599624340438e-09
events O 0 6.464958013374655e-10
, O 0 5.6771119055776254e-11
deletions O 0 2.620102745876096e-10
and O 0 8.444122484574379e-11
substitutions O 0 1.4366902112428193e-09
, O 0 1.0005214712283106e-10
some O 0 1.2910368087093449e-11
of O 0 1.7226543524984095e-09
which O 0 7.296414167301535e-11
alter O 0 7.57322649036496e-09
splice O 0 3.172390705685757e-08
sites O 0 1.8634613851986614e-09
, O 0 2.863079218151654e-10
and O 0 3.291727723730986e-10
others O 0 1.1670016064613264e-08
codons O 0 3.466809062047105e-07
. O 0 6.432111945287033e-07

They O 0 3.889258248790384e-09
are O 0 1.8227419573690895e-11
distributed O 0 1.0944271530699545e-11
along O 0 2.0554119170568264e-11
the O 0 4.012515320006571e-10
C7 O 0 4.723270308204519e-07
gene O 0 1.4125374203644014e-09
, O 0 1.112099232147834e-10
but O 0 1.6358379928416156e-11
predominantly O 0 2.000111881672595e-11
towards O 0 3.656148439556972e-10
the O 0 6.06574124262238e-10
3 O 0 8.778468441050791e-08
end O 0 2.0459424376895186e-07
. O 0 1.886536722395249e-07

All O 0 9.751016882830754e-09
were O 0 2.286690614639042e-09
found O 0 1.3007635246697902e-10
in O 0 2.2993730530718182e-10
compound O 0 1.2916150815556193e-08
heterozygous O 0 5.922497603449983e-09
individuals O 0 1.1474191596860805e-09
. O 0 1.4989434760082077e-07

The O 0 1.7021824533003382e-05
C6 O 1 0.9937888979911804
/ O 0 0.000794262858107686
C7 O 0 9.999713074648753e-05
marker O 0 3.946523179365613e-07
haplotypes O 0 9.5561983926018e-07
associated O 0 2.1577906750280818e-07
with O 0 1.3977360602268618e-08
most O 0 4.311843326831877e-07
C7 B-Disease 1 0.9999840259552002
defects I-Disease 1 0.9670618772506714
are O 0 6.159547316642033e-10
tabulated O 0 1.7065383417502744e-07
. O 0 4.245749085640682e-09
. O 0 1.752518663522551e-08

A O 0 1.952711272679153e-06
genome O 0 1.8782996491495396e-08
- O 0 9.325289873629572e-09
wide O 0 1.1264801313970452e-09
search O 0 4.728619718008531e-10
for O 0 1.5840161127211871e-10
chromosomal O 0 2.369205958530074e-06
loci O 0 1.7467677082549926e-07
linked O 0 9.574333716955152e-07
to O 0 6.1716871613271e-09
mental O 1 0.9999880790710449
health O 0 1.315289523518004e-06
wellness O 0 1.3218838148532086e-06
in O 0 1.192394627480553e-09
relatives O 0 1.4165438821933662e-09
at O 0 1.927858761519019e-08
high O 0 1.0472798095406688e-07
risk O 0 1.4194039010817505e-07
for O 0 4.6870777623553295e-06
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 6.412106401398887e-09
the O 0 1.5504969752555553e-08
Old O 0 5.73714203255804e-07
Order O 0 1.086624568102934e-08
Amish O 0 4.768766714846606e-08
. O 0 1.8163659021297462e-08

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9982953667640686
BPAD B-Disease 1 1.0
; O 1 0.9999992847442627
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 3.910638213255879e-08
is O 0 2.827942879868317e-10
characterized O 0 7.131448764852166e-10
by O 0 1.3703229523320815e-11
episodes O 0 6.036336763770578e-09
of O 0 3.28087459422477e-08
mania B-Disease 0 2.498978517451178e-07
and O 0 2.9582496452462692e-09
/ O 0 2.2184199224284384e-06
or O 0 6.192973245333633e-08
hypomania B-Disease 0 0.0001475262688472867
interspersed O 0 1.183544728888819e-08
with O 0 1.1423698792478731e-10
periods O 0 5.284190365273389e-07
of O 0 9.770947144716047e-07
depression B-Disease 1 0.7765798568725586
. O 0 1.4351553545566276e-06

Compelling O 0 3.645759250048286e-07
evidence O 0 1.8033688320429064e-08
supports O 0 5.499521393836915e-10
a O 0 7.046654232345517e-11
significant O 0 1.0868370092786961e-10
genetic O 0 6.691127096836169e-10
component O 0 1.2188899667364694e-08
in O 0 1.1608072281177328e-09
the O 0 2.4567168299682862e-09
susceptibility O 0 1.5619446003256598e-07
to O 0 6.662336460294682e-09
develop O 0 1.0945144822471775e-05
BPAD B-Disease 1 1.0
. O 0 3.3629999961704016e-05

To O 0 6.975679145426739e-09
date O 0 4.271467801686413e-08
, O 0 3.0156163677297343e-10
however O 0 2.7539950875343777e-10
, O 0 6.614114811398508e-11
linkage O 0 3.6997838126495708e-09
studies O 0 4.4766257367712115e-10
have O 0 5.879721015622508e-11
attempted O 0 1.3600441883809822e-09
only O 0 7.097760313518053e-12
to O 0 1.8318279185192132e-11
identify O 0 2.718300251558503e-09
chromosomal O 0 7.315337825275492e-06
loci O 0 1.0751870149761089e-07
that O 0 4.075915160939303e-09
cause O 0 7.624683462381654e-08
or O 0 3.737037623796624e-10
increase O 0 1.2698876672434523e-10
the O 0 9.43812472620209e-10
risk O 0 8.744840407359789e-09
of O 0 6.859692547322993e-08
developing O 0 7.110512524377555e-05
BPAD B-Disease 1 1.0
. O 0 4.374340733193094e-06

To O 0 2.566097734302275e-08
determine O 0 7.415454916781528e-08
whether O 0 8.923833227925115e-09
there O 0 5.648913004030476e-10
could O 0 1.4639754686296413e-10
be O 0 6.745956571130307e-11
protective O 0 1.092342771791266e-09
alleles O 0 8.300374970682256e-11
that O 0 1.879658928505279e-11
prevent O 0 5.96017402099136e-10
or O 0 1.4144752036315822e-10
reduce O 0 9.361390551632098e-10
the O 0 5.3098214713998e-10
risk O 0 6.01429483992888e-09
of O 0 7.262158163712229e-08
developing O 0 3.9469079638365656e-05
BPAD B-Disease 1 1.0
, O 0 1.1313551206981742e-09
similar O 0 1.2275368221903449e-11
to O 0 2.8276593306425513e-12
what O 0 3.3680762172305645e-12
is O 0 8.336159453697922e-13
observed O 0 1.1581810163696638e-11
in O 0 2.1048690568292727e-11
other O 0 6.06200867281359e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.3644607927717516e-09
we O 0 6.033042398989608e-10
used O 0 8.636006576523414e-09
mental O 0 0.29775911569595337
health O 0 2.08624499009602e-07
wellness O 0 9.984065627577365e-07
( O 0 3.8186895312541935e-10
absence O 0 4.289625366027394e-08
of O 0 4.341572790167447e-08
any O 0 1.746346356412687e-07
psychiatric B-Disease 1 0.999992847442627
disorder I-Disease 0 3.162263965350576e-05
) O 0 1.8884063757163005e-10
as O 0 1.140836938806622e-10
the O 0 1.1564576379852198e-10
phenotype O 0 2.3822480099688903e-10
in O 0 2.9019103786609435e-10
our O 0 7.979260585599945e-10
genome O 0 6.630551663278084e-10
- O 0 3.150253835570993e-09
wide O 0 2.9036115734015766e-09
linkage O 0 7.562920067982759e-09
scan O 0 1.1396065247026854e-07
of O 0 1.925323367402143e-08
several O 0 1.135419203102117e-09
large O 0 1.4934998793236787e-09
multigeneration O 0 1.4658020575097908e-07
Old O 0 9.209937701371018e-08
Order O 0 5.703916006183363e-09
Amish O 0 1.2896260948025429e-08
pedigrees O 0 3.5896283723246825e-09
exhibiting O 0 4.027507216619597e-09
an O 0 6.737636837339522e-11
extremely O 0 7.692340986409363e-09
high O 0 2.319753455992668e-08
incidence O 0 6.648472208325984e-06
of O 0 1.2305003110668622e-05
BPAD B-Disease 1 1.0
. O 0 7.54903976485366e-06

We O 0 8.304566989636442e-08
have O 0 2.2846580183255583e-10
found O 0 9.552506702315e-11
strong O 0 8.642782670098548e-12
evidence O 0 3.413764756987625e-11
for O 0 8.48910872153219e-12
a O 0 5.7160314675952506e-11
locus O 0 1.7457044143576184e-10
on O 0 2.2759616413736694e-08
chromosome O 0 1.6465028807033377e-07
4p O 0 8.659588274895214e-06
at O 0 4.134730318128277e-07
D4S2949 O 0 1.398736770852338e-07
( O 0 6.3709715281135e-10
maximum O 0 2.660736875270686e-08
GENEHUNTER O 0 1.6772742128523532e-06
- O 0 3.803783954481332e-08
PLUS O 0 3.0346139823222984e-08
nonparametric O 0 1.026533951176134e-07
linkage O 0 1.767952362285996e-08
score O 0 8.251465288822146e-09
= O 0 6.431385646266108e-09
4 O 0 9.570205961040301e-09
. O 0 9.321830807262899e-11
05 O 0 1.1905726182703802e-08
, O 0 1.8759036546356356e-09
P O 0 1.1622893936191758e-07
= O 0 5.404583891532866e-09
5 O 0 2.0987458437815576e-09
. O 0 7.76711056582613e-11
22 O 0 2.0638444286902313e-09
x O 0 2.3455406505945575e-08
10 O 0 3.2394861904094796e-08
( O 0 1.549680161971878e-09
- O 0 6.79307810003138e-09
4 O 0 6.760454418497375e-09
) O 0 6.308031874624476e-11
; O 0 1.0487095220002018e-10
SIBPAL O 0 5.673213010481959e-08
Pempirical O 0 3.032074147313324e-08
value O 0 5.498412392057617e-09
< O 0 1.168993257749662e-08
3 O 0 3.626750011420654e-09
x O 0 8.958469521758161e-09
10 O 0 1.1628998208834673e-08
( O 0 3.3492200679496875e-10
- O 0 6.293385257372108e-10
5 O 0 4.1328643285432065e-10
) O 0 8.386271711791071e-12
) O 0 5.382519083219073e-12
and O 0 1.2292823009518727e-11
suggestive O 0 2.244730179512544e-09
evidence O 0 2.5479909848691307e-10
for O 0 4.018211111067593e-11
a O 0 1.715436820370897e-10
locus O 0 1.0206739897711259e-09
on O 0 9.375014542456483e-08
chromosome O 0 5.451760785035731e-07
4q O 0 4.5791600200573157e-07
at O 0 2.2885731709720858e-07
D4S397 O 0 3.746440668805917e-08
( O 0 4.214940618751939e-10
maximum O 0 5.743084674492138e-09
GENEHUNTER O 0 2.612964635773096e-07
- O 0 1.3929986941718653e-08
PLUS O 0 4.681463217082182e-09
nonparametric O 0 1.308611174977159e-08
linkage O 0 4.878333736968443e-09
score O 0 4.68552796561994e-09
= O 0 3.660930003590579e-09
3 O 0 4.695583477598575e-09
. O 0 1.970866109202163e-10
29 O 0 7.91167487079747e-09
, O 0 1.1083517437171508e-09
P O 0 1.7352367365219834e-07
= O 0 1.378199065982244e-08
2 O 0 1.681899597372194e-08
. O 0 7.815825764367901e-11
57 O 0 2.9530631273644303e-09
x O 0 2.1740213185239554e-08
10 O 0 2.19674252122104e-08
( O 0 5.609476216861253e-10
- O 0 2.272342980447206e-09
3 O 0 2.285147404634813e-09
) O 0 3.259307754244212e-11
; O 0 6.46716222241217e-11
SIBPAL O 0 7.744813501631143e-08
Pempirical O 0 2.548134681035208e-08
value O 0 5.791551682676754e-09
< O 0 2.2843291702656643e-08
1 O 0 1.6607170749693978e-08
x O 0 2.4118124386518502e-08
10 O 0 1.9559038832994702e-08
( O 0 5.290987092898547e-10
- O 0 2.1377204451056286e-09
3 O 0 6.128963558893474e-09
) O 0 3.796479103312933e-11
) O 0 1.775062215270129e-11
that O 0 1.3565116911695707e-11
are O 0 1.773451351050337e-11
linked O 0 5.187593909994348e-09
to O 0 1.4039609474991721e-09
mental O 1 0.9997269511222839
health O 0 6.450541695812717e-05
wellness O 0 8.827445708448067e-05
. O 0 1.183781705549336e-06

These O 0 3.3805414023646563e-09
findings O 0 2.17260676116382e-09
are O 0 1.1085852721914868e-11
consistent O 0 8.652963762179056e-11
with O 0 1.7251210225957547e-12
the O 0 5.986991458151181e-11
hypothesis O 0 9.431461861497681e-11
that O 0 1.302736239196245e-12
certain O 0 3.916514682011929e-11
alleles O 0 4.133755282520468e-10
could O 0 1.0144844964088406e-09
prevent O 0 6.06248296008971e-09
or O 0 5.250983536875253e-10
modify O 0 3.177221152839138e-09
the O 0 1.1201297667184917e-09
clinical O 0 5.099597188973348e-08
manifestations O 0 3.798263605858665e-07
of O 0 2.5784547688090242e-06
BPAD B-Disease 1 1.0
and O 0 7.10421854677179e-09
perhaps O 0 1.0388433446806289e-09
other O 0 8.844909527017109e-11
related O 0 4.332252501626499e-06
affective B-Disease 1 0.997443675994873
disorders I-Disease 1 0.9999997615814209
. O 0 1.5540963431703858e-05

Segregation O 0 0.0032572404015809298
distortion O 1 0.9989711046218872
in O 0 0.017654715105891228
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00016395296552218497

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995604157447815
DM B-Disease 1 1.0
) O 0 4.655740326597879e-08
is O 0 1.0169410868954287e-09
an O 0 1.5071182080106382e-09
autosomal B-Disease 1 0.999983549118042
dominant I-Disease 1 0.9999994039535522
disease I-Disease 1 0.9994626641273499
which O 0 4.5086565036989157e-10
, O 0 3.8672766378144985e-11
in O 0 6.439357380649824e-11
the O 0 4.694166721996851e-10
typical O 0 4.1946861983888084e-08
pedigree O 0 2.910031771108379e-09
, O 0 7.349924141530906e-11
shows O 0 2.387834097117292e-10
a O 0 3.517163504884735e-10
three O 0 3.7091371640762816e-10
generation O 0 9.681244250714371e-09
anticipation O 0 5.125624014112873e-08
cascade O 0 1.819936187530402e-06
. O 0 5.559276701205818e-07

This O 0 4.862891755941234e-10
results O 0 2.264334497681375e-09
in O 0 1.0837868380519922e-08
infertility B-Disease 1 0.9999996423721313
and O 1 0.9999983310699463
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0002443569537717849
CDM B-Disease 0 0.0002166458434658125
) O 0 1.7485835002162275e-10
with O 0 5.606144021230719e-12
the O 0 3.7321370993659286e-10
disappearance O 0 2.4468228332352737e-08
of O 0 4.707512957224935e-08
DM B-Disease 1 1.0
in O 0 5.2682640472312414e-08
that O 0 3.7509648720401856e-09
pedigree O 0 1.8793539879879972e-07
. O 0 6.915920636174633e-08

The O 0 1.196970877970216e-08
concept O 0 2.2543982680645058e-08
of O 0 4.214430404658742e-08
segregation O 0 9.310024893238733e-07
distortion O 0 2.410116849205224e-06
, O 0 2.2439328173362583e-10
where O 0 5.092999286193667e-11
there O 0 5.1301029396766396e-12
is O 0 1.7617852706222625e-12
preferential O 0 1.797892529298295e-10
transmission O 0 1.7842357591391078e-09
of O 0 2.6317778512030543e-10
the O 0 9.0155070908704e-11
larger O 0 5.413946374543954e-11
allele O 0 1.6691595328133246e-10
at O 0 1.1442376823822542e-08
the O 0 2.4994726288696256e-09
DM B-Disease 1 0.9996132254600525
locus O 0 1.3175119661923418e-08
, O 0 1.44105671839867e-09
has O 0 6.303329386225798e-11
been O 0 1.1091928070472434e-10
put O 0 6.059474033648371e-10
forward O 0 1.1946922562344753e-08
to O 0 5.304416350604413e-10
explain O 0 9.82294157125807e-09
partially O 0 3.801946757420183e-09
the O 0 1.5683988552339656e-09
maintenance O 0 1.2964670759174624e-06
of O 0 6.993932402110659e-06
DM B-Disease 1 1.0
in O 0 4.4215990868679e-08
the O 0 1.1339653660513704e-08
population O 0 1.6673426528335256e-10
. O 0 2.720122260768676e-08

In O 0 8.843437626637751e-08
a O 0 1.5518400786618258e-08
survey O 0 2.6935684793727432e-09
of O 0 3.317694208249122e-08
DM B-Disease 1 0.9999998807907104
in O 0 1.7813123420751253e-08
Northern O 0 4.256015984083206e-08
Ireland O 0 9.992332294928019e-09
, O 0 2.9705515824929307e-10
59 O 0 2.3931072234972817e-08
pedigrees O 0 2.7783732647890247e-08
were O 0 8.351804581252509e-09
ascertained O 0 6.35958883776766e-07
. O 0 1.254952337603754e-07

Sibships O 0 5.752105153078446e-06
where O 0 5.0996140643633225e-09
the O 0 1.6274143144201503e-10
status O 0 8.318938871099135e-10
of O 0 2.367364748678824e-09
all O 0 6.432826493707466e-11
the O 0 1.7186593814777495e-10
members O 0 2.0893814456357518e-11
had O 0 8.311226706858577e-11
been O 0 1.8693333339592222e-11
identified O 0 3.6694133842551935e-11
were O 0 4.8315292738854154e-11
examined O 0 4.56009813243341e-10
to O 0 9.643228056355202e-12
determine O 0 1.1672236510662515e-09
the O 0 5.063034436147973e-10
transmission O 0 8.080566260559863e-08
of O 0 9.75970593231068e-09
the O 0 1.552355222145252e-08
DM B-Disease 1 0.9999998807907104
expansion O 0 1.3401722753769718e-07
from O 0 7.370863919220483e-09
affected O 0 9.30265309229128e-10
parents O 0 8.116451954975901e-11
to O 0 1.0110802473040081e-10
their O 0 8.685360208815496e-10
offspring O 0 1.397581428363992e-08
. O 0 3.0022018648878657e-08

Where O 0 1.2123045678436029e-07
the O 0 2.0879264539530595e-08
transmitting O 0 6.262297574721742e-06
parent O 0 2.236167517821741e-08
was O 0 2.0247327370270796e-07
male O 0 2.9003473400734947e-08
, O 0 6.967209031927268e-09
58 O 0 6.643292067565199e-07
. O 0 4.6336458581208717e-07

3 O 0 7.558365382465126e-07
% O 0 3.2438871588880147e-09
of O 0 7.917321021011503e-09
the O 0 1.4774239609494089e-09
offspring O 0 1.6769970134777878e-10
were O 0 1.78385375915191e-10
affected O 0 4.444040274664829e-11
, O 0 1.7340058208747955e-11
and O 0 7.45415448116793e-12
in O 0 8.082773339523897e-11
the O 0 5.328956720340727e-10
case O 0 1.18087439826553e-09
of O 0 1.4722029151315041e-09
a O 0 5.410976111619448e-10
female O 0 1.279311212520895e-09
transmitting O 0 1.2205869097670075e-06
parent O 0 5.2623786217509405e-08
, O 0 2.981396107770706e-08
68 O 0 5.033363777329214e-06
. O 0 2.7980931918136775e-06

7 O 0 8.061405424086843e-06
% O 0 5.2485056301065924e-08
were O 0 1.3491573191970474e-08
affected O 0 2.442574853489532e-08
. O 0 8.23216552703343e-08

Studies O 0 1.286788773313674e-07
on O 0 1.9083068991676555e-07
meiotic O 0 3.8922985368117224e-06
drive O 0 8.886097191407316e-08
in O 0 2.1022442453499934e-08
DM B-Disease 1 0.9999979734420776
have O 0 4.858904945059805e-10
shown O 0 1.0927714982900127e-10
increased O 0 2.3397462786678425e-11
transmission O 0 4.711388501554836e-10
of O 0 7.388225448101693e-11
the O 0 2.1786881326812946e-11
larger O 0 5.003434819239594e-11
allele O 0 1.4071235843182706e-10
at O 0 1.0803525185565377e-08
the O 0 2.8759095105357346e-09
DM B-Disease 1 0.6461107134819031
locus O 0 3.360695277621062e-09
in O 0 3.289714722853887e-09
non O 0 3.0368546504178084e-06
- O 0 6.8643648774013855e-06
DM O 1 0.9999996423721313
heterozygotes O 0 4.351506504463032e-06
for O 0 4.398425801355188e-08
CTGn O 0 3.169851333950646e-05
. O 0 3.8984438788247644e-07

This O 0 3.4408313975831106e-09
study O 0 2.4316637592392e-09
provides O 0 1.5240018969020497e-10
further O 0 1.5348594617492495e-10
evidence O 0 2.786665620480022e-10
that O 0 1.2798151427517723e-11
the O 0 8.382953775587509e-10
DM B-Disease 1 0.9999992847442627
expansion O 0 3.2613965572636516e-07
tends O 0 6.290412191134465e-09
to O 0 2.0023915858757846e-10
be O 0 3.577828588952059e-10
transmitted O 0 3.001421333692633e-09
preferentially O 0 5.74909098105536e-09
. O 0 3.020379679696816e-08

Diagnosis O 1 0.8375162482261658
of O 0 0.04540027305483818
hemochromatosis B-Disease 1 1.0
. O 0 0.0004115827614441514

If O 0 8.876897481968626e-06
untreated O 1 0.9999967813491821
, O 0 1.5652282172595733e-06
hemochromatosis B-Disease 1 1.0
can O 0 2.6435891413711943e-06
cause O 0 0.009171395562589169
serious O 0 0.05435378476977348
illness O 0 0.1542569398880005
and O 0 6.285923448423603e-10
early B-Disease 0 7.584954175854364e-08
death I-Disease 0 2.1446686204740217e-08
, O 0 6.368550825586183e-11
but O 0 2.2853977391101843e-11
the O 0 2.818766331458278e-10
disease O 0 3.084084099214124e-08
is O 0 3.3735427645842364e-11
still O 0 8.396856127079744e-11
substantially O 0 3.352736976935944e-09
under O 0 4.635316486201191e-07
- O 0 2.3084086933522485e-05
diagnosed O 0 5.9732388763222843e-05
. O 0 2.8797813911296544e-07

The O 0 1.0050960952412424e-07
cornerstone O 0 9.248122296412475e-06
of O 0 1.7942323182751352e-08
screening O 0 4.68769112416112e-09
and O 0 8.868188128285937e-11
case O 0 1.029654278505987e-10
detection O 0 9.556904156937662e-10
is O 0 3.2664506949969807e-12
the O 0 1.9339252421701758e-11
measurement O 0 8.787007566013472e-09
of O 0 4.4010104005565154e-08
serum O 0 5.091025556680506e-08
transferrin O 0 1.3513572127976659e-07
saturation O 0 3.9684881159018914e-08
and O 0 2.637794649373859e-09
the O 0 4.599794323212336e-09
serum O 0 5.870876762514854e-08
ferritin O 0 1.2456333706722944e-06
level O 0 1.0008556046159356e-06
. O 0 1.3690220157513977e-07

Once O 0 6.018956355546834e-07
the O 0 1.4039401641241511e-08
diagnosis O 0 1.0311823643860407e-06
is O 0 8.11331446470831e-10
suspected O 0 3.25183044935784e-08
, O 0 5.772602396092452e-10
physicians O 0 4.6187667024355505e-09
must O 0 8.446300880926572e-10
use O 0 2.05628047922346e-09
serum O 0 1.1037558067528153e-07
ferritin O 0 3.232110202588956e-06
levels O 0 2.2258362264437892e-07
and O 0 3.071931686804419e-08
hepatic O 1 0.9884985089302063
iron O 1 0.999698281288147
stores O 0 2.6881910031306688e-08
on O 0 6.061929980205605e-08
liver O 0 8.155461017622656e-08
biopsy O 0 1.5552210186342563e-08
specimens O 0 2.69555072707206e-10
to O 0 6.69135302722168e-11
assess O 0 5.27087484769595e-09
patients O 0 4.2801567845529576e-10
for O 0 1.8595264217324825e-10
the O 0 2.1480406342533342e-09
presence O 0 3.7563648191962784e-08
of O 0 5.38881249667611e-05
iron B-Disease 1 0.9999997615814209
overload I-Disease 1 0.8317277431488037
. O 0 3.6085330066271126e-06

Liver O 0 0.0004207759047858417
biopsy O 0 9.203662193613127e-05
is O 0 1.9969395026464554e-08
also O 0 5.108860556823913e-10
used O 0 3.7015185361255476e-10
to O 0 5.392983629115555e-11
establish O 0 1.5817525067518545e-09
the O 0 3.640845402941295e-10
presence O 0 2.364314299896364e-09
or O 0 2.851537894699163e-09
absence O 0 7.178194323387288e-07
of O 0 6.075136298022699e-06
cirrhosis B-Disease 1 1.0
, O 0 1.9112587068548237e-08
which O 0 6.197020674392206e-10
can O 0 1.227034807094185e-09
affect O 0 9.72535119103668e-08
prognosis O 0 6.025157745170873e-06
and O 0 2.7321751971953745e-08
management O 0 6.8911522248527035e-06
. O 0 1.0418719966764911e-06

A O 0 1.31828460325778e-06
DNA O 0 5.614352716065696e-08
- O 0 2.8275988217529857e-09
based O 0 9.581264948099744e-11
test O 0 4.1591799448958966e-11
for O 0 1.694487085368568e-11
the O 0 4.6005468878895783e-10
HFE O 0 2.3512252766977326e-07
gene O 0 2.027086276612522e-09
is O 0 2.412890998115813e-10
commercially O 0 4.36274433246453e-10
available O 0 1.205242017299213e-10
, O 0 4.181738635922194e-11
but O 0 4.6012269515338655e-12
its O 0 2.6203501174437704e-12
place O 0 1.7827142539950103e-10
in O 0 1.6396146593211647e-11
the O 0 1.3373348262124551e-10
diagnosis O 0 3.14228060460664e-07
of O 0 2.7531264095159713e-06
hemochromatosis B-Disease 1 1.0
is O 0 1.500048796287956e-07
still O 0 1.0252263926702199e-08
being O 0 2.5797686209472204e-09
evaluated O 0 4.8448434597503365e-08
. O 0 1.0026624863712641e-07

Currently O 0 4.4413187083591765e-07
, O 0 1.2849308284046401e-09
the O 0 6.907990846016787e-10
most O 0 3.4322350517257405e-11
useful O 0 4.1192338429141273e-10
role O 0 5.669291702758983e-10
for O 0 5.896162030838425e-11
this O 0 6.9226512543207885e-12
test O 0 3.062694889366391e-11
is O 0 2.8609744781582513e-12
in O 0 2.3995196021114884e-12
the O 0 1.5062458225134634e-11
detection O 0 5.4178568298368646e-09
of O 0 3.266500669951711e-08
hemochromatosis B-Disease 1 1.0
in O 0 2.1601126221071354e-08
the O 0 2.7299510207967614e-08
family O 0 2.291956846534049e-09
members O 0 3.059269226834971e-10
of O 0 2.6884269033189412e-08
patients O 0 9.071817963501871e-09
with O 0 4.889286198128673e-10
a O 0 1.5877443360068355e-08
proven O 0 6.704335078211443e-07
case O 0 9.26964194292168e-09
of O 0 9.489140140317431e-09
the O 0 2.0306240244849505e-08
disease O 0 1.0271865903632715e-05
. O 0 7.783969380170674e-08

It O 0 5.635872213360926e-09
is O 0 9.568685843674984e-10
crucial O 0 8.810775398160331e-08
to O 0 1.8481287611393782e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999996423721313
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.00011773212463594973
because O 0 3.1931008948049566e-07
phlebotomy O 1 0.9990345239639282
therapy O 1 0.9314625263214111
can O 0 2.092207829207382e-08
avert O 0 7.77616587583907e-05
serious O 1 0.9995321035385132
chronic O 1 1.0
disease O 1 0.9999867677688599
and O 0 1.558148632341272e-08
can O 0 2.2580248781878254e-09
even O 0 1.5110875883905805e-09
lead O 0 2.2794532927861155e-09
to O 0 2.802827692161003e-10
normal O 0 1.1828991546281031e-06
life O 0 2.3096081491758014e-08
expectancy O 0 1.2155489947929254e-08
. O 0 1.3428897993605915e-09
. O 0 1.6395075519426427e-08

Prevalence O 0 4.015247668576194e-06
of O 0 1.901122601566385e-07
the O 0 1.3675468757412546e-08
I1307K O 0 8.412593643924993e-08
APC B-Disease 0 6.764659499225445e-09
gene O 0 3.0166519282559534e-10
variant O 0 1.2891188116981311e-09
in O 0 4.642857279191226e-11
Israeli O 0 3.2660116278115936e-10
Jews O 0 5.2888957102759093e-11
of O 0 2.1101792188615853e-11
differing O 0 2.9754252447306007e-12
ethnic O 0 7.50602965199354e-12
origin O 0 2.5849721668746994e-11
and O 0 2.850936674236859e-11
risk O 0 8.235286230728889e-09
for O 0 8.233984658545523e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9996328353881836

BACKGROUND O 0 2.4153307549568126e-06
& O 0 3.7058990187688323e-07
AIMS O 0 9.173258597172662e-09
Israeli O 0 2.416516986514239e-09
Jews O 0 1.1037211145037418e-09
of O 0 6.02050076459193e-10
European O 0 6.569347288376548e-10
birth O 0 4.7167589833918555e-09
, O 0 2.5527729929919474e-10
i O 0 7.992863593209165e-10
. O 0 2.4248530267056978e-11
e O 0 1.6924595058753766e-10
. O 0 1.926322990009055e-11
, O 0 1.3124892839222468e-10
Ashkenazim O 0 2.106418328651216e-08
, O 0 1.472898747412188e-10
have O 0 8.453013462805803e-12
the O 0 1.5560977506545726e-10
highest O 0 0.0056427777744829655
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.7880129814147949
of O 0 1.1974063340858265e-07
any O 0 6.813603570243743e-10
Israeli O 0 2.6476504544348245e-08
ethnic O 0 1.516027658965413e-08
group O 0 8.992399713747545e-09
. O 0 3.645539692342936e-08

The O 0 2.9426524861264625e-07
I1307K O 0 7.820949576853309e-07
APC B-Disease 0 6.045603129223309e-08
gene O 0 4.630444916386978e-09
variant O 0 2.203078430795813e-08
was O 0 9.06429775682227e-08
found O 0 4.203782655309851e-09
in O 0 2.5508224421599834e-09
6 O 0 1.6783253613539273e-06
. O 0 3.3896409945555206e-07

1 O 0 1.5085387303770403e-06
% O 0 4.122725716371178e-09
of O 0 4.976267842238258e-09
American O 0 1.0263254690556778e-09
Jews O 0 2.2878020311534186e-10
, O 0 1.1608415617647694e-11
28 O 0 3.828184436116544e-10
% O 0 1.1025296647870775e-10
of O 0 4.526098162926928e-09
their O 0 3.143230742352898e-07
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 3.5846696846419945e-05
, O 0 3.021984606998984e-10
but O 0 8.859578001785273e-12
not O 0 6.0471714441456825e-12
in O 0 4.4909735652520766e-11
non O 0 6.107540428956781e-08
- O 0 5.9848652256278e-08
Jews O 0 9.820992907805248e-09
. O 0 3.082637434204116e-08

We O 0 8.608019896882979e-08
assessed O 0 5.596465868507039e-08
the O 0 1.4404933912359752e-09
I1307K O 0 1.085831069502774e-08
prevalence O 0 5.389202417660499e-10
in O 0 6.95241086923204e-12
Israeli O 0 6.312377009987102e-11
Jews O 0 3.578918758573302e-11
of O 0 2.309269789280144e-11
differing O 0 1.8987710709295058e-11
ethnic O 0 6.864404010487046e-12
origin O 0 7.0332767387881745e-12
and O 0 4.081377596998337e-12
risk O 0 1.4096090961146501e-09
for O 0 3.417868867927609e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9973630309104919

METHODS O 0 5.508102844942186e-07
DNA O 0 8.851585242553028e-09
samples O 0 8.783483940177916e-10
from O 0 1.4096863953927397e-10
500 O 0 3.3584812014764154e-11
unrelated O 0 4.044371226807897e-10
Jews O 0 5.3619872431021065e-11
of O 0 2.333944149057743e-10
European O 0 6.404671792914485e-10
or O 0 2.6974281142067014e-10
non O 0 1.600782506550047e-09
- O 0 7.415020680801021e-11
European O 0 3.6127725810963796e-11
origin O 0 2.466997786609859e-11
, O 0 3.653851093216032e-12
with O 0 1.0821466335866892e-12
or O 0 2.4098820161633228e-11
without O 0 2.6631713501146237e-10
a O 0 2.654691744208293e-10
personal O 0 4.692969124420188e-09
and O 0 3.2357423407347596e-09
/ O 0 1.3241549368103733e-06
or O 0 4.8169429334166125e-08
family O 0 2.5137580905720824e-09
history O 0 7.041166316668068e-09
of O 0 7.588325701135545e-08
neoplasia B-Disease 0 3.576137942218338e-06
, O 0 2.9301268078540943e-09
were O 0 9.300542003209955e-10
examined O 0 3.494243783208617e-09
for O 0 1.5289630672654653e-10
the O 0 2.004890836682094e-10
I1307K O 0 1.911527602871388e-09
variant O 0 2.3226155720923458e-10
by O 0 1.8130540471728018e-11
the O 0 8.660509115410164e-11
allele O 0 1.8346961450088628e-10
- O 0 2.565615497829299e-10
specific O 0 5.908365463547227e-11
oligonucleotide O 0 1.9946250873204008e-08
( O 0 1.1275033129365397e-09
ASO O 0 1.0319861303287325e-06
) O 0 1.1480124628704402e-09
method O 0 6.744691916082957e-08
. O 0 6.71176252353689e-08

RESULTS O 0 1.175475432546591e-07
In O 0 9.29247878644901e-09
persons O 0 3.8111167555143766e-09
at O 0 4.0162714043390224e-08
average O 0 1.706561003622653e-09
risk O 0 3.2620555145967955e-08
for O 0 3.699426770253922e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1583692867134232e-06
I1307K O 0 1.058536440723401e-06
was O 0 1.3855557767783466e-07
found O 0 5.526777369091462e-10
in O 0 4.6136749976000146e-10
5 O 0 5.262057811705745e-08
. O 0 4.559815636184794e-08

0 O 0 9.788398074306315e-07
% O 0 1.1706041469494721e-08
of O 0 1.9804772932729975e-08
120 O 0 1.0732073896235761e-08
European O 0 8.02863642235252e-09
and O 0 4.997879443635611e-09
1 O 0 1.3368767213250976e-06
. O 0 7.490569942092407e-08

6 O 0 2.170470452256268e-06
% O 0 1.0044115761331796e-08
of O 0 1.5606500980425153e-08
188 O 0 1.518927916777102e-08
non O 0 3.1211644824225004e-08
- O 0 1.7699657295366933e-09
European O 0 1.476649136300523e-09
Jews O 0 7.220964381993156e-10
( O 0 6.664147012003241e-11
P O 0 3.341502718967604e-08
= O 0 2.210367444632766e-09
0 O 0 1.94596760927368e-09
. O 0 1.1526127968730648e-10
08 O 0 1.053594544941916e-08
) O 0 5.887065945842096e-09
. O 0 1.0578335718491871e-07

It O 0 2.582073932444473e-08
occurred O 0 5.343547400116222e-07
in O 0 6.163969334949115e-09
15 O 0 1.830877778274953e-07
. O 0 9.150596724794013e-08

4 O 0 1.1832895552288392e-06
% O 0 9.790077193372326e-09
of O 0 8.036725951399148e-09
52 O 0 5.0069651535977755e-08
Ashkenazi O 0 2.8338256186088984e-08
Israelis O 0 1.5810718068109963e-08
with O 0 3.765846745551471e-09
familial O 0 1.3234277503215708e-05
cancer B-Disease 0 3.7668185541406274e-05
( O 0 8.511690019474827e-09
P O 0 5.726937160943635e-06
= O 0 2.332460091736266e-08
0 O 0 2.5344257803538994e-09
. O 0 2.9043064828093712e-11
02 O 0 4.415545706848434e-09
) O 0 9.360243136136148e-11
and O 0 1.4596759911889023e-10
was O 0 4.021520005892398e-09
not O 0 2.799967722955099e-11
detected O 0 5.479543485620297e-10
in O 0 1.4775189405291655e-10
51 O 0 4.325081182088297e-09
non O 0 3.180345231612591e-08
- O 0 1.4766126099630128e-09
European O 0 3.80274284283999e-10
Jews O 0 2.8308244637287316e-10
at O 0 4.919840979056289e-09
increased O 0 2.3930513126657615e-09
cancer B-Disease 0 3.922146447621344e-07
risk O 0 2.1282103546127473e-07
. O 0 2.554527327447431e-07

Colorectal B-Disease 1 0.9998677968978882
neoplasia I-Disease 1 0.9777056574821472
occurred O 0 0.004893711768090725
personally O 0 3.212300327959383e-07
or O 0 1.4692631555845992e-09
in O 0 8.564314535330908e-11
the O 0 7.239908672573847e-11
families O 0 1.5650287055885004e-12
of O 0 2.263335907581876e-10
13 O 0 3.832898887168312e-09
of O 0 2.381632491221808e-08
20 O 0 4.3403222349525095e-08
Ashkenazi O 0 6.797303608863103e-09
I1307K O 0 8.073629764737689e-09
carriers O 0 1.1829838497678935e-10
, O 0 7.538631524584005e-11
8 O 0 4.069925285676845e-09
of O 0 8.480026458812517e-09
whom O 0 1.1089781537521048e-08
also O 0 1.1218915796362694e-09
had O 0 4.938663256126574e-09
a O 0 1.1543426214899455e-09
personal O 0 2.4471962234429157e-08
or O 0 1.855744358181255e-08
family O 0 2.0643089460037345e-09
history O 0 1.496486135010855e-08
of O 0 4.093947154615307e-07
noncolonic O 0 0.0004439838230609894
neoplasia B-Disease 0 0.026718394830822945
. O 0 2.1544157789321616e-05

CONCLUSIONS O 0 3.400984496693127e-06
The O 0 5.315379780768126e-08
I1307K O 0 3.9410323893207533e-07
APC O 0 5.5172616697518606e-08
variant O 0 5.888449905455673e-08
may O 0 3.4519211933314864e-09
represent O 0 5.329790497832221e-10
a O 0 1.2652560110737454e-09
susceptibility O 0 3.954464489197562e-08
gene O 0 2.004132149124871e-08
for O 0 1.0736479794104525e-07
colorectal B-Disease 1 1.0
, I-Disease 0 3.2533555440750206e-06
or I-Disease 0 9.801273392895382e-08
other I-Disease 0 1.000133220685484e-08
, I-Disease 0 6.541031272178088e-09
cancers I-Disease 0 0.007595276925712824
in O 0 4.879034065652377e-08
Ashkenazi O 0 9.350037544209044e-07
Jews O 0 1.4207820697720308e-08
, O 0 3.607458221033255e-10
and O 0 2.2333351834546988e-10
partially O 0 1.4237498291436168e-08
explains O 0 6.253873530148724e-10
the O 0 6.467915092400744e-11
higher O 0 9.114240917540428e-09
incidence O 0 7.681547140236944e-05
of O 0 0.23524105548858643
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.7764018878096977e-07
European O 0 1.0136112393865915e-07
Israelis O 0 2.2519536457821232e-07
. O 0 1.0441562636742674e-07

Systematic O 0 2.9409964241722264e-08
analysis O 0 6.662654428168935e-09
of O 0 2.6133079700230155e-08
coproporphyrinogen O 0 3.137033672828693e-06
oxidase O 0 5.165992433830979e-07
gene O 0 3.0286000765045173e-06
defects O 0 0.01453231368213892
in O 0 3.1756329121890303e-07
hereditary B-Disease 1 0.9999990463256836
coproporphyria I-Disease 1 0.9941860437393188
and O 0 2.0660556288021326e-07
mutation O 0 6.150090570145039e-08
update O 0 4.573019793951971e-07
. O 0 7.882462682573532e-07

Hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.999854326248169
( O 0 8.09920379651885e-07
HC B-Disease 1 1.0
) O 0 2.26108589629348e-08
is O 0 3.460819131273496e-10
an O 0 1.005499905559759e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.015379061922430992
autosomal O 1 1.0
dominant O 1 0.9999972581863403
inheritance O 0 0.021644352003932
caused O 0 7.789970624116904e-08
by O 0 6.922429990341428e-11
deficient B-Disease 0 5.139829184486189e-08
activity I-Disease 0 4.789483476486112e-09
of I-Disease 0 1.9749096580312653e-08
coproporphyrinogen I-Disease 0 1.5472729728571721e-06
III I-Disease 0 0.09826653450727463
oxidase I-Disease 0 3.074258714264033e-08
( O 0 4.186355706536915e-09
CPO O 0 2.7386039391785744e-07
) O 0 6.907427962943302e-09
. O 0 8.288964181701886e-08

Clinical O 0 2.464042881911155e-05
manifestations O 0 5.82620850764215e-05
of O 0 2.006859403991257e-06
the O 0 1.2172037600066687e-07
disease O 0 3.192513031535782e-05
are O 0 4.171476532255358e-12
characterized O 0 4.5608787579975996e-11
by O 0 9.752620586112037e-12
acute O 0 0.0028194012120366096
attacks O 0 1.8127284562297064e-08
of O 0 0.0735260546207428
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 2.526184061935055e-08
precipitated O 0 3.943924742344507e-09
by O 0 2.0441912051971656e-11
drugs O 0 4.667857211870796e-09
, O 0 5.1767753278531004e-11
fasting O 0 2.6326276714172536e-09
, O 0 6.499899507517171e-10
cyclical O 0 1.317061901318084e-06
hormonal O 0 4.233053186908364e-05
changes O 0 1.0199158850809908e-07
, O 0 5.172973516209822e-08
or O 0 1.5239429558278061e-06
infectious B-Disease 1 0.9998352527618408
diseases I-Disease 1 0.999467670917511
. O 0 1.9127485302306013e-06

Skin O 1 0.9999575614929199
photosensitivity O 1 0.9999333620071411
may O 0 5.985703865007963e-06
also O 0 1.2927981352106599e-08
be O 0 6.577634548143863e-10
present O 0 5.5721889324900076e-09
. O 0 4.6010516285832637e-08

The O 0 3.1377408049593214e-07
seven O 0 1.8837896220702532e-07
exons O 0 1.1649560605064835e-07
, O 0 3.4758043110372228e-09
the O 0 8.708687104785895e-09
exon O 0 7.007305953266041e-07
/ O 0 4.4962692413719196e-07
intron O 0 6.415559141714766e-07
boundaries O 0 1.0125866367616254e-08
and O 0 1.0567617891865666e-09
part O 0 4.170352951859968e-09
of O 0 1.2751077349548723e-07
3 O 0 4.716626449408068e-07
noncoding O 0 6.762081170563761e-07
sequence O 0 6.372980365654257e-09
of O 0 3.579005891651832e-08
the O 0 1.1418351597569654e-08
CPO O 0 2.0648896281727502e-07
gene O 0 2.862944104009557e-09
were O 0 1.170532226701937e-09
systematically O 0 6.180353451235021e-10
analyzed O 0 1.6937252989013274e-10
by O 0 2.1521312509875656e-11
an O 0 7.198243390238446e-11
exon O 0 1.2324958831300137e-08
- O 0 6.8336243330691104e-09
by O 0 2.6425586163725256e-09
- O 0 6.12328733495815e-07
exon O 0 8.261467314696347e-07
denaturing O 0 2.6551520932116546e-05
gradient O 0 5.569105724134715e-06
gel O 0 5.9979320212733e-06
electrophoresis O 0 1.558378130539495e-06
( O 0 1.2568958318581736e-08
DGGE O 0 3.766890870338102e-07
) O 0 2.6621352344768923e-10
strategy O 0 7.494706522059857e-10
followed O 0 5.773083747162566e-11
by O 0 5.656346484944619e-12
direct O 0 1.1516371190012364e-10
sequencing O 0 4.974946565816651e-10
in O 0 1.7008029429277371e-09
seven O 0 2.1744734013395828e-08
unrelated O 0 4.3758160472862073e-07
heterozygous O 0 1.8367363452398422e-07
HC B-Disease 1 0.9999874830245972
patients O 0 2.5297433694504434e-06
from O 0 3.842101392592667e-08
France O 0 5.4074842381623967e-08
, O 0 3.020521055496772e-10
Holland O 0 7.095416254543352e-09
, O 0 6.091616794323684e-11
and O 0 2.5095603373159747e-10
Czech O 0 1.9536539639375405e-06
Republic O 0 1.3720161405217368e-05
. O 0 2.223564933956368e-06

Seven O 0 8.190629330329102e-08
novel O 0 5.331012520315426e-09
mutations O 0 9.310853754662674e-10
and O 0 2.1304577546565895e-10
two O 0 6.942700581102912e-11
new O 0 2.6912302941717314e-10
polymorphisms O 0 7.956772130057743e-09
were O 0 7.872326790447914e-09
detected O 0 6.126038556431013e-07
. O 0 5.957486237662124e-08

Among O 0 5.177905659792259e-09
these O 0 2.1424256813062925e-10
mutations O 0 8.593608602502911e-10
two O 0 7.397535362052565e-10
are O 0 1.0561285873622595e-10
missense O 0 2.005627486312278e-08
( O 0 5.058439778160562e-10
G197W O 0 3.154362104851316e-08
, O 0 6.662981277827384e-10
W427R O 0 2.3358881051649405e-08
) O 0 3.0549601737206444e-10
, O 0 1.4358184086127324e-10
two O 0 7.03941349655679e-11
are O 0 1.427772396839222e-11
nonsense O 0 4.292733279953609e-09
( O 0 5.5243927488124456e-11
Q306X O 0 4.990877933153115e-09
, O 0 2.5362090205760524e-10
Q385X O 0 6.271986485728576e-09
) O 0 1.6493827137420425e-10
, O 0 1.8170950855100898e-10
two O 0 1.0972326519587128e-10
are O 0 8.927174104111923e-12
small O 0 4.664390748643221e-11
deletions O 0 4.36099684142377e-10
( O 0 2.375944996302337e-10
662de14bp O 0 1.4156047001279148e-08
; O 0 7.770611931690041e-10
1168del3bp O 0 5.761739885201678e-08
removing O 0 2.7920319212171307e-07
a O 0 9.180574522815732e-09
glycine O 0 5.065193775521948e-08
at O 0 2.225991266868732e-07
position O 0 4.9029253545995743e-08
390 O 0 5.24182031114151e-09
) O 0 1.3014957167545305e-10
, O 0 5.167778358017294e-11
and O 0 1.4359737357527713e-11
one O 0 2.1839136402079795e-11
is O 0 9.907448993151657e-12
a O 0 9.549337709469086e-11
splicing O 0 8.646022786606977e-10
mutation O 0 1.1190209175948596e-10
( O 0 5.486508469765283e-10
IVS1 O 0 3.407242843422864e-07
- O 0 8.528383688144459e-08
15c O 0 4.1996537447630544e-07
- O 0 4.652650886782794e-08
- O 0 1.5018418508816467e-08
> O 0 4.9087152120819155e-09
g O 0 8.467210044216245e-09
) O 0 7.401794455130783e-11
which O 0 2.671187403213704e-11
creates O 0 3.939532033925275e-10
a O 0 1.513336539415988e-10
new O 0 4.774677875296618e-10
acceptor O 0 2.302297019696198e-09
splice O 0 5.16687009621819e-07
site O 0 1.4265746983710414e-07
. O 0 1.56786200022907e-07

The O 0 7.997949325044829e-08
pathological O 0 3.287904110038653e-05
significance O 0 2.242889536319126e-07
of O 0 5.4924505832332216e-08
the O 0 1.2934147086696157e-08
point O 0 1.7436853738672653e-07
mutations O 0 9.605001238810473e-10
G197W O 0 1.2497767265529092e-08
, O 0 3.36263655809077e-10
W427R O 0 1.2717844555254487e-08
, O 0 1.0213024870253662e-10
and O 0 1.1124726834177423e-10
the O 0 4.721679713881599e-10
in O 0 1.5792745999831936e-09
- O 0 4.744685533353277e-09
frame O 0 1.0269608452517787e-07
deletion O 0 1.732490950701049e-08
390delGly O 0 1.4295620687221344e-08
were O 0 1.7297620280576353e-10
assessed O 0 3.7217298687330924e-10
by O 0 3.1403623191456065e-12
their O 0 1.2706325791880801e-12
respective O 0 1.9239482229593818e-10
expression O 0 2.023330530898093e-10
in O 0 1.249334524722201e-10
a O 0 4.789707519492481e-11
prokaryotic O 0 7.931611617495449e-11
system O 0 8.51170189886119e-10
using O 0 3.891021949087303e-10
site O 0 2.682299715672798e-09
- O 0 1.019594075835073e-09
directed O 0 1.3768057804952605e-09
mutagenesis O 0 8.065327961048752e-07
. O 0 2.3949777983034437e-07

These O 0 1.589100739884941e-09
mutations O 0 1.3543129950832622e-09
resulted O 0 7.77976183474749e-10
in O 0 1.0974755132453495e-10
the O 0 4.968725986209677e-10
absence O 0 2.6075174019979386e-08
or O 0 7.810255220341844e-10
a O 0 5.970835492696835e-10
dramatic O 0 6.0423501757611575e-09
decrease O 0 1.9049007704552423e-08
of O 0 5.578917239290604e-07
CPO O 0 1.8731370801106095e-05
activity O 0 5.362584261092707e-07
. O 0 1.4391488889486936e-07

The O 0 2.589111147699441e-08
two O 0 1.2599002952029537e-09
polymorphisms O 0 2.460665449177668e-09
were O 0 1.9084445135320038e-10
localized O 0 2.768796525387529e-09
in O 0 6.489518367125413e-10
noncoding O 0 2.1387232607139595e-07
part O 0 2.0140444867422502e-09
of O 0 1.0824378726681516e-08
the O 0 1.9286889862968337e-09
gene O 0 3.7856059953433885e-10
1 O 0 3.517234148375792e-08
) O 0 1.202209165551693e-10
a O 0 2.0606267803202627e-09
C O 0 3.452391013070155e-07
/ O 0 3.2615577794103956e-08
G O 0 6.515569594967019e-08
polymorphism O 0 4.77213113470043e-09
in O 0 1.4259259328852636e-09
the O 0 4.4406127663876305e-09
promotor O 0 1.1458272638265043e-05
region O 0 1.0274937523035987e-07
, O 0 2.6763511407068563e-09
142 O 0 1.723815579168786e-08
bp O 0 6.603321622833391e-08
upstream O 0 6.274643027381899e-09
from O 0 8.78683570348926e-10
the O 0 8.298542963913746e-10
transcriptional O 0 1.0630819780033107e-08
initiation O 0 7.082381792145043e-09
site O 0 7.855168959736147e-09
( O 0 6.712832512079103e-10
- O 0 5.638904010396573e-09
142C O 0 2.776974561413681e-08
/ O 0 4.500910932847546e-08
G O 0 1.1232415175754795e-07
) O 0 4.671070197304061e-10
, O 0 1.2816234185031306e-10
and O 0 1.8259754819283103e-10
2 O 0 5.275866143961139e-08
) O 0 2.568896206867066e-10
a O 0 3.017401439819878e-09
6 O 0 4.483140969568922e-08
bp O 0 1.3309236379654976e-08
deletion O 0 2.27632956928403e-09
polymorphism O 0 1.8319347150352883e-09
in O 0 5.244378264990246e-10
the O 0 2.6267692465609116e-09
3 O 0 9.906938203130267e-08
noncoding O 0 5.914000666962238e-07
part O 0 6.885184866689542e-09
of O 0 4.361234573480033e-08
the O 0 2.82716889898893e-08
CPO O 0 7.801238552929135e-07
gene O 0 1.2972665608401712e-08
, O 0 2.7365076871177507e-09
574 O 0 7.260039325274192e-08
bp O 0 3.1300120895139116e-07
downstream O 0 5.6798608483177304e-08
of O 0 7.199983542705013e-08
the O 0 6.371776439806354e-09
last O 0 4.997507740966967e-09
base O 0 3.249720714748605e-09
of O 0 3.5052309943495175e-09
the O 0 4.650676788120478e-10
normal O 0 1.6256477053389062e-08
termination O 0 1.2861814946418804e-09
codon O 0 6.494694226866216e-10
( O 0 2.2648991016005482e-10
+ O 0 6.491762682969693e-09
574 O 0 9.560011449138983e-08
delATTCTT O 0 1.1608775594140752e-06
) O 0 4.473437797969382e-08
. O 0 2.4203473003581166e-07

Five O 0 8.413009027208318e-07
intragenic O 0 1.0107900379807688e-05
dimorphisms O 0 8.200247066270094e-06
are O 0 5.860578133898287e-10
now O 0 1.8794195366655941e-10
well O 0 2.7106971181578565e-11
characterized O 0 1.5096607297593323e-10
and O 0 1.9539321549633115e-11
the O 0 1.67242594772965e-10
high O 0 7.366197873892588e-09
degree O 0 7.56979332550145e-08
of O 0 1.6794111656892596e-09
allelic O 0 1.2255362058510855e-08
heterogeneity O 0 2.0829384439480236e-08
in O 0 5.756508159038276e-09
HC B-Disease 1 0.9994792342185974
is O 0 6.78093581285566e-09
demonstrated O 0 2.1602271083054347e-09
with O 0 2.7367556137969373e-11
seven O 0 5.623796914266954e-11
new O 0 4.211890818756059e-12
different O 0 3.728646731648855e-12
mutations O 0 1.1625255445790739e-11
making O 0 5.38081801337853e-11
a O 0 6.183840939311125e-11
total O 0 5.0540301110846286e-11
of O 0 9.819082436024473e-09
nineteen O 0 4.295934274978208e-07
CPO O 0 8.359716048289556e-06
gene B-Disease 0 1.9368667381058913e-06
defects I-Disease 0 0.00010450170520925894
reported O 0 5.1553030289142043e-08
so O 0 1.4114330815218068e-09
far O 0 1.8893151487731075e-09
. O 0 4.130027431159533e-10
. O 0 1.1844526248694365e-08

Coincidence O 0 3.320620635349769e-06
of O 0 1.894635914823084e-07
two O 0 1.1008008948820702e-09
novel O 0 1.2584736586163103e-09
arylsulfatase O 0 2.408309462964553e-08
A O 0 1.409514949202162e-09
alleles O 0 1.503485391740611e-10
and O 0 1.7679875619069918e-10
mutation O 0 2.704398094355298e-10
459 O 0 4.8590367285328284e-09
+ O 0 1.8767098097782764e-08
1G O 0 4.3363303348087356e-07
> O 0 9.961280511561199e-08
A O 0 1.7393313456182113e-08
within O 0 7.459243001051163e-09
a O 0 3.3149660794151714e-09
family O 0 8.780134397312622e-10
with O 0 5.09852471353156e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.1154392964840554e-09
molecular O 0 3.350256960743536e-09
basis O 0 2.3026307527374e-09
of O 0 3.3971143675870508e-09
phenotypic O 0 1.0234757610305678e-06
heterogeneity O 0 6.480572210421087e-06
. O 0 1.9544681890693028e-06

In O 0 4.312969963393698e-07
a O 0 2.0000219080884563e-07
family O 0 5.508657530128858e-09
with O 0 4.015960619607739e-10
three O 0 1.0522268389934197e-08
siblings O 0 2.3513727853696764e-08
, O 0 1.7156789877681433e-10
one O 0 4.19567193488124e-11
developed O 0 3.4670379900347825e-09
classical O 0 0.04680382087826729
late O 1 0.999968409538269
infantile O 1 0.9999997615814209
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.1733491191989742e-06
MLD B-Disease 1 0.9999998807907104
) O 0 4.029343969591537e-09
, O 0 5.618599474566111e-10
fatal O 0 6.128171037289576e-08
at O 0 2.6564418220687003e-08
age O 0 3.839098283719977e-08
5 O 0 1.8613913965737083e-08
years O 0 1.8903243415024917e-09
, O 0 3.430958642192117e-11
with O 0 7.075448560378561e-11
deficient O 0 4.459990066152386e-07
arylsulfatase O 0 5.644621523970272e-06
A O 0 6.24717358732596e-07
( O 0 2.3797965820193667e-09
ARSA O 0 4.517458762620663e-07
) O 0 1.4339272824681615e-10
activity O 0 2.716993019458158e-10
and O 0 4.552882376662737e-11
increased O 0 1.3146872479552485e-09
galactosylsulfatide O 0 4.611542010479752e-07
( O 0 9.869101091908306e-09
GS O 0 0.0015097836731001735
) O 0 7.510924326936674e-09
excretion O 0 1.1316258508031751e-07
. O 0 6.237797123276323e-08

The O 0 4.727326086140238e-08
two O 0 1.843874497531317e-09
other O 0 6.15520190372365e-10
siblings O 0 1.1706421609858353e-08
, O 0 9.862473060451293e-10
apparently O 0 6.572536648263849e-08
healthy O 0 8.496022552151317e-09
at O 0 6.974237862777954e-07
12 O 0 8.423255337675073e-08
( O 0 1.0265975847190134e-09
1 O 0 6.773027649842334e-08
/ O 0 1.461953846870756e-08
2 O 0 2.4756415584192837e-08
) O 0 2.128762791042682e-11
and O 0 5.71970699969615e-11
15 O 0 2.1114616721717994e-09
years O 0 3.8095379628622084e-10
, O 0 2.467811892337135e-11
respectively O 0 4.293361499652093e-10
, O 0 2.3920906921937046e-11
and O 0 2.6840932254579286e-11
their O 0 1.0116011500693745e-10
father O 0 5.31383896884563e-08
, O 0 3.359445610584544e-09
apparently O 0 9.20268590220985e-08
healthy O 0 2.5509487855401858e-09
as O 0 4.177172774344484e-10
well O 0 2.126921277989524e-10
, O 0 1.0341023870541477e-10
presented O 0 1.6089011012354604e-08
ARSA O 0 2.3246926502906717e-05
and O 0 3.93828116784789e-08
GS O 1 0.8593069911003113
values O 0 5.307252415320818e-09
within O 0 5.381806666981959e-10
the O 0 7.594381373765557e-11
range O 0 2.173974555930158e-09
of O 0 2.5694967931144674e-08
MLD B-Disease 1 1.0
patients O 0 2.351037437620107e-06
. O 0 2.55876472010641e-07

Mutation O 0 8.288375319409624e-09
screening O 0 9.548508650425447e-09
and O 0 1.0007963208158444e-10
sequence O 0 2.3176811858593993e-10
analysis O 0 1.8861169570616454e-10
disclosed O 0 3.400413728371632e-09
the O 0 8.79904066275472e-11
involvement O 0 7.351404374134063e-09
of O 0 4.7009427461830455e-09
three O 0 3.196872488953062e-10
different O 0 1.092920087764071e-09
ARSA O 0 8.510682164342143e-06
mutations O 0 1.2861469667058145e-09
being O 0 6.562309029511937e-10
the O 0 3.108483193070555e-10
molecular O 0 5.378730794092235e-09
basis O 0 1.1530074672805313e-08
of O 0 1.831928564399732e-08
intrafamilial O 0 3.419202414534084e-07
phenotypic O 0 3.117041387667996e-06
heterogeneity O 0 1.776658791641239e-05
. O 0 2.4832804683683207e-06

The O 0 1.368212707575367e-07
late O 0 0.00011189332144567743
infantile O 0 0.0002549376222305
patient O 0 2.675465111678932e-06
inherited O 0 0.0021712067537009716
from O 0 4.103891342310817e-07
his O 0 8.708990861805432e-08
mother O 0 4.0316134430895545e-08
the O 0 2.6845106138040364e-09
frequent O 0 4.784233897936474e-09
0 O 0 7.665714285565173e-09
- O 0 1.4063730180424727e-09
type O 0 2.7091491272557278e-09
mutation O 0 3.228256828524678e-10
459 O 0 5.3361399743323545e-09
+ O 0 7.955967440409495e-09
1G O 0 1.41104152362459e-07
> O 0 2.073397631363605e-08
A O 0 7.106929267308715e-09
, O 0 1.2627866807779498e-10
and O 0 8.029699821721081e-11
from O 0 1.5714561873991784e-09
his O 0 4.4756718331484535e-09
father O 0 3.14775689957969e-08
a O 0 7.305552829350859e-10
novel O 0 1.386841613770784e-10
, O 0 4.002972953109918e-11
single O 0 1.0171578856965624e-10
basepair O 0 6.491542592357291e-08
microdeletion O 0 1.5775991357713792e-07
of O 0 4.8220908155371944e-08
guanine O 0 7.08889871248175e-08
at O 0 1.8050040750949847e-07
nucleotide O 0 6.419938358703803e-09
7 O 0 2.7793058521297098e-08
in O 0 6.0759108855279464e-09
exon O 0 1.5156986421516194e-07
1 O 0 2.9568673198809847e-07
( O 0 3.1078564166620026e-09
7delG O 0 1.0877862877123334e-07
) O 0 3.438753282125617e-08
. O 0 2.0332970507297432e-07

The O 0 6.030332144746353e-08
two O 0 1.841717178763247e-08
clinically O 0 7.787481990817469e-06
unaffected O 0 1.211243585430566e-07
siblings O 0 3.9887555480788706e-09
carried O 0 2.1875333489074222e-10
the O 0 3.138425352933183e-10
maternal O 0 2.867026172026499e-09
mutation O 0 1.5190682045584936e-10
459 O 0 1.6259043000843576e-09
+ O 0 9.597589389898076e-09
1G O 0 1.50473852045252e-07
> O 0 1.7645060523818756e-08
A O 0 5.7565632261002975e-09
and O 0 6.668367941164988e-11
, O 0 2.999907613987496e-11
on O 0 6.593725565551267e-10
their O 0 1.1160298379886413e-11
paternal O 0 2.2380002018262957e-10
allele O 0 3.226958145141623e-10
, O 0 6.287251275161054e-11
a O 0 9.022732561092539e-11
novel O 0 6.479126957170678e-11
cytosine O 0 1.0957692531121666e-09
to O 0 1.8258569656204315e-10
thymidine O 0 6.94471040674216e-08
transition O 0 5.348462082110927e-07
at O 0 9.31254589886521e-07
nucleotide O 0 1.7572791932707332e-07
2435 O 0 5.132984824740561e-06
in O 0 1.1014609668791309e-08
exon O 0 1.353473777498948e-07
8 O 0 3.1702917624443216e-08
, O 0 8.087461950134767e-11
resulting O 0 7.644738314604993e-11
in O 0 3.7219127085874604e-11
substitution O 0 5.484112608478142e-10
of O 0 2.7009043890302564e-09
alanine O 0 7.126122358869225e-09
464 O 0 1.4350861832213013e-08
by O 0 2.8965094767130495e-09
valine O 0 4.3944774006376974e-06
( O 0 2.292696876793343e-08
A464V O 0 8.567494091948902e-07
) O 0 2.7051335393935005e-08
. O 0 1.509890381612422e-07

The O 0 4.142971476994717e-07
fathers O 0 1.434115262100022e-07
genotype O 0 2.6691644450238527e-08
thus O 0 8.8363858452567e-09
was O 0 4.8867086377413216e-08
7delG O 0 2.1705064057186974e-07
/ O 0 5.327900112206407e-07
A464V O 0 2.0600834886863595e-06
. O 0 3.1416604429068684e-07

Mutation O 0 5.571649452917882e-08
A464V O 0 4.939942641613015e-07
was O 0 4.333960745839249e-08
not O 0 9.444963561255904e-11
found O 0 6.247909134504681e-11
in O 0 7.85640372202856e-11
18 O 0 1.1910541886095416e-08
unrelated O 0 8.164470273186453e-07
MLD B-Disease 1 1.0
patients O 0 4.187811271094688e-07
and O 0 6.320032941431464e-09
50 O 0 1.266657676524119e-07
controls O 0 4.958239969710121e-06
. O 0 5.386755788094888e-07

A464V O 0 1.067365246854024e-05
, O 0 4.053588753549775e-08
although O 0 1.3559653844197328e-08
clearly O 0 3.076828036796542e-08
modifying O 0 6.08307402671926e-07
ARSA O 0 0.0007547385757789016
and O 0 3.7153014886825986e-07
GS O 1 0.9999551773071289
levels O 0 2.5546810320520308e-06
, O 0 3.0717308696637247e-09
apparently O 0 1.1517172993080749e-08
bears O 0 1.6395754753872893e-09
little O 0 3.875245957463136e-10
significance O 0 1.2319499864688055e-09
for O 0 1.3051998370983142e-10
clinical O 0 1.4761570632515486e-08
manifestation O 0 3.539682609243755e-07
of O 0 1.9264509774075123e-06
MLD B-Disease 1 1.0
, O 0 5.1263864264683434e-08
mimicking O 0 1.3197244186358148e-07
the O 0 1.70280980427151e-08
frequent O 0 9.81054952831073e-08
ARSA O 0 5.4170992370927706e-05
pseudodeficiency O 0 1.7874364857561886e-05
allele O 0 1.8848944591809413e-06
. O 0 1.2986574802198447e-06

Our O 0 7.217334996312275e-08
results O 0 2.2914496966564e-09
demonstrate O 0 1.3298749879098182e-09
that O 0 1.6506494521922876e-12
in O 0 2.662223956909071e-12
certain O 0 2.4294361661292285e-11
genetic O 0 8.309455346022787e-10
conditions O 0 4.3354825152164267e-07
MLD B-Disease 1 1.0
- O 0 0.00022139081556815654
like O 0 2.4638978857183247e-08
ARSA O 0 0.0006220137584023178
and O 0 1.063780175059037e-07
GS O 1 0.9999995231628418
values O 0 1.792201231864965e-07
need O 0 1.8793666622940464e-09
not O 0 1.8281770194916724e-11
be O 0 4.5621813618557105e-12
paralleled O 0 4.9760161269229997e-11
by O 0 6.016166731459549e-12
clinical O 0 3.1609086903472416e-08
disease O 0 7.073042951333264e-08
, O 0 9.126652211755015e-11
a O 0 2.6172461420337356e-10
finding O 0 2.1008281780865445e-09
with O 0 5.595699598126558e-11
serious O 0 6.68595276920314e-08
diagnostic O 0 1.371499934066378e-06
and O 0 1.2500485979671794e-08
prognostic O 0 0.000722403172403574
implications O 0 1.241694189957343e-05
. O 0 2.1261787424009526e-06

Moreover O 0 9.554030384606449e-07
, O 0 9.188089400424815e-09
further O 0 4.556258037524685e-09
ARSA O 0 2.8348529212962603e-06
alleles O 0 6.273302766146571e-09
functionally O 0 3.0929381722444305e-08
similar O 0 4.5169196161154446e-10
to O 0 2.6571739253355986e-10
A464V O 0 4.0155665459451484e-08
might O 0 5.32657862262198e-10
exist O 0 1.7192167134361114e-10
which O 0 1.3289405166594381e-11
, O 0 6.521649973528776e-12
together O 0 2.5929274352631815e-11
with O 0 1.4376325130349699e-10
0 O 0 6.82706087218321e-08
- O 0 1.0739487521504998e-08
type O 0 6.894399717793931e-08
mutations O 0 1.5992451807278485e-08
, O 0 1.79714276793419e-09
may O 0 3.3076414496235884e-08
cause O 0 2.156802338504349e-06
pathological O 1 0.9974811673164368
ARSA O 1 0.9583101272583008
and O 0 1.4742796565769822e-06
GS O 1 0.9999979734420776
levels O 0 3.952349288738333e-06
, O 0 3.489419864166621e-10
but O 0 1.1756099566051503e-11
not O 0 1.5669522970829242e-12
clinical O 0 1.2159398488087447e-10
outbreak O 0 2.924886374766622e-11
of O 0 1.127649085219673e-10
the O 0 1.227929202762823e-09
disease O 0 4.755106530751618e-08
. O 0 8.711939503136534e-10
. O 0 3.812871085528968e-08

Human O 0 0.003101045498624444
MLH1 O 1 0.9999986886978149
deficiency O 1 0.9999970197677612
predisposes O 0 0.00010871254198718816
to O 0 3.875076970416558e-07
hematological B-Disease 1 0.9999942779541016
malignancy I-Disease 1 0.9999443292617798
and O 0 1.1788000620072125e-06
neurofibromatosis B-Disease 1 0.9999555349349976
type I-Disease 1 0.7982987761497498
1 I-Disease 1 0.9878218770027161
. O 0 2.457019036228303e-06

Heterozygous O 0 8.824717042443808e-06
germ O 0 0.000562345318030566
- O 0 2.8013508313051716e-07
line O 0 7.374984178909472e-09
mutations O 0 1.7104120897393216e-10
in O 0 4.83488457603265e-11
the O 0 2.3389087888681104e-10
DNA O 0 7.393227008378744e-08
mismatch O 0 0.00042520390707068145
repair O 0 0.02316436916589737
genes O 0 1.236169140383936e-07
lead O 0 1.4226372968551004e-07
to O 0 1.0414830597937907e-07
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997453093528748

The O 0 1.0930732230463036e-07
disease O 0 1.9530091321939835e-06
susceptibility O 0 1.0274956707689853e-07
of O 0 4.4642835206332165e-08
individuals O 0 9.142999135569596e-10
who O 0 1.6076096898132164e-08
constitutionally O 0 8.413699106313288e-07
lack O 0 1.4352850996601774e-07
both O 0 1.090298629158326e-09
wild O 0 4.092997329951942e-10
- O 0 4.0248712696033806e-10
type O 0 7.276598767980147e-10
alleles O 0 1.9543802687316258e-10
is O 0 2.141318511394985e-10
unknown O 0 1.2274151117708243e-07
. O 0 9.944839973741182e-08

We O 0 1.1902076124670202e-07
have O 0 2.324228587369248e-10
identified O 0 5.351589171809223e-10
three O 0 4.718958557248243e-11
offspring O 0 4.7435853856026e-11
in O 0 6.048339606934405e-11
a O 0 3.2069444877436126e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9973253011703491
who O 0 1.3891228434204095e-07
developed O 0 5.841262827743776e-05
hematological B-Disease 1 0.9999932050704956
malignancy I-Disease 1 0.9998892545700073
at O 0 7.976042979862541e-05
a O 0 5.6385491831179024e-09
very O 0 1.2638130819642157e-10
early O 0 1.3760025341369442e-09
age O 0 2.140474464340514e-09
, O 0 4.195768038561809e-11
and O 0 2.615697415608853e-11
at O 0 4.953351506742365e-09
least O 0 2.9917020250014303e-11
two O 0 1.2814516808790088e-11
of O 0 1.1825732060266603e-10
them O 0 8.268326127935932e-12
displayed O 0 1.7288854792241182e-09
signs O 0 8.949827545734479e-09
of O 0 7.670617208077601e-08
neurofibromatosis B-Disease 0 0.0006411771173588932
type I-Disease 0 0.00011410584556870162
1 I-Disease 0 0.051234204322099686
( O 0 4.878280890352471e-08
NF1 B-Disease 0 8.701063052285463e-06
) O 0 7.626079678857423e-08
. O 0 3.452818759797083e-07

DNA O 0 1.2723280207183052e-08
sequence O 0 1.2747612965213762e-09
analysis O 0 3.7712069578255125e-10
and O 0 1.8957386008211508e-11
allele O 0 2.1321680532260245e-11
- O 0 2.1279996861856e-11
specific O 0 3.1690396834482826e-12
amplification O 0 7.548332514595302e-10
in O 0 2.3608073829173293e-10
two O 0 9.93213178368535e-10
siblings O 0 1.9001143769514783e-08
revealed O 0 3.0632310910050364e-08
a O 0 2.5070844955621396e-08
homozygous O 0 5.3384031417635924e-08
MLH1 O 0 9.540968676446937e-06
mutation O 0 4.6070645076667915e-09
( O 0 1.968124774265334e-09
C676T O 0 3.3401778409825056e-07
- O 0 1.8077810182148824e-07
- O 0 9.319603577750968e-08
> O 0 4.9678394731245135e-08
Arg226Stop O 0 3.5944745491178764e-07
) O 0 5.733016283926418e-09
. O 0 3.551025429260335e-08

Thus O 0 2.259599227727449e-07
, O 0 2.0461211391875622e-08
a O 0 1.686377437692954e-08
homozygous O 0 2.183580107839589e-07
germ O 0 0.002149332780390978
- O 0 2.7721646347345086e-06
line O 0 3.607083840506675e-07
MLH1 O 0 4.253499355399981e-05
mutation O 0 5.2620854340545975e-09
and O 0 1.5338710301904257e-09
consequent O 0 1.1846946108562406e-05
mismatch O 1 0.9999998807907104
repair O 1 0.9999998807907104
deficiency O 1 0.9999080896377563
results O 0 1.9285323560325196e-07
in O 0 3.999857511871596e-08
a O 0 2.2072590866173414e-08
mutator O 0 8.569458259444218e-06
phenotype O 0 8.521436889452616e-09
characterized O 0 1.9181747301644236e-09
by O 0 3.7337177793972387e-10
leukemia B-Disease 1 0.9999972581863403
and O 0 1.8331016917727538e-06
/ O 1 0.9999992847442627
or O 1 0.9981871247291565
lymphoma B-Disease 1 1.0
associated O 1 0.9980332255363464
with O 0 3.233736265428888e-07
neurofibromatosis B-Disease 1 0.9999970197677612
type I-Disease 1 0.9650694131851196
1 I-Disease 1 0.7643746733665466
. O 0 3.011802718333456e-08
. O 0 8.625836045439428e-08

Missense O 0 4.4004373194184154e-05
mutations O 0 1.4453053154284135e-07
in O 0 3.2644686953631208e-09
the O 0 8.998949918570531e-10
most O 0 5.476113659752535e-11
ancient O 0 2.553353528611524e-09
residues O 0 3.1491801166794176e-08
of O 0 1.0040208664463535e-08
the O 0 9.349440333039638e-09
PAX6 O 0 7.651862688362598e-06
paired O 0 5.915105916187713e-08
domain O 0 4.889580509370717e-07
underlie O 0 1.3070192608211073e-06
a O 0 4.488632132648718e-09
spectrum O 0 6.798725848966569e-07
of O 0 8.905149115889799e-07
human O 1 0.9999889135360718
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9920611381530762

Mutations O 0 3.1047599691191863e-07
of O 0 3.967746664557126e-08
the O 0 4.545919196630166e-09
human O 0 5.820502124720406e-08
PAX6 O 0 0.0005199234583415091
gene O 0 1.8168122551287524e-05
underlie O 1 0.9993112087249756
aniridia B-Disease 1 1.0
( O 0 0.2932143807411194
congenital B-Disease 1 1.0
absence I-Disease 1 0.9507988095283508
of I-Disease 0 0.010242127813398838
the I-Disease 0 6.023108198860427e-07
iris I-Disease 0 1.8481657662050566e-06
) O 0 1.1294534196792938e-09
, O 0 3.4243571866987565e-10
a O 0 8.482934354958616e-10
rare O 0 1.2195903309475398e-07
dominant O 1 0.9999134540557861
malformation B-Disease 1 1.0
of I-Disease 1 0.9999911785125732
the I-Disease 1 0.996775209903717
eye I-Disease 1 0.9999995231628418
. O 0 2.3273036276805215e-05

The O 0 8.97920671150132e-08
spectrum O 0 1.476387410548341e-06
of O 0 1.1380708286878871e-07
PAX6 O 0 9.81866178335622e-05
mutations O 0 1.253599464234867e-07
in O 0 3.034191564665889e-08
aniridia B-Disease 1 1.0
patients O 0 8.983866450762434e-08
is O 0 4.4751571892653885e-10
highly O 0 1.6184044104861073e-09
biased O 0 5.478582032480972e-10
, O 0 1.2495555805347447e-11
with O 0 5.797975381055531e-12
92 O 0 5.689280158094334e-09
% O 0 2.636073304085329e-10
of O 0 2.7144870795581255e-09
all O 0 1.6877400865755732e-10
reported O 0 7.675936553042106e-10
mutations O 0 8.760123182405266e-11
leading O 0 6.552478559740393e-10
to O 0 9.866456956997283e-11
premature O 0 4.781187001867693e-09
truncation O 0 1.1255759346795458e-07
of O 0 6.919535167071444e-07
the O 0 1.4324572816803993e-07
protein O 0 2.1394311033873237e-07
( O 0 1.3902480278105145e-09
nonsense O 0 8.665343109726109e-09
, O 0 1.3175256718955808e-10
splicing O 0 7.5725881121258e-10
, O 0 5.378683956558383e-11
insertions O 0 1.8058694817302268e-10
and O 0 6.74823460999896e-11
deletions O 0 6.15596518205308e-10
) O 0 1.7319540246418796e-10
and O 0 5.66447111438606e-10
just O 0 3.834185857698458e-09
2 O 0 2.7208436392811564e-08
% O 0 1.7571491484069668e-10
leading O 0 3.3663968834751756e-10
to O 0 7.895020574799627e-12
substitution O 0 1.6488708176609634e-09
of O 0 3.0973009046419975e-08
one O 0 6.534344176856166e-10
amino O 0 2.843781654604527e-09
acid O 0 1.4563785732946144e-09
by O 0 6.833329735389526e-11
another O 0 2.5773490008873523e-09
( O 0 3.5247136320748496e-09
missense O 0 1.304314451999744e-07
) O 0 1.1801994936888605e-08
. O 0 3.030022242000996e-07

The O 0 2.928223175047151e-08
extraordinary O 0 1.1868180216367819e-08
conservation O 0 3.332946141298976e-09
of O 0 4.422533006476215e-09
the O 0 5.132107183669632e-09
PAX6 O 0 1.3449096513795666e-05
protein O 0 1.7089617188048578e-07
at O 0 1.833061560319038e-07
the O 0 4.203606351893541e-09
amino O 0 3.791151925724989e-08
acid O 0 2.617328576093314e-08
level O 0 4.922594030176697e-07
amongst O 0 1.64339599706409e-08
vertebrates O 0 5.6061345787838945e-08
predicts O 0 6.8920700257990575e-09
that O 0 3.763712119742024e-10
pathological O 0 5.8974066632799804e-05
missense O 0 1.2234118003107142e-06
mutations O 0 1.9263076467268547e-08
should O 0 1.6240910838405398e-09
in O 0 3.702627093815636e-10
fact O 0 3.476876841990162e-10
be O 0 6.11494535562862e-11
common O 0 1.9887121116557438e-10
even O 0 3.297947331892814e-11
though O 0 1.636171927110741e-11
they O 0 6.55230947624319e-12
are O 0 4.1896243418992896e-12
hardly O 0 5.911637290800797e-10
ever O 0 1.873249749761996e-10
seen O 0 1.3934124964976036e-09
in O 0 3.0907545411906767e-09
aniridia B-Disease 1 0.9999998807907104
patients O 0 2.664643034222536e-06
. O 0 3.766639338209643e-07

This O 0 1.3549235511334246e-08
indicates O 0 1.2526189863137915e-08
that O 0 9.960336028180805e-11
there O 0 1.6135767721969785e-10
is O 0 5.469057498541652e-11
a O 0 3.22085802473282e-10
heavy O 0 9.267825618053394e-08
ascertainment O 0 3.3338303637719946e-06
bias O 0 1.4237008905126913e-08
in O 0 6.167397148537646e-11
the O 0 3.948549820442793e-11
selection O 0 2.045065783384814e-10
of O 0 1.0668615990638841e-09
patients O 0 2.0679728762740268e-10
for O 0 4.413859278074028e-10
PAX6 O 0 1.7961074263439514e-06
mutation O 0 4.00235133923843e-09
analysis O 0 4.054908853134975e-09
and O 0 1.0066660699470376e-10
that O 0 3.286713609607084e-11
the O 0 6.347852243848706e-10
missing O 0 5.144478336660541e-07
PAX6 O 0 0.0010780873708426952
missense O 0 1.5912748494884e-05
mutations O 0 1.3644600471707236e-07
frequently O 0 3.2898292090521863e-08
may O 0 1.9108505000531295e-08
underlie O 0 5.088123202767747e-07
phenotypes O 0 2.1513326942113054e-07
distinct O 0 2.4301163747963983e-08
from O 0 9.308269000030123e-08
textbook O 0 2.4176044462365098e-05
aniridia B-Disease 1 0.9999995231628418
. O 0 5.228465852269437e-06

Here O 0 8.6683280642319e-07
we O 0 4.090892069541496e-09
present O 0 1.3078519378595388e-09
four O 0 8.603514567440129e-10
novel O 0 1.6992076634636533e-09
PAX6 O 0 1.8875009573093848e-06
missense O 0 5.594255867436004e-07
mutations O 0 2.6009840947693874e-09
, O 0 5.070127651052303e-10
two O 0 1.8070031582162471e-10
in O 0 8.463217349152785e-10
association O 0 9.966155678498012e-10
with O 0 1.122862913760514e-10
atypical O 0 1.2215475635457551e-06
phenotypes O 0 5.017740249968483e-07
ectopia B-Disease 0 1.0078082596010063e-05
pupillae I-Disease 0 4.757674105348997e-06
( O 0 4.898994543367508e-10
displaced B-Disease 0 4.653321061809379e-10
pupils I-Disease 0 7.073522323430836e-10
) O 0 7.704524795926204e-10
and O 0 7.670543311633082e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.015281506814062595
( O 0 2.668787679738216e-08
searching B-Disease 0 2.7592250262387097e-07
gaze I-Disease 0 8.035501082304108e-07
) O 0 3.4515831859316393e-10
, O 0 9.941488604559012e-11
and O 0 3.331760561886554e-11
two O 0 1.0179302539770063e-10
in O 0 5.132290703535602e-10
association O 0 1.7496477877632088e-10
with O 0 4.9931392354096715e-11
more O 0 5.156320370680589e-10
recognizable O 0 2.64239429270674e-06
aniridia B-Disease 1 1.0
phenotypes O 0 1.1451411410234869e-05
. O 0 6.891887665005925e-07

Strikingly O 0 1.6940716704993974e-06
, O 0 4.1796219818479585e-09
all O 0 2.2841874225409953e-10
four O 0 4.719852286783066e-10
mutations O 0 3.0874416911963465e-10
are O 0 1.7881177441503304e-11
located O 0 8.81759221194045e-10
within O 0 4.834158628952423e-10
the O 0 1.5340817505204996e-09
PAX6 O 0 7.396851060548215e-07
paired O 0 3.6260875191374e-08
domain O 0 4.784144991276662e-08
and O 0 1.707055941047031e-09
affect O 0 9.233644959749654e-09
amino O 0 1.4602594688994941e-08
acids O 0 2.4203039572512353e-09
which O 0 4.917912604929242e-11
are O 0 6.144146823261476e-12
highly O 0 1.6573138694742084e-10
conserved O 0 1.6045546002985134e-09
in O 0 4.71489403075509e-10
all O 0 1.8947705904270862e-10
known O 0 2.453139469338339e-09
paired O 0 1.7604721236352816e-08
domain O 0 1.4162102957016032e-07
proteins O 0 6.644711447734153e-08
. O 0 3.02430322562941e-07

Our O 0 5.35846851335009e-08
results O 0 1.6164731775347718e-09
support O 0 5.15052112071146e-10
the O 0 3.535902681761627e-10
hypothesis O 0 1.60514754266039e-10
that O 0 8.837952071572008e-13
the O 0 5.556684886526275e-12
under O 0 2.2289518841756006e-10
- O 0 1.4106142642855701e-10
representation O 0 4.54767723478966e-10
of O 0 2.3657051428926934e-08
missense O 0 4.0049692984212015e-07
mutations O 0 8.310680144063554e-09
is O 0 5.978732509070994e-10
caused O 0 1.7989981726529436e-09
by O 0 3.661514980102254e-10
ascertainment O 0 0.0001690127101028338
bias O 0 1.3609422921945225e-06
and O 0 2.063348381042829e-09
suggest O 0 7.652503630772856e-10
that O 0 7.743882791955148e-12
a O 0 4.978626885754345e-11
substantial O 0 4.834020406185857e-10
burden O 0 3.8555356240976835e-08
of O 0 9.701939234219026e-07
PAX6 B-Disease 1 0.9991025924682617
- I-Disease 0 0.0022066975943744183
related I-Disease 0 0.01967894285917282
disease I-Disease 0 0.13813237845897675
remains O 0 1.9457128530575574e-07
to O 0 2.3184064390502357e-10
be O 0 5.023259586067752e-10
uncovered O 0 8.050859179320469e-08
. O 0 8.20855994287939e-10
. O 0 1.3490055295051206e-08

The O 0 4.021774913098852e-08
chromosomal O 0 1.3281591009217664e-06
order O 0 8.439879906063652e-09
of O 0 1.1378765663039303e-07
genes O 0 3.893705624591348e-08
controlling O 0 6.644370387220988e-06
the O 0 1.339207642558904e-07
major O 0 1.90135438060679e-06
histocompatibility O 0 0.05965453386306763
complex O 0 0.0002856532228179276
, O 0 3.0417690588535606e-09
properdin O 0 6.110068540010616e-08
factor O 0 8.486757963055425e-09
B O 0 4.5858902808504354e-07
, O 0 1.1503511476718131e-09
and O 0 1.2614198574567581e-09
deficiency B-Disease 0 0.00043667579302564263
of I-Disease 0 1.0046482202596962e-05
the I-Disease 0 2.86958595552278e-07
second I-Disease 0 2.2805119215263403e-07
component I-Disease 0 1.845434326241957e-06
of I-Disease 0 1.3036606105742976e-06
complement I-Disease 0 1.8352251345277182e-06
. O 0 1.7346191043543513e-06

The O 0 6.283219988745259e-08
relationship O 0 2.893208872478681e-08
of O 0 6.072527813927309e-09
the O 0 1.0871480105034692e-10
genes O 0 7.779946825658968e-12
coding O 0 1.5014686161052282e-09
for O 0 1.7757607884139048e-10
HLA O 0 7.1877139795617495e-09
to O 0 1.037290670025115e-10
those O 0 4.3382467757036025e-11
coding O 0 7.986313832475389e-09
for O 0 6.297515842135226e-10
properdin O 0 3.662266223614097e-08
Factor O 0 3.5681602117421107e-09
B O 0 7.397289181199085e-08
allotypes O 0 7.16625265795301e-08
and O 0 2.6402596775554343e-10
for O 0 3.138139748060098e-09
deficiency B-Disease 0 0.00020601798314601183
of I-Disease 0 1.5799094398971647e-05
the I-Disease 0 2.4179203705898544e-07
second I-Disease 0 8.905423243277255e-08
component I-Disease 0 2.9821813996022684e-07
of I-Disease 0 4.2954056311828026e-07
complement I-Disease 0 1.9946713791796356e-07
( O 0 4.853322188580478e-09
C2 O 0 3.543934212757449e-08
) O 0 7.856418987595148e-11
was O 0 5.636879851778076e-10
studied O 0 3.4468417009492214e-09
in O 0 5.175393100187442e-11
families O 0 6.8028317354307255e-12
of O 0 6.446304046114903e-10
patients O 0 4.7557753291016525e-09
with O 0 7.555728842589815e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.8806218504905701

Patients O 0 5.888630028039188e-08
were O 0 3.1460267724270352e-09
selected O 0 1.1118871795501306e-10
because O 0 6.915672895457803e-11
they O 0 6.370697806096226e-12
were O 0 4.3615770717320146e-11
heterozygous O 0 1.6568586780341121e-10
or O 0 2.787574615581434e-10
homozygous O 0 2.7771600130677143e-08
for O 0 5.465008712235431e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.001380411209538579

12 O 0 1.453890490665799e-06
families O 0 5.521593182677975e-10
with O 0 5.597399765910893e-10
15 O 0 1.6606506392236042e-08
matings O 0 2.1720779841416515e-07
informative O 0 3.855226538007628e-08
for O 0 3.6390656532603316e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 2.997749788846704e-06
found O 0 6.530250828973294e-08
. O 0 4.0924081901039244e-08

Of O 0 1.5468289120690315e-06
57 O 0 8.482180078317469e-07
informative O 0 6.053380019466204e-08
meioses O 0 5.346606144485122e-07
, O 0 6.086497972290772e-10
two O 0 1.1413136408178204e-10
crossovers O 0 6.228696447507787e-10
were O 0 1.2730888565570808e-10
noted O 0 4.2686856827067743e-10
between O 0 3.0937936656982856e-08
the O 0 6.655721449533303e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.0462771093955325e-08
and O 0 1.4318781715871864e-09
the O 0 3.762989031486086e-09
HLA O 0 1.3714969782085973e-07
- O 0 9.238650733323084e-08
B O 0 2.0990934501696756e-07
gene O 0 6.531615248661637e-10
, O 0 7.289917974828697e-11
with O 0 2.3187679207281597e-11
a O 0 1.3069285931255337e-10
recombinant O 0 5.94769025696884e-11
fraction O 0 3.431915862606161e-10
of O 0 1.0146127493726453e-08
0 O 0 1.4895896072175674e-07
. O 0 4.9183796591023565e-08

035 O 0 0.012590168975293636
. O 0 5.544465602724813e-05

A O 0 2.2065114535507746e-06
lod O 0 1.2627690921362955e-05
score O 0 6.659150386667534e-08
of O 0 2.260232179196464e-08
13 O 0 5.778950207258049e-09
was O 0 8.194887546331131e-10
calculated O 0 1.8069547247367979e-10
for O 0 1.5291351518342822e-10
linkage O 0 2.055952109003556e-06
between O 1 0.9831299185752869
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.2856470448241453e-06
HLA O 0 3.787491323237191e-06
- O 0 4.353634039944154e-07
B O 0 6.283477773649793e-07
at O 0 2.9489221731182624e-08
a O 0 1.5622923787983467e-10
maximum O 0 2.1455867638131565e-10
likelihood O 0 2.601512408273443e-11
value O 0 4.281730525690364e-11
of O 0 4.6570299699899564e-11
the O 0 9.068327685990418e-12
recombinant O 0 1.778573295585506e-11
fraction O 0 2.021424971854202e-10
of O 0 7.52484408117482e-10
0 O 0 2.610353710963409e-08
. O 0 4.241760720447019e-08

04 O 0 0.003569961292669177
. O 0 8.626603084849194e-05

18 O 0 1.730617100292875e-06
families O 0 1.1052990744886415e-09
with O 0 8.31905044851311e-10
21 O 0 2.7269273061847343e-08
informative O 0 2.054477254986864e-09
matings O 0 7.409372670963421e-09
for O 0 1.53137960645644e-10
both O 0 2.671392551611973e-10
properdin O 0 3.2416931361467505e-08
Factor O 0 3.2497826651933792e-09
B O 0 6.773570504492454e-08
allotype O 0 4.4673583943222184e-08
and O 0 1.3269485510392087e-09
HLA O 0 1.1989362747044652e-07
- O 0 2.0835054215240234e-07
B O 0 1.5540963431703858e-06
were O 0 3.747882448834616e-09
found O 0 2.6503370609276544e-09
. O 0 1.0643926628972622e-08

Of O 0 3.1137494715949288e-06
72 O 0 2.6658021852199454e-06
informative O 0 1.9608312129548722e-07
meioses O 0 1.1932891084143193e-06
, O 0 1.579039676791183e-09
three O 0 3.795322667254908e-10
recombinants O 0 4.5216133059966523e-08
were O 0 1.0905710778885691e-09
found O 0 2.522642372770889e-10
, O 0 1.456079874728733e-11
giving O 0 3.890514993498684e-11
a O 0 4.951485749193907e-11
recombinant O 0 4.273484066619204e-10
fraction O 0 1.4510161960856749e-09
of O 0 4.383894491866158e-08
0 O 0 3.215957349311793e-07
. O 0 9.359934693975447e-08

042 O 0 0.0017653778195381165
. O 0 3.8923051761230454e-05

A O 0 1.8026626094069798e-06
lod O 0 1.817347583710216e-05
score O 0 1.5185374024895282e-07
of O 0 6.155195819701476e-08
16 O 0 1.090289245553322e-07
between O 0 6.024055210218648e-08
HLA O 0 1.7294890142238728e-07
- O 0 4.7781810508240596e-08
B O 0 4.2306186998075646e-08
and O 0 2.0832065239506647e-10
Factor O 0 7.943560254020099e-10
B O 0 4.477483983578168e-08
allotypes O 0 4.857936630742188e-08
was O 0 3.167885864741038e-08
calculated O 0 1.1990822557095271e-08
at O 0 7.010639180293765e-09
a O 0 3.3783481567795093e-10
maximum O 0 5.261450164439907e-10
likelihood O 0 1.9028686959465801e-10
value O 0 1.7123247264549946e-10
of O 0 2.671280419086486e-10
the O 0 3.370648551936917e-11
recombinant O 0 9.521129024081532e-11
fraction O 0 7.043459704370036e-10
of O 0 3.1247726628436112e-09
0 O 0 1.1535468757983836e-07
. O 0 6.270003183317385e-08

04 O 0 0.002738424576818943
. O 0 6.732174369972199e-05

A O 0 5.617629881271569e-07
crossover O 0 6.422929743621353e-08
was O 0 6.725936430029833e-08
shown O 0 1.003021221634981e-09
to O 0 6.97688296025234e-11
have O 0 1.2142033038731181e-11
occurred O 0 6.086439685581979e-10
between O 0 9.167459846803894e-11
genes O 0 4.123946410056201e-12
for O 0 2.8678436361784243e-11
Factor O 0 5.979337025507903e-10
B O 0 6.080516357087618e-08
and O 0 3.099840384379604e-09
HLA O 0 1.0882656908961508e-07
- O 0 1.8270473844950175e-07
D O 0 5.791675903310534e-07
, O 0 9.434560910293044e-10
in O 0 4.1930342531415477e-10
which O 0 3.3139152533223637e-10
HLA O 0 1.560105999942607e-07
- O 0 7.675906203985505e-07
D O 0 5.14653265781817e-06
segregared O 0 3.6172295949654654e-06
with O 0 9.828339031514588e-09
HLA O 0 1.0757643394754268e-05
- O 0 1.3931414741819026e-06
A O 0 1.7019483777858113e-07
and O 0 8.993738198626033e-09
B O 0 2.0577333998517133e-05
. O 0 1.468512209612527e-07

These O 0 4.233740025227917e-09
studies O 0 2.310263313987093e-09
suggest O 0 1.6146635417602084e-10
that O 0 9.915988386302588e-13
the O 0 5.433868632831462e-12
genes O 0 5.146293113877931e-12
for O 0 1.0054604718257032e-11
Factor O 0 2.120748687772789e-09
B O 0 1.1410160368541256e-05
and O 0 2.9346783776418306e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.4296242229791005e-09
located O 0 5.031787431164503e-09
outside O 0 3.8030782967268806e-09
those O 0 6.538168617620244e-11
for O 0 2.553819933304169e-10
HLA O 0 3.700322181998672e-08
, O 0 2.439290158751106e-10
that O 0 6.234965668761028e-12
the O 0 1.3006712894225725e-11
order O 0 2.998340117854603e-11
of O 0 1.5886795212693983e-09
genese O 0 2.3325000597651524e-08
is O 0 2.3534521553791876e-10
HLA O 0 2.9044825211599345e-08
- O 0 4.2786268750205636e-08
A O 0 1.465308656634079e-07
, O 0 5.87841164634284e-10
- O 0 1.82896009448541e-09
B O 0 4.081868709704395e-08
, O 0 3.088784783500387e-10
- O 0 1.6558866500204772e-09
D O 0 1.017610973264027e-08
, O 0 5.6184359248367954e-11
Factor O 0 1.988546216580289e-09
B O 0 2.453726665407885e-06
allotype O 0 0.00012583711941260844
, O 0 5.282348411128623e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 9.7682684163658e-10
that O 0 7.789583214568019e-12
the O 0 4.187821270318359e-11
genes O 0 1.2320058861980954e-10
coding O 0 8.43402645500646e-08
for O 0 1.6235428290656273e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 8.463222123111791e-09
Factor O 0 1.128786397686099e-08
B O 0 1.0261913274689505e-07
allotypes O 0 3.569829587490858e-08
are O 0 2.0076107443145474e-11
approximately O 0 6.236217792165988e-11
3 O 0 1.6827844673272807e-09
- O 0 7.78794251310444e-10
- O 0 3.6584432705488723e-10
5 O 0 8.006977303409712e-10
centimorgans O 0 4.522973995335633e-09
from O 0 6.410268982293132e-10
the O 0 9.601026640382315e-10
HLA O 0 2.3857969821960978e-08
- O 0 1.0036953490555334e-08
A O 0 9.683644108804401e-09
and O 0 4.0677661239385543e-10
HLA O 0 2.3444357566404506e-08
- O 0 1.88928730437965e-08
B O 0 3.565250139558884e-08
loci O 0 8.151426200697642e-10
, O 0 8.101016385486659e-11
and O 0 2.2108034153367484e-11
that O 0 4.1743015294359864e-12
the O 0 3.265225242965464e-11
apparent O 0 4.9650523692434945e-09
lack O 0 1.7975334554165556e-09
of O 0 2.9297804182704112e-09
recombinants O 0 9.108123144585534e-09
between O 0 5.635353295119216e-10
the O 0 7.073113622579896e-11
Factor O 0 8.08165312449205e-10
B O 0 1.0073704004298634e-07
gene O 0 5.093473021133832e-08
and O 0 1.6608080386504298e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.2832111881143646e-06
suggests O 0 7.756847253403976e-08
that O 0 5.390196622379051e-11
these O 0 3.3685276790151875e-11
two O 0 1.0143292455966346e-10
genes O 0 1.8384593847287078e-09
lie O 0 7.294531911838931e-08
in O 0 1.7178933831019094e-09
close O 0 6.946127939500002e-08
proximity O 0 1.0163233810089878e-07
to O 0 2.9404956247702785e-09
one O 0 6.306630329078189e-09
another O 0 2.4581428448300358e-08
. O 0 2.7653973688757105e-07

Distribution O 0 1.1868909410850392e-07
of O 0 4.60911508071149e-07
emerin O 0 1.3425324141280726e-05
and O 0 1.5215171345062117e-08
lamins O 0 9.149668585450854e-06
in O 0 3.359432731997458e-09
the O 0 4.9402646418172935e-09
heart O 0 1.1748225006158464e-06
and O 0 1.3116091546194752e-09
implications O 0 7.677584079601729e-08
for O 0 4.7853134788056195e-08
Emery B-Disease 1 0.9999855756759644
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.05248267576098442

Emerin O 0 0.00010619711974868551
is O 0 7.042014971148092e-08
a O 0 7.499460963344973e-08
nuclear O 0 1.7807860785978846e-06
membrane O 0 2.7838687799430772e-08
protein O 0 1.103812241609603e-08
which O 0 9.428080538498307e-11
is O 0 1.1182762355010922e-10
missing O 0 9.2798320139309e-09
or O 0 3.9419316699707e-09
defective O 0 5.6059857342916075e-06
in O 0 1.2131938831316802e-07
Emery B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5338764190673828
EDMD B-Disease 1 1.0
) O 0 3.763429390346573e-07
. O 0 1.534571794081785e-07

It O 0 3.3569282908985087e-09
is O 0 1.0369806124899128e-09
one O 0 3.821623920097217e-11
member O 0 6.073880287615907e-10
of O 0 1.1476911865315742e-08
a O 0 1.1025707458145462e-08
family O 0 3.3501674767677514e-09
of O 0 9.746018037048998e-08
lamina O 0 0.00014262455806601793
- O 0 2.5992305836552987e-06
associated O 0 9.072531526044258e-08
proteins O 0 7.866664542000024e-10
which O 0 1.6712747852309917e-10
includes O 0 5.232567712454284e-10
LAP1 O 0 1.1937171393583412e-06
, O 0 1.4475386445056415e-09
LAP2 O 0 1.9014613599210861e-06
and O 0 2.4229981576695536e-08
lamin O 0 1.4476586329692509e-05
B O 0 9.555958058626857e-06
receptor O 0 2.0420398527676298e-07
( O 0 2.007531918479799e-07
LBR O 0 1.162888111139182e-05
) O 0 6.860425827426297e-08
. O 0 4.195518670258025e-07

A O 0 2.384538220212562e-06
panel O 0 6.002150030326447e-07
of O 0 6.275339359262944e-08
16 O 0 4.5906290324637666e-08
monoclonal O 0 1.0915512937970107e-09
antibodies O 0 1.6576680306190639e-10
( O 0 9.511841314591152e-10
mAbs O 0 9.811968126882675e-09
) O 0 3.037228246682844e-10
has O 0 5.895172544567728e-11
been O 0 2.639165795625953e-11
mapped O 0 5.975275829683824e-11
to O 0 1.3988327857150651e-11
six O 0 1.5016104679133058e-11
specific O 0 1.764900552092552e-11
sites O 0 4.0143041668549984e-11
throughout O 0 3.12018522130586e-10
the O 0 5.247819956366584e-10
emerin O 0 2.4764917228026206e-08
molecule O 0 1.3337920767853007e-09
using O 0 1.9769852421802625e-09
phage O 0 8.998610745436508e-09
- O 0 1.0390673876869982e-09
displayed O 0 1.887719536242116e-09
peptide O 0 7.471185892171661e-10
libraries O 0 9.61816404299043e-10
and O 0 1.2817530370412555e-10
has O 0 1.3757649533485683e-11
been O 0 1.1926026138864287e-11
used O 0 1.3481057416220299e-11
to O 0 2.5966341923866487e-11
localize O 0 1.9896475578207173e-08
emerin O 0 3.8276522218438913e-07
in O 0 2.7845734607012673e-09
human O 0 1.89465332312011e-08
and O 0 4.350881965820008e-08
rabbit O 0 2.4164125989045715e-07
heart O 0 0.0003837740223389119
. O 0 5.566535946854856e-06

Several O 0 5.44487690490314e-08
mAbs O 0 4.2270173139513645e-07
against O 0 7.469622254063779e-09
different O 0 1.0574695563647651e-09
emerin O 0 1.1103967523240499e-07
epitopes O 0 6.657778328644781e-08
did O 0 1.8573085291961888e-09
not O 0 8.813687280007088e-11
recognize O 0 1.61124324993267e-09
intercalated O 0 8.700838094455321e-08
discs O 0 7.608870419062441e-06
in O 0 1.2723570641526294e-08
the O 0 1.2053698483782682e-08
heart O 0 2.851364297384862e-05
, O 0 2.83725709593341e-10
though O 0 4.4536117849158785e-11
they O 0 4.679965182746715e-12
recognized O 0 7.945511609763756e-11
cardiomyocyte O 0 2.6255284168996695e-08
nuclei O 0 5.482034826087556e-09
strongly O 0 8.912449112052911e-10
, O 0 1.1094467011751874e-10
both O 0 1.6065687669097883e-10
at O 0 4.2296743885117394e-08
the O 0 4.263927877445894e-09
rim O 0 2.993875725110229e-08
and O 0 4.0347558627473745e-10
in O 0 2.0058865679573046e-09
intranuclear O 0 2.4536279852327425e-07
spots O 0 4.161685751569166e-08
or O 0 1.753602063558901e-08
channels O 0 6.728181460857741e-07
. O 0 3.2911259495449485e-07

A O 0 3.0452908958977787e-06
polyclonal O 0 4.802329272024508e-07
rabbit O 0 3.453088481819577e-08
antiserum O 0 3.5163895972800674e-07
against O 0 5.2228614322302747e-08
emerin O 0 2.7575936201174045e-06
did O 0 5.084579424163849e-09
recognize O 0 3.291616312850465e-09
both O 0 1.9236154891189017e-09
nuclear O 0 2.1188178322972817e-07
membrane O 0 4.6413388687938095e-09
and O 0 2.0271045952924283e-10
intercalated O 0 6.845312316983154e-09
discs O 0 3.0580181942241325e-08
but O 0 6.20560478004073e-11
, O 0 9.102326531396088e-12
after O 0 5.553699514160293e-11
affinity O 0 1.7690805764747353e-10
purification O 0 3.385496993857373e-09
against O 0 2.0334138817190706e-09
a O 0 1.7787005202052342e-09
pure O 0 1.430603333574254e-07
- O 0 6.554781606382676e-09
emerin O 0 5.006812742180955e-08
band O 0 1.4848232865460886e-08
on O 0 6.703190535972681e-08
a O 0 4.967363409491554e-09
western O 0 4.0305736526136116e-09
blot O 0 4.916316242997709e-08
, O 0 2.317035868726336e-10
it O 0 3.6611359777172225e-11
stained O 0 6.519970696672317e-08
only O 0 1.57774515674447e-09
the O 0 1.1769534680183824e-08
nuclear O 0 4.468433871807065e-06
membrane O 0 3.566393615983543e-07
. O 0 1.1809441247123686e-07

These O 0 4.663630370771443e-09
results O 0 3.0667197670197766e-09
would O 0 2.446577662684746e-10
not O 0 1.9862320121966093e-11
be O 0 1.1382194665954248e-11
expected O 0 8.43140904316364e-11
if O 0 6.303906702198603e-11
immunostaining O 0 1.746352218390257e-08
at O 0 2.72071396523188e-08
intercalated O 0 6.473256064509769e-08
discs O 0 3.898164777638158e-07
were O 0 2.433399037826689e-09
due O 0 5.485182974496183e-09
to O 0 1.7750090286483555e-10
a O 0 2.115116554124441e-10
product O 0 5.533292921078292e-11
of O 0 1.4989106622564918e-09
the O 0 7.776393973202289e-10
emerin O 0 9.847087767411722e-08
gene O 0 4.729774349954141e-10
and O 0 4.0648964749756544e-10
, O 0 1.169830760039403e-10
therefore O 0 6.087345072458561e-10
, O 0 9.804138056956901e-11
cast O 0 7.384707290114534e-10
some O 0 4.842359846435329e-11
doubt O 0 4.624123306484762e-10
upon O 0 8.181452043620752e-11
the O 0 1.3792074426977052e-10
hypothesis O 0 1.846316655118585e-09
that O 0 2.0625801067097882e-10
cardiac B-Disease 0 0.30833154916763306
defects I-Disease 0 0.04945968836545944
in O 0 4.36035452366923e-06
EDMD B-Disease 1 1.0
are O 0 8.705897336369617e-09
caused O 0 3.611384524759842e-09
by O 0 2.7841406263773294e-11
absence O 0 1.4017087046624965e-08
of O 0 4.685047727548408e-08
emerin O 0 1.376450313728128e-06
from O 0 1.8970037984900046e-08
intercalated O 0 2.2328658815240487e-06
discs O 0 0.00030323289684019983
. O 0 8.08348545433546e-07

Although O 0 8.758398450936511e-08
emerin O 0 1.0738933724496746e-06
was O 0 4.518389218333141e-08
abundant O 0 1.0814219519872381e-09
in O 0 1.5430283439865633e-10
the O 0 7.065240059667133e-11
membranes O 0 8.48173753453807e-10
of O 0 5.138355962941432e-09
cardiomyocyte O 0 5.1301327630426385e-08
nuclei O 0 3.0625111335780275e-09
, O 0 5.191053142894475e-11
it O 0 4.9665224190198476e-12
was O 0 1.4467934628115131e-09
absent O 0 2.2153687773140973e-09
from O 0 2.311006941368987e-10
many O 0 2.0785697815717263e-11
non O 0 3.651970459372933e-08
- O 0 5.2616766055280095e-08
myocyte O 0 1.1378140243323287e-06
cells O 0 1.4845819018560746e-09
in O 0 1.7830585896660978e-09
the O 0 1.6754032827748233e-08
heart O 0 0.00016633383347652853
. O 0 1.745195504554431e-06

This O 0 1.588040254851819e-09
distribution O 0 1.234523949733557e-08
of O 0 1.8926053613199656e-08
emerin O 0 3.432587902807427e-07
was O 0 1.535265070629066e-08
similar O 0 4.06888134296679e-11
to O 0 2.419530895081401e-11
that O 0 1.4378292827188499e-11
of O 0 1.0647581483169688e-08
lamin O 0 1.0332594229112146e-06
A O 0 6.407879027392482e-08
, O 0 4.2318570869781524e-10
a O 0 2.641569463168736e-10
candidate O 0 2.338426952075423e-10
gene O 0 5.371469380399674e-10
for O 0 4.777045981008143e-10
an O 0 4.89914386836432e-10
autosomal O 0 1.2959874311491149e-06
form O 0 3.2501347391189483e-07
of O 1 0.931581974029541
EDMD B-Disease 1 1.0
. O 0 0.0002902626583818346

In O 0 1.2418632877597702e-07
contrast O 0 3.509772739107575e-07
, O 0 8.337801915558885e-08
lamin O 0 5.951848652330227e-05
B1 O 0 0.0001979753142222762
was O 0 4.7014927986310795e-06
absent O 0 1.020228637571563e-06
from O 0 1.2469147492311095e-08
cardiomyocyte O 0 4.295626752082171e-07
nuclei O 0 8.098649573184957e-08
, O 0 4.3915809877503875e-10
showing O 0 2.8605970925354995e-09
that O 0 9.024630487353136e-10
lamin O 0 2.678418923096615e-06
B1 O 0 1.8220029005533434e-06
is O 0 9.152940211309968e-11
not O 0 9.814461743307135e-12
essential O 0 6.571753696782423e-10
for O 0 6.263922713856118e-11
localization O 0 4.626218981229613e-07
of O 0 4.0535343970304893e-08
emerin O 0 4.724874145267677e-07
to O 0 2.0947543699634252e-09
the O 0 1.857592835108335e-08
nuclear O 0 4.341367912275018e-06
lamina O 0 9.536819561617449e-06
. O 0 3.571665843082883e-07

Lamin O 1 0.5920566916465759
B1 O 0 0.011366927064955235
is O 0 1.9924730310094674e-08
also O 0 6.704055088846417e-10
almost O 0 2.1407806638507054e-09
completely O 0 5.6696215722240595e-08
absent O 0 4.761613752179983e-07
from O 0 7.746586305756864e-08
skeletal O 1 0.657503068447113
muscle O 0 0.000146489663165994
nuclei O 0 0.0004414369468577206
. O 0 2.479486965967226e-06

In O 0 9.684420092526125e-07
EDMD B-Disease 1 0.9999997615814209
, O 0 3.743360288410713e-09
the O 0 1.689608175592383e-10
additional O 0 1.6375432954074398e-10
absence O 0 1.8435729387533684e-08
of O 0 6.669624497135374e-08
lamin O 0 0.00010846061923075467
B1 O 0 0.012311629019677639
from O 0 2.172897438867949e-06
heart O 1 0.9999916553497314
and O 0 0.003774543758481741
skeletal O 1 1.0
muscle O 1 0.9999815225601196
nuclei O 1 0.5659382343292236
which O 0 2.743805183058612e-08
already O 0 9.491764707547645e-09
lack O 0 3.0567235853595776e-08
emerin O 0 1.8730467843397491e-07
may O 0 2.1056932586471788e-10
offer O 0 5.709197004044597e-12
an O 0 5.553567046338859e-13
alternative O 0 2.3074733096484223e-11
explanation O 0 1.9471248224878224e-10
of O 0 7.516910982552361e-10
why O 0 2.9378369181820574e-10
these O 0 3.982912610833722e-11
tissues O 0 8.271962559369683e-10
are O 0 1.7741854860253703e-11
particularly O 0 2.2531365662104008e-10
affected O 0 1.38721450992918e-10
. O 0 8.471761070438788e-10
. O 0 3.6665223746013e-08

Genetic O 0 2.1328490618088836e-07
mapping O 0 4.5926174152555177e-07
of O 0 5.5874949111967e-07
the O 0 1.2238967883604346e-07
copper B-Disease 0 0.0014816505135968328
toxicosis I-Disease 0 0.0004221564158797264
locus O 0 4.351039706307347e-08
in O 0 4.605775316690597e-08
Bedlington O 0 9.251148185285274e-06
terriers O 0 8.790092920207826e-07
to O 0 4.3577732533606195e-09
dog O 0 8.006374230262736e-08
chromosome O 0 3.8869757190695964e-08
10 O 0 1.0276952622234603e-08
, O 0 1.1194328797259345e-10
in O 0 1.197202476044268e-10
a O 0 4.429588085219649e-10
region O 0 5.06061370586508e-09
syntenic O 0 4.000048292596148e-08
to O 0 5.19893239570024e-10
human O 0 1.0385982740501731e-08
chromosome O 0 2.856057790268096e-07
region O 0 1.604317390047072e-07
2p13 O 0 2.4823473268043017e-06
- O 0 4.994951723347185e-07
p16 O 0 8.732208129913488e-07
. O 0 2.3270261806374037e-07

Abnormal O 1 0.9999688863754272
hepatic B-Disease 1 0.9999995231628418
copper I-Disease 1 0.9998515844345093
accumulation I-Disease 0 0.00039800527156330645
is O 0 1.246110548080992e-09
recognized O 0 5.545784942384557e-10
as O 0 4.311341006424385e-10
an O 0 1.7057287138300126e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.04134223982691765
man O 0 0.0005641849129460752
, O 0 2.6724438217939905e-09
mouse O 0 5.7236661632487085e-08
, O 0 1.508919567072553e-08
rat O 0 9.893961987472721e-07
and O 0 4.1690423557838585e-08
dog O 0 7.990834092197474e-06
. O 0 6.622076398343779e-07

The O 0 1.3855493818937248e-07
major O 0 6.104535827944346e-07
cause O 0 4.5090491767041385e-06
of O 0 4.223025462124497e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999991655349731
in O 0 0.26777952909469604
man O 1 0.7446081638336182
is O 0 8.597252687536638e-09
a O 0 2.6366944183564556e-08
dysfunctional O 0 3.7987451833032537e-06
ATP7B O 0 0.00011031245958292857
gene O 0 9.082209118105311e-08
, O 0 6.453959588981206e-09
causing O 0 1.0883295544772409e-06
Wilson B-Disease 0 8.111316674330737e-06
disease I-Disease 0 6.798294634791091e-05
( O 0 2.886352135078596e-08
WD B-Disease 0 1.540050834591966e-05
) O 0 1.1469815319742338e-07
. O 0 4.4467097382039356e-07

Mutations O 0 2.409661021829379e-07
in O 0 2.521019304424499e-08
the O 0 1.214522349357594e-08
ATP7B O 0 3.1246840990206692e-06
genes O 0 1.0519132231934236e-09
have O 0 2.783875213685505e-11
also O 0 4.15143440457566e-12
been O 0 3.3031331576199863e-12
demonstrated O 0 1.7653660477900956e-10
in O 0 1.3976174384477957e-10
mouse O 0 1.2638746049731253e-08
and O 0 3.763400258094407e-08
rat O 0 1.6268858189505409e-06
. O 0 1.567592846640764e-07

The O 0 7.013189247118135e-07
ATP7B O 0 4.656249438994564e-05
gene O 0 2.529525389149967e-08
has O 0 3.6642813783238637e-10
been O 0 2.0889598384421504e-10
excluded O 0 5.324567453612872e-10
in O 0 3.961728861634484e-11
the O 0 7.386393580111061e-11
much O 0 4.5684903082765516e-10
rarer O 0 4.3222634360517986e-08
human O 0 3.979243601293092e-08
copper B-Disease 1 0.8999814987182617
overload I-Disease 1 0.9991793036460876
disease O 1 0.9099822044372559
non B-Disease 0 1.427464849257376e-05
- I-Disease 0 5.712502684218634e-07
Indian I-Disease 0 5.388611157286505e-08
childhood I-Disease 0 0.0022031834814697504
cirrhosis I-Disease 1 0.9999068975448608
, O 0 2.2103590069377788e-09
indicating O 0 2.6442185330211032e-08
genetic O 0 6.257709372903264e-08
heterogeneity O 0 4.7154708227026276e-07
. O 0 3.9901394188746053e-07

By O 0 3.440726592529586e-09
investigating O 0 9.686936408570546e-08
the O 0 4.882634296876631e-09
common O 0 2.6943307602778077e-06
autosomal O 1 0.9998255372047424
recessive O 1 0.9999210834503174
copper B-Disease 1 0.9999998807907104
toxicosis I-Disease 1 0.9999997615814209
( O 0 4.991404125576082e-07
CT B-Disease 0 0.0007342781755141914
) O 0 3.0287721219934838e-09
in O 0 1.777578795270074e-08
Bedlington O 0 3.841355282929726e-05
terriers O 0 1.7743086573318578e-06
, O 0 4.171727130408698e-10
we O 0 1.2437638419182662e-10
have O 0 5.269288477771639e-12
identified O 0 1.1833714563813658e-11
a O 0 5.823821893485848e-12
new O 0 2.395248929754068e-12
locus O 0 1.5270044950721484e-10
involved O 0 2.8983992983455664e-09
in O 0 5.692745830288004e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.011609688401222229

We O 0 1.2520987979769416e-07
examined O 0 2.615724667975883e-07
whether O 0 6.71014710462714e-09
the O 0 6.252946604945464e-09
WD B-Disease 0 9.285321311836015e-07
gene O 0 4.526031105456241e-08
ATP7B O 0 1.3313953786564525e-05
was O 0 4.203841115213436e-07
also O 0 8.638638138158683e-10
causative O 0 9.478737794665903e-09
for O 0 1.7039134547758295e-09
CT B-Disease 0 8.454079761577304e-06
by O 0 5.72652147923236e-10
investigating O 0 1.0424052021562602e-07
the O 0 2.0360616304060386e-08
chromosomal O 0 0.00010541208030190319
co O 0 6.965702050365508e-05
- O 0 2.616091251184116e-06
localization O 0 0.009066738188266754
of O 0 8.41474684420973e-06
ATP7B O 0 5.3097559430170804e-05
and O 0 3.807084425488938e-09
C04107 O 0 2.647726304871867e-08
, O 0 2.7921600795344226e-11
using O 0 2.316999543616749e-11
fluorescence O 0 5.910126832375795e-10
in O 0 4.513543983009072e-10
situ O 0 8.316391841844961e-08
hybridization O 0 7.57159490660797e-09
( O 0 1.5712193768280258e-09
FISH O 0 1.591397591482746e-08
) O 0 1.5466091740634624e-09
. O 0 2.4925039809886584e-08

C04107 O 0 2.858900734281633e-05
is O 0 1.3732711856562219e-08
an O 0 1.19546883503574e-09
anonymous O 0 1.660745674314512e-08
microsatellite O 0 9.055983127836953e-07
marker O 0 7.659708671781118e-07
closely O 0 6.832387953181751e-07
linked O 0 1.6256807384706917e-06
to O 0 1.0436824737780626e-07
CT B-Disease 1 0.9996484518051147
. O 0 1.1024551895388868e-05

However O 0 8.872123089531669e-07
, O 0 9.297446013079025e-08
BAC O 0 3.161778295179829e-05
clones O 0 1.067210142480235e-08
containing O 0 1.815834926865989e-09
ATP7B O 0 1.4756849395780591e-06
and O 0 3.0139732931644403e-09
C04107 O 0 5.60196582455319e-08
mapped O 0 5.495665256205484e-09
to O 0 7.207368590833596e-10
the O 0 4.982564583144722e-09
canine O 0 5.1440662218738e-07
chromosome O 0 2.589173675460188e-07
regions O 0 1.9062454725826683e-08
CFA22q11 O 0 6.781312436032749e-07
and O 0 1.5974853662115152e-09
CFA10q26 O 0 1.1450022441295005e-07
, O 0 1.793577092401577e-10
respectively O 0 1.3784243746428615e-09
, O 0 5.4869667837076364e-11
demonstrating O 0 2.3644497471053683e-09
that O 0 3.575250373533123e-10
WD B-Disease 0 1.1990300663455855e-07
cannot O 0 1.979033825705301e-09
be O 0 5.208122821898087e-10
homologous O 0 3.864545128351438e-09
to O 0 4.149722787616383e-09
CT B-Disease 0 0.00046234854380600154
. O 0 4.61944296148431e-07

The O 0 2.1234147880022647e-06
copper O 0 5.759917257819325e-05
transport O 0 5.207384106142854e-07
genes O 0 3.6672638259460655e-08
CTR1 O 0 4.44120178144658e-06
and O 0 1.2558096784687223e-09
CTR2 O 0 2.2452745724876877e-06
were O 0 1.557740714197564e-09
also O 0 2.6488736551422143e-11
excluded O 0 9.461768174512386e-11
as O 0 3.562179370919516e-11
candidate O 0 7.189639855686991e-11
genes O 0 3.7629278165640656e-11
for O 0 4.199781633573707e-10
CT B-Disease 0 7.222758540592622e-06
since O 0 7.835954107804355e-09
they O 0 1.10757771010217e-10
both O 0 1.2982180608300808e-10
mapped O 0 2.3492465750507563e-09
to O 0 1.683118200368483e-09
canine O 0 1.456482891626365e-06
chromosome O 0 1.6845438040036242e-06
region O 0 7.554963872280496e-07
CFA11q22 O 0 8.973784861154854e-05
. O 0 1.3628723536385223e-06

2 O 0 0.000528884818777442
- O 0 2.569179741840344e-05
22 O 0 5.11926191393286e-06
. O 0 5.12804945174139e-07

5 O 0 0.00014635744446422905
. O 0 1.1326508683850989e-05

A O 0 6.278991122599109e-07
transcribed O 0 7.128313939119835e-08
sequence O 0 8.519551286667593e-09
identified O 0 2.480527561132817e-09
from O 0 5.357839727437863e-10
the O 0 9.516177845725338e-10
C04107 O 0 4.701447053889751e-08
- O 0 5.360091481776408e-09
containing O 0 1.6748497033702847e-09
BAC O 0 6.56471411275561e-06
was O 0 6.354787274176488e-08
found O 0 4.701030120735084e-10
to O 0 2.467637726100147e-11
be O 0 3.719003577318247e-11
homologous O 0 6.297876664618229e-10
to O 0 1.502980795375919e-10
a O 0 5.224111143675714e-10
gene O 0 2.3776811075570947e-10
expressed O 0 5.672709524340291e-10
from O 0 1.414189765291951e-09
human O 0 2.5806445869136496e-09
chromosome O 0 3.826552941177397e-08
2p13 O 0 1.5836211275654932e-07
- O 0 1.517650716209573e-08
p16 O 0 1.2097228996310605e-08
, O 0 2.397719522928554e-10
a O 0 2.4649671193088807e-10
region O 0 2.187555248056583e-09
devoid O 0 4.652473251098854e-08
of O 0 1.405485394734285e-09
any O 0 3.363598566341608e-10
positional O 0 3.130836034870299e-07
candidate O 0 4.129692854348832e-08
genes O 0 2.4460481640176113e-08
. O 0 1.632238166848765e-07

Molecular O 0 2.8240467031537264e-07
analysis O 0 1.4425038941112689e-08
of O 0 7.415254632547885e-09
the O 0 1.9685830743298993e-09
APC B-Disease 0 5.51149481609059e-09
gene O 0 9.745898532642627e-10
in O 0 1.030012297675853e-09
205 O 0 2.518211417168459e-09
families O 0 4.094580230429301e-11
: O 0 2.9671751167192895e-11
extended O 0 1.1841809754997712e-09
genotype O 0 1.4533712011655098e-08
- O 0 1.8259703082890155e-08
phenotype O 0 1.0036814712677256e-09
correlations O 0 1.935068283387409e-08
in O 0 6.839566690786114e-10
FAP B-Disease 0 3.0807374429286938e-09
and O 0 5.849352252562667e-11
evidence O 0 7.216447439617468e-10
for O 0 8.705801704533833e-12
the O 0 3.84794800190047e-11
role O 0 1.5291096167047158e-09
of O 0 1.4925643654351006e-07
APC B-Disease 0 5.908509024266095e-07
amino O 0 2.8931435736012645e-07
acid O 0 2.984502884828544e-07
changes O 0 1.0021270924198689e-07
in O 1 0.7948148846626282
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.999998927116394
. O 0 0.00013848775415681303

BACKGROUND O 0 1.5748702935525216e-05
/ O 0 6.623737363042892e-07
AIMS O 0 1.3734021031552857e-08
The O 0 2.8253224759744455e-10
development O 0 1.555511808248866e-08
of O 0 0.007447340060025454
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.097734512877651e-07
a O 0 5.8173252881488224e-09
variable O 0 7.167616722369985e-09
range O 0 4.230398698013005e-09
of O 0 1.4448519047860486e-09
extracolonic O 0 2.9136887746972207e-07
manifestations O 0 6.519823728012852e-06
in O 0 6.288702934398316e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
( O 0 4.80054382023809e-07
FAP B-Disease 0 8.260161621365114e-08
) O 0 8.760462355539289e-10
is O 0 6.654214679269188e-11
the O 0 3.7367008792754675e-11
result O 0 1.946541816622016e-10
of O 0 1.385623282779136e-09
the O 0 7.238614707638646e-10
dominant O 0 6.262199008233438e-07
inheritance O 0 2.7435100946604507e-06
of O 0 0.0004792885738424957
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999884366989136
coli I-Disease 1 0.9999040365219116
( O 0 4.796626029701656e-08
APC B-Disease 0 3.7182823575676593e-07
) O 0 2.563470680172486e-08
gene O 0 4.922264906781493e-07
mutations O 0 1.9467183847154956e-06
. O 0 1.2749803772749146e-06

In O 0 4.669201913998222e-09
this O 0 5.235450267759845e-11
study O 0 6.27163321276214e-11
, O 0 2.5939649733741632e-12
direct O 0 4.4960628102497235e-12
mutation O 0 2.325122082716402e-12
analysis O 0 9.255499838767278e-11
of O 0 1.0969234409685669e-09
the O 0 1.412372885312152e-09
APC B-Disease 0 1.2096790236171273e-08
gene O 0 4.015878296570463e-09
was O 0 6.519609740962551e-08
performed O 0 1.1031870528199761e-08
to O 0 2.91540819263858e-10
determine O 0 5.563589411394787e-08
genotype O 0 1.4999386621639132e-07
- O 0 6.438727950808243e-08
phenotype O 0 8.75872885330864e-09
correlations O 0 7.597797235803228e-08
for O 0 1.713808983616616e-09
nine O 0 1.8472476881470357e-08
extracolonic O 0 4.5602376985698356e-07
manifestations O 0 3.963685344388068e-07
and O 0 7.489219244760648e-10
to O 0 3.1452795229425234e-11
investigate O 0 4.438366896231116e-10
the O 0 8.088757441626626e-11
incidence O 0 1.5231002237214852e-07
of O 0 5.00953518667302e-08
APC B-Disease 0 1.0448535192608688e-07
mutations O 0 1.4945065629490273e-08
in O 0 2.0352540985868472e-08
non O 1 0.9999600648880005
- O 1 0.9999998807907104
FAP O 1 0.9999997615814209
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6015140414237976

METHODS O 0 2.274144890179741e-06
The O 0 5.8030430238886765e-08
APC B-Disease 0 4.105417517052956e-08
gene O 0 1.163232621337329e-08
was O 0 1.8531480350247875e-08
analysed O 0 7.604303853270267e-09
in O 0 4.810868925453349e-10
190 O 0 5.052136486938252e-09
unrelated O 0 7.611864027978754e-09
FAP B-Disease 0 5.066727037927876e-09
and O 0 4.608310399945026e-10
15 O 0 8.217293157031236e-08
non O 0 0.30088332295417786
- O 1 0.9999845027923584
FAP O 1 0.999998927116394
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.694025043747388e-06
using O 0 4.200258629794007e-08
denaturing O 0 5.705453531845706e-06
gradient O 0 1.7260008178254793e-07
gel O 0 2.147276347841398e-07
electrophoresis O 0 7.818311331675432e-08
, O 0 4.693181954174008e-10
the O 0 8.472197943198978e-10
protein O 0 1.9237291759566233e-09
truncation O 0 1.126085447111791e-08
test O 0 9.004942347345946e-10
, O 0 3.019402089465828e-11
and O 0 1.1553987801227183e-11
direct O 0 3.048103991432072e-10
sequencing O 0 4.979885392941696e-09
. O 0 7.12139680558721e-08

RESULTS O 0 1.955752850335557e-06
Chain O 0 4.844806653636624e-07
terminating O 0 9.178126703091039e-08
signals O 0 2.1804247296586254e-08
were O 0 6.44487740952826e-10
only O 0 1.4496702449573462e-11
identified O 0 8.432646941836097e-11
in O 0 4.558904295737243e-11
patients O 0 1.7194595747227481e-10
belonging O 0 2.804811938261764e-10
to O 0 4.6893586236329554e-11
the O 0 7.435644877595848e-10
FAP B-Disease 0 1.822094652936812e-08
group O 0 6.8396484032007265e-09
( O 0 1.5471165459857161e-09
105 O 0 2.8452106448639825e-07
patients O 0 3.223940581165152e-08
) O 0 8.748677338132893e-09
. O 0 3.0674561912746867e-07

Amino O 0 2.3236754032041063e-07
acid O 0 1.0524014548707328e-08
changes O 0 9.468866801753961e-10
were O 0 2.345757477151267e-10
identified O 0 1.0897285157573933e-10
in O 0 4.035230830035097e-11
four O 0 1.352639528162669e-10
patients O 0 1.7282185404976502e-10
, O 0 4.4263852999604225e-11
three O 0 3.597893094564597e-10
of O 0 2.501115204722737e-06
whom O 0 2.563769839980523e-06
belonged O 0 3.271343666710891e-05
to O 0 6.374107353046554e-10
the O 0 8.006523444237246e-09
non O 0 1.493833951826673e-05
- O 0 3.4065769227709097e-07
FAP O 0 1.4200505660255658e-08
group O 0 1.888336242927835e-08
of O 1 0.9999908208847046
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 0 7.131788152037188e-05

Genotype O 0 2.460422365402337e-05
- O 0 8.120077836792916e-06
phenotype O 0 3.788629143741673e-08
correlations O 0 1.3634570450449246e-07
identified O 0 8.683045393809152e-09
significant O 0 3.1593401228491302e-09
differences O 0 1.1729368054602674e-07
in O 0 1.575201191705844e-09
the O 0 6.363575222323448e-10
nature O 0 1.0553075080466101e-09
of O 0 1.2153305029016792e-09
certain O 0 2.717241709415674e-10
extracolonic O 0 3.034654483258237e-08
manifestations O 0 1.2082240097299746e-08
in O 0 9.714163917706742e-10
FAP B-Disease 0 2.8751925285064317e-08
patients O 0 2.857243552867317e-09
belonging O 0 7.77003794638631e-09
to O 0 1.5041717871255855e-09
three O 0 8.231423542781613e-09
mutation O 0 1.0904889080620705e-07
subgroups O 0 2.658923904164112e-06
. O 0 1.733937665449048e-06

CONCLUSIONS O 0 9.137748975263094e-07
Extended O 0 3.5140294585289666e-07
genotype O 0 3.037478109035874e-07
- O 0 8.410989238427646e-08
phenotype O 0 3.1722555693391996e-09
correlations O 0 3.717420327120635e-08
made O 0 1.413553385454236e-09
in O 0 1.3138969079395935e-10
this O 0 7.1450974477305085e-12
study O 0 1.5654304241774497e-10
may O 0 8.802044509925722e-11
have O 0 3.86387579917602e-12
the O 0 1.5380294260403105e-11
potential O 0 3.1371193837115285e-11
to O 0 7.474456817369024e-12
determine O 0 3.5863417791048846e-10
the O 0 2.6605349867647732e-11
most O 0 1.7594211677851579e-12
appropriate O 0 2.966586698516238e-11
surveillance O 0 2.188840664274494e-09
and O 0 6.18772255656097e-11
prophylactic O 0 6.490019899274557e-08
treatment O 0 1.341789523934267e-08
regimens O 0 2.4771294349079653e-08
for O 0 1.7075565961199857e-10
those O 0 1.0698381763818432e-10
patients O 0 5.058208296659927e-10
with O 0 4.120009541863645e-11
mutations O 0 2.1475980993557187e-09
associated O 0 5.230587163396194e-08
with O 0 2.2386243969663155e-09
life O 0 1.2837015219702153e-06
threatening O 0 7.721154133832897e-07
conditions O 0 8.800194336799905e-06
. O 0 5.642704650199448e-07

This O 0 6.025191012781761e-09
study O 0 3.4935103698785497e-09
also O 0 8.622698388638383e-11
provided O 0 6.582940442756424e-11
evidence O 0 1.5982920542612078e-10
for O 0 1.024169464514113e-11
the O 0 1.1264366522878433e-10
pathological O 0 3.476612255326472e-05
nature O 0 1.7074084368573494e-08
of O 0 2.5527512548251252e-08
amino O 0 2.272808075076682e-08
acid O 0 8.65127258720122e-09
changes O 0 1.159050633248171e-09
in O 0 1.1196128468782263e-09
APC O 0 7.314201244668084e-09
associated O 0 5.777077038970901e-09
with O 0 6.220370746268244e-11
both O 0 3.3237140817377053e-10
FAP B-Disease 0 8.714569510459569e-09
and O 0 7.1906760545914494e-09
non O 1 0.9999983310699463
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9970460534095764
. O 0 2.0970065861547482e-07
. O 0 5.747432396674412e-07

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999991655349731
and O 0 2.5781824660953134e-05
cancer B-Disease 1 0.9991183876991272
risk O 0 8.788946615823079e-06
of O 0 1.8518744582252111e-06
the O 0 2.2866052518111246e-07
APC O 0 3.6437713788473047e-06
I1307K O 0 3.527632088662358e-06
polymorphism O 0 7.181008641055087e-07
. O 0 1.8295826009762095e-07

Germ O 0 0.12430404871702194
- O 0 2.876838379961555e-06
line O 0 4.920153173770814e-08
and O 0 3.5528713304699977e-10
somatic O 0 1.1218835638260316e-08
truncating O 0 2.276057209371629e-08
mutations O 0 2.060237758172434e-09
of O 0 5.810560921304386e-09
the O 0 4.0360355058055575e-09
APC B-Disease 0 4.802677366910757e-08
gene O 0 1.2176374575290083e-08
are O 0 2.0088260221928778e-10
thought O 0 7.001895729885632e-10
to O 0 5.771344166460857e-11
initiate O 0 1.0110123582762753e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 9.756242798175663e-05
formation O 0 0.0007915028254501522
in O 1 0.9696616530418396
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.004738273099064827
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 3.710269993462134e-07
respectively O 0 9.984779353544582e-06
. O 0 9.186794613924576e-07

Recently O 0 5.808846026411629e-07
, O 0 3.944895521357239e-09
an O 0 1.1169765112839514e-09
isoleucine O 0 2.353963054702035e-06
- O 0 1.398362087456917e-06
- O 0 4.29570064852669e-07
> O 0 5.843283545914346e-08
lysine O 0 4.829196598166163e-08
polymorphism O 0 3.261929393261198e-09
at O 0 1.479567846018881e-08
codon O 0 5.877641040541448e-09
1307 O 0 2.7778571620729053e-07
( O 0 2.655618502878099e-10
I1307K O 0 5.897337729265928e-09
) O 0 9.129368094829005e-11
of O 0 2.445128099992644e-09
the O 0 1.7861833123689053e-09
APC B-Disease 0 1.3979333246538772e-08
gene O 0 8.34746882727444e-10
has O 0 8.091164543921892e-11
been O 0 1.3223437102249935e-11
identified O 0 2.6138570474731893e-11
in O 0 1.0606747424812824e-10
6 O 0 7.085327435873978e-09
% O 0 3.586731467386528e-10
- O 0 3.633840561789725e-09
7 O 0 1.0379052284292811e-08
% O 0 4.491275962248409e-10
of O 0 2.0699548741731633e-09
the O 0 8.268603024497168e-10
Ashkenazi O 0 5.956937609852275e-09
Jewish O 0 6.963180032570904e-10
population O 0 4.836286579545934e-11
. O 0 1.3867212267371087e-08

To O 0 1.3344365612510956e-08
assess O 0 1.501557420624522e-07
the O 0 2.320659442389683e-09
risk O 0 2.4075919036192772e-09
of O 0 9.82585901532218e-10
this O 0 1.8161656206716614e-11
common O 0 3.4988567598759346e-10
APC B-Disease 0 4.494268956989345e-09
allelic O 0 2.7846757788552168e-08
variant O 0 3.2307431752087723e-07
in O 0 2.139402397460799e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999954700469971
, O 0 4.732324043743574e-08
we O 0 1.0763802071878104e-09
have O 0 1.607104380130231e-11
analyzed O 0 1.4002909942689712e-10
a O 0 2.0099822847785553e-11
large O 0 7.68079176649561e-12
cohort O 0 4.680933973766344e-10
of O 0 5.535111258225811e-10
unselected O 0 1.1723602710844716e-06
Ashkenazi O 0 2.7358202814298238e-08
Jewish O 0 1.8974624094170167e-09
subjects O 0 6.236107452650685e-08
with O 0 8.335648282731256e-10
adenomatous B-Disease 0 3.231183995922038e-07
polyps I-Disease 0 1.1036842550993242e-07
and O 0 1.2782915836950792e-09
. O 0 5.8376214973066e-09
or O 1 0.9999053478240967
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 3.2092324886434653e-07
for O 0 7.737648743955106e-09
the O 0 7.134693191801489e-08
APC O 0 8.293896485156438e-07
I1307K O 0 2.057238816632889e-06
polymorphism O 0 6.647956638516916e-07
. O 0 7.227392018194223e-08

The O 0 1.9886597613094636e-07
APC O 0 9.93138158378315e-08
I1307K O 0 5.686245430069903e-08
allele O 0 2.147155786502708e-09
was O 0 7.78055309069714e-09
identified O 0 3.547434013206896e-10
in O 0 2.3236038093621403e-10
48 O 0 5.406305181310245e-09
( O 0 1.2415431183132597e-10
10 O 0 4.77985373503742e-10
. O 0 1.7877085228823475e-11
1 O 0 4.333255976263217e-09
% O 0 7.993941619766076e-11
) O 0 3.7444988082446784e-11
of O 0 4.082847837594272e-09
476 O 0 1.896022183700552e-07
patients O 0 1.3492066841536143e-07
. O 0 2.376179111251986e-07

Compared O 0 2.60291610487684e-08
with O 0 8.847440835513254e-11
the O 0 1.676849770149147e-10
frequency O 0 1.4363422673469017e-09
in O 0 3.261876185822743e-11
two O 0 3.4793079875528043e-12
separate O 0 2.4680789096481748e-12
population O 0 8.108470898838746e-14
control O 0 3.5567496170507695e-10
groups O 0 8.499575175624496e-12
, O 0 3.4260868447821835e-11
the O 0 2.9917376909160964e-10
APC O 0 6.989929968170827e-09
I1307K O 0 1.6380509393343345e-08
allele O 0 1.168787622241041e-09
is O 0 8.825899733277964e-11
associated O 0 1.0786938703377658e-10
with O 0 2.4985725294301986e-12
an O 0 3.5849699944745517e-12
estimated O 0 2.5720032006959492e-11
relative O 0 1.4465539877051015e-08
risk O 0 1.0715690557105972e-08
of O 0 2.6789373919200443e-07
1 O 0 8.021526446100324e-05
. O 0 6.087333872528689e-07

5 O 0 4.5194978156359866e-05
- O 0 6.030164058756782e-06
1 O 0 9.114067324844655e-06
. O 0 2.6628495675140584e-07

7 O 0 4.46737467427738e-05
for O 0 9.128558303928003e-06
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.5879983901977539
( O 0 2.8573435884027276e-07
both O 0 6.36786694485636e-08
P O 0 2.9577844543382525e-05
= O 0 3.786129454397269e-08
. O 0 6.256140605565008e-10
01 O 0 6.028998456031331e-08
) O 0 7.78129471967759e-09
. O 0 6.710815370070122e-08

Furthermore O 0 6.966885166548309e-07
, O 0 4.951811849451815e-09
compared O 0 2.9492355224647326e-09
with O 0 4.894987193360123e-10
noncarriers O 0 3.3146204714284977e-07
, O 0 8.798759498773734e-10
APC O 0 6.6572680701426634e-09
I1307K O 0 1.9599520229007794e-08
carriers O 0 2.0285588486768091e-10
had O 0 2.5401871578401014e-11
increased O 0 2.0430597318099597e-12
numbers O 0 2.770725923001427e-12
of O 0 8.106864068935238e-10
adenomas B-Disease 0 0.00016846373910084367
and O 0 0.00013638910604640841
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
per O 0 2.42074911511736e-05
patient O 0 4.056778834637953e-06
( O 0 8.30817548092e-09
P O 0 1.4885274595144438e-06
= O 0 4.7569184147278065e-09
. O 0 6.365211135950233e-11
03 O 0 2.876523907957562e-09
) O 0 7.735988238888325e-11
, O 0 2.6994854268602708e-11
as O 0 3.0688465657569e-11
well O 0 1.4919958324366434e-10
as O 0 4.1575956566397565e-10
a O 0 2.6481590253979448e-09
younger O 0 1.574180963359595e-08
age O 0 2.0256172206245537e-07
at O 0 6.021120043442352e-06
diagnosis O 0 2.617715836095158e-05
. O 0 6.08835023285792e-07

We O 0 2.816634037117183e-07
conclude O 0 1.7360825665946322e-07
that O 0 2.1130278082814868e-10
the O 0 3.5060046532642275e-10
APC O 0 6.199423641106705e-09
I1307K O 0 3.203443199595313e-08
variant O 0 2.532759957318831e-08
leads O 0 4.549544740939382e-09
to O 0 6.174933342428801e-10
increased O 0 3.499313905308554e-08
adenoma B-Disease 1 1.0
formation O 0 4.953513780492358e-06
and O 0 1.0394564320392874e-08
directly O 0 2.649381825037267e-09
contributes O 0 1.5966436506253956e-10
to O 0 4.239530254634971e-11
3 O 0 1.071244160044671e-08
% O 0 4.701074529656069e-10
- O 0 6.898063231730589e-10
4 O 0 1.8635679666090255e-09
% O 0 7.36112074073425e-11
of O 0 3.745315169112473e-10
all O 0 5.420913717912867e-10
Ashkenazi O 0 5.7878551160683855e-06
Jewish O 0 6.483485776698217e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.2962538423598744e-05

The O 0 1.4437260276167763e-08
estimated O 0 2.285112321587235e-09
relative O 0 5.3010129619224244e-08
risk O 0 2.739134474794014e-09
for O 0 1.7876480851164445e-10
carriers O 0 1.9108775672904699e-10
may O 0 2.797801712528525e-10
justify O 0 1.8842327698109784e-10
specific O 0 6.00135956554948e-12
clinical O 0 1.0839531355832932e-10
screening O 0 4.1672474498932743e-11
for O 0 1.3582256847000096e-11
the O 0 5.4816106515032104e-11
360 O 0 1.5782627427185503e-09
, O 0 3.597054251680554e-11
000 O 0 5.213380838142712e-10
Americans O 0 3.458824546220818e-11
expected O 0 1.544857020085999e-10
to O 0 6.758539561335652e-11
harbor O 0 1.0178070830590968e-08
this O 0 4.737570145213477e-12
allele O 0 8.136508827805145e-11
, O 0 1.6072115860410463e-11
and O 0 5.057006896569405e-12
genetic O 0 4.5337140291978884e-11
testing O 0 3.542895143926472e-11
in O 0 3.5581863844225126e-11
the O 0 1.0425966340266157e-10
setting O 0 1.4236892775798538e-09
of O 0 1.3185553093819635e-08
long O 0 7.997000395221221e-09
- O 0 1.2024993445436394e-08
term O 0 2.652482677945045e-08
- O 0 6.60571286559275e-09
outcome O 0 6.33150731843557e-09
studies O 0 2.896701212229402e-10
may O 0 5.543539932650887e-11
impact O 0 1.6081815046309345e-10
significantly O 0 6.524571549704206e-09
on O 0 0.0035795727744698524
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.00031104375375434756
in O 0 1.6219943443918083e-10
this O 0 2.483644886974723e-11
population O 0 7.959401367163554e-12
. O 0 5.440223382890963e-09

Localization O 0 2.4109116566251032e-05
of O 0 7.737600071777706e-07
human O 0 5.6232689615853815e-08
BRCA1 O 0 1.0494089153212371e-08
and O 0 4.074226511718848e-10
its O 0 5.752035653339149e-11
loss O 0 5.710904638078773e-09
in O 0 3.0044111642979487e-09
high O 0 2.5056488084373996e-06
- O 0 7.01509605960382e-08
grade O 0 2.334731561859371e-06
, O 0 2.884314564965962e-09
non B-Disease 0 0.164415642619133
- I-Disease 1 0.9999843835830688
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 1 0.9928683638572693

Although O 0 7.508876187500846e-09
the O 0 3.6674439041206597e-09
link O 0 2.434639689852247e-08
between O 0 1.8577416938114766e-08
the O 0 8.393037376208667e-09
BRCA1 O 0 5.139123615549579e-08
tumour B-Disease 1 0.9999996423721313
- O 0 1.3357041552808369e-06
suppressor O 0 3.721350765317766e-07
gene O 0 1.0922541093805194e-07
and O 0 8.397492479161883e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.967250645160675
established O 0 5.0400785767124034e-06
, O 0 5.460294438819346e-10
the O 0 1.0360771129924728e-09
role O 0 1.57211044182759e-08
, O 0 9.9060558367281e-11
if O 0 1.6956186454919475e-11
any O 0 2.464984640015988e-11
, O 0 9.061895331341496e-12
of O 0 5.422837179303031e-10
BRCA1 O 0 1.5563151878339454e-09
in O 0 1.8914615651510758e-08
non B-Disease 1 0.9999914169311523
- I-Disease 1 0.9999986886978149
familial I-Disease 1 0.9999926090240479
cancers I-Disease 1 0.9999997615814209
is O 0 2.1086098911382578e-07
unclear O 0 4.194513167021796e-06
. O 0 2.4704581846890505e-07

BRCA1 O 0 9.881056030280888e-06
mutations O 0 6.295839938275094e-08
are O 0 2.860350012401369e-10
rare O 0 1.9088131075761794e-09
in O 0 4.894651350895174e-10
sporadic B-Disease 0 1.9584145775297657e-05
cancers I-Disease 0 0.0134736942127347
, O 0 3.0934854677866497e-09
but O 0 1.1109592135127855e-09
loss O 0 6.08009855795899e-08
of O 0 1.0497361699890462e-06
BRCA1 O 0 6.0287317360518955e-09
resulting O 0 2.6016588883237546e-09
from O 0 6.449735190372508e-10
reduced O 0 1.0035282604903273e-09
expression O 0 2.7677868330577837e-10
or O 0 6.279413100607201e-11
incorrect O 0 5.051402074407463e-10
subcellular O 0 2.254806652501884e-08
localization O 0 8.54970352293094e-08
is O 0 1.121454595853777e-10
postulated O 0 8.75959360602252e-10
to O 0 1.3467693106561374e-11
be O 0 5.2043746916197176e-12
important O 0 1.9239106835433617e-11
in O 0 1.1328833010582073e-10
non B-Disease 0 0.000168183512869291
- I-Disease 1 0.9933158755302429
familial I-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999994039535522

Epigenetic O 0 0.003113064682111144
loss O 0 0.0001469935232307762
, O 0 6.071442015809225e-08
however O 0 4.080161986053099e-09
, O 0 2.926450470841502e-10
has O 0 8.414631838538078e-12
not O 0 7.138840842253746e-13
received O 0 4.423639839851168e-12
general O 0 7.327850132243796e-11
acceptance O 0 1.7262617724167484e-10
due O 0 1.4200715048318102e-09
to O 0 8.803069384555329e-11
controversy O 0 2.3193086340356217e-10
regarding O 0 6.416899234196194e-10
the O 0 2.0174655002147546e-10
subcellular O 0 3.658237801573705e-08
localization O 0 7.015215715000522e-07
of O 0 1.0513224424357759e-07
BRCA1 O 0 3.883209309663016e-09
proteins O 0 6.731462054432313e-10
, O 0 1.0057812221964113e-10
reports O 0 1.2356771161847746e-10
of O 0 9.978653459086217e-10
which O 0 2.654781429412001e-11
have O 0 2.8509692870382075e-11
ranged O 0 6.299513355401132e-09
from O 0 5.931399815750638e-11
exclusively O 0 5.175612716179501e-10
nuclear O 0 4.373496409471045e-08
, O 0 2.5151174545823274e-11
to O 0 2.284469488578189e-11
conditionally O 0 3.547133076153841e-08
nuclear O 0 2.71196910262006e-07
, O 0 7.443701210974041e-11
to O 0 4.351597554519415e-11
the O 0 1.777171187988813e-09
ER O 0 2.9294690193637507e-06
/ O 0 2.0548316115309717e-07
golgi O 0 1.84883572273975e-06
, O 0 1.3379783947442547e-09
to O 0 6.960325649174592e-10
cytoplasmic O 0 4.445462309377035e-08
invaginations O 0 9.679988579591736e-07
into O 0 1.5519407980946198e-08
the O 0 1.3602602599860347e-08
nucleus O 0 6.189785608512466e-07
. O 0 5.544499117604573e-07

In O 0 1.3195595727211185e-07
an O 0 3.6919240997690395e-09
attempt O 0 2.865873938162622e-08
to O 0 1.8329902040647994e-09
resolve O 0 2.1281130102579482e-07
this O 0 1.466725629839516e-10
issue O 0 3.384748037404961e-09
, O 0 9.860625510560439e-11
we O 0 8.720014293972511e-11
have O 0 1.097656947973702e-11
comprehensively O 0 4.033726686003547e-09
characterized O 0 2.308708335618803e-09
19 O 0 5.841098982273252e-08
anti O 0 1.106881882151356e-06
- O 0 1.4383465440914733e-06
BRCA1 O 0 4.180293444733252e-08
antibodies O 0 6.574565336592286e-09
. O 0 2.22234930902232e-07

These O 0 4.061194047721983e-09
reagents O 0 2.742936544564145e-08
detect O 0 9.561197344964967e-08
a O 0 1.2763725187880937e-08
220 O 0 3.0630499026074176e-08
- O 0 2.675377785976707e-08
kD O 0 6.73605242695885e-08
protein O 0 8.207468482623881e-09
localized O 0 7.592999118344324e-09
in O 0 8.330148792978775e-10
discrete O 0 5.8968232963252376e-08
nuclear O 0 7.531089067924768e-07
foci O 0 2.246398054239762e-07
in O 0 2.5341440057502496e-10
all O 0 6.863570128912144e-11
epithelial O 0 2.2743300576166803e-08
cell O 0 4.3184934384044027e-07
lines O 0 7.117618494589806e-09
, O 0 2.1255008170184553e-11
including O 0 2.203141098375272e-12
those O 0 1.028248493295525e-11
derived O 0 9.171399750762532e-10
from O 0 4.9378748201434064e-08
breast B-Disease 0 0.005807830020785332
malignancies I-Disease 0 0.0028224384877830744
. O 0 1.0864631803997327e-05

Immunohistochemical O 0 1.875477323665109e-06
staining O 0 8.568932798880269e-07
of O 0 1.1217828159715282e-06
human O 0 2.850854627922672e-07
breast O 0 7.635021574969869e-07
specimens O 0 5.414034554007685e-09
also O 0 1.16358478408074e-09
revealed O 0 4.347443791630212e-07
BRCA1 O 0 3.2824181062096613e-07
nuclear O 0 4.115549472771818e-06
foci O 0 3.877796643791953e-06
in O 0 3.3627662876511977e-09
benign O 0 0.11318176984786987
breast O 1 0.9240617156028748
, O 0 3.282762577327958e-07
invasive B-Disease 1 0.9999983310699463
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.0010291105136275291
low B-Disease 1 1.0
- I-Disease 1 0.999998927116394
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.010967197827994823

Conversely O 0 1.441705649085634e-06
, O 0 3.711008744744504e-08
BRCA1 O 0 1.3329458425914709e-08
expression O 0 4.993258251317911e-09
was O 0 3.446258389772083e-08
reduced O 0 4.7252681767417926e-09
or O 0 1.8860091266503787e-10
undetectable O 0 4.922938501294993e-09
in O 0 5.014747297971134e-11
the O 0 6.252200840384248e-11
majority O 0 3.113204485871712e-11
of O 0 9.331375672161357e-09
high O 0 2.975941924887593e-06
- O 0 1.704862881979352e-07
grade O 0 2.5675044525996782e-05
, O 0 9.167595038661602e-08
ductal B-Disease 1 0.9999988079071045
carcinomas I-Disease 1 1.0
, O 0 1.1225689888760826e-07
suggesting O 0 7.067861407250575e-09
that O 0 5.38305580666254e-11
absence O 0 3.1848372827880667e-08
of O 0 3.3692398915263766e-07
BRCA1 O 0 4.157504562840586e-08
may O 0 1.2750238642667e-09
contribute O 0 1.4145776217056039e-10
to O 0 5.396584915051683e-11
the O 0 2.2465451721132013e-10
pathogenesis O 0 1.1470037861727178e-06
of O 0 9.746573326196994e-09
a O 0 3.128050873879573e-10
significant O 0 4.0824407743222935e-10
percentage O 0 1.1968475099877196e-08
of O 0 1.0601240774121834e-07
sporadic B-Disease 1 0.9991466999053955
breast I-Disease 1 0.9999847412109375
cancers I-Disease 1 0.9999375343322754
. O 0 4.83543601603742e-07
. O 0 3.7301381325960392e-06

